,median,median_perc,mean,std,min,max,over_threshold,names
hsa:347411,0.0,0.0,4.148270717821782e-09,1.977485119157311e-08,0.0,1.7418515e-07,False,MPC1L; mitochondrial pyruvate carrier 1
hsa:8907,5.77965385e-09,7.160859261523507e-06,1.2943179223726738e-06,2.7733212914038005e-06,0.0,2.011896e-05,False,AP1M1; adaptor related protein complex 1 subunit mu
hsa:5810,3.06726855e-09,3.800275755934289e-06,5.115045317997523e-06,1.7131414382236602e-05,0.0,0.00013230485,False,RAD1; RAD1 checkpoint DNA
hsa:7358,1.43381185e-05,0.017764601707686442,0.00015398189726475894,0.00027792913372415247,0.0,0.0016421132,False,UGDH; UDP-glucose
hsa:406910,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR125A; microRNA
hsa:55304,0.0,0.0,5.25416735995792e-06,1.7018575606644175e-05,0.0,0.000115432085,False,SPTLC3; serine palmitoyltransferase long chain base subunit
hsa:5528,0.0,0.0,1.891472467381683e-05,4.3767291034464184e-05,0.0,0.00033047862,False,PPP2R5D; protein phosphatase 2 regulatory subunit
hsa:2767,0.0,0.0,0.0004249052330603959,0.0006983662568679193,0.0,0.004764327,False,GNA11; G protein subunit alpha
hsa:727,6.0211185e-06,0.007460028454031986,3.4712828379504954e-05,5.4414529370895804e-05,0.0,0.00023713504,False,C5; complement
hsa:10999,1.78691715e-05,0.022139495816263614,0.0002316849705722773,0.00040552242388683477,0.0,0.0029261848,False,SLC27A4; solute carrier family 27 member
hsa:7469,0.0,0.0,4.302761206347969e-05,0.0001334068708103729,0.0,0.0009959246,False,NELFA; negative elongation factor complex member
hsa:5279,1.6693421399999999e-07,0.00020682768266252604,2.8906966958554454e-05,6.504143988595895e-05,0.0,0.000550162,False,PIGC; phosphatidylinositol glycan anchor biosynthesis class
hsa:100133941,0.00022640644,0.28051241386066156,0.0006418713343737622,0.001153435056165306,0.0,0.0072389017,False,CD24; CD24
hsa:302,0.0,0.0,4.5789634548861383e-07,2.369703379265298e-06,0.0,2.6160676e-05,False,ANXA2; annexin
hsa:5948,0.0,0.0,1.3859736422277235e-05,3.802231537126449e-05,0.0,0.00029733934,False,RBP2; retinol binding protein
hsa:2691,0.0,0.0,3.927529553534654e-06,2.9615009740367103e-05,0.0,0.00040647606,False,GHRH; growth hormone releasing
hsa:390154,0.0,0.0,1.1194566336633663e-09,1.5910468165327168e-08,-0.0,2.2613024e-07,False,OR5T3; olfactory receptor family 5 subfamily T member
hsa:25942,1.6755559e-06,0.002075975533502816,7.751456852722771e-05,0.00023891606814572516,0.0,0.0016306458,False,SIN3A; SIN3 transcription regulator family member
hsa:6550,0.0,0.0,3.3851397786138615e-05,0.00015988413156511457,0.0,0.0017881197,False,SLC9A3; solute carrier family 9 member
hsa:391112,0.0,0.0,2.623094925742574e-08,3.091658006032203e-07,0.0,4.343878e-06,False,OR6Y1; olfactory receptor family 6 subfamily Y member
hsa:6249,0.0,0.0,5.620483483049503e-07,9.584035225319124e-07,0.0,6.626233e-06,False,CLIP1; CAP-Gly domain containing linker protein
hsa:390748,0.0,0.0,7.13674097152475e-08,3.7359501638038273e-07,0.0,4.1066087e-06,False,PABPN1L; PABPN1 like
hsa:221955,5.14484015e-07,0.0006374339570039387,7.291164688966831e-06,1.616095887289151e-05,0.0,8.308723e-05,False,DAGLB; diacylglycerol lipase
hsa:51209,6.9196875e-08,8.573334944829514e-05,1.5851526935693075e-06,6.942857005755742e-06,0.0,6.615806e-05,False,RAB9B; RAB9B
hsa:134864,0.0,0.0,6.126507023762377e-08,5.090196589006155e-07,-0.0,6.442609e-06,False,TAAR1; trace amine associated receptor
hsa:2660,0.0,0.0,5.585663375128712e-06,1.8408318261129094e-05,0.0,0.0001278433,False,MSTN;
hsa:23057,3.3844649e-06,0.004193274796978755,9.618228424579699e-05,0.0001469221270704888,0.0,0.0006739559,False,NMNAT2; nicotinamide nucleotide adenylyltransferase
hsa:4726,0.0,0.0,5.752561691138615e-06,1.0460669003269518e-05,0.0,6.8257796e-05,False,NDUFS6; NADH:ubiquinone oxidoreductase subunit
hsa:808,0.0,0.0,0.0007261878220544554,0.0018561073742963047,0.0,0.017670633,False,CALM3; calmodulin
hsa:1138,2.596965385e-08,3.217580864126181e-05,3.4917590330847287e-05,7.200469856539961e-05,0.0,0.00044343885,False,CHRNA5; cholinergic receptor nicotinic alpha 5
hsa:64750,2.9691872499999998e-05,0.0367875526288828,0.0001446252388668317,0.0002433681086143547,0.0,0.0014215499,False,SMURF2; SMAD specific E3 ubiquitin protein ligase
hsa:219437,0.0,0.0,4.5952436757425746e-07,6.202052549798159e-06,-0.0,8.810872e-05,False,OR5L1; olfactory receptor family 5 subfamily L member
hsa:29990,0.000121587015,0.15064353766510558,0.0015336971304938118,0.002911959404391028,0.0,0.017240683,False,PILRB; paired immunoglobin like type 2 receptor
hsa:6091,7.872669200000001e-08,9.754057529540607e-05,7.025463888297029e-07,1.8450401762414617e-06,0.0,1.7070632e-05,False,ROBO1; roundabout guidance receptor
hsa:3183,0.0,0.0,1.486006526534654e-07,2.7301957683560636e-07,0.0,1.6539609e-06,False,HNRNPC; heterogeneous nuclear ribonucleoprotein
hsa:5437,0.0,0.0,4.037532561059405e-05,0.00010146772279157026,0.0,0.0006573968,False,POLR2H; RNA polymerase II
hsa:135250,0.0,0.0,4.517435200193069e-07,2.69793300528875e-06,0.0,2.8278908e-05,False,RAET1E; retinoic acid early transcript
hsa:5833,1.83270235e-06,0.002270676399870106,0.0003738068211582178,0.0008006994513155045,0.0,0.0042231088,False,PCYT2; phosphate cytidylyltransferase 2
hsa:51103,0.0,0.0,4.0145017399123764e-07,2.0492531194045e-06,0.0,1.772634e-05,False,NDUFAF1; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:89953,0.0,0.0,5.046244781831682e-07,1.0815354996398776e-06,0.0,5.9421654e-06,False,KLC4; kinesin light chain
hsa:2218,0.0,0.0,3.2697785470297036e-05,6.516914268382855e-05,0.0,0.0003548325,False,FKTN;
hsa:10681,3.1655449e-05,0.03922037911480374,0.00026246412519801977,0.0004350761923701775,0.0,0.0031217462,False,GNB5; G protein subunit beta
hsa:23463,2.8284541499999996e-07,0.00035043901627122696,2.313401919227227e-05,5.6672411797500466e-05,0.0,0.00033178288,False,ICMT; isoprenylcysteine carboxyl
hsa:661,2.7061738499999996e-07,0.00033528876607489606,0.00015157214021831677,0.000307871472027114,0.0,0.0020745469,False,POLR3D; RNA polymerase III subunit
hsa:6898,4.49250935e-07,0.0005566116591295247,1.3209275240627228e-05,7.129942412892416e-05,0.0,0.0008348994,False,TAT; tyrosine
hsa:348327,1.9605115e-08,2.429029020846697e-05,7.715592414059406e-08,1.6184557690278953e-07,0.0,1.0135689e-06,False,ZNF530; zinc finger protein
hsa:10239,1.2597563500000002e-07,0.0001560809377219113,2.027150952017822e-06,4.518830816155477e-06,0.0,4.5996676e-05,False,AP3S2; adaptor related protein complex 3 subunit sigma
hsa:4759,0.0,0.0,2.9312453514851487e-08,2.9256419851337296e-07,-0.0,3.283483e-06,False,NEU2; neuraminidase
hsa:1789,8.4009455e-08,0.00010408579812998528,0.0001435025829939901,0.00047583775627345744,0.0,0.0032327438,False,DNMT3B; DNA methyltransferase 3
hsa:1938,3.32587015e-06,0.004120677238525638,1.7636450107123772e-05,2.6088285726792864e-05,0.0,0.00014681475,False,EEF2; eukaryotic translation elongation factor
hsa:84455,1.4605246e-05,0.018095566585865544,0.00010231894589562872,0.00026681812404616645,0.0,0.0021611655,False,EFCAB7; EF-hand calcium binding domain
hsa:57172,3.4202793e-07,0.0004237648021499097,6.9799667322326724e-06,2.263383075873907e-05,0.0,0.00024477555,False,CAMK1G; calcium/calmodulin dependent protein kinase
hsa:7919,0.0,0.0,5.277234857326731e-07,9.329013057542244e-07,0.0,4.397027e-06,False,DDX39B; DExD-box helicase
hsa:57493,0.0,0.0,1.1001295535228717e-05,9.094870507038468e-05,0.0,0.0012249335,False,HEG1; heart development protein with EGF like domains
hsa:5805,3.5852294000000003e-07,0.000444201743218175,1.6868250383148515e-05,4.134262324894414e-05,0.0,0.00023111969,False,PTS; 6-pyruvoyltetrahydropterin
hsa:10423,1.3554886500000001e-05,0.0167941951285586,0.00011482839474100496,0.00031996752443405103,0.0,0.0023082464,False,CDIPT; CDP-diacylglycerol--inositol
hsa:720,0.0,0.0,6.50718546290099e-05,0.00017513820920692243,0.0,0.0011450079,False,C4A; complement C4A (Rodgers blood
hsa:79158,0.0,0.0,4.613431691529704e-07,1.4890843238938705e-06,0.0,1.3998038e-05,False,GNPTAB; N-acetylglucosamine-1-phosphate transferase subunits alpha and
hsa:27085,2.7940907e-08,3.4618146321395524e-05,1.567309863146396e-07,3.0035928503987484e-07,0.0,1.5538895e-06,False,MTBP; MDM2 binding
hsa:54576,0.0,0.0,6.913889565069309e-06,4.1733618393117687e-05,0.0,0.00045896973,False,UGT1A8; UDP glucuronosyltransferase family 1 member
hsa:26531,0.0,0.0,1.1833849104950495e-06,1.243034528590757e-05,-0.0,0.00016813274,False,OR11A1; olfactory receptor family 11 subfamily A member
hsa:26986,3.54707495e-07,0.0004394744939097958,2.626177187366337e-06,6.533093683376389e-06,0.0,6.0710983e-05,False,PABPC1; poly(A) binding protein cytoplasmic
hsa:9423,1.5439027000000002e-08,1.912860222275448e-05,4.677993829902969e-06,2.4017952252839573e-05,0.0,0.00025528003,False,NTN1; netrin
hsa:60436,1.82241245e-08,2.257927448526739e-05,4.117026253620523e-05,9.926369461102027e-05,0.0,0.00079022534,False,TGIF2; TGFB induced factor homeobox
hsa:411,1.77015295e-06,0.0021931791202894715,4.080114258252477e-05,7.535453475068671e-05,0.0,0.00043615184,False,ARSB; arylsulfatase
hsa:1456,0.0,0.0,1.6264621041089105e-05,3.2978515621760934e-05,0.0,0.00022723993,False,CSNK1G3; casein kinase 1 gamma
hsa:4092,5.176393e-08,6.413432831333913e-05,3.106928230376239e-05,0.00019571407262857602,0.0,0.0018544651,False,SMAD7; SMAD family member
hsa:962,2.06560025e-07,0.00025592315845727976,6.299283322029706e-06,1.5255619699474318e-05,0.0,0.00012710622,False,CD48; CD48
hsa:8526,0.0,0.0,9.347165207128714e-05,0.0001948298771331799,0.0,0.0011833321,False,DGKE; diacylglycerol kinase
hsa:54626,1.13341245e-09,1.4042721675639016e-06,6.671171023267329e-09,1.784712902468533e-08,0.0,1.816103e-07,False,HES2; hes family bHLH transcription factor
hsa:26497,0.0,0.0,6.912596192821781e-07,6.758309870890752e-06,0.0,9.039329e-05,False,OR10D3; olfactory receptor family 10 subfamily D member
hsa:8440,0.0,0.0,1.701979109335149e-05,5.8421273623715566e-05,0.0,0.0005939009,False,NCK2; NCK adaptor protein
hsa:84920,0.0,0.0,2.3347081952279214e-05,5.114970620617143e-05,0.0,0.00033364168,False,ALG10; ALG10
hsa:9973,2.9635112e-09,3.671722766433259e-06,3.3489125188316825e-08,6.745514606087993e-08,0.0,5.4543676e-07,False,CCS; copper chaperone for superoxide
hsa:7010,0.0,0.0,9.016975198920792e-06,2.1762487860899786e-05,0.0,0.00014330828,False,TEK; TEK receptor tyrosine
hsa:5573,0.0,0.0,2.2600976622871285e-06,1.6463458503799575e-05,0.0,0.0002158861,False,PRKAR1A; protein kinase cAMP-dependent type I regulatory subunit
hsa:81537,0.0,0.0,4.994120886737625e-06,1.6038157132686604e-05,0.0,0.000120483135,False,SGPP1; sphingosine-1-phosphate phosphatase
hsa:55024,4.1922480999999994e-08,5.19409975278871e-05,1.02780940280297e-06,2.780090155950356e-06,0.0,2.2376566e-05,False,BANK1; B cell scaffold protein with ankyrin repeats
hsa:605,0.0,0.0,3.024056809961386e-06,9.912803457375605e-06,0.0,5.8112182e-05,False,BCL7A; BAF chromatin remodeling complex subunit
hsa:841,0.0,0.0,7.961903157752476e-05,0.00029092046735998455,0.0,0.0018599832,False,CASP8; caspase
hsa:57154,1.8231556000000003e-05,0.022588481944223093,8.277494540099008e-05,0.00014522368563989926,0.0,0.0008600657,False,SMURF1; SMAD specific E3 ubiquitin protein ligase
hsa:11285,2.995343e-05,0.03711161640413743,0.0009024332487760396,0.0026982789921152577,0.0,0.017281758,False,B4GALT7; beta-1
hsa:6793,0.0,0.0,1.5269699838811877e-05,7.066899689774946e-05,0.0,0.00069902104,False,STK10; serine/threonine kinase
hsa:10746,0.0,0.0,1.2016929136732676e-05,4.587193696015086e-05,0.0,0.00047614588,False,MAP3K2; mitogen-activated protein kinase kinase kinase
hsa:3883,0.0,0.0,6.35409004950495e-09,5.3840043000786075e-08,0.0,6.8607227e-07,False,KRT33A; keratin
hsa:4669,9.151763e-06,0.011338825566139769,6.801976226287127e-05,0.0001571211014662565,0.0,0.0011395018,False,NAGLU;
hsa:100130933,9.248968999999999e-09,1.1459261582455115e-05,4.4147248822207914e-07,1.7046922384094728e-06,0.0,1.33715785e-05,False,SMIM6; small integral membrane protein
hsa:3640,0.0,0.0,2.8586583033579217e-06,9.834863897877327e-06,0.0,8.7876186e-05,False,INSL3; insulin like
hsa:712,1.19849045e-05,0.014849023248563535,0.00014899452580792092,0.0002619983377637508,0.0,0.0015569356,False,C1QA; complement C1q A
hsa:27115,0.0,0.0,4.1281664607871295e-06,4.471797790076611e-05,0.0,0.00062864984,False,PDE7B; phosphodiesterase
hsa:2940,0.0,0.0,2.542364613861386e-07,2.1946563493704984e-06,0.0,2.6051948e-05,False,GSTA3; glutathione S-transferase alpha
hsa:5010,0.0,0.0,7.497312068361383e-06,3.8898327601030483e-05,0.0,0.00035214607,False,CLDN11; claudin
hsa:80704,1.93603855e-06,0.002398707594129368,7.52412136176238e-05,0.00014189781505947113,0.0,0.0006683463,False,SLC19A3; solute carrier family 19 member
hsa:9140,1.72566255e-05,0.021380565297058007,0.00027065117433435653,0.0005186648931028531,0.0,0.003604015,False,ATG12; autophagy related
hsa:6122,0.0,0.0,6.416035499465347e-07,1.3082617685693606e-06,0.0,6.2548515e-06,False,RPL3; ribosomal protein
hsa:30,1.4959927e-05,0.018535008253074803,0.00018596078515237634,0.00040982994236636215,0.0,0.0023120863,False,ACAA1; acetyl-CoA acyltransferase
hsa:5467,5.25402495e-06,0.006509617046267066,4.478328024636635e-05,0.000126409463928889,0.0,0.0012212995,False,PPARD; peroxisome proliferator activated receptor
hsa:26053,8.2269893e-08,0.0001019305204988354,1.2229958367922772e-05,7.792740507480813e-05,0.0,0.0007564926,False,AUTS2; activator of transcription and developmental regulator
hsa:4824,1.29028625e-08,1.5986352268015037e-05,1.3856295389960393e-06,1.332437102510298e-05,0.0,0.00014426843,False,NKX3-1; NK3 homeobox
hsa:10673,0.0,0.0,2.034437862547525e-05,0.00013022657639566386,0.0,0.0012412939,False,TNFSF13B; TNF superfamily member
hsa:23127,0.0,0.0,1.2715625673554456e-05,4.516749640203615e-05,0.0,0.00038829533,False,COLGALT2; collagen beta(1-O)galactosyltransferase
hsa:1175,0.0,0.0,5.626367149722771e-05,0.0002534062839760798,0.0,0.0023003998,False,AP2S1; adaptor related protein complex 2 subunit sigma
hsa:51385,0.0,0.0,1.2273777020594059e-07,2.844044362396892e-07,0.0,1.5720938e-06,False,ZNF589; zinc finger protein
hsa:1967,0.0,0.0,4.001120225049504e-08,1.1746873388204964e-07,0.0,9.95428e-07,False,EIF2B1; eukaryotic translation initiation factor 2B subunit
hsa:134111,0.0,0.0,2.0550338826485157e-07,4.619907940349538e-07,0.0,3.1188486e-06,False,UBE2QL1; ubiquitin conjugating enzyme E2 Q family like
hsa:57801,0.0,0.0,2.9758509047871283e-07,8.393368524347265e-07,0.0,5.2819573e-06,False,HES4; hes family bHLH transcription factor
hsa:114879,0.0,0.0,7.024512401950495e-05,0.00018009529030401993,0.0,0.0010282118,False,OSBPL5; oxysterol binding protein like
hsa:2994,0.0,0.0,1.212531948773268e-06,5.138280562845781e-06,0.0,5.9129023e-05,False,GYPB; glycophorin B (MNS blood
hsa:9992,0.0,0.0,2.766144706795545e-06,9.37222839525219e-06,0.0,8.255996e-05,False,KCNE2; potassium voltage-gated channel subfamily E regulatory subunit
hsa:92421,0.0,0.0,9.401226195255445e-07,8.106696555480208e-06,0.0,0.000103003455,False,CHMP4C; charged multivesicular body protein
hsa:326,0.0,0.0,1.231065459789901e-05,4.7871965203990256e-05,0.0,0.00042462302,False,AIRE; autoimmune
hsa:3164,0.0,0.0,0.00011222393288960396,0.0004172988344577564,0.0,0.0031152137,False,NR4A1; nuclear receptor subfamily 4 group A member
hsa:285659,0.0,0.0,1.714024797029703e-07,2.126098624113561e-06,-0.0,2.9969495e-05,False,OR2V2; olfactory receptor family 2 subfamily V member
hsa:4524,0.0,0.0,6.582945541445544e-05,0.0002001600354704576,0.0,0.0013506003,False,MTHFR; methylenetetrahydrofolate
hsa:6494,4.3684051e-07,0.0005412354256894038,9.10971815692574e-06,2.244041740692107e-05,0.0,0.00018629599,False,SIPA1; signal-induced proliferation-associated
hsa:23067,4.53260575e-08,5.615795116124852e-05,1.7476405218767327e-05,6.244354225893056e-05,0.0,0.0005232402,False,SETD1B; SET domain containing 1B
hsa:9101,2.5207911e-06,0.003123202662872454,1.3455670614930697e-05,2.9850710043020715e-05,0.0,0.00019371534,False,USP8; ubiquitin specific peptidase
hsa:8813,0.0,0.0,9.347586922255943e-05,0.00024272155101133288,0.0,0.0013209818,False,DPM1; dolichyl-phosphate mannosyltransferase subunit 1
hsa:1730,1.31610245e-08,1.6306209096235544e-05,1.2121128935495048e-07,3.096463858479358e-07,0.0,2.6513364e-06,False,DIAPH2; diaphanous related formin
hsa:58511,3.0724834e-09,3.806736836111255e-06,1.5854766060257934e-05,5.9436888550108265e-05,0.0,0.0005142607,False,DNASE2B; deoxyribonuclease 2
hsa:390197,0.0,0.0,3.4493549158415844e-08,3.3180873931394454e-07,-0.0,3.4323286e-06,False,OR4D10; olfactory receptor family 4 subfamily D member
hsa:100132074,0.0,0.0,1.734116247418812e-05,7.891406511107747e-05,0.0,0.00084495294,False,FOXO6; forkhead box
hsa:146909,3.0924395e-11,3.831461988727252e-08,7.279323450178218e-08,1.7258602777490865e-07,0.0,1.2537423e-06,False,KIF18B; kinesin family member
hsa:567,0.0,0.0,1.6626105739490097e-05,5.770705088023938e-05,0.0,0.00041587878,False,B2M;
hsa:129807,1.46495965e-07,0.00018150515843540931,3.372985968435643e-05,8.522520440462918e-05,0.0,0.0006199354,False,NEU4; neuraminidase
hsa:2048,1.55060675e-07,0.00019211663872773912,2.7933254940346525e-06,2.164940591337639e-05,0.0,0.00029432648,False,EPHB2; EPH receptor
hsa:581,0.0,0.0,0.00038822417915841575,0.0006098437283097637,0.0,0.0035738505,False,BAX; BCL2 associated X
hsa:4326,1.1314988e-06,0.0014019011988724436,2.6057814578821782e-05,8.793931070483111e-05,0.0,0.0010373546,False,MMP17; matrix metallopeptidase
hsa:29101,0.0,0.0,6.28049609464557e-07,1.6802466165869347e-06,0.0,8.900726e-06,False,SSU72; SSU72 homolog
hsa:5019,0.0,0.0,6.065387466574257e-05,0.00013981585114179732,0.0,0.00068899133,False,OXCT1; 3-oxoacid CoA-transferase
hsa:4157,1.05264935e-06,0.0013042085292156724,4.855605355504949e-05,0.00017084592544162644,0.0,0.0017213965,False,MC1R; melanocortin 1
hsa:653,0.0,0.0,8.025835502062379e-06,4.931877228122665e-05,0.0,0.0006268901,False,BMP5; bone morphogenetic protein
hsa:6139,4.4083198e-07,0.0005461807659568999,1.0959680134554455e-06,2.04370261488479e-06,0.0,1.35496175e-05,False,RPL17; ribosomal protein
hsa:22985,0.0,0.0,3.074720870470298e-07,5.891895548581852e-07,0.0,2.7352185e-06,False,ACIN1; apoptotic chromatin condensation inducer
hsa:11041,0.0,0.0,9.721689173118816e-05,0.00024653267053197813,0.0,0.0013929391,False,B4GAT1; beta-1
hsa:54567,0.0,0.0,9.37109940638614e-05,0.0003655417526068899,0.0,0.0040466175,False,DLL4; delta like canonical Notch ligand
hsa:7270,5.2938695e-06,0.006558983534692448,0.00010721754421664854,0.00026061063058344016,0.0,0.0014588444,False,TTF1; transcription termination factor
hsa:79724,0.0,0.0,8.056140424242571e-08,1.8059131404149295e-07,0.0,1.1086653e-06,False,ZNF768; zinc finger protein
hsa:390078,0.0,0.0,5.870516353069307e-07,6.045985258160437e-06,0.0,8.5704516e-05,False,OR52E6; olfactory receptor family 52 subfamily E member
hsa:51073,1.3869868e-08,1.7184450020983267e-05,1.8565356742524746e-07,4.4602752918258654e-07,0.0,2.6418127e-06,False,MRPL4; mitochondrial ribosomal protein
hsa:51292,0.0,0.0,8.688381507293566e-07,2.7028255616165816e-06,0.0,1.3685201e-05,False,GMPR2; guanosine monophosphate reductase
hsa:10610,0.0,0.0,4.347043115059407e-05,0.0002580077391881906,0.0,0.0034773275,False,ST6GALNAC2; ST6 N-acetylgalactosaminide alpha-2
hsa:57132,6.40431e-09,7.93479398029479e-06,5.08069713049406e-06,3.081220190046849e-05,0.0,0.00043460084,False,CHMP1B; charged multivesicular body protein
hsa:9545,7.2433835e-07,0.000897438690393916,1.045722646336633e-05,3.696214354320622e-05,0.0,0.00034009406,False,RAB3D; RAB3D
hsa:4642,0.0,0.0,5.72568105029703e-07,1.1840790553080491e-06,0.0,9.241392e-06,False,MYO1D; myosin
hsa:79324,0.0,0.0,1.3152809029702973e-07,1.7758935187353195e-06,-0.0,2.5229006e-05,False,OR51G1; olfactory receptor family 51 subfamily G member
hsa:118788,0.0,0.0,3.9595116653841585e-06,9.340715223433312e-06,0.0,6.387643e-05,False,PIK3AP1; phosphoinositide-3-kinase adaptor protein
hsa:81300,0.0,0.0,1.4020666831683168e-08,1.9927111651672465e-07,0.0,2.8321747e-06,False,OR4P4; olfactory receptor family 4 subfamily P member
hsa:991,2.19063145e-06,0.0027141423888763115,3.119216727060742e-05,0.0001052790089716616,0.0,0.0010041661,False,CDC20; cell division cycle
hsa:8569,0.0,0.0,6.494897291539605e-06,1.9585554796739724e-05,0.0,0.00013024142,False,MKNK1; MAPK interacting serine/threonine kinase
hsa:28987,1.10171567e-07,0.00013650005802830347,1.5914483373864347e-06,2.8918439003477257e-06,0.0,1.5455236e-05,False,NOB1; NIN1 (RPN12) binding protein 1
hsa:5743,0.0,0.0,0.0003033440324968316,0.0010337979526152748,0.0,0.0075688274,False,PTGS2; prostaglandin-endoperoxide synthase
hsa:7327,2.2020465e-08,2.728285375400193e-05,9.473111078663366e-07,1.8910582750928633e-06,0.0,1.1192122e-05,False,UBE2G2; ubiquitin conjugating enzyme E2
hsa:10465,0.0,0.0,6.578456728465348e-07,1.929000411369756e-06,0.0,1.14243985e-05,False,PPIH; peptidylprolyl isomerase
hsa:79443,0.0,0.0,9.606309286113862e-08,2.2400392211098623e-07,0.0,1.3041721e-06,False,FYCO1; FYVE and coiled-coil domain autophagy adaptor
hsa:51119,0.0,0.0,1.4852939456502472e-06,3.70813791676644e-06,0.0,2.4452773e-05,False,SBDS; SBDS ribosome maturation
hsa:7291,3.3623625e-08,4.1658904276290404e-05,2.959712296595049e-07,7.336282103662811e-07,0.0,5.3469257e-06,False,TWIST1; twist family bHLH transcription factor
hsa:9653,0.0,0.0,6.995384743564356e-05,0.0003451591737180426,0.0,0.00300976,False,HS2ST1; heparan sulfate 2-O-sulfotransferase
hsa:8764,0.00014815742499999998,0.18356366947039987,0.0004968713301980198,0.0007755131637657865,0.0,0.0052767727,False,TNFRSF14; TNF receptor superfamily member
hsa:8408,0.0,0.0,4.843192163514852e-06,1.1823644823621865e-05,0.0,9.317611e-05,False,ULK1; unc-51 like autophagy activating kinase
hsa:5214,0.0,0.0,0.00012715936721138614,0.00032877034804959347,0.0,0.0029594747,False,PFKP; phosphofructokinase
hsa:51196,0.0,0.0,1.3870781917623759e-05,5.749562872535553e-05,0.0,0.0006858638,False,PLCE1; phospholipase C epsilon
hsa:55626,0.0,0.0,1.8315658484752466e-06,4.248593404318101e-06,0.0,2.2641416e-05,False,AMBRA1; autophagy and beclin 1 regulator
hsa:1001,0.0,0.0,1.6736725429059408e-06,4.688218402332836e-06,0.0,3.5018023e-05,False,CDH3; cadherin
hsa:29775,2.03019055e-07,0.00025153597741195177,6.067823745297027e-07,1.7161961747540208e-06,0.0,1.3246077e-05,False,CARD10; caspase recruitment domain family member
hsa:11035,0.0,0.0,3.868870198044554e-06,1.477327934667914e-05,0.0,0.00013285904,False,RIPK3; receptor interacting serine/threonine kinase
hsa:9486,1.3338682499999999e-06,0.0016526323305096637,5.05523228569307e-05,0.00010329775424270274,0.0,0.0005036792,False,CHST10; carbohydrate sulfotransferase
hsa:55131,0.0,0.0,7.015876285138614e-07,1.8939057277631688e-06,0.0,1.8961326e-05,False,RBM28; RNA binding motif protein
hsa:8883,5.09453885e-09,6.3120174069272e-06,2.4269021901188122e-08,4.434983696499385e-08,0.0,3.3487527e-07,False,NAE1; NEDD8 activating enzyme E1 subunit
hsa:10641,0.0,0.0,7.538915390396042e-07,2.1266390292350967e-06,0.0,2.1908485e-05,False,NPRL2; NPR2 like
hsa:3134,0.0,0.0,8.319485856930691e-05,0.00016109040237850632,0.0,0.00096093374,False,HLA-F; major histocompatibility complex
hsa:2572,0.0,0.0,4.763799707661021e-05,0.0002437795161917619,0.0,0.0020921102,False,GAD2; glutamate decarboxylase
hsa:2567,8.12110025e-07,0.0010061857932715705,5.89231811482178e-05,0.00019787684486401316,0.0,0.0025270944,False,GABRG3; gamma-aminobutyric acid type A receptor subunit
hsa:2056,3.0569438e-06,0.003787483626236,1.7527543722777224e-05,3.762545656595207e-05,0.0,0.00038637937,False,EPO;
hsa:171558,8.5395312e-08,0.00010580284333565917,1.014458428640594e-05,4.8932395636551195e-05,0.0,0.0006323501,False,PTCRA; pre T cell antigen receptor
hsa:23620,0.0,0.0,2.641157208187128e-07,9.668124759745271e-07,0.0,8.278086e-06,False,NTSR2; neurotensin receptor
hsa:9479,0.0,0.0,2.1243467165495053e-07,4.331611308527266e-07,0.0,3.5382802e-06,False,MAPK8IP1; mitogen-activated protein kinase 8 interacting protein
hsa:5664,3.61475135e-06,0.004478594454709792,0.00025361159224688125,0.00047122260419281707,0.0,0.002390797,False,PSEN2; presenilin
hsa:8243,4.6480013e-08,5.758767569908758e-05,4.702311851372773e-06,9.300101904945807e-06,0.0,4.828706e-05,False,SMC1A; structural maintenance of chromosomes
hsa:4939,1.101327e-10,1.36451902702026e-07,4.0301169247707896e-06,9.314126740310027e-06,0.0,6.475544e-05,False,OAS2; 2'-5'-oligoadenylate synthetase
hsa:7161,0.0,0.0,1.7273774847821786e-06,5.473632840486074e-06,0.0,4.562594e-05,False,TP73; tumor protein
hsa:10193,2.4767095999999997e-09,3.068586690060024e-06,6.660876289049503e-07,1.3151192703928405e-06,0.0,9.670581e-06,False,RNF41; ring finger protein
hsa:8673,2.7522524e-06,0.003409977932950136,2.5914934680772273e-05,8.299354666680141e-05,0.0,0.0008223743,False,VAMP8; vesicle associated membrane protein
hsa:3305,3.9536344e-06,0.004898462822287866,3.173937867064851e-05,6.379869021734461e-05,0.0,0.00055978086,False,HSPA1L; heat shock protein family A (Hsp70) member 1
hsa:55331,7.6541898e-08,9.483366537390255e-05,1.4937477902495055e-05,3.0717976408267184e-05,0.0,0.00018673114,False,ACER3; alkaline ceramidase
hsa:81442,0.0,0.0,1.0893003465346535e-08,1.5481866795771867e-07,0.0,2.2003867e-06,False,OR6N2; olfactory receptor family 6 subfamily N member
hsa:7772,2.8524197500000003e-09,3.5340829943544224e-06,3.0440779882851476e-08,8.128034688820594e-08,0.0,4.430773e-07,False,ZNF229; zinc finger protein
hsa:26039,1.636932e-06,0.002028121402579187,2.4083741118712864e-05,6.364907903882959e-05,0.0,0.000609142,False,SS18L1; SS18L1 subunit of BAF chromatin remodeling
hsa:390326,0.0,0.0,9.523276473267326e-08,9.899745168942465e-07,-0.0,1.2276313e-05,False,OR6C76; olfactory receptor family 6 subfamily C member
hsa:8924,0.0,0.0,4.68456972878218e-07,9.004974446463308e-07,0.0,4.058976e-06,False,HERC2; HECT and RLD domain containing E3 ubiquitin protein ligase
hsa:654254,2.1612614e-09,2.6777535669827805e-06,2.1031263764059406e-08,4.134517331475524e-08,0.0,2.4705693e-07,False,ZNF732; zinc finger protein
hsa:4040,0.0,0.0,2.376829908709901e-05,7.434901037472842e-05,0.0,0.00084172765,False,LRP6; LDL receptor related protein
hsa:3373,4.6891848e-06,0.005809792986836962,4.6902110555792086e-05,8.886477213509357e-05,0.0,0.0005269166,False,HYAL1; hyaluronidase
hsa:6718,0.0,0.0,2.313799544574258e-06,1.652665338116229e-05,0.0,0.00021604693,False,AKR1D1; aldo-keto reductase family 1 member
hsa:10282,6.18048665e-07,0.0007657481956012797,4.6727424096658414e-05,0.00010641086003034043,0.0,0.00081031915,False,BET1; Bet1 golgi vesicular membrane trafficking
hsa:387748,0.0,0.0,2.696522394059406e-07,1.116508181308652e-06,0.0,9.7190195e-06,False,OR56B1; olfactory receptor family 56 subfamily B member
hsa:5871,0.0,0.0,1.3359496608762377e-07,3.729471262842407e-07,0.0,2.8920836e-06,False,MAP4K2; mitogen-activated protein kinase kinase kinase kinase
hsa:9615,0.0,0.0,1.3811793458762378e-08,7.022837678732886e-08,0.0,7.033729e-07,False,GDA; guanine
hsa:64377,0.0,0.0,1.3416832290341588e-06,5.0162746709685715e-06,0.0,4.065859e-05,False,CHST8; carbohydrate sulfotransferase
hsa:53637,0.0,0.0,2.4331460443811875e-06,9.696564657045374e-06,0.0,7.13758e-05,False,S1PR5; sphingosine-1-phosphate receptor
hsa:3467,0.0,0.0,2.472914816691089e-06,6.63837911081895e-06,0.0,4.3092685e-05,False,IFNW1; interferon omega
hsa:81399,0.0,0.0,1.7151582867247522e-05,8.023268361519639e-05,0.0,0.0010032045,False,OR4F16; olfactory receptor family 4 subfamily F member
hsa:4200,2.0432526e-07,0.00025315433560682847,3.198169259851188e-06,6.701370056152076e-06,0.0,4.9972066e-05,False,ME2; malic enzyme
hsa:8835,3.2032769e-05,0.03968786998652057,0.0002228716768841585,0.0004614797781984361,0.0,0.0027596983,False,SOCS2; suppressor of cytokine signaling
hsa:11027,0.0,0.0,7.565491458613861e-06,2.488412547649443e-05,0.0,0.00017777199,False,LILRA2; leukocyte immunoglobulin like receptor
hsa:55173,0.0,0.0,8.88185362579208e-08,2.5980627609494534e-07,0.0,1.5306047e-06,False,MRPS10; mitochondrial ribosomal protein
hsa:116028,2.334486e-06,0.002892374894388695,0.00010156454769251483,0.0001855690420810455,0.0,0.000981088,False,RMI2; RecQ mediated genome instability
hsa:6332,0.0,0.0,1.2381906411717824e-06,5.3408605883159566e-06,0.0,5.1315772e-05,False,SCN7A; sodium voltage-gated channel alpha subunit
hsa:1003,8.4287653e-07,0.0010443047910509893,7.980085296683167e-06,3.252553039226843e-05,0.0,0.0003768316,False,CDH5; cadherin
hsa:79735,1.8644103e-08,2.309961826526137e-05,4.088528552265346e-06,1.250722041296397e-05,0.0,0.00010320111,False,TBC1D17; TBC1 domain family member
hsa:2564,0.0,0.0,0.00019414487945113864,0.0005698615880890802,0.0,0.003119493,False,GABRE; gamma-aminobutyric acid type A receptor subunit
hsa:1075,9.1691155e-07,0.001136032491775502,4.101969972801981e-06,7.291542160635338e-06,0.0,4.5156703e-05,False,CTSC; cathepsin
hsa:4358,1.00433585e-06,0.0012443492049532662,0.00021058942032760902,0.0007807996874802035,0.0,0.004738107,False,MPV17; mitochondrial inner membrane protein
hsa:6164,0.0,0.0,4.828368092376238e-07,1.1679206180343443e-06,0.0,1.0058291e-05,False,RPL34; ribosomal protein
hsa:4998,0.0,0.0,6.830081023323615e-07,1.7952097903958538e-06,0.0,9.814071e-06,False,ORC1; origin recognition complex subunit
hsa:55110,0.0,0.0,3.886355682148512e-07,8.523389736719359e-07,0.0,4.252704e-06,False,MAGOHB; mago homolog B
hsa:441669,0.0,0.0,2.096853118811881e-08,2.0168973088979424e-07,0.0,2.4812275e-06,False,OR4Q3; olfactory receptor family 4 subfamily Q member
hsa:2879,4.8619208e-06,0.006023808949989933,0.00011359978910198022,0.0003980754214711253,0.0,0.0030652448,False,GPX4; glutathione peroxidase
hsa:79143,3.6681779500000005e-08,4.5447887932205166e-05,4.873348353811388e-06,1.2754731670933869e-05,0.0,0.00011531969,False,MBOAT7; membrane bound O-acyltransferase domain containing
hsa:79798,0.0,0.0,2.269392445298514e-06,8.047032293260467e-06,0.0,6.846215e-05,False,ARMC5; armadillo repeat containing
hsa:6585,2.63057475e-08,3.259222100587803e-05,2.0244142917320808e-05,9.203695508493772e-05,0.0,0.0010032123,False,SLIT1; slit guidance ligand
hsa:10434,1.54346285e-06,0.001912315258160308,1.537043452991188e-05,3.297186886377672e-05,0.0,0.00021276089,False,LYPLA1; lysophospholipase
hsa:653509,0.0,0.0,2.8946057655977726e-07,1.6710877709381496e-06,0.0,1.9205316e-05,False,SFTPA1; surfactant protein
hsa:4646,0.0,0.0,3.435270495594059e-07,1.0662226010095674e-06,0.0,9.81622e-06,False,MYO6; myosin
hsa:11186,5.3151745e-05,0.06585379943634266,0.00033367219030693067,0.0006169535894482871,0.0,0.0036663273,False,RASSF1; Ras association domain family member
hsa:11283,0.0,0.0,6.58133300019802e-07,7.374872692632348e-06,-0.0,0.00010117105,False,CYP4F8; cytochrome P450 family 4 subfamily F member
hsa:56895,0.0,0.0,7.003954367379209e-05,0.0002060384704740705,0.0,0.0011912776,False,AGPAT4; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:55361,0.0,0.0,4.678067242054455e-06,1.5841432595731263e-05,0.0,0.00016009634,False,PI4K2A; phosphatidylinositol 4-kinase type 2
hsa:10327,5.970448e-06,0.007397248860542833,0.00016981098470049503,0.00039616996679294863,0.0,0.0036275007,False,AKR1A1; aldo-keto reductase family 1 member
hsa:7694,0.0,0.0,5.2229738761386125e-08,1.0307419481219994e-07,0.0,5.313001e-07,False,ZNF135; zinc finger protein
hsa:403277,0.0,0.0,3.6065324504950496e-08,3.5354984271253613e-07,0.0,4.191345e-06,False,OR5K3; olfactory receptor family 5 subfamily K member
hsa:759,0.0,0.0,4.685752239196039e-05,0.00027098605473388466,0.0,0.0031539157,False,CA1; carbonic anhydrase
hsa:5740,9.745373e-07,0.0012074294813356533,1.6125862363292082e-05,4.654464733505264e-05,0.0,0.00031723434,False,PTGIS; prostaglandin I2
hsa:51121,0.0,0.0,9.867839825742575e-08,2.5172729702478395e-07,0.0,2.322699e-06,False,RPL26L1; ribosomal protein L26 like
hsa:7639,0.0,0.0,4.549261664752476e-08,9.769633090166817e-08,0.0,7.014267e-07,False,ZNF85; zinc finger protein
hsa:51052,0.0,0.0,4.4172588695856445e-07,2.7501222011669503e-06,0.0,3.0039835e-05,False,PRLH; prolactin releasing
hsa:406908,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR124-2; microRNA
hsa:729,0.0,0.0,6.984859326980199e-07,2.119360232148355e-06,0.0,1.6975204e-05,False,C6; complement
hsa:391121,0.0,0.0,1.0639212376237624e-07,1.5121161885685592e-06,0.0,2.1491209e-05,False,OR10J4; olfactory receptor family 10 subfamily J member 4
hsa:23475,0.0,0.0,3.346067355568317e-05,0.00011333247845001735,0.0,0.0014500237,False,QPRT; quinolinate
hsa:9956,1.156417075e-07,0.0001432774373105004,5.378746712268813e-05,0.00020516676859586892,0.0,0.0014180706,False,HS3ST2; heparan sulfate-glucosamine 3-sulfotransferase
hsa:1675,4.38741315e-06,0.0054359047971891125,5.7100195130198036e-05,0.00014114550322883763,0.0,0.0010701207,False,CFD; complement factor
hsa:57534,1.084379375e-08,1.3435213062930787e-05,6.698515233143564e-07,1.5220813742541332e-06,0.0,8.605178e-06,False,MIB1; MIB E3 ubiquitin protein ligase
hsa:5713,0.0,0.0,3.648950410693069e-06,8.03744289255323e-06,0.0,6.4786276e-05,False,PSMD7; proteasome 26S subunit
hsa:64215,0.0,0.0,1.6744604067207923e-07,4.145558262551225e-07,0.0,3.1141774e-06,False,DNAJC1; DnaJ heat shock protein family (Hsp40) member
hsa:386653,0.0,0.0,1.958652310082178e-06,5.747372411241579e-06,0.0,4.2018513e-05,False,IL31; interleukin
hsa:57472,0.0,0.0,1.7048753082163369e-06,7.03181270144105e-06,0.0,6.746577e-05,False,CNOT6; CCR4-NOT transcription complex subunit
hsa:6361,1.7918314499999997e-05,0.022200382872101573,7.014822547806929e-05,0.00012255597465413672,0.0,0.0007092773,False,CCL17; C-C motif chemokine ligand
hsa:817,0.0,0.0,0.0003022879993777228,0.0004964132809007171,0.0,0.0020017822,False,CAMK2D; calcium/calmodulin dependent protein kinase II
hsa:64979,4.81765275e-09,5.968961845983508e-06,1.4679883165544552e-07,4.5944049644745377e-07,0.0,4.0273053e-06,False,MRPL36; mitochondrial ribosomal protein
hsa:164,2.4998524e-08,3.097260091273765e-05,2.0502570681955437e-06,4.272687589757256e-06,0.0,3.692096e-05,False,AP1G1; adaptor related protein complex 1 subunit gamma
hsa:391013,0.0,0.0,1.4520647367227724e-05,4.506849848757533e-05,0.0,0.0003940974,False,PLA2G2C; phospholipase A2 group
hsa:6884,7.4743165e-08,9.260507622369627e-05,2.803792203356438e-06,1.2306553631487653e-05,0.0,0.00013986326,False,TAF13; TATA-box binding protein associated factor
hsa:6160,2.7378821499999998e-08,3.392173521047006e-05,6.96331416339109e-07,1.6551312169174834e-06,0.0,1.2759724e-05,False,RPL31; ribosomal protein
hsa:1508,0.0,0.0,2.5163569745425747e-05,0.00011504078434964769,0.0,0.0010116292,False,CTSB; cathepsin
hsa:329,0.0,0.0,0.0005012288905247524,0.0009565162428123795,0.0,0.0044069807,False,BIRC2; baculoviral IAP repeat containing
hsa:7498,0.0,0.0,0.0003167644493065842,0.0011902405490129215,0.0,0.011102743,False,XDH; xanthine
hsa:390275,0.0,0.0,4.498100764579208e-06,3.1643089043977624e-05,0.0,0.00031442745,False,OR8A1; olfactory receptor family 8 subfamily A member
hsa:9319,0.0,0.0,8.081191550645545e-07,2.4318638630785444e-06,0.0,1.4603294e-05,False,TRIP13; thyroid hormone receptor interactor
hsa:64769,0.0,0.0,9.776205000024752e-07,2.9494799918919967e-06,0.0,2.236408e-05,False,MEAF6; MYST/Esa1 associated factor
hsa:116071,0.0,0.0,2.5079980308683174e-06,8.751748863721993e-06,0.0,8.768345e-05,False,BATF2; basic leucine zipper ATF-like transcription factor
hsa:253959,0.0,0.0,1.0772078295148516e-06,2.85177433345915e-06,0.0,1.6739461e-05,False,RALGAPA1; Ral GTPase activating protein catalytic subunit alpha
hsa:2243,0.0,0.0,3.4752008801485154e-07,3.5800851560999297e-06,0.0,4.8584876e-05,False,FGA; fibrinogen alpha
hsa:10972,2.0024448500000002e-07,0.00024809834848176155,2.6178340748910883e-06,5.944862583658957e-06,0.0,5.2851366e-05,False,TMED10; transmembrane p24 trafficking protein
hsa:65005,3.18061415e-08,3.940708368436323e-05,3.751975067584159e-07,7.377091835096164e-07,0.0,3.5187347e-06,False,MRPL9; mitochondrial ribosomal protein
hsa:3839,0.0,0.0,4.6621152230198043e-07,1.1352051098801815e-06,0.0,6.3555212e-06,False,KPNA3; karyopherin subunit alpha
hsa:64388,7.53853275e-08,9.340070091072283e-05,1.755495237644802e-05,5.836333601755253e-05,0.0,0.0005855487,False,GREM2; gremlin 2
hsa:51284,0.0,0.0,4.609111157732675e-06,2.288782566163689e-05,0.0,0.00021917098,False,TLR7; toll like receptor
hsa:4082,0.0,0.0,5.97324358987624e-06,1.9306990222644263e-05,0.0,0.00012014801,False,MARCKS; myristoylated alanine rich protein kinase C
hsa:390162,0.0,0.0,7.290415841584159e-10,1.0361627746126917e-08,0.0,1.472664e-07,False,OR5M9; olfactory receptor family 5 subfamily M member
hsa:9353,7.4192188e-08,9.192242829083841e-05,3.151694369605941e-06,2.7333341085928182e-05,0.0,0.00034687092,False,SLIT2; slit guidance ligand
hsa:4690,0.0,0.0,1.9331531389504947e-05,4.785069413691037e-05,0.0,0.00032025352,False,NCK1; NCK adaptor protein
hsa:1360,0.0,0.0,2.116905936771782e-06,1.268216424766541e-05,0.0,0.00015887343,False,CPB1; carboxypeptidase
hsa:2550,3.40279185e-05,0.04215981469912632,0.0007123194478643564,0.0012489329047185671,0.0,0.008396424,False,GABBR1; gamma-aminobutyric acid type B receptor subunit
hsa:10370,0.0,0.0,1.66967178728297e-06,8.989281433639119e-06,0.0,8.74509e-05,False,CITED2; Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain
hsa:5063,3.49387425e-06,0.004328830485533489,4.0974413252277224e-05,7.371558280960312e-05,0.0,0.000551836,False,PAK3; p21 (RAC1) activated kinase
hsa:284349,5.35431025e-09,6.6338682450304085e-06,3.978601316188117e-08,7.457196009626695e-08,0.0,3.875362e-07,False,ZNF283; zinc finger protein
hsa:3918,0.0,0.0,2.0332250716130702e-05,4.7254149068715486e-05,0.0,0.00031055574,False,LAMC2; laminin subunit gamma
hsa:125919,0.0,0.0,2.577531597603961e-08,5.39457110031761e-08,0.0,2.8634898e-07,False,ZNF543; zinc finger protein
hsa:2197,1.86468085e-07,0.00023102970318037339,1.4208648811237619e-06,2.2719275244919873e-06,0.0,1.0538351e-05,False,FAU; FAU ubiquitin like and ribosomal protein S30
hsa:23293,1.36311715e-07,0.00016888710503171444,9.138651098198023e-07,1.5486835126207799e-06,0.0,6.6876687e-06,False,SMG6; SMG6 nonsense mediated mRNA decay
hsa:5531,0.0,0.0,4.78929694341584e-06,1.0606539775729647e-05,0.0,5.839044e-05,False,PPP4C; protein phosphatase 4 catalytic
hsa:53828,0.0,0.0,2.175371467567327e-06,1.5411744782273847e-05,0.0,0.0001753646,False,FXYD4; FXYD domain containing ion transport regulator
hsa:3434,9.6465295e-08,0.00011951829971899565,2.8275907205693067e-07,5.433265222504146e-07,0.0,3.8659473e-06,False,IFIT1; interferon induced protein with tetratricopeptide repeats
hsa:56923,0.0,0.0,4.756797071325348e-07,1.8115391611872773e-06,0.0,1.6137403e-05,False,NMUR2; neuromedin U receptor
hsa:26476,0.0,0.0,6.784226237623763e-08,8.809064488845786e-07,0.0,1.24647e-05,False,OR10J1; olfactory receptor family 10 subfamily J member
hsa:93408,0.0,0.0,1.1755065016435645e-07,1.2300479936832718e-06,0.0,1.7240622e-05,False,MYL10; myosin light chain
hsa:5817,0.0,0.0,0.0001245643911751981,0.0002882613152876571,0.0,0.0016753136,False,PVR; PVR cell adhesion
hsa:10998,0.000180555965,0.22370472138111938,0.00036768346520297016,0.0004960502287819969,0.0,0.0025717837,False,SLC27A5; solute carrier family 27 member
hsa:10148,0.0,0.0,4.595779873019801e-06,1.8689062962864496e-05,0.0,0.00019136429,False,EBI3; Epstein-Barr virus induced
hsa:4312,0.0,0.0,3.0133550365326722e-05,0.0001340083036335585,0.0,0.0014203285,False,MMP1; matrix metallopeptidase
hsa:8390,0.0,0.0,6.858171632871288e-06,3.3591239066892324e-05,0.0,0.0003013528,False,OR1G1; olfactory receptor family 1 subfamily G member
hsa:283208,0.0,0.0,1.8704343944159905e-05,9.944996395999549e-05,0.0,0.0008175225,False,P4HA3; prolyl 4-hydroxylase subunit alpha
hsa:4007,4.9018480000000003e-08,6.073277839879715e-05,4.988058304257424e-07,1.1219523823329592e-06,0.0,8.902553e-06,False,PRICKLE3; prickle planar cell polarity protein
hsa:4637,3.2708063e-06,0.00405245438461759,8.764059562632668e-05,0.00021578625153723577,0.0,0.0014156937,False,MYL6; myosin light chain
hsa:286151,0.0,0.0,1.4813271978836237e-06,5.335454827443809e-06,0.0,4.155372e-05,False,FBXO43; F-box protein
hsa:51639,4.5008981e-08,5.576510061161977e-05,4.333106761534657e-07,1.0717238312252885e-06,0.0,6.5406916e-06,False,SF3B6; splicing factor 3b subunit
hsa:714,0.0,0.0,0.00020404221936980196,0.00039555313913638344,0.0,0.002605928,False,C1QC; complement C1q C
hsa:5509,0.0,0.0,2.3246609935297033e-06,9.690024085461123e-06,0.0,0.0001110314,False,PPP1R3D; protein phosphatase 1 regulatory subunit
hsa:9997,0.0,0.0,1.5345024247655444e-05,5.011304791748511e-05,0.0,0.0004871969,False,SCO2; synthesis of cytochrome C oxidase
hsa:5520,0.0,0.0,1.7873471205099008e-05,3.567402274881187e-05,0.0,0.00019864395,False,PPP2R2A; protein phosphatase 2 regulatory subunit
hsa:5627,0.0,0.0,1.2347535736158419e-05,4.5831910047002195e-05,0.0,0.00033090636,False,PROS1; protein
hsa:10993,0.0,0.0,4.037596591831683e-05,0.00012739965081556243,0.0,0.001203258,False,SDS; serine
hsa:3932,0.0,0.0,9.027649433287131e-05,0.00025348323608140143,0.0,0.0018764451,False,LCK; LCK proto-oncogene
hsa:5915,0.0,0.0,1.7607680621683165e-05,5.215982080768779e-05,0.0,0.000382883,False,RARB; retinoic acid receptor
hsa:11031,2.96515145e-09,3.673754998762141e-06,2.646220275222773e-07,6.686346525687837e-07,0.0,4.08495e-06,False,RAB31; RAB31
hsa:9518,0.0,0.0,1.2910373075579204e-05,5.7465765821532064e-05,0.0,0.0005459544,False,GDF15; growth differentiation factor
hsa:5830,5.2907235e-07,0.0006555085712466165,5.4915591095027734e-05,0.00020270578026717226,0.0,0.0012492039,False,PEX5; peroxisomal biogenesis factor
hsa:65003,6.8638615e-08,8.504167804459367e-05,2.5539789353366337e-07,3.9885431438167657e-07,0.0,2.3310038e-06,False,MRPL11; mitochondrial ribosomal protein
hsa:4217,1.81949265e-06,0.002254309882939866,2.6236201410891086e-05,7.735354179043884e-05,0.0,0.0007754367,False,MAP3K5; mitogen-activated protein kinase kinase kinase
hsa:23566,0.0,0.0,2.0989387751086634e-06,2.1377836347228413e-05,0.0,0.00030263345,False,LPAR3; lysophosphatidic acid receptor
hsa:5198,3.1684445e-08,3.925630449728095e-05,3.484358035001486e-06,7.82595242661504e-06,0.0,6.728535e-05,False,PFAS; phosphoribosylformylglycinamidine
hsa:2010,0.0,0.0,0.00016090248729108914,0.0005040011467780686,0.0,0.0034990432,False,EMD;
hsa:5331,0.0,0.0,0.0005731125833564357,0.0010047253938129887,0.0,0.006498534,False,PLCB3; phospholipase C beta
hsa:23193,4.1372179500000003e-07,0.0005125918652411823,6.41504830264505e-05,0.0001738954396883362,0.0,0.0012605237,False,GANAB; glucosidase II alpha
hsa:7422,6.5562895e-06,0.00812309311349231,7.227083232920791e-05,0.00011875982588828687,0.0,0.0006554734,False,VEGFA; vascular endothelial growth factor
hsa:6124,2.29144765e-07,0.0002839051360627553,1.4940529152722775e-06,2.772880460927301e-06,0.0,1.13216065e-05,False,RPL4; ribosomal protein
hsa:2119,5.43225853e-08,6.730444385616721e-05,8.219921733220794e-06,6.799774422830137e-05,0.0,0.00093164586,False,ETV5; ETS variant transcription factor
hsa:1394,1.62718445e-05,0.02016044410512497,6.196864934262382e-05,0.0001168475922977378,0.0,0.0011024035,False,CRHR1; corticotropin releasing hormone receptor
hsa:83658,0.0,0.0,5.053832881247526e-07,1.3767828868009707e-06,0.0,1.0257592e-05,False,DYNLRB1; dynein light chain roadblock-type
hsa:5660,0.0,0.0,1.4396392207920796e-05,3.3550971413343816e-05,0.0,0.00021619345,False,PSAP;
hsa:84557,6.4828821e-06,0.008032143019629102,2.610629870178218e-05,3.5142621337762325e-05,0.0,0.00018078795,False,MAP1LC3A; microtubule associated protein 1 light chain 3
hsa:6713,0.0,0.0,1.730051239752475e-05,6.279123054136588e-05,0.0,0.00063758524,False,SQLE; squalene
hsa:3831,2.0430133e-09,2.531246868827742e-06,8.95793668010396e-07,2.2508055477079027e-06,0.0,1.7388735e-05,False,KLC1; kinesin light chain
hsa:1855,2.62427785e-05,0.03251420385147027,0.00022373454724009906,0.0005630725810464946,0.0,0.004273823,False,DVL1; dishevelled segment polarity protein
hsa:1285,0.0,0.0,4.443292201925742e-06,1.4961557505710733e-05,0.0,0.00012859276,False,COL4A3; collagen type IV alpha 3
hsa:26828,0.0,0.0,9.452910138613861e-09,8.887738892655576e-08,0.0,1.1713817e-06,False,RNU5F-1; RNA
hsa:10793,4.191768499999999e-09,5.193505539330438e-06,4.331376309797031e-08,9.43627627991012e-08,0.0,5.305596e-07,False,ZNF273; zinc finger protein
hsa:4324,5.319623300000001e-07,0.000659089190533811,2.576954314064209e-05,6.724840850319341e-05,0.0,0.00058372563,False,MMP15; matrix metallopeptidase
hsa:4702,7.5892695e-08,9.40293176679999e-05,2.5987630668316835e-06,3.606977771607272e-06,0.0,1.5564154e-05,False,NDUFA8; NADH:ubiquinone oxidoreductase subunit
hsa:8228,3.2368373000000003e-06,0.004010367568595781,0.000179587060425,0.0003939354023616301,0.0,0.0023914964,False,PNPLA4; patatin like phospholipase domain containing
hsa:29883,2.23012805e-07,0.000276307777518992,2.6688961943648535e-05,0.00010938687880775237,0.0,0.0009828744,False,CNOT7; CCR4-NOT transcription complex subunit
hsa:211,0.0,0.0,0.0001483517047193069,0.00044473566570783535,0.0,0.0036146154,False,ALAS1; 5'-aminolevulinate synthase
hsa:10095,0.0,0.0,2.2280359892549485e-05,0.00011406358971639523,0.0,0.0008936947,False,ARPC1B; actin related protein 2/3 complex subunit
hsa:391211,0.0,0.0,6.489082851485149e-08,9.046770222912551e-07,-0.0,1.2856671e-05,False,OR2G6; olfactory receptor family 2 subfamily G member
hsa:81929,0.0,0.0,1.19257532569307e-06,3.074858298823172e-06,0.0,2.4297613e-05,False,SEH1L; SEH1 like
hsa:5734,0.0,0.0,2.8214508478514862e-05,6.652158826128775e-05,0.0,0.00035626977,False,PTGER4; prostaglandin E receptor
hsa:122876,0.0,0.0,8.75311759119307e-07,4.523906697469726e-06,0.0,5.7235895e-05,False,GPHB5; glycoprotein hormone subunit beta
hsa:79544,0.0,0.0,3.1107981361633663e-06,4.4007308769125496e-05,0.0,0.00062546955,False,OR4K1; olfactory receptor family 4 subfamily K member
hsa:27006,1.29005143e-07,0.00015983442901787524,6.175889729164852e-06,2.1566152254625137e-05,0.0,0.00022150195,False,FGF22; fibroblast growth factor
hsa:23569,0.0,0.0,2.1163111967376225e-07,7.532889091294379e-07,0.0,7.875862e-06,False,PADI4; peptidyl arginine deiminase
hsa:126017,0.0,0.0,1.8879909299306935e-08,3.980297806074165e-08,0.0,2.2434047e-07,False,ZNF813; zinc finger protein
hsa:247,4.0936354000000004e-07,0.000507192086726621,1.9324890051049515e-05,5.395821535318408e-05,0.0,0.0005045479,False,ALOX15B; arachidonate 15-lipoxygenase type
hsa:8740,6.76133725e-08,8.377142597726053e-05,2.5615139980076224e-05,0.00012759425301327927,0.0,0.0016722056,False,TNFSF14; TNF superfamily member
hsa:8396,1.3002485e-06,0.0016109782272699684,9.703782920404953e-05,0.00017356818213321007,0.0,0.0008260565,False,PIP4K2B; phosphatidylinositol-5-phosphate 4-kinase type 2
hsa:282890,0.0,0.0,1.0440032860346535e-08,4.840670900391956e-08,0.0,4.8724627e-07,False,ZNF311; zinc finger protein
hsa:113,0.000241623,0.29936538454583994,0.0005517508727128712,0.000721281857803044,0.0,0.0030396054,False,ADCY7; adenylate cyclase
hsa:51460,0.0,0.0,3.576494258138564e-05,0.00013530093237182705,0.0,0.0008453141,False,SFMBT1; Scm like with four mbt domains
hsa:407014,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR25; microRNA
hsa:2560,0.0,0.0,5.762413421688118e-05,0.00013711756179820666,0.0,0.0010159904,False,GABRB1; gamma-aminobutyric acid type A receptor subunit
hsa:26212,3.0970436500000003e-07,0.00038371664255368976,9.669999177183958e-05,0.0002581481818528063,0.0,0.0018503008,False,OR2B6; olfactory receptor family 2 subfamily B member
hsa:3827,0.0,0.0,1.2987316744207917e-05,0.00011335898282392083,0.0,0.0015494156,False,KNG1; kininogen
hsa:338398,0.0,0.0,3.1041717851485153e-06,3.239089217522191e-05,0.0,0.00045234262,False,TAS2R60; taste 2 receptor member
hsa:390081,0.0,0.0,3.780916339237624e-07,1.3192085753824511e-06,0.0,9.121359e-06,False,OR52E4; olfactory receptor family 52 subfamily E member
hsa:6753,0.0,0.0,3.237571309014851e-06,9.71014097685508e-06,0.0,8.792824e-05,False,SSTR3; somatostatin receptor
hsa:6133,1.0886468e-07,0.0001348808548509861,1.1533838663579207e-06,2.3407210805682965e-06,0.0,1.1743298e-05,False,RPL9; ribosomal protein
hsa:4940,0.0,0.0,1.280341459571287e-05,3.311077538248435e-05,0.0,0.0002499907,False,OAS3; 2'-5'-oligoadenylate synthetase
hsa:5741,0.0,0.0,1.4780463093069305e-06,1.7099233620865275e-05,0.0,0.00024256665,False,PTH; parathyroid
hsa:442910,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR345; microRNA
hsa:3145,0.0,0.0,0.00016683242982426877,0.00042037270053277146,0.0,0.0024733588,False,HMBS; hydroxymethylbilane
hsa:10810,0.0,0.0,1.0609743331658417e-05,3.7761381652000564e-05,0.0,0.00036303748,False,WASF3; WASP family member
hsa:64425,2.61565785e-08,3.240740401806098e-05,6.932297127525597e-05,0.00024580873193208246,0.0,0.0019254424,False,POLR1E; RNA polymerase I subunit
hsa:84321,7.140315700000001e-08,8.846688251156547e-05,4.53739811728218e-07,7.498916989245431e-07,0.0,3.934546e-06,False,THOC3; THO complex subunit
hsa:57657,0.0,0.0,7.91725944797129e-05,0.00015954804875396075,0.0,0.0008575963,False,HCN3; hyperpolarization activated cyclic nucleotide gated potassium channel
hsa:120796,0.0,0.0,1.2754278707128713e-07,1.667438187478705e-06,-0.0,2.3646642e-05,False,OR56A1; olfactory receptor family 56 subfamily A member
hsa:283869,0.0,0.0,4.475749902631385e-06,1.691954947063389e-05,0.0,0.00013805703,False,NPW; neuropeptide
hsa:9451,0.0,0.0,3.0609714395346517e-06,1.163658891490884e-05,0.0,0.00012869148,False,EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase
hsa:7039,0.0,0.0,9.147039622425743e-06,3.702377494203686e-05,0.0,0.00038060077,False,TGFA; transforming growth factor
hsa:9791,0.0,0.0,2.095975623818712e-05,6.719004303376957e-05,0.0,0.0003746137,False,PTDSS1; phosphatidylserine synthase
hsa:9902,7.4252798e-08,9.199752269806505e-05,1.10902619285297e-06,2.0348349335317097e-06,0.0,9.711381e-06,False,MRC2; mannose receptor C type
hsa:2740,0.0,0.0,6.340587332871288e-07,4.425507360658037e-06,0.0,5.876667e-05,False,GLP1R; glucagon like peptide 1
hsa:3060,0.0,0.0,8.249411221818663e-06,2.801662628147671e-05,0.0,0.00030822644,False,HCRT; hypocretin neuropeptide
hsa:5481,5.48354215e-07,0.0006793983620797985,0.0001292976421265347,0.00047689958894475926,0.0,0.0034435324,False,PPID; peptidylprolyl isomerase
hsa:3297,1.80020505e-06,0.002230412986572524,2.4866902632326744e-05,4.993080611374012e-05,0.0,0.00029728425,False,HSF1; heat shock transcription factor
hsa:284654,7.5852953e-09,9.398007823668492e-06,1.322434722395198e-06,5.515658377812605e-06,0.0,4.6915204e-05,False,RSPO1; R-spondin
hsa:11224,0.0,0.0,5.523181369306931e-07,1.3322261027496273e-06,0.0,1.127082e-05,False,RPL35; ribosomal protein
hsa:3480,4.52085515e-05,0.056012363908063,0.0003032516428361386,0.0006369906566241142,0.0,0.0042926855,False,IGF1R; insulin like growth factor 1
hsa:440515,0.0,0.0,1.1622383700247528e-07,3.233540845212605e-07,0.0,1.7208149e-06,False,ZNF506; zinc finger protein
hsa:6517,0.0,0.0,1.35447629040099e-05,4.738252202933418e-05,0.0,0.00039067207,False,SLC2A4; solute carrier family 2 member
hsa:100505767,0.0,0.0,7.794382147772275e-07,3.144128691126864e-06,0.0,2.4132465e-05,False,SPDYE18; speedy/RINGO cell cycle regulator family member
hsa:222546,5.471015e-07,0.0006778462767745862,4.381598586732672e-05,0.00011722628112413849,-0.0,0.0008986977,False,RFX6; regulatory factor
hsa:3033,2.1652615e-06,0.002682709599623389,0.0001592908598069307,0.00029211020520914763,0.0,0.0019526355,False,HADH; hydroxyacyl-CoA
hsa:199857,0.0,0.0,5.583210130608913e-05,0.00012127670127628823,0.0,0.0006838812,False,ALG14; ALG14 UDP-N-acetylglucosaminyltransferase
hsa:3707,0.0,0.0,7.849777546444059e-06,2.129131581665035e-05,0.0,0.00015161456,False,ITPKB; inositol-trisphosphate 3-kinase
hsa:8671,0.0,0.0,1.9026015629950497e-05,6.446462065842274e-05,0.0,0.0006401937,False,SLC4A4; solute carrier family 4 member
hsa:56656,0.0,0.0,1.5051987651485148e-06,1.6880664180614208e-05,0.0,0.00023452645,False,OR2S2; olfactory receptor family 2 subfamily S member
hsa:390036,0.0,0.0,1.2215020297029703e-07,1.2979158480587432e-06,0.0,1.6650181e-05,False,OR52K1; olfactory receptor family 52 subfamily K member
hsa:10825,0.0,0.0,9.180425163910893e-05,0.00021908076563019544,0.0,0.0014064314,False,NEU3; neuraminidase
hsa:6187,1.0633833e-07,0.00013175076483783592,8.6995188009901e-07,1.921502069750199e-06,0.0,1.0906065e-05,False,RPS2; ribosomal protein
hsa:901,0.0,0.0,4.01751615691535e-05,9.818150182125535e-05,0.0,0.00052299025,False,CCNG2; cyclin
hsa:25873,1.0456901300000001e-07,0.00012955862144052485,9.998682597673268e-07,2.2774361333994862e-06,0.0,1.1828455e-05,False,RPL36; ribosomal protein
hsa:4299,0.0,0.0,8.47048470032589e-07,4.071018257558814e-06,0.0,3.713613e-05,False,AFF1; ALF transcription elongation factor
hsa:84971,5.75062025e-08,7.124887293504113e-05,0.0008126488731825814,0.002194140296686767,0.0,0.012628288,False,ATG4D; autophagy related 4D cysteine
hsa:25824,7.6603435e-09,9.490990831298037e-06,9.091752510965348e-06,5.610080076914208e-05,0.0,0.0005488014,False,PRDX5; peroxiredoxin
hsa:8633,0.0,0.0,2.897248340702906e-05,0.000130342342281202,0.0,0.0014520282,False,UNC5C; unc-5 netrin receptor
hsa:1510,3.02060965e-09,3.742466443323379e-06,1.3585753278125742e-07,6.135436085780331e-07,0.0,7.24802e-06,False,CTSE; cathepsin
hsa:23250,0.0,0.0,9.724450222986141e-05,0.0002461458354811448,0.0,0.0011851585,False,ATP11A; ATPase phospholipid transporting
hsa:2935,0.0,0.0,2.6900666478361397e-07,7.0593516739158e-07,0.0,4.754963e-06,False,GSPT1; G1 to S phase transition
hsa:1410,0.0,0.0,6.21028560927718e-05,0.00019122886892688866,0.0,0.0011039561,False,CRYAB; crystallin alpha
hsa:7095,5.91188615e-07,0.0007324692064439127,2.4228005936678208e-05,0.00015141493856226686,0.0,0.0015708846,False,SEC62; SEC62 homolog
hsa:390433,0.0,0.0,2.9334476732673264e-09,4.169212492621474e-08,0.0,5.9255643e-07,False,OR4K13; olfactory receptor family 4 subfamily K member
hsa:64744,4.2083780000000004e-08,5.2140843308966975e-05,1.2613280734980196e-06,3.1313440012084004e-06,0.0,1.9257473e-05,False,SMAP2; small
hsa:221458,1.28690705e-09,1.59444847509551e-06,4.954192956658912e-08,3.21249776071677e-07,0.0,3.6802164e-06,False,KIF6; kinesin family member
hsa:7043,0.0,0.0,0.00015802008843564358,0.0003698116091748812,0.0,0.0023749345,False,TGFB3; transforming growth factor beta
hsa:8528,0.0,0.0,8.508554815376239e-05,0.00026364784721405574,0.0,0.0021071325,False,DDO; D-aspartate
hsa:8394,9.135680249999999e-06,0.01131889940580609,3.431607040049504e-05,6.260228229439196e-05,0.0,0.00035540343,False,PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase type 1
hsa:125476,0.0,0.0,6.13456835645495e-07,4.29909509259611e-06,0.0,4.5847668e-05,False,INO80C; INO80 complex subunit
hsa:84445,0.0,0.0,2.984322534529703e-06,2.2821278638075097e-05,0.0,0.0002700666,False,LZTS2; leucine zipper tumor suppressor
hsa:26279,0.00015359314,0.19029839634348977,0.00038418125393821777,0.0005600445609502845,0.0,0.0031397038,False,PLA2G2D; phospholipase A2 group
hsa:1271,1.5352876e-05,0.019021863099227296,0.00025709497749277225,0.0004378543459250351,0.0,0.0028072433,False,CNTFR; ciliary neurotrophic factor
hsa:25981,0.0,0.0,1.4477704345643567e-07,4.90048793193364e-07,0.0,4.980281e-06,False,DNAH1; dynein axonemal heavy chain
hsa:54776,2.5938479e-06,0.003213718371334349,8.808302195773762e-05,0.0002358479742796265,0.0,0.0017006305,False,PPP1R12C; protein phosphatase 1 regulatory subunit
hsa:1907,1.7658733e-06,0.002187876731576594,3.797536546689605e-05,0.00010036722539431425,0.0,0.00074394984,False,EDN2; endothelin
hsa:64960,0.0,0.0,3.150649764516186e-07,7.144721901411325e-07,0.0,4.1076078e-06,False,MRPS15; mitochondrial ribosomal protein
hsa:26275,8.8660895e-05,0.10984882617074258,0.0005120399590034654,0.0009134841953835696,0.0,0.006625402,False,HIBCH; 3-hydroxyisobutyryl-CoA
hsa:84874,1.73210895e-08,2.1460434722358427e-05,9.781951224752471e-08,1.9494189508997768e-07,0.0,1.2132475e-06,False,ZNF514; zinc finger protein
hsa:115653,0.0,0.0,3.026171995841585e-07,1.7697029106640405e-06,0.0,1.9180861e-05,False,KIR3DL3; killer cell immunoglobulin like receptor
hsa:11060,0.0,0.0,3.89949894618812e-07,8.74321579016821e-07,0.0,5.791819e-06,False,WWP2; WW domain containing E3 ubiquitin protein ligase
hsa:3382,8.0680802e-05,0.09996167300379837,0.0002639880263038118,0.00035559689551640426,0.0,0.0015020203,False,ICA1; islet cell autoantigen
hsa:23291,5.68503585e-05,0.0704362971816481,0.000716496816509901,0.0015723929482822857,0.0,0.0098762745,False,FBXW11; F-box and WD repeat domain containing
hsa:10965,0.0,0.0,0.0002467982187873267,0.0005291636296405722,0.0,0.002488146,False,ACOT2; acyl-CoA thioesterase
hsa:3681,0.0,0.0,6.278633241721586e-06,2.8939605918408853e-05,0.0,0.00025153,False,ITGAD; integrin subunit alpha
hsa:25759,0.000173892795,0.21544920576652848,0.0005529626315452969,0.0009211258868201352,0.0,0.00518812,False,SHC2; SHC adaptor protein
hsa:59277,2.31705535e-08,2.8707787167063802e-05,3.058353212698021e-07,1.0854282599913258e-06,0.0,1.2133126e-05,False,NTN4; netrin
hsa:5698,1.7396491e-07,0.00021553855460627685,6.030150258732675e-06,1.1263986084800693e-05,0.0,6.8912566e-05,False,PSMB9; proteasome 20S subunit beta
hsa:1140,0.0,0.0,7.755242018663366e-06,1.8314711331831394e-05,0.0,0.00012459003,False,CHRNB1; cholinergic receptor nicotinic beta 1
hsa:53358,7.809200599999999e-07,0.0009675421382130856,2.5441949356633666e-05,6.281828352814175e-05,0.0,0.0005441552,False,SHC3; SHC adaptor protein
hsa:2769,8.09134115e-08,0.00010024987086748069,1.3807019307341579e-05,6.280451609042257e-05,0.0,0.00073792564,False,GNA15; G protein subunit alpha
hsa:406889,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7F2; microRNA
hsa:407047,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR9-2; microRNA
hsa:4741,0.0,0.0,4.0278831239257435e-08,8.286504830434837e-08,0.0,4.6546495e-07,False,NEFM; neurofilament medium
hsa:4855,0.0,0.0,0.00011113090593663365,0.0003820106262885502,0.0,0.004029524,False,NOTCH4; notch receptor
hsa:93661,0.0,0.0,5.146046903465348e-09,4.448562701465792e-08,0.0,5.4166804e-07,False,CAPZA3; capping actin protein of muscle Z-line subunit alpha
hsa:2494,0.0,0.0,6.07852351930693e-05,0.0002520751550590393,0.0,0.0018799093,False,NR5A2; nuclear receptor subfamily 5 group A member
hsa:4914,6.127991e-05,0.07592441043313121,0.00021656413072108913,0.00034678572688978443,0.0,0.0018969817,False,NTRK1; neurotrophic receptor tyrosine kinase
hsa:492,7.4639832e-05,0.092477048994164,0.00015332787458292076,0.0001946675308235192,0.0,0.0011437049,False,ATP2B3; ATPase plasma membrane Ca2+ transporting
hsa:27113,2.8824012499999998e-05,0.03571229388848163,0.000190772647326344,0.0003059364139893061,0.0,0.0015045524,False,BBC3; BCL2 binding component
hsa:9524,0.0,0.0,8.28705116065347e-05,0.0003544234646485031,0.0,0.0034894457,False,TECR; trans-2
hsa:2170,1.85332745e-06,0.0022962304282233515,8.922479048545843e-05,0.0003424781072989769,0.0,0.0027840384,False,FABP3; fatty acid binding protein
hsa:57819,3.7673859499999996e-07,0.0004667705241861678,3.418870407623764e-06,1.6669877205560563e-05,0.0,0.0001770424,False,LSM2; LSM2 homolog
hsa:6502,1.13179175e-06,0.001402264157239001,2.6137874804158408e-05,7.195079094931922e-05,0.0,0.0007879197,False,SKP2; S-phase kinase associated protein
hsa:196403,0.0,0.0,0.0002780744833700595,0.0006522388600197195,0.0,0.003895612,False,DTX3; deltex E3 ubiquitin ligase
hsa:7574,0.0,0.0,4.5313760308910925e-08,1.15678815962875e-07,0.0,5.78876e-07,False,ZNF26; zinc finger protein
hsa:10744,0.0,0.0,1.3386149068386143e-07,5.225526182914643e-07,0.0,4.877776e-06,False,PTTG2; pituitary tumor-transforming
hsa:5934,0.0,0.0,3.4902999873267327e-06,6.117849767061519e-06,0.0,2.8070273e-05,False,RBL2; RB transcriptional corepressor like
hsa:5519,0.0,0.0,0.0001237770440181683,0.00032922627501025064,0.0,0.0019698704,False,PPP2R1B; protein phosphatase 2 scaffold subunit
hsa:51564,0.0,0.0,2.1291591210099008e-05,5.6651871644025604e-05,0.0,0.000423194,False,HDAC7; histone deacetylase
hsa:1107,0.0,0.0,1.831344238784358e-06,9.32108600673704e-06,0.0,8.208537e-05,False,CHD3; chromodomain helicase DNA binding protein
hsa:1471,0.0,0.0,0.0001502853863730693,0.0006834716223222915,0.0,0.0057009812,False,CST3; cystatin
hsa:3123,7.069844750000001e-05,0.08759376351850352,0.000511504860290594,0.0009013734493122573,0.0,0.004354111,False,HLA-DRB1; major histocompatibility complex
hsa:11311,1.280707275e-08,1.586767095313897e-05,6.923146522648517e-07,1.972665444635478e-06,0.0,2.0025873e-05,False,VPS45; vacuolar protein sorting 45
hsa:4881,2.7460593e-06,0.0034023048233412386,5.751354240049505e-05,0.00016680070437255664,0.0,0.0015364999,False,NPR1; natriuretic peptide receptor
hsa:4311,0.0,0.0,3.0438275771782176e-05,0.00012125656337449448,0.0,0.0010347045,False,MME; membrane
hsa:5018,7.85422235e-07,0.000973120230324216,0.000156983199133104,0.0005009133413479215,0.0,0.0030677281,False,OXA1L; OXA1L mitochondrial inner membrane
hsa:279,0.0,0.0,2.2935377335495054e-05,9.126333020343982e-05,0.0,0.0010892404,False,AMY2A; amylase alpha
hsa:219959,0.0,0.0,1.365479391089109e-07,1.7465456852507221e-06,-0.0,2.4756933e-05,False,OR1S1; olfactory receptor family 1 subfamily S member
hsa:100129543,0.0,0.0,1.0900812868960394e-08,2.276033439609924e-08,0.0,1.568107e-07,False,ZNF730; zinc finger protein
hsa:3346,0.0,0.0,1.7462787352722774e-06,1.2978182506611825e-05,0.0,0.00014225095,False,HTN1; histatin
hsa:126231,1.62194205e-09,2.009549196514065e-06,3.689777279143564e-08,6.819739287065202e-08,0.0,3.9053543e-07,False,ZNF573; zinc finger protein
hsa:136,0.0,0.0,3.8123553251732663e-06,1.6381274298599443e-05,0.0,0.0002022451,False,ADORA2B; adenosine A2b
hsa:7301,0.0,0.0,0.00010590429896039608,0.00018111996042574616,0.0,0.0010297928,False,TYRO3; TYRO3 protein tyrosine
hsa:135152,0.0,0.0,4.933597093316832e-06,1.2639561851893497e-05,0.0,8.094106e-05,False,B3GAT2; beta-1
hsa:4481,3.7841525e-09,4.6884786147949555e-06,3.220361397579208e-07,5.536569805504687e-07,0.0,2.7770782e-06,False,MSR1; macrophage scavenger receptor
hsa:10667,0.0,0.0,1.4510520846806928e-06,5.0764797131849615e-06,0.0,6.189404e-05,False,FARS2; phenylalanyl-tRNA synthetase 2
hsa:5029,0.0,0.0,9.525204147331685e-06,3.094441995828826e-05,0.0,0.00035200015,False,P2RY2; purinergic receptor
hsa:7135,0.0,0.0,1.9101941320242576e-08,7.855068346224657e-08,0.0,7.342736e-07,False,TNNI1; troponin I1
hsa:5606,0.0,0.0,8.964719512405938e-05,0.00026597324101806897,0.0,0.0016241029,False,MAP2K3; mitogen-activated protein kinase kinase
hsa:139760,0.0,0.0,4.641806536831683e-07,3.85299568678208e-06,0.0,5.2396324e-05,False,GPR119; G protein-coupled receptor
hsa:5979,0.0,0.0,2.358004684164108e-05,0.00012044731847326532,0.0,0.0015347844,False,RET; ret
hsa:2288,6.846733699999999e-07,0.0008482946851017749,3.885526873709405e-05,0.00011682019960541402,0.0,0.00068816857,False,FKBP4; FKBP prolyl isomerase
hsa:57118,1.96742065e-06,0.0024375893000694324,2.7321922241497527e-05,8.748147323320874e-05,0.0,0.00079183566,False,CAMK1D; calcium/calmodulin dependent protein kinase
hsa:1785,0.0,0.0,0.00011565138361123766,0.00041778627808105494,0.0,0.004092727,False,DNM2; dynamin
hsa:64968,0.0,0.0,3.2333778312836624e-07,7.605453513795052e-07,0.0,4.108819e-06,False,MRPS6; mitochondrial ribosomal protein
hsa:801,0.0,0.0,0.00032828363460396054,0.0008060425054325757,0.0,0.0047971252,False,CALM1; calmodulin
hsa:4515,2.4247093e-07,0.00030041595047092967,4.67557108703911e-07,6.413581424168683e-07,0.0,3.8081755e-06,False,MTCP1; mature T cell proliferation
hsa:324,3.4492902e-05,0.04273591864736375,0.00014527169247658425,0.0002025533854847221,0.0,0.0010967011,False,APC; APC regulator of WNT signaling
hsa:2146,0.0,0.0,0.0001907644998945281,0.0005654807694411148,0.0,0.0035556734,False,EZH2; enhancer of zeste 2 polycomb repressive complex 2
hsa:5584,0.0,0.0,5.267559832178218e-06,1.1385933989085123e-05,0.0,8.8063665e-05,False,PRKCI; protein kinase C
hsa:1499,0.0,0.0,0.00021217533101930688,0.0004190228441395808,0.0,0.002191863,False,CTNNB1; catenin beta
hsa:24148,0.0,0.0,3.4688990951831676e-07,9.960493632234722e-07,0.0,5.2880737e-06,False,PRPF6; pre-mRNA processing factor
hsa:597,6.7323157e-07,0.0008341185559381745,4.699277852772277e-06,1.3319861800918296e-05,0.0,0.00010119038,False,BCL2A1; BCL2 related protein
hsa:9310,0.0,0.0,8.946920196386139e-08,2.3830344974352867e-07,0.0,1.3676023e-06,False,ZNF235; zinc finger protein
hsa:22954,1.09918695e-08,1.3618675538939543e-05,2.0779833668267324e-07,3.443572525860305e-07,0.0,2.0613927e-06,False,TRIM32; tripartite motif containing
hsa:346606,0.0,0.0,1.5627856019801982e-06,8.647546843374804e-06,0.0,0.00010746658,False,MOGAT3; monoacylglycerol O-acyltransferase
hsa:6785,4.5077902e-07,0.0005585049215823695,0.00025421559311673267,0.0007758628598200672,0.0,0.0041163764,False,ELOVL4; ELOVL fatty acid elongase
hsa:8793,1.53895515e-06,0.0019067303207002263,4.1773060518465376e-05,0.0001248473009092581,0.0,0.0009639745,False,TNFRSF10D; TNF receptor superfamily member
hsa:51805,2.37654165e-05,0.029444808852694276,0.0005316554894368811,0.001224779828762825,0.0,0.006737214,False,COQ3; coenzyme Q3
hsa:51176,0.0,0.0,6.242039813514852e-05,0.00022005454798848184,0.0,0.0017170429,False,LEF1; lymphoid enhancer binding factor
hsa:5739,0.0,0.0,6.01872867367822e-06,2.196752559384078e-05,0.0,0.00025904505,False,PTGIR; prostaglandin I2
hsa:26119,0.0,0.0,1.8385703539435146e-05,8.35067464826544e-05,0.0,0.00080717047,False,LDLRAP1; low density lipoprotein receptor adaptor protein
hsa:23683,7.44594175e-09,9.225351954469045e-06,4.1861089573242576e-06,1.7194474418882805e-05,0.0,0.00014442911,False,PRKD3; protein kinase
hsa:5558,0.0,0.0,4.635649278869159e-06,1.2926788590076658e-05,0.0,8.8188324e-05,False,PRIM2; DNA primase subunit
hsa:65220,0.0,0.0,7.904192792990099e-05,0.00019348585299002006,0.0,0.0013653059,False,NADK; NAD
hsa:362,4.8481523e-07,0.0006006750092608312,3.578465771841966e-05,0.00010232226221724182,0.0,0.00070644805,False,AQP5; aquaporin
hsa:2045,2.37763365e-08,2.9458338483562364e-05,1.0451587695754954e-05,4.1371486463805233e-05,0.0,0.00032849782,False,EPHA7; EPH receptor
hsa:8678,4.8012442e-05,0.059486320268827206,0.0009273318691636138,0.0016871468769323078,0.0,0.008516361,False,BECN1; beclin
hsa:6208,1.04187875e-07,0.00012908640015391292,1.834495594150001e-06,2.8622999713410397e-06,0.0,1.1844733e-05,False,RPS14; ribosomal protein
hsa:6019,0.0,0.0,9.04948712119802e-06,2.097568618551761e-05,0.0,0.0001230966,False,RLN2; relaxin
hsa:5977,5.1696906e-08,6.405128710644326e-05,4.1880315115014825e-06,1.3326026057729173e-05,0.0,8.976665e-05,False,DPF2; double PHD fingers
hsa:50509,0.0,0.0,3.9119556234683174e-05,0.00016206030932034162,0.0,0.0014296666,False,COL5A3; collagen type V alpha 3
hsa:406956,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR181B2; microRNA
hsa:9844,2.3800968e-07,0.0002948885635011249,4.0357532853853957e-05,0.0001041274353561235,0.0,0.0009257157,False,ELMO1; engulfment and cell motility
hsa:64211,0.0,0.0,6.964521703116534e-07,8.167340183634395e-06,0.0,0.00011572357,False,LHX5; LIM homeobox
hsa:1120,1.3869206e-06,0.0017183629818086315,5.1143467425886145e-05,8.689867836141841e-05,0.0,0.0004000276,False,CHKB; choline kinase
hsa:5802,6.747371999999999e-07,0.0008359839971583139,1.5876548551292076e-05,3.984880917732782e-05,0.0,0.00039795198,False,PTPRS; protein tyrosine phosphatase receptor type
hsa:144165,0.0,0.0,1.146624835857921e-06,9.417673976977897e-06,0.0,0.00012275024,False,PRICKLE1; prickle planar cell polarity protein
hsa:259290,0.0001132791925,0.1403503351245731,0.00039582050772772327,0.0007225765435643257,0.0,0.0054950374,False,TAS2R31; taste 2 receptor member
hsa:130399,3.1908312500000003e-07,0.00039533671222405695,1.1152284796781685e-05,4.285394031462266e-05,0.0,0.0005194074,False,ACVR1C; activin A receptor type
hsa:311,0.0,0.0,1.4460071373415841e-08,3.3647106278071696e-08,0.0,2.7339058e-07,False,ANXA11; annexin
hsa:7133,0.0,0.0,6.185700456188117e-05,0.00023392132258210548,0.0,0.0020502366,False,TNFRSF1B; TNF receptor superfamily member
hsa:86,0.0,0.0,1.3463938290742574e-06,3.735857147184672e-06,0.0,2.8792176e-05,False,ACTL6A; actin like
hsa:6752,0.0,0.0,2.0440441535742573e-05,4.138154985736507e-05,0.0,0.00025846294,False,SSTR2; somatostatin receptor
hsa:100506013,0.0,0.0,2.6288544146118813e-07,2.098230488592049e-06,0.0,2.5845591e-05,False,APELA; apelin receptor early endogenous
hsa:10802,9.774830899999999e-08,0.00012110792479395828,6.335143315599012e-07,1.2528617441190725e-06,0.0,6.9861794e-06,False,SEC24A; SEC24 homolog A
hsa:7805,2.16236185e-08,2.679116999426809e-05,1.6283336734193074e-06,2.9081712590841108e-06,0.0,1.6457529e-05,False,LAPTM5; lysosomal protein transmembrane
hsa:54205,9.5182335e-05,0.11792874154880105,0.0005989614339158417,0.0014577059552197836,0.0,0.009611417,False,CYCS; cytochrome c
hsa:8189,0.0,0.0,1.5937839855217818e-05,5.5079852615336845e-05,0.0,0.00035024303,False,SYMPK; symplekin scaffold
hsa:6642,6.2693597e-09,7.767593637388377e-06,7.851700268767329e-07,2.17386064340374e-06,0.0,1.2846628e-05,False,SNX1; sorting nexin
hsa:1066,0.0,0.0,1.846049640218613e-05,5.7673026903108594e-05,0.0,0.00047963677,False,CES1; carboxylesterase
hsa:10568,4.2009893e-08,5.204929900164549e-05,3.6872099645495056e-06,2.4626516903685112e-05,0.0,0.00033604642,False,SLC34A2; solute carrier family 34 member
hsa:151056,0.0,0.0,0.00015381548513365841,0.0004496301435232118,0.0,0.002743241,False,PLB1; phospholipase
hsa:788,0.0,0.0,7.643657729651484e-07,2.1966422898033682e-06,0.0,1.1185952e-05,False,SLC25A20; solute carrier family 25 member
hsa:126792,1.7135534e-05,0.021230535691173082,0.0005155957734346535,0.0011168911986536596,0.0,0.007120653,False,B3GALT6; beta-1
hsa:2520,0.0,0.0,7.435854344440594e-07,3.140383710264261e-06,0.0,2.9691471e-05,False,GAST;
hsa:3604,7.3860285e-09,9.151120804596555e-06,2.5037230841089104e-06,1.1369798334612385e-05,0.0,0.000128465,False,TNFRSF9; TNF receptor superfamily member
hsa:283189,0.0,0.0,2.004135532772277e-06,2.162857125622815e-05,-0.0,0.00030065482,False,OR9G4; olfactory receptor family 9 subfamily G member
hsa:2834,0.0,0.0,9.50469040007589e-06,2.550337273807161e-05,0.0,0.00021875533,False,PRLHR; prolactin releasing hormone
hsa:8531,0.0,0.0,5.351721842298514e-06,1.5041719441637238e-05,0.0,0.00012346906,False,YBX3; Y-box binding protein
hsa:2556,0.000197259155,0.2443995927199085,0.0008412516421388614,0.001305945882043158,0.0,0.006238055,False,GABRA3; gamma-aminobutyric acid type A receptor subunit
hsa:6389,1.73250515e-06,0.002146534354996826,7.606009527440592e-05,0.0002738249074258518,0.0,0.0018040136,False,SDHA; succinate dehydrogenase complex flavoprotein subunit
hsa:8623,0.0,0.0,3.0085045842376726e-05,9.477611812446148e-05,0.0,0.0007438236,False,ASMTL; acetylserotonin O-methyltransferase
hsa:92344,9.3258715e-06,0.011554542025480145,7.716290705871756e-05,0.00020094834539387615,0.0,0.0014987374,False,GORAB; golgin
hsa:29850,1.422875725e-05,0.01762910561393434,0.000111716961180198,0.00023997717469939763,0.0,0.0020363817,False,TRPM5; transient receptor potential cation channel subfamily M member
hsa:64837,3.46667745e-08,4.295134270808829e-05,2.840257281272277e-06,8.88541072974814e-06,0.0,4.8647653e-05,False,KLC2; kinesin light chain
hsa:1345,0.0,0.0,7.045698760089113e-05,0.000336252907514747,0.0,0.0027939097,False,COX6C; cytochrome c oxidase subunit
hsa:153527,0.0,0.0,2.165285169930692e-07,4.4056838973690475e-07,0.0,2.0354755e-06,False,ZMAT2; zinc finger matrin-type
hsa:11176,0.0,0.0,5.335467920990101e-06,1.6319257771891544e-05,0.0,8.8540415e-05,False,BAZ2A; bromodomain adjacent to zinc finger domain
hsa:1977,1.4793263e-06,0.0018328515359393542,1.8254717004702974e-05,3.787993621606368e-05,0.0,0.0002866495,False,EIF4E; eukaryotic translation initiation factor
hsa:2527,0.0,0.0,1.7103839215099013e-06,1.2873604789585895e-05,-0.0,0.0001720037,False,FUT5; fucosyltransferase
hsa:1791,0.0,0.0,1.5904100342722777e-05,8.433685223173692e-05,0.0,0.0010963634,False,DNTT; DNA
hsa:64127,0.0,0.0,1.1409302861795547e-05,5.1336101658616466e-05,0.0,0.0005298209,False,NOD2; nucleotide binding oligomerization domain containing
hsa:6489,0.000224649715,0.27833587166407314,0.0011804426043584154,0.002023679258106466,0.0,0.008999853,False,ST8SIA1; ST8 alpha-N-acetyl-neuraminide alpha-2
hsa:10946,5.3089317000000005e-08,6.577645256859239e-05,7.58642632057921e-07,2.37073147927819e-06,0.0,1.5333682e-05,False,SF3A3; splicing factor 3a subunit
hsa:50808,5.2068976e-09,6.451227334793505e-06,1.5069121719848009e-06,3.534960424600642e-06,0.0,2.2083017e-05,False,AK3; adenylate kinase
hsa:285126,0.0,0.0,6.306931827231189e-08,1.7761176060275126e-07,0.0,1.4383871e-06,False,DNAJC5G; DnaJ heat shock protein family (Hsp40) member C5
hsa:3784,0.0,0.0,4.6524567223267336e-05,0.0001615346399420099,0.0,0.0014446322,False,KCNQ1; potassium voltage-gated channel subfamily Q member
hsa:5860,6.00116775e-07,0.0007435309929943933,2.377506826729703e-05,4.49832702880558e-05,0.0,0.0002558777,False,QDPR; quinoid dihydropteridine
hsa:6591,0.0,0.0,1.1069214080439604e-05,7.368588185133621e-05,0.0,0.0009120029,False,SNAI2; snail family transcriptional repressor
hsa:7538,0.0,0.0,1.777156510303466e-06,4.959079442253479e-06,0.0,2.612615e-05,False,ZFP36; ZFP36 ring finger
hsa:342908,3.33419155e-09,4.13098726327891e-06,8.692027930727728e-08,2.1042043149874783e-07,0.0,1.4848309e-06,False,ZNF404; zinc finger protein
hsa:100996746,0.0,0.0,4.869824431344058e-06,1.809474538424872e-05,0.0,0.000142998,False,SPDYE11; speedy/RINGO cell cycle regulator family member
hsa:9588,0.0,0.0,0.0001233518656078465,0.00037093515262408684,0.0,0.0028758056,False,PRDX6; peroxiredoxin
hsa:3071,0.0,0.0,7.808784147079208e-07,1.7650263309385246e-06,0.0,8.226576e-06,False,NCKAP1L; NCK associated protein 1
hsa:2,0.0,0.0,2.876145451024752e-06,1.2373392049975527e-05,0.0,0.00016453571,False,A2M;
hsa:6240,8.24413e-06,0.010214288986130854,0.0002566668588308268,0.0005476034749332164,0.0,0.0029008011,False,RRM1; ribonucleotide reductase catalytic subunit
hsa:129401,4.39666875e-08,5.447372274429286e-05,2.2928793351361394e-07,4.7616234290989827e-07,0.0,3.0724818e-06,False,NUP35; nucleoporin
hsa:5290,0.0,0.0,0.0003153639716410892,0.0005779210784053448,0.0,0.0027355242,False,PIK3CA; phosphatidylinositol-4
hsa:197257,3.458448e-09,4.284938170007785e-06,3.905776094092079e-07,9.81100590340188e-07,0.0,7.2510425e-06,False,LDHD; lactate dehydrogenase
hsa:53832,0.0,0.0,6.805305868303963e-06,4.640524466509498e-05,0.0,0.00059071404,False,IL20RA; interleukin 20 receptor subunit
hsa:6873,2.51025e-07,0.00031101424804600336,1.4422540581980193e-06,4.948139680706214e-06,0.0,5.7546335e-05,False,TAF2; TATA-box binding protein associated factor
hsa:257194,4.37211795e-07,0.0005416954393338048,2.5294114110745557e-06,4.722171171187227e-06,0.0,3.05908e-05,False,NEGR1; neuronal growth regulator
hsa:7173,8.723409e-07,0.0010808104732726773,1.8235533145371286e-05,4.477052539696855e-05,0.0,0.00032361026,False,TPO; thyroid
hsa:4175,1.2473234500000002e-07,0.00015454052977667432,1.826834402440594e-05,4.055638962614107e-05,0.0,0.00027214424,False,MCM6; minichromosome maintenance complex component
hsa:7424,0.0,0.0,3.291132435872278e-05,9.775002186793925e-05,0.0,0.00075503846,False,VEGFC; vascular endothelial growth factor
hsa:23433,0.0,0.0,3.824100135056436e-06,2.6079097581192596e-05,0.0,0.00033185806,False,RHOQ; ras homolog family member
hsa:343170,0.0,0.0,2.6308458514851485e-07,1.141508176037483e-06,0.0,1.0926473e-05,False,OR14K1; olfactory receptor family 14 subfamily K member
hsa:8302,0.0,0.0,1.467327238980198e-07,5.192010567879874e-07,0.0,3.1832187e-06,False,KLRC4; killer cell lectin like receptor
hsa:26245,0.0,0.0,1.4711343487821782e-06,8.962463927383173e-06,0.0,7.4473086e-05,False,OR2M4; olfactory receptor family 2 subfamily M member
hsa:55062,0.0,0.0,3.3536026864316834e-05,0.00016318380471252888,0.0,0.00137107,False,WIPI1; WD repeat domain
hsa:4267,0.0,0.0,1.0357680645455446e-05,5.727078771961127e-05,0.0,0.0006087199,False,CD99; CD99 molecule (Xg blood
hsa:51116,0.0,0.0,1.7513875200252486e-07,4.950226714844726e-07,0.0,4.14175e-06,False,MRPS2; mitochondrial ribosomal protein
hsa:60673,0.0,0.0,2.656151789673268e-05,9.159421164450054e-05,0.0,0.0006445,False,ATG101; autophagy related
hsa:238,7.04387315e-07,0.000872719813197364,1.0948784313712867e-05,2.1915829056707606e-05,0.0,0.00011727527,False,ALK; ALK receptor tyrosine
hsa:6141,9.53954685e-09,1.1819280909281426e-05,3.8149630625594055e-07,1.0494571001907714e-06,0.0,7.513082e-06,False,RPL18; ribosomal protein
hsa:51091,5.7154750500000005e-06,0.007081343192516457,5.307389115400989e-05,9.482380248521287e-05,0.0,0.0006327744,False,SEPSECS; Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA
hsa:10189,3.3059069e-08,4.095943227222762e-05,7.196183128019801e-07,9.825553486624312e-07,0.0,4.407783e-06,False,ALYREF; Aly/REF export
hsa:92579,0.00026208043,0.324711673594356,0.000916045795371287,0.0014135917487676974,0.0,0.011432097,False,G6PC3; glucose-6-phosphatase catalytic subunit
hsa:1875,5.14667455e-08,6.376612349788877e-05,3.597774986817327e-05,0.00011289592679514636,0.0,0.00077795365,False,E2F5; E2F transcription factor
hsa:55367,0.0,0.0,3.44294566489604e-05,9.334698709174509e-05,0.0,0.0004664417,False,PIDD1; p53-induced death domain protein
hsa:10445,5.10713775e-08,6.327627156592401e-05,2.5456948773435637e-06,8.107024680317666e-06,0.0,4.8054422e-05,False,MCRS1; microspherule protein
hsa:495,0.0,0.0,9.641099807198025e-07,3.927273102894952e-06,0.0,4.413112e-05,False,ATP4A; ATPase H+/K+ transporting subunit
hsa:11253,2.1515412e-06,0.0026657104609421204,0.00020874019185204934,0.00040009665828389214,0.0,0.0017271554,False,MAN1B1; mannosidase alpha class 1B member
hsa:6506,4.3557666e-06,0.005396695443732284,4.909951181772773e-05,0.00011155563538129833,0.0,0.0010819988,False,SLC1A2; solute carrier family 1 member
hsa:5554,5.85834335e-06,0.007258353756779422,9.915156740168316e-05,0.00015721643636186126,0.0,0.00079969864,False,PRH1; proline rich protein HaeIII subfamily
hsa:2918,1.89315325e-05,0.023455736858265006,0.0001432723002872376,0.0003183257256953859,0.0,0.002144335,False,GRM8; glutamate metabotropic receptor
hsa:53349,4.83847975e-09,5.994766023830552e-06,4.4475307779816846e-07,9.227089044173388e-07,0.0,4.4789967e-06,False,ZFYVE1; zinc finger FYVE-type containing
hsa:3385,1.6694507e-07,0.0002068411329988543,2.3685242310574252e-06,6.638797265476219e-06,0.0,6.439112e-05,False,ICAM3; intercellular adhesion molecule
hsa:3718,1.6150856e-05,0.020010542113890178,0.00015402298083267324,0.00026143760465349345,0.0,0.001444174,False,JAK3; Janus kinase
hsa:887,0.0,0.0,1.0429320522148517e-05,6.922401679839275e-05,0.0,0.0009291395,False,CCKBR; cholecystokinin B
hsa:122786,0.0,0.0,0.00010277837533712873,0.00032754355861430007,0.0,0.002607049,False,FRMD6; FERM domain containing
hsa:6850,1.65061105e-06,0.0020450694334515447,3.1212038515396044e-05,8.143445153961088e-05,0.0,0.0006816879,False,SYK; spleen associated tyrosine
hsa:114786,0.0,0.0,6.686613756162723e-06,3.6631032473630456e-05,0.0,0.00031787486,False,XKR4; XK related
hsa:11146,0.0,0.0,2.720993150541089e-07,1.6748826843056287e-06,0.0,1.6097105e-05,False,GLMN; glomulin
hsa:406959,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR183; microRNA
hsa:27343,3.53899e-08,4.3847278705002506e-05,6.564908146245541e-05,0.0001980894099454882,0.0,0.0017681272,False,POLL; DNA polymerase
hsa:6810,3.76419335e-06,0.004663749683298541,0.00017234946760282178,0.00048671691529863413,0.0,0.0034711028,False,STX4; syntaxin
hsa:341416,0.0,0.0,1.3092047524752475e-07,1.860729563769437e-06,-0.0,2.6445936e-05,False,OR6C2; olfactory receptor family 6 subfamily C member
hsa:117145,1.0749721e-09,1.3318659071882605e-06,5.67323264715802e-05,0.00019863583265870838,0.0,0.0012174774,False,THEM4; thioesterase superfamily member
hsa:5048,5.24323385e-07,0.0006496247119558216,2.8690349969871277e-05,6.864304073881233e-05,0.0,0.0006464494,False,PAFAH1B1; platelet activating factor acetylhydrolase 1b regulatory subunit
hsa:89,1.7795159e-08,2.2047796017305325e-05,1.8457560075945535e-06,1.0078876976942467e-05,0.0,0.00013149677,False,ACTN3; actinin alpha
hsa:10870,0.0,0.0,2.524168781442425e-05,8.527552039007592e-05,0.0,0.00052921247,False,HCST; hematopoietic cell signal
hsa:80824,3.61231295e-08,4.475573332740125e-05,8.486644803123764e-05,0.0001823603691074375,0.0,0.0010803085,False,DUSP16; dual specificity phosphatase
hsa:4233,0.0,0.0,2.03281324969307e-05,6.9246362619916e-05,0.0,0.00062961807,False,MET; MET proto-oncogene
hsa:7224,0.0,0.0,2.954697754607425e-06,1.1494291162810566e-05,0.0,0.000106232255,False,TRPC5; transient receptor potential cation channel subfamily C member
hsa:50836,1.34200555e-05,0.016627142595630442,6.74217715846535e-05,0.00012040235989704233,0.0,0.00076588785,False,TAS2R8; taste 2 receptor member
hsa:2352,0.0,0.0,1.8181726387934656e-05,0.00012545015985809729,0.0,0.0016868723,False,FOLR3; folate receptor
hsa:26689,0.0,0.0,4.861446445376237e-06,2.4152396057528033e-05,-0.0,0.0002511349,False,OR4D1; olfactory receptor family 4 subfamily D member
hsa:9569,5.22371065e-07,0.0006472058320165918,8.621384339218807e-05,0.0002667231045424828,0.0,0.0017699802,False,GTF2IRD1; GTF2I repeat domain containing
hsa:6259,0.0,0.0,1.8197711959348012e-06,6.082026824436277e-06,0.0,6.111943e-05,False,RYK; receptor like tyrosine
hsa:84284,0.0,0.0,6.252828401420793e-05,0.0001423535426340841,0.0,0.00096170563,False,NTPCR; nucleoside-triphosphatase
hsa:147686,0.0,0.0,5.819739181529703e-08,1.398988144092323e-07,0.0,8.792239e-07,False,ZNF418; zinc finger protein
hsa:64422,0.0,0.0,0.00022085668850102473,0.0006252694652743348,0.0,0.0038722118,False,ATG3; autophagy related
hsa:1261,1.1974904999999998e-06,0.00148366340961949,4.400701370044553e-05,0.0001542202677104434,0.0,0.0014596058,False,CNGA3; cyclic nucleotide gated channel subunit alpha
hsa:2107,3.1811349e-07,0.00039413535658057886,1.1260878760628716e-06,1.82439086761372e-06,0.0,1.0057772e-05,False,ETF1; eukaryotic translation termination factor
hsa:4085,0.0,0.0,5.582715921287131e-05,0.00015399986279676802,0.0,0.0009715619,False,MAD2L1; mitotic arrest deficient 2 like
hsa:1432,0.0,0.0,0.00016669716655940602,0.0003269749533188864,0.0,0.0016130541,False,MAPK14; mitogen-activated protein kinase
hsa:6655,0.00015849522,0.19637196162607656,0.00020712304789603965,0.00024022845064249594,0.0,0.001291887,False,SOS2; SOS Ras/Rho guanine nucleotide exchange factor
hsa:127077,0.0,0.0,3.0208146386138616e-07,2.711674199906959e-06,-0.0,3.4037497e-05,False,OR2T11; olfactory receptor family 2 subfamily T member
hsa:440,0.0,0.0,0.00012428917069259892,0.00038221006976102466,0.0,0.0026224921,False,ASNS; asparagine synthetase
hsa:3675,0.0,0.0,0.0002118619817217822,0.00043840501227442486,0.0,0.002824219,False,ITGA3; integrin subunit alpha
hsa:7855,4.8185775e-06,0.005970107590136005,3.507953727653465e-05,7.160210645293725e-05,0.0,0.0006312426,False,FZD5; frizzled class receptor
hsa:4259,0.0,0.0,0.0006960494520940593,0.0014224667293191915,0.0,0.007311181,False,MGST3; microsomal glutathione S-transferase
hsa:8720,8.081486e-09,1.0012776780736196e-05,3.816239235138617e-07,1.0755568457461962e-06,0.0,1.0162094e-05,False,MBTPS1; membrane bound transcription factor peptidase
hsa:4629,0.0,0.0,7.12220167619604e-06,4.503599508366481e-05,0.0,0.00059889874,False,MYH11; myosin heavy chain
hsa:11105,0.0,0.0,5.03396730139302e-07,2.450095766480147e-06,-0.0,2.1328486e-05,False,PRDM7; PR/SET domain
hsa:9475,4.200398e-08,5.2041972929546314e-05,4.995719428613862e-05,0.00010127757108435056,0.0,0.0009863063,False,ROCK2; Rho associated coiled-coil containing protein kinase
hsa:5731,3.4527952e-08,4.277934479772332e-05,4.657280802733167e-06,1.529111503363549e-05,0.0,0.0001072182,False,PTGER1; prostaglandin E receptor
hsa:10213,0.0,0.0,3.4337787280693067e-06,9.76807367790232e-06,0.0,7.430378e-05,False,PSMD14; proteasome 26S subunit
hsa:8821,0.0,0.0,1.9436972041534656e-06,9.574477272454034e-06,0.0,7.564485e-05,False,INPP4B; inositol polyphosphate-4-phosphatase type II
hsa:966,0.0,0.0,6.0632346778415836e-05,0.00021510111762542393,0.0,0.0016655106,False,CD59; CD59 molecule (CD59 blood
hsa:28514,0.0,0.0,4.233105310871287e-05,9.183286430778329e-05,0.0,0.00053522945,False,DLL1; delta like canonical Notch ligand
hsa:574467,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520A; microRNA
hsa:1390,0.0,0.0,2.4485907701158423e-06,7.0205862264046615e-06,0.0,4.993553e-05,False,CREM; cAMP responsive element
hsa:84699,0.0,0.0,5.68126206837624e-05,0.00029378006880025396,0.0,0.0027299498,False,CREB3L3; cAMP responsive element binding protein 3 like
hsa:6233,1.92388835e-06,0.0023836537735274018,2.0148729523366325e-05,4.403338903345794e-05,0.0,0.0002921667,False,RPS27A; ribosomal protein
hsa:8884,6.547245999999999e-05,0.08111888423313228,0.0007887207664004453,0.001395276146901793,0.0,0.006650496,False,SLC5A6; solute carrier family 5 member
hsa:1909,0.0,0.0,7.439954029232672e-05,0.00045169380666651134,0.0,0.0055102143,False,EDNRA; endothelin receptor type
hsa:23643,0.0,0.0,2.8751976038712858e-05,7.453461739890686e-05,0.0,0.00044903226,False,LY96; lymphocyte antigen
hsa:5340,0.0,0.0,9.182847895846534e-06,4.373872573328253e-05,0.0,0.00037491185,False,PLG;
hsa:10690,4.2280712e-06,0.005238483756410569,0.00040908319690841565,0.0006880290519896934,0.0,0.0032133537,False,FUT9; fucosyltransferase
hsa:2735,0.0,0.0,6.12616547029703e-05,0.00030678415193013107,0.0,0.0037667458,False,GLI1; GLI family zinc finger
hsa:26260,0.0,0.0,1.298396966892079e-06,2.9443172570450826e-06,0.0,1.8872512e-05,False,FBXO25; F-box protein
hsa:100310812,2.9736922e-08,3.6843367931611007e-05,3.684629741173269e-06,1.3664715541071454e-05,0.0,0.00010192709,False,SPDYE2B; speedy/RINGO cell cycle regulator family member
hsa:3601,0.0,0.0,3.129190448699999e-05,7.931018513567964e-05,0.0,0.0006201723,False,IL15RA; interleukin 15 receptor subunit
hsa:29992,1.23305625e-06,0.0015277285624626022,0.0002548205115539603,0.0008391480057231058,0.0,0.008299543,False,PILRA; paired immunoglobin like type 2 receptor
hsa:11221,0.0,0.0,9.502130558811882e-08,2.9289490424211333e-07,0.0,3.2221817e-06,False,DUSP10; dual specificity phosphatase
hsa:3909,0.0,0.0,3.332139253497526e-05,9.224923235908188e-05,0.0,0.00073953543,False,LAMA3; laminin subunit alpha
hsa:10782,2.57629335e-08,3.191968684378723e-05,1.5215340527425741e-06,2.9045288260328285e-06,0.0,1.9309131e-05,False,ZNF274; zinc finger protein
hsa:4647,0.0,0.0,1.10323341969802e-07,5.571658751518762e-07,0.0,7.248421e-06,False,MYO7A; myosin
hsa:2786,0.00010384083,0.12865641931649383,0.0005132767499717821,0.0009251758978003522,0.0,0.0059060794,False,GNG4; G protein subunit gamma
hsa:100526767,0.0,0.0,1.1344165065261883e-05,6.471038614045873e-05,0.0,0.00065362855,False,RNF103-CHMP3; RNF103-CHMP3
hsa:343171,0.0,0.0,2.8640453426237624e-05,0.00012217282342359906,0.0,0.0010751194,False,OR2W3; olfactory receptor family 2 subfamily W member
hsa:5027,0.0,0.0,2.2808143631089106e-06,9.318259509574885e-06,0.0,8.59544e-05,False,P2RX7; purinergic receptor P2X
hsa:7421,0.0,0.0,2.540022876215842e-05,8.894747148652757e-05,0.0,0.0006792574,False,VDR; vitamin D
hsa:55650,1.1444592e-07,0.00014179588387902822,1.8112124220148513e-05,4.0943944120369047e-05,0.0,0.00024599067,False,PIGV; phosphatidylinositol glycan anchor biosynthesis class
hsa:1915,5.0786996e-06,0.006292392937538245,3.920904985064356e-05,7.295818589043723e-05,0.0,0.00039977764,False,EEF1A1; eukaryotic translation elongation factor 1 alpha
hsa:57521,9.548082800000001e-07,0.0011829856756589896,0.00026749639699801973,0.000811447890646134,0.0,0.009615239,False,RPTOR; regulatory associated protein of MTOR complex
hsa:5146,0.0,0.0,2.709456394186633e-08,1.1627395244799297e-07,0.0,1.0273822e-06,False,PDE6C; phosphodiesterase
hsa:719,0.0,0.0,4.1709719441702966e-05,0.00015015231731311794,0.0,0.0013483948,False,C3AR1; complement C3a receptor
hsa:2122,1.97324965e-08,2.4448112980850082e-05,1.066824288016337e-05,6.938273401468055e-05,0.0,0.0009435885,False,MECOM; MDS1 and EVI1 complex
hsa:11211,0.0,0.0,8.748238824282179e-06,4.0759661563866996e-05,0.0,0.0005240368,False,FZD10; frizzled class receptor
hsa:729759,0.0,0.0,2.4200149566237615e-05,0.00011623466939790592,0.0,0.0014884126,False,OR4F29; olfactory receptor family 4 subfamily F member
hsa:3284,0.0,0.0,1.0720402596905931e-05,7.420251828122e-05,0.0,0.0009015716,False,HSD3B2; hydroxy-delta-5-steroid dehydrogenase
hsa:51540,2.74136335e-05,0.03396486648425945,0.00041788911875396034,0.0008160310110750556,0.0,0.0044866744,False,SCLY; selenocysteine
hsa:8843,0.0,0.0,9.141872165965347e-07,1.2406362775841788e-05,0.0,0.00017635361,False,HCAR3; hydroxycarboxylic acid receptor
hsa:2145,1.6277373e-08,2.0167293790496236e-05,1.0991044897950495e-05,4.201184441915495e-05,0.0,0.00044170456,False,EZH1; enhancer of zeste 1 polycomb repressive complex 2
hsa:1635,0.0,0.0,3.9475231756949505e-05,0.00022137706119563288,0.0,0.0021803188,False,DCTD; dCMP
hsa:2002,2.72025035e-07,0.0003370328123103785,2.574421600381188e-05,5.4398468580412736e-05,0.0,0.00045354068,False,ELK1; ETS transcription factor
hsa:10607,0.0,0.0,3.995346478149506e-07,1.4257741041642152e-06,0.0,1.3025397e-05,False,TBL3; transducin beta like
hsa:574452,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR494; microRNA
hsa:4323,0.0,0.0,3.1745706162935644e-05,0.00013906427349570739,0.0,0.0010558978,False,MMP14; matrix metallopeptidase
hsa:54512,0.0,0.0,2.7399833297504936e-06,2.1300018106100474e-05,0.0,0.0002391219,False,EXOSC4; exosome component
hsa:5409,0.0,0.0,0.00013408070118985148,0.0004268681934393747,0.0,0.0033001914,False,PNMT; phenylethanolamine
hsa:6173,4.864720749999999e-07,0.0006027278024161097,1.4543019128019807e-06,1.9622833367015143e-06,0.0,7.5633184e-06,False,RPL36A; ribosomal protein
hsa:55605,0.0,0.0,1.789552832331684e-07,6.065950688765444e-07,0.0,5.1622114e-06,False,KIF21A; kinesin family member
hsa:1017,0.0,0.0,7.86711488892574e-05,0.0002479436770469292,0.0,0.0019283528,False,CDK2; cyclin dependent kinase
hsa:7148,0.0,0.0,2.330325047226733e-05,0.00014170424907897854,0.0,0.0016471216,False,TNXB; tenascin
hsa:5783,9.359566e-11,1.1596288742264472e-07,7.262545858169308e-07,2.9029244558722517e-06,0.0,3.3306427e-05,False,PTPN13; protein tyrosine phosphatase non-receptor type
hsa:341799,0.0,0.0,5.163014108910891e-07,4.406642902985701e-06,-0.0,4.9168728e-05,False,OR6S1; olfactory receptor family 6 subfamily S member
hsa:2643,0.0,0.0,3.5598443686633663e-06,9.17776663892563e-06,0.0,6.183714e-05,False,GCH1; GTP cyclohydrolase
hsa:88,3.3446291000000002e-06,0.004143919149603749,7.543802411019801e-05,0.00015580213124795518,0.0,0.0009665924,False,ACTN2; actinin alpha
hsa:1562,2.2286016e-05,0.02761186538464774,7.362096214297027e-05,0.00013801534751964266,0.0,0.0012754936,False,CYP2C18; cytochrome P450 family 2 subfamily C member
hsa:10058,6.8697242e-05,0.08511431556006104,0.0009357922236032673,0.002447330616067945,0.0,0.014914965,False,ABCB6; ATP binding cassette subfamily B member 6 (Langereis blood
hsa:6482,0.0,0.0,0.00015380527322920792,0.0004543267243531641,0.0,0.0042159823,False,ST3GAL1; ST3 beta-galactoside alpha-2
hsa:26086,0.0,0.0,0.00010995668679131183,0.00023383304604678338,0.0,0.0016915934,False,GPSM1; G protein signaling modulator
hsa:26585,1.76932615e-07,0.00021921547339523158,2.6223686208688125e-05,9.512913668305207e-05,0.0,0.00084333186,False,GREM1; gremlin 1
hsa:3099,0.0,0.0,0.0001114706232069307,0.0003630704641266936,0.0,0.0021139113,False,HK2; hexokinase
hsa:1808,7.33636135e-07,0.0009089584338866694,2.7277389684138595e-05,0.00010432299944921871,0.0,0.0010412191,False,DPYSL2; dihydropyrimidinase like
hsa:79133,4.1336230499999996e-08,5.1214646533268676e-05,5.828395527227723e-07,2.045591290191429e-06,0.0,1.9992114e-05,False,NDUFAF5; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:9031,0.0,0.0,7.098687120754952e-06,2.3567274454380554e-05,0.0,0.00015971086,False,BAZ1B; bromodomain adjacent to zinc finger domain
hsa:4314,0.0,0.0,7.44708669108911e-07,4.982576068153415e-06,0.0,5.8008092e-05,False,MMP3; matrix metallopeptidase
hsa:25984,1.0293441e-08,1.2753338561581119e-05,8.634221253504949e-06,2.5580417261888042e-05,0.0,0.0001661853,False,KRT23; keratin
hsa:4087,4.98180565e-05,0.06172343544053703,0.00028038087203346545,0.0004623811268067631,0.0,0.0030174048,False,SMAD2; SMAD family member
hsa:100506658,1.0628611e-06,0.0013168606544919747,3.324643941935593e-05,8.057276934513479e-05,0.0,0.00050647877,False,OCLN;
hsa:1027,8.418957500000001e-05,0.10430896270067765,0.00022664697925049512,0.00029256762439096903,0.0,0.0015895598,False,CDKN1B; cyclin dependent kinase inhibitor
hsa:130589,0.0,0.0,6.326780538205443e-05,0.00017615072412262994,0.0,0.001120162,False,GALM; galactose
hsa:57148,0.0,0.0,3.374654792376238e-07,6.566483902697397e-07,0.0,4.1113212e-06,False,RALGAPB; Ral GTPase activating protein non-catalytic subunit
hsa:6881,6.642944e-08,8.230456062032506e-05,4.552947096465346e-06,2.343923539628108e-05,0.0,0.0002386102,False,TAF10; TATA-box binding protein associated factor
hsa:1495,0.0,0.0,5.591918120762377e-05,0.00013594380886045425,0.0,0.0009519616,False,CTNNA1; catenin alpha
hsa:100137049,0.00028265013,0.3501970626115132,0.0009257023610403966,0.0018066355339501788,0.0,0.009259788,False,PLA2G4B; phospholipase A2 group
hsa:162966,4.5320334999999996e-09,5.615086111430322e-06,2.0957069127524757e-08,3.83891361950561e-08,0.0,3.4292614e-07,False,ZNF600; zinc finger protein
hsa:5244,0.0,0.0,0.0002098908728618812,0.00042690011157852314,0.0,0.002733561,False,ABCB4; ATP binding cassette subfamily B member
hsa:6539,0.0,0.0,1.1613888772544556e-05,4.8761703187464586e-05,0.0,0.0006305966,False,SLC6A12; solute carrier family 6 member
hsa:54831,5.22880245e-09,6.4783669442001785e-06,3.1389725753064346e-06,7.687155037184989e-06,0.0,5.0855586e-05,False,BEST2; bestrophin
hsa:79633,5.87924435e-05,0.07284249618938207,0.00020785537392574262,0.00041644180850880616,0.0,0.003630293,False,FAT4; FAT atypical cadherin
hsa:58510,0.0,0.0,2.6558734058777237e-06,2.279061635667524e-05,0.0,0.00032128292,False,PRODH2; proline dehydrogenase
hsa:51763,1.0020955e-07,0.00012415734624152326,1.6994192300130193e-05,5.8109277643766324e-05,0.0,0.0004121404,False,INPP5K; inositol polyphosphate-5-phosphatase
hsa:390437,0.0,0.0,5.4005836633663366e-09,7.675671559423263e-08,-0.0,1.0909179e-06,False,OR4N5; olfactory receptor family 4 subfamily N member
hsa:4359,1.3451797e-07,0.00016666469589971054,4.506532096709903e-06,1.0503252691629209e-05,0.0,6.5083674e-05,False,MPZ; myelin protein
hsa:2318,0.0,0.0,6.85517745049505e-07,1.7444527281545478e-06,0.0,1.330711e-05,False,FLNC; filamin
hsa:8800,3.2376208e-07,0.00040113383072207937,0.0001083193288761639,0.000402893653567402,0.0,0.0027158633,False,PEX11A; peroxisomal biogenesis factor 11
hsa:3329,5.9042457e-05,0.07315225721200473,0.00012710457989527726,0.00018295687497650153,0.0,0.0009261568,False,HSPD1; heat shock protein family D (Hsp60) member
hsa:84679,0.0,0.0,3.3407086798574256e-05,0.00010225071785277286,0.0,0.00072070415,False,SLC9A7; solute carrier family 9 member
hsa:122742,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4L1; olfactory receptor family 4 subfamily L member
hsa:163051,0.0,0.0,5.528416945049506e-08,1.041368011825676e-07,0.0,4.4853968e-07,False,ZNF709; zinc finger protein
hsa:6519,3.3416724500000003e-06,0.004140255927707582,2.4177903331282178e-05,4.561746886224319e-05,0.0,0.00037075908,False,SLC3A1; solute carrier family 3 member
hsa:6170,1.2858989e-07,0.0001593199400245724,5.670814491163365e-07,8.219003613357172e-07,0.0,3.3848557e-06,False,RPL39; ribosomal protein
hsa:158,2.0944258e-05,0.025949457833887028,0.00013462493422151985,0.00040952637599589795,0.0,0.00254036,False,ADSL; adenylosuccinate
hsa:219436,0.0,0.0,8.112040891089109e-08,7.429412838313428e-07,0.0,8.105255e-06,False,OR5D14; olfactory receptor family 5 subfamily D member
hsa:152002,0.0,0.0,4.278848348445542e-05,0.0001504263026524277,0.0,0.0018010709,False,XXYLT1; xyloside xylosyltransferase
hsa:3458,2.0737941e-06,0.0025693835777860306,4.966851509938121e-05,0.000130356912494204,0.0,0.0010458968,False,IFNG; interferon
hsa:4758,1.176774e-05,0.014579961387514693,0.00014018171780346537,0.0002733800794864631,0.0,0.0016843713,False,NEU1; neuraminidase
hsa:90423,1.55307805e-05,0.019242282715964672,0.00014094424077014847,0.0002232894623604179,0.0,0.0012327863,False,ATP6V1E2; ATPase H+ transporting V1 subunit
hsa:4718,0.0,0.0,1.467450856768317e-06,5.332269627661956e-06,0.0,4.069191e-05,False,NDUFC2; NADH:ubiquinone oxidoreductase subunit
hsa:115362,0.0,0.0,1.164561254381188e-07,3.7779589926488023e-07,0.0,4.109019e-06,False,GBP5; guanylate binding protein
hsa:314,5.41640335e-05,0.06710800179321197,0.000273499540019802,0.0004818324966254772,0.0,0.0032994114,False,AOC2; amine oxidase copper containing
hsa:23192,5.3654378e-06,0.006647655025613396,0.00020539356974840078,0.0004732336314629888,0.0,0.0028253759,False,ATG4B; autophagy related 4B cysteine
hsa:2829,7.12588705e-08,8.82881148298577e-05,1.0484815587413367e-05,2.877322820679099e-05,0.0,0.00018186068,False,XCR1; X-C motif chemokine receptor
hsa:26538,0.0,0.0,9.621967311881188e-08,1.16988716027161e-06,-0.0,1.6515045e-05,False,OR10H2; olfactory receptor family 10 subfamily H member
hsa:9636,0.0,0.0,1.4794347275445548e-05,9.134596708627636e-05,0.0,0.0009513548,False,ISG15; ISG15 ubiquitin like
hsa:9069,4.1768572999999995e-06,0.005175030902718692,0.00010020229971915848,0.00018841414912883743,0.0,0.0008644418,False,CLDN12; claudin
hsa:400720,9.5960285e-09,1.188926038504339e-05,5.3851315080495084e-08,9.042866956671672e-08,0.0,4.6124586e-07,False,ZNF772; zinc finger protein
hsa:1376,5.93230865e-06,0.007349995076014545,9.919281995410888e-05,0.0003122309074882102,0.0,0.0027652134,False,CPT2; carnitine palmitoyltransferase
hsa:90576,0.0,0.0,1.824332837594059e-08,4.097933475672603e-08,0.0,3.0954462e-07,False,ZNF799; zinc finger protein
hsa:6820,0.0,0.0,5.83553921914208e-06,3.0181708528770558e-05,0.0,0.0003497977,False,SULT2B1; sulfotransferase family 2B member
hsa:5217,4.65095235e-08,5.7624238535326856e-05,2.5634160298079212e-05,8.114572886692475e-05,0.0,0.000402997,False,PFN2; profilin
hsa:116150,5.049363999999999e-07,0.0006256046798408762,0.00010018273501364504,0.00036531211195902263,0.0,0.0025428024,False,NUS1; NUS1 dehydrodolichyl diphosphate synthase
hsa:1622,0.0,0.0,7.015594499148018e-05,0.0002639385329446672,0.0,0.0023670625,False,DBI; diazepam binding inhibitor
hsa:8766,0.0,0.0,0.0001938784364052971,0.0005140191949238175,0.0,0.0030157568,False,RAB11A; RAB11A
hsa:3111,0.0,0.0,0.00015093889715049505,0.0006058193622698686,0.0,0.004199338,False,HLA-DOA; major histocompatibility complex
hsa:4747,0.0,0.0,2.8443247326188118e-08,5.6303717202897754e-08,0.0,3.2590168e-07,False,NEFL; neurofilament light
hsa:126541,0.0,0.0,4.307704306930693e-09,6.122398151036716e-08,0.0,8.7015627e-07,False,OR10H4; olfactory receptor family 10 subfamily H member
hsa:64145,0.0,0.0,2.2957495917574255e-07,4.95220971879628e-07,0.0,3.3145789e-06,False,RBSN; rabenosyn
hsa:26354,2.51728335e-09,3.1188566406492352e-06,3.0041219319787116e-06,7.820834984707158e-06,0.0,4.2166193e-05,False,GNL3; G protein nucleolar
hsa:11232,0.0,0.0,2.9158360934222756e-06,1.2046099531763663e-05,0.0,0.00010607105,False,POLG2; DNA polymerase gamma 2
hsa:64983,7.2229277e-09,8.949042634423458e-06,1.4696424537079212e-07,2.4602353126229527e-07,0.0,9.723335e-07,False,MRPL32; mitochondrial ribosomal protein
hsa:8452,0.0,0.0,9.689896019950494e-05,0.00031908024584018096,0.0,0.0027338532,False,CUL3; cullin
hsa:9429,0.0,0.0,0.00014864658783683167,0.00039695734132958236,0.0,0.0026690923,False,ABCG2; ATP binding cassette subfamily G member 2 (Junior blood
hsa:391196,0.0,0.0,3.471408366336634e-07,3.571388508100535e-06,-0.0,4.3107386e-05,False,OR2M7; olfactory receptor family 2 subfamily M member
hsa:58494,0.0,0.0,2.1927140254826733e-05,0.00013850594748088428,0.0,0.00136184,False,JAM2; junctional adhesion molecule
hsa:8683,1.6518709e-07,0.00020466303588589772,4.583017007970297e-07,5.81728641550679e-07,0.0,2.8418724e-06,False,SRSF9; serine and arginine rich splicing factor
hsa:390037,0.0,0.0,3.3348710182920787e-06,1.2639221214803923e-05,0.0,9.787104e-05,False,OR52I1; olfactory receptor family 52 subfamily I member
hsa:26063,6.324379349999999e-07,0.0007835761728504816,0.00011693967673444054,0.00045626932928213984,0.0,0.0030171615,False,DECR2; 2
hsa:493911,2.76837785e-06,0.0034299569976096464,0.00011041404696270788,0.00026368242607403223,0.0,0.0014837991,False,PHOSPHO2; phosphatase
hsa:146198,0.0,0.0,9.689471170495052e-08,2.3835772381065195e-07,0.0,1.3020908e-06,False,ZFP90; ZFP90 zinc finger
hsa:55284,0.0,0.0,3.494018239371287e-07,1.0655155126692017e-06,0.0,6.6838884e-06,False,UBE2W; ubiquitin conjugating enzyme E2
hsa:5797,3.40638335e-07,0.0004220431256475155,3.8688513890217834e-05,0.00011251395300671175,0.0,0.0006595213,False,PTPRM; protein tyrosine phosphatase receptor type
hsa:1727,0.0,0.0,2.8020576421227718e-05,6.37204569395993e-05,0.0,0.00034484803,False,CYB5R3; cytochrome b5 reductase
hsa:5801,2.17451295e-08,2.694171935108242e-05,3.2901623313277237e-07,9.323367893153084e-07,0.0,7.753064e-06,False,PTPRR; protein tyrosine phosphatase receptor type
hsa:250,0.0,0.0,1.1465367180198019e-07,7.190758503115182e-07,0.0,8.802583e-06,False,ALPP; alkaline phosphatase
hsa:23410,2.09308065e-05,0.025932791732273277,0.0002064314362538614,0.0004364869522756179,0.0,0.0028226261,False,SIRT3; sirtuin
hsa:165324,0.0,0.0,5.937652274702967e-08,1.2964282169086753e-07,0.0,9.505543e-07,False,UBXN2A; UBX domain protein
hsa:79814,2.9509412000000002e-08,3.656148823208727e-05,2.893391082458069e-06,1.0268690552787183e-05,0.0,9.730674e-05,False,AGMAT;
hsa:54926,1.111451075e-07,0.0001377062524971804,4.541474458960395e-07,6.211508610807648e-07,0.0,2.9164926e-06,False,UBE2R2; ubiquitin conjugating enzyme E2
hsa:115727,0.0,0.0,1.3986077010891094e-07,4.0589069977963616e-07,0.0,4.218755e-06,False,RASGRP4; RAS guanyl releasing protein
hsa:1849,0.0,0.0,2.040943744065757e-05,6.455050805599387e-05,0.0,0.00073328195,False,DUSP7; dual specificity phosphatase
hsa:8925,0.0,0.0,7.25263881021089e-07,1.6114288912393531e-06,0.0,1.006226e-05,False,HERC1; HECT and RLD domain containing E3 ubiquitin protein ligase family member
hsa:50834,0.0,0.0,4.384890516009902e-05,0.0001037749492755082,-0.0,0.0009063503,False,TAS2R1; taste 2 receptor member
hsa:260425,2.21848165e-07,0.00027486481512941215,1.1328150638450495e-06,2.5257579508124238e-06,0.0,1.5279478e-05,False,MAGI3; membrane associated guanylate kinase
hsa:8325,1.1916637e-06,0.0014764441373537223,5.412137183777227e-05,0.00017094937384766793,0.0,0.001710725,False,FZD8; frizzled class receptor
hsa:90321,0.0,0.0,8.989172936386144e-08,1.9214341577065604e-07,0.0,8.1514287e-07,False,ZNF766; zinc finger protein
hsa:6786,1.8034208e-06,0.002234397227457511,4.763636004177227e-06,7.593934594201023e-06,0.0,7.099394e-05,False,STIM1; stromal interaction molecule
hsa:55256,0.0,0.0,7.798203386057422e-05,0.00021284244978100417,0.0,0.0014817239,False,ADI1; acireductone dioxygenase
hsa:9245,0.0,0.0,6.925774281055248e-06,2.709752617996735e-05,0.0,0.0002233291,False,GCNT3; glucosaminyl (N-acetyl) transferase 3
hsa:81696,0.0,0.0,3.5748216584158416e-08,4.6012983170210434e-07,0.0,6.5225818e-06,False,OR5V1; olfactory receptor family 5 subfamily V member
hsa:548596,1.9987088499999997e-06,0.002476354666051756,7.611131752180692e-05,0.0001677802772787691,0.0,0.00082483195,False,CKMT1A; creatine kinase
hsa:2200,2.29645565e-07,0.00028452561583736514,4.808254748672773e-05,0.00018591914392567188,0.0,0.0014051601,False,FBN1; fibrillin
hsa:3695,0.0,0.0,6.582922126485148e-05,0.00014721842040859933,0.0,0.0011125546,False,ITGB7; integrin subunit beta
hsa:2585,0.0,0.0,9.604502459381188e-06,3.164951334468133e-05,0.0,0.00025271342,False,GALK2; galactokinase
hsa:80145,0.0,0.0,2.553975759855941e-07,6.282124468774877e-07,0.0,3.6946633e-06,False,THOC7; THO complex subunit
hsa:1504,0.0,0.0,3.696311748217822e-07,1.6984431556266713e-06,0.0,1.2986233e-05,False,CTRB1; chymotrypsinogen
hsa:1740,5.538446150000001e-07,0.0006862008424202898,1.025402097942079e-05,2.444504418802841e-05,0.0,0.00016823731,False,DLG2; discs large MAGUK scaffold protein
hsa:8106,1.62522305e-07,0.00020136142806604208,5.3005436628703264e-05,0.00016363136767510422,0.0,0.0008118723,False,PABPN1; poly(A) binding protein nuclear
hsa:55233,0.00013657449,0.16921267726169267,0.0005749040074950494,0.0011224283589932127,0.0,0.008314353,False,MOB1A; MOB kinase activator
hsa:22936,0.0,0.0,8.984657625836637e-06,3.270014380129178e-05,0.0,0.00023808489,False,ELL2; elongation factor for RNA polymerase II
hsa:26013,0.0,0.0,0.00014908480102557585,0.0006349363948078541,0.0,0.0047417046,False,L3MBTL1; L3MBTL histone methyl-lysine binding protein
hsa:89801,4.8231575e-08,5.975782105646615e-05,1.0451386319188118e-06,2.18170813216106e-06,0.0,1.1804442e-05,False,PPP1R3F; protein phosphatase 1 regulatory subunit
hsa:140469,0.0,0.0,4.7692100694504965e-09,3.3905414212018545e-08,0.0,4.415841e-07,False,MYO3B; myosin
hsa:8942,0.0,0.0,2.115562849691583e-05,7.238868003819147e-05,0.0,0.00066600554,False,KYNU;
hsa:7089,3.74810225e-08,4.643813177505361e-05,9.04603855634208e-05,0.0005878111957244742,0.0,0.0063888323,False,TLE2; TLE family member 2
hsa:79981,0.0,0.0,1.97258016390099e-05,8.910047897123256e-05,0.0,0.0008284105,False,FRMD1; FERM domain containing
hsa:55627,4.7360612e-06,0.005867871776985768,3.860331159029702e-05,8.449868162120448e-05,0.0,0.00059809745,False,SMPD4; sphingomyelin phosphodiesterase
hsa:1108,0.0,0.0,1.3598897400297024e-06,4.716787690867824e-06,0.0,3.406736e-05,False,CHD4; chromodomain helicase DNA binding protein
hsa:390058,0.0,0.0,1.3852960965346535e-07,9.829329902163695e-07,0.0,9.132132e-06,False,OR51B6; olfactory receptor family 51 subfamily B member
hsa:2074,1.5012335500000002e-07,0.00018599941188912747,1.5081098539242576e-06,3.2962720221473533e-06,0.0,2.0180667e-05,False,ERCC6; ERCC excision repair 6
hsa:23600,4.1602991499999995e-05,0.0515451573263092,0.00016817198752945545,0.0003201075399540596,0.0,0.0022262568,False,AMACR; alpha-methylacyl-CoA
hsa:55711,8.713307999999999e-07,0.0010795589824173788,7.646475379004951e-05,0.00016172560608627154,0.0,0.00094570336,False,FAR2; fatty acyl-CoA reductase
hsa:408,0.0,0.0,0.00012409360161673267,0.00034906196480442414,0.0,0.0022077118,False,ARRB1; arrestin beta
hsa:256435,0.0,0.0,0.0001269813212366337,0.0003306950568054371,0.0,0.0019207635,False,ST6GALNAC3; ST6 N-acetylgalactosaminide alpha-2
hsa:23418,0.0,0.0,2.2839297653574256e-06,8.147287600486129e-06,0.0,8.075659e-05,False,CRB1; crumbs cell polarity complex component
hsa:2768,1.4707262e-05,0.018221962082444216,0.00014516735752257435,0.0002548924698376114,0.0,0.0014220318,False,GNA12; G protein subunit alpha
hsa:2246,0.0,0.0,1.531076364311881e-05,7.735651907870367e-05,0.0,0.0007025419,False,FGF1; fibroblast growth factor
hsa:406885,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7C; microRNA
hsa:8398,7.3114903e-05,0.09058769675331729,0.00021063571830297036,0.0003179124273914056,0.0,0.0019191949,False,PLA2G6; phospholipase A2 group
hsa:11069,0.0,0.0,1.5701780368019805e-05,4.434129397235103e-05,0.0,0.0004613432,False,RAPGEF4; Rap guanine nucleotide exchange factor
hsa:2069,0.0,0.0,2.131933438194208e-06,1.4574052021951942e-05,0.0,0.00018225514,False,EREG;
hsa:3859,2.0879348e-07,0.0002586903582476177,8.23429688488515e-06,3.023436426249888e-05,0.0,0.00033096553,False,KRT12; keratin
hsa:340024,0.0,0.0,1.636006083812871e-05,6.716851776099194e-05,0.0,0.000531093,False,SLC6A19; solute carrier family 6 member
hsa:7768,0.0,0.0,7.476432690168317e-08,1.9379623610268615e-07,0.0,1.0606105e-06,False,ZNF225; zinc finger protein
hsa:168417,0.0,0.0,1.3458888153534655e-08,4.0136589664871354e-08,0.0,3.8679775e-07,False,ZNF679; zinc finger protein
hsa:219988,0.0,0.0,2.019725338094059e-06,1.5519832776937648e-05,0.0,0.00017973875,False,PATL1; PAT1 homolog 1
hsa:55971,1.677173e-08,2.0779790835098476e-05,3.123075038975247e-07,6.618031434595819e-07,0.0,3.4868654e-06,False,BAIAP2L1; BAR/IMD domain containing adaptor protein 2 like
hsa:1803,0.0,0.0,3.2572986480099017e-06,7.1130726195393826e-06,0.0,5.275829e-05,False,DPP4; dipeptidyl peptidase
hsa:7186,2.7743778e-05,0.03437390798775122,0.00020525199074455442,0.00041660088270532527,0.0,0.0023174123,False,TRAF2; TNF receptor associated factor
hsa:148206,0.0,0.0,5.8966976056930686e-08,1.7379815445767872e-07,0.0,8.581698e-07,False,ZNF714; zinc finger protein
hsa:5345,1.5684114e-09,1.943225942427166e-06,2.246251090114852e-06,6.943084712002958e-06,0.0,6.424461e-05,False,SERPINF2; serpin family F member
hsa:6457,0.0,0.0,2.2771316575216328e-07,5.527236614728821e-07,0.0,3.2391135e-06,False,SH3GL3; SH3 domain containing GRB2 like 3
hsa:7336,2.1518298e-09,2.6660680297579193e-06,8.848915388143564e-07,4.829308015142049e-06,0.0,5.1310228e-05,False,UBE2V2; ubiquitin conjugating enzyme E2
hsa:10907,0.0,0.0,1.860219885735644e-07,6.360814081240995e-07,0.0,5.4270586e-06,False,TXNL4A; thioredoxin like
hsa:58477,1.2304876e-06,0.001524546063714496,8.980254635569801e-05,0.00030505011500200777,0.0,0.0022130997,False,SRPRB; SRP receptor subunit
hsa:2558,0.0,0.0,2.5462991312574255e-05,7.645893488500202e-05,0.0,0.00083472516,False,GABRA5; gamma-aminobutyric acid type A receptor subunit
hsa:5867,1.43585325e-07,0.00017789894187955784,5.363117418153464e-07,9.5823747786743e-07,0.0,9.037583e-06,False,RAB4A; RAB4A
hsa:80010,4.87579495e-06,0.006040998705311226,0.0001498769627745049,0.0003082249213369064,0.0,0.002094601,False,RMI1; RecQ mediated genome instability
hsa:2960,1.37350825e-07,0.0001701745386151706,2.644033820628713e-06,7.685964141669691e-06,0.0,8.120659e-05,False,GTF2E1; general transcription factor IIE subunit
hsa:11258,1.3771e-07,0.0001706195482458525,5.123997835529702e-07,1.1467354165628882e-06,0.0,6.578267e-06,False,DCTN3; dynactin subunit
hsa:10714,3.44586475e-06,0.0042693478103355414,5.247630371429702e-05,0.00016655823831201094,0.0,0.0014814407,False,POLD3; DNA polymerase delta 3
hsa:8897,7.6684543e-07,0.0009501039927455994,2.68407867596396e-05,6.735887996488342e-05,0.0,0.00037148345,False,MTMR3; myotubularin related protein
hsa:968,0.0,0.0,3.1204802614836625e-06,8.527927112705353e-06,0.0,6.969642e-05,False,CD68; CD68
hsa:8484,0.0,0.0,5.449897094764208e-07,3.4203754577231782e-06,0.0,4.539607e-05,False,GALR3; galanin receptor
hsa:83744,1.27040065e-08,1.5739974220770993e-05,5.407893393084161e-08,1.0428524575269617e-07,0.0,6.2865223e-07,False,ZNF484; zinc finger protein
hsa:1812,0.0,0.0,6.5255768756485154e-06,2.613956251327301e-05,0.0,0.00030361523,False,DRD1; dopamine receptor
hsa:3952,0.0,0.0,2.0983088465193074e-06,1.0154997014893128e-05,0.0,0.0001265344,False,LEP;
hsa:5193,1.6362528999999998e-08,2.0272800131723622e-05,2.3987130776782175e-06,5.63522148444289e-06,0.0,5.1683754e-05,False,PEX12; peroxisomal biogenesis factor
hsa:9306,3.0728371e-07,0.0003807175062341845,3.095747785400992e-05,0.0001282006669240646,0.0,0.0009962597,False,SOCS6; suppressor of cytokine signaling
hsa:147700,0.0,0.0,7.195226168529697e-09,2.7813725495533268e-08,0.0,2.490976e-07,False,KLC3; kinesin light chain
hsa:2073,1.98639875e-07,0.0002461102732997793,1.010500202980198e-06,1.8138441255902913e-06,0.0,1.3034212e-05,False,ERCC5; ERCC excision repair 5
hsa:5073,0.0,0.0,1.1710314269980205e-05,4.9830231340521245e-05,0.0,0.00048094548,False,PARN; poly(A)-specific
hsa:26100,0.0,0.0,1.6345016083829208e-05,7.31274525597722e-05,0.0,0.00057119946,False,WIPI2; WD repeat domain
hsa:5211,0.0,0.0,0.00011284932142128708,0.00021008917198814316,0.0,0.0015212684,False,PFKL; phosphofructokinase
hsa:9829,2.4907677500000002e-08,3.0860044171834904e-05,1.2590440463405947e-06,3.881018131175917e-06,0.0,2.5253354e-05,False,DNAJC6; DnaJ heat shock protein family (Hsp40) member
hsa:9132,0.0,0.0,7.222757908615843e-06,2.1126165766770062e-05,0.0,0.000120852004,False,KCNQ4; potassium voltage-gated channel subfamily Q member
hsa:375790,0.0,0.0,6.359557396455446e-05,0.00013796703492764724,0.0,0.00078554347,False,AGRN;
hsa:4992,0.0,0.0,4.331989353092576e-06,1.7053914644712912e-05,-0.0,0.0001429302,False,OR1F1; olfactory receptor family 1 subfamily F member
hsa:9348,3.99626535e-06,0.004951281596743544,0.0004179218907060148,0.00117917519751893,0.0,0.0071626836,False,NDST3; N-deacetylase and N-sulfotransferase
hsa:6888,0.0,0.0,5.058601302599009e-06,1.0710425524568973e-05,0.0,9.810309e-05,False,TALDO1; transaldolase
hsa:23417,0.0,0.0,0.00033824808246840096,0.0007277458456294965,0.0,0.0043548313,False,MLYCD; malonyl-CoA
hsa:79923,2.75652665e-09,3.4152736311862108e-06,5.71752406670218e-07,2.2311104884495742e-06,0.0,1.9982164e-05,False,NANOG; Nanog
hsa:338662,0.0,0.0,2.0437278846534653e-07,2.131633873377348e-06,-0.0,2.8352037e-05,False,OR8D4; olfactory receptor family 8 subfamily D member
hsa:2561,0.0,0.0,4.5421441044816836e-05,0.00016917855812601678,0.0,0.001599785,False,GABRB2; gamma-aminobutyric acid type A receptor subunit
hsa:4887,0.0,0.0,1.42528560346398e-05,3.934888530219708e-05,0.0,0.00029146444,False,NPY2R; neuropeptide Y receptor
hsa:815,0.0,0.0,8.560801073069308e-05,0.0002402743932587638,0.0,0.0016753698,False,CAMK2A; calcium/calmodulin dependent protein kinase II
hsa:3684,0.0,0.0,5.778204914356436e-05,0.00020715741113510951,0.0,0.0018580084,False,ITGAM; integrin subunit alpha
hsa:6404,0.0,0.0,2.486717880712871e-05,0.00015044815072861952,0.0,0.001267995,False,SELPLG; selectin P
hsa:9064,0.0,0.0,1.5608018347029703e-07,3.1534951045966085e-07,0.0,1.9069844e-06,False,MAP3K6; mitogen-activated protein kinase kinase kinase
hsa:3717,0.0,0.0,0.0001269717723618812,0.00027244223283591295,0.0,0.0017946879,False,JAK2; Janus kinase
hsa:399968,0.0,0.0,7.764997473664452e-07,2.079737353195542e-06,0.0,1.6773425e-05,False,PATE4; prostate and testis expressed
hsa:80339,1.25379165e-06,0.0015534192499994336,9.19890728786139e-06,3.262906347077356e-05,0.0,0.00029172588,False,PNPLA3; patatin like phospholipase domain containing
hsa:54657,0.0,0.0,1.7183575207920796e-05,9.324954626274205e-05,0.0,0.0010803042,False,UGT1A4; UDP glucuronosyltransferase family 1 member
hsa:2492,0.0,0.0,1.6340069132772277e-06,9.642209907884938e-06,0.0,8.449324e-05,False,FSHR; follicle stimulating hormone
hsa:27089,0.0,0.0,7.850162929297033e-05,0.00017324152292893911,0.0,0.0008658478,False,UQCRQ; ubiquinol-cytochrome c reductase complex III subunit
hsa:27005,2.2901851499999998e-07,0.0002837487151930578,5.690848387455445e-06,3.645877634824788e-05,0.0,0.0004978925,False,USP21; ubiquitin specific peptidase
hsa:119679,0.0,0.0,1.9464983168316832e-08,2.7664939018197237e-07,0.0,3.9319266e-06,False,OR52J3; olfactory receptor family 52 subfamily J member
hsa:7251,2.3919900500000003e-06,0.0029636211004253443,4.635524952385643e-05,0.00010857845247621763,0.0,0.00079061877,False,TSG101; tumor susceptibility
hsa:25915,0.0,0.0,2.2071123328762372e-07,8.155328787703955e-07,0.0,7.090111e-06,False,NDUFAF3; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:2160,0.0,0.0,7.772211722334164e-08,3.041005855599261e-07,0.0,3.100691e-06,False,F11; coagulation factor
hsa:574031,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR363; microRNA
hsa:5438,0.0,0.0,3.905746044424157e-05,0.0001263850189564192,0.0,0.0007811767,False,POLR2I; RNA polymerase II subunit
hsa:444,1.8667556499999998e-07,0.0002312867661668671,6.154330875699015e-05,0.00032732698877555483,0.0,0.0027144712,False,ASPH; aspartate
hsa:6218,8.45648875e-08,0.00010477396632569413,1.001723883965347e-06,1.6352992844754974e-06,0.0,7.010321e-06,False,RPS17; ribosomal protein
hsa:3931,0.0,0.0,6.230874918267327e-05,0.00021870901537494698,0.0,0.0020266424,False,LCAT; lecithin-cholesterol
hsa:9073,0.0,0.0,1.8708318627722774e-07,2.5956057803426257e-06,0.0,3.688589e-05,False,CLDN8; claudin
hsa:392517,0.0,0.0,2.5391554603960402e-09,1.5302615845820768e-08,0.0,1.6959606e-07,False,NCBP2L; nuclear cap binding protein subunit 2
hsa:442184,0.0,0.0,4.3707804752475245e-08,4.138160907274727e-07,-0.0,5.573255e-06,False,OR2B3; olfactory receptor family 2 subfamily B member
hsa:79058,0.0,0.0,1.0607289777933018e-05,3.209201260698248e-05,0.0,0.00024200065,False,ASPSCR1; ASPSCR1 tether for SLC2A4
hsa:58484,0.0,0.0,6.693942727664157e-06,2.11031888799764e-05,0.0,0.000195611,False,NLRC4; NLR family CARD domain containing
hsa:10284,0.0,0.0,2.4282244641732665e-07,4.816315197164453e-07,0.0,2.167548e-06,False,SAP18; Sin3A associated protein
hsa:51096,4.3850656499999995e-09,5.432996298245628e-06,1.7846379665881188e-06,3.695355904580445e-06,0.0,2.2162061e-05,False,UTP18; UTP18 small subunit processome
hsa:3588,1.68493185e-06,0.0020875921216472917,0.00024935342796282177,0.0006875818102526501,0.0,0.00587627,False,IL10RB; interleukin 10 receptor subunit
hsa:93100,0.0,0.0,4.2294267698163365e-05,0.0001414683872278891,0.0,0.0011350403,False,NAPRT; nicotinate
hsa:5685,1.13162463e-07,0.0001402057099371723,6.734936715560396e-06,1.8084108719446875e-05,0.0,0.00012396174,False,PSMA4; proteasome 20S subunit alpha
hsa:85366,1.555371e-05,0.0192706918433447,5.694135129580197e-05,8.57846480128107e-05,0.0,0.00053804636,False,MYLK2; myosin light chain kinase
hsa:390083,0.0,0.0,9.88934705529703e-07,5.168724735092025e-06,0.0,4.9703784e-05,False,OR56A3; olfactory receptor family 56 subfamily A member
hsa:56623,7.8830688e-08,9.766942396681248e-05,9.023486237139104e-05,0.0002992182168179474,0.0,0.0019551215,False,INPP5E; inositol polyphosphate-5-phosphatase
hsa:83700,0.0,0.0,2.9655778864059412e-05,8.686199384467215e-05,0.0,0.00067163224,False,JAM3; junctional adhesion molecule
hsa:6723,0.0,0.0,6.96998130239109e-05,0.0002000715992807407,0.0,0.0016792096,False,SRM; spermidine
hsa:8972,0.0,0.0,1.4850058018118816e-05,3.856478109958369e-05,0.0,0.00035850643,False,MGAM;
hsa:256933,0.0,0.0,3.0287637793089113e-06,6.907554088400018e-06,0.0,5.0167797e-05,False,NPB; neuropeptide
hsa:7534,4.623572300000001e-06,0.0057285005962387425,1.8604543708861388e-05,2.885124553963213e-05,0.0,0.00017470091,False,YWHAZ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:163131,1.2165707e-08,1.5073033421185137e-05,6.015099049920792e-08,1.2220787409316198e-07,0.0,7.633016e-07,False,ZNF780B; zinc finger protein
hsa:9748,3.5909054e-08,4.449049866687911e-05,3.0001976696425744e-06,1.2131586359175288e-05,0.0,0.00012229891,False,SLK; STE20 like
hsa:1806,0.0,0.0,8.273017924059405e-05,0.0003179270080180106,0.0,0.003928463,False,DPYD; dihydropyrimidine
hsa:113278,0.0,0.0,4.347678081178218e-05,0.00018294741586264,0.0,0.0015709057,False,SLC52A3; solute carrier family 52 member
hsa:650,0.0,0.0,3.314671352707922e-05,0.00012308241805536848,0.0,0.00081094593,False,BMP2; bone morphogenetic protein
hsa:1384,1.11006605e-07,0.00013753465105951487,2.4440577508266347e-05,8.15439619988729e-05,0.0,0.00054636924,False,CRAT; carnitine
hsa:390927,0.0,0.0,3.1324853330594055e-08,5.8705324430943225e-08,0.0,2.8594124e-07,False,ZNF793; zinc finger protein
hsa:4613,0.0,0.0,1.4021535496797184e-05,6.820640106583281e-05,0.0,0.00085923617,False,MYCN; MYCN proto-oncogene
hsa:3821,3.2051550000000005e-07,0.0003971113921704564,1.5203394326455444e-05,5.839917715871343e-05,0.0,0.00048351206,False,KLRC1; killer cell lectin like receptor
hsa:11313,2.01584705e-08,2.4975885048561064e-05,1.3858297645267325e-05,3.628936548283401e-05,0.0,0.00019206361,False,LYPLA2; lysophospholipase
hsa:152586,0.0,0.0,5.447956343352474e-06,2.8650502655423447e-05,0.0,0.0003043204,False,MGAT4D; MGAT4 family member
hsa:101954277,0.0,0.0,2.7103517716831682e-08,1.8874347019987206e-07,0.0,2.2065199e-06,False,RNVU1-19; RNA
hsa:990,1.8567802999999998e-08,2.3005084305990737e-05,1.009300806221782e-06,1.751403186409387e-06,0.0,9.508262e-06,False,CDC6; cell division cycle
hsa:3593,1.97270965e-06,0.002444142250404718,2.628703131019802e-05,6.240825179481743e-05,0.0,0.0005589604,False,IL12B; interleukin
hsa:4501,7.3367255e-07,0.0009090035512408875,5.0591164846398024e-05,0.00014034519906125083,0.0,0.001146008,False,MT1X; metallothionein
hsa:8454,1.25606025e-05,0.015562299936429637,0.0004493198605643563,0.000660956434366601,0.0,0.0025429719,False,CUL1; cullin
hsa:4821,0.0,0.0,2.2452516033168316e-06,1.3065719626285703e-05,0.0,0.00010256011,False,NKX2-2; NK2 homeobox
hsa:71,0.0,0.0,0.00048425207367821767,0.0008575829622336719,0.0,0.0058199465,False,ACTG1; actin gamma
hsa:29089,3.1645015e-06,0.003920745162684791,0.00010034188564764355,0.00016645187162055004,0.0,0.0008847138,False,UBE2T; ubiquitin conjugating enzyme E2
hsa:166378,5.6974311e-08,7.058987150126137e-05,6.4813176641396e-07,1.2984431619325988e-06,0.0,7.728572e-06,False,AFG2A; AFG2 AAA ATPase homolog
hsa:5690,0.0,0.0,1.770451647836634e-06,3.452732110201662e-06,0.0,2.5852101e-05,False,PSMB2; proteasome 20S subunit beta
hsa:54905,2.69452105e-08,3.338450107399173e-05,7.377662598059654e-06,2.0176422034029233e-05,0.0,0.00012918281,False,CYP2W1; cytochrome P450 family 2 subfamily W member
hsa:7423,2.17924255e-06,0.002700031801605835,3.86296377559406e-05,9.35516053213038e-05,0.0,0.0007234542,False,VEGFB; vascular endothelial growth factor
hsa:129642,9.97120925e-06,0.012354100774815668,0.00019643330248812134,0.00037184689989727953,0.0,0.0019602035,False,MBOAT2; membrane bound O-acyltransferase domain containing
hsa:8295,0.0,0.0,1.375207067326238e-06,5.4146775440310385e-06,0.0,4.8495174e-05,False,TRRAP; transformation/transcription domain associated
hsa:5500,0.0,0.0,0.00014129709392079207,0.0004400126025073041,0.0,0.004773299,False,PPP1CB; protein phosphatase 1 catalytic subunit
hsa:10621,3.9622396499999996e-06,0.004909124530715304,0.00023942944853401005,0.0005980359195093144,0.0,0.0031951761,False,POLR3F; RNA polymerase III subunit
hsa:41,0.0,0.0,5.299090476782178e-05,0.00010778737045125412,0.0,0.0004921441,False,ASIC1; acid sensing ion channel subunit
hsa:80264,1.02449215e-09,1.2693224008018454e-06,4.952116586732671e-08,9.941691600590911e-08,0.0,5.166587e-07,False,ZNF430; zinc finger protein
hsa:55666,6.70668965e-09,8.30943546807156e-06,7.768451160138616e-07,1.7356594380470342e-06,0.0,1.4605459e-05,False,NPLOC4; NPL4 homolog
hsa:55500,0.0,0.0,4.129996879057425e-06,1.217029813518457e-05,0.0,0.000108349916,False,ETNK1; ethanolamine kinase
hsa:3274,2.36990195e-06,0.002936254448449386,1.0245696792717817e-05,2.4558678478742394e-05,0.0,0.0001921122,False,HRH2; histamine receptor
hsa:4644,1.20088725e-07,0.00014878719053750932,1.0444083164247525e-06,2.457603252690583e-06,0.0,1.9855828e-05,False,MYO5A; myosin
hsa:11073,0.0,0.0,1.7725057782603962e-05,5.4853032662947195e-05,0.0,0.000525808,False,TOPBP1; DNA topoisomerase II binding protein
hsa:158326,1.42937935e-06,0.001770968404392929,1.9982422485277234e-05,5.5978345342789974e-05,0.0,0.00038531443,False,FREM1; FRAS1 related extracellular matrix
hsa:10556,9.5847538e-08,0.00011875291288967526,2.5657775255038916e-06,4.879785425336367e-06,0.0,2.377802e-05,False,RPP30; ribonuclease P/MRP subunit
hsa:10499,8.918279000000001e-07,0.0011049544216908526,4.697300802302475e-05,9.32878332620902e-05,0.0,0.00057810306,False,NCOA2; nuclear receptor coactivator
hsa:8777,7.4241676e-08,9.198374279380546e-05,4.061742737064358e-06,1.774942589198446e-05,0.0,0.00016473765,False,MPDZ; multiple PDZ domain crumbs cell polarity complex
hsa:29881,2.61718175e-06,0.0032426284791394213,1.3954871982945054e-05,3.43482500577101e-05,0.0,0.0003102596,False,NPC1L1; NPC1 like intracellular cholesterol transporter
hsa:7074,0.0,0.0,4.221315495841584e-05,0.0001097812037158203,0.0,0.00091024843,False,TIAM1; TIAM Rac1 associated GEF
hsa:64919,0.0,0.0,1.0791560428064086e-05,3.39951315481983e-05,0.0,0.00022046934,False,BCL11B; BCL11 transcription factor
hsa:466,0.0,0.0,7.818415788128713e-06,2.077729125926746e-05,0.0,0.00020394525,False,ATF1; activating transcription factor
hsa:81931,8.0520145e-11,9.976262264607173e-08,7.540743322272276e-08,1.7882581433102564e-07,0.0,9.367297e-07,False,ZNF93; zinc finger protein
hsa:4929,0.0,0.0,1.5978209305737623e-05,9.197334740815546e-05,0.0,0.0009738887,False,NR4A2; nuclear receptor subfamily 4 group A member
hsa:91661,1.73429445e-08,2.1487512568752392e-05,8.013482502054458e-08,1.6833503548395632e-07,0.0,9.683068e-07,False,ZNF765; zinc finger protein
hsa:100289678,3.11763615e-08,3.862680063233889e-05,1.1459031589306936e-07,1.648423400347599e-07,0.0,7.414508e-07,False,ZNF783; zinc finger protein
hsa:7637,0.0,0.0,5.8513813358415825e-08,1.2560781390822875e-07,0.0,7.364157e-07,False,ZNF84; zinc finger protein
hsa:55614,0.0,0.0,4.101601672559407e-08,1.8140215215503373e-07,0.0,1.7553011e-06,False,KIF16B; kinesin family member
hsa:6637,3.1073471000000004e-08,3.8499321650211306e-05,2.2696229867574257e-07,3.8079080363661224e-07,0.0,2.674126e-06,False,SNRPG; small nuclear ribonucleoprotein polypeptide
hsa:26056,7.29096005e-10,9.033333163964549e-07,4.043135129732179e-07,1.0274497535560545e-06,0.0,6.2299496e-06,False,RAB11FIP5; RAB11 family interacting protein
hsa:8936,3.97514185e-07,0.0004925110062160935,0.00016585619256123766,0.0003182786171840087,0.0,0.0019114123,False,WASF1; WASP family member
hsa:3567,3.6330795500000006e-05,0.04501302676365152,0.0001048161266247525,0.0001938517125690325,0.0,0.0015804038,False,IL5; interleukin
hsa:94030,1.19502098e-07,0.00014806037306798047,2.08146715040693e-05,4.540335652620629e-05,0.0,0.00032587408,False,LRRC4B; leucine rich repeat containing
hsa:2787,6.70578675e-06,0.00830831679557057,0.00019680417233316835,0.0004739369501552324,0.0,0.0036954668,False,GNG5; G protein subunit gamma
hsa:4068,4.7729617e-08,5.9135906546275224e-05,1.8615870785912317e-05,7.93994454119734e-05,0.0,0.0007378292,False,SH2D1A; SH2 domain containing
hsa:128367,0.0,0.0,3.314957920792079e-08,4.71144043298615e-07,-0.0,6.696215e-06,False,OR10X1; olfactory receptor family 10 subfamily X member
hsa:4634,0.0,0.0,4.40337586661386e-05,0.00012929609934863505,0.0,0.0011374432,False,MYL3; myosin light chain
hsa:79924,0.0,0.0,6.505393848787128e-06,2.7151248103647142e-05,0.0,0.00033169525,False,ADM2; adrenomedullin
hsa:124,0.0,0.0,4.610209254683169e-05,0.0001546594470542699,0.0,0.001350985,False,ADH1A; alcohol dehydrogenase 1A (class I)
hsa:51175,4.3423825e-08,5.380112849180855e-05,4.7214354514350987e-07,1.3847486240858407e-06,0.0,8.395384e-06,False,TUBE1; tubulin epsilon
hsa:10393,0.0,0.0,4.87285145831683e-06,1.2387398185660995e-05,0.0,8.5565705e-05,False,ANAPC10; anaphase promoting complex subunit
hsa:26007,1.05973975e-05,0.013129933730533196,0.00013338297591514858,0.0003216040413703889,0.0,0.0021959364,False,TKFC; triokinase and FMN
hsa:8643,0.0,0.0,3.2154123449108904e-05,0.00010573143403394184,0.0,0.0007607823,False,PTCH2; patched
hsa:22905,7.50621575e-09,9.300030065361287e-06,3.1999251653752485e-07,6.204578142034459e-07,0.0,3.3293102e-06,False,EPN2; epsin
hsa:1299,0.0,0.0,3.074899856089109e-05,0.00011793479462180278,0.0,0.00093119603,False,COL9A3; collagen type IX alpha 3
hsa:200316,0.0,0.0,7.533495380242571e-06,2.261807341292602e-05,0.0,0.00024302737,False,APOBEC3F; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:5874,4.6755012e-07,0.0005792839318618409,1.9287722060308907e-05,4.273602001896863e-05,0.0,0.00027938705,False,RAB27B; RAB27B
hsa:283459,1.7915556e-07,0.00022196965153534765,1.6336854704335645e-05,5.027917729547264e-05,0.0,0.00029452977,False,GATC; glutamyl-tRNA amidotransferase subunit
hsa:8650,6.72455e-08,8.33156403425058e-05,0.00011042542138178763,0.00044218442288761965,0.0,0.0045343284,False,NUMB; NUMB endocytic adaptor
hsa:119695,0.0,0.0,3.424906930693069e-09,4.867707336878102e-08,-0.0,6.918312e-07,False,OR52R1; olfactory receptor family 52 subfamily R member
hsa:6944,8.21140125e-08,0.00010173738811563636,6.538856826217823e-06,1.6269389865599314e-05,0.0,9.245275e-05,False,VPS72; vacuolar protein sorting 72
hsa:79482,0.0,0.0,6.201099009900991e-08,8.81341763675149e-07,-0.0,1.252622e-05,False,OR5AL1; olfactory receptor family 5 subfamily AL member 1
hsa:6885,8.8947178e-05,0.1102035242764028,0.00016503046086138612,0.00024498473370080244,0.0,0.0014313613,False,MAP3K7; mitogen-activated protein kinase kinase kinase
hsa:6809,1.1711912e-07,0.00014510791769190175,2.6811769261103952e-05,9.657836350114216e-05,0.0,0.0010239229,False,STX3; syntaxin
hsa:9047,1.91289685e-06,0.002370035555790533,5.9967566803990086e-05,0.0001758226122375769,0.0,0.0011211958,False,SH2D2A; SH2 domain containing
hsa:8065,7.903885750000001e-08,9.792734122807576e-05,3.7234390248094057e-07,1.1659341623406982e-06,0.0,1.3639029e-05,False,CUL5; cullin
hsa:343406,0.0,0.0,9.414222837128714e-06,4.454272992022558e-05,-0.0,0.0003722949,False,OR10R2; olfactory receptor family 10 subfamily R member
hsa:114548,1.4427921e-08,1.7875864956407294e-05,2.2632379329762374e-05,5.402149176330246e-05,0.0,0.00035298764,False,NLRP3; NLR family pyrin domain containing
hsa:5366,0.0,0.0,0.0001802574055552129,0.0005121587569247287,0.0,0.003445387,False,PMAIP1; phorbol-12-myristate-13-acetate-induced protein
hsa:613,7.3751205e-07,0.0009137606041454692,1.7775296798717813e-05,4.641454397204538e-05,0.0,0.0004268911,False,BCR; BCR activator of RhoGEF and
hsa:8450,1.8595343e-07,0.00023039205737685538,1.5276979837524757e-06,3.2553568614007502e-06,0.0,2.3308097e-05,False,CUL4B; cullin
hsa:2322,1.66750025e-07,0.000206599476693665,6.850339521678214e-06,2.4942154019502734e-05,0.0,0.00020688768,False,FLT3; fms related receptor tyrosine kinase
hsa:255231,5.84891285e-08,7.246669582429465e-05,2.271178692169455e-06,8.742652299266604e-06,0.0,5.949346e-05,False,MCOLN2; mucolipin TRP cation channel
hsa:91662,0.0,0.0,9.296026450891089e-09,3.4596101296721964e-08,0.0,3.265815e-07,False,NLRP12; NLR family pyrin domain containing
hsa:10913,0.0,0.0,3.0565489046138614e-07,1.5180325014703497e-06,0.0,1.8129163e-05,False,EDAR; ectodysplasin A
hsa:10390,2.1514198e-05,0.026655600491117735,0.0012051676638353962,0.0026390610115898535,0.0,0.012814436,False,CEPT1; choline/ethanolamine phosphotransferase
hsa:51069,0.0,0.0,3.0837291532267317e-07,7.356227269128107e-07,0.0,3.4829386e-06,False,MRPL2; mitochondrial ribosomal protein
hsa:57568,2.897569e-07,0.00035900218850569063,1.5948873576474253e-06,3.035346347901984e-06,0.0,1.6262891e-05,False,SIPA1L2; signal induced proliferation associated 1 like
hsa:2358,6.0507164e-09,7.496699576877284e-06,3.005906992748021e-06,1.4851245006350991e-05,0.0,0.00019939586,False,FPR2; formyl peptide receptor
hsa:3133,0.0,0.0,0.000167906648830198,0.00035254256801722425,0.0,0.003026742,False,HLA-E; major histocompatibility complex
hsa:154141,0.0,0.0,2.886962755054456e-05,0.00015305863196021343,0.0,0.0013781438,False,MBOAT1; membrane bound O-acyltransferase domain containing
hsa:10459,2.3840884e-06,0.0029538311363457794,3.435558259341583e-05,9.570722113571951e-05,0.0,0.0006267308,False,MAD2L2; mitotic arrest deficient 2 like
hsa:2697,0.0,0.0,3.666396794732673e-05,9.788680187520753e-05,0.0,0.00063316955,False,GJA1; gap junction protein alpha
hsa:3418,0.0,0.0,0.0001952169493930693,0.00035911053545839724,0.0,0.0018074039,False,IDH2; isocitrate dehydrogenase (NADP(+))
hsa:54437,2.69565635e-09,3.3398567181981234e-06,5.775686523748513e-06,2.130701704179406e-05,0.0,0.00014875483,False,SEMA5B; semaphorin
hsa:638,0.0,0.0,1.5728647282335638e-06,4.389844610715214e-06,0.0,3.1689655e-05,False,BIK; BCL2 interacting
hsa:147949,0.0,0.0,9.594609791138609e-08,2.681153111133295e-07,0.0,1.4592704e-06,False,ZNF583; zinc finger protein
hsa:55902,2.56087625e-06,0.0031728672492087194,0.00026322513315455445,0.0007760989064571121,0.0,0.004213583,False,ACSS2; acyl-CoA synthetase short chain family member
hsa:6232,0.0,0.0,1.3641857757653461e-06,3.831923591984856e-06,0.0,2.1155403e-05,False,RPS27; ribosomal protein
hsa:85409,0.0,0.0,2.7475881084405937e-06,1.3087938956109808e-05,0.0,0.00015615762,False,NKD2; NKD inhibitor of WNT signaling pathway
hsa:201595,0.0,0.0,0.00012795179793356434,0.0003936317842607852,0.0,0.001997896,False,STT3B; STT3 oligosaccharyltransferase complex catalytic subunit
hsa:51010,2.2661187500000001e-07,0.0002807669431388105,2.591098190252524e-05,0.00010739244245131973,0.0,0.00094949035,False,EXOSC3; exosome component
hsa:1768,7.14492925e-09,8.852404334351737e-06,2.6696713460693065e-07,1.1103788709324905e-06,0.0,9.331217e-06,False,DNAH6; dynein axonemal heavy chain
hsa:9230,0.0,0.0,0.00013940758735940601,0.00048044317961038466,0.0,0.0035711327,False,RAB11B; RAB11B
hsa:83933,0.0,0.0,1.3828695298762378e-05,3.503353067539594e-05,0.0,0.00024441446,False,HDAC10; histone deacetylase
hsa:51020,7.972825e-09,9.878148280758397e-06,1.7179541099389602e-05,5.744119665310879e-05,0.0,0.0005360059,False,HDDC2; HD domain containing
hsa:9229,0.0,0.0,3.774085483752971e-06,2.3623090502141325e-05,0.0,0.0002686349,False,DLGAP1; DLG associated protein
hsa:5257,0.0,0.0,3.2276061389257425e-06,7.829233860996012e-06,0.0,5.8093337e-05,False,PHKB; phosphorylase kinase regulatory subunit
hsa:283927,1.5752168999999999e-07,0.00019516578016646007,7.698264640010495e-05,0.00028259416303514745,0.0,0.0017630197,False,NUDT7; nudix hydrolase
hsa:203228,0.0,0.0,1.3631548373762373e-07,3.379164036675943e-07,0.0,2.7106164e-06,False,C9orf72; C9orf72-SMCR8 complex
hsa:127608,0.0,0.0,3.9843588985148514e-07,3.3731672759804908e-06,0.0,3.8155584e-05,False,OR2AJ1; olfactory receptor family 2 subfamily AJ member
hsa:116,0.0,0.0,4.235531229158416e-05,0.00016965063701558997,0.0,0.0015931157,False,ADCYAP1; adenylate cyclase activating polypeptide
hsa:79501,0.0,0.0,1.3752580587623761e-06,9.909163868434e-06,-0.0,9.431109e-05,False,OR4F5; olfactory receptor family 4 subfamily F member
hsa:6169,0.0,0.0,1.3567772307722769e-06,2.7344417267976276e-06,0.0,1.287313e-05,False,RPL38; ribosomal protein
hsa:390181,0.0,0.0,7.981236844064355e-06,2.5367856481819037e-05,0.0,0.00024835055,False,OR5AK2; olfactory receptor family 5 subfamily AK member
hsa:800,2.15689255e-07,0.00026723406615049365,3.489303338265346e-05,9.131679658162274e-05,0.0,0.00059540186,False,CALD1; caldesmon
hsa:8089,2.8198256999999998e-08,3.4936997100141215e-05,5.169291292569802e-06,1.5413226124618612e-05,0.0,0.000106715146,False,YEATS4; YEATS domain containing
hsa:23474,5.827643e-08,7.220316723535725e-05,0.00012350216802222767,0.0003642574833982597,0.0,0.0036363793,False,ETHE1; ETHE1 persulfide
hsa:7223,1.64588215e-07,0.00020392104342379814,8.755466474495048e-06,4.378108452171645e-05,0.0,0.0005009994,False,TRPC4; transient receptor potential cation channel subfamily C member
hsa:5092,0.0,0.0,7.998574434532177e-06,1.8519882854257054e-05,0.0,0.00016149132,False,PCBD1; pterin-4 alpha-carbinolamine dehydratase
hsa:776,0.00023288979,0.2885451365977159,0.0005019121561485149,0.0006783041122651127,0.0,0.0032778617,False,CACNA1D; calcium voltage-gated channel subunit alpha1
hsa:2523,0.0,0.0,4.789790571692574e-05,0.00011308681728831109,0.0,0.0008335063,False,FUT1; fucosyltransferase 1 (H blood
hsa:8702,0.0,0.0,0.00016187495253267324,0.00044008714709518974,0.0,0.002716005,False,B4GALT4; beta-1
hsa:55157,3.1174165e-07,0.0003862407921895045,1.700529583458911e-05,5.5100057007825385e-05,0.0,0.00037301602,False,DARS2; aspartyl-tRNA synthetase 2
hsa:64981,0.0,0.0,1.531569801882178e-07,2.888168803932272e-07,0.0,1.5070763e-06,False,MRPL34; mitochondrial ribosomal protein
hsa:7728,0.0,0.0,3.7470090579207925e-08,5.864655223105147e-08,0.0,3.671368e-07,False,ZNF175; zinc finger protein
hsa:64784,0.0,0.0,2.3724119316816833e-06,1.0627940891317109e-05,0.0,8.111147e-05,False,CRTC3; CREB regulated transcription coactivator
hsa:30815,1.3450908250000001e-05,0.016665368448997245,9.903747820757428e-05,0.0004210226886402746,0.0,0.003902973,False,ST6GALNAC6; ST6 N-acetylgalactosaminide alpha-2
hsa:7477,0.0,0.0,8.56871970891089e-06,4.392660590203842e-05,0.0,0.0004829079,False,WNT7B; Wnt family member
hsa:3882,0.0,0.0,1.9976535660183168e-05,7.529665352382817e-05,0.0,0.0008542261,False,KRT32; keratin
hsa:8030,3.2755470000000005e-07,0.0004058328003761945,1.863885659695545e-05,4.0797686801912735e-05,0.0,0.0002466562,False,CCDC6; coiled-coil domain containing
hsa:619552,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR483; microRNA
hsa:219417,0.0,0.0,2.4280110396039603e-07,3.3325523811034706e-06,-0.0,4.73423e-05,False,OR8U1; olfactory receptor family 8 subfamily U member
hsa:6595,0.0,0.0,2.044049798539604e-06,5.469274371241324e-06,0.0,4.049969e-05,False,SMARCA2; SWI/SNF related
hsa:7462,9.7258375e-08,0.0001205009077454485,2.8687206110427227e-06,9.833140607365863e-06,0.0,7.830607e-05,False,LAT2; linker for activation of T cells family member
hsa:25791,0.0,0.0,2.6466559695781197e-06,2.4946825729088107e-05,0.0,0.00031671472,False,NGEF; neuronal guanine nucleotide exchange
hsa:27177,0.0,0.0,4.581632787029703e-08,4.0271373714297613e-07,0.0,5.2288938e-06,False,IL36B; interleukin 36
hsa:4744,6.2090135000000005e-09,7.692826072343327e-06,4.8776792365059435e-08,8.603639404802573e-08,0.0,4.5668543e-07,False,NEFH; neurofilament heavy
hsa:55790,1.5763866e-06,0.0019531070332787404,0.0001884054825975445,0.0006013336676528635,0.0,0.0046096905,False,CSGALNACT1; chondroitin sulfate N-acetylgalactosaminyltransferase
hsa:8644,0.0,0.0,6.75595841480198e-05,0.00019726413117133188,0.0,0.0012177387,False,AKR1C3; aldo-keto reductase family 1 member
hsa:29984,0.0,0.0,4.765325933910892e-07,3.919525512274008e-06,0.0,4.8443588e-05,False,RHOD; ras homolog family member
hsa:6857,1.1160472500000001e-07,0.00013827570809383922,7.231704575908912e-05,0.000229208737553335,0.0,0.0015434377,False,SYT1; synaptotagmin
hsa:80700,0.0,0.0,6.355048786410893e-07,2.0750551183351505e-06,0.0,1.6978316e-05,False,UBXN6; UBX domain protein
hsa:350,0.0,0.0,1.4620208425480195e-06,1.3264800743103394e-05,0.0,0.00017711968,False,APOH; apolipoprotein
hsa:3805,0.0,0.0,1.1690712353415843e-07,5.809510653151394e-07,0.0,7.2223047e-06,False,KIR2DL4; killer cell immunoglobulin like receptor
hsa:1665,2.30821885e-08,2.8598304948047428e-05,3.3076716839603956e-07,5.18297556842048e-07,0.0,2.8703737e-06,False,DHX15; DEAH-box helicase
hsa:155061,0.0,0.0,5.558428611336632e-08,1.0072066379168717e-07,0.0,5.6087515e-07,False,ZNF746; zinc finger protein
hsa:123876,0.0,0.0,2.720596770070792e-06,3.402327394316694e-05,0.0,0.00048346643,False,ACSM2A; acyl-CoA synthetase medium chain family member
hsa:1956,0.0,0.0,0.00017927058772277231,0.0006694736932501414,0.0,0.0059403824,False,EGFR; epidermal growth factor
hsa:1080,0.0,0.0,4.155802838514852e-05,0.00012091798882321459,0.0,0.0007878389,False,CFTR; CF transmembrane conductance
hsa:5550,0.000141198135,0.1749412679315728,0.00038690420670327215,0.0005622665066663634,0.0,0.002859966,False,PREP; prolyl
hsa:4636,0.0,0.0,1.1418303963118821e-05,2.5805493110610217e-05,0.0,0.00022300416,False,MYL5; myosin light chain
hsa:8915,0.0,0.0,2.0663465151485162e-05,4.9596788911372804e-05,0.0,0.00034612836,False,BCL10; BCL10 immune signaling
hsa:83756,1.20209995e-06,0.0014893744130082191,9.057416425031188e-05,0.00020660618966855063,0.0,0.0013848711,False,TAS1R3; taste 1 receptor member
hsa:7054,0.0,0.0,0.00016539033411633655,0.00035318431904751094,0.0,0.0020141674,False,TH; tyrosine
hsa:8833,2.47858955e-06,0.003070915905220324,5.996137408532178e-05,0.00017101683691645453,0.0,0.001305428,False,GMPS; guanine monophosphate
hsa:8973,0.0,0.0,1.4936576229190598e-05,8.120043676756635e-05,0.0,0.00078772084,False,CHRNA6; cholinergic receptor nicotinic alpha 6
hsa:23002,0.0,0.0,6.539535697623764e-06,2.128007921328621e-05,0.0,0.0001301389,False,DAAM1; dishevelled associated activator of morphogenesis
hsa:29922,8.7216878e-07,0.0010805972205194707,0.00030882184971792095,0.0005655404813810035,0.0,0.0027970665,False,NME7; NME/NM23 family member
hsa:574461,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520E; microRNA
hsa:6868,0.0,0.0,0.00016663302917122578,0.00045204638906668875,0.0,0.002461953,False,ADAM17; ADAM metallopeptidase domain
hsa:277,0.0,0.0,2.9601089885148514e-06,1.0790413910401828e-05,0.0,0.00012575444,False,AMY1B; amylase alpha
hsa:6580,2.75142995e-06,0.003408958936163739,4.034093655970297e-05,9.873994088502312e-05,0.0,0.00064447,False,SLC22A1; solute carrier family 22 member
hsa:2180,3.6240819e-05,0.04490154793290035,0.00010584317114108908,0.00018909295742872685,0.0,0.001311764,False,ACSL1; acyl-CoA synthetase long chain family member
hsa:170712,0.0,0.0,1.2390793788217821e-06,1.1135383172156567e-05,0.0,0.00015125716,False,COX7B2; cytochrome c oxidase subunit
hsa:5313,0.0,0.0,7.864487780762377e-06,3.582793353095494e-05,0.0,0.00029762572,False,PKLR; pyruvate kinase
hsa:121129,0.0,0.0,4.338421138613861e-09,6.166054971492094e-08,0.0,8.7636107e-07,False,OR2AP1; olfactory receptor family 2 subfamily AP member
hsa:659,4.502219099999999e-06,0.005578146750024315,9.633027388777229e-05,0.0002220218675766436,0.0,0.0016501019,False,BMPR2; bone morphogenetic protein receptor type
hsa:2939,0.0,0.0,1.6317960908316832e-06,1.318994852797504e-05,0.0,0.00014515634,False,GSTA2; glutathione S-transferase alpha
hsa:116444,1.0294313e-08,1.2754418949687071e-05,1.9838916469876245e-05,4.741765982298024e-05,0.0,0.00027617172,False,GRIN3B; glutamate ionotropic receptor NMDA type subunit
hsa:23428,3.333592e-08,4.130244434507211e-05,3.1972362204356424e-05,6.765620176280564e-05,0.0,0.00041551358,False,SLC7A8; solute carrier family 7 member
hsa:26272,0.0,0.0,2.4425408204970296e-07,5.356145946528067e-07,0.0,3.0946387e-06,False,FBXO4; F-box protein
hsa:8099,6.848652200000001e-08,8.485323828748558e-05,8.443302981035448e-06,2.1941525975106255e-05,0.0,0.00014333059,False,CDK2AP1; cyclin dependent kinase 2 associated protein
hsa:5469,4.235073e-06,0.005247158826869561,1.6386578899702967e-05,2.958278874002527e-05,0.0,0.00017162331,False,MED1; mediator complex subunit
hsa:6446,0.0,0.0,0.0002170615560366337,0.0008999481145683218,0.0,0.006852407,False,SGK1; serum/glucocorticoid regulated kinase
hsa:5518,7.13028605e-05,0.08834261743625764,0.0003473312899663366,0.000541007455843338,0.0,0.0031882117,False,PPP2R1A; protein phosphatase 2 scaffold subunit
hsa:9843,0.0,0.0,0.00010825099686081186,0.00040121138888754066,0.0,0.0031837597,False,HEPH;
hsa:5709,1.25925735e-09,1.5601911276034373e-06,3.95293578525594e-06,7.1364839393868565e-06,0.0,6.254576e-05,False,PSMD3; proteasome 26S subunit
hsa:54963,0.0,0.0,0.00023410082751640102,0.0005275764477580673,0.0,0.002236561,False,UCKL1; uridine-cytidine kinase 1 like
hsa:3276,4.3372713e-06,0.00537378018898919,5.9557574878079215e-05,0.0001332957479290136,0.0,0.0007230224,False,PRMT1; protein arginine methyltransferase
hsa:1364,4.5326186e-07,0.0005615811036981689,2.473283100906782e-05,8.654333057186875e-05,0.0,0.0009480758,False,CLDN4; claudin
hsa:7334,0.0,0.0,1.3774613356747528e-06,6.516006557866202e-06,0.0,6.99298e-05,False,UBE2N; ubiquitin conjugating enzyme E2
hsa:284161,9.328944e-07,0.0011558348782883276,1.423928998242574e-05,3.3171168052195936e-05,0.0,0.00028361205,False,GDPD1; glycerophosphodiester phosphodiesterase domain containing
hsa:92483,0.0,0.0,6.968460846955442e-06,4.35477238039308e-05,0.0,0.00058011,False,LDHAL6B; lactate dehydrogenase A like
hsa:3357,0.0,0.0,3.62052069490594e-05,0.00012543143561537316,0.0,0.0009639648,False,HTR2B; 5-hydroxytryptamine receptor
hsa:219447,0.0,0.0,2.1808415841584157e-09,3.099558263800361e-08,-0.0,4.4053e-07,False,OR5AS1; olfactory receptor family 5 subfamily AS member
hsa:2781,2.0742838e-07,0.00025699903049138784,9.48425814233168e-05,0.0002036075680345235,0.0,0.0012130146,False,GNAZ; G protein subunit alpha
hsa:56302,0.0,0.0,7.585049711361386e-07,3.7709319092067313e-06,0.0,3.7297235e-05,False,TRPV5; transient receptor potential cation channel subfamily V member
hsa:2739,1.5335506e-07,0.00019000342065511293,2.191110863642078e-06,3.650074971583809e-06,0.0,3.0310652e-05,False,GLO1; glyoxalase
hsa:53918,0.0,0.0,2.1855137800574257e-07,5.105705610999176e-07,0.0,2.6874554e-06,False,PELO; pelota mRNA surveillance and ribosome rescue
hsa:27346,9.811355e-08,0.00012156045006024879,1.1994716329576728e-05,2.6159837846809853e-05,0.0,0.0002074161,False,TMEM97; transmembrane protein
hsa:79671,0.0,0.0,1.285509672702971e-05,2.8535735103370818e-05,0.0,0.00018835493,False,NLRX1; NLR family member
hsa:79767,6.3682355e-09,7.890098497808443e-06,1.5095031649391094e-05,4.5190459630224654e-05,0.0,0.00039665579,False,ELMO3; engulfment and cell motility
hsa:5222,7.20815165e-07,0.0008930735445578361,2.8814313862821772e-05,5.740642111716339e-05,0.0,0.00028111183,False,PGA5; pepsinogen
hsa:23016,7.961779e-08,9.864462538764906e-05,4.338986051009901e-06,2.986164858570659e-05,0.0,0.0003427746,False,EXOSC7; exosome component
hsa:1553,0.0,0.0,6.670849532673267e-06,8.605503159359935e-05,0.0,0.0012214867,False,CYP2A13; cytochrome P450 family 2 subfamily A member
hsa:219484,0.0,0.0,1.0035645214851487e-06,9.536458625752962e-06,-0.0,0.00010723595,False,OR5M8; olfactory receptor family 5 subfamily M member
hsa:285973,0.0,0.0,1.776670772730198e-05,0.00011259122094172526,0.0,0.0013041651,False,ATG9B; autophagy related
hsa:5062,4.61835925e-06,0.005722041746220711,3.610763136455446e-05,7.109037884075935e-05,0.0,0.0005148549,False,PAK2; p21 (RAC1) activated kinase
hsa:5970,0.0,0.0,0.000334875281519802,0.0006300969790815384,0.0,0.0028238771,False,RELA; RELA proto-oncogene
hsa:114112,1.4505418999999999e-06,0.0017971883210346415,0.00011398224826123764,0.00038098490527728197,0.0,0.0023802253,False,TXNRD3; thioredoxin reductase
hsa:3556,0.0,0.0,5.0112656244356454e-05,0.00013684709616345442,0.0,0.0010165516,False,IL1RAP; interleukin 1 receptor accessory
hsa:51412,0.0,0.0,9.673943410742572e-07,3.6627620958704747e-06,0.0,2.7288672e-05,False,ACTL6B; actin like
hsa:377,0.0,0.0,7.982299534450498e-07,2.3260543541933927e-06,0.0,2.4006526e-05,False,ARF3; ADP ribosylation factor
hsa:8850,8.055053e-06,0.00998002689678599,0.0001150219167747525,0.00023205688276181868,0.0,0.0015773787,False,KAT2B; lysine acetyltransferase
hsa:4928,0.0,0.0,6.517503278212872e-06,4.7149716425416054e-05,0.0,0.00064906274,False,NUP98; nucleoporin 98 and 96
hsa:115111,2.0034530499999998e-08,2.4822326216162607e-05,5.174724108539554e-06,1.656295645943781e-05,0.0,0.00012204865,False,SLC26A7; solute carrier family 26 member
hsa:1308,0.0,0.0,3.5644548887524746e-06,1.1336782719770396e-05,0.0,7.641716e-05,False,COL17A1; collagen type XVII alpha 1
hsa:11000,7.833828999999999e-06,0.009705935407851704,5.68378670319752e-05,0.00019571611330659205,0.0,0.00150938,False,SLC27A3; solute carrier family 27 member
hsa:9054,7.2449917e-07,0.000897637942704924,8.200432108039606e-05,0.00015543699939605087,0.0,0.00079414196,False,NFS1; NFS1 cysteine
hsa:64208,0.0,0.0,5.574840076664851e-06,2.442731439173445e-05,0.0,0.0002835713,False,POPDC3; popeye domain containing
hsa:50506,0.0,0.0,6.332549483896038e-06,1.9271126013072697e-05,0.0,0.00014004188,False,DUOX2; dual oxidase
hsa:5832,8.182954750000001e-08,0.00010138494247049981,6.826619210024055e-05,0.00013706850056537695,0.0,0.0010234314,False,ALDH18A1; aldehyde dehydrogenase 18 family member
hsa:29108,1.139125085e-06,0.0014113499919992617,7.417485164287131e-05,0.0001964186752920812,0.0,0.0019921514,False,PYCARD; PYD and CARD domain
hsa:58492,5.87829985e-09,7.283079404986293e-06,3.667140363960398e-08,6.509590679132106e-08,0.0,4.655922e-07,False,ZNF77; zinc finger protein
hsa:1478,0.0,0.0,1.4388926084405937e-07,3.5264018433863757e-07,0.0,1.942078e-06,False,CSTF2; cleavage stimulation factor subunit
hsa:2889,6.55800285e-07,0.0008125215915053468,7.976269974267329e-06,2.268231155422784e-05,0.0,0.00023446068,False,RAPGEF1; Rap guanine nucleotide exchange factor
hsa:5166,7.49717625e-10,9.288830331090949e-07,4.3769623613638624e-07,1.2825923911895893e-06,0.0,1.0064803e-05,False,PDK4; pyruvate dehydrogenase kinase
hsa:80237,4.5922585e-07,0.0005689703512440463,1.767623482222276e-05,5.05073411682787e-05,0.0,0.00038953032,False,ELL3; elongation factor for RNA polymerase II
hsa:6497,0.0,0.0,5.235147976108416e-05,0.00013602214336472837,0.0,0.0010425475,False,SKI; SKI
hsa:3423,4.20033145e-06,0.005204114839022922,0.00012618604110707922,0.0003390601709495222,0.0,0.0022493973,False,IDS; iduronate
hsa:51274,6.943254999999999e-08,8.60253453965403e-05,8.099200938337578e-06,2.492499333250571e-05,0.0,0.00021896623,False,KLF3; KLF transcription factor
hsa:406,0.0,0.0,0.00014663720996856434,0.000906237845938282,0.0,0.007585273,False,BMAL1; basic helix-loop-helix ARNT like
hsa:121130,0.0,0.0,7.048772722772277e-08,6.102499202135579e-07,0.0,7.674713e-06,False,OR10P1; olfactory receptor family 10 subfamily P member
hsa:10992,0.0,0.0,1.5776545409405935e-07,2.697474195539748e-07,0.0,1.3384863e-06,False,SF3B2; splicing factor 3b subunit
hsa:10458,9.5348858e-07,0.0011813505974669915,4.421639078868319e-05,0.00014604629148284447,0.0,0.0010551182,False,BAIAP2; BAR/IMD domain containing adaptor protein
hsa:339221,0.0,0.0,3.2686100667148505e-07,1.7498173776893802e-06,0.0,1.58885e-05,False,ENPP7; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:4293,7.190722450000001e-10,8.909141064412967e-07,8.261681966430692e-08,3.2941105692812836e-07,0.0,3.9496745e-06,False,MAP3K9; mitogen-activated protein kinase kinase kinase
hsa:29958,6.5877922e-08,8.162124240080972e-05,3.100447014300942e-06,6.33432863710641e-06,0.0,3.2687e-05,False,DMGDH; dimethylglycine
hsa:3597,0.0,0.0,2.989185457220298e-05,0.00015789900540932671,0.0,0.0012968166,False,IL13RA1; interleukin 13 receptor subunit alpha
hsa:349565,0.0,0.0,3.1566785671213176e-05,7.011641711551057e-05,0.0,0.000597821,False,NMNAT3; nicotinamide nucleotide adenylyltransferase
hsa:5723,0.0,0.0,6.765329510580645e-05,0.00013648334962510495,0.0,0.00068032264,False,PSPH; phosphoserine
hsa:26834,0.0,0.0,1.0238516096534656e-07,3.263629911624703e-07,0.0,3.7145965e-06,False,RNU4-2; RNA
hsa:158835,0.0,0.0,1.141455077811881e-06,5.756139948998666e-06,0.0,5.8575963e-05,False,AWAT2; acyl-CoA wax alcohol acyltransferase
hsa:2917,7.281167e-09,9.021199798435909e-06,4.502067182727721e-06,1.512576819364469e-05,0.0,0.0001799764,False,GRM7; glutamate metabotropic receptor
hsa:285242,0.0,0.0,1.2909961404504948e-05,9.48385180928174e-05,0.0,0.0012865416,False,HTR3E; 5-hydroxytryptamine receptor
hsa:773,0.0,0.0,0.00013353790164752474,0.0005294465630711921,0.0,0.0058459025,False,CACNA1A; calcium voltage-gated channel subunit alpha1
hsa:122042,0.0,0.0,6.082344600643563e-08,4.840027063506245e-07,0.0,6.3048255e-06,False,RXFP2; relaxin family peptide receptor
hsa:832,0.0,0.0,1.9518037479554458e-06,6.020129705227851e-06,0.0,2.9856328e-05,False,CAPZB; capping actin protein of muscle Z-line subunit
hsa:3456,0.0,0.0,1.4817857520792077e-06,8.906894252894088e-06,0.0,8.1112776e-05,False,IFNB1; interferon beta
hsa:5557,0.0,0.0,5.310275601143564e-06,2.2688278655813092e-05,0.0,0.0002464381,False,PRIM1; DNA primase subunit
hsa:134860,0.0,0.0,4.867533728861387e-09,6.915946311793298e-08,0.0,9.829421e-07,False,TAAR9; trace amine associated receptor
hsa:215,8.949472e-06,0.011088191632262769,0.0002565767507693071,0.00048346227502758023,0.0,0.002623964,False,ABCD1; ATP binding cassette subfamily D member
hsa:79001,0.0,0.0,0.00013950862027336633,0.00040046790327548707,0.0,0.0028479937,False,VKORC1; vitamin K epoxide reductase complex subunit
hsa:10538,0.0,0.0,1.8995768131089105e-06,6.212951511514474e-06,0.0,5.6670084e-05,False,BATF; basic leucine zipper ATF-like transcription
hsa:23275,2.40702515e-06,0.002982249246310401,0.00012844031343460397,0.0003369417084376002,0.0,0.0020296508,False,POFUT2; protein O-fucosyltransferase
hsa:4478,1.8289928999999998e-06,0.002266080475948527,2.253388024576238e-05,4.5034767959779024e-05,0.0,0.000328844,False,MSN;
hsa:4163,0.0,0.0,2.183274613420793e-06,8.376104509387932e-06,0.0,8.799056e-05,False,MCC; MCC regulator of WNT signaling
hsa:7644,0.0,0.0,8.516076207844556e-08,2.0787258236375975e-07,0.0,1.7794515e-06,False,ZNF91; zinc finger protein
hsa:4091,0.0,0.0,6.341372112873764e-06,3.594935422497653e-05,0.0,0.0003451075,False,SMAD6; SMAD family member
hsa:374659,1.29059225e-08,1.599014353820335e-05,2.708602594731188e-06,9.252739802696235e-06,0.0,9.429544e-05,False,HDDC3; HD domain containing
hsa:5577,8.4474057e-08,0.00010466142940842636,6.453177425352476e-06,1.947331538596744e-05,0.0,0.00013923233,False,PRKAR2B; protein kinase cAMP-dependent type II regulatory subunit
hsa:5862,0.0,0.0,4.581435973372278e-06,9.716202769595778e-06,0.0,7.5250435e-05,False,RAB2A; RAB2A
hsa:2305,8.182772499999999e-08,0.00010138268443457882,1.832080139361237e-06,5.766487004355189e-06,0.0,4.5241068e-05,False,FOXM1; forkhead box
hsa:51060,2.26767735e-06,0.0028096005012297723,0.00010377504246193058,0.0003268322626405369,0.0,0.0021615867,False,TXNDC12; thioredoxin domain containing
hsa:1025,4.3615726000000004e-06,0.00540388894527259,1.7368218270663368e-05,4.577764570869654e-05,0.0,0.0004533854,False,CDK9; cyclin dependent kinase
hsa:441531,0.0,0.0,8.175541551318257e-06,2.2796008843106026e-05,0.0,0.00019417236,False,PGAM4; phosphoglycerate mutase family member
hsa:4967,0.0,0.0,4.5046516338316845e-05,0.00010850446707473852,0.0,0.00061377144,False,OGDH; oxoglutarate
hsa:6756,0.0,0.0,4.904110015435502e-06,2.3683190227505402e-05,-0.0,0.00017368741,False,SSX1; SSX family member
hsa:51699,2.19936225e-09,2.7249596508894173e-06,1.907501012874109e-06,5.488543610712733e-06,0.0,3.3638815e-05,False,VPS29; VPS29 retromer complex
hsa:1431,0.0,0.0,2.8737192182722782e-05,6.420461274506916e-05,0.0,0.00036820126,False,CS; citrate
hsa:7058,0.0,0.0,3.633283875618812e-05,0.00016602249145930602,0.0,0.0016142941,False,THBS2; thrombospondin
hsa:23396,4.03213775e-07,0.0004995726681940659,1.2675917827391088e-05,2.8416122218815506e-05,0.0,0.00028103444,False,PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase type 1
hsa:147657,0.0,0.0,6.528807718564356e-08,1.340400258005164e-07,0.0,6.036605e-07,False,ZNF480; zinc finger protein
hsa:913,0.0,0.0,4.908944736860398e-06,1.6401453174661724e-05,0.0,0.00014556396,False,CD1E; CD1e
hsa:2847,0.0,0.0,4.256958799663365e-06,1.4579913424738506e-05,0.0,0.00012849507,False,MCHR1; melanin concentrating hormone receptor
hsa:84992,0.0,0.0,7.966064602376238e-06,2.0909560060675177e-05,0.0,0.00019972696,False,PIGY; phosphatidylinositol glycan anchor biosynthesis class
hsa:729230,0.0,0.0,1.2232033663425743e-05,4.736476367361225e-05,0.0,0.00044730146,False,CCR2; C-C motif chemokine receptor
hsa:30061,0.0,0.0,4.9328857870099e-05,0.00014318117232686684,0.0,0.0011541835,False,SLC40A1; solute carrier family 40 member
hsa:152831,0.0,0.0,3.480472245316831e-08,1.0225199931618614e-07,0.0,1.2003384e-06,False,KLB; klotho
hsa:2885,0.000171273125,0.21220349440240666,0.0007340183195629012,0.001546596437645612,0.0,0.01147511,False,GRB2; growth factor receptor bound protein
hsa:7263,0.0,0.0,7.880525456039604e-05,0.00018487383208002058,0.0,0.0012597056,False,TST; thiosulfate
hsa:407034,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30E; microRNA
hsa:4711,4.5048482e-06,0.005581404144943299,6.83146601732673e-06,8.048734849968475e-06,0.0,4.4942743e-05,False,NDUFB5; NADH:ubiquinone oxidoreductase subunit
hsa:146664,0.0,0.0,0.00011104647428732675,0.0003147178912987504,0.0,0.0024591705,False,MGAT5B; alpha-1
hsa:1540,0.0,0.0,5.024877528168316e-05,0.00013389387956326483,0.0,0.001116011,False,CYLD; CYLD lysine 63
hsa:170958,1.6968594500000001e-09,2.102370145927716e-06,7.610861403943564e-08,1.797989766398782e-07,0.0,1.2399043e-06,False,ZNF525; zinc finger protein
hsa:574455,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR193B; microRNA
hsa:7520,5.0680195e-07,0.0006279160537297011,0.00010124924580549508,0.00023767414107821842,0.0,0.0020484207,False,XRCC5; X-ray repair cross complementing
hsa:27180,0.0,0.0,2.691879788168317e-06,1.3494993611006847e-05,0.0,0.0001330101,False,SIGLEC9; sialic acid binding Ig like lectin
hsa:54658,0.0,0.0,2.188528269356436e-05,0.00011558379882222593,0.0,0.0013447709,False,UGT1A1; UDP glucuronosyltransferase family 1 member
hsa:10257,1.9882625e-05,0.024634118767276836,0.00015700745924009902,0.00030453625954625813,0.0,0.0021732594,False,ABCC4; ATP binding cassette subfamily C member
hsa:55737,0.0,0.0,6.741842603140395e-07,1.7756701225010653e-06,0.0,1.7644667e-05,False,VPS35; VPS35 retromer complex
hsa:5700,4.0853845e-08,5.061698190404531e-05,9.38745996745545e-06,2.7899059737013698e-05,0.0,0.00029083894,False,PSMC1; proteasome 26S subunit
hsa:23047,1.15514545e-07,0.00014311988587412098,2.7750767922158418e-06,5.655333156417894e-06,0.0,3.0060042e-05,False,PDS5B; PDS5 cohesin associated factor
hsa:6829,0.0,0.0,6.621857003732677e-05,0.00020480798462920257,0.0,0.0016233391,False,SUPT5H; SPT5 homolog
hsa:10005,6.01982995e-06,0.007458431969979324,0.00039356494866386144,0.0007885187711816406,0.0,0.0036498494,False,ACOT8; acyl-CoA thioesterase
hsa:348980,0.0,0.0,2.298453920207426e-06,1.3281167679414562e-05,0.0,0.00016982183,False,HCN1; hyperpolarization activated cyclic nucleotide gated potassium channel
hsa:4249,5.9238650000000006e-08,7.339533586300319e-05,6.17691446249195e-05,0.0001766030477116043,0.0,0.0014321695,False,MGAT5; alpha-1
hsa:1824,0.0,0.0,4.804071751698019e-06,1.8410368337471833e-05,0.0,0.00017022288,False,DSC2; desmocollin
hsa:5837,0.0,0.0,9.169974289534652e-05,0.00022731868096953164,0.0,0.0013689395,False,PYGM; glycogen phosphorylase
hsa:390195,0.0,0.0,2.4897374925742573e-07,2.3794339439030795e-06,0.0,2.9029572e-05,False,OR5AN1; olfactory receptor family 5 subfamily AN member
hsa:4350,0.0,0.0,2.187113483333663e-05,0.00015063569397997712,0.0,0.0014623835,False,MPG; N-methylpurine DNA
hsa:27175,3.5731238499999997e-09,4.4270189319111265e-06,5.475318283747526e-07,2.0463892775613905e-06,0.0,2.1058004e-05,False,TUBG2; tubulin gamma
hsa:346528,0.0,0.0,7.550543775683169e-06,3.3546502003921194e-05,0.0,0.00025797883,False,OR2A1; olfactory receptor family 2 subfamily A member
hsa:6385,0.0,0.0,1.9487277438465347e-05,8.57893263711039e-05,0.0,0.000876329,False,SDC4; syndecan
hsa:84002,0.0,0.0,6.519497019521288e-05,0.00028654484607190406,0.0,0.002880712,False,B3GNT5; UDP-GlcNAc:betaGal beta-1
hsa:403244,0.0,0.0,6.430364356435644e-07,9.139264917276812e-06,-0.0,0.00012989336,False,OR2T35; olfactory receptor family 2 subfamily T member
hsa:10683,4.62708705e-06,0.005732855291302261,0.00014744684011863172,0.0003686227423905635,0.0,0.0022323707,False,DLL3; delta like canonical Notch ligand
hsa:8626,0.0,0.0,2.1090447078267332e-08,8.759336724780369e-08,0.0,7.870851e-07,False,TP63; tumor protein
hsa:393046,0.0,0.0,7.279277757673267e-07,8.55059435383311e-06,0.0,0.000120308425,False,OR2A5; olfactory receptor family 2 subfamily A member
hsa:127385,0.0,0.0,5.099529702970297e-08,7.247793488143974e-07,0.0,1.030105e-05,False,OR10J5; olfactory receptor family 10 subfamily J member
hsa:9928,3.07307925e-09,3.8074750806673677e-06,1.2028687259372279e-06,4.60094689908979e-06,0.0,3.0311216e-05,False,KIF14; kinesin family member
hsa:8553,0.0,0.0,0.00032300855699780195,0.0015312056941696134,0.0,0.011338124,False,BHLHE40; basic helix-loop-helix family member
hsa:5428,0.0,0.0,1.8974340537306926e-05,6.80100120941574e-05,0.0,0.0005068164,False,POLG; DNA polymerase gamma
hsa:8509,1.0163309e-06,0.0012592107982448673,0.00024788634914321776,0.0008079184850699777,0.0,0.005098628,False,NDST2; N-deacetylase and N-sulfotransferase
hsa:9706,2.2132529e-07,0.00027421698493342744,0.0005637827111790347,0.0018945968254000514,0.0,0.011077503,False,ULK2; unc-51 like autophagy activating kinase
hsa:11164,0.0,0.0,2.372389015614357e-06,8.84694954350708e-06,0.0,9.44574e-05,False,NUDT5; nudix hydrolase
hsa:594,4.92044285e-06,0.006096316434801648,5.551389500512376e-05,0.0001833183645476745,0.0,0.0021158813,False,BCKDHB; branched chain keto acid dehydrogenase E1 subunit
hsa:2034,0.0,0.0,1.148389978453466e-05,8.387058937126966e-05,0.0,0.0008002584,False,EPAS1; endothelial PAS domain protein
hsa:9630,0.0,0.0,1.3226030695792076e-05,4.593784317137523e-05,0.0,0.0004083869,False,GNA14; G protein subunit alpha
hsa:29796,3.04493255e-07,0.00037726019615139903,0.00017662623170995064,0.0005113181425830032,0.0,0.0030270815,False,UQCR10; ubiquinol-cytochrome c reductase
hsa:10814,0.0,0.0,3.325771355347525e-05,0.00012718836735017998,0.0,0.0009201936,False,CPLX2; complexin
hsa:549,8.2751307e-08,0.00010252698146172283,1.9551615929430682e-06,3.6115289831504943e-06,0.0,2.028464e-05,False,AUH; AU RNA binding methylglutaconyl-CoA
hsa:2121,0.0,0.0,2.9172731015049503e-05,0.0001481078994319343,0.0,0.0013765688,False,EVC; EvC ciliary complex subunit
hsa:8677,1.8223594e-08,2.2578617207870367e-05,5.433930773985151e-07,1.3041349895273527e-06,0.0,1.1382228e-05,False,STX10; syntaxin
hsa:79586,6.48282365e-07,0.0008032070601412595,0.0003890258208440595,0.001304784604620306,0.0,0.008343099,False,CHPF; chondroitin polymerizing
hsa:2642,0.0,0.0,1.6216006302044558e-05,4.8155706996867045e-05,0.0,0.00043622206,False,GCGR; glucagon
hsa:5427,7.375923249999999e-07,0.0009138600630390531,7.462467162194063e-05,0.00023932946107821195,0.0,0.0012547331,False,POLE2; DNA polymerase epsilon 2
hsa:1139,1.0557982e-06,0.001308109882526935,0.0005996240473138616,0.001332866164933423,0.0,0.009513499,False,CHRNA7; cholinergic receptor nicotinic alpha 7
hsa:341,0.0,0.0,9.653053457524747e-05,0.00025157047396903243,0.0,0.0015360622,False,APOC1; apolipoprotein
hsa:527,0.0,0.0,0.00016078116977841578,0.0009905587673295912,0.0,0.011216625,False,ATP6V0C; ATPase H+ transporting V0 subunit
hsa:10057,0.0,0.0,0.0009326957980402967,0.001482400055970661,0.0,0.008093039,False,ABCC5; ATP binding cassette subfamily C member
hsa:100169851,0.0,0.0,2.2848467086394554e-07,1.278122995398619e-06,0.0,1.3766902e-05,False,PATE3; prostate and testis expressed
hsa:23171,2.26673005e-08,2.8084268181417368e-05,1.1532475462079209e-06,2.9548446002989375e-06,0.0,2.7041444e-05,False,GPD1L; glycerol-3-phosphate dehydrogenase 1
hsa:8871,0.0,0.0,3.4566042791222777e-06,1.9358854175428763e-05,0.0,0.00021039872,False,SYNJ2; synaptojanin
hsa:6210,0.0,0.0,3.9773682623762386e-07,1.1818367683201874e-06,0.0,1.0852882e-05,False,RPS15A; ribosomal protein
hsa:3586,0.0,0.0,7.910543183762376e-05,0.00025706657547868214,0.0,0.0015887445,False,IL10; interleukin
hsa:8741,0.0,0.0,1.8541713825544563e-05,4.667447663701265e-05,0.0,0.00038746357,False,TNFSF13; TNF superfamily member
hsa:79587,0.0,0.0,2.258752852985149e-06,7.2472083212128355e-06,0.0,6.417902e-05,False,CARS2; cysteinyl-tRNA synthetase 2
hsa:143187,0.0,0.0,7.245357842549505e-06,3.510990539855902e-05,0.0,0.0002971897,False,VTI1A; vesicle transport through interaction with t-SNAREs
hsa:1069,0.0,0.0,2.028270647027228e-06,4.842950397646515e-06,0.0,2.8438018e-05,False,CETN2; centrin
hsa:22987,9.280982e-08,0.00011498924959101652,3.527277614607425e-05,9.818844371554276e-05,0.0,0.0006254189,False,SV2C; synaptic vesicle glycoprotein
hsa:117178,5.49413915e-08,6.807113062035089e-05,2.342642012467078e-05,6.030408321957256e-05,0.0,0.00032572044,False,SSX2IP; SSX family member 2 interacting
hsa:85477,0.0,0.0,2.1062126263861387e-06,7.3543415884209564e-06,0.0,4.6320918e-05,False,SCIN;
hsa:84976,0.0,0.0,5.7943204548118844e-05,0.00013805750962224867,0.0,0.0010358003,False,DISP1; dispatched RND transporter family member
hsa:6144,1.2392957e-07,0.00015354590986640587,8.452953713366339e-07,1.698328233422633e-06,0.0,9.769655e-06,False,RPL21; ribosomal protein
hsa:5501,4.55490445e-05,0.05643422696696124,0.00036325307284405936,0.0005822423182812215,0.0,0.003784942,False,PPP1CC; protein phosphatase 1 catalytic subunit
hsa:8876,2.68221325e-07,0.0003323201023992737,3.843052799534652e-06,7.818464754982046e-06,0.0,5.1956253e-05,False,VNN1; vanin
hsa:83998,0.0,0.0,1.0339381635544554e-07,5.897855514032168e-07,0.0,5.604856e-06,False,REG4; regenerating family member
hsa:90865,0.0,0.0,2.8709930278366336e-05,0.00010736757253702989,0.0,0.0007669283,False,IL33; interleukin
hsa:545,8.59413285e-06,0.010647934532218727,8.378074048019798e-05,0.00018399501633770238,0.0,0.0011053593,False,ATR; ATR serine/threonine
hsa:6375,3.47685675e-05,0.04307746191275455,0.00013599717377489102,0.0003218491829358687,0.0,0.0031699794,False,XCL1; X-C motif chemokine ligand
hsa:1564,1.7125739000000001e-06,0.0021218399909638933,9.88307747655446e-05,0.0002591735090967566,0.0,0.0019567427,False,CYP2D7; cytochrome P450 family 2 subfamily D member 7
hsa:6677,0.0,0.0,1.765017774009901e-07,1.2882408807345708e-06,0.0,1.5332345e-05,False,SPAM1; sperm adhesion molecule
hsa:55659,0.0,0.0,1.607808560618812e-08,5.299584166873006e-08,0.0,4.275778e-07,False,ZNF416; zinc finger protein
hsa:23335,2.19712055e-07,0.00027221822357321833,1.961954698871931e-06,4.218679784764709e-06,0.0,3.979997e-05,False,WDR7; WD repeat domain
hsa:84812,9.51741425e-06,0.011791859122820703,0.00017594992405801964,0.00048507433686382606,0.0,0.0028252464,False,PLCD4; phospholipase C delta
hsa:3706,0.0,0.0,1.9136111216980193e-06,6.663534325894842e-06,0.0,7.188919e-05,False,ITPKA; inositol-trisphosphate 3-kinase
hsa:2178,7.330975499999999e-06,0.009082911393590971,0.00012703603860547027,0.00022518985601330743,0.0,0.0012165612,False,FANCE; FA complementation group
hsa:83734,2.4896193e-07,0.0003084581513834547,0.0001956205449203099,0.000595611716548748,0.0,0.003430012,False,ATG10; autophagy related
hsa:200959,0.0,0.0,1.6389129153564357e-06,9.338089575227674e-06,0.0,8.943197e-05,False,GABRR3; gamma-aminobutyric acid type A receptor subunit
hsa:5395,2.1319728e-06,0.002641465659781027,0.00027717657776351495,0.0006571054586797994,0.0,0.0038611644,False,PMS2; PMS1 homolog 2
hsa:1642,0.0,0.0,2.1890243465841577e-06,4.352444438343829e-06,0.0,3.2835487e-05,False,DDB1; damage specific DNA binding protein
hsa:80331,2.1013749e-09,2.6035555597500072e-06,8.999356842329205e-07,2.518889818104378e-06,0.0,2.1941007e-05,False,DNAJC5; DnaJ heat shock protein family (Hsp40) member
hsa:8817,0.0,0.0,4.5265525581732674e-06,1.4402198594635964e-05,0.0,9.733269e-05,False,FGF18; fibroblast growth factor
hsa:983,1.1232542500000001e-05,0.013916863895158949,0.0003694932598231933,0.0007393515525358541,0.0,0.0057328674,False,CDK1; cyclin dependent kinase
hsa:259285,0.0,0.0,5.71854445891089e-07,4.773635230900167e-06,0.0,6.217525e-05,False,TAS2R39; taste 2 receptor member
hsa:9519,0.0,0.0,1.7548591794356434e-06,7.941126315508137e-06,0.0,8.9138564e-05,False,TBPL1; TATA-box binding protein like
hsa:5000,1.77882685e-08,2.2039258845007105e-05,1.1924129700948512e-06,3.0828406104617148e-06,0.0,1.6225165e-05,False,ORC4; origin recognition complex subunit
hsa:382,1.33164465e-06,0.0016498773408394915,1.7136043950534652e-05,4.2185805089194635e-05,0.0,0.00029576008,False,ARF6; ADP ribosylation factor
hsa:127602,1.5419296e-08,1.9104155963902985e-05,3.188891777113862e-07,9.717850411033558e-07,0.0,6.732901e-06,False,DNAH14; dynein axonemal heavy chain
hsa:84295,0.0,0.0,1.1266347782019804e-06,3.4980834406579905e-06,0.0,2.1556456e-05,False,PHF6; PHD finger protein
hsa:25885,9.3564295e-09,1.1592402690321455e-05,8.778544033937622e-05,0.0003420457669300002,0.0,0.0026170297,False,POLR1A; RNA polymerase I subunit
hsa:3106,0.0,0.0,0.00016172470896138615,0.00046870330791544244,0.0,0.00425116,False,HLA-B; major histocompatibility complex
hsa:4046,0.0,0.0,5.409734678402476e-06,2.1089838760673754e-05,0.0,0.00019378404,False,LSP1; lymphocyte specific protein
hsa:79296,0.0,0.0,2.0187293564356438e-08,2.3804138501317343e-07,0.0,3.2953724e-06,False,OR52E1; olfactory receptor family 52 subfamily E member 1
hsa:50831,8.44437475e-06,0.010462387662941568,7.763858818663367e-05,0.00018392125805583422,0.0,0.0012591046,False,TAS2R3; taste 2 receptor member
hsa:7314,7.357404e-07,0.000911565570214384,7.574974302787127e-06,1.827965853577271e-05,0.0,0.00017901816,False,UBB; ubiquitin
hsa:27086,0.0,0.0,2.01159287759901e-07,4.269901542834015e-07,0.0,3.7696313e-06,False,FOXP1; forkhead box
hsa:11181,0.0,0.0,1.967236015371286e-06,1.0139490394404837e-05,0.0,0.00011476112,False,TREH;
hsa:3205,0.0,0.0,3.01658440655198e-07,1.8998951641435914e-06,0.0,2.357244e-05,False,HOXA9; homeobox
hsa:116984,0.0,0.0,7.350326600301978e-08,1.8133008690427667e-07,0.0,1.103572e-06,False,ARAP2; ArfGAP with RhoGAP domain
hsa:51561,8.388806249999999e-06,0.010393539559196745,5.331765300396041e-05,8.695205673641207e-05,0.0,0.000481671,False,IL23A; interleukin 23 subunit
hsa:22823,0.0,0.0,6.31143727139084e-05,0.0002511063790374148,0.0,0.0016670902,False,MTF2; metal response element binding transcription factor
hsa:939,0.0,0.0,1.0920639675465341e-05,4.462052352599375e-05,0.0,0.00036884224,False,CD27; CD27
hsa:2902,2.9509566499999998e-05,0.036561679654062464,0.0005714763745280197,0.001227992333617933,0.0,0.0074226786,False,GRIN1; glutamate ionotropic receptor NMDA type subunit
hsa:10915,0.0,0.0,1.4042934664851487e-07,3.5114955659348665e-07,0.0,2.294099e-06,False,TCERG1; transcription elongation regulator
hsa:64901,1.81703015e-10,2.2512589016200246e-07,1.9347930643084165e-07,5.618089104568193e-07,0.0,3.5200624e-06,False,RANBP17; RAN binding protein
hsa:9790,4.7574529e-08,5.8943756052495886e-05,2.216581475385594e-06,4.550327314477096e-06,0.0,2.4387975e-05,False,BMS1; BMS1 ribosome biogenesis
hsa:55252,2.8996254e-08,3.5925697177416254e-05,3.15880316509617e-05,0.00011280436010597303,0.0,0.000632773,False,ASXL2; ASXL transcriptional regulator
hsa:2207,0.0,0.0,0.00026082357897539603,0.0007845035343710171,0.0,0.004730145,False,FCER1G; Fc epsilon receptor
hsa:136051,0.0,0.0,3.022714886767326e-08,1.0751019609516873e-07,0.0,1.0295947e-06,False,ZNF786; zinc finger protein
hsa:51761,3.823361e-10,4.737057051781358e-07,6.355127061286982e-05,0.00023258920805906467,0.0,0.0019231135,False,ATP8A2; ATPase phospholipid transporting
hsa:7326,0.0,0.0,8.430934726311876e-07,2.0539872558745266e-06,0.0,1.8467164e-05,False,UBE2G1; ubiquitin conjugating enzyme E2
hsa:51206,0.0,0.0,2.3392454947351493e-06,8.580709548772388e-06,0.0,7.6276054e-05,False,GP6; glycoprotein VI
hsa:390067,0.0,0.0,3.289453175445544e-07,1.8766013345208058e-06,0.0,2.3931134e-05,False,OR52H1; olfactory receptor family 52 subfamily H member
hsa:79168,0.0,0.0,1.5226516414841583e-05,5.211723475441577e-05,0.0,0.0004105301,False,LILRA6; leukocyte immunoglobulin like receptor
hsa:2931,0.0,0.0,8.230347254257429e-06,2.2488054974176838e-05,0.0,0.00019914877,False,GSK3A; glycogen synthase kinase 3
hsa:7535,0.0,0.0,7.415884229356435e-05,0.000189219603076277,0.0,0.0011712837,False,ZAP70; zeta chain of T cell receptor associated protein kinase
hsa:79017,0.0,0.0,7.814945126069307e-05,0.0002565925259176967,0.0,0.0019594561,False,GGCT;
hsa:5329,5.3862761999999994e-08,6.673473327800355e-05,3.715731688930692e-06,1.1491332348987886e-05,0.0,9.5877054e-05,False,PLAUR; plasminogen activator
hsa:3694,0.0,0.0,7.376096068306931e-05,0.00024066878338782592,0.0,0.0017622969,False,ITGB6; integrin subunit beta
hsa:796,0.0,0.0,6.1140485322277245e-06,2.9271324027928724e-05,0.0,0.00024311629,False,CALCA; calcitonin related polypeptide
hsa:401992,0.0,0.0,1.7797980047524753e-07,1.3655754562556962e-06,-0.0,1.6216485e-05,False,OR2T2; olfactory receptor family 2 subfamily T member
hsa:84643,0.0,0.0,2.7331260198019802e-11,2.27585921713846e-10,0.0,3.0771634e-09,False,KIF2B; kinesin family member
hsa:5601,0.00028465040000000004,0.35267535150679846,0.0006098217873910895,0.0007242710274596461,0.0,0.0030970327,False,MAPK9; mitogen-activated protein kinase
hsa:2131,1.4990148e-07,0.00018572451382604528,9.325033169782177e-05,0.00048155010595997254,0.0,0.0047482094,False,EXT1; exostosin glycosyltransferase
hsa:9365,2.8877004e-06,0.003577794914801885,2.6243455809405942e-05,5.418468821389281e-05,0.0,0.0005457364,False,KL;
hsa:162466,0.0,0.0,4.6158201266009905e-07,1.6366690975195505e-06,0.0,1.5824846e-05,False,PHOSPHO1; phosphoethanolamine/phosphocholine phosphatase
hsa:338376,0.0,0.0,1.863864069797029e-06,8.066776703727986e-06,0.0,6.9074486e-05,False,IFNE; interferon
hsa:548593,0.0,0.0,3.0296803786777225e-05,0.0001457258103208362,0.0,0.0014399411,False,SLX1A; SLX1 homolog A
hsa:55870,1.8901599e-06,0.002341864993467618,1.876987060465347e-05,5.3277562026869365e-05,0.0,0.00034392127,False,ASH1L; ASH1 like histone lysine
hsa:3769,0.0,0.0,2.9258104584179197e-06,7.993678437908073e-06,0.0,7.66997e-05,False,KCNJ13; potassium inwardly rectifying channel subfamily J member
hsa:3814,0.0,0.0,5.012477013379704e-06,1.6479114561237937e-05,0.0,0.00011949942,False,KISS1; KiSS-1 metastasis
hsa:51013,3.90517245e-07,0.0004838419571862239,2.8912144596098994e-05,0.00011659514889442898,0.0,0.0010900188,False,EXOSC1; exosome component
hsa:7419,1.1699343999999999e-05,0.01449522030392001,0.00017553028293564355,0.000296286842298087,0.0,0.0017379958,False,VDAC3; voltage dependent anion channel
hsa:648,0.0,0.0,6.085797390692772e-05,0.0001366051148906001,0.0,0.00082748913,False,BMI1; BMI1 proto-oncogene
hsa:967,3.0041926000000002e-06,0.0037221260929165135,5.799886397574255e-06,1.1983150742537429e-05,0.0,0.00012693765,False,CD63; CD63
hsa:246213,5.5752398e-07,0.0006907594917132358,4.655650394346537e-05,0.0001668869552207267,0.0,0.001136748,False,SLC17A8; solute carrier family 17 member
hsa:9187,0.0,0.0,8.703161571336635e-05,0.0005098986558799326,0.0,0.0053673303,False,SLC24A1; solute carrier family 24 member
hsa:8787,1.64097035e-05,0.02033124826097149,0.00023332654135693065,0.0004075849690341365,0.0,0.002512284,False,RGS9; regulator of G protein signaling
hsa:4221,8.109337149999999e-07,0.0010047283720182331,1.9064509268126726e-05,4.9594047115421746e-05,0.0,0.00043854865,False,MEN1; menin
hsa:55851,1.033418275e-05,0.012803816660337532,0.00028406095935879687,0.0007103514885496738,0.0,0.0049185483,False,PSENEN; presenilin enhancer
hsa:55207,7.847686e-08,9.723103914714262e-05,2.5691734944554454e-07,4.889189246845552e-07,0.0,3.653057e-06,False,ARL8B; ADP ribosylation factor like GTPase
hsa:94160,0.0,0.0,6.592889804846534e-07,2.607342497448624e-06,0.0,2.1087302e-05,False,ABCC12; ATP binding cassette subfamily C member
hsa:6602,0.0,0.0,2.0260403669207903e-06,4.840835089793005e-06,0.0,3.287879e-05,False,SMARCD1; SWI/SNF related
hsa:6789,0.0,0.0,4.562270192358417e-06,2.3804695847016385e-05,0.0,0.00028612552,False,STK4; serine/threonine kinase
hsa:24146,2.9287995e-06,0.0036287157620556146,4.087175495841584e-05,0.00010460338981160239,0.0,0.00081252016,False,CLDN15; claudin
hsa:5579,0.0011492818,1.4239339301661478,0.002040264525960396,0.002477462360377206,0.0,0.012138994,True,PRKCB; protein kinase C
hsa:55247,9.061938e-08,0.00011227534440432242,5.528120872716288e-05,0.00017995140600660515,0.0,0.0014364043,False,NEIL3; nei like DNA glycosylase
hsa:64963,4.970382e-10,6.158189902326024e-07,9.5253562510396e-08,3.2375990051772034e-07,0.0,3.1656843e-06,False,MRPS11; mitochondrial ribosomal protein
hsa:6442,0.0,0.0,3.2138449777079204e-05,0.00018278512872029482,0.0,0.0022973705,False,SGCA; sarcoglycan
hsa:219858,0.0,0.0,1.078845291381188e-06,7.0311216665432445e-06,0.0,7.2648094e-05,False,OR8B12; olfactory receptor family 8 subfamily B member
hsa:54961,2.8438840499999995e-07,0.00035235074567902496,1.0494732000831677e-05,2.9325721557351603e-05,0.0,0.00017865191,False,SSH3; slingshot protein phosphatase
hsa:6716,1.6137341500000002e-08,1.9993797956713733e-05,3.5178484885642566e-06,8.69969773406236e-06,0.0,5.887655e-05,False,SRD5A2; steroid 5 alpha-reductase
hsa:2593,0.0,0.0,0.00014798204334549506,0.0003354794575060056,0.0,0.0021022777,False,GAMT; guanidinoacetate
hsa:56950,0.0,0.0,1.1115203672160395e-05,3.239244032695233e-05,0.0,0.00018877993,False,SMYD2; SET and MYND domain containing
hsa:5335,0.00016393264,0.2031088009552681,0.00034478376666782166,0.0004432259610896894,0.0,0.0019449831,False,PLCG1; phospholipase C gamma
hsa:340267,0.0,0.0,1.1987830359594061e-05,6.485967183441484e-05,0.0,0.0007518668,False,COL28A1; collagen type XXVIII alpha 1
hsa:54659,0.0,0.0,3.5284466485148514e-06,2.6779396942310244e-05,0.0,0.00025852912,False,UGT1A3; UDP glucuronosyltransferase family 1 member
hsa:84134,1.1774459e-08,1.4588286075225562e-05,5.6733933924282185e-08,8.972180140381943e-08,0.0,4.1407174e-07,False,TOMM40L; translocase of outer mitochondrial membrane 40
hsa:606495,6.0809683e-07,0.0007534180990802045,2.7284554449638597e-05,5.337274004529264e-05,0.0,0.000290423,False,CYB5RL; cytochrome b5 reductase
hsa:972,7.87071885e-07,0.0009751641090386432,2.144074060627723e-05,7.202199575309785e-05,0.0,0.00052729197,False,CD74; CD74
hsa:8674,0.0,0.0,3.2226524783108915e-05,9.62974277026322e-05,0.0,0.00078763,False,VAMP4; vesicle associated membrane protein
hsa:6201,3.1588696999999997e-07,0.0003913767490970238,8.692864216980192e-07,1.5576273810721835e-06,0.0,9.175502e-06,False,RPS7; ribosomal protein
hsa:8775,0.0,0.0,3.5257461080321775e-05,0.0002334036891786303,0.0,0.0029058624,False,NAPA; NSF attachment protein
hsa:27289,0.0,0.0,9.299164921316831e-07,6.808819006842479e-06,0.0,8.441774e-05,False,RND1; Rho family GTPase
hsa:29925,7.2551033e-07,0.0008988907468760392,5.6305725858861356e-05,0.00016684526213263064,0.0,0.0011398572,False,GMPPB; GDP-mannose pyrophosphorylase
hsa:100169751,0.0,0.0,4.306093869682178e-07,4.919459535825837e-06,0.0,6.907746e-05,False,RNA5S1; RNA
hsa:3581,2.14493105e-06,0.0026575206358979164,3.049939937386286e-05,6.655638676590652e-05,0.0,0.0004981987,False,IL9R; interleukin 9
hsa:4843,0.0,0.0,2.791722653702969e-05,0.00013374611273289644,0.0,0.001836286,False,NOS2; nitric oxide synthase
hsa:7692,1.92469055e-09,2.384647681025789e-06,1.7113422236076747e-07,4.238329543995024e-07,0.0,2.2604027e-06,False,ZNF133; zinc finger protein
hsa:1101,2.0137493500000002e-07,0.00024949895024136163,7.687698044193074e-06,4.761100427408551e-05,0.0,0.0006008062,False,CHAD;
hsa:54209,0.0,0.0,1.563130445242574e-05,5.863992611713876e-05,0.0,0.0004902108,False,TREM2; triggering receptor expressed on myeloid cells
hsa:2876,0.0,0.0,5.9141456211138604e-05,0.00018210129866699543,0.0,0.0015773923,False,GPX1; glutathione peroxidase
hsa:2904,0.0,0.0,1.2569123081608911e-05,6.483665846758651e-05,0.0,0.00065821473,False,GRIN2B; glutamate ionotropic receptor NMDA type subunit
hsa:476,0.0,0.0,0.0006337925345074257,0.0014121726188701263,0.0,0.0117636155,False,ATP1A1; ATPase Na+/K+ transporting subunit alpha
hsa:83594,0.0,0.0,0.00012647815082069303,0.00028895772786223533,0.0,0.0016367699,False,NUDT12; nudix hydrolase
hsa:1668,0.0,0.0,2.3112293595049505e-06,1.2331945730896081e-05,0.0,0.00015056654,False,DEFA3; defensin alpha
hsa:2099,0.0,0.0,7.1720692389232675e-06,2.86456667056568e-05,0.0,0.0003554069,False,ESR1; estrogen receptor
hsa:914,1.33623035e-06,0.0016555589185200594,2.5715408439316846e-05,5.817937216329179e-05,0.0,0.00047146587,False,CD2; CD2
hsa:8277,0.0,0.0,2.3389487623322523e-06,7.614697784073035e-06,0.0,6.198373e-05,False,TKTL1; transketolase like
hsa:732,0.0,0.0,1.0795453214039606e-06,1.3557924136573553e-05,0.0,0.00019258472,False,C8B; complement C8 beta
hsa:146434,0.0,0.0,1.6254970967202973e-08,3.33467148316577e-08,0.0,2.106478e-07,False,ZNF597; zinc finger protein
hsa:23446,2.36554065e-07,0.00029308508972492937,8.4996119832054e-06,4.77187117226878e-05,0.0,0.00052074844,False,SLC44A1; solute carrier family 44 member
hsa:2913,0.0,0.0,1.716327294207921e-05,4.006032779534958e-05,0.0,0.00031740539,False,GRM3; glutamate metabotropic receptor
hsa:1128,0.0,0.0,5.3573769358465353e-05,0.00012474235872860095,0.0,0.00075960346,False,CHRM1; cholinergic receptor muscarinic
hsa:10769,0.0,0.0,2.144775168762376e-06,7.816606125747285e-06,0.0,6.564251e-05,False,PLK2; polo like kinase
hsa:8767,0.0,0.0,2.570427369653465e-06,9.29753196332904e-06,0.0,8.971895e-05,False,RIPK2; receptor interacting serine/threonine kinase
hsa:90701,1.67640985e-06,0.002077033558070564,0.00010414476700257424,0.0002774308237997136,0.0,0.0019804034,False,SEC11C; SEC11 homolog C
hsa:284340,0.0,0.0,9.316655668549502e-07,3.93540004184819e-06,0.0,3.1652886e-05,False,CXCL17; C-X-C motif chemokine ligand
hsa:10112,7.15744555e-09,8.867911744501395e-06,1.204905918888505e-06,4.201032537603678e-06,0.0,2.376598e-05,False,KIF20A; kinesin family member
hsa:8322,0.0,0.0,4.583486940262377e-05,0.00014232455366127182,0.0,0.0012437623,False,FZD4; frizzled class receptor
hsa:441234,0.0,0.0,1.4796401356831684e-09,8.915975971001489e-09,0.0,9.9347574e-08,False,ZNF716; zinc finger protein
hsa:64577,1.0050062e-05,0.012451797533097152,6.061147659138615e-05,0.0001021266227152848,0.0,0.0006116217,False,ALDH8A1; aldehyde dehydrogenase 8 family member
hsa:8504,1.4479502000000001e-07,0.0001793977263862405,5.5997195520752454e-05,0.00021086219043738678,0.0,0.001394605,False,PEX3; peroxisomal biogenesis factor
hsa:242,0.0,0.0,1.2665347504413364e-05,3.052309437161085e-05,0.0,0.00017994546,False,ALOX12B; arachidonate 12-lipoxygenase
hsa:859,0.0,0.0,1.6399518655440592e-06,8.473781440834455e-06,0.0,9.010318e-05,False,CAV3; caveolin
hsa:25909,0.0,0.0,6.787300491707921e-08,1.6750283356667334e-07,0.0,7.896246e-07,False,AHCTF1; AT-hook containing transcription factor
hsa:2941,0.0008132367,1.0075817178922943,0.001242516125029703,0.001402089892348092,0.0,0.008019,True,GSTA4; glutathione S-transferase alpha
hsa:135112,8.5194655e-07,0.0010555423389050367,3.222994085058911e-06,8.01834806179666e-06,0.0,9.021699e-05,False,NCOA7; nuclear receptor coactivator
hsa:340156,1.22673765e-07,0.00015198999612168958,1.0934803329665842e-05,2.2207300213198965e-05,0.0,0.000113608156,False,MYLK4; myosin light chain kinase family member
hsa:9727,2.3220251499999998e-08,2.8769361855239842e-05,4.863258042232672e-07,8.704099008551238e-07,0.0,4.9696328e-06,False,RAB11FIP3; RAB11 family interacting protein
hsa:80230,0.0,0.0,3.4681562767574266e-07,6.207643341852777e-07,0.0,2.5559798e-06,False,RUFY1; RUN and FYVE domain containing
hsa:654364,0.0,0.0,0.00017150082128257436,0.0005131918200871737,0.0,0.0027604285,False,NME1-NME2; NME1-NME2
hsa:11315,1.67780155e-09,2.078757842619934e-06,1.6869096103490096e-07,3.9699782417400006e-07,0.0,1.9261472e-06,False,PARK7; Parkinsonism associated
hsa:81050,0.0,0.0,2.0208004653465347e-07,2.768322811987322e-06,0.0,3.9324255e-05,False,OR5AC2; olfactory receptor family 5 subfamily AC member
hsa:8427,0.0,0.0,1.1773310643613861e-07,2.2635837008113767e-07,0.0,1.3041085e-06,False,ZNF282; zinc finger protein
hsa:102157402,5.60451625e-07,0.0006943867770761305,3.881325527903466e-06,7.993435005055856e-06,0.0,7.808911e-05,False,AK6; adenylate kinase
hsa:132884,0.0,0.0,1.2358913635237128e-05,4.1500273552940864e-05,0.0,0.0003056992,False,EVC2; EvC ciliary complex subunit
hsa:59285,0.0,0.0,1.8453067938019798e-05,0.0001427140152414188,0.0,0.0014800025,False,CACNG6; calcium voltage-gated channel auxiliary subunit gamma
hsa:285613,4.948542e-09,6.131130640589844e-06,2.6261408132526085e-05,7.74952380047245e-05,0.0,0.0006747099,False,RELL2; RELT like
hsa:84759,4.3648235e-08,5.407916736205655e-05,0.0001225404572579208,0.00033740494414892893,0.0,0.001954428,False,PCGF1; polycomb group ring finger
hsa:445,0.0,0.0,8.240665389752475e-05,0.0001700073734367428,0.0,0.0014500817,False,ASS1; argininosuccinate synthase
hsa:169355,0.0,0.0,2.7372129814702978e-05,8.353298459064938e-05,0.0,0.00068341836,False,IDO2; indoleamine 2
hsa:23373,0.0,0.0,1.4723465663366331e-07,6.389350042330533e-07,0.0,5.117129e-06,False,CRTC1; CREB regulated transcription coactivator
hsa:8313,0.0,0.0,4.8967173475891117e-05,9.88572779175585e-05,0.0,0.0005801443,False,AXIN2; axin
hsa:79813,0.0,0.0,1.0004228237425744e-05,2.8971517956307247e-05,0.0,0.00024483798,False,EHMT1; euchromatic histone lysine methyltransferase
hsa:1211,2.7476326500000002e-05,0.034042541680963954,0.00015891591923584156,0.0003397835474733865,0.0,0.002649503,False,CLTA; clathrin light chain
hsa:50937,7.30030455e-06,0.009044910786276533,0.00012977276703437629,0.00023171513820903586,0.0,0.0013391308,False,CDON; cell adhesion associated
hsa:53354,0.0,0.0,4.1108974303415846e-05,0.00011700873171103927,0.0,0.0005277947,False,PANK1; pantothenate kinase
hsa:10939,0.0,0.0,1.5461490185148516e-07,3.002666457306554e-07,0.0,1.2338162e-06,False,AFG3L2; AFG3 like matrix AAA peptidase subunit
hsa:23432,1.8985686e-05,0.023522831809292034,6.821135027453465e-05,0.00013723601978679037,0.0,0.0010046157,False,GPR161; G protein-coupled receptor
hsa:11151,5.7923785e-07,0.0007176624812569811,2.383663786000001e-06,3.71011493002633e-06,0.0,1.7501257e-05,False,CORO1A; coronin
hsa:6135,6.2239055e-07,0.0007711276920593106,1.6938010915693072e-06,2.745186423587412e-06,0.0,1.3461336e-05,False,RPL11; ribosomal protein
hsa:7329,0.0,0.0,2.817408328985149e-06,5.996079245860679e-06,0.0,4.3880827e-05,False,UBE2I; ubiquitin conjugating enzyme E2
hsa:253430,7.120448e-08,8.822072624123767e-05,8.752233171019795e-06,2.6609621761614825e-05,0.0,0.00020546741,False,IPMK; inositol polyphosphate
hsa:270,0.0,0.0,6.254439378941435e-09,3.388592730577384e-08,0.0,3.8745438e-07,False,AMPD1; adenosine monophosphate deaminase
hsa:255189,0.0,0.0,4.203627799653467e-06,1.72285114645003e-05,0.0,0.00017126535,False,PLA2G4F; phospholipase A2 group
hsa:9474,2.76211575e-05,0.03422198398574933,0.00021849347835049503,0.00042926334560764833,0.0,0.003312968,False,ATG5; autophagy related
hsa:3098,0.00048538245,0.6013777819001168,0.0008008209971039602,0.000995683960927121,0.0,0.005391193,False,HK1; hexokinase
hsa:2327,0.0,0.0,3.927088707949504e-05,0.00012911880797400588,0.0,0.0010174918,False,FMO2; flavin containing dimethylaniline monoxygenase
hsa:59350,2.62132035e-08,3.247756110120252e-05,1.1596163048826729e-06,3.7379377955797727e-06,0.0,3.051318e-05,False,RXFP1; relaxin family peptide receptor
hsa:8784,0.0,0.0,1.3040041015891085e-06,7.552018124715312e-06,0.0,9.268237e-05,False,TNFRSF18; TNF receptor superfamily member
hsa:56261,7.1326698e-08,8.837215155492231e-05,3.117295592297028e-05,6.961740020000826e-05,0.0,0.00037954602,False,GPCPD1; glycerophosphocholine phosphodiesterase
hsa:326625,0.0,0.0,5.643665943618812e-05,0.00012750544539856396,0.0,0.000911749,False,MMAB; metabolism of cobalamin associated
hsa:6615,3.08361335e-07,0.00038205265902394877,2.692600656148317e-06,1.359429148675437e-05,0.0,0.0001745181,False,SNAI1; snail family transcriptional repressor
hsa:337876,0.0,0.0,5.654427481004454e-05,0.00031654658023967197,0.0,0.0035773166,False,CHSY3; chondroitin sulfate synthase
hsa:108,0.000218512075,0.270731475729895,0.0005346836434371287,0.00082930983326452,0.0,0.0057113324,False,ADCY2; adenylate cyclase
hsa:4651,0.0,0.0,2.622244103896039e-06,1.9758267988711984e-05,0.0,0.00022384981,False,MYO10; myosin
hsa:948,0.0,0.0,8.692756600198019e-05,0.000272217524796984,0.0,0.0027540557,False,CD36; CD36
hsa:93978,0.0,0.0,1.0953536848753963e-06,5.027499390846786e-06,0.0,4.6757592e-05,False,CLEC6A; C-type lectin domain containing
hsa:6869,0.0,0.0,1.1656553375267327e-06,6.332132504571904e-06,0.0,5.6678768e-05,False,TACR1; tachykinin receptor
hsa:407010,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR23A; microRNA
hsa:4297,4.02305265e-07,0.0004984470450310651,4.7715617188217844e-05,0.00016313193752195393,0.0,0.0011653658,False,KMT2A; lysine methyltransferase
hsa:203859,1.26132235e-07,0.00015627496154919547,8.452220541051634e-05,0.0001631494551913146,0.0,0.0012323338,False,ANO5; anoctamin
hsa:8763,0.0,0.0,1.7889045223866335e-06,5.0175512019753165e-06,0.0,2.4712426e-05,False,CD164; CD164
hsa:47,0.0,0.0,2.7897125713792072e-05,9.570700699122692e-05,0.0,0.0006516642,False,ACLY; ATP citrate
hsa:132660,0.0,0.0,3.7634610668713856e-06,1.3435853155065167e-05,0.0,0.00010093754,False,LIN54; lin-54 DREAM MuvB core complex
hsa:116986,5.47821165e-07,0.0006787379252909491,1.8955376540405447e-05,6.629383523490749e-05,0.0,0.0006147586,False,AGAP2; ArfGAP with GTPase domain
hsa:8630,2.7210461e-05,0.03371314039199323,0.0001258781018166832,0.0002268661348203535,0.0,0.0018781831,False,HSD17B6; hydroxysteroid 17-beta dehydrogenase
hsa:728340,4.16388345e-07,0.0005158956598557707,2.860673068257425e-06,5.281702491997632e-06,0.0,2.8699453e-05,False,GTF2H2C; GTF2H2 family member
hsa:3141,0.0,0.0,6.741129771118811e-05,0.00014662686468484802,0.0,0.0009202537,False,HLCS; holocarboxylase
hsa:3290,0.0,0.0,7.210840156173267e-05,0.0003137406837665848,0.0,0.0030490695,False,HSD11B1; hydroxysteroid 11-beta dehydrogenase
hsa:10154,2.9769882e-08,3.688420461965243e-05,2.475756498824259e-06,7.231172957654403e-06,0.0,5.021853e-05,False,PLXNC1; plexin
hsa:1443,0.0,0.0,1.5862064111633667e-05,5.448373839744232e-05,0.0,0.00053782563,False,CSH2; chorionic somatomammotropin hormone
hsa:8820,0.0,0.0,9.356511982368317e-07,6.052673194051453e-06,0.0,7.847212e-05,False,HESX1; HESX homeobox
hsa:1305,7.785418499999999e-06,0.009645955902802282,2.9539235866113868e-05,5.201666648990996e-05,0.0,0.00032535146,False,COL13A1; collagen type XIII alpha 1
hsa:440275,0.0,0.0,1.834449181039603e-06,9.177161436740244e-06,0.0,0.00012670357,False,EIF2AK4; eukaryotic translation initiation factor 2 alpha kinase
hsa:1794,3.87848475e-08,4.805354120422832e-05,6.237509110539603e-07,1.4537975431863926e-06,0.0,9.402838e-06,False,DOCK2; dedicator of cytokinesis
hsa:5087,1.93748875e-05,0.02400504358844103,0.00016703798445396042,0.00029513171064258234,0.0,0.0018194321,False,PBX1; PBX homeobox
hsa:2780,0.0,0.0,4.468672274720296e-06,1.5174814663304665e-05,0.0,0.00015645438,False,GNAT2; G protein subunit alpha transducin
hsa:2053,0.0,0.0,8.43828376840792e-05,0.0002718820426046818,0.0,0.0016266762,False,EPHX2; epoxide hydrolase
hsa:1603,0.0,0.0,7.412714418388612e-05,0.00021770647114658585,0.0,0.0013825326,False,DAD1; defender against cell death
hsa:2193,0.0,0.0,1.3918209295742574e-06,6.774052250546917e-06,0.0,7.515308e-05,False,FARSA; phenylalanyl-tRNA synthetase subunit
hsa:51362,0.0,0.0,1.128546317863861e-07,3.196569546042217e-07,0.0,2.5815611e-06,False,CDC40; cell division cycle
hsa:347688,3.4301702999999996e-09,4.249902744843078e-06,1.86487615383302e-05,5.877981748155073e-05,0.0,0.00036231847,False,TUBB8; tubulin beta 8 class
hsa:7547,0.0,0.0,3.4850178934752475e-08,2.640517942632791e-07,0.0,3.0877566e-06,False,ZIC3; Zic family member
hsa:6511,0.0,0.0,5.11798388270198e-06,2.7816252298382035e-05,0.0,0.00025992442,False,SLC1A6; solute carrier family 1 member
hsa:23640,6.2657701e-08,7.763146204882508e-05,1.5187315801242571e-06,3.5747235796894043e-06,0.0,2.6814316e-05,False,HSPBP1; HSPA (Hsp70) binding protein
hsa:51534,1.6238393e-08,2.011899845979677e-05,4.039672006297029e-07,9.492464802113912e-07,0.0,9.466192e-06,False,VTA1; vesicle trafficking
hsa:390260,0.0,0.0,1.5078230805940594e-06,9.186506166507642e-06,-0.0,9.922335e-05,False,OR6X1; olfactory receptor family 6 subfamily X member
hsa:11200,9.00377e-07,0.0011155465615493134,0.0001020112529683197,0.00022272741329019993,0.0,0.0012601025,False,CHEK2; checkpoint kinase
hsa:65264,0.0,0.0,1.9293779064603958e-07,4.475270943438085e-07,0.0,2.865679e-06,False,UBE2Z; ubiquitin conjugating enzyme E2
hsa:7515,2.5303193500000002e-08,3.1350079472423145e-05,4.3966138793054495e-05,0.00014794530765787324,0.0,0.0008494632,False,XRCC1; X-ray repair cross complementing
hsa:7283,5.8198614e-08,7.210675498667306e-05,1.1720773473493563e-06,2.78822515651489e-06,0.0,1.5424946e-05,False,TUBG1; tubulin gamma
hsa:10857,0.0,0.0,1.4409200109373267e-05,4.1077079892188785e-05,0.0,0.00032326108,False,PGRMC1; progesterone receptor membrane component
hsa:5476,0.0,0.0,0.00019135310788346535,0.0005512113386285522,0.0,0.005298764,False,CTSA; cathepsin
hsa:1179,0.0,0.0,3.6639643870396034e-07,1.2317033882467689e-06,0.0,9.318711e-06,False,CLCA1; chloride channel accessory
hsa:6191,1.4583898e-07,0.00018069116900904737,1.3555723465000006e-06,2.3862219900930424e-06,0.0,1.1231689e-05,False,RPS4X; ribosomal protein S4
hsa:102,0.0,0.0,2.9155204709900982e-05,0.00012157873700399392,0.0,0.00095956825,False,ADAM10; ADAM metallopeptidase domain
hsa:9585,0.0,0.0,9.12573950149505e-08,2.8162545067744665e-07,0.0,2.078564e-06,False,KIF20B; kinesin family member
hsa:1359,0.0,0.0,3.8204786646039604e-05,0.00012928261970566999,0.0,0.0011730276,False,CPA3; carboxypeptidase
hsa:10505,2.4484233e-07,0.0003033540609691521,5.823697379235651e-06,1.985980975055993e-05,0.0,0.00015184985,False,SEMA4F; ssemaphorin
hsa:50487,2.62891575e-07,0.0003257166637436689,1.204857991133663e-05,6.381667597934418e-05,0.0,0.00083000236,False,PLA2G3; phospholipase A2 group
hsa:5081,0.0,0.0,2.859341214905715e-06,9.150719532287522e-06,0.0,6.727851e-05,False,PAX7; paired box
hsa:5136,0.0,0.0,0.0003955421853400991,0.0020492532999857164,0.0,0.017153164,False,PDE1A; phosphodiesterase
hsa:644,4.4065945e-06,0.0054596700522304715,0.0003471328440069803,0.0007135478368263682,0.0,0.0049818223,False,BLVRA; biliverdin reductase
hsa:994,0.0,0.0,1.2027291046910883e-05,3.587041854890115e-05,0.0,0.00018158743,False,CDC25B; cell division cycle
hsa:79178,5.695568e-06,0.0070566788117314184,9.920262440477729e-05,0.00027955112694608993,0.0,0.0015315495,False,THTPA; thiamine
hsa:10267,4.2579433e-09,5.275494606800192e-06,0.000153409375383498,0.00041781490695755926,0.0,0.0031047715,False,RAMP1; receptor activity modifying protein
hsa:2937,0.0,0.0,1.4827860448841581e-05,4.421810230306645e-05,0.0,0.00038872167,False,GSS; glutathione
hsa:204,1.5760301500000001e-06,0.00195266539986089,2.5112786319950487e-05,5.327689679808879e-05,0.0,0.00048522852,False,AK2; adenylate kinase
hsa:8515,0.0,0.0,3.2832212853861395e-05,9.480024241475992e-05,0.0,0.0006916833,False,ITGA10; integrin subunit alpha
hsa:3872,3.25435625e-06,0.004032073147963594,1.5726819096485152e-05,3.3959219322085475e-05,0.0,0.00031403455,False,KRT17; keratin
hsa:727837,0.0,0.0,1.066405329709505e-06,5.560319129290512e-06,-0.0,5.8917627e-05,False,SSX2B; SSX family member
hsa:6757,0.0,0.0,6.677452342910891e-07,5.557988318154062e-06,0.0,7.309719e-05,False,SSX2; SSX family member
hsa:396,0.0,0.0,0.0002933387063767327,0.000793995478682769,0.0,0.0055361716,False,ARHGDIA; Rho GDP dissociation inhibitor
hsa:139065,0.0,0.0,7.159006149490095e-07,5.331166194336009e-06,0.0,7.2094015e-05,False,SLITRK4; SLIT and NTRK like family member
hsa:29986,0.0,0.0,1.8046653567227722e-09,7.024786180293568e-09,0.0,5.470822e-08,False,SLC39A2; solute carrier family 39 member
hsa:57677,6.9481607e-09,8.60861259003403e-06,4.113623605346534e-08,9.048160663693217e-08,0.0,6.9613156e-07,False,ZFP14; ZFP14 zinc finger
hsa:80834,0.0,0.0,8.141671734168317e-07,6.854052321314788e-06,0.0,9.5340445e-05,False,TAS1R2; taste 1 receptor member
hsa:23380,5.34027235e-09,6.616475607194953e-06,4.205193180842574e-06,1.4023929246002121e-05,0.0,0.00011430113,False,SRGAP2; SLIT-ROBO Rho GTPase activating protein
hsa:53829,0.0,0.0,1.5873432635069303e-06,5.978730256217134e-06,0.0,6.606291e-05,False,P2RY13; purinergic receptor
hsa:25865,2.64887565e-08,3.281896498165993e-05,4.322658796485149e-06,1.2757028268662537e-05,0.0,9.984277e-05,False,PRKD2; protein kinase
hsa:26290,3.28110735e-06,0.004065217150556577,0.0001468044096643713,0.00037184734162597606,0.0,0.0027406178,False,GALNT8; polypeptide N-acetylgalactosaminyltransferase
hsa:1147,6.99180625e-05,0.08662688430742342,0.00025653665258415845,0.00040700457521049207,0.0,0.0020714113,False,CHUK; component of inhibitor of nuclear factor kappa B kinase
hsa:6520,0.0,0.0,0.00010123182407128713,0.00023616765182024068,0.0,0.0018200106,False,SLC3A2; solute carrier family 3 member
hsa:100861540,0.0,0.0,4.423227098019802e-06,1.7423510005547257e-05,0.0,0.00017517142,False,CYP3A7-CYP3A51P; CYP3A7-CYP3A51P
hsa:389898,0.0,0.0,4.2126520435643567e-10,2.372380840101932e-09,0.0,2.1254397e-08,False,UBE2NL; ubiquitin conjugating enzyme E2 N like
hsa:7068,0.0,0.0,1.7886682401851486e-06,9.39386423817828e-06,0.0,0.00010434901,False,THRB; thyroid hormone receptor
hsa:57459,0.0,0.0,1.1022038864430695e-06,3.5522427087053417e-06,0.0,3.1054806e-05,False,GATAD2B; GATA zinc finger domain containing
hsa:2248,0.0,0.0,3.1016456719059405e-06,2.1840218716199632e-05,0.0,0.000294745,False,FGF3; fibroblast growth factor
hsa:348995,0.0,0.0,1.1179440692574256e-07,3.05938936979102e-07,0.0,1.7097581e-06,False,NUP43; nucleoporin
hsa:3569,0.0,0.0,0.00039523765846534664,0.001245224466004069,0.0,0.0072321882,False,IL6; interleukin
hsa:2186,2.3851125499999998e-08,2.9551000348305368e-05,1.129324049584158e-06,5.619166402019219e-06,0.0,5.584469e-05,False,BPTF; bromodomain PHD finger transcription
hsa:51074,3.8731061999999996e-07,0.0004798690219680563,1.95545226664901e-05,5.0718105083113575e-05,0.0,0.00038751384,False,APIP; APAF1 interacting
hsa:2719,3.8750093000000006e-08,4.8010481171627136e-05,6.292631158946285e-07,2.933729291522773e-06,0.0,3.220181e-05,False,GPC3; glypican
hsa:4205,7.81649445e-08,9.684458295876937e-05,1.4569820771232676e-05,3.57666602274666e-05,0.0,0.00030006512,False,MEF2A; myocyte enhancer factor
hsa:10850,0.0001087049,0.13468289107625134,0.00032055740863793817,0.0005752186845902708,0.0,0.0038226806,False,CCL27; C-C motif chemokine ligand
hsa:80329,2.89964825e-08,3.59259802837032e-05,1.7358468505590896e-05,9.892284650110546e-05,0.0,0.0012299324,False,ULBP1; UL16 binding protein
hsa:608,4.210235e-07,0.0005216385111530584,2.281274792113911e-05,5.179885467484638e-05,0.0,0.00029836435,False,TNFRSF17; TNF receptor superfamily member
hsa:8692,0.0,0.0,1.3388756056435643e-05,3.701739921017202e-05,0.0,0.0004052582,False,HYAL2; hyaluronidase
hsa:6540,4.14247925e-07,0.0005132437283079063,1.3054559202004949e-05,2.9080346252483963e-05,0.0,0.0002467549,False,SLC6A13; solute carrier family 6 member
hsa:100529215,0.0,0.0,3.057912373797029e-08,9.303450420155903e-08,0.0,8.4484634e-07,False,ZNF559-ZNF177; ZNF559-ZNF177
hsa:22872,0.0,0.0,9.767809342900982e-07,3.772990466352741e-06,0.0,3.5957153e-05,False,SEC31A; SEC31 homolog A
hsa:7433,2.584752225e-09,3.2024490375206016e-06,1.8845271611759902e-06,4.318684562107004e-06,0.0,2.870554e-05,False,VIPR1; vasoactive intestinal peptide receptor
hsa:405,0.0,0.0,2.8471089851237628e-05,6.543807295324843e-05,0.0,0.00057935907,False,ARNT; aryl hydrocarbon receptor nuclear
hsa:26648,0.0,0.0,3.1250986399158414e-06,1.7842657259820618e-05,-0.0,0.00021296868,False,OR7E24; olfactory receptor family 7 subfamily E member
hsa:81318,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4A5; olfactory receptor family 4 subfamily A member
hsa:6659,0.0,0.0,3.4505692169702987e-07,1.0858924817475845e-06,0.0,1.0586448e-05,False,SOX4; SRY-box transcription factor
hsa:23365,5.5136675e-07,0.0006831308242159893,2.838381834004949e-05,7.684026095002677e-05,0.0,0.0007560249,False,ARHGEF12; Rho guanine nucleotide exchange factor
hsa:10947,1.7141668e-09,2.123813557723031e-06,1.9866371128940595e-06,5.3686145631875654e-06,0.0,5.202202e-05,False,AP3M2; adaptor related protein complex 3 subunit mu
hsa:342926,1.3873444499999999e-08,1.7188881222888e-05,1.219283104014851e-07,2.245351736078706e-07,0.0,1.1052301e-06,False,ZNF677; zinc finger protein
hsa:51626,0.0,0.0,8.347296945057918e-05,0.00018344428819977714,0.0,0.0010010448,False,DYNC2LI1; dynein cytoplasmic 2 light intermediate chain
hsa:5333,0.0,0.0,5.904076259999999e-06,1.5351926225998066e-05,0.0,0.00017229991,False,PLCD1; phospholipase C delta
hsa:3934,0.0,0.0,1.3906235634594055e-05,6.453869524866334e-05,0.0,0.00053549197,False,LCN2; lipocalin
hsa:11036,2.3593090500000002e-08,2.9231300870187453e-05,3.951971142346536e-07,3.0902129319514938e-06,0.0,4.2526637e-05,False,GTF2A1L; general transcription factor IIA subunit 1
hsa:8521,0.0,0.0,1.6889038688153463e-07,5.666673614245486e-07,0.0,5.1827146e-06,False,GCM1; glial cells missing transcription factor
hsa:51619,0.0,0.0,5.7842055908910876e-05,0.0002143183396828662,0.0,0.001551278,False,UBE2D4; ubiquitin conjugating enzyme E2 D4
hsa:343169,0.0,0.0,5.980376140594059e-07,4.182080962412012e-06,0.0,3.4799035e-05,False,OR6F1; olfactory receptor family 6 subfamily F member
hsa:26227,1.99366195e-06,0.002470101672093133,3.0283670103712876e-05,6.539883362258153e-05,0.0,0.00045457762,False,PHGDH; phosphoglycerate
hsa:60401,6.9141727e-07,0.0008566502233445691,2.1964193418977227e-05,4.4232847252129294e-05,0.0,0.00022994299,False,EDA2R; ectodysplasin A2
hsa:3574,0.00027870307,0.3453067453208351,0.00044627001077662695,0.0005544817047696747,0.0,0.003098415,False,IL7; interleukin
hsa:84109,0.0,0.0,7.956393884296537e-07,5.701830035955928e-06,0.0,7.7213124e-05,False,QRFPR; pyroglutamylated RFamide peptide
hsa:4225,2.6439483e-07,0.00032757916239299227,3.455779121823762e-06,8.090377093813329e-06,0.0,6.5284745e-05,False,MEP1B; meprin A subunit
hsa:344807,0.0,0.0,6.745518311287129e-10,9.248098105653954e-09,0.0,1.3143556e-07,False,CD200R1L; CD200 receptor 1
hsa:133,0.0,0.0,1.851214419608911e-05,5.6595158741124286e-05,0.0,0.0004721969,False,ADM;
hsa:1813,5.9689408e-05,0.07395381474128512,0.0005319006890292078,0.0011714295811121273,0.0,0.007959142,False,DRD2; dopamine receptor
hsa:3758,0.0,0.0,4.736714293300495e-06,2.4797397982783536e-05,0.0,0.00024309818,False,KCNJ1; potassium inwardly rectifying channel subfamily J member
hsa:2565,0.0,0.0,4.205064446836633e-05,0.00017543524340013177,0.0,0.0017108251,False,GABRG1; gamma-aminobutyric acid type A receptor subunit
hsa:5053,1.3666439e-06,0.0016932406131068914,2.162547930777228e-05,5.6322509881727985e-05,0.0,0.00042218092,False,PAH; phenylalanine
hsa:30835,0.0,0.0,5.2773013320297025e-05,0.0001550662791677585,0.0,0.0015896328,False,CD209; CD209
hsa:124538,0.0,0.0,3.2502758628712873e-07,2.304612018319774e-06,0.0,2.1750195e-05,False,OR4D2; olfactory receptor family 4 subfamily D member
hsa:11222,1.9180915999999998e-08,2.3764717325260644e-05,3.107290073284158e-07,6.430096228109652e-07,0.0,3.4376524e-06,False,MRPL3; mitochondrial ribosomal protein
hsa:2175,0.0,0.0,1.9250874931257422e-05,7.0738335615063e-05,0.0,0.0007360997,False,FANCA; FA complementation group
hsa:6583,0.0,0.0,1.6081864531396037e-06,9.878824428735469e-06,0.0,9.218385e-05,False,SLC22A4; solute carrier family 22 member
hsa:10000,0.00087757165,1.0872912531868955,0.0011191163446534651,0.001167312539156521,0.0,0.0046756025,True,AKT3; AKT serine/threonine kinase
hsa:91975,6.797105e-09,8.421458023960679e-06,9.881740281881185e-08,1.794932175758653e-07,0.0,1.0436781e-06,False,ZNF300; zinc finger protein
hsa:4598,5.69489405e-07,0.00070558438030571,0.00024164118427955455,0.0007658760107804875,0.0,0.00433107,False,MVK; mevalonate
hsa:1435,0.0,0.0,0.00011720692613069305,0.00038638481752080494,0.0,0.0022209934,False,CSF1; colony stimulating factor
hsa:7405,0.0,0.0,1.5371569165000008e-07,4.5814756732329185e-07,0.0,2.6920527e-06,False,UVRAG; UV radiation resistance
hsa:6688,0.0,0.0,2.4235073658663364e-05,7.333212377664503e-05,0.0,0.00062492426,False,SPI1; Spi-1
hsa:23435,0.0,0.0,1.3607945913970299e-06,3.876459117925138e-06,0.0,2.0729927e-05,False,TARDBP; TAR DNA binding
hsa:2741,0.0,0.0,2.0186947605773117e-06,9.377549729119644e-06,0.0,8.016676e-05,False,GLRA1; glycine receptor alpha
hsa:664,0.0,0.0,6.108407164349653e-05,0.0001250136554421519,0.0,0.0008603891,False,BNIP3; BCL2 interacting protein
hsa:6452,1.05371125e-09,1.3055241990891913e-06,4.372425753204158e-05,0.0001525303261718895,0.0,0.0009603069,False,SH3BP2; SH3 domain binding protein
hsa:55276,0.0,0.0,4.140642354267327e-05,9.336341416032076e-05,0.0,0.00043495296,False,PGM2; phosphoglucomutase
hsa:286075,1.28367155e-08,1.5904397644111048e-05,1.605004160084158e-07,3.58716120490399e-07,0.0,1.951956e-06,False,ZNF707; zinc finger protein
hsa:3712,4.39877e-07,0.0005449975675240786,2.5487991430495053e-06,5.049162651906316e-06,0.0,3.3032193e-05,False,IVD; isovaleryl-CoA
hsa:1000,9.56639325e-06,0.011852542986400209,5.5831224308920804e-05,0.00011537427591023205,0.0,0.0007430064,False,CDH2; cadherin
hsa:55052,4.3987827000000004e-08,5.449991410251045e-05,1.7293102102475252e-07,3.76659767440595e-07,0.0,2.9764053e-06,False,MRPL20; mitochondrial ribosomal protein
hsa:5297,0.0,0.0,4.408809169325744e-05,0.00013413660110203236,0.0,0.0010223242,False,PI4KA; phosphatidylinositol 4-kinase
hsa:10564,0.0,0.0,9.20344871133663e-07,2.365639107753662e-06,0.0,1.2892725e-05,False,ARFGEF2; ADP ribosylation factor guanine nucleotide exchange factor
hsa:1201,0.0,0.0,1.432061515456436e-06,3.7366778363941988e-06,0.0,1.8906352e-05,False,CLN3; CLN3 lysosomal/endosomal transmembrane protein
hsa:8140,0.0,0.0,1.970202963663366e-05,0.00016991224886690103,0.0,0.0020904748,False,SLC7A5; solute carrier family 7 member
hsa:10813,3.0622341e-08,3.794038187241629e-05,1.098947419214198e-06,2.3810544191803556e-06,0.0,1.2917923e-05,False,UTP14A; UTP14A small subunit processome
hsa:10313,0.0,0.0,2.4291569114356424e-08,1.115682837374429e-07,0.0,1.1992759e-06,False,RTN3; reticulon
hsa:127623,0.0,0.0,4.948456071559406e-06,3.079683681483242e-05,0.0,0.00030188562,False,OR2B11; olfactory receptor family 2 subfamily B member
hsa:9135,0.0,0.0,4.442601942415841e-07,1.0434642127005499e-06,0.0,5.7821603e-06,False,RABEP1; rabaptin
hsa:256471,0.0,0.0,6.552401076752477e-07,1.3367129604423886e-06,0.0,6.8778577e-06,False,MFSD8; major facilitator superfamily domain containing
hsa:140,0.0,0.0,1.3880245360752468e-05,0.00010753004931770688,0.0,0.0014797829,False,ADORA3; adenosine A3
hsa:3553,0.0,0.0,0.00011354894911138614,0.00043993227669756853,0.0,0.0039043718,False,IL1B; interleukin 1
hsa:5321,0.0,0.0,0.00017918219597029702,0.00046029072067111943,0.0,0.0024385136,False,PLA2G4A; phospholipase A2 group
hsa:10910,0.0,0.0,4.921710095990097e-07,9.156494176838748e-07,0.0,4.3214036e-06,False,SUGT1; SGT1 homolog
hsa:79077,0.0,0.0,9.094806695779454e-05,0.0002830517025072392,0.0,0.0018431465,False,DCTPP1; dCTP pyrophosphatase
hsa:2118,0.0,0.0,5.1314361583938625e-06,5.2466567225910694e-05,0.0,0.00073658855,False,ETV4; ETS variant transcription factor
hsa:403274,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5H15; olfactory receptor family 5 subfamily H member
hsa:6993,1.063533905e-07,0.00013176942445374147,3.645493412277228e-07,9.449735546245247e-07,0.0,9.086629e-06,False,DYNLT1; dynein light chain Tctex-type
hsa:1763,4.3006965e-08,5.328464846216825e-05,2.945345024197426e-06,1.4050312998896422e-05,0.0,0.00018884795,False,DNA2; DNA replication helicase/nuclease
hsa:2696,0.0,0.0,3.6488066587753967e-06,2.6164424182637243e-05,0.0,0.000317892,False,GIPR; gastric inhibitory polypeptide
hsa:406982,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR20A; microRNA
hsa:81858,0.0,0.0,6.704027838267328e-06,5.0076569737428e-05,0.0,0.000660708,False,SHARPIN; SHANK associated RH domain
hsa:2832,0.0,0.0,9.930267092002226e-07,3.117977289306858e-06,0.0,2.233329e-05,False,NPBWR2; neuropeptides B and W receptor
hsa:778,0.00014820389500000002,0.18362124474022046,0.00026734368799653465,0.00033225367884978966,0.0,0.0015556378,False,CACNA1F; calcium voltage-gated channel subunit alpha1
hsa:7253,1.070557825e-05,0.013263967211717551,5.148648583673266e-05,0.0001189066863059413,0.0,0.001066202,False,TSHR; thyroid stimulating hormone
hsa:5962,0.0,0.0,3.409074075717822e-06,1.0558122911873707e-05,0.0,8.8190005e-05,False,RDX;
hsa:81099,0.0,0.0,2.500921018811881e-07,3.1314179750368903e-06,0.0,4.421392e-05,False,OR4F17; olfactory receptor family 4 subfamily F member
hsa:8900,2.67910775e-06,0.0033193533803424755,3.90348648171287e-05,7.478063884640312e-05,0.0,0.0003629337,False,CCNA1; cyclin
hsa:113026,0.0,0.0,2.945674919282179e-05,0.00016464944296060407,0.0,0.0019615158,False,PLCD3; phospholipase C delta
hsa:118429,0.0,0.0,3.9333958475396036e-07,9.03886228339661e-07,0.0,5.996432e-06,False,ANTXR2; ANTXR cell adhesion molecule
hsa:403257,0.0,0.0,2.2008826732673267e-09,3.128042003203681e-08,-0.0,4.445783e-07,False,OR4C45; olfactory receptor family 4 subfamily C member 45
hsa:26524,0.0,0.0,0.00013890824313514852,0.0005992065091894707,0.0,0.0051652733,False,LATS2; large tumor suppressor kinase
hsa:54738,0.0,0.0,1.8176250300699706e-05,6.056039461379279e-05,0.0,0.0006746133,False,FEV; FEV transcription factor
hsa:51172,5.7798884e-08,7.161149863622418e-05,1.464031948358911e-06,2.779570006573452e-06,0.0,1.5629508e-05,False,NAGPA; N-acetylglucosamine-1-phosphodiester
hsa:3419,0.0,0.0,5.516399851633665e-06,2.905396310859041e-05,0.0,0.0003396811,False,IDH3A; isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit
hsa:155,7.14829125e-07,0.0008856569775650136,7.997482550811882e-06,3.327488125118826e-05,0.0,0.00034254135,False,ADRB3; adrenoceptor beta
hsa:341640,0.0,0.0,1.7502536055633666e-06,1.0128722744393817e-05,0.0,0.000100546225,False,FREM2; FRAS1 related extracellular matrix
hsa:2194,0.0,0.0,4.4239553067623736e-05,0.00016962436113055566,0.0,0.0022414126,False,FASN; fatty acid
hsa:6237,0.0,0.0,6.801250428168317e-05,0.00045028210640888163,0.0,0.0057549914,False,RRAS; RAS
hsa:730051,0.0,0.0,7.557741547351486e-08,1.775205074057004e-07,0.0,9.649249e-07,False,ZNF814; zinc finger protein
hsa:56896,7.241038e-08,8.971480882950049e-05,1.603256433209307e-05,6.355444543591785e-05,0.0,0.0005955588,False,DPYSL5; dihydropyrimidinase like
hsa:9092,0.0,0.0,1.5008531399891089e-07,3.433833950558453e-07,0.0,2.1938495e-06,False,SART1; spliceosome associated factor 1
hsa:26050,1.7897551500000001e-07,0.00022174657988794424,4.175376355944555e-06,1.1128836172101937e-05,0.0,8.812025e-05,False,SLITRK5; SLIT and NTRK like family member
hsa:2998,8.1953307e-07,0.0010153827766751623,2.4031450190683168e-05,0.00010157382326292942,0.0,0.0013698048,False,GYS2; glycogen synthase
hsa:55072,0.0,0.0,4.3768108173613865e-06,3.104124117813505e-05,0.0,0.00037011082,False,RNF31; ring finger protein
hsa:5023,0.0,0.0,1.1052199413326735e-06,3.7266664861524253e-06,0.0,4.166607e-05,False,P2RX1; purinergic receptor P2X
hsa:9378,0.0,0.0,6.394333217918565e-06,1.4119989777377127e-05,0.0,7.215411e-05,False,NRXN1; neurexin
hsa:3211,0.0,0.0,1.983773444710892e-07,1.7590109738526152e-06,0.0,2.376045e-05,False,HOXB1; homeobox
hsa:10424,0.0,0.0,1.7753449954722774e-05,3.8844522988429516e-05,0.0,0.0003009494,False,PGRMC2; progesterone receptor membrane component
hsa:8773,2.51335773e-07,0.0003113992887029419,2.981734233568813e-05,8.225474193537124e-05,0.0,0.0008675287,False,SNAP23; synaptosome associated protein
hsa:3768,3.8815928000000004e-07,0.00048092049234649167,8.938996706589105e-06,2.8524270013608806e-05,0.0,0.00016199092,False,KCNJ12; potassium inwardly rectifying channel subfamily J member
hsa:9343,0.0,0.0,1.6854280897856443e-07,4.585346152642362e-07,0.0,3.5352123e-06,False,EFTUD2; elongation factor Tu GTP binding domain containing
hsa:8675,1.6881561e-07,0.00020915868938383575,1.7003998731252478e-05,4.848995076110652e-05,0.0,0.00033408424,False,STX16; syntaxin
hsa:9564,0.0,0.0,5.6861923267326723e-05,0.00013286444265285107,0.0,0.0012014282,False,BCAR1; BCAR1 scaffold protein
hsa:6416,8.252655e-06,0.010224851266639138,0.00017406712355594065,0.00035789576192474406,0.0,0.0017100021,False,MAP2K4; mitogen-activated protein kinase kinase
hsa:148103,0.0,0.0,9.164088827940595e-08,1.9097746246257429e-07,0.0,1.1387158e-06,False,ZNF599; zinc finger protein
hsa:7494,0.0,0.0,2.362577795000001e-06,5.172935960440288e-06,0.0,3.4338682e-05,False,XBP1; X-box binding protein
hsa:493869,0.0,0.0,5.772512466663365e-05,0.00022113358480254584,0.0,0.0015681585,False,GPX8; glutathione peroxidase 8
hsa:8701,0.0,0.0,6.707092819742573e-09,3.2124655847549575e-08,0.0,3.2345474e-07,False,DNAH11; dynein axonemal heavy chain
hsa:23299,5.68216165e-07,0.0007040068649937607,1.792429462769307e-05,4.6859034753937554e-05,0.0,0.0003153226,False,BICD2; BICD cargo adaptor
hsa:9716,1.9899791e-08,2.4655387049646948e-05,2.2460173392232653e-07,4.3158769511899465e-07,0.0,3.348595e-06,False,AQR; aquarius intron-binding spliceosomal
hsa:388558,1.3404838e-08,1.6608288460306708e-05,7.657263577079205e-08,1.6451598810277988e-07,0.0,8.933202e-07,False,ZNF808; zinc finger protein
hsa:90639,0.0,0.0,7.639669753688116e-07,2.0905579883190345e-06,0.0,1.0279406e-05,False,COX19; cytochrome c oxidase assembly factor
hsa:7920,5.7922092500000005e-06,0.007176415115681128,0.0001141123116762376,0.0002766989542459537,0.0,0.002545485,False,ABHD16A; abhydrolase domain containing 16A
hsa:4214,8.2499485e-06,0.01022149797488598,0.00010912081926656435,0.00024001564412796583,0.0,0.0016123863,False,MAP3K1; mitogen-activated protein kinase kinase kinase
hsa:8705,1.37142465e-07,0.00016991638532875343,3.0067250831435648e-05,0.00010037245200300202,0.0,0.0008333196,False,B3GALT4; beta-1
hsa:9582,0.0,0.0,4.432135349818811e-06,2.2693925046465915e-05,0.0,0.0002975926,False,APOBEC3B; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:51009,0.0,0.0,2.1818126017079202e-07,9.160516846980178e-07,0.0,8.031104e-06,False,DERL2; derlin
hsa:2901,5.2760008e-08,6.536844623053927e-05,5.649749006250496e-05,0.00012510753097082653,0.0,0.00070056116,False,GRIK5; glutamate ionotropic receptor kainate type subunit
hsa:6445,2.0968113e-05,0.025979013634652433,7.493649188102476e-05,0.00013742220991587654,0.0,0.0011705124,False,SGCG; sarcoglycan
hsa:2747,2.2236352999999998e-07,0.000275503340606732,9.401213672475249e-05,0.0002490871771865896,0.0,0.0024476126,False,GLUD2; glutamate dehydrogenase
hsa:2946,0.000329933245,0.40877976336640887,0.0007169799743613856,0.0009166811097403654,0.0,0.0045147403,False,GSTM2; glutathione S-transferase mu
hsa:7168,6.612445e-06,0.008192668496845154,0.00043024788909900983,0.0008365750918488189,0.0,0.0050382605,False,TPM1; tropomyosin
hsa:79065,0.0,0.0,5.273894321790547e-05,0.00013022116007455368,0.0,0.0006706431,False,ATG9A; autophagy related
hsa:9610,0.0,0.0,5.880556757524752e-07,1.2311322401102183e-06,0.0,7.45893e-06,False,RIN1; Ras and Rab interactor
hsa:5170,0.000233367365,0.28913684112718735,0.0006292323413712872,0.0008519239737730358,0.0,0.0064333864,False,PDPK1; 3-phosphoinositide dependent protein kinase
hsa:23708,0.0,0.0,2.16848885029208e-08,1.1738596420652317e-07,0.0,1.1316017e-06,False,GSPT2; G1 to S phase transition
hsa:55593,0.0,0.0,7.563213338267327e-06,4.537897149508712e-05,0.0,0.0004971419,False,OTUD5; OTU deubiquitinase
hsa:6441,0.0,0.0,4.582838725955445e-08,1.1760586670121439e-07,0.0,9.810581e-07,False,SFTPD; surfactant protein
hsa:10569,0.0,0.0,3.594601562460397e-07,8.734852253128819e-07,0.0,5.3353892e-06,False,SLU7; SLU7 homolog
hsa:10411,0.0,0.0,0.0001006423292314505,0.0004017953268308493,0.0,0.004696582,False,RAPGEF3; Rap guanine nucleotide exchange factor
hsa:168620,2.23560105e-05,0.027698586973273796,9.88018287759406e-05,0.00016318688254845837,0.0,0.0010668735,False,BHLHA15; basic helix-loop-helix family member
hsa:341947,0.0,0.0,1.5192427271190098e-05,3.715714106735455e-05,0.0,0.00019624284,False,COX8C; cytochrome c oxidase subunit
hsa:6337,0.0,0.0,5.8174952443202976e-05,0.00021943091461002745,0.0,0.001671073,False,SCNN1A; sodium channel epithelial 1 subunit
hsa:6480,0.0,0.0,8.066647415282177e-05,0.00022716167368776096,0.0,0.0023706004,False,ST6GAL1; ST6 beta-galactoside alpha-2
hsa:57461,5.82239675e-08,7.213816739475126e-05,2.470884232896039e-07,3.915434756530945e-07,0.0,1.7971714e-06,False,ISY1; ISY1 splicing factor
hsa:10347,5.924949e-05,0.07340876637569642,0.0003523154166271287,0.0007582534945492297,0.0,0.0059468024,False,ABCA7; ATP binding cassette subfamily A member
hsa:64965,1.2856371e-07,0.00015928750360185017,3.3163396181485145e-07,4.773634686842935e-07,0.0,2.113463e-06,False,MRPS9; mitochondrial ribosomal protein
hsa:390892,0.0,0.0,3.676043564356435e-08,5.224639556929614e-07,-0.0,7.425608e-06,False,OR7A10; olfactory receptor family 7 subfamily A member
hsa:26471,0.0,0.0,6.5398642357505786e-06,6.16891046533302e-05,0.0,0.0008596956,False,NUPR1; nuclear protein 1
hsa:4137,1.0665313e-08,1.3214079485590137e-05,5.570559445084156e-07,1.5667636850464314e-06,0.0,1.2427353e-05,False,MAPT; microtubule associated protein
hsa:5499,0.0,0.0,0.0002447857425841584,0.000633673838766328,0.0,0.0038278757,False,PPP1CA; protein phosphatase 1 catalytic subunit
hsa:79861,0.0,0.0,1.3159492662227723e-07,1.0795023651252095e-06,0.0,1.3949558e-05,False,TUBAL3; tubulin alpha like
hsa:390063,0.0,0.0,9.327397611386139e-07,6.515712313710279e-06,0.0,8.1449434e-05,False,OR51I1; olfactory receptor family 51 subfamily I member
hsa:27141,0.0,0.0,2.366450022940594e-05,0.00012200050602814735,0.0,0.0011903701,False,CIDEB; cell death inducing DFFA like effector
hsa:1454,0.000330765135,0.4098104560974396,0.0019259783176648513,0.002800560530216658,0.0,0.01297749,False,CSNK1E; casein kinase 1
hsa:10617,1.50986985e-07,0.00018706942975603303,1.7456146333063366e-06,4.3371280060949055e-06,0.0,2.7767073e-05,False,STAMBP; STAM binding
hsa:4215,1.06651135e-06,0.0013213832309641584,4.338419412262377e-05,0.0001210425833823394,0.0,0.0012194429,False,MAP3K3; mitogen-activated protein kinase kinase kinase
hsa:9252,2.4563832e-05,0.030434027441921543,9.57916644140594e-05,0.00017133420619432034,0.0,0.0009465651,False,RPS6KA5; ribosomal protein S6 kinase
hsa:6340,0.0,0.0,5.0274107645049485e-06,2.58783399547932e-05,0.0,0.0003047767,False,SCNN1G; sodium channel epithelial 1 subunit
hsa:8405,1.4006955e-06,0.001735429768644241,0.00023871530588654458,0.0005384713538953628,0.0,0.0040607443,False,SPOP; speckle type BTB/POZ
hsa:1326,0.0,0.0,1.3462638745392076e-05,4.757454374667957e-05,0.0,0.0004216203,False,MAP3K8; mitogen-activated protein kinase kinase kinase
hsa:3101,0.000116431972,0.14425655699668685,0.0004329806101970297,0.0006376186152662558,0.0,0.0038698784,False,HK3; hexokinase
hsa:3613,0.0,0.0,5.882145244029212e-05,0.0002175076545083054,0.0,0.0013433909,False,IMPA2; inositol monophosphatase
hsa:5322,0.0,0.0,3.409258116435644e-05,0.00010504405703480073,0.0,0.00060668634,False,PLA2G5; phospholipase A2 group
hsa:50944,0.0,0.0,2.2765719830173268e-05,5.3540235860101034e-05,0.0,0.00045194928,False,SHANK1; SH3 and multiple ankyrin repeat domains
hsa:5923,1.3865101e-08,1.7178543816738925e-05,2.420651530762376e-07,8.498461016327265e-07,0.0,7.2325033e-06,False,RASGRF1; Ras protein specific guanine nucleotide releasing factor
hsa:2203,0.0,0.0,0.00012225894425198024,0.0003558111944783202,0.0,0.0023242075,False,FBP1; fructose-bisphosphatase
hsa:3291,5.96488335e-05,0.07390354386146301,0.0002675467084064059,0.0004366264206784049,0.0,0.0026114455,False,HSD11B2; hydroxysteroid 11-beta dehydrogenase
hsa:6402,0.0,0.0,3.1527839559846526e-06,9.54908865907705e-06,0.0,5.331128e-05,False,SELL; selectin
hsa:84539,0.0,0.0,2.4786882994371286e-07,1.5481175808816276e-06,0.0,1.8717272e-05,False,MCHR2; melanin concentrating hormone receptor
hsa:482,0.0,0.0,0.0004415406066970298,0.001275364132299923,0.0,0.008194197,False,ATP1B2; ATPase Na+/K+ transporting subunit beta
hsa:392392,0.0,0.0,9.939045381881186e-06,2.8416911497178625e-05,0.0,0.00020026373,False,OR1K1; olfactory receptor family 1 subfamily K member
hsa:8714,5.016018e-07,0.0006214731865173658,9.164122963267327e-05,0.00021434258662799194,0.0,0.0014762337,False,ABCC3; ATP binding cassette subfamily C member
hsa:2737,0.0,0.0,5.2171464513861396e-05,0.00019247652219050532,0.0,0.0017493868,False,GLI3; GLI family zinc finger
hsa:926,1.9135526500000003e-05,0.023708480770289298,6.883613297608911e-05,0.00010645216098765035,0.0,0.0005859996,False,CD8B; CD8 subunit
hsa:2650,0.0,0.0,2.5855476930356433e-05,9.115525893446629e-05,0.0,0.0008917739,False,GCNT1; glucosaminyl (N-acetyl) transferase
hsa:407035,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR31; microRNA
hsa:7097,0.0,0.0,4.589861712128712e-05,0.00016483305497506996,0.0,0.0013639674,False,TLR2; toll like receptor
hsa:55844,1.7552789e-05,0.02174750511680175,5.6848396470544514e-05,0.00011283843351057072,0.0,0.00077072834,False,PPP2R2D; protein phosphatase 2 regulatory subunit
hsa:6168,1.59820585e-08,1.9801405862383177e-05,6.736368733366338e-07,1.6211327311801077e-06,0.0,1.3704439e-05,False,RPL37A; ribosomal protein
hsa:533,5.30612865e-06,0.0065741723418588,0.0001604497127809901,0.0004016074452801182,0.0,0.0021622472,False,ATP6V0B; ATPase H+ transporting V0 subunit
hsa:135946,0.0,0.0,6.796487669306931e-07,3.920057156398102e-06,0.0,3.6991336e-05,False,OR6B1; olfactory receptor family 6 subfamily B member
hsa:51447,0.0,0.0,4.648994063567079e-05,0.000161579386687915,0.0,0.00087393663,False,IP6K2; inositol hexakisphosphate kinase
hsa:8424,0.0,0.0,5.727645041925817e-07,3.84021245472023e-06,0.0,5.1830866e-05,False,BBOX1; gamma-butyrobetaine hydroxylase
hsa:1616,6.317170850000001e-07,0.0007826830561461535,2.846875829297028e-06,5.2367197304276114e-06,0.0,3.5179793e-05,False,DAXX; death domain associated
hsa:84957,0.0,0.0,4.494244895990099e-06,2.660862527243799e-05,0.0,0.0002952085,False,RELT; RELT TNF
hsa:6370,9.802227500000001e-06,0.012144736241762197,5.1111921786287124e-05,9.816597080489889e-05,0.0,0.00057876704,False,CCL25; C-C motif chemokine ligand
hsa:51378,0.0,0.0,4.107145543574258e-07,1.8247369229066662e-06,0.0,1.4855315e-05,False,ANGPT4; angiopoietin
hsa:200909,0.0,0.0,1.9369402064356436e-07,1.5585787100197887e-06,0.0,1.6581127e-05,False,HTR3D; 5-hydroxytryptamine receptor
hsa:4713,1.5840894499999999e-06,0.0019626506886937832,3.732316601336634e-06,5.611126571044958e-06,0.0,2.9234405e-05,False,NDUFB7; NADH:ubiquinone oxidoreductase subunit
hsa:79947,0.0,0.0,0.00010354191258676827,0.00038107065918715767,0.0,0.0025140005,False,DHDDS; dehydrodolichyl diphosphate synthase
hsa:3897,3.3895272e-06,0.004199546871186038,3.734625676960395e-05,7.440348109445799e-05,0.0,0.0005553495,False,L1CAM; L1 cell adhesion
hsa:4916,6.9322728e-06,0.008588927844404988,4.5766379086386104e-05,0.00011460290355560022,0.0,0.0010189413,False,NTRK3; neurotrophic receptor tyrosine kinase
hsa:3912,0.0,0.0,2.1282984607920793e-05,7.172689656650365e-05,0.0,0.0005593429,False,LAMB1; laminin subunit beta
hsa:23553,0.0,0.0,9.460819104905447e-07,4.115527765408933e-06,0.0,3.7691636e-05,False,HYAL4; hyaluronidase
hsa:604,1.21436035e-07,0.00015045647688960518,5.916043928193069e-06,3.263286508814396e-05,0.0,0.000433314,False,BCL6; BCL6 transcription
hsa:26246,0.0,0.0,7.204149219227723e-05,0.00020494687519942946,0.0,0.0012938192,False,OR2L2; olfactory receptor family 2 subfamily L member
hsa:2321,0.0,0.0,1.1433776195920796e-05,4.69419030571718e-05,0.0,0.0005504146,False,FLT1; fms related receptor tyrosine kinase
hsa:6263,0.0,0.0,1.7325712822970302e-05,4.7521570681194244e-05,0.0,0.0003934445,False,RYR3; ryanodine receptor
hsa:79643,0.0,0.0,6.746539913185645e-05,0.00017486224775395344,0.0,0.0010283177,False,CHMP6; charged multivesicular body protein
hsa:80174,0.0,0.0,4.483864973774259e-07,1.2604312099064968e-06,0.0,8.744351e-06,False,DBF4B; DBF4 zinc finger
hsa:1657,8.379243e-09,1.0381690910625384e-05,1.0887090416742574e-06,2.041547007980572e-06,0.0,1.0210821e-05,False,DMXL1; Dmx like
hsa:7306,0.0,0.0,1.1942852181158415e-05,5.904963904512291e-05,0.0,0.0007594574,False,TYRP1; tyrosinase related protein
hsa:2905,0.0,0.0,9.99822925928713e-05,0.0005012103972373326,0.0,0.006319059,False,GRIN2C; glutamate ionotropic receptor NMDA type subunit
hsa:3029,7.094420749999999e-08,8.789825455166668e-05,3.6407580447871268e-06,7.214566513561197e-06,0.0,3.390311e-05,False,HAGH; hydroxyacylglutathione
hsa:51102,6.312239000000001e-07,0.000782072011182813,8.29167699832921e-05,0.00017324204888996707,0.0,0.00096013217,False,MECR; mitochondrial trans-2-enoyl-CoA
hsa:2911,3.72441965e-05,0.04614470976406768,0.00018001353803217816,0.00047968147650348503,0.0,0.0046701604,False,GRM1; glutamate metabotropic receptor
hsa:4018,0.0,0.0,1.3271824097891092e-06,6.3433286888173095e-06,0.0,4.5784764e-05,False,LPA;
hsa:392391,0.0,0.0,3.2690349695049503e-07,1.5543909300012123e-06,0.0,1.3674008e-05,False,OR5C1; olfactory receptor family 5 subfamily C member
hsa:820,0.0,0.0,1.6383555987341584e-05,5.301076850241719e-05,0.0,0.00049108407,False,CAMP; cathelicidin antimicrobial
hsa:192111,2.26481145e-06,0.00280604971651321,0.0001549756493579357,0.000572268935418741,0.0,0.004313317,False,PGAM5; PGAM family member 5
hsa:3481,0.0,0.0,1.2687491245445544e-06,3.194304864838525e-06,0.0,1.8896511e-05,False,IGF2; insulin like growth factor
hsa:255725,-0.0,0.0,9.289576810792079e-07,5.818793075656242e-06,-0.0,6.620162e-05,False,OR52B2; olfactory receptor family 52 subfamily B member
hsa:131890,0.0,0.0,6.4089917847762394e-06,1.3718900778755897e-05,0.0,9.5401054e-05,False,GRK7; G protein-coupled receptor kinase
hsa:23429,0.0,0.0,9.327438906204953e-06,6.410630508909095e-05,0.0,0.0005932248,False,RYBP; RING1 and YY1 binding
hsa:3841,0.0,0.0,1.2228345315374752e-05,3.911290894833904e-05,0.0,0.00020420297,False,KPNA5; karyopherin subunit alpha
hsa:10332,0.0,0.0,0.00010652959390297034,0.00038520979026910533,0.0,0.0036686326,False,CLEC4M; C-type lectin domain family 4 member
hsa:54938,3.8799755999999997e-07,0.0004807201249560166,3.3414949762673267e-06,7.270576800193364e-06,0.0,5.8326485e-05,False,SARS2; seryl-tRNA synthetase 2
hsa:9162,7.851983550000001e-05,0.09728428481118766,0.0002867545191029208,0.0005231347872949986,0.0,0.0031704355,False,DGKI; diacylglycerol kinase
hsa:224,0.0,0.0,0.00039677463860089115,0.000700599047587985,0.0,0.0043057553,False,ALDH3A2; aldehyde dehydrogenase 3 family member
hsa:988,1.09984875e-09,1.3626875089954656e-06,9.766942867920789e-08,1.8219403075119167e-07,0.0,1.159592e-06,False,CDC5L; cell division cycle 5
hsa:9200,1.14124805e-06,0.001413980297200349,1.1061323598019797e-05,2.8268719458123436e-05,0.0,0.00021301524,False,HACD1; 3-hydroxyacyl-CoA dehydratase
hsa:10970,1.29727025e-07,0.000160728824346659,4.5120189704222794e-07,6.491175327044465e-07,0.0,3.1251616e-06,False,CKAP4; cytoskeleton associated protein
hsa:3127,0.00018012149500000002,0.22316642296323855,0.00035093676781980203,0.0005152226778470089,0.0,0.003712791,False,HLA-DRB5; major histocompatibility complex
hsa:6281,0.0,0.0,1.552271066059406e-07,2.69900686594727e-07,0.0,1.3924224e-06,False,S100A10; S100 calcium binding protein
hsa:81579,0.0,0.0,0.00011991279159851478,0.0002048470839785213,0.0,0.0011614269,False,PLA2G12A; phospholipase A2 group
hsa:2859,0.0,0.0,3.501900396969802e-06,1.0372228434518026e-05,0.0,6.645734e-05,False,GPR35; G protein-coupled receptor
hsa:100169753,0.0,0.0,1.7102314547435646e-07,1.1063259404314402e-06,0.0,1.2931051e-05,False,RNA5S2; RNA
hsa:729359,3.11405675e-08,3.858245268295313e-05,5.953026387976733e-06,2.5336562627574422e-05,0.0,0.00025075063,False,PLIN4; perilipin
hsa:6750,1.3736887000000002e-06,0.0017019689595848698,4.445553716762375e-05,0.00011263656088774404,0.0,0.00083744485,False,SST;
hsa:51168,3.19017915e-09,3.95255918521776e-06,4.200087971915842e-08,1.5877289249900984e-07,0.0,1.8649926e-06,False,MYO15A; myosin
hsa:9482,3.2924383999999996e-07,0.0004079256062996858,5.287009401508414e-05,0.00015912432982123693,0.0,0.0011403048,False,STX8; syntaxin
hsa:100169755,0.0,0.0,2.534978272067326e-07,1.936904261085276e-06,0.0,2.4505925e-05,False,RNA5S4; RNA
hsa:57599,2.2920965e-06,0.002839855270974509,0.00020062733640668323,0.0004268208731439985,0.0,0.0032894025,False,WDR48; WD repeat domain
hsa:25978,0.0,0.0,1.4703508977623763e-05,0.0001257464241321206,0.0,0.0015592343,False,CHMP2B; charged multivesicular body protein
hsa:3921,5.981970700000001e-08,7.411525222960759e-05,8.426270005227723e-07,1.5384854593748344e-06,0.0,1.0067337e-05,False,RPSA; ribosomal protein
hsa:3383,0.0,0.0,7.38152432089109e-05,0.00021149743481711615,0.0,0.0013626441,False,ICAM1; intercellular adhesion molecule
hsa:3547,0.0,0.0,6.361957212823016e-05,0.0004314794881146091,0.0,0.005230543,False,IGSF1; immunoglobulin superfamily member
hsa:390432,0.0,0.0,2.6507723762376234e-07,2.6250036249890845e-06,0.0,2.9847848e-05,False,OR4Q2; olfactory receptor family 4 subfamily Q member 2
hsa:57761,7.9675065e-08,9.871558780596133e-05,1.1382843496881192e-05,3.199337664678028e-05,0.0,0.00021584985,False,TRIB3; tribbles pseudokinase
hsa:55907,3.8723577e-06,0.00479776284525705,0.00023235869573742072,0.0006526251870735355,0.0,0.004446134,False,CMAS; cytidine monophosphate N-acetylneuraminic acid
hsa:3337,1.05254827e-07,0.00013040832934017396,1.535553978185148e-05,3.2203783498572854e-05,0.0,0.00016165742,False,DNAJB1; DnaJ heat shock protein family (Hsp40) member
hsa:56001,0.0,0.0,2.6736653755127225e-05,0.00010534892830620167,0.0,0.0007206806,False,NXF2; nuclear RNA export factor
hsa:9469,0.0,0.0,0.0002755878826790594,0.001269302922476005,0.0,0.011026133,False,CHST3; carbohydrate sulfotransferase
hsa:780852,0.0,0.0,3.8711115625737645e-07,1.2756181187337291e-06,0.0,1.17616755e-05,False,SNORD3B-2; small nucleolar RNA
hsa:574473,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520B; microRNA
hsa:55226,0.0,0.0,2.6289843043797037e-06,6.56954994563557e-06,0.0,3.7099682e-05,False,NAT10; N-acetyltransferase
hsa:26154,2.28736275e-07,0.0002833990262721595,9.50102412365574e-05,0.0003440619371003257,0.0,0.0033372974,False,ABCA12; ATP binding cassette subfamily A member
hsa:5694,9.6591807e-07,0.001196750452007158,8.803810808980198e-06,2.1098622735854796e-05,0.0,0.00020221564,False,PSMB6; proteasome 20S subunit beta
hsa:114805,3.873549e-06,0.004799238838778402,0.0001209590176181287,0.0003041475651543355,0.0,0.0025873757,False,GALNT13; polypeptide N-acetylgalactosaminyltransferase
hsa:930,4.6467213500000005e-06,0.005757181741059893,7.849776132103961e-05,0.00023424380981499948,0.0,0.0018485708,False,CD19; CD19
hsa:8480,4.90389185e-08,6.075810123400754e-05,1.9957257052353963e-05,6.165784202487071e-05,0.0,0.00034820513,False,RAE1; ribonucleic acid export
hsa:10013,3.6403938500000003e-06,0.004510364927194682,4.732685121886139e-05,0.00015881889676202588,0.0,0.0018936786,False,HDAC6; histone deacetylase
hsa:284433,0.0,0.0,1.1149960837772277e-06,6.8535379052191396e-06,-0.0,6.9425e-05,False,OR10H5; olfactory receptor family 10 subfamily H member
hsa:6625,0.0,0.0,2.9039042474059415e-07,4.927115233527329e-07,0.0,2.0053003e-06,False,SNRNP70; small nuclear ribonucleoprotein U1 subunit
hsa:6538,4.57184865e-07,0.0005664416173926444,4.568464424552077e-05,0.0001313612912678835,0.0,0.0010574298,False,SLC6A11; solute carrier family 6 member
hsa:1816,0.0,0.0,1.0136011106188117e-06,3.5074588915647943e-06,0.0,2.610739e-05,False,DRD5; dopamine receptor
hsa:80267,0.0,0.0,1.7719648217079204e-07,4.3275299025619703e-07,0.0,2.2912445e-06,False,EDEM3; ER degradation enhancing alpha-mannosidase like protein
hsa:5163,6.857963300000001e-07,0.000849686006922254,7.274641239446882e-05,0.00017105887484686935,0.0,0.0012339514,False,PDK1; pyruvate dehydrogenase kinase
hsa:2936,8.440236e-06,0.01045725984611416,4.070495719009902e-05,7.681899202523101e-05,0.0,0.0005059858,False,GSR; glutathione-disulfide
hsa:4995,0.0,0.0,6.646177053227722e-06,3.0446287565136633e-05,0.0,0.00033491114,False,OR3A2; olfactory receptor family 3 subfamily A member
hsa:84911,9.426063e-09,1.1678677008183466e-05,5.1767862921782175e-08,8.228798296140236e-08,0.0,3.5070929e-07,False,ZNF382; zinc finger protein
hsa:10682,0.0,0.0,1.5180426960792082e-05,4.484979402422656e-05,0.0,0.0004936734,False,EBP; EBP cholestenol
hsa:875,7.80260435e-06,0.009667248778869535,0.00026737476446844056,0.0006943058651157965,0.0,0.0043000234,False,CBS; cystathionine
hsa:4088,0.0,0.0,9.227085826633662e-05,0.0003787331277820271,0.0,0.0025288458,False,SMAD3; SMAD family member
hsa:29895,0.0,0.0,1.7320489827227719e-06,7.063701557845411e-06,0.0,6.183511e-05,False,MYL11; myosin light chain
hsa:5580,0.0,0.0,7.108195898019803e-05,0.00018465741453015057,0.0,0.0012483203,False,PRKCD; protein kinase C
hsa:10787,1.96923925e-07,0.0002439842503979387,1.413914929144059e-05,4.371669188783376e-05,0.0,0.00023381546,False,NCKAP1; NCK associated protein
hsa:6732,0.0,0.0,1.580481825881189e-07,3.2268510321985906e-07,0.0,1.5854961e-06,False,SRPK1; SRSF protein kinase
hsa:2938,0.0,0.0,1.3996996414356435e-05,8.015395586113538e-05,0.0,0.00078470923,False,GSTA1; glutathione S-transferase alpha
hsa:4173,3.310587e-07,0.0004101741764349662,9.279818152089106e-06,2.0895598929928773e-05,0.0,0.00014867328,False,MCM4; minichromosome maintenance complex component
hsa:410,3.0563055e-07,0.0003786692787098354,3.369797127170794e-05,0.00010309202442081095,0.0,0.00084120705,False,ARSA; arylsulfatase
hsa:23621,0.0,0.0,1.9018825547425747e-08,6.058320165823351e-08,0.0,6.250731e-07,False,BACE1; beta-secretase
hsa:260293,0.0,0.0,3.2214665051173264e-05,9.283801171139425e-05,0.0,0.000706791,False,CYP4X1; cytochrome P450 family 4 subfamily X member
hsa:9935,0.0,0.0,1.7180227586485148e-05,8.458485903715009e-05,0.0,0.0009758784,False,MAFB; MAF bZIP transcription factor
hsa:284371,0.0,0.0,7.60218453069307e-08,1.3481223369172152e-07,0.0,6.495303e-07,False,ZNF841; zinc finger protein
hsa:175,0.0,0.0,2.045337888064356e-05,5.502863078929051e-05,0.0,0.00033006695,False,AGA;
hsa:30814,0.0,0.0,2.167609900990099e-07,2.180030278902153e-06,0.0,2.3647188e-05,False,PLA2G2E; phospholipase A2 group
hsa:57379,0.0,0.0,4.573411635643565e-06,2.2526876792282998e-05,0.0,0.00026243454,False,AICDA; activation induced cytidine
hsa:9562,0.0,0.0,2.492831380158071e-05,5.6076722923922754e-05,0.0,0.0002740032,False,MINPP1; multiple inositol-polyphosphate phosphatase
hsa:3990,0.0,0.0,9.354293882742576e-06,4.0656780830827796e-05,0.0,0.00045788637,False,LIPC; lipase C
hsa:80179,1.78360935e-08,2.2098512928914282e-05,1.8044137189108919e-07,3.8910568401250833e-07,0.0,2.0814878e-06,False,MYO19; myosin
hsa:51004,0.0,0.0,0.00021001914320029703,0.00041473857698002734,0.0,0.0020278317,False,COQ6; coenzyme Q6
hsa:1674,0.0,0.0,3.513162773494556e-05,0.00014415831266981067,0.0,0.0017153608,False,DES;
hsa:5588,8.3037405e-06,0.010288145035660369,5.083473001754457e-05,9.842032578838421e-05,0.0,0.0006256083,False,PRKCQ; protein kinase C
hsa:2263,0.0,0.0,8.82283188427723e-06,3.938810172987124e-05,0.0,0.0004597129,False,FGFR2; fibroblast growth factor receptor
hsa:146956,1.0978612e-06,0.0013602249798899827,0.0003423117625648515,0.0008693126298857721,0.0,0.0044133225,False,EME1; essential meiotic structure-specific endonuclease
hsa:5824,1.06050225e-07,0.00013139380931574332,5.270032576729405e-05,0.00019692549860652684,0.0,0.0013338276,False,PEX19; peroxisomal biogenesis factor
hsa:6257,2.6483128e-05,0.03281199139857009,0.0001599256554277228,0.0003220413173390851,0.0,0.0025159244,False,RXRB; retinoid X receptor
hsa:636,0.0,0.0,4.783837231139604e-05,0.0001527251992889087,0.0,0.001214337,False,BICD1; BICD cargo adaptor
hsa:147658,9.07556015e-10,1.1244411973502734e-06,1.426444703653466e-08,3.678980017176132e-08,0.0,2.9506762e-07,False,ZNF534; zinc finger protein
hsa:143502,0.0,0.0,2.9727279135470296e-07,1.7309170149437968e-06,0.0,1.4269708e-05,False,OR52I2; olfactory receptor family 52 subfamily I member
hsa:8546,4.13953185e-07,0.0005128785521721865,9.73149639791831e-07,1.6662407471535096e-06,0.0,1.0868677e-05,False,AP3B1; adaptor related protein complex 3 subunit beta
hsa:27010,9.7780365e-08,0.00012114764144662383,3.447482774529703e-05,8.437979791608649e-05,0.0,0.0006939085,False,TPK1; thiamin pyrophosphokinase
hsa:55437,3.431379e-07,0.0004251400296567461,2.4332869601930695e-06,5.266215327656027e-06,0.0,3.271549e-05,False,STRADB; STE20 related adaptor
hsa:1600,3.17750375e-09,3.936854653797853e-06,3.953376686193071e-08,9.428422446549007e-08,0.0,6.853438e-07,False,DAB1; DAB adaptor protein
hsa:23013,1.6985577000000002e-07,0.0002104474238933369,0.0001117216990242534,0.00026859220136160323,0.0,0.0020863533,False,SPEN; spen family transcriptional
hsa:6060,0.0,0.0,1.4791896991435646e-07,5.739508406647846e-07,0.0,6.6048115e-06,False,RNU1-4; RNA
hsa:3563,3.83676455e-06,0.0047536637444390495,5.7207213383069314e-05,0.00014986759147075842,0.0,0.0012413404,False,IL3RA; interleukin 3 receptor subunit
hsa:80025,0.0,0.0,2.966209945513366e-05,6.66725722941024e-05,0.0,0.0003740101,False,PANK2; pantothenate kinase
hsa:1902,6.8708162e-07,0.0008512784519092913,6.629649422673269e-05,0.00013614559883427815,0.0,0.0009596832,False,LPAR1; lysophosphatidic acid receptor
hsa:9340,0.0,0.0,5.605732442094456e-07,2.2370014079096813e-06,0.0,1.8687735e-05,False,GLP2R; glucagon like peptide 2
hsa:407032,0.0,0.0,1.947239108910891e-10,2.767546765185659e-09,0.0,3.933423e-08,False,MIR30C2; microRNA
hsa:55040,0.0,0.0,1.2446703784546538e-08,4.699175769599234e-08,0.0,4.7705504e-07,False,EPN3; epsin
hsa:10800,1.29084875e-07,0.00015993321514684727,3.1337895742425733e-06,7.451199925552629e-06,0.0,4.3925927e-05,False,CYSLTR1; cysteinyl leukotriene receptor
hsa:56963,6.4946183e-07,0.0008046683903676179,4.422046823008417e-05,0.00017874890157415954,0.0,0.0015102791,False,RGMA; repulsive guidance molecule BMP co-receptor
hsa:5106,0.0,0.0,0.00015927888018811882,0.00036063399573214123,0.0,0.0017798387,False,PCK2; phosphoenolpyruvate carboxykinase 2
hsa:2566,0.0,0.0,0.00013982425871287126,0.0003071167876680735,0.0,0.0018582551,False,GABRG2; gamma-aminobutyric acid type A receptor subunit
hsa:6582,0.0,0.0,4.5296052146586625e-07,4.973205454559933e-06,0.0,6.973322e-05,False,SLC22A2; solute carrier family 22 member
hsa:57134,0.0,0.0,1.868346786750941e-05,0.0001112132594411945,0.0,0.0011300826,False,MAN1C1; mannosidase alpha class 1C member
hsa:442900,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR326; microRNA
hsa:354,0.0,0.0,6.242201810240099e-06,7.655934109583097e-05,0.0,0.0010843445,False,KLK3; kallikrein related peptidase
hsa:9693,2.6896845e-07,0.0003332457732291566,2.1129845071074255e-05,7.082682299736075e-05,0.0,0.00047519305,False,RAPGEF2; Rap guanine nucleotide exchange factor
hsa:3991,0.0,0.0,0.00010161086861089108,0.0003128573832844178,0.0,0.0017820586,False,LIPE; lipase E
hsa:3326,0.0,0.0,0.00014143652768910885,0.0004486514041065104,0.0,0.004876487,False,HSP90AB1; heat shock protein 90 alpha family class B member
hsa:4862,0.0,0.0,0.00015194512599757425,0.0009506624265190211,0.0,0.008968038,False,NPAS2; neuronal PAS domain protein
hsa:10846,0.0,0.0,2.9090484105742568e-05,0.00014091114276142605,0.0,0.0013251553,False,PDE10A; phosphodiesterase
hsa:1439,6.26321115e-07,0.0007759975724213103,7.680100214866336e-06,1.4848157181133544e-05,0.0,0.00010156887,False,CSF2RB; colony stimulating factor 2 receptor subunit
hsa:5525,1.1845416e-07,0.00014676200179392876,7.99975691128713e-06,1.7936608999587514e-05,0.0,0.00016294012,False,PPP2R5A; protein phosphatase 2 regulatory subunit
hsa:27134,0.0,0.0,2.4083417045408915e-06,1.5167145011434688e-05,0.0,0.00019568256,False,TJP3; tight junction protein
hsa:2208,6.86309565e-07,0.000850321893378168,1.0281177960410887e-05,2.0556087491833312e-05,0.0,0.000102495746,False,FCER2; Fc epsilon receptor
hsa:54361,2.4138099e-05,0.02990655396771232,9.115574421970297e-05,0.00014536134131589893,0.0,0.0007843055,False,WNT4; Wnt family member
hsa:442191,0.0,0.0,4.810042217821782e-07,6.765152755198017e-06,0.0,9.6150594e-05,False,OR14J1; olfactory receptor family 14 subfamily J member
hsa:10587,3.80940175e-05,0.04719761859501561,0.000163223574374604,0.0002833421493065216,0.0,0.0014484623,False,TXNRD2; thioredoxin reductase
hsa:170960,0.0,0.0,9.338524716683168e-08,2.7294916400870507e-07,0.0,1.8539563e-06,False,ZNF721; zinc finger protein
hsa:83657,0.0,0.0,7.629036906138615e-08,3.6283797700496897e-07,0.0,4.77422e-06,False,DYNLRB2; dynein light chain roadblock-type
hsa:11065,0.0,0.0,7.356253488727722e-07,1.7954632015324737e-06,0.0,1.0647241e-05,False,UBE2C; ubiquitin conjugating enzyme E2
hsa:55161,7.65412e-10,9.483280056782691e-07,3.191090398972771e-07,6.74534914379527e-07,0.0,3.4397337e-06,False,TMEM33; transmembrane protein
hsa:486,0.0001047622,0.12979797572610302,0.0002573571958787129,0.00036518945511348095,0.0,0.0017526967,False,FXYD2; FXYD domain containing ion transport regulator
hsa:9957,0.0,0.0,5.4412635962970294e-05,0.000301277645908339,0.0,0.0030972387,False,HS3ST1; heparan sulfate-glucosamine 3-sulfotransferase
hsa:54941,0.0,0.0,6.0425490903054496e-06,3.35024404521802e-05,0.0,0.00036310928,False,RNF125; ring finger protein
hsa:2746,0.0,0.0,0.0005047986301089111,0.0011544074686556422,0.0,0.008825417,False,GLUD1; glutamate dehydrogenase
hsa:10241,0.0,0.0,4.666446637178216e-06,1.853776743891633e-05,0.0,0.00017476853,False,CALCOCO2; calcium binding and coiled-coil domain
hsa:4985,1.716918985e-08,2.127223452148919e-05,4.2323226186834156e-05,0.00019787670733144858,0.0,0.0022187047,False,OPRD1; opioid receptor delta
hsa:3320,0.0,0.0,0.0003286433770930694,0.0010344617263190216,0.0,0.007371571,False,HSP90AA1; heat shock protein 90 alpha family class A member
hsa:4648,0.0,0.0,3.364961955465346e-08,2.5913689776750687e-07,0.0,3.0236363e-06,False,MYO7B; myosin
hsa:54898,0.0,0.0,0.00016189724738811885,0.0005832301377299186,0.0,0.003760366,False,ELOVL2; ELOVL fatty acid elongase
hsa:4976,2.8447049000000002e-08,3.524524471213151e-05,2.709180337136139e-07,4.2902684570081374e-07,0.0,1.8831311e-06,False,OPA1; OPA1 mitochondrial dynamin like
hsa:8732,1.5926741500000001e-09,1.973286936140056e-06,1.0233407451049506e-07,3.0100631907975404e-07,0.0,2.0019465e-06,False,RNGTT; RNA guanylyltransferase and
hsa:7076,0.0,0.0,1.01564615560099e-05,5.641823733507706e-05,0.0,0.00058871444,False,TIMP1; TIMP metallopeptidase inhibitor
hsa:11052,0.0,0.0,5.323718872940593e-06,1.5228928299029743e-05,0.0,0.00011029928,False,CPSF6; cleavage and polyadenylation specific factor
hsa:35,0.0,0.0,0.00047485617118069284,0.0010351637084269143,0.0,0.005734341,False,ACADS; acyl-CoA dehydrogenase short
hsa:1743,7.836922500000001e-06,0.00970976818377574,9.384944743861389e-05,0.00017890742678126236,0.0,0.0011255431,False,DLST; dihydrolipoamide
hsa:9638,8.931502499999999e-07,0.0011065927831723926,7.470357979915845e-06,1.68386814268018e-05,0.0,0.00013516775,False,FEZ1; fasciculation and elongation protein zeta
hsa:2023,0.0,0.0,7.264391708193069e-05,0.00019294870360107052,0.0,0.00107499,False,ENO1; enolase
hsa:9757,3.1867319e-06,0.003948288121114278,4.765965912781686e-05,0.00016731268134146664,0.0,0.0010574177,False,KMT2B; lysine methyltransferase
hsa:10449,0.0,0.0,5.576208736377725e-05,0.000157013054496663,0.0,0.0013906904,False,ACAA2; acetyl-CoA acyltransferase
hsa:1212,3.32845625e-06,0.004123881357425635,8.639606875297028e-05,0.00019092804967351122,0.0,0.0012930781,False,CLTB; clathrin light chain
hsa:7299,0.0,0.0,1.0131554684158413e-07,4.972662259664495e-07,0.0,4.206161e-06,False,TYR;
hsa:146542,0.0,0.0,9.700551709391091e-08,1.9292978460423218e-07,0.0,1.2383285e-06,False,ZNF688; zinc finger protein
hsa:116987,0.0,0.0,1.5904981993688113e-06,4.968902263698336e-06,0.0,2.735349e-05,False,AGAP1; ArfGAP with GTPase domain
hsa:3067,0.0,0.0,2.322848762015843e-05,0.0001163682930905515,0.0,0.00112381,False,HDC; histidine
hsa:100169764,0.0,0.0,1.2160093240396038e-07,1.095678030057063e-06,0.0,1.504233e-05,False,RNA5S13; RNA
hsa:2956,1.07946695e-05,0.013374349237915055,0.00020602752028777243,0.0004703655023636408,0.0,0.0028237395,False,MSH6; mutS homolog
hsa:2689,0.0,0.0,9.147771143564355e-08,7.898824581847377e-07,0.0,8.560496e-06,False,GH2; growth hormone
hsa:6548,0.0,0.0,0.00021737461099059403,0.0007175042348848713,0.0,0.0038500482,False,SLC9A1; solute carrier family 9 member
hsa:57412,1.09123595e-07,0.00013520164462902745,4.72605137871287e-07,1.002190073394237e-06,0.0,7.3352276e-06,False,AS3MT; arsenite
hsa:6309,4.03500725e-06,0.00499928192697509,2.6487957330896043e-05,6.905953422707785e-05,0.0,0.0004337361,False,SC5D;
hsa:860,0.0,0.0,1.308477865688911e-05,6.815524482155265e-05,0.0,0.0005801276,False,RUNX2; RUNX family transcription factor
hsa:6137,0.0,0.0,8.180460688856438e-07,1.711604256089117e-06,0.0,8.2116685e-06,False,RPL13; ribosomal protein
hsa:78989,0.0,0.0,5.49459907580891e-07,9.279756048641764e-07,0.0,4.800711e-06,False,COLEC11; collectin subfamily member
hsa:9723,5.3376435e-09,6.6132185220202675e-06,8.617193026046039e-07,6.198933300974484e-06,0.0,7.751551e-05,False,SEMA3E; semaphorin
hsa:100529261,0.0,0.0,4.2452727146354455e-06,1.9123155627525684e-05,0.0,0.00022705561,False,CHURC1-FNTB; CHURC1-FNTB
hsa:844,2.3943091e-08,2.966494350467894e-05,1.5779614698298516e-06,5.507851775268844e-06,0.0,3.349681e-05,False,CASQ1; calsequestrin
hsa:1071,0.0,0.0,0.00011284477962184658,0.00023946616237706562,0.0,0.0014349124,False,CETP; cholesteryl ester transfer
hsa:81620,1.87239115e-08,2.3198499175988105e-05,6.158433657331683e-07,1.2471290367754686e-06,0.0,1.0342975e-05,False,CDT1; chromatin licensing and DNA replication factor
hsa:9542,3.28024655e-06,0.004064150638995107,1.5161564563965342e-05,3.119240223326271e-05,0.0,0.0002700509,False,NRG2; neuregulin
hsa:81631,0.0,0.0,2.2503588824059414e-05,0.0001551722897082967,0.0,0.00196696,False,MAP1LC3B; microtubule associated protein 1 light chain 3
hsa:101954271,0.0,0.0,2.767435870792079e-08,3.3913961061873144e-07,0.0,4.8131033e-06,False,RNU6-9; RNA
hsa:3570,0.0,0.0,5.834460143762377e-05,0.00019134078577649703,0.0,0.0017153657,False,IL6R; interleukin 6
hsa:6510,0.0,0.0,3.089084567277228e-05,5.435600804773301e-05,0.0,0.00035905617,False,SLC1A5; solute carrier family 1 member
hsa:10454,7.3081836499999995e-06,0.009054672811420559,6.0760033935524734e-05,0.00010084094635887567,0.0,0.0005527083,False,TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein
hsa:119548,0.0,0.0,1.5273439518811877e-06,1.7386475642290087e-05,0.0,0.00024620263,False,PNLIPRP3; pancreatic lipase related protein
hsa:6626,0.0,0.0,1.8666782817222774e-07,3.935963741556291e-07,0.0,2.2579652e-06,False,SNRPA; small nuclear ribonucleoprotein polypeptide
hsa:7086,1.71625035e-07,0.0002126395028638343,6.336119619414359e-05,0.0002003405346229989,0.0,0.0012129013,False,TKT;
hsa:55326,8.110495999999999e-06,0.010048719508894006,0.00013194705694930694,0.00027191260179933613,0.0,0.0012421266,False,AGPAT5; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:79888,0.0,0.0,1.7823721126460397e-05,5.202806165797885e-05,0.0,0.00042667915,False,LPCAT1; lysophosphatidylcholine acyltransferase
hsa:7483,0.0,0.0,1.715899422574257e-05,4.7256878147199166e-05,0.0,0.0003434733,False,WNT9A; Wnt family member
hsa:24145,0.0,0.0,2.0179875353465341e-07,5.591767912656507e-07,0.0,4.0840223e-06,False,PANX1; pannexin
hsa:81469,0.0,0.0,1.5492770940594057e-08,1.7885694622425334e-07,0.0,2.4539906e-06,False,OR2G3; olfactory receptor family 2 subfamily G member
hsa:9971,0.0,0.0,1.5111274595514856e-06,6.781635756476249e-06,0.0,6.247324e-05,False,NR1H4; nuclear receptor subfamily 1 group H member
hsa:7551,1.0695833e-08,1.325189306929839e-05,2.2752322432242572e-07,5.643310761463142e-07,0.0,3.0035465e-06,False,ZNF3; zinc finger protein
hsa:407045,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR7-3; microRNA
hsa:9632,3.14046575e-07,0.000389096541679306,1.2164320341089114e-06,3.6726939284165225e-06,0.0,3.8371803e-05,False,SEC24C; SEC24 homolog C
hsa:390439,0.0,0.0,1.1132089159405941e-07,1.4935441890106435e-06,0.0,2.1195092e-05,False,OR11G2; olfactory receptor family 11 subfamily G member
hsa:344838,0.0,0.0,1.8145530685436556e-06,1.3604660601542766e-05,0.0,0.0001788724,False,PAQR9; progestin and adipoQ receptor family member
hsa:8050,1.1609343e-06,0.0014383711118227797,0.00015961557816839114,0.00041741344536476573,0.0,0.0026105952,False,PDHX; pyruvate dehydrogenase complex component
hsa:3576,0.0,0.0,0.00010592571626039605,0.00036579882781459457,0.0,0.002888861,False,CXCL8; C-X-C motif chemokine ligand
hsa:22943,0.0,0.0,1.518307546792326e-06,7.811830050219561e-06,0.0,9.103033e-05,False,DKK1; dickkopf WNT signaling pathway inhibitor
hsa:84219,9.145603499999999e-08,0.00011331194086164311,4.976406712153467e-07,9.318317868213228e-07,0.0,7.0375377e-06,False,WDR24; WD repeat domain
hsa:55777,3.7771066e-08,4.679748905442073e-05,2.2135657378421586e-05,7.821843857657147e-05,0.0,0.00052803004,False,MBD5; methyl-CpG binding domain protein
hsa:9455,4.598082e-06,0.005696918696081518,2.7263721134158427e-05,5.81553836789089e-05,0.0,0.00036957365,False,HOMER2; homer scaffold protein
hsa:7090,0.0,0.0,2.2343259135306925e-05,8.272555533133764e-05,0.0,0.0007705256,False,TLE3; TLE family member 3
hsa:7517,0.0,0.0,1.1313441509653466e-05,3.9588062083211586e-05,0.0,0.0003909502,False,XRCC3; X-ray repair cross complementing
hsa:84152,0.0,0.0,2.2464709805594052e-05,7.552516210232708e-05,0.0,0.0005743381,False,PPP1R1B; protein phosphatase 1 regulatory inhibitor subunit
hsa:83593,3.2920560499999996e-07,0.0004078782340069897,2.0885849874185154e-05,6.0555950529288335e-05,0.0,0.00045777304,False,RASSF5; Ras association domain family member
hsa:6229,0.0,0.0,6.497126362227722e-07,1.0605843563649436e-06,0.0,4.5102356e-06,False,RPS24; ribosomal protein
hsa:79891,1.8639017e-09,2.3093316827294783e-06,1.0002246468910888e-07,1.957929900721197e-07,0.0,1.1768675e-06,False,ZNF671; zinc finger protein
hsa:1769,0.0,0.0,1.7699009755230694e-08,1.1921215525764532e-07,0.0,1.1926807e-06,False,DNAH8; dynein axonemal heavy chain
hsa:26121,0.0,0.0,1.679572297326732e-07,3.007921862886676e-07,0.0,1.8769141e-06,False,PRPF31; pre-mRNA processing factor
hsa:65108,3.50375785e-06,0.004341076040446296,9.090964651945549e-05,0.00026983913272233623,0.0,0.0017595378,False,MARCKSL1; MARCKS like
hsa:100526760,0.0,0.0,1.0553235026674756e-05,2.7399071897052727e-05,0.0,0.0001977583,False,ABHD14A-ACY1; ABHD14A-ACY1
hsa:54474,0.0,0.0,1.935461550848515e-06,5.651859213201304e-06,0.0,4.4157652e-05,False,KRT20; keratin
hsa:645745,0.0,0.0,2.427163886237624e-07,2.4099390052062935e-06,0.0,3.261156e-05,False,MT1HL1; metallothionein 1H like
hsa:64499,2.2159063e-09,2.7454573513988706e-06,5.113052933644753e-06,2.9586852528071027e-05,0.0,0.0002796431,False,TPSB2; tryptase beta
hsa:178,0.0,0.0,0.00011872260792178215,0.00023986508432378607,0.0,0.0014692949,False,AGL; amylo-alpha-1
hsa:5241,0.0,0.0,1.3486636759673268e-06,8.535714366375521e-06,0.0,0.00010831694,False,PGR; progesterone
hsa:729747,0.0,0.0,1.144583449953465e-08,3.815192811999015e-08,0.0,3.4467786e-07,False,ZNF878; zinc finger protein
hsa:2774,1.0879754e-05,0.013479766992273665,9.904411632159675e-05,0.0002861883277354085,0.0,0.0019784428,False,GNAL; G protein subunit alpha
hsa:84456,2.34828455e-08,2.909470983034747e-05,1.9761452630868024e-05,5.5848843776045614e-05,0.0,0.00031176963,False,L3MBTL3; L3MBTL histone methyl-lysine binding protein
hsa:2903,0.0,0.0,0.00015003681451936638,0.0006335753925225641,0.0,0.0050496426,False,GRIN2A; glutamate ionotropic receptor NMDA type subunit
hsa:9223,0.0,0.0,3.961109806661881e-06,1.634248257163888e-05,0.0,0.00017281395,False,MAGI1; membrane associated guanylate kinase
hsa:7416,7.059293e-05,0.08746302974330904,0.00022282963700445552,0.00043188105173912455,0.0,0.0026035297,False,VDAC1; voltage dependent anion channel
hsa:10025,1.8882436e-07,0.00023394907414866183,1.1454375654066826e-05,3.488373532396141e-05,0.0,0.00032006792,False,MED16; mediator complex subunit
hsa:79109,2.7292727e-08,3.3815066089153885e-05,1.3129131315000002e-06,3.0055557803356687e-06,0.0,1.8711276e-05,False,MAPKAP1; MAPK associated protein
hsa:5111,0.0,0.0,0.0001101607868242574,0.0003938770237470828,0.0,0.003951347,False,PCNA; proliferating cell nuclear
hsa:254531,2.8498467e-06,0.003530895044106699,2.2642316981683165e-05,4.107550873512819e-05,0.0,0.0002610385,False,LPCAT4; lysophosphatidylcholine acyltransferase
hsa:9527,0.0,0.0,5.517491151740593e-05,0.00014366438564399178,0.0,0.001072542,False,GOSR1; golgi SNAP receptor complex member
hsa:146,0.0,0.0,7.65868246451238e-06,3.167495945282229e-05,0.0,0.00022385712,False,ADRA1D; adrenoceptor alpha
hsa:4494,0.0,0.0,2.024300033042079e-05,4.931324281853317e-05,0.0,0.00036688446,False,MT1F; metallothionein
hsa:1906,0.0,0.0,4.041626427376237e-05,0.0001535220653567347,0.0,0.001390508,False,EDN1; endothelin
hsa:2188,4.1752196e-07,0.0005173001829781635,0.00010116814615118812,0.00022517165757671064,0.0,0.0012403004,False,FANCF; FA complementation group
hsa:100169766,0.0,0.0,2.2958790414321784e-07,2.2911855061600625e-06,0.0,3.2053755e-05,False,RNA5S15; RNA
hsa:8453,3.893505900000001e-06,0.004823964982576149,3.094892489140594e-05,5.454119859800096e-05,0.0,0.00031470472,False,CUL2; cullin
hsa:954,0.0,0.0,0.0001727843233649931,0.0010377176377584884,0.0,0.0108425645,False,ENTPD2; ectonucleoside triphosphate diphosphohydrolase
hsa:5902,0.0,0.0,2.6304534809663356e-05,0.00011352077327233996,0.0,0.0008505036,False,RANBP1; RAN binding protein
hsa:7703,0.0,0.0,1.846027942027723e-05,6.584804385181065e-05,0.0,0.00056022214,False,PCGF2; polycomb group ring finger
hsa:1388,0.000166007425,0.20567941223554745,0.00031959984057178205,0.00045309527058459226,0.0,0.0022820523,False,ATF6B; activating transcription factor 6
hsa:9369,2.3370404500000002e-08,2.895539799660764e-05,8.204032648514852e-07,2.1890018349052375e-06,0.0,1.5710919e-05,False,NRXN3; neurexin
hsa:3832,1.81576035e-09,2.249685648389594e-06,9.286497184490098e-08,5.287019667890311e-07,0.0,6.0458083e-06,False,KIF11; kinesin family member
hsa:56300,0.0,0.0,1.386480171084159e-06,6.107532447778758e-06,0.0,6.372176e-05,False,IL36G; interleukin 36
hsa:4605,1.2245775e-08,1.5172235846491572e-05,1.0193778550984462e-05,3.879117852837347e-05,0.0,0.00029891782,False,MYBL2; MYB proto-oncogene like
hsa:406896,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR103A2; microRNA
hsa:2568,7.4474105e-05,0.09227171702210576,0.0005682165892001981,0.0013877257839546022,0.0,0.014507077,False,GABRP; gamma-aminobutyric acid type A receptor subunit
hsa:4697,2.7071192499999996e-07,0.0003354058989780342,4.296432069702968e-06,9.727264747861057e-06,0.0,8.6123626e-05,False,NDUFA4; NDUFA4 mitochondrial complex
hsa:4801,2.40747255e-07,0.0002982803564703293,1.4310643789801974e-06,3.1599437139553863e-06,0.0,2.6536436e-05,False,NFYB; nuclear transcription factor Y subunit
hsa:1453,0.0,0.0,0.00017526720842326728,0.0008065903509231112,0.0,0.008308622,False,CSNK1D; casein kinase 1
hsa:146754,0.0,0.0,2.895829177371288e-08,2.426751473334656e-07,0.0,3.4026784e-06,False,DNAH2; dynein axonemal heavy chain
hsa:27153,3.3675068e-09,4.172264097965553e-06,1.1018364123138613e-07,2.5716220302010883e-07,0.0,1.3596406e-06,False,ZNF777; zinc finger protein
hsa:118813,0.0,0.0,7.562454285811883e-07,1.7928044128596327e-06,0.0,9.6772565e-06,False,ZFYVE27; zinc finger FYVE-type containing
hsa:8991,2.0586269e-08,2.5505917630147395e-05,4.752950271023763e-05,0.0001574242822588272,0.0,0.0013242878,False,SELENBP1; selenium binding protein
hsa:7167,6.6256864e-06,0.00820907428935218,0.0003193395157912872,0.0006363090899031949,0.0,0.0037307637,False,TPI1; triosephosphate isomerase
hsa:79778,0.0,0.0,1.527601303866832e-06,5.319939893676139e-06,0.0,4.6709265e-05,False,MICALL2; MICAL like
hsa:5538,0.0,0.0,2.1549917934737627e-05,6.896174111445056e-05,0.0,0.000353608,False,PPT1; palmitoyl-protein thioesterase
hsa:286826,0.0,0.0,3.6131172609819303e-06,1.4501230443894638e-05,0.0,0.00011440406,False,LIN9; lin-9 DREAM MuvB core complex
hsa:9815,3.99803555e-07,0.0004953474834157711,6.808424157156436e-06,2.4231054145801e-05,0.0,0.00026241486,False,GIT2; GIT ArfGAP
hsa:100533105,0.0,0.0,2.0319775382554455e-06,1.0816362693276038e-05,0.0,0.00014223374,False,C8orf44-SGK3; C8orf44-SGK3
hsa:403239,0.0,0.0,0.0,0.0,0.0,0.0,False,OR2T27; olfactory receptor family 2 subfamily T member
hsa:5224,5.13488235e-06,0.006362002083019399,0.00023090328372970303,0.0003751699911674556,0.0,0.0017560691,False,PGAM2; phosphoglycerate mutase
hsa:51703,0.0,0.0,4.0439693471386106e-05,0.0001660050304259185,0.0,0.0016314804,False,ACSL5; acyl-CoA synthetase long chain family member
hsa:7576,3.78492125e-10,4.6894310785064794e-07,4.555661086113862e-08,9.315830296631606e-08,0.0,4.4501053e-07,False,ZNF28; zinc finger protein
hsa:11326,0.0,0.0,1.0976688732227721e-06,4.362424309620735e-06,0.0,4.331051e-05,False,VSIG4; V-set and immunoglobulin domain containing
hsa:25800,0.0,0.0,2.7232560190019793e-08,7.097063282124427e-08,0.0,4.9686736e-07,False,SLC39A6; solute carrier family 39 member
hsa:255027,1.12659365e-07,0.00013958238299298966,4.841395263368025e-05,0.00019704704425333152,0.0,0.0015196451,False,MPV17L; MPV17 mitochondrial inner membrane protein
hsa:79660,0.0,0.0,2.4416283538613862e-06,6.63679491141464e-06,0.0,5.1543386e-05,False,PPP1R3B; protein phosphatase 1 regulatory subunit
hsa:151903,8.230028e-08,0.00010196816929857795,4.3807987307673275e-07,9.275758668142993e-07,0.0,6.1072615e-06,False,CCDC12; coiled-coil domain containing
hsa:25847,0.0,0.0,6.13488016188119e-06,2.1412263011682262e-05,0.0,0.00019072091,False,ANAPC13; anaphase promoting complex subunit
hsa:5617,6.6878248e-08,8.286062349309482e-05,1.5056585607460396e-05,7.089694309193898e-05,0.0,0.0008750824,False,PRL;
hsa:54910,5.632487700000001e-07,0.0006978523759162884,1.7799046575732678e-05,6.905806892559615e-05,0.0,0.00072202826,False,SEMA4C; semaphorin
hsa:9,0.0,0.0,0.0001370780373910892,0.0006343937614374839,0.0,0.008242631,False,NAT1; N-acetyltransferase
hsa:7869,2.5063196e-09,3.1052728045292696e-06,5.712272847575399e-06,4.575098033772191e-05,0.0,0.00041278786,False,SEMA3B; semaphorin
hsa:1181,3.93202325e-06,0.004871687100480638,2.9426171844950493e-05,4.9665565788301165e-05,0.0,0.00026907225,False,CLCN2; chloride voltage-gated channel
hsa:9798,0.0,0.0,3.934020321712871e-07,8.670985811192232e-07,0.0,5.44379e-06,False,IST1; IST1 factor associated with
hsa:406888,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7F1; microRNA
hsa:401427,0.0,0.0,2.0022648591881184e-05,8.517672142971896e-05,0.0,0.0008083118,False,OR2A7; olfactory receptor family 2 subfamily A member
hsa:407051,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR9-3; microRNA
hsa:8379,0.0,0.0,2.6928719563663378e-05,7.285416960858516e-05,0.0,0.0004484711,False,MAD1L1; mitotic arrest deficient 1 like
hsa:5292,0.0,0.0,4.215220499809405e-05,0.00020769913236483452,0.0,0.001748395,False,PIM1; Pim-1 proto-oncogene
hsa:10228,0.0,0.0,1.2833322278326729e-05,4.662782958492967e-05,0.0,0.00033258053,False,STX6; syntaxin
hsa:117248,0.0,0.0,6.783404671756435e-05,0.00035087194937446635,0.0,0.00440097,False,GALNT15; polypeptide N-acetylgalactosaminyltransferase
hsa:256148,0.0,0.0,2.4835131683168315e-07,2.5836291456609736e-06,-0.0,3.200446e-05,False,OR4S1; olfactory receptor family 4 subfamily S member
hsa:5435,0.0,0.0,0.00020784182002034156,0.0006218675335629923,0.0,0.0034887083,False,POLR2F; RNA polymerase II
hsa:256051,3.5969105500000003e-09,4.4564901105347534e-06,8.187665596188125e-08,1.5101312665746688e-07,0.0,8.314113e-07,False,ZNF549; zinc finger protein
hsa:59082,0.0,0.0,3.5361694623762383e-09,2.1319944804826752e-08,0.0,2.3826702e-07,False,CARD18; caspase recruitment domain family member
hsa:6498,0.0,0.0,2.0824371988712873e-05,9.656248550150837e-05,0.0,0.00066729216,False,SKIL; SKI like
hsa:79788,0.0,0.0,4.6566782618613856e-08,1.1861126407897351e-07,0.0,8.395349e-07,False,ZNF665; zinc finger protein
hsa:6188,0.0,0.0,2.216904112460396e-06,4.46169749424315e-06,0.0,3.4299548e-05,False,RPS3; ribosomal protein
hsa:389434,0.0,0.0,7.556449047173267e-07,4.204412135286051e-06,0.0,4.2216572e-05,False,IYD; iodotyrosine
hsa:6672,0.0,0.0,1.5822358620792084e-07,3.189288471157191e-07,0.0,2.398605e-06,False,SP100; SP100 nuclear
hsa:4548,0.0,0.0,0.00019427977291069305,0.00036959799791147984,0.0,0.0021715418,False,MTR; 5-methyltetrahydrofolate-homocysteine
hsa:154064,0.0,0.0,2.2713032107012175e-07,1.488503900192621e-06,0.0,1.624593e-05,False,RAET1L; retinoic acid early transcript
hsa:3269,0.0,0.0,4.8562933477079225e-05,0.00011170504503855172,0.0,0.00072691304,False,HRH1; histamine receptor
hsa:342909,0.0,0.0,3.0160718708118813e-08,5.417472220346714e-08,0.0,2.1020522e-07,False,ZNF284; zinc finger protein
hsa:2678,5.01918665e-05,0.06218657750233198,0.000225804245029703,0.00036181372359183565,0.0,0.0021385218,False,GGT1; gamma-glutamyltransferase
hsa:55748,4.9299201999999996e-05,0.06108058655232755,0.0004945519608673268,0.0013370536809669876,0.0,0.014443793,False,CNDP2; carnosine dipeptidase
hsa:5533,0.0,0.0,0.00014051458198366336,0.00029921311882209983,0.0,0.0020788454,False,PPP3CC; protein phosphatase 3 catalytic subunit
hsa:8482,0.0,0.0,5.67347423618812e-06,5.133806709060658e-05,0.0,0.00065470394,False,SEMA7A; semaphorin 7A (John Milton Hagen blood
hsa:140886,0.0,0.0,4.943851316272277e-07,2.3289090549071933e-06,0.0,2.9520466e-05,False,PABPC5; poly(A) binding protein cytoplasmic
hsa:847,0.0,0.0,0.00012669769923217812,0.00023858678098023732,0.0,0.0023882398,False,CAT;
hsa:5160,1.0656972500000001e-05,0.013203745796372618,0.00012831579240049504,0.00024173747891597657,0.0,0.0014790355,False,PDHA1; pyruvate dehydrogenase E1 subunit alpha
hsa:1442,0.0,0.0,2.7016134332128717e-06,1.1589414210392919e-05,0.0,8.2292645e-05,False,CSH1; chorionic somatomammotropin hormone
hsa:114785,2.6218275e-09,3.2483844573999913e-06,1.8070203007648518e-05,9.325754438888245e-05,0.0,0.0006569854,False,MBD6; methyl-CpG binding domain protein
hsa:5009,2.6944334e-08,3.3383415110488445e-05,4.908945038016337e-06,1.6545551937329935e-05,0.0,0.000161046,False,OTC; ornithine
hsa:275,1.29214775e-05,0.016009415828327263,3.618496105049502e-05,5.5849447420307116e-05,0.0,0.00038375577,False,AMT;
hsa:8542,1.08412505e-06,0.0013432062034203199,0.0001469313705981188,0.00037172003978755305,0.0,0.0018613111,False,APOL1; apolipoprotein
hsa:5966,0.0,0.0,1.7006202801291795e-06,8.14614913354632e-06,0.0,9.682911e-05,False,REL; REL proto-oncogene
hsa:1718,0.0,0.0,3.9921804197178196e-05,0.00012774637955467285,0.0,0.00079541944,False,DHCR24; 24-dehydrocholesterol
hsa:6278,0.0,0.0,3.030277880436633e-06,1.2838347637364612e-05,0.0,0.00010496007,False,S100A7; S100 calcium binding protein
hsa:2729,1.1825437e-06,0.0014651446654199327,4.499946541594061e-05,0.00011760918652512525,0.0,0.00093137723,False,GCLC; glutamate-cysteine ligase catalytic
hsa:9976,1.09780705e-08,1.3601578892753756e-05,2.5708581821881196e-07,5.166310790216073e-07,0.0,2.2769443e-06,False,CLEC2B; C-type lectin domain family 2 member
hsa:7474,0.0,0.0,1.3387382927227718e-05,4.439103900387171e-05,0.0,0.00041225489,False,WNT5A; Wnt family member
hsa:729597,0.0,0.0,2.3740807853584156e-06,5.9243509798946495e-06,0.0,3.2310327e-05,False,SPDYE6; speedy/RINGO cell cycle regulator family member
hsa:2987,1.069883075e-08,1.325560721315689e-05,8.60804052326089e-06,3.475954942330538e-05,0.0,0.00037394205,False,GUK1; guanylate kinase
hsa:221357,0.0,0.0,3.2753257425742574e-09,4.655112524347681e-08,0.0,6.616158e-07,False,GSTA5; glutathione S-transferase alpha
hsa:390271,0.0,0.0,5.168542026732674e-07,6.572341868198923e-06,0.0,9.313469e-05,False,OR8B3; olfactory receptor family 8 subfamily B member
hsa:6134,8.3779832e-08,0.00010380130047166811,3.7031328021683157e-07,1.0614928055121733e-06,0.0,1.1297097e-05,False,RPL10; ribosomal protein
hsa:9516,2.12592915e-07,0.0002633977715312535,1.6107015887905936e-06,3.942791538774546e-06,0.0,3.6479792e-05,False,LITAF; lipopolysaccharide induced TNF
hsa:10478,3.2784566e-07,0.0004061932931781523,4.648078528698021e-06,8.629759920185934e-06,0.0,5.9909144e-05,False,SLC25A17; solute carrier family 25 member
hsa:7083,0.0,0.0,3.73265062830505e-05,9.486720618350641e-05,0.0,0.0008022616,False,TK1; thymidine kinase
hsa:666,1.6168672500000001e-06,0.0020032616350919605,0.0002798420693658267,0.000575433486318815,0.0,0.003103265,False,BOK; BCL2 family apoptosis regulator
hsa:9146,2.7670639999999996e-07,0.00034283291674341843,3.0225366133779215e-05,7.33332785314883e-05,0.0,0.0004309634,False,HGS; hepatocyte growth factor-regulated tyrosine kinase
hsa:259287,0.0,0.0,1.8433772702970298e-06,2.5376744778950432e-05,0.0,0.00036062006,False,TAS2R41; taste 2 receptor member
hsa:10134,1.0085202e-07,0.00012495335191403442,7.864860753267324e-07,1.387815288969018e-06,0.0,5.7957236e-06,False,BCAP31; B cell receptor associated protein
hsa:192666,0.0,0.0,3.031245967589109e-07,3.1617643671629755e-06,0.0,4.394537e-05,False,KRT24; keratin
hsa:134083,0.0,0.0,3.6537181782178215e-08,4.904718595177964e-07,-0.0,6.9603307e-06,False,OR2Y1; olfactory receptor family 2 subfamily Y member
hsa:7850,0.0,0.0,1.5908478037277224e-05,7.439479811196201e-05,0.0,0.00056485296,False,IL1R2; interleukin 1 receptor type
hsa:84720,0.0,0.0,1.7441432755297026e-05,4.801634617211553e-05,0.0,0.0003976031,False,PIGO; phosphatidylinositol glycan anchor biosynthesis class
hsa:27190,0.0,0.0,1.2118819950693078e-05,3.343232339837594e-05,0.0,0.00025018599,False,IL17B; interleukin
hsa:137492,0.0,0.0,2.80539748784901e-07,5.310634061550305e-07,0.0,2.3844427e-06,False,VPS37A; VPS37A subunit of
hsa:55744,0.0,0.0,9.297225009980195e-07,2.759220813713513e-06,0.0,1.4199804e-05,False,COA1; cytochrome c oxidase assembly factor
hsa:291,0.0,0.0,4.49908888068812e-05,0.00014869007911668528,0.0,0.0012100273,False,SLC25A4; solute carrier family 25 member
hsa:283365,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6C6; olfactory receptor family 6 subfamily C member
hsa:10060,0.0,0.0,0.0001260235756168317,0.0004076112378934961,0.0,0.003419752,False,ABCC9; ATP binding cassette subfamily C member
hsa:57142,2.29861355e-09,2.8479297472427223e-06,4.860012085074258e-08,1.0951952905093485e-07,0.0,8.9596364e-07,False,RTN4; reticulon
hsa:7166,0.0,0.0,1.534848723997524e-05,3.5489246244981686e-05,0.0,0.00034042858,False,TPH1; tryptophan hydroxylase
hsa:435,1.95241255e-06,0.0024189946065683895,9.188247412425747e-05,0.0002192365209075912,0.0,0.0020616855,False,ASL; argininosuccinate
hsa:5426,3.38672965e-06,0.00419608077056012,3.418170604324255e-05,9.237714671357584e-05,0.0,0.00066333683,False,POLE; DNA polymerase epsilon
hsa:5080,0.00017798738,0.22052230316653024,0.0007103946648762374,0.0016666467981659788,0.0,0.013158263,False,PAX6; paired box
hsa:3739,9.076986e-08,0.00011246178569122995,1.7202664384163366e-05,5.872503164935076e-05,0.0,0.0006785136,False,KCNA4; potassium voltage-gated channel subfamily A member
hsa:138883,0.0,0.0,3.552136959851485e-07,2.9111428664098274e-06,0.0,3.9383274e-05,False,OR1N1; olfactory receptor family 1 subfamily N member
hsa:11154,8.57951775e-08,0.00010629826756751672,1.1316544212611384e-06,3.3471197214793317e-06,0.0,3.526584e-05,False,AP4S1; adaptor related protein complex 4 subunit sigma
hsa:4160,0.0,0.0,8.60620041577475e-06,2.2461442088322785e-05,0.0,0.00018830526,False,MC4R; melanocortin 4
hsa:6256,0.0,0.0,0.0001260747423168317,0.0004642097300032103,0.0,0.0032869864,False,RXRA; retinoid X receptor
hsa:5521,0.0,0.0,2.2891209354345544e-05,5.767643663634225e-05,0.0,0.00044812044,False,PPP2R2B; protein phosphatase 2 regulatory subunit
hsa:3361,0.0,0.0,8.806180657306933e-06,6.982365432721117e-05,0.0,0.0009779833,False,HTR5A; 5-hydroxytryptamine receptor
hsa:9379,1.54160085e-06,0.0019100082826404925,3.0510343459222774e-05,6.32465902126347e-05,0.0,0.00046740068,False,NRXN2; neurexin
hsa:9978,0.0,0.0,0.0012153904995495048,0.003071873570870991,0.0,0.01635087,False,RBX1; ring-box
hsa:10891,2.9475011500000003e-06,0.0036518866797409827,2.603901267506186e-05,8.089280973716512e-05,0.0,0.00066592934,False,PPARGC1A; PPARG coactivator 1
hsa:434,0.0,0.0,1.383271919926734e-06,1.1499069754669678e-05,0.0,0.00015686215,False,ASIP; agouti signaling
hsa:2495,2.90665615e-06,0.003601280656590145,0.0003831812434688122,0.0010537586951523512,0.0,0.007261085,False,FTH1; ferritin heavy chain
hsa:91807,0.0,0.0,2.2059261257128707e-05,8.040632894671765e-05,0.0,0.000664694,False,MYLK3; myosin light chain kinase
hsa:340419,0.0,0.0,1.4799458746546548e-06,1.5388595132350914e-05,0.0,0.00021313914,False,RSPO2; R-spondin
hsa:763,0.0,0.0,5.4690507404356455e-06,3.428027934704879e-05,-0.0,0.0004495061,False,CA5A; carbonic anhydrase
hsa:6783,0.0,0.0,2.1690494283718564e-06,1.0395980485819693e-05,0.0,9.830663e-05,False,SULT1E1; sulfotransferase family 1E member
hsa:1215,0.0,0.0,1.1333539378415838e-05,5.964874344093155e-05,0.0,0.00068635383,False,CMA1; chymase
hsa:57176,0.0,0.0,1.5122312079752474e-06,3.2508899931456415e-06,0.0,2.0867548e-05,False,VARS2; valyl-tRNA synthetase 2
hsa:84628,5.417811e-07,0.000671254422555668,1.3697335729108921e-05,4.335348586737648e-05,0.0,0.00028544106,False,NTNG2; netrin
hsa:9051,0.0,0.0,1.4204608945346531e-07,5.6162589948071e-07,0.0,5.4466045e-06,False,PSTPIP1; proline-serine-threonine phosphatase interacting protein
hsa:55366,1.9778155e-08,2.45046828206844e-05,2.4293193764470294e-06,8.225891053906448e-06,0.0,8.1256134e-05,False,LGR4; leucine rich repeat containing G protein-coupled receptor
hsa:219981,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5A2; olfactory receptor family 5 subfamily A member
hsa:368,1.0617344000000001e-05,0.013154646988968214,7.300590912504949e-05,0.00013678198614230707,0.0,0.000804514,False,ABCC6; ATP binding cassette subfamily C member
hsa:219464,0.0,0.0,1.2427402202970297e-08,1.7356205676327398e-07,-0.0,2.4666103e-06,False,OR5T2; olfactory receptor family 5 subfamily T member
hsa:4968,0.0,0.0,1.2473330881123762e-05,4.740712292627367e-05,0.0,0.00042147824,False,OGG1; 8-oxoguanine DNA
hsa:5994,1.97777505e-06,0.002450418165441277,0.00018755846816930687,0.00036191011038163104,0.0,0.0016903582,False,RFXAP; regulatory factor X associated
hsa:5746,0.0,0.0,3.821836177841326e-06,1.3740023938000374e-05,0.0,9.1535236e-05,False,PTH2R; parathyroid hormone 2
hsa:6455,0.0,0.0,2.3079485570000002e-07,5.887977024747389e-07,0.0,4.506401e-06,False,SH3GL1; SH3 domain containing GRB2 like 1
hsa:406902,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR10A; microRNA
hsa:11231,1.15183985e-06,0.0014271032957560853,0.00017326946721493564,0.0004911402331438801,0.0,0.0034720113,False,SEC63; SEC63 homolog
hsa:6045,9.3399329e-08,0.00011571963779279465,6.650231448905938e-05,0.00025005639470917877,0.0,0.0016844556,False,RNF2; ring finger protein
hsa:5641,6.504727700000001e-07,0.0008059209219637522,5.714769321782181e-06,1.3003942590136068e-05,0.0,8.8562985e-05,False,LGMN;
hsa:387129,0.0,0.0,7.059199961784058e-07,3.1098313220308754e-06,0.0,3.773775e-05,False,NPSR1; neuropeptide S receptor
hsa:23401,0.0,0.0,2.0164151762376235e-06,9.19020430071651e-06,0.0,9.998471e-05,False,FRAT2; FRAT regulator of WNT signaling pathway
hsa:8550,0.0,0.0,2.6394732540000005e-07,5.430461959295072e-07,0.0,3.7734412e-06,False,MAPKAPK5; MAPK activated protein kinase
hsa:3866,2.0766536999999998e-08,2.5729265569463224e-05,5.865282156414358e-06,1.782868587065257e-05,0.0,0.00016625316,False,KRT15; keratin
hsa:10861,6.00411125e-09,7.438956859290108e-06,7.681293832566829e-08,1.4779115628962824e-07,0.0,8.397866e-07,False,SLC26A1; solute carrier family 26 member
hsa:8735,0.0,0.0,1.0920928699573763e-09,1.2347849789470531e-08,0.0,1.7114435e-07,False,MYH13; myosin heavy chain
hsa:119682,0.0,0.0,6.290578217821782e-08,8.940591485766398e-07,-0.0,1.2706968e-05,False,OR51L1; olfactory receptor family 51 subfamily L member
hsa:673,0.00049286275,0.6106457029424772,0.0007423613986455445,0.0008334433238854005,0.0,0.004972608,False,BRAF; B-Raf proto-oncogene
hsa:5507,0.0,0.0,1.5856601138613857e-06,6.689569495359808e-06,0.0,8.133941e-05,False,PPP1R3C; protein phosphatase 1 regulatory subunit
hsa:6464,3.42517075e-06,0.004243708416454199,0.00015296649778316835,0.00026697589747086723,0.0,0.0014789157,False,SHC1; SHC adaptor protein
hsa:55127,9.56202e-10,1.1847124629422748e-06,6.085440559396037e-07,1.5962500694672317e-06,0.0,9.031443e-06,False,HEATR1; HEAT repeat containing
hsa:26248,4.6267546e-06,0.005732443393336867,0.0001443769374536881,0.00038723235151485026,0.0,0.0026096236,False,OR2K2; olfactory receptor family 2 subfamily K member
hsa:481,0.0017004190500000001,2.106780409118014,0.002194252679597525,0.002808253857678124,0.0,0.026028756,True,ATP1B1; ATPase Na+/K+ transporting subunit beta
hsa:6495,0.0,0.0,1.4441785338239604e-06,1.200947694917921e-05,0.0,0.00012792465,False,SIX1; SIX homeobox
hsa:1908,4.8190616e-09,5.9707073789916136e-06,6.616809124227229e-06,3.759798366884889e-05,0.0,0.00039233107,False,EDN3; endothelin
hsa:1236,1.1094814e-05,0.013746221425835157,0.0001855007319739108,0.0004182411172425575,0.0,0.002581562,False,CCR7; C-C motif chemokine receptor
hsa:7349,0.0,0.0,5.728512626742572e-06,1.3982777919933935e-05,0.0,8.776664e-05,False,UCN;
hsa:5371,0.0,0.0,1.2130192843811882e-05,4.779957261159559e-05,0.0,0.00046117982,False,PML; PML nuclear body
hsa:4716,0.0,0.0,3.3558488595049494e-06,7.390620538122971e-06,0.0,5.972702e-05,False,NDUFB10; NADH:ubiquinone oxidoreductase subunit
hsa:27338,0.0,0.0,4.816728567524751e-07,1.3233825877171033e-06,0.0,7.842416e-06,False,UBE2S; ubiquitin conjugating enzyme E2
hsa:22,0.0,0.0,0.0001734025252087623,0.0004046353479052842,0.0,0.0028044337,False,ABCB7; ATP binding cassette subfamily B member
hsa:6934,7.5014583e-06,0.009294135693349071,5.2018872680693065e-05,0.0001254328288983651,0.0,0.0010500606,False,TCF7L2; transcription factor 7 like
hsa:5693,0.0,0.0,4.1524765185643545e-06,1.5095119824746151e-05,0.0,0.00016685194,False,PSMB5; proteasome 20S subunit beta
hsa:1890,0.0,0.0,0.00015578781322871284,0.0006392891022770952,0.0,0.0053725434,False,TYMP; thymidine
hsa:1329,0.0,0.0,0.000377788807389703,0.0011958923673518697,0.0,0.0075362213,False,COX5B; cytochrome c oxidase subunit
hsa:3655,0.0,0.0,0.0001688194236262377,0.0003433041180575043,0.0,0.0018168082,False,ITGA6; integrin subunit alpha
hsa:694,2.82153725e-07,0.0003495820281416345,3.82646019122624e-06,2.313945507262152e-05,0.0,0.00024833047,False,BTG1; BTG anti-proliferation factor
hsa:25834,0.0,0.0,7.347432818394261e-05,0.00025083654233193543,0.0,0.0019474176,False,MGAT4C; MGAT4 family member
hsa:6512,0.0,0.0,1.3406522244772279e-05,5.082264632433833e-05,0.0,0.00049946253,False,SLC1A7; solute carrier family 1 member
hsa:29086,0.0,0.0,1.2232736854145551e-05,4.4877981087126244e-05,0.0,0.0003395383,False,BABAM1; BRISC and BRCA1 A complex member
hsa:409,0.0,0.0,0.0002617476795044554,0.0005225088083809463,0.0,0.0028242762,False,ARRB2; arrestin beta
hsa:6193,4.5837251e-08,5.679130824523818e-05,1.2607933673910893e-06,2.372347472660848e-06,0.0,1.1953561e-05,False,RPS5; ribosomal protein
hsa:9179,1.3296350000000001e-08,1.6473874303382042e-05,2.3220962196584153e-06,4.21149689778489e-06,0.0,2.13657e-05,False,AP4M1; adaptor related protein complex 4 subunit mu
hsa:101954272,0.0,0.0,2.530275317079208e-08,9.366950106905515e-08,0.0,8.167239e-07,False,RNVU1-3; RNA
hsa:3689,0.0,0.0,8.615212445891091e-05,0.00015363048302318463,0.0,0.0008590814,False,ITGB2; integrin subunit beta
hsa:83547,1.95695015e-08,2.424616589446324e-05,4.795205180168317e-07,7.671188444039415e-07,0.0,3.7165555e-06,False,RILP; Rab interacting lysosomal
hsa:133121,0.0,0.0,9.792141311584157e-07,4.143599335376483e-06,0.0,4.0724135e-05,False,ENPP6; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:7390,1.8865009e-05,0.023373315759450595,0.00022466780464806927,0.00042598839623174606,0.0,0.0024620402,False,UROS; uroporphyrinogen III
hsa:2167,0.0,0.0,3.378137309415842e-05,0.00019594845491011626,0.0,0.0024202922,False,FABP4; fatty acid binding protein
hsa:2688,0.0,0.0,1.842266758181683e-06,7.845079396490193e-06,0.0,0.00010037363,False,GH1; growth hormone
hsa:886,0.0,0.0,3.7638668773960405e-06,2.4594285677862363e-05,0.0,0.00033260076,False,CCKAR; cholecystokinin A
hsa:140803,0.0,0.0,1.8190156051666728e-06,7.836913102144755e-06,0.0,7.24347e-05,False,TRPM6; transient receptor potential cation channel subfamily M member
hsa:26494,0.0,0.0,9.155750297029703e-08,8.009979661126243e-07,0.0,8.333849e-06,False,OR8G1; olfactory receptor family 8 subfamily G member
hsa:7153,1.04874665e-06,0.0012993731729529531,1.4460199910044556e-05,4.207397859234994e-05,0.0,0.00041711298,False,TOP2A; DNA topoisomerase II
hsa:2060,4.34365165e-09,5.381685297076114e-06,4.283182615480199e-07,1.1030969531023207e-06,0.0,1.150805e-05,False,EPS15; epidermal growth factor receptor pathway substrate
hsa:9985,4.6988928500000003e-08,5.821821039304817e-05,2.2371320055198026e-06,6.996812918239554e-06,0.0,6.6999426e-05,False,REC8; REC8 meiotic recombination
hsa:346517,-0.0,0.0,1.0947337522128714e-06,6.362973076698843e-06,0.0,6.7150366e-05,False,OR6V1; olfactory receptor family 6 subfamily V member
hsa:22794,0.0,0.0,2.856104471519802e-07,6.580682142473137e-07,0.0,2.6335404e-06,False,CASC3; CASC3 exon junction complex
hsa:401665,-0.0,0.0,1.1142254207920792e-08,1.4837271856840856e-07,-0.0,2.1044184e-06,False,OR51T1; olfactory receptor family 51 subfamily T member
hsa:54947,1.58909125e-06,0.0019688478047813307,2.6107724996222768e-05,5.5116560015163744e-05,0.0,0.0002761943,False,LPCAT2; lysophosphatidylcholine acyltransferase
hsa:79718,1.99959765e-07,0.00024774558689744265,6.299892431514852e-06,2.0783107126460813e-05,0.0,0.0001381641,False,TBL1XR1; TBL1X/Y related
hsa:3683,3.7178793e-05,0.04606367631970128,0.0001172392484826733,0.00024663368632836004,0.0,0.0022155656,False,ITGAL; integrin subunit alpha
hsa:4706,1.19547895e-06,0.00148117114506155,0.00015943552494559901,0.0005116637360109039,0.0,0.003032501,False,NDUFAB1; NADH:ubiquinone oxidoreductase subunit
hsa:390436,0.0,0.0,3.610219653465347e-08,5.131086201912812e-07,-0.0,7.2926437e-06,False,OR4K17; olfactory receptor family 4 subfamily K member
hsa:140465,6.01262485e-06,0.007449505015458475,0.00021959648029807918,0.0005313115236311133,0.0,0.0042685815,False,MYL6B; myosin light chain
hsa:162963,0.0,0.0,5.0156318003960406e-08,1.0802056466285146e-07,0.0,5.07247e-07,False,ZNF610; zinc finger protein
hsa:7633,0.0,0.0,5.167844458564356e-08,8.839931791478928e-08,0.0,3.5582914e-07,False,ZNF79; zinc finger protein
hsa:654,0.0,0.0,5.3510327785346515e-05,0.00018714995774701747,0.0,0.0018979413,False,BMP6; bone morphogenetic protein
hsa:3156,8.085203e-06,0.010017382058935527,0.00022241017088405954,0.0007234014347012223,0.0,0.0051617636,False,HMGCR; 3-hydroxy-3-methylglutaryl-CoA
hsa:10022,3.682772e-09,4.56287048821781e-06,6.678610974463861e-06,2.195182156047643e-05,0.0,0.00018048288,False,INSL5; insulin like
hsa:4012,4.93650935e-05,0.06116222461756059,0.0001986863359900988,0.00036152015079042197,0.0,0.0018419685,False,LNPEP; leucyl and cystinyl
hsa:80336,5.096122499999999e-07,0.000631397951314737,3.978317156224851e-05,0.00015975490859162432,0.0,0.0013153398,False,PABPC1L; poly(A) binding protein cytoplasmic 1
hsa:56681,0.0,0.0,1.3989934339222773e-05,3.247759603228808e-05,0.0,0.00019616882,False,SAR1A; secretion associated Ras related GTPase
hsa:8600,9.5849895e-07,0.0011875583315890201,1.5700451534178214e-05,4.660618521012913e-05,0.0,0.00036805603,False,TNFSF11; TNF superfamily member
hsa:6392,0.0,0.0,8.457456780444553e-06,5.4820754526217676e-05,0.0,0.0006411472,False,SDHD; succinate dehydrogenase complex subunit
hsa:9879,0.0,0.0,1.9827173822772284e-07,4.464183455671521e-07,0.0,3.1349205e-06,False,DDX46; DEAD-box helicase
hsa:5155,0.0,0.0,0.00010904933294108915,0.0003722924966146022,0.0,0.0022657344,False,PDGFB; platelet derived growth factor subunit
hsa:125965,1.8064326e-07,0.00022381287789454706,4.5928584518039634e-05,0.00014257829326172936,0.0,0.0013117231,False,COX6B2; cytochrome c oxidase subunit
hsa:5187,0.0,0.0,0.0003222182061381188,0.00131406603761847,0.0,0.010424923,False,PER1; period circadian regulator
hsa:358,0.0,0.0,0.0003269759981463366,0.0008269674961491287,0.0,0.0059421635,False,AQP1; aquaporin 1 (Colton blood
hsa:5692,1.0284697e-07,0.0001274250494506916,5.743191791435644e-06,1.4373612446220243e-05,0.0,9.2432e-05,False,PSMB4; proteasome 20S subunit beta
hsa:51179,0.0,0.0,6.258154112435646e-07,4.206910709124683e-06,0.0,5.792571e-05,False,HAO2; hydroxyacid oxidase
hsa:717,6.5500948e-06,0.008115418021519914,4.361738167227721e-05,9.255869175019086e-05,0.0,0.00064137625,False,C2; complement
hsa:5707,3.4927624e-07,0.0004327452928749543,8.095859157920786e-06,2.12416248931962e-05,0.0,0.00015133304,False,PSMD1; proteasome 26S subunit
hsa:4041,9.262799e-06,0.011476396636933658,2.666411620643564e-05,6.827942822331103e-05,0.0,0.0006619787,False,LRP5; LDL receptor related protein
hsa:6845,0.0,0.0,5.044764739131188e-06,1.5237274610891545e-05,0.0,0.00014404926,False,VAMP7; vesicle associated membrane protein
hsa:55813,2.1724403499999998e-07,0.0002691604030993113,1.8557526225251487e-06,3.3806734597682293e-06,0.0,2.3297778e-05,False,UTP6; UTP6 small subunit processome
hsa:54434,8.174998000000001e-08,0.00010128636015327484,5.401579476519803e-06,1.6705909925431183e-05,0.0,0.00010925272,False,SSH1; slingshot protein phosphatase
hsa:6817,0.0,0.0,3.0370034511881196e-05,0.000120848538389258,0.0,0.0009105762,False,SULT1A1; sulfotransferase family 1A member
hsa:29079,0.0,0.0,4.067742431435644e-06,9.37950357839805e-06,0.0,7.120244e-05,False,MED4; mediator complex subunit
hsa:22829,0.0,0.0,1.4515352776539604e-06,7.367796693520159e-06,0.0,8.326154e-05,False,NLGN4Y; neuroligin 4
hsa:113878,0.0,0.0,4.50612625929703e-05,0.00016956089606226415,0.0,0.00134352,False,DTX2; deltex E3 ubiquitin ligase
hsa:3091,0.0,0.0,8.620626334059406e-05,0.00024130722046129086,0.0,0.0024825786,False,HIF1A; hypoxia inducible factor 1 subunit
hsa:2001,0.0,0.0,1.3588343125836637e-06,1.2975554550415158e-05,0.0,0.00017948085,False,ELF5; E74 like ETS transcription factor
hsa:79473,0.0,0.0,9.454701380198019e-07,1.0947013249918036e-05,0.0,0.00015493334,False,OR52N1; olfactory receptor family 52 subfamily N member
hsa:388566,0.0,0.0,3.0922924208415845e-08,1.1011574353833197e-07,0.0,1.1473546e-06,False,ZNF470; zinc finger protein
hsa:60490,0.0,0.0,3.184960437131189e-05,8.23338432691034e-05,0.0,0.00047518616,False,PPCDC; phosphopantothenoylcysteine
hsa:116519,0.0,0.0,1.3525962982722776e-06,5.213800357244609e-06,0.0,4.0500337e-05,False,APOA5; apolipoprotein
hsa:148581,0.0,0.0,1.9769360318316834e-09,9.912258769453043e-09,0.0,9.917105e-08,False,UBE2U; ubiquitin conjugating enzyme E2
hsa:6203,0.0,0.0,5.205529705940594e-07,1.2942128456128255e-06,0.0,1.1528704e-05,False,RPS9; ribosomal protein
hsa:9023,0.0,0.0,8.254826565361386e-05,0.0003793431006345834,0.0,0.003842839,False,CH25H; cholesterol
hsa:5624,0.0,0.0,1.1962830287004951e-06,5.028693346646583e-06,0.0,6.413595e-05,False,PROC; protein C
hsa:120775,0.0,0.0,3.4482187393564356e-07,2.770084493652322e-06,-0.0,3.5708526e-05,False,OR2D3; olfactory receptor family 2 subfamily D member
hsa:4707,1.4278547e-06,0.001769079397826717,3.34973854930693e-06,4.531664766519343e-06,0.0,2.3515826e-05,False,NDUFB1; NADH:ubiquinone oxidoreductase subunit
hsa:10594,1.1181905e-08,1.3854125187916919e-05,1.2909498218009897e-06,4.229928346450487e-06,0.0,2.865445e-05,False,PRPF8; pre-mRNA processing factor
hsa:599,0.0,0.0,5.216013629237624e-07,1.3502520200797787e-06,0.0,7.0505494e-06,False,BCL2L2; BCL2 like
hsa:7031,0.0,0.0,1.0335836132871287e-07,1.2071997167377406e-06,0.0,1.668335e-05,False,TFF1; trefoil factor
hsa:220074,6.42770435e-06,0.0079637790462196,0.00015951980812970305,0.00030624250119693484,0.0,0.0016156131,False,LRTOMT; leucine rich transmembrane and O-methyltransferase domain
hsa:407006,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR221; microRNA
hsa:219432,0.0,0.0,1.754701908910891e-07,2.084892709057327e-06,0.0,2.92205e-05,False,OR4C6; olfactory receptor family 4 subfamily C member
hsa:5892,0.0,0.0,1.6147545050123768e-05,3.474956452431078e-05,0.0,0.00023435883,False,RAD51D; RAD51 paralog
hsa:91445,1.6269318500000002e-08,2.0157314448753836e-05,9.88912348428797e-07,2.7614183934383015e-06,0.0,2.6072641e-05,False,RNF185; ring finger protein
hsa:3835,0.0,0.0,4.142836838654945e-05,0.00014647147429128706,0.0,0.0007812998,False,KIF22; kinesin family member
hsa:1158,0.0,0.0,1.8097203646465343e-06,1.1844628215836963e-05,0.0,0.0001575129,False,CKM; creatine kinase
hsa:6161,0.0,0.0,7.698467787252474e-07,2.0091079555992395e-06,0.0,1.7498527e-05,False,RPL32; ribosomal protein
hsa:5914,6.077080650000001e-07,0.0007529364281145971,6.265943554608909e-05,0.00014023467149647023,0.0,0.0007404087,False,RARA; retinoic acid receptor
hsa:56616,3.5648383e-07,0.0004416753324489962,0.0008545074163054852,0.0013877765346198866,0.0,0.00708115,False,DIABLO; diablo IAP-binding mitochondrial
hsa:123096,0.0,0.0,4.2600516861881197e-07,1.118129853959217e-06,0.0,1.03646635e-05,False,SLC25A29; solute carrier family 25 member
hsa:50943,0.0,0.0,8.187432412742572e-06,2.3333474546517094e-05,0.0,0.00020409131,False,FOXP3; forkhead box
hsa:54795,0.0,0.0,7.712687550633665e-06,3.0420049628119594e-05,0.0,0.00024480553,False,TRPM4; transient receptor potential cation channel subfamily M member
hsa:147495,0.0,0.0,4.340530715998516e-06,1.4002491218703081e-05,0.0,0.00010703236,False,APCDD1; APC down-regulated
hsa:693210,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR625; microRNA
hsa:572,0.00011789175249999999,0.1460651917323495,0.00023831820306287137,0.0003417161854362175,0.0,0.0022962585,False,BAD; BCL2 associated agonist of cell
hsa:623,6.33278205e-06,0.007846172482103286,3.848640761785148e-05,6.79773465616883e-05,0.0,0.00053169543,False,BDKRB1; bradykinin receptor
hsa:8395,0.0,0.0,1.6960569988217823e-06,5.404201545816354e-06,0.0,5.017661e-05,False,PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase type 1
hsa:8372,5.2649205e-08,6.523116384142965e-05,4.248845044544554e-05,9.642795234458912e-05,0.0,0.00060473674,False,HYAL3; hyaluronidase
hsa:268,5.4580911e-05,0.06762450350495303,0.0001949738099812871,0.000339227078243973,0.0,0.0018882595,False,AMH; anti-Mullerian
hsa:280,0.000236991685,0.2936272909209453,0.0006390799334920791,0.0010778233463546037,0.0,0.008553291,False,AMY2B; amylase alpha
hsa:23327,9.000433e-08,0.00011151331148624375,0.00013157805010232673,0.0004109791157644624,0.0,0.004247298,False,NEDD4L; NEDD4 like E3 ubiquitin protein
hsa:2147,5.324737500000001e-07,0.0006597228282461332,1.121615602664852e-05,5.6791843541261526e-05,0.0,0.00060749555,False,F2; coagulation factor II
hsa:55775,0.0,0.0,3.430303897499505e-05,9.266014128497757e-05,0.0,0.00055774685,False,TDP1; tyrosyl-DNA phosphodiesterase
hsa:84634,0.0,0.0,6.132879108695048e-06,2.001243559281117e-05,0.0,0.00016737453,False,KISS1R; KISS1
hsa:5691,0.0,0.0,2.4135818970792077e-06,7.019171353519353e-06,0.0,7.4045965e-05,False,PSMB3; proteasome 20S subunit beta
hsa:283358,1.0933977e-07,0.000135469480522151,2.0723718091925743e-05,7.397834606944201e-05,0.0,0.00064088707,False,B4GALNT3; beta-1
hsa:2555,0.0,0.0,0.00021006443227241582,0.0008847303887132524,0.0,0.008059578,False,GABRA2; gamma-aminobutyric acid type A receptor subunit
hsa:3857,0.0,0.0,1.2201952034821775e-05,7.04244149717215e-05,0.0,0.0009571121,False,KRT9; keratin
hsa:2138,4.4851597500000003e-10,5.557010604571061e-07,2.6561373448774013e-05,8.402721584850397e-05,0.0,0.00069008383,False,EYA1; EYA transcriptional coactivator and phosphatase
hsa:1472,0.0,0.0,6.400363854806933e-07,4.6738222540351575e-06,-0.0,5.670196e-05,False,CST4; cystatin
hsa:338339,0.0,0.0,3.5077514897603956e-07,1.3983411726559252e-06,0.0,1.4947209e-05,False,CLEC4D; C-type lectin domain family 4 member
hsa:51343,0.0,0.0,9.60757244975247e-06,4.591342778110244e-05,0.0,0.00043741788,False,FZR1; fizzy and cell division cycle 20 related
hsa:8694,5.61537875e-05,0.06957326160441216,0.0007470902865064358,0.0011857957658397663,0.0,0.00672448,False,DGAT1; diacylglycerol O-acyltransferase
hsa:7175,1.1870879499999999e-05,0.01470774887496152,5.887966599287133e-05,0.0001451784412679695,0.0,0.0010598568,False,TPR; translocated promoter region
hsa:55294,0.0,0.0,4.295805104603961e-07,7.053439370893218e-07,0.0,3.4303819e-06,False,FBXW7; F-box and WD repeat domain containing
hsa:27044,0.0,0.0,1.5869859307425746e-07,4.167836846631183e-07,0.0,3.215368e-06,False,SND1; staphylococcal nuclease and tudor domain containing
hsa:94039,0.0,0.0,4.898803428148516e-08,1.247354388572478e-07,0.0,1.1470948e-06,False,ZNF101; zinc finger protein
hsa:26091,3.8585103e-08,4.7806062325754755e-05,3.010029052539604e-07,5.680390752054182e-07,0.0,3.548238e-06,False,HERC4; HECT and RLD domain containing E3 ubiquitin protein ligase
hsa:4502,0.0,0.0,0.0001041332689120792,0.00026424084102368283,0.0,0.0017884922,False,MT2A; metallothionein
hsa:79720,1.9660196e-08,2.4358534310833753e-05,3.062893864707921e-07,6.298956285802216e-07,0.0,3.3480492e-06,False,VPS37B; VPS37B subunit of
hsa:79868,0.0,0.0,0.00017768136801318322,0.0005451239057230684,0.0,0.0030386546,False,ALG13; ALG13 UDP-N-acetylglucosaminyltransferase
hsa:1850,0.0,0.0,5.0841638703737634e-05,0.0001732137266496125,0.0,0.0020840513,False,DUSP8; dual specificity phosphatase
hsa:2115,0.0,0.0,4.616395653002476e-06,4.707859670310837e-05,0.0,0.0006565972,False,ETV1; ETS variant transcription factor
hsa:442903,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR331; microRNA
hsa:10928,4.4777755e-07,0.0005547861687287388,1.1975837072623769e-05,2.5193581942288487e-05,0.0,0.00014749022,False,RALBP1; ralA binding protein
hsa:1943,1.0937540299999999e-07,0.00013551362899620983,2.754515829898909e-05,0.00010643904566178151,0.0,0.0010701261,False,EFNA2; ephrin
hsa:4486,1.9548448999999998e-07,0.00024220082327260813,2.8941933920584143e-06,1.0655543483052694e-05,0.0,9.408204e-05,False,MST1R; macrophage stimulating 1
hsa:5430,0.0,0.0,3.613344662133663e-05,9.659653018778435e-05,0.0,0.0005910434,False,POLR2A; RNA polymerase II subunit
hsa:8742,0.0,0.0,1.3190545240000008e-05,4.273367303045516e-05,0.0,0.0005095271,False,TNFSF12; TNF superfamily member
hsa:10758,0.0,0.0,3.824523721217821e-05,0.00010421199413427308,0.0,0.00064875185,False,TRAF3IP2; TRAF3 interacting protein
hsa:4595,0.0,0.0,4.694230450259903e-06,2.227542163295878e-05,0.0,0.00023409221,False,MUTYH; mutY DNA
hsa:84448,3.2009819e-08,3.965943546010824e-05,8.9555886607104e-06,3.219149401036017e-05,0.0,0.0002334234,False,ABLIM2; actin binding LIM protein family member
hsa:57805,0.0,0.0,2.1248301470044546e-05,7.302559452738719e-05,0.0,0.0005589627,False,CCAR2; cell cycle and apoptosis regulator
hsa:147945,0.0,0.0,8.197411916831682e-09,5.4438303089968704e-08,0.0,7.3016844e-07,False,NLRP4; NLR family pyrin domain containing
hsa:4920,0.0,0.0,2.5360538695831703e-06,1.8054366389615377e-05,0.0,0.00021283062,False,ROR2; receptor tyrosine kinase like orphan receptor
hsa:4709,0.0,0.0,2.4671167750990093e-06,4.686113175464001e-06,0.0,2.7759485e-05,False,NDUFB3; NADH:ubiquinone oxidoreductase subunit
hsa:574476,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520C; microRNA
hsa:64895,0.0,0.0,1.340605297336634e-07,2.736946333382982e-07,0.0,1.8534083e-06,False,PAPOLG; poly(A) polymerase
hsa:80233,0.0,0.0,0.0002304054915673763,0.0007139113630261341,0.0,0.005241603,False,FAAP100; FA core complex associated protein
hsa:7373,0.0,0.0,3.257671975381188e-05,0.00018611052565620492,0.0,0.0018155477,False,COL14A1; collagen type XIV alpha 1
hsa:8647,0.0,0.0,3.994635353410891e-05,0.00013631345854250325,0.0,0.001459415,False,ABCB11; ATP binding cassette subfamily B member
hsa:5148,1.5666468e-05,0.0194103964328524,0.00011117687837574258,0.0001978696611061699,0.0,0.0011429864,False,PDE6G; phosphodiesterase
hsa:404281,0.0,0.0,2.226562962636683e-06,1.1775207414261139e-05,0.0,0.00013325855,False,YY2; YY2 transcription
hsa:5393,0.0,0.0,1.675148430671782e-05,7.159020216079617e-05,0.0,0.00066546886,False,EXOSC9; exosome component
hsa:10020,2.8968715999999996e-06,0.003589157822367583,0.00014563693228920296,0.00036306475697927036,0.0,0.0027570848,False,GNE; glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine
hsa:269,1.6691302000000001e-06,0.002068014237800519,6.061115435223266e-05,0.00013160417694177935,0.0,0.00094294245,False,AMHR2; anti-Mullerian hormone receptor type
hsa:10948,0.0,0.0,6.877900230734159e-05,0.00014625719915653873,0.0,0.00092804024,False,STARD3; StAR related lipid transfer domain containing
hsa:7748,2.13516185e-09,2.6454168199751554e-06,1.6324794564465345e-07,3.0307145206399646e-07,0.0,1.4477506e-06,False,ZNF195; zinc finger protein
hsa:6326,0.00039783186999999996,0.4929046106833397,0.0010643081948277227,0.0017688950067264024,0.0,0.0109485295,False,SCN2A; sodium voltage-gated channel alpha subunit
hsa:63971,1.2171632e-08,1.5080374361010544e-05,1.5427448756955445e-07,5.56062130319115e-07,0.0,5.892591e-06,False,KIF13A; kinesin family member
hsa:317,0.00035299023,0.43734684175295596,0.0006547009224410895,0.0008968641041918161,0.0,0.004576055,False,APAF1; apoptotic peptidase activating factor
hsa:360,0.0,0.0,3.1613817545826736e-05,0.0001002853197731654,0.0,0.0006318647,False,AQP3; aquaporin 3 (Gill blood
hsa:5058,0.0,0.0,0.0007066385690841585,0.0014888411191064743,0.0,0.013602278,False,PAK1; p21 (RAC1) activated kinase
hsa:65243,9.629064e-09,1.193019061586233e-05,7.688263049108914e-08,1.863539136539104e-07,0.0,1.1733846e-06,False,ZFP69B; ZFP69 zinc finger protein
hsa:127396,1.07923123e-08,1.337142872089287e-05,4.5936262580891105e-08,7.192206752131142e-08,0.0,4.3257853e-07,False,ZNF684; zinc finger protein
hsa:6155,1.5827124e-07,0.00019609445551601842,1.8666047589396047e-06,3.585332098818306e-06,0.0,1.8597479e-05,False,RPL27; ribosomal protein
hsa:53342,0.0,0.0,6.20518493222772e-06,2.6656519964024386e-05,0.0,0.0002843913,False,IL17D; interleukin
hsa:117579,0.0,0.0,3.847474203663367e-08,3.10875637391616e-07,0.0,3.8168296e-06,False,RLN3; relaxin
hsa:2222,5.4648323999999995e-06,0.006770802667397413,1.9065135540346526e-05,5.901321996669684e-05,0.0,0.00044485336,False,FDFT1; farnesyl-diphosphate farnesyltransferase
hsa:2990,0.0,0.0,6.316482015544557e-05,0.00017788625478684273,0.0,0.0010811298,False,GUSB; glucuronidase
hsa:3983,0.0,0.0,7.641021114535644e-07,4.465294665251475e-06,0.0,5.7584424e-05,False,ABLIM1; actin binding LIM protein
hsa:92597,0.000112241915,0.1390651719668098,0.00030515525982970293,0.0005545291988536516,0.0,0.0057202717,False,MOB1B; MOB kinase activator
hsa:1142,0.0,0.0,1.6498024338853665e-07,1.9841565504820195e-06,0.0,2.8131868e-05,False,CHRNB3; cholinergic receptor nicotinic beta 3
hsa:6228,0.0,0.0,7.768246123940597e-07,1.3194194550050754e-06,0.0,6.1150245e-06,False,RPS23; ribosomal protein
hsa:2692,0.0,0.0,3.800295394435643e-07,3.152895741199575e-06,0.0,4.4089287e-05,False,GHRHR; growth hormone releasing hormone
hsa:57519,0.0,0.0,7.617144966485147e-08,2.9326373467178745e-07,0.0,2.9358478e-06,False,STARD9; StAR related lipid transfer domain containing
hsa:3146,0.0,0.0,0.0002293906854415841,0.0007818067082404,0.0,0.0046654693,False,HMGB1; high mobility group box
hsa:2968,0.0,0.0,2.675482257128713e-06,6.136341740539238e-06,0.0,3.6733574e-05,False,GTF2H4; general transcription factor IIH subunit
hsa:8707,0.0,0.0,2.3092037569737636e-05,0.00012331577401923077,0.0,0.0015892088,False,B3GALT2; beta-1
hsa:7431,0.0,0.0,6.396363500940596e-07,1.8831657918662696e-06,0.0,1.6837168e-05,False,VIM;
hsa:9861,0.0,0.0,3.656206452752474e-06,9.685693934634979e-06,0.0,8.6054824e-05,False,PSMD6; proteasome 26S subunit
hsa:728,0.0,0.0,2.812745812217822e-05,8.805737740764062e-05,0.0,0.00077640504,False,C5AR1; complement C5a receptor
hsa:3915,0.0,0.0,5.518095568762376e-05,0.00020854152813984834,0.0,0.0018266509,False,LAMC1; laminin subunit gamma
hsa:56893,0.0,0.0,5.322704776143566e-07,2.004208550923612e-06,0.0,2.0058647e-05,False,UBQLN4; ubiquilin
hsa:488,8.2380985e-05,0.10206816095235167,0.00033187277021287133,0.0004843911793420743,0.0,0.002631483,False,ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting
hsa:23175,2.0257661999999997e-05,0.02509878105407866,0.00011800397538663367,0.000212916452922537,0.0,0.0014277741,False,LPIN1; lipin
hsa:374654,4.57701805e-05,0.056708209425903176,0.00010115506243346529,0.00016154359914699506,0.0,0.001232074,False,KIF7; kinesin family member
hsa:811,0.0,0.0,8.327966513187129e-05,0.00032928648358117416,0.0,0.0040718312,False,CALR;
hsa:81697,0.0,0.0,7.993191503960396e-07,5.129534719803905e-06,-0.0,5.3585856e-05,False,OR2B2; olfactory receptor family 2 subfamily B member
hsa:56886,0.0,0.0,4.2849273036440607e-07,1.4153535156386045e-06,0.0,7.790972e-06,False,UGGT1; UDP-glucose glycoprotein glucosyltransferase
hsa:27350,0.0,0.0,8.106034795324259e-06,2.6882110051155358e-05,0.0,0.00024666684,False,APOBEC3C; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:1581,0.0,0.0,2.4010799225495054e-06,1.9028013881964464e-05,0.0,0.00025927022,False,CYP7A1; cytochrome P450 family 7 subfamily A member
hsa:3804,0.0,0.0,3.4137527110891086e-07,1.048883068595652e-06,0.0,8.698566e-06,False,KIR2DL3; killer cell immunoglobulin like receptor
hsa:3884,0.0,0.0,1.5598514834158418e-07,1.4025473498890962e-06,0.0,1.881279e-05,False,KRT33B; keratin
hsa:25946,0.0,0.0,4.729275202283961e-05,0.00017796426386807487,0.0,0.0017257067,False,ZNF385A; zinc finger protein
hsa:10533,6.54765025e-07,0.0008112389279840556,0.0005673230161668069,0.001951665978378293,0.0,0.013928602,False,ATG7; autophagy related
hsa:11332,4.942008499999999e-06,0.006123035783146925,0.0004440173982521287,0.0013936439993593858,0.0,0.007909838,False,ACOT7; acyl-CoA thioesterase
hsa:5298,1.5249344999999998e-07,0.0001889359055221225,6.635528047425744e-06,1.9870365874781367e-05,0.0,0.00016556459,False,PI4KB; phosphatidylinositol 4-kinase
hsa:8659,0.0,0.0,2.4051458599727723e-05,6.40448546238633e-05,0.0,0.00050359254,False,ALDH4A1; aldehyde dehydrogenase 4 family member
hsa:10342,0.0,0.0,2.4516186443886135e-05,8.879970443693516e-05,0.0,0.0007775117,False,TFG; trafficking from ER to golgi
hsa:5730,7.17018515e-06,0.008883695818256626,6.784732479653464e-05,0.0001455908222434468,0.0,0.00080275506,False,PTGDS; prostaglandin D2
hsa:225,2.50913275e-05,0.031087582331992852,0.0003478050517623762,0.0007366964412357788,0.0,0.0062978505,False,ABCD2; ATP binding cassette subfamily D member
hsa:885,0.0,0.0,2.137261517277228e-06,8.548094817229035e-06,0.0,6.846945e-05,False,CCK;
hsa:912,3.2321611e-06,0.004004573863479904,2.1262322725274267e-05,5.669456246556525e-05,0.0,0.000545751,False,CD1D; CD1d
hsa:7771,0.0,0.0,2.0905919947277215e-08,3.019184865722856e-08,0.0,1.6623306e-07,False,ZNF112; zinc finger protein
hsa:2313,0.0,0.0,5.449286001910286e-06,2.3960359381387528e-05,0.0,0.00020910705,False,FLI1; Fli-1 proto-oncogene
hsa:1235,1.52560955e-07,0.00018901954267704475,6.06362743597228e-05,0.0001581505773669279,0.0,0.0012052822,False,CCR6; C-C motif chemokine receptor
hsa:10126,5.1835071e-08,6.422247038930861e-05,3.069772145154951e-06,1.0114169586771528e-05,0.0,5.5237193e-05,False,DNAL4; dynein axonemal light chain
hsa:22869,0.0,0.0,6.83370464772277e-08,1.441089309748552e-07,0.0,7.379647e-07,False,ZNF510; zinc finger protein
hsa:3818,1.15599332e-07,0.00014322493503276683,2.390545768061881e-06,6.946651861935414e-06,0.0,5.7470086e-05,False,KLKB1; kallikrein
hsa:83464,2.6931367e-07,0.0003336734929332118,0.00013162797250074255,0.00026770735470926647,0.0,0.0012474571,False,APH1B; aph-1 homolog B
hsa:26259,0.0,0.0,1.2241737854108904e-07,3.2721267240434646e-07,0.0,2.1194662e-06,False,FBXW8; F-box and WD repeat domain containing
hsa:84449,0.0,0.0,1.3863727518316832e-07,3.45430608916138e-07,0.0,1.8822067e-06,False,ZNF333; zinc finger protein
hsa:551,0.0,0.0,2.0433146920297032e-06,7.123545031636273e-06,0.0,5.1522933e-05,False,AVP; arginine
hsa:249,0.0,0.0,3.717239475927248e-05,0.00016625582438312115,0.0,0.002173299,False,ALPL; alkaline phosphatase
hsa:10125,5.1141578e-08,6.336324838385032e-05,4.721231790156435e-06,1.674963080097036e-05,0.0,0.00015104176,False,RASGRP1; RAS guanyl releasing protein
hsa:4725,9.8834763e-07,0.001224540165132953,9.525619215133662e-06,1.4970276234866062e-05,0.0,0.00011610751,False,NDUFS5; NADH:ubiquinone oxidoreductase subunit
hsa:4123,2.83511045e-05,0.03512637166553595,0.0001647171523744059,0.00026535901924070485,0.0,0.0013255606,False,MAN2C1; mannosidase alpha class 2C member
hsa:26871,0.0,0.0,2.5183756354582677e-07,7.5155977336412e-07,0.0,6.3702387e-06,False,RNU1-1; RNA
hsa:1536,0.0,0.0,3.202014616856435e-05,0.00012841603539138276,0.0,0.0013466022,False,CYBB; cytochrome b-245 beta
hsa:4893,0.00026999434,0.3345168275342176,0.000523460434247525,0.0007575554429034856,0.0,0.0037999835,False,NRAS; NRAS proto-oncogene
hsa:55651,2.4413165e-08,3.0247354466280282e-05,3.1213604161253963e-06,5.472208522157219e-06,0.0,2.8298256e-05,False,NHP2; NHP2
hsa:6804,4.0587298e-06,0.005028673625212252,0.0001700551822218812,0.0003065017753992718,0.0,0.002080822,False,STX1A; syntaxin
hsa:10297,0.00013510279,0.16738927453746477,0.0002402888046815347,0.0002833065710599707,0.0,0.001901351,False,APC2; APC regulator of WNT signaling pathway
hsa:4686,5.750154e-09,7.1243096203912685e-06,6.786066480425738e-07,1.2698349725442137e-06,0.0,6.9800217e-06,False,NCBP1; nuclear cap binding protein subunit
hsa:4691,3.14198845e-07,0.000389285200735376,1.5924422909653464e-06,3.174622594066936e-06,0.0,2.1672873e-05,False,NCL;
hsa:390113,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4X1; olfactory receptor family 4 subfamily X member
hsa:100129842,1.60241085e-08,1.985350485304281e-05,1.0543657242361394e-07,2.3935750043869713e-07,0.0,1.3476634e-06,False,ZNF737; zinc finger protein
hsa:2535,0.0,0.0,4.519859257752475e-05,0.0001547040515513718,0.0,0.0009577678,False,FZD2; frizzled class receptor
hsa:318,0.0,0.0,1.3517167262527724e-05,9.791937649121525e-05,0.0,0.00092120806,False,NUDT2; nudix hydrolase
hsa:5863,0.0,0.0,2.464900282430693e-06,5.882635089656316e-06,0.0,3.6191657e-05,False,RGL2; ral guanine nucleotide dissociation stimulator like
hsa:2651,1.62815545e-06,0.0020172474573598334,8.144694845950494e-05,0.00018913824807210045,0.0,0.0012969765,False,GCNT2; glucosaminyl (N-acetyl) transferase 2 (I blood
hsa:6477,8.394911e-06,0.010401103205171286,0.00013478757440948014,0.00030039079297090394,0.0,0.0015162434,False,SIAH1; siah E3 ubiquitin protein ligase
hsa:442319,0.0,0.0,2.4440354061059412e-08,5.8347603812608896e-08,0.0,3.9845642e-07,False,ZNF727; zinc finger protein
hsa:2309,0.0,0.0,9.693419869945047e-05,0.00024306040462781603,0.0,0.002057609,False,FOXO3; forkhead box
hsa:119772,0.0,0.0,2.0256323292079205e-08,2.828006064755179e-07,-0.0,4.0190557e-06,False,OR52M1; olfactory receptor family 52 subfamily M member
hsa:23530,3.94368865e-05,0.04886140264942966,0.00015830909555702966,0.00032070397516731515,0.0,0.0022967737,False,NNT; nicotinamide nucleotide
hsa:246184,3.6202817e-06,0.004485446432188852,2.935194025756932e-05,7.831936690371568e-05,0.0,0.0005337821,False,CDC26; cell division cycle
hsa:406906,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR122; microRNA
hsa:140801,0.0,0.0,1.432511371287129e-10,7.702840844454246e-10,0.0,7.570468e-09,False,RPL10L; ribosomal protein L10
hsa:60485,3.9198906e-05,0.048566550239282816,0.0003224238687111385,0.0005668089348468918,0.0,0.0055235373,False,SAV1; salvador family WW domain containing protein
hsa:5277,0.0,0.0,6.9368922766336645e-06,2.8909377190052318e-05,0.0,0.0002552233,False,PIGA; phosphatidylinositol glycan anchor biosynthesis class
hsa:8912,0.0,0.0,8.365296119331684e-05,0.0001935473891979505,0.0,0.0010475476,False,CACNA1H; calcium voltage-gated channel subunit alpha1
hsa:9350,0.0,0.0,7.60578605619703e-07,5.3769662752844465e-06,0.0,6.026627e-05,False,CER1; cerberus 1
hsa:7009,2.2477621999999998e-07,0.00027849260847295293,1.023369228465347e-06,1.8575573788249737e-06,0.0,1.4637105e-05,False,TMBIM6; transmembrane BAX inhibitor motif containing
hsa:4179,0.0,0.0,8.009929894158413e-05,0.0001859877438770369,0.0,0.0012573949,False,CD46; CD46
hsa:6322,4.1229655e-08,5.1082601920211695e-05,1.782456845699703e-05,5.181525270207208e-05,0.0,0.00031199268,False,SCML1; Scm polycomb group protein like
hsa:1022,1.99785615e-07,0.00024752981902054905,5.717619117311883e-06,1.7442985503203464e-05,0.0,0.000183827,False,CDK7; cyclin dependent kinase
hsa:187,4.02488965e-07,0.0004986746451400823,5.341884462004952e-06,1.5660999530946972e-05,0.0,0.00017273732,False,APLNR; apelin
hsa:3780,1.6790984e-05,0.020803646101832378,6.261447300094057e-05,0.0001247703928478176,0.0,0.0009557496,False,KCNN1; potassium calcium-activated channel subfamily N member
hsa:5346,8.92815235e-07,0.0011061777072305181,4.085901505517177e-05,9.33222445018956e-05,0.0,0.0005236957,False,PLIN1; perilipin
hsa:5024,0.0003733956,0.46262862964918333,0.0009070290320346534,0.0012323850648127178,0.0,0.0055420166,False,P2RX3; purinergic receptor P2X
hsa:84061,0.0,0.0,2.549972936242574e-05,0.0001425152448647106,0.0,0.0013225938,False,MAGT1; magnesium transporter
hsa:55353,3.1286329999999996e-07,0.00038763049094987014,3.054850830014232e-06,6.422294351051668e-06,0.0,4.3147535e-05,False,LAPTM4B; lysosomal protein transmembrane 4
hsa:10461,5.7799865e-09,7.161271407284337e-06,1.1641517911258912e-05,4.56859856295388e-05,0.0,0.0003250672,False,MERTK; MER proto-oncogene
hsa:1045,0.0,0.0,1.2819221638613862e-09,1.1842633199496056e-08,0.0,1.5713138e-07,False,CDX2; caudal type homeobox
hsa:1159,9.908682e-08,0.000122766309385797,5.708935952399106e-05,0.00012542205472695778,0.0,0.0007732846,False,CKMT1B; creatine kinase
hsa:3611,1.76015175e-06,0.002180787861659623,0.00011942135219675736,0.00031905809746909057,0.0,0.0029246786,False,ILK; integrin linked
hsa:100131017,0.0,0.0,1.422643003257426e-07,3.5760258268324417e-07,0.0,1.9431552e-06,False,ZNF316; zinc finger protein
hsa:125962,0.0,0.0,5.7618964158415844e-08,6.757255385371294e-07,-0.0,9.482287e-06,False,OR7G1; olfactory receptor family 7 subfamily G member
hsa:51744,2.534982e-08,3.140784864217324e-05,5.184799059738112e-06,2.6715715914968727e-05,0.0,0.00031562315,False,CD244; CD244
hsa:5687,0.0,0.0,2.1704715273712863e-06,7.270327601512421e-06,0.0,7.5430515e-05,False,PSMA6; proteasome 20S subunit alpha
hsa:2912,0.0,0.0,6.576084991742574e-05,0.0001500171620217407,0.0,0.0010117893,False,GRM2; glutamate metabotropic receptor
hsa:253558,6.1341485000000004e-06,0.007600070045334207,0.00010052224018564359,0.00029643608765180586,0.0,0.0020777544,False,LCLAT1; lysocardiolipin acyltransferase
hsa:29880,1.05136745e-07,0.00013026202843612948,0.00014016280210795112,0.0004383447149352807,0.0,0.0027417205,False,ALG5; ALG5 dolichyl-phosphate
hsa:10890,0.0,0.0,5.689045475797031e-06,1.339636154071981e-05,0.0,6.596196e-05,False,RAB10; RAB10
hsa:158431,0.0,0.0,2.9939139714950496e-08,4.877065061072588e-08,0.0,2.0501133e-07,False,ZNF782; zinc finger protein
hsa:10007,0.0,0.0,2.3841671627886147e-05,6.775186975800606e-05,0.0,0.0004249613,False,GNPDA1; glucosamine-6-phosphate deaminase
hsa:51079,0.0,0.0,6.269132025891088e-06,9.130764532728171e-06,0.0,5.3334727e-05,False,NDUFA13; NADH:ubiquinone oxidoreductase subunit
hsa:56954,0.0,0.0,8.096617605792077e-06,4.320742886495639e-05,0.0,0.0004572465,False,NIT2; nitrilase family member
hsa:11320,0.0,0.0,1.5181866392524749e-05,6.494229892142889e-05,0.0,0.0005965923,False,MGAT4A; alpha-1
hsa:1141,0.00021504531500000001,0.2664362391815195,0.0012967352518533173,0.0024287771830143853,0.0,0.020520246,False,CHRNB2; cholinergic receptor nicotinic beta 2
hsa:10735,0.0,0.0,7.294403824801982e-07,1.7716606537634973e-06,0.0,1.1191843e-05,False,STAG2; STAG2 cohesin complex
hsa:1583,0.0,0.0,5.4260954218331675e-05,0.00024753646617299807,0.0,0.0026247452,False,CYP11A1; cytochrome P450 family 11 subfamily A member
hsa:5236,0.0,0.0,5.720406763217821e-05,0.0001459650323390776,0.0,0.0013233717,False,PGM1; phosphoglucomutase
hsa:7699,1.42847935e-08,1.769853324925779e-05,6.565315363841582e-08,1.1216332686280252e-07,0.0,7.107891e-07,False,ZNF140; zinc finger protein
hsa:50507,0.0,0.0,1.6173300929777227e-05,4.120946101275715e-05,0.0,0.0002653828,False,NOX4; NADPH oxidase
hsa:2091,0.0,0.0,1.7980990529534662e-06,4.506096976771387e-06,0.0,2.8562155e-05,False,FBL;
hsa:119764,-0.0,0.0,2.4963044554455447e-10,3.5479152452165705e-09,-0.0,5.042535e-08,False,OR4X2; olfactory receptor family 4 subfamily X member
hsa:148266,1.76986985e-08,2.1928283658481934e-05,8.35814835871287e-08,1.5427989634681155e-07,0.0,7.965889e-07,False,ZNF569; zinc finger protein
hsa:29968,2.52498295e-05,0.03128396269388425,0.0001418669346185149,0.00033200830497142855,0.0,0.0024284916,False,PSAT1; phosphoserine aminotransferase
hsa:3760,6.025556150000001e-06,0.00746552660114021,0.00012420058107902472,0.00033302785710269286,0.0,0.0023084227,False,KCNJ3; potassium inwardly rectifying channel subfamily J member
hsa:6209,1.9507317e-07,0.00024169120717657672,5.476756097475245e-07,9.877807948316513e-07,0.0,8.715098e-06,False,RPS15; ribosomal protein
hsa:7278,0.0,0.0,7.876260658091136e-05,0.0004398709730797534,0.0,0.0036752843,False,TUBA3C; tubulin alpha
hsa:25804,1.6446285e-07,0.00020376571904891005,1.2638303075816825e-05,4.839301577238318e-05,0.0,0.00042923383,False,LSM4; LSM4 homolog
hsa:3594,4.34785945e-07,0.0005386898665278198,2.4990372568415842e-05,6.72277433305616e-05,0.0,0.000652753,False,IL12RB1; interleukin 12 receptor subunit beta
hsa:2249,0.0,0.0,2.970507314995049e-07,3.3924761624992483e-06,0.0,4.734817e-05,False,FGF4; fibroblast growth factor
hsa:2923,0.0,0.0,1.8009213258118812e-06,4.9840830430904045e-06,0.0,4.5725665e-05,False,PDIA3; protein disulfide isomerase family A member
hsa:406967,0.0,0.0,3.0645024752475246e-09,4.355476363156217e-08,-0.0,6.190295e-07,False,MIR192; microRNA
hsa:339983,0.0,0.0,4.310180600366338e-06,9.709026014596157e-06,0.0,6.277173e-05,False,NAT8L; N-acetyltransferase 8
hsa:889,4.5631879000000006e-07,0.0005653685702265198,2.249317037735149e-05,4.771620918874959e-05,0.0,0.0002396177,False,KRIT1; KRIT1 ankyrin repeat
hsa:3833,1.4662254e-08,1.8166198197269217e-05,1.353241432059406e-07,5.65952297323398e-07,0.0,6.1914225e-06,False,KIFC1; kinesin family member
hsa:23509,3.9122572e-08,4.847197415478787e-05,9.102177711907916e-05,0.00022805451355579944,0.0,0.0013666719,False,POFUT1; protein O-fucosyltransferase
hsa:1164,1.14542045e-06,0.0014191498056100578,1.2968628583947036e-05,2.967192129632045e-05,0.0,0.00022518933,False,CKS2; CDC28 protein kinase regulatory subunit
hsa:81856,0.0,0.0,3.50871438480198e-08,6.097304566432828e-08,0.0,2.6610655e-07,False,ZNF611; zinc finger protein
hsa:83605,3.9141446e-07,0.00048495358610191206,1.1186225794287126e-05,3.0483780948783417e-05,0.0,0.00016519256,False,CCM2; CCM2 scaffold
hsa:3251,4.9147707e-06,0.006089288770357652,4.446057642272276e-05,7.742666421361378e-05,0.0,0.00052967784,False,HPRT1; hypoxanthine phosphoribosyltransferase
hsa:79026,0.0,0.0,2.3569243946955443e-07,7.50325157827664e-07,0.0,6.490176e-06,False,AHNAK; AHNAK
hsa:2597,3.1049015e-07,0.00038469021224157266,7.194276071905941e-05,0.00016659356767030465,0.0,0.0008514265,False,GAPDH; glyceraldehyde-3-phosphate
hsa:56832,0.0,0.0,7.078808217326731e-07,4.082775770143125e-06,0.0,4.888405e-05,False,IFNK; interferon
hsa:169841,0.0,0.0,2.2765572828613858e-08,6.81957633221438e-08,0.0,5.1567173e-07,False,ZNF169; zinc finger protein
hsa:6470,0.0,0.0,6.131408799158416e-05,0.0001335476803587393,0.0,0.0008552989,False,SHMT1; serine hydroxymethyltransferase
hsa:139189,5.0593006e-05,0.06268358019112413,0.00022611054237658919,0.00043007254224049576,0.0,0.0023591644,False,DGKK; diacylglycerol kinase
hsa:284958,6.4965599e-06,0.008049089501779978,5.9588739164223765e-05,0.0001583869604847711,0.0,0.00147571,False,NT5DC4; 5'-nucleotidase domain containing
hsa:80031,1.1072284500000001e-08,1.3718307889329425e-05,3.3537070733663357e-06,2.448380852321229e-05,0.0,0.000308083,False,SEMA6D; semaphorin
hsa:10483,8.56435435e-09,1.0611039650093686e-05,4.572461096475246e-07,7.27363313998031e-07,0.0,4.9355676e-06,False,SEC23B; SEC23 homolog B
hsa:7673,0.0,0.0,8.695532133712875e-08,2.003282055723387e-07,0.0,1.0373284e-06,False,ZNF222; zinc finger protein
hsa:260434,0.0,0.0,6.889970097029703e-09,5.4353590326218156e-08,0.0,6.8514913e-07,False,PYDC1; pyrin domain containing
hsa:3811,0.0,0.0,2.2397948653861386e-06,8.372875088538922e-06,0.0,7.922533e-05,False,KIR3DL1; killer cell immunoglobulin like receptor
hsa:127829,0.0,0.0,4.615000573836632e-07,1.3834691928258713e-06,0.0,1.2731923e-05,False,ARL8A; ADP ribosylation factor like GTPase
hsa:10842,1.50598915e-08,1.8658861987956968e-05,2.4260450659237956e-05,9.88880100061424e-05,0.0,0.00088423904,False,PPP1R17; protein phosphatase 1 regulatory subunit
hsa:27257,0.0,0.0,3.7991021077653467e-06,2.8568943984254664e-05,0.0,0.00030760557,False,LSM1; LSM1 homolog
hsa:116985,1.95662345e-08,2.4242118155997487e-05,4.6985437091930716e-07,8.371921451907534e-07,0.0,4.395301e-06,False,ARAP1; ArfGAP with RhoGAP domain
hsa:58505,0.0,0.0,0.00013784870657405947,0.0004451657585102439,0.0,0.0026781939,False,OSTC; oligosaccharyltransferase complex non-catalytic
hsa:4938,2.8896001e-07,0.0003580148599761602,1.782979276311386e-05,5.939318313654995e-05,0.0,0.00044870397,False,OAS1; 2'-5'-oligoadenylate synthetase
hsa:22978,0.00011581602,0.1434934065211867,0.0004722765904021485,0.0007849448383235599,0.0,0.0039436817,False,NT5C2; 5'-nucleotidase
hsa:1297,8.331810499999999e-06,0.0103229231252636,5.929621581155941e-05,0.00010569217440218368,0.0,0.00071443815,False,COL9A1; collagen type IX alpha 1
hsa:3824,2.3490100499999997e-06,0.0029103698609829884,1.1746550339032178e-05,2.5701922425064767e-05,0.0,0.0001867425,False,KLRD1; killer cell lectin like receptor
hsa:595,0.00125293175,1.5523538535174306,0.001554072556683168,0.0015546326049635719,0.0,0.008350514,True,CCND1; cyclin
hsa:10616,0.0,0.0,4.215026915202972e-06,1.153479466127286e-05,0.0,0.000101075035,False,RBCK1; RANBP2-type and C3HC4-type zinc finger containing
hsa:1537,1.38189345e-06,0.0017121344576494267,0.0001645064450382177,0.0004146779606645811,0.0,0.002633387,False,CYC1; cytochrome
hsa:377841,0.0,0.0,4.616038891092525e-06,1.6928362503581644e-05,0.0,0.00016837977,False,ENTPD8; ectonucleoside triphosphate diphosphohydrolase
hsa:9123,1.7679507e-07,0.0002190450582782214,1.5420748835280698e-05,5.90644176128621e-05,0.0,0.0005865042,False,SLC16A3; solute carrier family 16 member
hsa:23369,0.0,0.0,1.1035225217985147e-07,2.631584053059888e-07,0.0,1.8157962e-06,False,PUM2; pumilio RNA binding family member
hsa:6443,7.5687915e-05,0.09377559991990764,0.0004299278097277226,0.0007368766854634099,0.0,0.0038800824,False,SGCB; sarcoglycan
hsa:8438,1.56079345e-07,0.00019337874761751913,2.7945669753852968e-05,7.023874168907107e-05,0.0,0.00040236217,False,RAD54L; RAD54
hsa:80349,1.45848135e-07,0.0001807025118451827,2.6429189527623736e-06,7.8111359078366e-06,0.0,6.164604e-05,False,SKIC8; SKI8 subunit of superkiller
hsa:2977,0.0,0.0,4.278968000148513e-05,0.00016561764509460757,0.0,0.0019634068,False,GUCY1A2; guanylate cyclase 1 soluble subunit alpha
hsa:4093,1.1369030999999999e-06,0.0014085970032772439,4.8662809046514864e-05,0.00012326954418723652,0.0,0.001018596,False,SMAD9; SMAD family member
hsa:11100,4.2780942999999996e-08,5.300461236069686e-05,5.771668929905939e-06,1.5131124875380337e-05,0.0,7.95029e-05,False,HNRNPUL1; heterogeneous nuclear ribonucleoprotein U like
hsa:7710,5.6900955e-09,7.0498985090825514e-06,3.121470645470298e-08,5.979303905180422e-08,0.0,4.7488834e-07,False,ZNF154; zinc finger protein
hsa:57121,1.06741119e-07,0.0001322498112194959,1.389372135628713e-06,2.7402093045355653e-06,0.0,2.010029e-05,False,LPAR5; lysophosphatidic acid receptor
hsa:6611,0.0,0.0,0.00016532256231816824,0.00036109858268084587,0.0,0.0022204584,False,SMS; spermine
hsa:390538,0.0,0.0,1.7114285675742576e-06,8.328894152641535e-06,0.0,7.97951e-05,False,OR4M2; olfactory receptor family 4 subfamily M member
hsa:1232,0.0,0.0,2.3775773856757425e-06,9.469729268859223e-06,0.0,8.4755266e-05,False,CCR3; C-C motif chemokine receptor
hsa:441273,1.53107405e-07,0.00018969658176018283,1.145515772461882e-05,3.317475179034885e-05,0.0,0.00021007178,False,SPDYE2; speedy/RINGO cell cycle regulator family member
hsa:8013,0.0,0.0,1.464627095263613e-06,7.012055262917254e-06,0.0,7.717181e-05,False,NR4A3; nuclear receptor subfamily 4 group A member
hsa:79885,0.0,0.0,1.2895700563465357e-05,4.794143651628079e-05,0.0,0.00056870887,False,HDAC11; histone deacetylase
hsa:440279,0.0,0.0,5.592141842465213e-07,2.974275550484174e-06,0.0,3.4694312e-05,False,UNC13C; unc-13 homolog
hsa:3135,0.0,0.0,6.4544511131480205e-06,2.362845549329222e-05,0.0,0.00022229558,False,HLA-G; major histocompatibility complex
hsa:6880,5.81170465e-08,7.200569471507663e-05,1.6643268233920792e-06,3.988276187940417e-06,0.0,3.187321e-05,False,TAF9; TATA-box binding protein associated factor
hsa:64328,1.3438458e-08,1.66499428732907e-05,1.953763562564357e-07,4.0862020624401883e-07,0.0,2.1266337e-06,False,XPO4; exportin
hsa:2906,3.12575525e-06,0.0038727394429024886,8.454636139702972e-05,0.0002118590818332841,0.0,0.0015787344,False,GRIN2D; glutamate ionotropic receptor NMDA type subunit
hsa:84631,0.0,0.0,1.3535274102545643e-06,6.643309596154767e-06,0.0,7.777778e-05,False,SLITRK2; SLIT and NTRK like family member
hsa:1379,3.8675807e-06,0.004791844251240854,1.3845452168415836e-05,2.5775711426108264e-05,0.0,0.00017516478,False,CR1L; complement C3b/C4b receptor 1
hsa:5045,0.0,0.0,1.4510292925346538e-05,4.4361821579288045e-05,0.0,0.00041234682,False,FURIN; furin
hsa:1638,9.4367457e-07,0.0011691912629765385,9.99208600738614e-06,5.3711172619028054e-05,0.0,0.0006727443,False,DCT; dopachrome
hsa:9695,0.0,0.0,4.6314067794207907e-07,1.7055035986276952e-06,0.0,1.5467684e-05,False,EDEM1; ER degradation enhancing alpha-mannosidase like protein
hsa:3631,0.0,0.0,6.4229065514059385e-06,2.429172871457042e-05,0.0,0.00025346814,False,INPP4A; inositol polyphosphate-4-phosphatase type I
hsa:3192,0.0,0.0,2.0505111058237626e-07,4.4539283417294206e-07,0.0,2.9776782e-06,False,HNRNPU; heterogeneous nuclear ribonucleoprotein
hsa:26291,0.0,0.0,2.3664231027722773e-06,1.81886619195871e-05,0.0,0.00021351011,False,FGF21; fibroblast growth factor
hsa:6675,0.0,0.0,1.3039360691138612e-05,4.550291798235141e-05,0.0,0.0004601042,False,UAP1; UDP-N-acetylglucosamine pyrophosphorylase
hsa:7100,0.0,0.0,1.2723466113366335e-05,4.115871973818475e-05,0.0,0.00032140978,False,TLR5; toll like receptor
hsa:2157,0.0,0.0,1.2055817801732673e-06,2.8480468157952252e-06,0.0,3.1012256e-05,False,F8; coagulation factor
hsa:6599,0.0,0.0,6.76977480781683e-06,1.932680795172025e-05,0.0,0.00012037567,False,SMARCC1; SWI/SNF related
hsa:50614,2.8949745e-07,0.0003586807358748549,0.00011673966729894059,0.0003650381889882647,0.0,0.003900622,False,GALNT9; polypeptide N-acetylgalactosaminyltransferase
hsa:6184,6.575122350000001e-07,0.0008146426584984447,5.3030294799405934e-05,0.00018179076555759573,0.0,0.0017000623,False,RPN1; ribophorin
hsa:1607,0.0,0.0,3.74179296045594e-05,0.00012768632640233863,0.0,0.0011074836,False,DGKB; diacylglycerol kinase
hsa:100532731,0.0,0.0,4.158530534000001e-05,7.818803529014978e-05,0.0,0.00047110568,False,COMMD3-BMI1; COMMD3-BMI1
hsa:2134,0.0,0.0,5.260175584888617e-05,0.00022151911129230395,0.0,0.0018744408,False,EXTL1; exostosin like glycosyltransferase
hsa:6484,0.0,0.0,0.00014931328374851485,0.00029304329956629386,0.0,0.001785958,False,ST3GAL4; ST3 beta-galactoside alpha-2
hsa:4210,8.641680500000001e-09,1.0706844985803449e-05,5.274292606899504e-07,2.660645660933981e-06,0.0,2.433085e-05,False,MEFV; MEFV innate immunity regulator
hsa:28964,1.8331132499999999e-06,0.0022711854955957188,9.98599573555396e-05,0.0002413796722745619,0.0,0.0014162646,False,GIT1; GIT ArfGAP
hsa:10902,7.217582e-09,8.94241943408174e-06,1.3185163191975249e-06,8.154823213426646e-06,0.0,7.8324156e-05,False,BRD8; bromodomain containing
hsa:91734,0.0,0.0,2.2661889777240415e-07,2.467902807864661e-06,0.0,3.4212357e-05,False,IDI2; isopentenyl-diphosphate delta isomerase
hsa:9652,2.7121957e-07,0.00033603485955148037,3.308311594093563e-05,0.00013774971408059224,0.0,0.0012687399,False,SKIC3; SKI3 subunit of superkiller
hsa:23466,0.0,0.0,2.019273838010217e-05,7.649868859447026e-05,0.0,0.00052597513,False,CBX6; chromobox
hsa:5462,3.6359655e-09,4.504878302574288e-06,1.013311361076857e-06,3.997066575934812e-06,0.0,3.626121e-05,False,POU5F1B; POU class 5 homeobox
hsa:148268,0.0,0.0,5.081640075811881e-08,1.007329161359965e-07,0.0,5.142756e-07,False,ZNF570; zinc finger protein
hsa:6261,0.0,0.0,2.888170422104952e-05,0.00011753953793544928,0.0,0.0012780557,False,RYR1; ryanodine receptor
hsa:1962,0.0,0.0,0.00031156136454059397,0.0005801311098008436,0.0,0.003097123,False,EHHADH; enoyl-CoA hydratase and 3-hydroxyacyl CoA
hsa:84775,2.36546905e-09,2.930762186482796e-06,4.7508220340098996e-08,9.032359178682338e-08,0.0,3.905756e-07,False,ZNF607; zinc finger protein
hsa:29929,0.0,0.0,6.153252668420545e-05,0.00019124368095505378,0.0,0.0010947135,False,ALG6; ALG6
hsa:89845,9.2168535e-05,0.11419471210647045,0.000498010657247525,0.0009405345074665846,0.0,0.0066068894,False,ABCC10; ATP binding cassette subfamily C member
hsa:9922,1.4816560999999999e-08,1.8357381049866503e-05,1.1547145553004457e-06,3.7556493627179894e-06,0.0,2.3670946e-05,False,IQSEC1; IQ motif and Sec7 domain ArfGEF
hsa:8831,1.83790625e-07,0.00022771239132468872,1.5983794454648514e-06,4.0743695803722164e-06,0.0,2.4072498e-05,False,SYNGAP1; synaptic Ras GTPase activating protein
hsa:6927,3.71878995e-05,0.04607495906544306,0.00023092924626465342,0.0005279730846383686,0.0,0.0036057704,False,HNF1A; HNF1 homeobox
hsa:51602,1.3740359249999999e-08,1.702399163438182e-05,1.324836321589406e-06,3.878708520172913e-06,0.0,2.394815e-05,False,NOP58; NOP58
hsa:574484,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520G; microRNA
hsa:1770,0.0,0.0,4.651904213846534e-08,2.2493972361846344e-07,0.0,2.334762e-06,False,DNAH9; dynein axonemal heavy chain
hsa:3672,4.4818295e-06,0.0055528845007983075,0.0001254543992841585,0.0002635739453499751,0.0,0.0015770778,False,ITGA1; integrin subunit alpha
hsa:145226,8.399458749999999e-08,0.00010406737763667655,2.918626819373763e-05,5.371733263397026e-05,0.0,0.0003614168,False,RDH12; retinol dehydrogenase
hsa:1310,7.6512243e-08,9.479692350545995e-05,5.668738888959404e-06,1.5365469160253235e-05,0.0,0.00013201608,False,COL19A1; collagen type XIX alpha 1
hsa:286362,0.0,0.0,2.2510211470792076e-06,1.329365868076974e-05,0.0,0.00015494494,False,OR13C9; olfactory receptor family 13 subfamily C member
hsa:57541,2.79644975e-08,3.4647374412695315e-05,9.995438634405939e-08,1.5293300365781256e-07,0.0,8.3040885e-07,False,ZNF398; zinc finger protein
hsa:340980,0.0,0.0,1.2451193698613864e-06,6.7268947121270696e-06,0.0,6.2336934e-05,False,OR52B6; olfactory receptor family 52 subfamily B member
hsa:6328,0.000244166965,0.3025172991421166,0.0009033067039663363,0.0016647777664612817,0.0,0.010917873,False,SCN3A; sodium voltage-gated channel alpha subunit
hsa:3171,1.04752395e-06,0.0012978582755479701,5.850274449361386e-05,0.00020006657470514528,0.0,0.0017151554,False,FOXA3; forkhead box
hsa:23179,7.720632e-08,9.565686907359471e-05,4.0196354987128704e-07,7.987985625160762e-07,0.0,4.5961997e-06,False,RGL1; ral guanine nucleotide dissociation stimulator like
hsa:6932,2.91431375e-05,0.03610768248287534,8.221186146435642e-05,0.00013882293297243608,0.0,0.0009479999,False,TCF7; transcription factor
hsa:1051,0.0,0.0,5.203457254108912e-05,0.0001636894301037844,0.0,0.0014515946,False,CEBPB; CCAAT enhancer binding protein
hsa:6158,1.01210478e-07,0.00012539747319807417,4.765290179801981e-07,6.831446792987196e-07,0.0,3.2061212e-06,False,RPL28; ribosomal protein
hsa:259286,0.0,0.0,2.039354786930693e-06,7.931861807459835e-06,0.0,6.236962e-05,False,TAS2R40; taste 2 receptor member
hsa:26870,9.892745e-09,1.2256885359170835e-05,5.983242813116832e-07,2.4978960471591537e-06,0.0,2.6723197e-05,False,RNU1-2; RNA
hsa:6877,1.601397e-07,0.00019840943482845358,7.708367755792077e-07,1.5360266450009038e-06,0.0,9.774462e-06,False,TAF5; TATA-box binding protein associated factor
hsa:5034,0.0,0.0,4.894728129473762e-07,1.8074318466294814e-06,0.0,1.8300341e-05,False,P4HB; prolyl 4-hydroxylase subunit
hsa:1874,0.0,0.0,2.804465741537525e-05,9.355810962702516e-05,0.0,0.0007996653,False,E2F4; E2F transcription factor
hsa:343,1.45906065e-06,0.0018077428579355158,2.7179381829173272e-05,6.856255767423844e-05,0.0,0.0005769678,False,AQP8; aquaporin
hsa:1846,0.0,0.0,8.411859657356439e-06,4.02782128828331e-05,0.0,0.0003847433,False,DUSP4; dual specificity phosphatase
hsa:4191,6.1073033e-06,0.007566809454988048,4.574865972861387e-05,9.753693191237513e-05,0.0,0.00080018386,False,MDH2; malate dehydrogenase
hsa:566,0.0,0.0,1.7518760967569324e-06,6.793336897255861e-06,0.0,6.798098e-05,False,AZU1; azurocidin
hsa:973,5.91235835e-06,0.007325277109466225,5.360902217282178e-05,0.0001290042687975191,0.0,0.00092674885,False,CD79A; CD79a
hsa:10371,8.4603362e-08,0.0001048216353534262,4.213524243381191e-06,1.5920271995620583e-05,0.0,0.00011508153,False,SEMA3A; semaphorin
hsa:3633,1.5188196000000001e-06,0.0018817828336282507,1.696848435811881e-05,3.670784932992946e-05,0.0,0.0002003956,False,INPP5B; inositol polyphosphate-5-phosphatase
hsa:2893,0.000435575365,0.539667939897773,0.0010743435040079209,0.0017993471598618904,0.0,0.016316429,False,GRIA4; glutamate ionotropic receptor AMPA type subunit
hsa:120066,0.0,0.0,5.335074346534654e-07,5.188509353709901e-06,0.0,6.787778e-05,False,OR5P3; olfactory receptor family 5 subfamily P member
hsa:6405,0.0,0.0,2.8829188834925767e-06,2.9458300733569274e-05,0.0,0.00040987408,False,SEMA3F; semaphorin
hsa:8534,1.1986003499999998e-07,0.00014850384884490642,2.169810386471782e-05,8.638699977859632e-05,0.0,0.0009825884,False,CHST1; carbohydrate sulfotransferase
hsa:54566,0.0,0.0,2.848269719990792e-06,1.257162741719191e-05,0.0,0.00013098863,False,EPB41L4B; erythrocyte membrane protein band 4.1 like
hsa:64781,0.0,0.0,1.274443199319306e-05,3.7999943324775796e-05,0.0,0.00031138476,False,CERK; ceramide
hsa:140838,9.251119e-07,0.001146192538340442,4.255177244735642e-05,0.00011014381039150772,0.0,0.00077498745,False,NANP; N-acetylneuraminic acid
hsa:80763,0.0,0.0,4.008541567224357e-07,1.4912626811806097e-06,0.0,1.0899595e-05,False,SPX; spexin
hsa:3444,0.0,0.0,2.4296567118811887e-06,1.4657836258648706e-05,0.0,0.00016666071,False,IFNA7; interferon alpha
hsa:782,0.00011537818999999999,0.14295094513996176,0.0005085646791495048,0.000865512886314483,0.0,0.005165783,False,CACNB1; calcium voltage-gated channel auxiliary subunit beta
hsa:5328,0.0,0.0,1.5136454195396055e-05,0.0001161813247089787,0.0,0.0012935377,False,PLAU; plasminogen activator
hsa:283694,0.0,0.0,4.2620907576252475e-05,0.00022284401714343577,0.0,0.0025989579,False,OR4N4; olfactory receptor family 4 subfamily N member
hsa:6423,0.0,0.0,5.266699770222773e-07,2.1488132730796696e-06,0.0,2.0064534e-05,False,SFRP2; secreted frizzled related protein
hsa:9001,5.55156515e-07,0.0006878262565902391,7.2309958440099014e-06,2.4243759744210565e-05,0.0,0.0002469648,False,HAP1; huntingtin associated protein
hsa:57556,0.0,0.0,2.0080422422480204e-06,1.5788411010433738e-05,0.0,0.00020746235,False,SEMA6A; semaphorin
hsa:55083,0.0,0.0,8.76137697787129e-08,3.703995095009505e-07,0.0,4.0342024e-06,False,KIF26B; kinesin family member
hsa:115509,1.4211279e-09,1.7607450460937986e-06,2.8779292007574234e-08,6.14002755371569e-08,0.0,3.274878e-07,False,ZNF689; zinc finger protein
hsa:9975,0.0,0.0,0.0001671821301545693,0.00041255091490753593,0.0,0.0040747956,False,NR1D2; nuclear receptor subfamily 1 group D member
hsa:5199,0.0,0.0,3.828931886089108e-08,1.4043329008425515e-07,0.0,1.7129964e-06,False,CFP; complement factor
hsa:59,7.58621925e-07,0.0009399152576639241,8.276323031742574e-05,0.00019626966613923337,0.0,0.0010992924,False,ACTA2; actin alpha 2
hsa:5165,0.0,0.0,1.0196459505495048e-07,3.1852368057143297e-07,0.0,1.9010251e-06,False,PDK3; pyruvate dehydrogenase kinase
hsa:2339,2.6077257e-07,0.0003230912648922369,9.218365980462478e-05,0.00028180593094526997,0.0,0.0016610483,False,FNTA; farnesyltransferase
hsa:2542,5.69195065e-07,0.0007052196997608644,8.628837303201486e-05,0.0002400032068294958,0.0,0.0023747787,False,SLC37A4; solute carrier family 37 member
hsa:51181,2.447549615e-05,0.03032458133909013,0.00025560956218195546,0.0005128423922042192,0.0,0.004293866,False,DCXR; dicarbonyl and L-xylulose
hsa:2662,0.0,0.0,5.670288217227725e-06,2.2754700144120058e-05,0.0,0.00028535622,False,GDF10; growth differentiation factor
hsa:653857,0.0,0.0,5.4930518919653466e-06,1.5666064302985305e-05,0.0,8.8678935e-05,False,ACTR3C; actin related protein
hsa:6175,1.51635595e-07,0.0001878730427484645,6.792332946331687e-07,1.858306848725599e-06,0.0,1.9009782e-05,False,RPLP0; ribosomal protein lateral stalk subunit
hsa:219875,0.0,0.0,2.436375049504951e-09,3.462739555805112e-08,-0.0,4.9214776e-07,False,OR4D5; olfactory receptor family 4 subfamily D member
hsa:10898,0.0,0.0,2.9789438842586635e-05,9.640500520664899e-05,0.0,0.0005010823,False,CPSF4; cleavage and polyadenylation specific factor
hsa:54413,4.2735423500000003e-07,0.0005294821473869137,6.286722459319406e-06,1.0747226837549098e-05,0.0,6.3231426e-05,False,NLGN3; neuroligin
hsa:230,0.0,0.0,2.141560628089109e-05,5.702072693903714e-05,0.0,0.0004753452,False,ALDOC; aldolase
hsa:1814,0.0,0.0,2.4545785301980197e-08,1.0028247157668367e-07,0.0,8.235227e-07,False,DRD3; dopamine receptor
hsa:5897,8.088555999999999e-06,0.010021536349439251,8.01596545754421e-05,0.00017744946855733916,0.0,0.0009699714,False,RAG2; recombination activating
hsa:996,1.4941285e-06,0.0018511911240378567,4.2044803447601465e-05,0.0001259656990665422,0.0,0.0009258158,False,CDC27; cell division cycle
hsa:7436,0.0,0.0,5.002119466782178e-07,1.430771332638297e-06,0.0,1.5137332e-05,False,VLDLR; very low density lipoprotein
hsa:163087,0.0,0.0,2.970243689306931e-08,5.635162468134397e-08,0.0,3.316291e-07,False,ZNF383; zinc finger protein
hsa:7994,1.4028774999999999e-07,0.00017381332168634877,1.58340156222292e-05,5.332290056357664e-05,0.0,0.00043954086,False,KAT6A; lysine acetyltransferase
hsa:4804,0.0,0.0,0.0005992695307226235,0.002696829732832429,0.0,0.021677809,False,NGFR; nerve growth factor
hsa:90649,0.0,0.0,3.080737891034654e-08,5.096175230302126e-08,0.0,2.5630519e-07,False,ZNF486; zinc finger protein
hsa:8823,0.0,0.0,5.080617145663365e-06,2.4178269333457922e-05,0.0,0.00018337303,False,FGF16; fibroblast growth factor
hsa:54433,0.0,0.0,1.1781645333490104e-06,2.4556406119448685e-06,0.0,1.2204486e-05,False,GAR1; GAR1
hsa:5495,0.0,0.0,3.4320567089257434e-07,1.0112111191624365e-06,0.0,6.751269e-06,False,PPM1B; protein phosphatase
hsa:6368,0.0,0.0,1.5665849324356436e-05,8.448666421063235e-05,0.0,0.00081547425,False,CCL23; C-C motif chemokine ligand
hsa:26061,8.8867365e-08,0.00011010463779027871,2.403688993300989e-06,1.154179889784222e-05,0.0,0.00011540539,False,HACL1; 2-hydroxyacyl-CoA lyase
hsa:283093,0.0,0.0,3.6424508331683167e-07,4.802699961608635e-06,-0.0,6.808898e-05,False,OR4C12; olfactory receptor family 4 subfamily C member
hsa:10498,0.0,0.0,2.1845393659991088e-05,8.07341819505656e-05,0.0,0.000677999,False,CARM1; coactivator associated arginine methyltransferase
hsa:975,0.0,0.0,9.4112148114901e-05,0.0002488952994181284,0.0,0.0015190453,False,CD81; CD81
hsa:390980,0.0,0.0,1.2953894634356438e-08,3.626398917258918e-08,0.0,2.3797537e-07,False,ZNF805; zinc finger protein
hsa:84313,0.0,0.0,7.07472492938614e-07,1.5600043212765247e-06,0.0,1.189272e-05,False,VPS25; vacuolar protein sorting 25
hsa:23001,0.0,0.0,3.580924796521782e-07,9.137201896006832e-07,0.0,5.8949513e-06,False,WDFY3; WD repeat and FYVE domain containing
hsa:55217,0.0,0.0,6.854513471980199e-06,3.042340074551078e-05,0.0,0.0003736457,False,TMLHE; trimethyllysine hydroxylase
hsa:1213,0.0,0.0,0.00010122873298925738,0.00032712341260282047,0.0,0.0034083368,False,CLTC; clathrin heavy
hsa:7367,0.0,0.0,1.384571332792079e-05,3.9901977146056184e-05,0.0,0.0003014391,False,UGT2B17; UDP glucuronosyltransferase family 2 member
hsa:80818,1.94781905e-08,2.4133033648657727e-05,1.3128683379475244e-07,2.1559878295009994e-07,0.0,1.3673384e-06,False,ZNF436; zinc finger protein
hsa:50964,0.0,0.0,2.784717955876732e-07,1.1341665152212273e-06,0.0,1.25453225e-05,False,SOST;
hsa:2224,0.0,0.0,6.196968736851485e-05,0.00014133208717580117,0.0,0.0008262333,False,FDPS; farnesyl diphosphate
hsa:11269,0.0,0.0,6.389742403438612e-07,1.3594186558374004e-06,0.0,7.571023e-06,False,DDX19B; DEAD-box helicase
hsa:4437,2.8458517500000003e-05,0.03525945392198597,0.000160484735460396,0.00032964622184098315,0.0,0.0025642586,False,MSH3; mutS homolog
hsa:5905,2.23691735e-08,2.7714895629969466e-05,2.5933722255559403e-07,4.90396418102121e-07,0.0,2.8442387e-06,False,RANGAP1; Ran GTPase activating protein
hsa:2742,0.0,0.0,4.007186478447705e-06,2.646345389921373e-05,0.0,0.00027827985,False,GLRA2; glycine receptor alpha
hsa:83692,9.5515582e-07,0.0011834162697901154,7.901048417668317e-06,2.2031161997976014e-05,0.0,0.0001800037,False,CD99L2; CD99 molecule like
hsa:3122,0.00014617408,0.18110635026398303,0.0008401059483118816,0.0012121450896659266,0.0,0.0057217344,False,HLA-DRA; major histocompatibility complex
hsa:157570,0.0,0.0,3.5411825785608225e-07,8.240921615186903e-07,0.0,4.5189017e-06,False,ESCO2; establishment of sister chromatid cohesion N-acetyltransferase
hsa:7417,1.534995925e-05,0.01901824931252084,0.00026601450973019806,0.0005532889900031735,0.0,0.0035504506,False,VDAC2; voltage dependent anion channel
hsa:9860,1.80279275e-07,0.0002233619087836018,1.0543454160445544e-05,3.749324957359446e-05,0.0,0.00027550908,False,LRIG2; leucine rich repeats and immunoglobulin like domains
hsa:9454,0.0,0.0,1.9535186563762372e-05,0.00013574460574108984,0.0,0.0017769535,False,HOMER3; homer scaffold protein
hsa:6546,0.0005068631749999999,0.6279919101078968,0.0009460603405529702,0.0011265958841982769,0.0,0.005781967,False,SLC8A1; solute carrier family 8 member
hsa:9459,0.0,0.0,1.4747845214730199e-05,5.4981359977791215e-05,0.0,0.0004748993,False,ARHGEF6; Rac/Cdc42 guanine nucleotide exchange factor
hsa:6400,5.6946104999999996e-08,7.055492491076088e-05,3.2035696632920777e-07,6.009462414507102e-07,0.0,5.029033e-06,False,SEL1L; SEL1L adaptor subunit of SYVN1 ubiquitin
hsa:2921,0.0,0.0,8.031603265106437e-05,0.00032769603015569867,0.0,0.0028291799,False,CXCL3; C-X-C motif chemokine ligand
hsa:4842,6.6149843999999995e-06,0.008195814755510577,5.404771958732675e-05,0.00013024717098301575,0.0,0.0008174414,False,NOS1; nitric oxide synthase
hsa:94026,0.0,0.0,9.059997262376238e-11,4.0244112914500154e-10,0.0,4.098934e-09,False,POM121L2; POM121 transmembrane nucleoporin like
hsa:123745,0.0,0.0,2.9835391478069316e-06,1.9739717270825615e-05,0.0,0.0002741488,False,PLA2G4E; phospholipase A2 group
hsa:103625684,0.0,0.0,6.53907814059406e-09,4.576392193918931e-08,0.0,4.6577225e-07,False,RNU6-2; RNA
hsa:407019,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR27B; microRNA
hsa:154664,0.0,0.0,1.033114469939604e-05,3.819435018817275e-05,0.0,0.00027988222,False,ABCA13; ATP binding cassette subfamily A member
hsa:3454,0.0,0.0,8.375871112425743e-05,0.00023713568808885214,0.0,0.001847785,False,IFNAR1; interferon alpha and beta receptor subunit
hsa:55802,5.9283245e-08,7.345058805060048e-05,1.484609769386684e-05,6.134690292824081e-05,0.0,0.00050475885,False,DCP1A; decapping mRNA
hsa:6588,0.0,0.0,4.1986419647920775e-07,4.638026491984868e-06,0.0,6.5716944e-05,False,SLN;
hsa:1582,0.0,0.0,1.2039919105099008e-05,9.568067696199938e-05,0.0,0.0012036432,False,CYP8B1; cytochrome P450 family 8 subfamily B member
hsa:834,0.0,0.0,7.507425213019805e-05,0.00021577953695131054,0.0,0.0015690143,False,CASP1; caspase
hsa:401494,1.59956145e-07,0.0001981820143711283,9.933470790988613e-06,1.991984936533841e-05,0.0,0.00012972762,False,HACD4; 3-hydroxyacyl-CoA dehydratase
hsa:11201,0.0,0.0,0.00017239235815301985,0.0005524416833045169,0.0,0.0038968474,False,POLI; DNA polymerase
hsa:84503,3.00771825e-09,3.726494292831356e-06,6.209512651485149e-08,1.3182778026146986e-07,0.0,6.8412345e-07,False,ZNF527; zinc finger protein
hsa:11194,0.0,0.0,8.51332847531188e-05,0.0001900653415180309,0.0,0.001176707,False,ABCB8; ATP binding cassette subfamily B member
hsa:204962,1.6302057e-07,0.0002019787670334861,1.1446410201297517e-05,3.7646468181991444e-05,0.0,0.00031671918,False,SLC44A5; solute carrier family 44 member
hsa:6722,0.0,0.0,1.483492031188614e-05,0.0001222156443721791,0.0,0.0016113843,False,SRF; serum response
hsa:390072,0.0,0.0,1.3260390326039604e-05,6.783956388103652e-05,0.0,0.0006405934,False,OR52N4; olfactory receptor family 52 subfamily N member
hsa:10960,0.0,0.0,2.617764828450497e-07,1.0027563100315213e-06,0.0,8.564103e-06,False,LMAN2; lectin
hsa:5829,0.0,0.0,4.8784903857227744e-05,0.00010240974784427488,0.0,0.0006477277,False,PXN;
hsa:6935,0.0,0.0,1.2502312520346534e-05,4.9792543489459777e-05,0.0,0.00056999887,False,ZEB1; zinc finger E-box binding homeobox
hsa:56992,0.0,0.0,1.234550505283663e-07,3.250824198092152e-07,0.0,1.7927046e-06,False,KIF15; kinesin family member
hsa:10901,2.316536e-06,0.002870135253904975,0.00012338737043118811,0.0003111976745118749,0.0,0.003057198,False,DHRS4; dehydrogenase/reductase
hsa:3716,0.0,0.0,6.0599933096534664e-05,0.00014637854128581623,0.0,0.000908006,False,JAK1; Janus kinase
hsa:5151,0.0,0.0,0.00010580762806633661,0.0002231850603456233,0.0,0.0011834035,False,PDE8A; phosphodiesterase
hsa:7277,0.0,0.0,7.700115831747526e-05,0.00024539064099880905,0.0,0.0020132028,False,TUBA4A; tubulin alpha
hsa:642843,0.0,0.0,1.3799155192326732e-06,5.57804535277692e-06,0.0,3.3277487e-05,False,CPSF4L; cleavage and polyadenylation specific factor 4
hsa:406891,0.0,0.0,5.679720792079208e-09,8.072399960202235e-08,0.0,1.1473036e-06,False,MIRLET7I; microRNA
hsa:10858,0.0,0.0,4.082767332019804e-05,8.797268306388047e-05,0.0,0.00072249694,False,CYP46A1; cytochrome P450 family 46 subfamily A member
hsa:6657,0.0,0.0,8.837547346479212e-06,5.1700776629906465e-05,0.0,0.0004915646,False,SOX2; SRY-box transcription factor
hsa:284323,0.0,0.0,3.0071019055940605e-08,1.1530303481398491e-07,0.0,1.2941938e-06,False,ZNF780A; zinc finger protein
hsa:6584,0.0,0.0,1.1502507282435541e-05,2.8982883870934225e-05,0.0,0.0001827458,False,SLC22A5; solute carrier family 22 member
hsa:3394,0.0,0.0,1.4633276609227724e-05,4.17280421965454e-05,0.0,0.00028321883,False,IRF8; interferon regulatory factor
hsa:23239,6.73756e-08,8.347683127436831e-05,2.489616519782178e-07,3.8110335234078494e-07,0.0,2.270795e-06,False,PHLPP1; PH domain and leucine rich repeat protein phosphatase
hsa:1029,1.78411355e-05,0.0221047598518847,0.00011068597506237622,0.00019684329735333291,0.0,0.001037935,False,CDKN2A; cyclin dependent kinase inhibitor
hsa:125893,5.9823608e-11,7.412008547960907e-08,2.3974155840801988e-08,4.9271998131644106e-08,0.0,3.2549463e-07,False,ZNF816; zinc finger protein
hsa:55825,2.22318395e-07,0.0002754474193714544,2.4370423207936132e-05,8.964920864976365e-05,0.0,0.00055801036,False,PECR; peroxisomal trans-2-enoyl-CoA
hsa:245711,0.0,0.0,7.618849266163369e-07,1.8246252508422542e-06,0.0,1.0231749e-05,False,SPDYA; speedy/RINGO cell cycle regulator family member
hsa:123720,0.0,0.0,7.373369566633663e-07,2.0487806185936252e-06,0.0,1.661244e-05,False,WHAMM; WASP homolog associated with actin
hsa:2629,2.53390095e-05,0.03139445467930698,0.0001371614271425742,0.00023643364091524457,0.0,0.0011526204,False,GBA1; glucosylceramidase beta
hsa:51167,0.0,0.0,7.541451293946534e-05,0.00028110124425718275,0.0,0.0018315054,False,CYB5R4; cytochrome b5 reductase
hsa:10572,0.0,0.0,9.814535447080984e-05,0.0002532826059543124,0.0,0.0013097599,False,SIVA1; SIVA1 apoptosis inducing
hsa:3620,2.33194095e-06,0.002889221635502172,0.00011554740497222776,0.00027195741723893597,0.0,0.0015212306,False,IDO1; indoleamine 2
hsa:9422,1.47043155e-09,1.8218311436166485e-06,5.296394770752474e-08,9.005976747220778e-08,0.0,7.220503e-07,False,ZNF264; zinc finger protein
hsa:133396,0.0,0.0,6.566870007658419e-07,4.979824920370798e-06,0.0,6.6251494e-05,False,IL31RA; interleukin 31 receptor
hsa:84364,0.0,0.0,7.766791462257426e-07,1.7552665925573084e-06,0.0,1.0840007e-05,False,ARFGAP2; ADP ribosylation factor GTPase activating protein
hsa:135941,-0.0,0.0,3.1639063064356436e-07,2.829952580054251e-06,-0.0,3.7226528e-05,False,OR2A14; olfactory receptor family 2 subfamily A member
hsa:1870,0.00019367585,0.2399599595754229,0.00042602809840148483,0.0006562045216126861,0.0,0.0043357783,False,E2F2; E2F transcription factor
hsa:9709,6.9072885e-08,8.557972866703741e-05,1.1719658141123761e-06,2.9953404224596956e-06,0.0,2.9031e-05,False,HERPUD1; homocysteine inducible ER protein with ubiquitin like domain
hsa:55781,0.0,0.0,6.039504326809901e-07,2.3096482835760267e-06,0.0,1.7581593e-05,False,RIOK2; RIO kinase
hsa:5078,0.0,0.0,5.562076070831683e-05,0.00015907975518057442,-0.0,0.0010679633,False,PAX4; paired box
hsa:797,0.0,0.0,5.43905805268812e-06,1.77643481199457e-05,0.0,0.0001334201,False,CALCB; calcitonin related polypeptide
hsa:9394,1.36085702e-07,0.00016860708008103773,0.00044651592582588615,0.0013178927213433663,0.0,0.008516989,False,HS6ST1; heparan sulfate 6-O-sulfotransferase
hsa:81624,0.0,0.0,8.343182159888903e-06,2.9743024553305413e-05,0.0,0.00016045751,False,DIAPH3; diaphanous related formin
hsa:29785,0.0,0.0,6.443793150247527e-05,0.00022455521827626,0.0,0.0026165908,False,CYP2S1; cytochrome P450 family 2 subfamily S member
hsa:6863,0.0,0.0,1.4244544056287138e-06,7.659496540664833e-06,0.0,8.077432e-05,False,TAC1; tachykinin precursor
hsa:1434,1.36325505e-07,0.00016890419052710556,7.770645535247528e-07,1.62177910315325e-06,0.0,1.0119613e-05,False,CSE1L; chromosome segregation 1
hsa:390093,0.0,0.0,0.0,0.0,0.0,0.0,False,OR10A6; olfactory receptor family 10 subfamily A member 6
hsa:6156,0.0,0.0,1.0336566906683168e-06,2.4361616826558197e-06,0.0,1.2203517e-05,False,RPL30; ribosomal protein
hsa:336,0.0,0.0,1.6658035731886134e-05,0.00010687844710955839,0.0,0.0012036934,False,APOA2; apolipoprotein
hsa:4287,9.208697500000001e-08,0.00011409366112720292,4.6227059452955463e-07,7.958851339117761e-07,0.0,5.3403255e-06,False,ATXN3; ataxin
hsa:10520,0.0,0.0,5.199856876702972e-08,1.0346109503479123e-07,0.0,6.8593744e-07,False,ZNF211; zinc finger protein
hsa:348180,0.0,0.0,9.451202312079208e-05,0.0002124641190216641,0.0,0.0010475119,False,CTU2; cytosolic thiouridylase subunit
hsa:23512,0.0,0.0,8.933864284822278e-06,3.211169095747869e-05,0.0,0.00020134421,False,SUZ12; SUZ12 polycomb repressive complex 2
hsa:374900,8.8936615e-09,1.1019043696039e-05,4.304961289207921e-08,9.296327355521233e-08,0.0,6.5654444e-07,False,ZNF568; zinc finger protein
hsa:91937,2.57523615e-08,3.190658837697977e-05,6.570960020227135e-05,0.00017986171141505498,0.0,0.0012404391,False,TIMD4; T cell immunoglobulin and mucin domain containing
hsa:7384,0.0,0.0,4.0511111813861364e-05,0.00015554450546410755,0.0,0.0012610044,False,UQCRC1; ubiquinol-cytochrome c reductase core protein
hsa:2078,6.036301e-08,7.47883922515422e-05,3.14754251138119e-06,1.1798776480423551e-05,0.0,0.00010353257,False,ERG; ETS transcription factor
hsa:378884,2.8227407e-09,3.4973113285105033e-06,1.1825304431455451e-07,3.056051224595534e-07,0.0,2.345134e-06,False,NHLRC1; NHL repeat containing E3 ubiquitin protein ligase
hsa:10580,0.0,0.0,2.8878511202475255e-05,0.0001538702274421008,0.0,0.0016149783,False,SORBS1; sorbin and SH3 domain containing
hsa:8120,0.0,0.0,1.8761586635356444e-06,4.557049037004379e-06,0.0,2.2735416e-05,False,AP3B2; adaptor related protein complex 3 subunit beta
hsa:5138,3.876578e-05,0.04802991700673955,0.0001085146026212871,0.00021046339123143655,0.0,0.0020910269,False,PDE2A; phosphodiesterase
hsa:5433,0.0,0.0,7.639533569109408e-05,0.0002795230501364211,0.0,0.0018480943,False,POLR2D; RNA polymerase II subunit
hsa:4522,0.0,0.0,2.3296728876039607e-05,6.825497859907806e-05,0.0,0.0003852521,False,MTHFD1; methylenetetrahydrofolate dehydrogenase
hsa:5095,4.916896e-06,0.006091921968570469,0.0005631780468459605,0.0018457860434111491,0.0,0.01026994,False,PCCA; propionyl-CoA carboxylase subunit
hsa:166012,0.0,0.0,3.375791263679209e-05,0.0001377559200659508,0.0,0.0013735496,False,CHST13; carbohydrate sulfotransferase
hsa:8309,0.0,0.0,4.290091213316831e-05,0.00011845111336532222,0.0,0.0010393037,False,ACOX2; acyl-CoA oxidase
hsa:10131,0.0,0.0,1.1657054306888616e-07,2.5455142951371967e-07,0.0,1.9414017e-06,False,TRAP1; TNF receptor associated protein
hsa:57713,0.0,0.0,7.727944017973265e-06,3.4236733150490264e-05,0.0,0.0003282598,False,SFMBT2; Scm like with four mbt domains
hsa:665,2.75035905e-08,3.4076321154955484e-05,5.566294195955448e-06,1.7028475167297474e-05,0.0,0.0001532906,False,BNIP3L; BCL2 interacting protein 3
hsa:57171,1.48640205e-07,0.00018416182287612302,0.00014855791566328327,0.0003829597134572062,0.0,0.0021401348,False,DOLPP1; dolichyldiphosphatase
hsa:115201,3.8257317999999995e-09,4.7399944188932685e-06,0.0003138908064070582,0.0010946862196557865,0.0,0.006215372,False,ATG4A; autophagy related 4A cysteine
hsa:84870,0.0,0.0,2.994619232106931e-06,2.6572833589389365e-05,0.0,0.00031661152,False,RSPO3; R-spondin
hsa:163059,0.0,0.0,3.1760924347029714e-08,1.054183716929509e-07,0.0,9.868418e-07,False,ZNF433; zinc finger protein
hsa:399694,0.0,0.0,5.6485735863366334e-05,0.0002283216303975186,0.0,0.0020801956,False,SHC4; SHC adaptor protein
hsa:29964,2.9349362500000002e-08,3.6363190553000974e-05,3.7231912149851483e-06,1.2479840047657377e-05,0.0,0.000111183144,False,PRICKLE4; prickle planar cell polarity protein
hsa:8435,0.0,0.0,3.3588398913316828e-06,1.1285272329344447e-05,0.0,9.535254e-05,False,SOAT2; sterol O-acyltransferase
hsa:5973,0.0,0.0,5.863900436584159e-06,1.6385215354471438e-05,0.0,9.216697e-05,False,RENBP; renin binding
hsa:388561,3.4860615000000003e-09,4.319150666525735e-06,3.535933430000001e-08,8.394538503400838e-08,0.0,7.5941745e-07,False,ZNF761; zinc finger protein
hsa:4695,0.0,0.0,3.6493868014108915e-06,1.2569326581233628e-05,0.0,0.00012837203,False,NDUFA2; NADH:ubiquinone oxidoreductase subunit
hsa:6343,0.0,0.0,6.7043998951683155e-06,4.1726284044625616e-05,0.0,0.00047760725,False,SCT;
hsa:55119,0.0,0.0,5.573076095074259e-07,1.677526719647221e-06,0.0,1.070396e-05,False,PRPF38B; pre-mRNA processing factor
hsa:3977,7.066557499999999e-07,0.0008755303524096585,3.901790711699481e-05,7.376178986459718e-05,0.0,0.00048597588,False,LIFR; LIF receptor subunit
hsa:157855,0.0,0.0,1.3497490447376238e-06,9.218630744660771e-06,0.0,9.881248e-05,False,KCNU1; potassium calcium-activated channel subfamily U member
hsa:5194,0.0,0.0,3.0082450075158403e-06,7.697150843890036e-06,0.0,5.199265e-05,False,PEX13; peroxisomal biogenesis factor
hsa:523,0.0,0.0,3.893105489881188e-05,0.00014090094192724923,0.0,0.0014602311,False,ATP6V1A; ATPase H+ transporting V1 subunit
hsa:9514,1.89975385e-07,0.0002353751678638581,8.307363913590592e-06,2.3739225088445774e-05,0.0,0.00015711343,False,GAL3ST1; galactose-3-O-sulfotransferase
hsa:4942,0.0,0.0,3.80690308428713e-05,0.00013926900859705956,0.0,0.0010998589,False,OAT; ornithine
hsa:140885,1.0031367e-06,0.0012428634854610068,8.980173587186135e-05,0.00023472865726302953,0.0,0.0016125878,False,SIRPA; signal regulatory protein
hsa:219477,0.0,0.0,1.451821089108911e-08,2.0634254624430752e-07,0.0,2.9326786e-06,False,OR8J1; olfactory receptor family 8 subfamily J member
hsa:29107,0.0,0.0,3.3893491264273065e-06,9.233783833915004e-06,0.0,6.721863e-05,False,NXT1; nuclear transport factor 2 like export factor
hsa:2900,0.0,0.0,3.535582007019803e-06,1.2222862934894393e-05,0.0,0.00011593706,False,GRIK4; glutamate ionotropic receptor kainate type subunit
hsa:85301,0.0,0.0,1.6164006542326732e-05,7.878372347322513e-05,0.0,0.0007045196,False,COL27A1; collagen type XXVII alpha 1
hsa:79549,0.0,0.0,8.756736477722771e-08,6.855662510148704e-07,-0.0,8.019666e-06,False,OR6J1; olfactory receptor family 6 subfamily J member
hsa:54753,9.492875000000001e-09,1.1761455551915961e-05,6.162034190346535e-08,1.119158520194944e-07,0.0,4.960775e-07,False,ZNF853; zinc finger protein
hsa:51645,2.2598379999999997e-09,2.7998877254288777e-06,5.982655040019804e-07,2.147455815405025e-06,0.0,1.7034055e-05,False,PPIL1; peptidylprolyl isomerase like
hsa:1468,0.0,0.0,0.0001871555916732674,0.0003183097590918453,0.0,0.0016164437,False,SLC25A10; solute carrier family 25 member
hsa:6532,1.0196534e-07,0.00012633272999444306,1.126429305400688e-05,3.069967788802559e-05,0.0,0.00025023503,False,SLC6A4; solute carrier family 6 member
hsa:9677,1.86840525e-07,0.0002314911478434239,2.071518217960396e-06,1.3225880066765541e-05,0.0,0.0001677865,False,PPIP5K1; diphosphoinositol pentakisphosphate kinase
hsa:407007,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR222; microRNA
hsa:80095,1.1961379e-08,1.481987569078082e-05,8.00610537222772e-08,1.7722151464034238e-07,0.0,1.2022358e-06,False,ZNF606; zinc finger protein
hsa:442186,0.0,0.0,7.632357822178218e-08,9.538065828682948e-07,0.0,1.3488803e-05,False,OR2J3; olfactory receptor family 2 subfamily J member
hsa:10798,0.0,0.0,1.6471521782178218e-09,2.341043101350252e-08,-0.0,3.3272474e-07,False,OR5I1; olfactory receptor family 5 subfamily I member
hsa:406988,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR205; microRNA
hsa:64116,0.0,0.0,8.295709175196531e-06,6.752959706507488e-05,0.0,0.00072989205,False,SLC39A8; solute carrier family 39 member
hsa:1146,0.0,0.0,1.6034909021963367e-07,6.825426952971679e-07,0.0,6.09371e-06,False,CHRNG; cholinergic receptor nicotinic gamma
hsa:27123,4.2912382000000003e-08,5.316746228301106e-05,1.6402400651742556e-06,1.357543069771936e-05,0.0,0.00017126632,False,DKK2; dickkopf WNT signaling pathway inhibitor
hsa:25825,0.0,0.0,2.2238905405088118e-08,6.19594543145174e-08,0.0,4.3942742e-07,False,BACE2; beta-secretase
hsa:51510,0.0,0.0,1.2260134969509908e-05,9.850583215109057e-05,0.0,0.0013298269,False,CHMP5; charged multivesicular body protein
hsa:4242,0.0,0.0,8.80055614871287e-05,0.0002713831299642724,0.0,0.002486779,False,MFNG; MFNG O-fucosylpeptide
hsa:50617,3.1072445499999997e-06,0.0038498051079107337,3.1621192325495056e-05,8.487912608738052e-05,0.0,0.00067463546,False,ATP6V0A4; ATPase H+ transporting V0 subunit
hsa:26149,0.0,0.0,3.145085421831683e-08,6.14212599339009e-08,0.0,3.8236826e-07,False,ZNF658; zinc finger protein
hsa:23761,0.0,0.0,6.924418874514849e-06,2.0156301486687105e-05,0.0,0.000106178755,False,PISD; phosphatidylserine
hsa:5578,0.0,0.0,0.0005762305012103962,0.0008734454589035663,0.0,0.0061283503,False,PRKCA; protein kinase C
hsa:7350,0.0,0.0,5.240076767252971e-06,2.2888967667108787e-05,0.0,0.00021410662,False,UCP1; uncoupling protein
hsa:6373,3.26669035e-07,0.0004047354816470015,1.709912166237129e-05,4.489301782233547e-05,0.0,0.0003525451,False,CXCL11; C-X-C motif chemokine ligand
hsa:10893,3.59867125e-07,0.0004458671577665654,7.806077228900991e-06,2.3669966767099917e-05,0.0,0.00025631365,False,MMP24; matrix metallopeptidase
hsa:1945,0.0,0.0,1.1747982746237625e-06,5.274974044927035e-06,0.0,6.915476e-05,False,EFNA4; ephrin
hsa:27097,9.27132125e-08,0.00011486955510254683,1.9074290333465346e-06,9.936745933701662e-06,0.0,0.00010924925,False,TAF5L; TATA-box binding protein associated factor 5
hsa:5077,0.0,0.0,4.1829895227227726e-08,2.1223249051378985e-07,0.0,2.6369873e-06,False,PAX3; paired box
hsa:843,2.83728625e-07,0.00035153329331142903,1.8839279096017822e-05,0.00011961094304417688,0.0,0.0013289838,False,CASP10; caspase
hsa:23205,0.0,0.0,4.690242422891091e-05,0.0002712163394303924,0.0,0.0027732563,False,ACSBG1; acyl-CoA synthetase bubblegum family member
hsa:5599,0.00033319663,0.4128230229296381,0.0011799238526633664,0.001824264924820133,0.0,0.010819168,False,MAPK8; mitogen-activated protein kinase
hsa:9672,4.1807674e-07,0.0005179875427412586,1.715655025122278e-05,2.6021952802709713e-05,0.0,0.00014671056,False,SDC3; syndecan
hsa:6300,0.000316848775,0.39256840354913775,0.0006064463794024751,0.0007952462182437515,0.0,0.003585362,False,MAPK12; mitogen-activated protein kinase
hsa:8739,1.85726435e-07,0.00023011081575058227,1.6527210789933173e-06,2.9736922158272673e-06,0.0,1.4422366e-05,False,HRK; harakiri
hsa:390442,0.0,0.0,1.711403915700495e-05,6.833315287862092e-05,0.0,0.00049522356,False,OR11H4; olfactory receptor family 11 subfamily H member
hsa:155054,0.0,0.0,2.2741636736435646e-08,5.2613509607571925e-08,0.0,3.5497817e-07,False,ZNF425; zinc finger protein
hsa:10840,0.0,0.0,3.80819164540693e-06,1.1178631562272346e-05,0.0,8.4108215e-05,False,ALDH1L1; aldehyde dehydrogenase 1 family member
hsa:60496,1.9118087e-06,0.0023686873627658885,3.869801914861388e-05,7.139465449274097e-05,0.0,0.0004733498,False,AASDHPPT; aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl
hsa:9376,0.0,0.0,1.2332173054490101e-06,4.431423006899243e-06,0.0,3.603572e-05,False,SLC22A8; solute carrier family 22 member
hsa:118471,0.0,0.0,6.431410664380694e-08,2.644148803462609e-07,0.0,2.4997669e-06,False,PRAP1; proline rich acidic protein
hsa:489,7.417263700000001e-05,0.09189820504788036,0.00027287190221980196,0.0004372412935067558,0.0,0.0024654064,False,ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting
hsa:84867,9.073317e-09,1.1241632761828578e-05,2.954131238844554e-07,7.632252913183029e-07,0.0,5.2099085e-06,False,PTPN5; protein tyrosine phosphatase non-receptor type
hsa:4908,2.7490527499999998e-08,3.406013639597839e-05,8.099685439405941e-07,2.21612265812171e-06,0.0,2.1963226e-05,False,NTF3; neurotrophin
hsa:57502,8.904363e-08,0.0001103230261039201,4.838986349461882e-06,1.339289292565436e-05,0.0,7.7359364e-05,False,NLGN4X; neuroligin 4
hsa:84869,2.44866465e-05,0.030338396368352952,0.00042153981122722755,0.0010891825527114976,0.0,0.005702142,False,CBR4; carbonyl reductase
hsa:254879,0.0,0.0,6.460214787128713e-07,7.733288433873904e-06,-0.0,0.000109471635,False,OR2T6; olfactory receptor family 2 subfamily T member
hsa:6143,0.0,0.0,1.4091963379207919e-06,2.848982037815596e-06,0.0,1.2646963e-05,False,RPL19; ribosomal protein
hsa:746,2.12397495e-06,0.002631556506096196,0.00010527285514287126,0.0002796774450989934,0.0,0.0020122386,False,TMEM258; transmembrane protein
hsa:9616,3.13773015e-08,3.887576070803798e-05,9.139525611039604e-07,1.928257883232427e-06,0.0,1.5861035e-05,False,RNF7; ring finger protein
hsa:2621,0.0,0.0,1.603989266458911e-05,5.059994670252932e-05,0.0,0.00037639245,False,GAS6; growth arrest specific
hsa:55509,1.8177207e-07,0.00022521144773156255,3.07177629509901e-06,8.86487509909468e-06,0.0,7.094531e-05,False,BATF3; basic leucine zipper ATF-like transcription factor
hsa:84883,0.0,0.0,1.3235988569881435e-05,4.796149632760247e-05,0.0,0.00042935397,False,AIFM2; apoptosis inducing factor mitochondria associated
hsa:29985,0.0,0.0,8.816191636851486e-08,2.405746511768003e-07,0.0,1.799708e-06,False,SLC39A3; solute carrier family 39 member
hsa:9334,2.69201235e-06,0.0033353418853333504,0.0002481138844489108,0.0006664609294520592,0.0,0.0057685445,False,B4GALT5; beta-1
hsa:162967,1.3387405e-08,1.6586689371028005e-05,1.0622125201009902e-07,1.3680498220979005e-07,0.0,5.9603985e-07,False,ZNF320; zinc finger protein
hsa:11024,1.01459345e-07,0.00012570581373335337,1.939296409436633e-06,5.081227536986951e-06,0.0,4.4825338e-05,False,LILRA1; leukocyte immunoglobulin like receptor
hsa:57343,0.0,0.0,7.305911410643568e-08,1.2723622179988045e-07,0.0,4.97783e-07,False,ZNF304; zinc finger protein
hsa:11337,0.0,0.0,0.0002507427402367327,0.0008208140217169569,0.0,0.009873457,False,GABARAP; GABA type A receptor-associated
hsa:64005,6.15889495e-08,7.63073033231183e-05,2.165314638841584e-07,4.1277689500183635e-07,0.0,3.0810609e-06,False,MYO1G; myosin
hsa:3359,7.192634e-05,0.08911509431252335,0.0002818444468574257,0.0007243485213024444,0.0,0.008362609,False,HTR3A; 5-hydroxytryptamine receptor
hsa:3053,0.0,0.0,8.466177758267333e-08,3.295017065892129e-07,0.0,3.8271337e-06,False,SERPIND1; serpin family D member
hsa:64065,4.529486e-07,0.0005611929817049694,5.5330467565328735e-06,1.229603736984276e-05,0.0,8.992362e-05,False,PERP; p53 apoptosis effector related to
hsa:2150,0.0,0.0,1.897868938656435e-05,6.111690510218297e-05,0.0,0.00046912458,False,F2RL1; F2R like trypsin receptor
hsa:79184,8.54992765e-07,0.0010593165297928422,1.850302784422277e-05,3.314571346713483e-05,0.0,0.000213235,False,BRCC3; BRCA1/BRCA2-containing complex subunit
hsa:8324,0.0,0.0,3.7024877313811886e-05,0.00013812413512857813,0.0,0.0012953224,False,FZD7; frizzled class receptor
hsa:10063,0.0,0.0,1.88877714359802e-06,4.319648741631126e-06,0.0,2.6258558e-05,False,COX17; cytochrome c oxidase copper chaperone
hsa:27030,0.0,0.0,0.0001279291276432149,0.00038812653057612945,0.0,0.0023681617,False,MLH3; mutL homolog
hsa:254973,0.0,0.0,5.057554041435643e-06,3.488593185396621e-05,-0.0,0.00036461288,False,OR1L4; olfactory receptor family 1 subfamily L member
hsa:388,0.0,0.0,1.4989498083378714e-07,7.028173042980236e-07,0.0,8.172212e-06,False,RHOB; ras homolog family member
hsa:51710,0.0,0.0,1.1625420738118808e-07,3.114252205922183e-07,0.0,1.9438248e-06,False,ZNF44; zinc finger protein
hsa:259230,3.95508575e-07,0.0004900261011826364,1.162943235861386e-05,3.608970661606675e-05,0.0,0.00028934563,False,SGMS1; sphingomyelin synthase
hsa:26003,0.0,0.0,1.584761584703465e-07,3.4207556101214624e-07,0.0,2.125344e-06,False,GORASP2; golgi reassembly stacking protein
hsa:701,0.0,0.0,1.8839747605643569e-06,5.784994329176253e-06,0.0,5.646598e-05,False,BUB1B; BUB1 mitotic checkpoint serine/threonine kinase
hsa:57679,1.0272722e-08,1.2727668193270134e-05,4.308471994243069e-08,7.274791306591966e-08,0.0,4.1078e-07,False,ALS2; alsin Rho guanine nucleotide exchange factor
hsa:403278,0.0,0.0,8.66563613861386e-09,1.2316183027522718e-07,0.0,1.7504585e-06,False,OR5K4; olfactory receptor family 5 subfamily K member
hsa:8086,0.0,0.0,1.3920132998663364e-07,2.9178369442966555e-07,0.0,1.4616579e-06,False,AAAS; aladin WD repeat
hsa:5708,0.0,0.0,7.3597472088415825e-06,2.2741525655044162e-05,0.0,0.0001704155,False,PSMD2; proteasome 26S subunit ubiquitin receptor
hsa:6811,0.0,0.0,2.9923456275029706e-05,0.00011867245297788711,0.0,0.00090972387,False,STX5; syntaxin
hsa:79023,4.1938293e-08,5.196058823514776e-05,1.065046001351485e-07,2.3780026199508292e-07,0.0,2.0488794e-06,False,NUP37; nucleoporin
hsa:283160,0.0,0.0,1.3328293226732671e-06,1.1925181857972327e-05,0.0,0.00013484684,False,OR8D2; olfactory receptor family 8 subfamily D member
hsa:8861,2.57331905e-08,3.188283594535228e-05,2.9861046094777225e-06,7.852221134653763e-06,0.0,7.273237e-05,False,LDB1; LIM domain binding
hsa:3720,3.17184445e-07,0.00039298429102106925,3.790347891865841e-05,0.00010793286424551799,0.0,0.00077379815,False,JARID2; jumonji and AT-rich interaction domain containing
hsa:51728,0.0,0.0,5.3394156789158436e-05,0.00017859348257485334,0.0,0.0011324317,False,POLR3K; RNA polymerase III subunit
hsa:412,0.0,0.0,2.586022715723762e-05,0.00011713640419896739,0.0,0.00094002206,False,STS; steroid
hsa:1571,0.000187884605,0.23278473914349315,0.00043161185615425745,0.0006882592360315032,0.0,0.003813252,False,CYP2E1; cytochrome P450 family 2 subfamily E member
hsa:1447,0.0,0.0,4.933517626584159e-08,4.036107973053226e-07,0.0,4.6203522e-06,False,CSN2; casein
hsa:53371,1.4933611499999998e-07,0.0001850240394894392,2.7692902715346527e-07,3.4427662926939063e-07,0.0,1.9942272e-06,False,NUP54; nucleoporin
hsa:28956,0.0,0.0,1.1024907277475243e-06,3.4614597963522582e-06,0.0,3.19777e-05,False,LAMTOR2; late endosomal/lysosomal adaptor
hsa:390429,0.0,0.0,2.9569959965000003e-06,1.6267062142295496e-05,-0.0,0.00015563793,False,OR4N2; olfactory receptor family 4 subfamily N member
hsa:66004,4.9195635e-09,6.095226940213382e-06,7.2624806163415825e-06,2.2039905188973883e-05,0.0,0.00019257657,False,LYNX1; Ly6/neurotoxin
hsa:58508,3.3961017e-08,4.20769252669357e-05,3.509122377939803e-05,0.00012675783063285213,0.0,0.00096074905,False,KMT2C; lysine methyltransferase
hsa:7132,0.0,0.0,0.00039010265102970283,0.0011868993793122528,0.0,0.009836424,False,TNFRSF1A; TNF receptor superfamily member
hsa:7936,0.0,0.0,3.781656097956931e-05,0.00010053657173309385,0.0,0.00071382115,False,NELFE; negative elongation factor complex member
hsa:5360,0.0,0.0,9.371693025544556e-05,0.00039676584799494996,0.0,0.0037632356,False,PLTP; phospholipid transfer
hsa:5188,0.0,0.0,1.16092452155297e-06,5.997873145894181e-06,0.0,6.962552e-05,False,GATB; glutamyl-tRNA amidotransferase subunit
hsa:57486,0.000154282055,0.19115194631139182,0.0003626248496442772,0.00048724757439794897,0.0,0.0025267403,False,NLN;
hsa:6571,5.06987805e-07,0.0006281463238345535,0.0005425396031683663,0.001258997576297376,0.0,0.006811979,False,SLC18A2; solute carrier family 18 member
hsa:57449,4.04847385e-08,5.0159667371443405e-05,1.0581473773450491e-07,1.941864500798448e-07,0.0,1.2624188e-06,False,PLEKHG5; pleckstrin homology and RhoGEF domain containing
hsa:4991,0.0,0.0,8.873850283958417e-06,5.454697825161415e-05,-0.0,0.0006277232,False,OR1D2; olfactory receptor family 1 subfamily D member
hsa:29894,0.0,0.0,5.979186599400296e-07,1.0808071464994904e-06,0.0,6.448183e-06,False,CPSF1; cleavage and polyadenylation specific factor
hsa:81027,7.5015423e-08,9.294239767432672e-05,8.501611461851832e-05,0.00034731950470696113,0.0,0.0028440284,False,TUBB1; tubulin beta 1 class
hsa:8994,0.0,0.0,0.00016612277999623765,0.00047675220207546383,0.0,0.0041567204,False,LIMD1; LIM domain containing
hsa:23586,0.0,0.0,1.6755116867262383e-05,4.36624640837166e-05,0.0,0.0002339975,False,RIGI; RNA sensor
hsa:1053,0.0,0.0,1.0466293689559056e-06,9.217134752725693e-06,0.0,0.00012516177,False,CEBPE; CCAAT enhancer binding protein
hsa:340485,3.0537454000000005e-07,0.0003783520881605186,4.032481647968318e-06,8.063901293201063e-06,0.0,4.0461116e-05,False,ACER2; alkaline ceramidase
hsa:3908,0.0,0.0,0.0001372121289341584,0.0004911159533987923,0.0,0.0046768948,False,LAMA2; laminin subunit alpha
hsa:92552,0.0,0.0,1.0596316633663366e-09,8.522663261826127e-09,0.0,1.00113695e-07,False,ATXN3L; ataxin 3
hsa:845,0.0,0.0,2.470512969380891e-05,0.00012782469128156965,0.0,0.0011897179,False,CASQ2; calsequestrin
hsa:2773,0.000271572295,0.33647187777931437,0.00036445969567326723,0.00041838494483183495,0.0,0.0021887822,False,GNAI3; G protein subunit alpha
hsa:30837,8.0092595e-06,0.009923289795031607,0.00015514241957047132,0.0003051479910539821,0.0,0.0020699634,False,SOCS7; suppressor of cytokine signaling
hsa:2958,0.0,0.0,2.6397892109801977e-06,1.1826716545057714e-05,0.0,0.00012675478,False,GTF2A2; general transcription factor IIA subunit
hsa:4124,1.1008239e-07,0.0001363895697598123,3.466466781039604e-05,0.00013773626480697226,0.0,0.0012313797,False,MAN2A1; mannosidase alpha class 2A member
hsa:3339,6.765996e-06,0.008382914682690036,6.288477764881188e-05,0.00016767644662974316,0.0,0.001082229,False,HSPG2; heparan sulfate proteoglycan
hsa:164091,0.0,0.0,8.653995523955446e-07,2.6815657131267453e-06,0.0,1.7920434e-05,False,PAQR7; progestin and adipoQ receptor family member
hsa:7276,0.0,0.0,3.7275454350331678e-06,1.3076107650158486e-05,0.0,0.00010186314,False,TTR;
hsa:5575,0.0,0.0,1.1842966940103962e-06,8.712674758967802e-06,0.0,0.000118605225,False,PRKAR1B; protein kinase cAMP-dependent type I regulatory subunit
hsa:387787,0.0,0.0,4.836481213427722e-06,1.2518462226664948e-05,0.0,8.698442e-05,False,LIPT2; lipoyl(octanoyl) transferase
hsa:285676,4.3194542999999995e-10,5.35170533247117e-07,5.085042639101483e-08,1.3193082175025796e-07,0.0,9.681575e-07,False,ZNF454; zinc finger protein
hsa:153129,7.484204e-08,9.272758009293459e-05,6.319607710643564e-07,1.777002733397089e-06,0.0,1.482726e-05,False,SLC38A9; solute carrier family 38 member
hsa:5928,1.5483006000000001e-06,0.0019183091200405372,1.9126637550113864e-05,4.53984420355872e-05,0.0,0.00032131423,False,RBBP4; RB binding protein 4
hsa:3249,4.5781983e-09,5.672283245413767e-06,3.252323391618813e-08,1.332212507554502e-07,0.0,1.7289356e-06,False,HPN;
hsa:2255,0.0,0.0,1.0870339864882676e-05,4.400193214102619e-05,0.0,0.0005360523,False,FGF10; fibroblast growth factor
hsa:51276,6.1990788e-09,7.680517205696327e-06,5.195465567170792e-08,1.0838575671962928e-07,0.0,9.0805014e-07,False,ZNF571; zinc finger protein
hsa:9611,0.0,0.0,9.873470026153467e-05,0.00028590091797402536,0.0,0.0023776926,False,NCOR1; nuclear receptor corepressor
hsa:462,0.0,0.0,3.202447510721781e-07,1.4059727384054412e-06,0.0,1.352737e-05,False,SERPINC1; serpin family C member
hsa:1477,0.0,0.0,4.7099291588351497e-07,8.883398799297509e-07,0.0,3.994932e-06,False,CSTF1; cleavage stimulation factor subunit
hsa:121536,0.0,0.0,1.75104659173869e-05,6.796832102235893e-05,0.0,0.0005325572,False,AEBP2; AE binding protein
hsa:4987,0.0,0.0,1.242735119183153e-05,2.997497338909981e-05,0.0,0.00023153011,False,OPRL1; opioid related nociceptin receptor
hsa:92285,2.6605291000000002e-09,3.2963348568509517e-06,9.840576399663364e-08,1.6380042346374553e-07,0.0,6.316181e-07,False,ZNF585B; zinc finger protein
hsa:4363,0.0,0.0,0.00028633595977722767,0.0005232957778959344,0.0,0.0031412796,False,ABCC1; ATP binding cassette subfamily C member
hsa:65258,1.68745925e-07,0.00020907235125864864,2.5200981671237635e-05,6.012878757327084e-05,0.0,0.00038764128,False,MPPE1; metallophosphoesterase
hsa:2668,4.2964236499999994e-09,5.32317088254881e-06,2.550403200564356e-07,1.6367550388574965e-06,0.0,1.9149289e-05,False,GDNF; glial cell derived neurotrophic
hsa:23516,0.0,0.0,3.972961788737624e-06,1.1028309584738597e-05,0.0,9.33408e-05,False,SLC39A14; solute carrier family 39 member
hsa:4126,6.074091e-06,0.0075256601730026755,6.766348937116335e-05,0.0001309014448867051,0.0,0.0006464972,False,MANBA; mannosidase
hsa:29924,1.1383664e-07,0.0001410409998593112,1.7089284353222778e-06,4.096558440706046e-06,0.0,2.4974139e-05,False,EPN1; epsin
hsa:8578,8.6135705e-08,0.00010672017337112785,2.0806393040999995e-05,6.77366318639311e-05,0.0,0.00047796828,False,SCARF1; scavenger receptor class F member
hsa:148203,0.0,0.0,1.7489111648267333e-07,3.732882574082787e-07,0.0,1.9570111e-06,False,ZNF738; zinc finger protein
hsa:51363,0.0,0.0,0.00042672112787452013,0.001067425690967302,0.0,0.005707249,False,CHST15; carbohydrate sulfotransferase
hsa:874,0.0,0.0,4.528393118494158e-05,0.00015506507295331805,0.0,0.0014774717,False,CBR3; carbonyl reductase
hsa:57030,0.0,0.0,0.0001475663206919307,0.0010467209322680907,0.0,0.014293917,False,SLC17A7; solute carrier family 17 member
hsa:3399,0.0,0.0,0.00010596783146237623,0.0005200939741375948,0.0,0.004106431,False,ID3; inhibitor of DNA binding
hsa:50814,0.0,0.0,4.924631266188118e-05,0.00013652993185288658,0.0,0.0008251931,False,NSDHL; NAD(P) dependent steroid
hsa:6182,4.3858254e-08,5.433937611162482e-05,2.910280763074257e-07,6.799542372084314e-07,0.0,3.8061041e-06,False,MRPL12; mitochondrial ribosomal protein
hsa:7171,0.0,0.0,0.0003802446684497672,0.0008418014452852248,0.0,0.004984123,False,TPM4; tropomyosin
hsa:23436,0.0,0.0,2.6587347481188117e-07,1.7507990373041249e-06,0.0,1.8133993e-05,False,CELA3B; chymotrypsin like elastase
hsa:374378,0.0,0.0,0.00011240240484190101,0.00030946891280867963,0.0,0.0024985184,False,GALNT18; polypeptide N-acetylgalactosaminyltransferase
hsa:22999,2.2263837e-07,0.00027584386109645603,1.7823932520937133e-05,4.8019677812317594e-05,0.0,0.0002485522,False,RIMS1; regulating synaptic membrane exocytosis
hsa:7114,0.0,0.0,1.852315799139604e-05,6.237483351223647e-05,0.0,0.0003548453,False,TMSB4X; thymosin beta 4
hsa:1871,4.5419123e-05,0.05627325719252639,0.00012569823459792088,0.000206369053438153,0.0,0.0011330132,False,E2F3; E2F transcription factor
hsa:5319,2.3182759e-05,0.028722909503104136,4.587108348539609e-05,6.035670488477928e-05,0.0,0.00038608254,False,PLA2G1B; phospholipase A2 group
hsa:1738,2.8867259000000002e-05,0.03576587531534398,0.00023159552642326722,0.0003887656019223162,0.0,0.0023389328,False,DLD; dihydrolipoamide
hsa:1026,0.0,0.0,0.00028103009206435634,0.0006209641173724145,0.0,0.003967383,False,CDKN1A; cyclin dependent kinase inhibitor
hsa:390191,0.0,0.0,5.257125720792079e-07,2.738582731715256e-06,0.0,2.7241915e-05,False,OR5B12; olfactory receptor family 5 subfamily B member
hsa:4617,0.0,0.0,2.2676626554455446e-09,1.4158745205701183e-08,-0.0,1.7901968e-07,False,MYF5; myogenic factor
hsa:339318,0.0,0.0,3.5077225609900984e-08,1.167121622101874e-07,0.0,1.0671945e-06,False,ZNF181; zinc finger protein
hsa:54,0.0,0.0,4.198274459207427e-05,0.000229852599269778,0.0,0.0028303813,False,ACP5; acid phosphatase 5
hsa:83401,0.0,0.0,4.2491308730524756e-06,1.9079206607009907e-05,0.0,0.00023054107,False,ELOVL3; ELOVL fatty acid elongase
hsa:210,0.0,0.0,0.00012800019994127726,0.0004205751693196124,0.0,0.0039687348,False,ALAD; aminolevulinate
hsa:4066,0.0,0.0,1.986391577656685e-06,1.6510570301114973e-05,0.0,0.00023131484,False,LYL1; LYL1 basic helix-loop-helix family
hsa:8879,2.3297585499999998e-07,0.00028865176916920507,2.2311550070152487e-05,3.94720076311235e-05,0.0,0.0002780707,False,SGPL1; sphingosine-1-phosphate lyase
hsa:4430,0.0,0.0,2.7719049203981196e-06,6.4248136228149325e-06,0.0,2.7426595e-05,False,MYO1B; myosin
hsa:5348,0.0,0.0,4.9636805547706424e-05,0.000462478621729811,0.0,0.0058619613,False,FXYD1; FXYD domain containing ion transport regulator
hsa:317749,2.85855085e-07,0.0003541679287377806,7.981180347613861e-05,0.00014923753414985773,0.0,0.0008127676,False,DHRS4L2; dehydrogenase/reductase 4 like
hsa:5547,0.0,0.0,0.00011720551163069312,0.0003715495894587844,0.0,0.0029320964,False,PRCP;
hsa:89941,0.0,0.0,7.373083352636141e-06,2.4098801982901203e-05,0.0,0.00012216448,False,RHOT2; ras homolog family member
hsa:50700,0.0,0.0,1.2302289454990096e-05,7.580584978196307e-05,0.0,0.0008309107,False,RDH8; retinol dehydrogenase
hsa:201562,0.0,0.0,6.23070654480198e-06,1.9512103289065837e-05,0.0,0.00017526872,False,HACD2; 3-hydroxyacyl-CoA dehydratase
hsa:3703,0.0,0.0,0.0001262064890632672,0.0004096489230672307,0.0,0.0022156823,False,STT3A; STT3 oligosaccharyltransferase complex catalytic subunit
hsa:7345,9.725107499999999e-09,1.2049186321199273e-05,1.843396902378218e-07,3.8314518930468856e-07,0.0,3.3181454e-06,False,UCHL1; ubiquitin C-terminal hydrolase
hsa:594857,0.0,0.0,7.801119708910892e-08,1.108183464654676e-06,0.0,1.5750284e-05,False,NPS; neuropeptide
hsa:3449,0.0,0.0,1.2390650794059405e-06,1.3010038270192705e-05,0.0,0.00018151378,False,IFNA16; interferon alpha
hsa:126969,3.4385112e-08,4.260236929651472e-05,1.036039212416337e-06,5.342838472577652e-06,0.0,4.510378e-05,False,SLC44A3; solute carrier family 44 member
hsa:6166,2.54391895e-07,0.00031518575413772666,1.2876186889207917e-06,2.502495702745384e-06,0.0,1.3485442e-05,False,RPL36AL; ribosomal protein L36a
hsa:3860,1.39536605e-07,0.00017288267016817924,1.3488237002386141e-05,5.481466874421036e-05,0.0,0.00061335316,False,KRT13; keratin
hsa:10955,3.6405613000000004e-07,0.0004510572393924432,1.4000270394242092e-05,3.180900931616316e-05,0.0,0.00024494468,False,SERINC3; serine incorporator
hsa:9246,0.0,0.0,4.4152339839108913e-07,1.093186288744929e-06,0.0,6.4351275e-06,False,UBE2L6; ubiquitin conjugating enzyme E2
hsa:2051,0.0,0.0,9.731164078352573e-06,3.6360794474617005e-05,0.0,0.00029875722,False,EPHB6; EPH receptor
hsa:2891,0.0015262292000000001,1.8909631589835805,0.002665910254418811,0.003176678209115984,0.0,0.01612356,True,GRIA2; glutamate ionotropic receptor AMPA type subunit
hsa:2346,0.0,0.0,4.007811441648515e-05,0.00011290149932800196,0.0,0.0012397098,False,FOLH1; folate hydrolase
hsa:253782,0.0,0.0,3.934841448633663e-05,8.675043295713146e-05,0.0,0.0005842946,False,CERS6; ceramide synthase
hsa:779,0.0,0.0,2.422781269178217e-05,0.00019426348887887992,0.0,0.0026561758,False,CACNA1S; calcium voltage-gated channel subunit alpha1
hsa:3066,0.000287185715,0.3558165489504186,0.000688452342613861,0.0008884378482118927,0.0,0.004346494,False,HDAC2; histone deacetylase
hsa:2710,0.0,0.0,4.497629406613863e-05,0.00017736655932394722,0.0,0.0018563087,False,GK; glycerol
hsa:9134,4.196331e-05,0.05199158372740298,0.00023472073872297025,0.0003616659748072565,0.0,0.0015136567,False,CCNE2; cyclin
hsa:22877,0.0,0.0,1.1115166167178215e-05,3.267232377490158e-05,0.0,0.00024677737,False,MLXIP; MLX interacting
hsa:55215,0.0,0.0,3.378574672637128e-05,9.047159303583554e-05,0.0,0.0005572111,False,FANCI; FA complementation group
hsa:6195,0.0,0.0,2.6328135258168326e-05,5.286131152001332e-05,0.0,0.0002994528,False,RPS6KA1; ribosomal protein S6 kinase
hsa:92935,1.3557588499999999e-05,0.01679754284491442,4.869823371188117e-05,8.563784139342868e-05,0.0,0.0005094855,False,MARS2; methionyl-tRNA synthetase 2
hsa:6892,2.514458e-08,3.1153560964575536e-05,1.9082163183574254e-06,4.3034761868746405e-06,0.0,2.354054e-05,False,TAPBP; TAP binding
hsa:26832,0.0,0.0,1.8929527048663366e-08,8.009197880730492e-08,0.0,7.1414354e-07,False,RNU5B-1; RNA
hsa:102723555,1.01504487e-07,0.00012576174364147127,1.1109022458163377e-05,3.4080265640765446e-05,0.0,0.00024685948,False,SPDYE16; speedy/RINGO cell cycle regulator family member
hsa:3110,0.0,0.0,7.638735535257428e-05,0.00023779747671715857,0.0,0.0016589138,False,MNX1; motor neuron and pancreas homeobox
hsa:643246,6.1002657e-08,7.558090029145806e-05,4.676780891584158e-06,9.165547676374976e-06,0.0,5.7167235e-05,False,MAP1LC3B2; microtubule associated protein 1 light chain 3 beta
hsa:27019,0.0,0.0,2.8712678601237625e-08,1.5518283891211217e-07,0.0,2.0954851e-06,False,DNAI1; dynein axonemal intermediate chain
hsa:6731,1.134842e-07,0.00014060433473997512,8.894490752623761e-06,4.424768185359781e-05,0.0,0.00044483613,False,SRP72; signal recognition particle
hsa:2949,0.0,0.0,0.00012779476089866336,0.000422358468697497,0.0,0.0036362146,False,GSTM5; glutathione S-transferase mu
hsa:23633,2.30608785e-08,2.8571902344219684e-05,1.4233498199618814e-05,4.577292288657677e-05,0.0,0.0003283526,False,KPNA6; karyopherin subunit alpha
hsa:58528,1.7206198e-07,0.00021318086775024984,2.347812362007624e-06,5.647606462303091e-06,0.0,3.2952834e-05,False,RRAGD; Ras related GTP binding
hsa:55821,2.0800837000000002e-10,2.5771762486933513e-07,2.9788199659897403e-06,2.4212403548934837e-05,0.0,0.00033091815,False,ALLC;
hsa:5869,7.8855555e-06,0.009770023361248983,0.000227309589444307,0.0005191585794521274,0.0,0.0036425276,False,RAB5B; RAB5B
hsa:51266,0.0,0.0,6.86864635041089e-08,3.7780274572150654e-07,0.0,4.5523316e-06,False,CLEC1B; C-type lectin domain family 1 member
hsa:1145,0.0,0.0,8.814696062734657e-07,4.275183242915952e-06,0.0,5.3083004e-05,False,CHRNE; cholinergic receptor nicotinic epsilon
hsa:4649,3.1083589e-08,3.851185762137644e-05,1.2672068158341584e-06,4.0533035232556015e-06,0.0,2.0588355e-05,False,MYO9A; myosin
hsa:151,0.0,0.0,4.034188697328713e-06,2.682658022366373e-05,0.0,0.00033176676,False,ADRA2B; adrenoceptor alpha
hsa:6230,0.0,0.0,7.0173071084703e-07,1.933724472755942e-06,0.0,1.843742e-05,False,RPS25; ribosomal protein
hsa:254122,1.25149865e-09,1.550578275312572e-06,6.352599613618812e-07,1.8911605190119716e-06,0.0,1.4135402e-05,False,SNX32; sorting nexin
hsa:6609,0.0,0.0,2.7869828948628714e-05,0.00017256730015616185,0.0,0.0021769784,False,SMPD1; sphingomyelin phosphodiesterase
hsa:790,4.62420335e-06,0.005729282452791792,0.00018294587365544563,0.0005613244580148166,0.0,0.003179467,False,CAD; carbamoyl-phosphate synthetase 2
hsa:283748,8.58099325e-05,0.10631654867589208,0.00023340011928019795,0.00035666544723806325,0.0,0.0026102534,False,PLA2G4D; phospholipase A2 group
hsa:3776,0.0,0.0,2.782493801942574e-05,6.573561246466849e-05,0.0,0.0003494166,False,KCNK2; potassium two pore domain channel subfamily K member
hsa:57038,9.158943e-08,0.00011347721422333257,4.311288078316832e-06,1.0180699817197568e-05,0.0,6.242332e-05,False,RARS2; arginyl-tRNA synthetase 2
hsa:5881,0.000161472015,0.20006014271764955,0.0005822696519638619,0.0008323525549753878,0.0,0.0047409073,False,RAC3; Rac family small GTPase
hsa:23352,0.0,0.0,5.473687018316834e-07,1.085514543742437e-06,0.0,5.8179517e-06,False,UBR4; ubiquitin protein ligase E3 component n-recognin
hsa:100,0.0,0.0,6.370223815846536e-05,0.00027100296562903355,0.0,0.0030874687,False,ADA; adenosine
hsa:406949,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR15B; microRNA
hsa:113457,1.4865459e-07,0.00018417964556293967,0.00011906993036464354,0.00043045844240382933,0.0,0.0023875441,False,TUBA3D; tubulin alpha
hsa:7292,0.0,0.0,2.930554006239976e-06,1.499952296881857e-05,0.0,0.0001831835,False,TNFSF4; TNF superfamily member
hsa:4143,0.0,0.0,4.6604044359252475e-06,1.8708625098905765e-05,0.0,0.00016138762,False,MAT1A; methionine adenosyltransferase
hsa:3678,0.0,0.0,0.0005232182551980197,0.001956468187083218,0.0,0.023473673,False,ITGA5; integrin subunit alpha
hsa:112744,0.0,0.0,2.4693623442336627e-06,7.99519277861294e-06,0.0,6.320425e-05,False,IL17F; interleukin
hsa:4099,0.0,0.0,4.691659316270791e-07,3.1349740530482735e-06,0.0,4.015527e-05,False,MAG; myelin associated
hsa:3785,0.0,0.0,6.0483424685891106e-05,0.00017248792422045408,0.0,0.0015144001,False,KCNQ2; potassium voltage-gated channel subfamily Q member
hsa:54106,4.1117912499999996e-06,0.005094415551203609,6.10927680690099e-05,0.0001389661405361053,0.0,0.0010366355,False,TLR9; toll like receptor
hsa:84649,0.00027522136,0.340992986063533,0.0003635567773475246,0.00043573149415809456,0.0,0.0028047503,False,DGAT2; diacylglycerol O-acyltransferase
hsa:1829,3.9356831e-08,4.876221571133806e-05,6.964987218426236e-06,1.77008021518687e-05,0.0,0.00011734876,False,DSG2; desmoglein
hsa:10795,0.0,0.0,6.94002107780198e-08,2.0769547027644608e-07,0.0,1.1920082e-06,False,ZNF268; zinc finger protein
hsa:4780,0.0,0.0,1.0760013530693067e-06,3.817557250392252e-06,0.0,3.234381e-05,False,NFE2L2; NFE2 like bZIP transcription factor
hsa:283464,1.02475305e-06,0.0012696456499496007,4.668798576439109e-05,0.00012648980954954483,0.0,0.0008047712,False,GXYLT1; glucoside xylosyltransferase
hsa:2205,0.0,0.0,2.4422826654801988e-05,0.00011662550115773256,0.0,0.0009831206,False,FCER1A; Fc epsilon receptor
hsa:1109,0.0,0.0,2.1170581342128712e-06,7.146331455687623e-06,0.0,6.4740794e-05,False,AKR1C4; aldo-keto reductase family 1 member
hsa:731,0.0,0.0,2.3228057631714846e-06,2.0785694997356403e-05,0.0,0.00027176863,False,C8A; complement C8 alpha
hsa:51170,5.11902615e-06,0.0063423566129671444,8.660720115503959e-05,0.0001783780815579405,0.0,0.0011074484,False,HSD17B11; hydroxysteroid 17-beta dehydrogenase
hsa:387712,5.721911750000001e-07,0.0007089318116967797,1.3156677673326735e-05,3.435121740960552e-05,0.0,0.00024665726,False,ENO4; enolase
hsa:119504,1.481912e-07,0.0001836055159248477,1.4387401401732682e-05,4.1125138456565417e-05,0.0,0.00039520315,False,ANAPC16; anaphase promoting complex subunit
hsa:65010,0.0,0.0,7.874176063465347e-06,2.0117159907479958e-05,0.0,0.00016190192,False,SLC26A6; solute carrier family 26 member
hsa:79726,1.0794128199999999e-07,0.00013373678579564423,1.0957141262440594e-06,3.2712595618516926e-06,0.0,2.9290797e-05,False,WDR59; WD repeat domain
hsa:117581,0.0,0.0,1.51127335754802e-07,9.707800363944098e-07,0.0,1.06224215e-05,False,TWIST2; twist family bHLH transcription factor
hsa:162972,0.0,0.0,3.039425799257426e-08,7.57041285290578e-08,0.0,3.6892584e-07,False,ZNF550; zinc finger protein
hsa:4298,4.0477256500000003e-07,0.0005015039734413984,9.298586055633659e-05,0.0002776405135063361,0.0,0.0017186017,False,MLLT1; MLLT1 super elongation complex
hsa:50604,0.0,0.0,9.014955766720298e-07,4.113551848882048e-06,0.0,4.7493224e-05,False,IL20; interleukin
hsa:5094,1.36379693e-07,0.0001689713282228455,1.6755223836363864e-05,3.032167449725096e-05,0.0,0.0001326272,False,PCBP2; poly(rC) binding protein
hsa:6776,0.0,0.0,9.032428255000002e-05,0.0002617124392005615,0.0,0.0016028333,False,STAT5A; signal transducer and activator of transcription
hsa:4708,0.0,0.0,4.334944578198019e-06,7.1654717119478415e-06,0.0,3.2291337e-05,False,NDUFB2; NADH:ubiquinone oxidoreductase subunit
hsa:4800,5.397793999999999e-07,0.000668774361923007,2.838289311386139e-06,6.662189826151276e-06,0.0,5.5383243e-05,False,NFYA; nuclear transcription factor Y subunit
hsa:6727,0.0,0.0,6.459670625618814e-05,0.0002172831159777524,0.0,0.0015183195,False,SRP14; signal recognition particle
hsa:540,4.4014425000000003e-07,0.0005453286841769629,2.076745411207921e-05,3.776428867276933e-05,0.0,0.0002836648,False,ATP7B; ATPase copper transporting
hsa:3001,0.0,0.0,2.3340237306514864e-06,5.570880364917632e-06,0.0,3.6038575e-05,False,GZMA; granzyme
hsa:92335,0.0,0.0,3.6724590247475244e-06,9.428641231939197e-06,0.0,8.0525686e-05,False,STRADA; STE20 related adaptor
hsa:9869,7.075886499999999e-07,0.0008766861942262191,0.00013413771473237628,0.0002655012509399182,0.0,0.0013853776,False,SETDB1; SET domain bifurcated histone lysine methyltransferase
hsa:81605,4.889334e-07,0.0006057773279377583,0.00011115852225445542,0.00029483662704142517,0.0,0.0015337107,False,URM1; ubiquitin related modifier
hsa:8202,0.0,0.0,1.1160508803990095e-05,3.034160596384512e-05,0.0,0.00019995405,False,NCOA3; nuclear receptor coactivator
hsa:6648,0.0,0.0,6.647680167653464e-05,0.000136601330082681,0.0,0.00067215774,False,SOD2; superoxide dismutase
hsa:4700,3.22739855e-06,0.003998673172684042,7.92287795084158e-06,1.4862718352573468e-05,0.0,0.00010567446,False,NDUFA6; NADH:ubiquinone oxidoreductase subunit
hsa:774,0.00033662944,0.41707619620255826,0.0012462627709752476,0.0019094363685311397,0.0,0.009347117,False,CACNA1B; calcium voltage-gated channel subunit alpha1
hsa:55048,0.0,0.0,8.457564267891087e-08,2.0023703465087093e-07,0.0,1.3469287e-06,False,VPS37C; VPS37C subunit of
hsa:9409,4.8601055e-07,0.0006021559834704692,3.1890474132227737e-06,1.176165565560855e-05,0.0,0.000110566325,False,PEX16; peroxisomal biogenesis factor
hsa:3078,0.0,0.0,2.997139914113862e-07,1.0762218768317738e-06,0.0,9.154241e-06,False,CFHR1; complement factor H related
hsa:183,0.0,0.0,0.00010528891122693067,0.0003836304349147854,0.0,0.002657429,False,AGT;
hsa:442890,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR133B; microRNA
hsa:5825,0.0,0.0,0.0006854406890415837,0.0016939250147123962,0.0,0.010152932,False,ABCD3; ATP binding cassette subfamily D member
hsa:54872,0.0,0.0,2.5874301787623764e-05,4.859665100404302e-05,0.0,0.00022647333,False,PIGG; phosphatidylinositol glycan anchor biosynthesis class
hsa:339745,1.3443920500000001e-05,0.016656710786167712,9.788295111287128e-05,0.00020762225328831686,0.0,0.0014968483,False,SPOPL; speckle type BTB/POZ protein
hsa:100169754,0.0,0.0,1.7601831930696535e-07,9.404157182240944e-07,0.0,9.359554e-06,False,RNA5S3; RNA
hsa:8131,0.0,0.0,5.918408882673268e-07,2.5213158411636875e-06,0.0,3.101981e-05,False,NPRL3; NPR3 like
hsa:6383,1.97984905e-06,0.002452987804124466,2.3236163847871288e-05,4.2482133195190165e-05,0.0,0.00030581278,False,SDC2; syndecan
hsa:3590,0.0001044326455,0.12938966521915082,0.00021205294064382657,0.000295788483676336,0.0,0.0015897239,False,IL11RA; interleukin 11 receptor subunit
hsa:201266,9.94501025e-09,1.2321640811526922e-05,3.231117912753466e-08,6.041154145862063e-08,0.0,3.9227416e-07,False,SLC39A11; solute carrier family 39 member
hsa:1398,6.920839999999999e-05,0.08574762866036059,0.0001319107803069307,0.0002509241362808933,0.0,0.0028512795,False,CRK; CRK proto-oncogene
hsa:7169,0.0,0.0,0.00013282894205658417,0.0005640620830822304,0.0,0.005447774,False,TPM2; tropomyosin
hsa:406992,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR210; microRNA
hsa:5733,2.4128043e-06,0.00298940948131327,3.0023149394401008e-05,6.977338936710541e-05,0.0,0.000447342,False,PTGER3; prostaglandin E receptor
hsa:170506,0.0,0.0,2.1158596586465342e-06,8.310820109085855e-06,0.0,8.806652e-05,False,DHX36; DEAH-box helicase
hsa:8560,0.0,0.0,3.1077475967906934e-05,8.167402949651862e-05,0.0,0.00067037164,False,DEGS1; delta 4-desaturase
hsa:255022,3.7914069e-06,0.0046974666508910615,4.278155040164357e-05,0.00010970574836674789,0.0,0.00081619056,False,CALHM1; calcium homeostasis modulator
hsa:26740,0.0,0.0,1.4612497558415845e-06,7.864777235757569e-06,0.0,7.237874e-05,False,OR1J2; olfactory receptor family 1 subfamily J member
hsa:51807,9.333190250000001e-07,0.0011563609789758153,5.733452719064357e-06,1.3112860328957995e-05,0.0,9.812686e-05,False,TUBA8; tubulin alpha
hsa:3442,0.0,0.0,4.3583706472277235e-06,9.711298341139883e-06,0.0,5.621057e-05,False,IFNA5; interferon alpha
hsa:4621,1.50529485e-08,1.8650259769356497e-05,7.283877627100497e-07,2.548654611075964e-06,0.0,1.6142034e-05,False,MYH3; myosin heavy chain
hsa:3692,1.45332045e-08,1.800630881094031e-05,3.0759689132315336e-06,6.282641345389051e-06,0.0,3.739694e-05,False,EIF6; eukaryotic translation initiation factor
hsa:221823,0.0,0.0,1.439072328440594e-07,1.8406717838288675e-06,0.0,2.6143893e-05,False,PRPS1L1; phosphoribosyl pyrophosphate synthetase 1 like
hsa:158067,0.0,0.0,4.488537253277229e-06,1.1411497188857603e-05,0.0,7.4896154e-05,False,AK8; adenylate kinase
hsa:81035,0.0,0.0,1.8068199409554448e-07,6.385718581966554e-07,0.0,5.45364e-06,False,COLEC12; collectin subfamily member
hsa:2563,0.0,0.0,4.8145807698143564e-05,0.00017680224649293714,0.0,0.0013845795,False,GABRD; gamma-aminobutyric acid type A receptor subunit
hsa:9129,2.3329668e-08,2.8904926402481457e-05,3.7440845954549525e-07,9.332023932467142e-07,0.0,6.0056886e-06,False,PRPF3; pre-mRNA processing factor
hsa:27429,5.1335918e-08,6.360403121012365e-05,0.0002353191163837129,0.0004705015095159867,0.0,0.0018799999,False,HTRA2; HtrA serine peptidase
hsa:126129,0.00021711524,0.2690008290326762,0.0003623578645727725,0.0005405779993428558,0.0,0.0033246796,False,CPT1C; carnitine palmitoyltransferase
hsa:9373,0.0,0.0,1.8628867327123772e-07,5.016544944961255e-07,0.0,2.6677549e-06,False,PLAA; phospholipase A2 activating
hsa:25920,0.0,0.0,8.26621930444703e-06,3.169246220440213e-05,0.0,0.00031330402,False,NELFB; negative elongation factor complex member
hsa:7088,0.0,0.0,0.0001357865413743069,0.0006905861158756106,0.0,0.007000988,False,TLE1; TLE family member 1
hsa:921,1.75365735e-07,0.00021727414482246665,1.460524028557253e-05,2.6865656838197332e-05,0.0,0.00013521989,False,CD5; CD5
hsa:7706,8.07132095e-07,0.0010000182515694468,4.298893000601335e-05,0.00013802408023603994,0.0,0.0013717144,False,TRIM25; tripartite motif containing
hsa:199746,0.0,0.0,2.6035176391831687e-07,5.774461929506807e-07,0.0,5.117563e-06,False,U2AF1L4; U2 small nuclear RNA auxiliary factor 1 like
hsa:9407,0.0,0.0,4.996204460916831e-07,2.0691477319957375e-06,0.0,1.6539345e-05,False,TMPRSS11D; transmembrane serine protease
hsa:10197,0.0,0.0,4.348319369282177e-06,1.7942287936595643e-05,0.0,0.00020925284,False,PSME3; proteasome activator subunit
hsa:9789,0.0,0.0,3.2354759004851485e-05,0.0002299523470541604,0.0,0.0026245592,False,SPCS2; signal peptidase complex subunit
hsa:343563,0.0,0.0,3.005741221782178e-07,1.5877610167557564e-06,-0.0,1.23653945e-05,False,OR2T29; olfactory receptor family 2 subfamily T member
hsa:8697,0.0,0.0,3.756948767183166e-05,0.00011413118864825221,0.0,0.0008367215,False,CDC23; cell division cycle
hsa:10749,0.0,0.0,2.0126485109900993e-07,5.439842030067028e-07,0.0,2.878986e-06,False,KIF1C; kinesin family member
hsa:55811,0.0,0.0,1.0306717885183168e-05,2.7459016120548797e-05,0.0,0.00025175264,False,ADCY10; adenylate cyclase
hsa:127,0.0,0.0,1.941002364445544e-05,0.0001357328905867235,0.0,0.0018506362,False,ADH4; alcohol dehydrogenase 4 (class II)
hsa:9440,1.8764337e-07,0.00023248585448209537,3.5260784433564334e-06,1.3856644556953949e-05,0.0,0.00015289453,False,MED17; mediator complex subunit
hsa:27430,3.8680935e-09,4.792479598741693e-06,0.0001490430661005693,0.0004766497038605069,0.0,0.0031890057,False,MAT2B; methionine adenosyltransferase 2 non-catalytic beta
hsa:1386,0.00034431485000000004,0.42659824385548234,0.0005192164137623762,0.0006402149435689673,0.0,0.003739673,False,ATF2; activating transcription factor
hsa:287,1.7039174500000002e-08,2.1111148469045457e-05,7.387473565248516e-07,1.5784360927183725e-06,0.0,8.583163e-06,False,ANK2; ankyrin
hsa:4626,0.0,0.0,1.7096218556089106e-09,2.155657337390407e-08,0.0,3.0618313e-07,False,MYH8; myosin heavy chain
hsa:3400,3.6261275e-07,0.00044926892450211495,5.899068147121779e-05,0.00026986592453715456,0.0,0.0023539094,False,ID4; inhibitor of DNA binding
hsa:7280,4.5887638e-07,0.0005685373658869518,0.0004961108593844554,0.0017617530197271295,0.0,0.012387441,False,TUBB2A; tubulin beta 2A class
hsa:112574,0.0,0.0,1.5853221134702972e-07,4.728579751822696e-07,0.0,4.574623e-06,False,SNX18; sorting nexin
hsa:10263,4.2381922e-08,5.2510234445072666e-05,4.27780631758911e-06,1.45753389968523e-05,0.0,0.00010086007,False,CDK2AP2; cyclin dependent kinase 2 associated protein
hsa:93973,2.3684973e-08,2.934514119145461e-05,2.673493134959553e-06,9.082109926128537e-06,0.0,6.066874e-05,False,ACTR8; actin related protein
hsa:1497,8.935466e-08,0.0001107083851779954,8.914347523856438e-07,1.704433413998355e-06,0.0,7.805075e-06,False,CTNS; cystinosin
hsa:8854,7.683274e-07,0.0009519401197655247,6.822037944760895e-05,0.00022660680658451033,0.0,0.0017096703,False,ALDH1A2; aldehyde dehydrogenase 1 family member
hsa:2172,2.3352180500000003e-07,0.00028932818876375034,0.0001494299697575644,0.00048148594541785254,0.0,0.004448103,False,FABP6; fatty acid binding protein
hsa:9658,0.0,0.0,2.2754104434158413e-07,9.423451746229334e-07,0.0,7.7563245e-06,False,ZNF516; zinc finger protein
hsa:3796,1.880939475e-09,2.3304410972499527e-06,3.863884988180446e-06,1.2907579525645878e-05,0.0,6.897549e-05,False,KIF2A; kinesin family member
hsa:2512,0.0,0.0,0.00015600475756520296,0.0004659867039738509,0.0,0.004579117,False,FTL; ferritin light
hsa:11282,0.0,0.0,5.328907360122277e-05,0.00015907381260601947,0.0,0.0012213583,False,MGAT4B; alpha-1
hsa:50840,0.00028924961500000003,0.3583736739640314,0.000794359601094059,0.0011742389040170814,0.0,0.007767026,False,TAS2R14; taste 2 receptor member
hsa:91319,0.0,0.0,1.7480257829326736e-07,4.6570421479744084e-07,0.0,3.7549949e-06,False,DERL3; derlin
hsa:100288814,0.0,0.0,1.657296832831683e-07,1.2074913681162624e-06,0.0,1.3639208e-05,False,CLDN34; claudin
hsa:1339,0.0,0.0,7.910417398950495e-06,3.802942865126925e-05,0.0,0.00043165873,False,COX6A2; cytochrome c oxidase subunit
hsa:8731,0.0,0.0,3.445877600106437e-07,7.165118716624399e-07,0.0,3.5574017e-06,False,RNMT; RNA guanine-7
hsa:26696,0.0,0.0,1.3332057658415843e-06,1.4775331372551859e-05,-0.0,0.0002058132,False,OR2T1; olfactory receptor family 2 subfamily T member
hsa:51554,0.0,0.0,2.6546212643920795e-05,7.059224601190917e-05,0.0,0.00056636904,False,ACKR4; atypical chemokine receptor
hsa:10523,0.0,0.0,9.24242828827723e-08,2.453173136696151e-07,0.0,1.8707441e-06,False,CHERP; calcium homeostasis endoplasmic reticulum
hsa:377677,1.9301654e-05,0.023914308952710416,0.0001229557921444555,0.0002389996434876214,0.0,0.0017914873,False,CA13; carbonic anhydrase
hsa:2548,5.2143332e-05,0.06460439873555664,0.0001774878420758911,0.00023774121184327285,0.0,0.0010892773,False,GAA; alpha
hsa:3000,3.79606135e-07,0.0004703233408253148,5.891335195272276e-05,0.00018693440936982302,0.0,0.0020391357,False,GUCY2D; guanylate cyclase 2D
hsa:79008,2.3465073e-06,0.0029072690108314218,7.661347131742574e-05,0.00021062890374563684,0.0,0.0019761263,False,SLX1B; SLX1 homolog B
hsa:3929,0.0,0.0,2.0375343834120285e-06,1.244469082453372e-05,0.0,0.0001386707,False,LBP; lipopolysaccharide binding
hsa:1891,0.0,0.0,5.394834884133665e-06,3.702678819820824e-05,0.0,0.00036278486,False,ECH1; enoyl-CoA hydratase
hsa:79679,3.8644761999999997e-08,4.787997846567777e-05,1.9773273861138625e-06,5.148541375956486e-06,-0.0,3.8383318e-05,False,VTCN1; V-set domain containing T cell activation inhibitor
hsa:23411,0.0001220399975,0.15120477264813714,0.0002545662565246534,0.00034749300806007885,0.0,0.0017825492,False,SIRT1; sirtuin
hsa:5425,5.4726512e-06,0.006780489982217141,0.00018503819720668327,0.00044074214073758596,0.0,0.0031379694,False,POLD2; DNA polymerase delta 2
hsa:6157,1.35930605e-07,0.0001684149184364637,1.6667778374306936e-06,3.259744233189034e-06,0.0,1.391414e-05,False,RPL27A; ribosomal protein
hsa:219865,0.0,0.0,6.103496435792081e-06,3.691169597768128e-05,0.0,0.000357226,False,OR8G5; olfactory receptor family 8 subfamily G member
hsa:390199,0.0,0.0,4.6557370099009907e-07,6.4689144306981305e-06,-0.0,9.1938084e-05,False,OR4D9; olfactory receptor family 4 subfamily D member
hsa:4089,0.0001043152325,0.12924419319084357,0.00024449144027227735,0.00042112483123027026,0.0,0.0020950632,False,SMAD4; SMAD family member
hsa:5527,0.0,0.0,1.1546927864851488e-05,2.4072748988228893e-05,0.0,0.00019720147,False,PPP2R5C; protein phosphatase 2 regulatory subunit
hsa:1513,0.0,0.0,1.6299078010742574e-05,7.672081147376313e-05,0.0,0.00070376054,False,CTSK; cathepsin
hsa:780854,0.0,0.0,0.0,0.0,-0.0,-0.0,False,SNORD3D; small nucleolar RNA
hsa:1358,9.5611818e-07,0.0011846086118745673,7.174321149069303e-06,1.6385668651117984e-05,0.0,0.00014665001,False,CPA2; carboxypeptidase
hsa:26188,0.0,0.0,4.344850926163366e-06,2.248645152503531e-05,-0.0,0.0002480315,False,OR1C1; olfactory receptor family 1 subfamily C member
hsa:2619,0.0,0.0,2.5488548370000003e-05,0.0001150578347671257,0.0,0.0012948638,False,GAS1; growth arrest specific
hsa:212,0.0,0.0,6.0756687565940605e-06,1.769427537484381e-05,0.0,0.0001476385,False,ALAS2; 5'-aminolevulinate synthase
hsa:4261,0.0,0.0,6.107470515891091e-05,0.00024884591637722934,0.0,0.0018877542,False,CIITA; class II major histocompatibility complex
hsa:388761,0.0,0.0,4.023642044554456e-08,3.506236416647936e-07,-0.0,4.3827995e-06,False,OR14A2; olfactory receptor family 14 subfamily A member
hsa:7325,0.0,0.0,2.30447685670297e-07,7.04197147775733e-07,0.0,4.381149e-06,False,UBE2E2; ubiquitin conjugating enzyme E2
hsa:596,0.00032864403,0.40718245539391756,0.0009492058860346535,0.0014752104285050743,0.0,0.0068974653,False,BCL2; BCL2 apoptosis
hsa:653166,0.0,0.0,3.5685224649504955e-06,2.5369935131843516e-05,-0.0,0.00031281373,False,OR1D4; olfactory receptor family 1 subfamily D member
hsa:143503,2.27483235e-07,0.00028184653829936167,5.0409957845217826e-05,0.00015440544575434995,0.0,0.0012922283,False,OR51E1; olfactory receptor family 51 subfamily E member
hsa:10073,0.0,0.0,4.0650691210742587e-08,1.0815626913690577e-07,0.0,7.6221903e-07,False,SNUPN; snurportin
hsa:80223,2.9271439e-09,3.6266645114269318e-06,1.4036473585396045e-07,2.3879863463426506e-07,0.0,1.4310924e-06,False,RAB11FIP1; RAB11 family interacting protein
hsa:3612,0.0,0.0,9.019321778658413e-05,0.00027419037373301166,0.0,0.0018402061,False,IMPA1; inositol monophosphatase
hsa:11345,9.35796e-06,0.011594298944904203,0.00036003890081683163,0.0008596446539802585,0.0,0.0056666187,False,GABARAPL2; GABA type A receptor associated protein like
hsa:284370,1.518106e-09,1.8808986995085189e-06,4.741005430123761e-08,1.0192230997491286e-07,0.0,5.1818586e-07,False,ZNF615; zinc finger protein
hsa:81539,2.0273542e-06,0.0025118456011787938,0.00020360913495554446,0.0005633345720937432,0.0,0.0036004633,False,SLC38A1; solute carrier family 38 member
hsa:6870,1.8066171e-09,2.2383573702362364e-06,4.638519677007427e-07,1.902106904954124e-06,0.0,1.7217011e-05,False,TACR3; tachykinin receptor
hsa:9846,7.22621865e-06,0.008953120046392812,7.873022813999997e-05,0.00015354228011281364,0.0,0.000728304,False,GAB2; GRB2 associated binding protein
hsa:2814,9.227465300000001e-08,0.00011432618988746495,1.1024216652079207e-06,2.184727902408185e-06,0.0,1.2804121e-05,False,GP5; glycoprotein V
hsa:6775,3.4010567e-06,0.004213831658648826,0.0001858290376464355,0.000467506116104758,0.0,0.0031281933,False,STAT4; signal transducer and activator of transcription
hsa:284273,3.2915431499999998e-06,0.00407814686867134,0.00014050405789331678,0.00039143423542752705,0.0,0.0023455098,False,PTGR3; prostaglandin reductase
hsa:821,0.0,0.0,4.2225901498514845e-05,0.00010690688967227266,0.0,0.00075894635,False,CANX;
hsa:890,1.17579435e-05,0.014567823747514762,5.7937098734901e-05,9.658068885282774e-05,0.0,0.00068459345,False,CCNA2; cyclin
hsa:8729,2.6636907000000002e-08,3.300252007121332e-05,3.115749325079208e-07,6.539970905240084e-07,0.0,4.2622255e-06,False,GBF1; golgi brefeldin A resistant guanine nucleotide exchange factor
hsa:29761,0.0,0.0,1.7993915006014854e-05,5.310138513644093e-05,0.0,0.00034793545,False,USP25; ubiquitin specific peptidase
hsa:1399,4.5135218e-06,0.005592150537461383,0.00016020543316188116,0.00034177593289581594,0.0,0.001739485,False,CRKL; CRK like proto-oncogene
hsa:55526,0.0,0.0,6.201616464237623e-05,0.0001292144487246844,0.0,0.0011512617,False,DHTKD1; dehydrogenase E1 and transketolase domain containing
hsa:79796,6.656956199999999e-08,8.247816858154287e-05,0.00013343249229578216,0.00039764157850462036,0.0,0.0022870288,False,ALG9; ALG9
hsa:8473,0.0,0.0,0.00016303014816831682,0.0003672237166443052,0.0,0.003203859,False,OGT; O-linked N-acetylglucosamine (GlcNAc)
hsa:6940,1.16635128e-09,1.445082626458295e-06,1.0099320472801982e-07,1.8760591972317298e-07,0.0,1.073963e-06,False,ZNF354A; zinc finger protein
hsa:7113,0.0,0.0,1.4755827334702973e-06,1.1989179725843777e-05,0.0,0.00016208382,False,TMPRSS2; transmembrane serine protease
hsa:6176,2.43884065e-07,0.0003021667924962757,1.1538112092509902e-06,2.2988511340019644e-06,0.0,1.1457605e-05,False,RPLP1; ribosomal protein lateral stalk subunit
hsa:1072,8.7013073e-07,0.001078072123066109,1.811166590722772e-05,7.734837019826144e-05,0.0,0.00094255595,False,CFL1; cofilin
hsa:6622,0.0,0.0,1.3400342402128717e-07,5.008193791223895e-07,0.0,5.2890814e-06,False,SNCA; synuclein
hsa:9173,0.0,0.0,2.1630339794549503e-06,1.4653176742518118e-05,0.0,0.00016052923,False,IL1RL1; interleukin 1 receptor like
hsa:635,0.0,0.0,5.732892831990104e-06,2.238567332810757e-05,0.0,0.0002150982,False,BHMT; betaine--homocysteine
hsa:4851,0.0,0.0,4.962227596064356e-05,0.0001922157540823283,0.0,0.0017999571,False,NOTCH1; notch receptor
hsa:29896,1.73588395e-08,2.1507206111119453e-05,6.5679287051633635e-06,3.577075273565286e-05,0.0,0.000481552,False,TRA2A; transformer 2 alpha
hsa:80201,0.0,0.0,7.075569822178217e-05,0.0002905819786518415,0.0,0.0020870082,False,HKDC1; hexokinase domain containing
hsa:59284,5.3419553e-05,0.06618560743849665,0.000339586201798886,0.000741398745939588,0.0,0.0052626063,False,CACNG7; calcium voltage-gated channel auxiliary subunit gamma
hsa:383,1.6100489500000002e-06,0.001994813916946548,1.8663048667138618e-05,7.98517285235644e-05,0.0,0.0010961605,False,ARG1; arginase
hsa:148022,0.0,0.0,4.158947374782177e-05,0.00011782912196412276,0.0,0.0011400176,False,TICAM1; TIR domain containing adaptor molecule
hsa:374875,0.000445998025,0.5525813778523159,0.0008123254744603955,0.001081477837814391,0.0,0.006570707,False,HSD11B1L; hydroxysteroid 11-beta dehydrogenase 1
hsa:678,0.0,0.0,4.1315299244900985e-07,1.0181869556648148e-06,0.0,7.780822e-06,False,ZFP36L2; ZFP36 ring finger protein like
hsa:4854,0.0,0.0,0.00014041701387227715,0.0003011941646171944,0.0,0.0016024347,False,NOTCH3; notch receptor
hsa:55163,2.2988574999999997e-06,0.0028482319957271788,6.357287526971285e-05,0.00011868233255163129,0.0,0.000578153,False,PNPO; pyridoxamine 5'-phosphate
hsa:1284,0.0,0.0,0.00010422996279544555,0.0002481657149779514,0.0,0.0010316963,False,COL4A2; collagen type IV alpha 2
hsa:116512,1.075760925e-08,1.3328432433667882e-05,1.6375711148512377e-05,5.1017355428867656e-05,-0.0,0.0004424509,False,MRGPRD; MAS related GPR family member
hsa:8649,1.5452736500000002e-07,0.00019145587980482146,2.0059113158386137e-06,4.116931021196266e-06,0.0,2.4503184e-05,False,LAMTOR3; late endosomal/lysosomal adaptor
hsa:7030,0.0,0.0,6.248220713144458e-06,3.199069321341731e-05,0.0,0.0004383141,False,TFE3; transcription factor binding to IGHM enhancer
hsa:6356,0.0,0.0,0.00011035847023762376,0.0003905511049977892,0.0,0.0027964443,False,CCL11; C-C motif chemokine ligand
hsa:11260,5.1738021e-08,6.410222765343423e-05,1.4117850700544558e-07,2.082463076034839e-07,0.0,9.809627e-07,False,XPOT; exportin for
hsa:6154,1.66880345e-07,0.00020676094020050838,7.67573103631188e-07,1.5376453886152293e-06,0.0,9.781128e-06,False,RPL26; ribosomal protein
hsa:26830,0.0,0.0,3.873139287128713e-09,3.773963380470857e-08,0.0,4.7349187e-07,False,RNU5D-1; RNA
hsa:5334,4.9837445e-07,0.0006174745734970242,1.6451897750643562e-05,4.082911920401747e-05,0.0,0.00027101455,False,PLCL1; phospholipase C like 1
hsa:407024,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR29B1; microRNA
hsa:107,0.00259562485,3.2159199718445186,0.0032881958983316845,0.0027154947829227255,0.0,0.012049589,True,ADCY1; adenylate cyclase
hsa:85480,0.0,0.0,7.5327538463405926e-06,5.247871729115768e-05,0.0,0.00053595094,False,TSLP; thymic stromal
hsa:30009,1.64502695e-07,0.00020381508609487517,1.2523389787831683e-05,3.693035116472054e-05,0.0,0.00021961147,False,TBX21; T-box transcription factor
hsa:57724,0.0,0.0,1.4285556140346537e-07,2.999226253345288e-07,0.0,1.4310367e-06,False,EPG5; ectopic P-granules 5 autophagy tethering
hsa:5728,0.0,0.0,0.00020756197483168322,0.0003893358041850525,0.0,0.0019968948,False,PTEN; phosphatase and tensin
hsa:3868,0.0,0.0,4.095749798947871e-06,3.6465056084499916e-05,0.0,0.000496114,False,KRT16; keratin
hsa:63970,8.8686593e-07,0.001098806654064613,6.385249859417426e-05,0.0001537329817313362,0.0,0.0012820394,False,TP53AIP1; tumor protein p53 regulated apoptosis inducing protein
hsa:114026,0.0,0.0,2.3588635346534655e-11,1.9830657937986913e-10,0.0,2.367974e-09,False,ZIM3; zinc finger imprinted
hsa:80012,1.49536285e-08,1.852720455527053e-05,7.25710928411228e-06,5.226305257744015e-05,0.0,0.0005519293,False,PHC3; polyhomeotic homolog
hsa:3565,0.0,0.0,3.3996671326732666e-05,8.106670337125494e-05,0.0,0.00054426445,False,IL4; interleukin
hsa:6768,5.3089333e-09,6.577647239222735e-06,1.1050496391683176e-07,1.9450287052618466e-07,0.0,1.3896383e-06,False,ST14; ST14 transmembrane serine protease
hsa:337,0.0,0.0,1.5410741239306927e-05,7.349507671890556e-05,0.0,0.00072392967,False,APOA4; apolipoprotein
hsa:1834,0.0,0.0,2.119918471628713e-07,7.029244276145205e-07,0.0,6.564957e-06,False,DSPP; dentin
hsa:3579,0.0,0.0,4.095978989351238e-06,2.414953909054234e-05,0.0,0.00033101588,False,CXCR2; C-X-C motif chemokine receptor
hsa:2790,0.0,0.0,0.00010702315470297028,0.0002482739995800629,0.0,0.0021423465,False,GNG10; G protein subunit gamma
hsa:55505,1.4980393e-08,1.85603651601578e-05,8.470893354649504e-07,1.776889225127794e-06,0.0,1.4031849e-05,False,NOP10; NOP10
hsa:55300,1.9292747500000002e-07,0.00023903274002405782,3.751275154183169e-06,1.9393590440658824e-05,0.0,0.00022870109,False,PI4K2B; phosphatidylinositol 4-kinase type 2
hsa:6907,0.0,0.0,2.1318268086287127e-06,1.6866706906387845e-05,0.0,0.00021064866,False,TBL1X; transducin beta like 1
hsa:1154,2.5198267e-06,0.0031220077932745424,4.349128175180695e-05,9.904377510678832e-05,0.0,0.00061914406,False,CISH; cytokine inducible SH2 containing
hsa:2215,5.447284900000001e-07,0.0006749061715230948,1.1424815844812874e-05,3.3432159555315684e-05,0.0,0.0002790769,False,FCGR3B; Fc gamma receptor
hsa:3984,0.0,0.0,3.9300774893277237e-05,0.00011142765565780823,0.0,0.0006995313,False,LIMK1; LIM domain kinase
hsa:221037,0.0,0.0,1.3388503519957274e-05,4.401141124430599e-05,0.0,0.0003700613,False,JMJD1C; jumonji domain containing
hsa:339403,0.0,0.0,4.1091066442722774e-07,3.026137520519368e-06,0.0,3.802201e-05,False,RXFP4; relaxin family peptide/INSL5 receptor
hsa:10715,0.0,0.0,2.354055171188118e-05,6.384701459752995e-05,0.0,0.00045534596,False,CERS1; ceramide synthase
hsa:163050,2.71294765e-08,3.3612802444096084e-05,7.833620256811881e-08,1.4810170046941354e-07,0.0,1.0011038e-06,False,ZNF564; zinc finger protein
hsa:5771,5.053809e-07,0.0006261554051999299,2.9293391327079216e-05,8.825407634513755e-05,0.0,0.00065654266,False,PTPN2; protein tyrosine phosphatase non-receptor type
hsa:3592,0.0,0.0,3.846656108157426e-05,0.00012208701252883482,0.0,0.000869477,False,IL12A; interleukin
hsa:534,2.92013435e-05,0.036179798388947505,0.00031936784180628715,0.0007112328808967358,0.0,0.004075409,False,ATP6V1G2; ATPase H+ transporting V1 subunit
hsa:6693,2.24166325e-08,2.7773696248226668e-05,3.1566716870806935e-06,6.526805855281338e-06,0.0,3.269944e-05,False,SPN;
hsa:90226,0.0,0.0,1.1083567660925743e-06,6.152442883187642e-06,0.0,5.629268e-05,False,UCN2; urocortin
hsa:6833,0.000135758985,0.16820228517185,0.0005438893320767326,0.0009486161792803683,0.0,0.005671934,False,ABCC8; ATP binding cassette subfamily C member
hsa:4224,3.1515755000000003e-07,0.0003904730143582142,1.5528689740056927e-05,6.241416837685398e-05,0.0,0.00070320955,False,MEP1A; meprin A subunit
hsa:22861,0.0,0.0,3.0347026506435657e-07,1.0281340853485037e-06,0.0,8.501614e-06,False,NLRP1; NLR family pyrin domain containing
hsa:8498,1.46361265e-08,1.813382682084925e-05,4.0209013305742606e-07,1.779641043506961e-06,0.0,1.678531e-05,False,RANBP3; RAN binding protein
hsa:3751,1.15168935e-06,0.0014269168296896341,6.871076723836382e-05,0.00015668203961700163,0.0,0.0009073631,False,KCND2; potassium voltage-gated channel subfamily D member
hsa:1520,7.358864e-07,0.0009117464608834994,3.004887215113366e-06,4.703108824127463e-06,0.0,2.6263291e-05,False,CTSS; cathepsin
hsa:1601,2.53793835e-09,3.1444477144203346e-06,4.7280347258267343e-07,9.807116917856433e-07,0.0,5.2965333e-06,False,DAB2; DAB adaptor protein
hsa:406887,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7E; microRNA
hsa:6189,2.75005e-07,0.0003407249209596301,1.2451376967079202e-06,2.290165585031391e-06,0.0,1.4291866e-05,False,RPS3A; ribosomal protein
hsa:9103,0.0,0.0,9.679482224412871e-05,0.0005059621113348566,0.0,0.004362056,False,FCGR2C; Fc gamma receptor IIc
hsa:1719,1.66436255e-05,0.020621072282210086,0.0002359936195034653,0.0004904189574314262,0.0,0.002988525,False,DHFR; dihydrofolate
hsa:100526794,0.0,0.0,4.8041842574257425e-08,3.2374440663982117e-07,0.0,3.7603706e-06,False,NT5C1B-RDH14; NT5C1B-RDH14
hsa:30011,0.0,0.0,5.966590750430692e-07,2.075938885399312e-06,0.0,2.5717902e-05,False,SH3KBP1; SH3 domain containing kinase binding protein
hsa:6317,0.0,0.0,9.014113146930691e-08,1.0223288300294913e-06,0.0,1.4257892e-05,False,SERPINB3; serpin family B member
hsa:79132,0.0,0.0,2.6498857913388123e-05,9.217621920777227e-05,0.0,0.0007926763,False,DHX58; DExH-box helicase
hsa:4988,0.0,0.0,5.386912286683169e-06,1.6148367118816238e-05,0.0,0.00013597182,False,OPRM1; opioid receptor mu
hsa:2043,0.0,0.0,1.8718025456356443e-06,1.750586188137139e-05,0.0,0.00023628563,False,EPHA4; EPH receptor
hsa:1836,0.0,0.0,1.5286136162608916e-07,3.5396963032310317e-07,0.0,2.7186284e-06,False,SLC26A2; solute carrier family 26 member
hsa:960,0.0,0.0,5.5721628694059416e-05,0.0002339919543633831,0.0,0.0030528721,False,CD44; CD44 molecule (Indian blood
hsa:5747,9.7041685e-05,0.12023243377907428,0.00021854104945544556,0.0003766992878172405,0.0,0.003884205,False,PTK2; protein tyrosine kinase
hsa:6908,0.0,0.0,2.377796119564356e-05,0.00010405084648437205,0.0,0.00077724096,False,TBP; TATA-box binding
hsa:10873,4.83878765e-06,0.005995147504906036,0.00011115388338188119,0.0004156626375092954,0.0,0.0034387098,False,ME3; malic enzyme
hsa:11112,2.67212515e-09,3.3107020982454495e-06,1.007895184816188e-06,2.9024754325664355e-06,0.0,3.093535e-05,False,HIBADH; 3-hydroxyisobutyrate
hsa:23492,0.0,0.0,2.0836622674114376e-05,0.00011205090962249442,0.0,0.0010554956,False,CBX7; chromobox
hsa:8505,0.0,0.0,1.5049128439680195e-05,5.078613381596026e-05,0.0,0.0003696112,False,PARG; poly(ADP-ribose)
hsa:645,0.0,0.0,9.974876010841586e-05,0.00027925117724806486,0.0,0.0021177784,False,BLVRB; biliverdin reductase
hsa:221937,2.0671514e-08,2.561153424034431e-05,6.546706348209817e-05,0.00026158589473867215,0.0,0.0017203391,False,FOXK1; forkhead box
hsa:10450,0.0,0.0,1.323844312232673e-07,4.69444222972476e-07,0.0,3.97224e-06,False,PPIE; peptidylprolyl isomerase
hsa:1573,0.0,0.0,8.779378653554453e-05,0.00028964973716371473,0.0,0.002265339,False,CYP2J2; cytochrome P450 family 2 subfamily J member
hsa:10507,1.633777e-07,0.0002024212429558232,2.8074518621683163e-06,2.142507165232453e-05,0.0,0.00028633754,False,SEMA4D; semaphorin
hsa:27,0.0,0.0,2.6312807804569314e-05,9.500120977460454e-05,0.0,0.0012092673,False,ABL2; ABL proto-oncogene 2
hsa:43,4.1355203e-06,0.00512381530279248,2.872847712623763e-05,7.193598468180446e-05,0.0,0.0005812865,False,ACHE; acetylcholinesterase (Cartwright blood
hsa:57105,0.0,0.0,1.2480281038175743e-06,3.404384656253376e-06,0.0,1.902364e-05,False,CYSLTR2; cysteinyl leukotriene receptor
hsa:10952,0.0,0.0,2.54062144040891e-05,0.00013280451607533368,0.0,0.0014460557,False,SEC61B; SEC61 translocon subunit
hsa:4360,3.58718605e-08,4.444441676892194e-05,7.9984217360396e-07,2.1069254794718324e-06,0.0,1.4552755e-05,False,MRC1; mannose receptor C-type
hsa:388569,8.1959792e-10,1.0154631243456565e-06,6.845742897544553e-08,1.2421084145545084e-07,0.0,6.8056653e-07,False,ZNF324B; zinc finger protein
hsa:7098,0.0,0.0,1.2525619145940595e-05,7.719497723248195e-05,0.0,0.0007385051,False,TLR3; toll like receptor
hsa:2762,9.4239162e-07,0.0011676017171961155,2.436743359806931e-05,4.8554586737107863e-05,0.0,0.0003180535,False,GMDS; GDP-mannose
hsa:6382,1.1976959e-06,0.0014839178955334377,5.3501385890297054e-05,0.0001498733359865235,0.0,0.0009793597,False,SDC1; syndecan
hsa:5162,2.6188587e-05,0.03244706181931018,0.00012652158019150992,0.00020393665512783704,0.0,0.0011763481,False,PDHB; pyruvate dehydrogenase E1 subunit
hsa:81030,0.0,0.0,3.910662047878713e-06,1.6203857830021417e-05,0.0,0.00016329362,False,ZBP1; Z-DNA binding protein
hsa:3595,0.0,0.0,7.696362869415843e-06,2.447590764466278e-05,0.0,0.00022087278,False,IL12RB2; interleukin 12 receptor subunit beta
hsa:3375,0.0,0.0,0.00012583740641851487,0.0007135922874382031,0.0,0.009655888,False,IAPP; islet amyloid
hsa:5568,0.0,0.0,1.2517229653465347e-06,8.766316513888116e-06,0.0,8.922137e-05,False,PRKACG; protein kinase cAMP-activated catalytic subunit
hsa:100169767,0.0,0.0,1.5214302457846532e-07,1.1919614165960234e-06,0.0,1.5985106e-05,False,RNA5S16; RNA
hsa:55916,0.0,0.0,3.2796301429359407e-06,1.657501031677738e-05,0.0,0.00020704638,False,NXT2; nuclear transport factor 2 like export factor
hsa:51005,7.78712485e-07,0.0009648070031523142,8.680717579145543e-05,0.0002850730086831617,0.0,0.00191234,False,AMDHD2; amidohydrolase domain containing
hsa:55860,1.2785483e-07,0.00015840921745443516,5.725643181237622e-06,1.8458954595807076e-05,0.0,9.990062e-05,False,ACTR10; actin related protein
hsa:64689,0.0,0.0,8.991120930069309e-08,2.141165690277292e-07,0.0,1.2543094e-06,False,GORASP1; golgi reassembly stacking protein
hsa:56983,0.0,0.0,3.432544328777228e-05,0.00013048568181263644,0.0,0.001478555,False,POGLUT1; protein O-glucosyltransferase
hsa:1292,2.49013585e-05,0.030852215074998322,7.809023934742578e-05,0.00016031283770408155,0.0,0.00093375053,False,COL6A2; collagen type VI alpha 2
hsa:2683,0.0,0.0,0.00027448795854207917,0.0006851727383884176,0.0,0.005687169,False,B4GALT1; beta-1
hsa:1741,1.2836856e-06,0.0015904571720405643,1.9791424364118817e-05,3.932633019761289e-05,0.0,0.00022294949,False,DLG3; discs large MAGUK scaffold protein
hsa:4303,0.0,0.0,3.1267526631635356e-06,6.668716579791216e-06,0.0,3.89667e-05,False,FOXO4; forkhead box
hsa:7643,6.7309748999999995e-09,8.339524338771128e-06,1.3821070762717823e-07,2.614054271607854e-07,0.0,1.3403877e-06,False,ZNF90; zinc finger protein
hsa:171392,0.0,0.0,1.109659071261386e-07,2.5216514516184103e-07,0.0,1.4643801e-06,False,ZNF675; zinc finger protein
hsa:23529,0.0,0.0,4.54918300872505e-05,0.000269700368966163,0.0,0.0025697881,False,CLCF1; cardiotrophin like cytokine factor
hsa:170572,0.0,0.0,1.0344300315346537e-06,5.196866104947937e-06,0.0,5.433861e-05,False,HTR3C; 5-hydroxytryptamine receptor
hsa:151449,0.0,0.0,6.709519393897524e-06,2.4130710018677937e-05,0.0,0.00030123245,False,GDF7; growth differentiation factor
hsa:7044,2.79451965e-08,3.462346091403368e-05,2.0170850817935655e-05,5.378127931813937e-05,0.0,0.00032119258,False,LEFTY2; left-right determination factor
hsa:1839,0.0,0.0,0.00011596927728861385,0.000388876499324623,0.0,0.0024338337,False,HBEGF; heparin binding EGF like growth
hsa:1500,1.6945425e-06,0.002099499497737256,2.836358447170791e-05,5.1423101319941503e-05,0.0,0.00026276,False,CTNND1; catenin delta
hsa:7294,9.502205e-08,0.00011773015209058752,1.6281949147765343e-06,4.2313506338173925e-06,0.0,3.2383166e-05,False,TXK; TXK tyrosine
hsa:79709,0.0,0.0,8.922889735178218e-05,0.0003037846444609583,0.0,0.0024513109,False,COLGALT1; collagen beta(1-O)galactosyltransferase
hsa:1291,7.646489050000001e-05,0.09473825483827304,0.00029068791875792085,0.0004526012344287037,0.0,0.0025962417,False,COL6A1; collagen type VI alpha 1
hsa:26285,0.0,0.0,8.36396894059406e-09,1.142379801383694e-07,0.0,1.6231578e-06,False,CLDN17; claudin
hsa:80712,0.0,0.0,1.9709598495049514e-08,2.756664987877305e-07,-0.0,3.9181623e-06,False,ESX1; ESX homeobox
hsa:4917,3.7854332e-08,4.6900653728767105e-05,8.135391238690599e-06,3.1722893547002054e-05,0.0,0.00024530094,False,NTN3; netrin
hsa:3708,0.0,0.0,0.0004832914880544553,0.0012408239979773718,0.0,0.006923017,False,ITPR1; inositol 1
hsa:406911,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR125B1; microRNA
hsa:286530,0.0,0.0,9.270080894303962e-07,3.7553949178845584e-06,0.0,3.4024477e-05,False,P2RY8; P2Y receptor family member
hsa:57181,3.21471775e-11,3.982961950787331e-08,8.325051072537131e-08,2.841967861447447e-07,0.0,2.6451557e-06,False,SLC39A10; solute carrier family 39 member
hsa:22824,9.713655500000001e-09,1.203499755446838e-05,2.3018785136450492e-07,6.127482281691035e-07,0.0,4.2284446e-06,False,HSPA4L; heat shock protein family A (Hsp70) member 4
hsa:9970,2.51207685e-11,3.112405905931771e-08,8.056032912345048e-08,1.371202300194784e-07,0.0,7.74055e-07,False,NR1I3; nuclear receptor subfamily 1 group I member
hsa:131450,0.0,0.0,3.15471793915594e-08,1.7481841947883088e-07,0.0,2.0324894e-06,False,CD200R1; CD200 receptor
hsa:1854,0.0,0.0,3.753309976633664e-05,0.00010779242291473948,0.0,0.0011369764,False,DUT; deoxyuridine
hsa:23381,0.0,0.0,4.2759986412623774e-07,8.88023813711318e-07,0.0,3.5946882e-06,False,SMG5; SMG5 nonsense mediated mRNA decay
hsa:402135,0.0,0.0,3.912666257490099e-06,1.4488670883238527e-05,0.0,0.00014717245,False,OR5K2; olfactory receptor family 5 subfamily K member
hsa:28960,1.4919367e-08,1.8484755338421897e-05,4.086129647415842e-06,3.393789286120293e-05,0.0,0.00036342815,False,DCPS; decapping enzyme
hsa:9770,0.0,0.0,0.00012533213476732675,0.00030013889561575276,0.0,0.0018504685,False,RASSF2; Ras association domain family member
hsa:9219,0.0,0.0,1.3162653565247523e-06,4.494759016588884e-06,0.0,3.7707872e-05,False,MTA2; metastasis associated 1 family member
hsa:3705,2.9524150000000003e-07,0.0003657974827785046,1.7403738792178217e-05,5.088087974118486e-05,0.0,0.00037328168,False,ITPK1; inositol-tetrakisphosphate
hsa:1288,0.0,0.0,3.4714514207128715e-06,1.2409964978807396e-05,0.0,0.000103717975,False,COL4A6; collagen type IV alpha 6
hsa:8458,5.50973185e-06,0.006826432061598905,4.2498177278532666e-05,7.540953703638824e-05,0.0,0.0005307655,False,TTF2; transcription termination factor
hsa:5799,1.7988379e-05,0.022287191189130636,0.00012393944236407673,0.00020149230731304985,0.0,0.001282173,False,PTPRN2; protein tyrosine phosphatase receptor type
hsa:6330,5.735531e-08,7.106192057004449e-05,1.0520092902673264e-06,2.2831418425332807e-06,0.0,1.5244637e-05,False,SCN4B; sodium voltage-gated channel beta subunit
hsa:56922,4.282492e-10,5.305909886039338e-07,1.3356966592435646e-06,3.6585575114243785e-06,0.0,3.9474628e-05,False,MCCC1; methylcrotonyl-CoA carboxylase subunit
hsa:117608,1.253907475e-08,1.55356275453197e-05,9.853383342227724e-08,1.4810358219938974e-07,0.0,8.489622e-07,False,ZNF354B; zinc finger protein
hsa:29780,3.8438809e-09,4.762480739734666e-06,2.784231150930692e-07,5.402896638210371e-07,0.0,4.0145774e-06,False,PARVB; parvin
hsa:1378,6.8161614e-07,0.0008445068468802682,1.316799859349505e-05,3.841854178337985e-05,0.0,0.00042393443,False,CR1; complement C3b/C4b receptor 1 (Knops blood
hsa:51655,0.0,0.0,4.4389862898019814e-05,0.00024330758041516133,0.0,0.002528378,False,RASD1; ras related dexamethasone induced
hsa:2618,0.0,0.0,0.00018804025962920786,0.00047672482340120734,0.0,0.0040476257,False,GART; phosphoribosylglycinamide formyltransferase
hsa:3998,6.07467965e-10,7.526389496923051e-07,2.970480909963366e-07,7.529730809754368e-07,0.0,5.3579492e-06,False,LMAN1; lectin
hsa:8792,0.0,0.0,6.455379945940596e-06,1.743642843587346e-05,0.0,0.00011741254,False,TNFRSF11A; TNF receptor superfamily member
hsa:50515,0.0,0.0,0.00011137891549606432,0.0006132372478243183,0.0,0.00462087,False,CHST11; carbohydrate sulfotransferase
hsa:6444,0.0,0.0,3.391530333464159e-05,0.00015405497526212208,0.0,0.0018652643,False,SGCD; sarcoglycan
hsa:9091,0.0,0.0,2.77254979670297e-05,5.872268238614555e-05,0.0,0.0005669944,False,PIGQ; phosphatidylinositol glycan anchor biosynthesis class
hsa:9197,1.8158767e-05,0.02249829803385153,9.092451448172773e-05,0.0002932276752918182,0.0,0.0025097341,False,SLC33A1; solute carrier family 33 member
hsa:55703,0.0,0.0,7.046635994455448e-05,0.00023430425255426313,0.0,0.001247853,False,POLR3B; RNA polymerase III subunit
hsa:10243,1.11522455e-05,0.013817377744076981,0.00018444518356495047,0.0005748609537924479,0.0,0.004514134,False,GPHN;
hsa:203068,7.084496e-07,0.0008777528916342668,7.68634565841089e-05,0.00022727075297740003,0.0,0.001921862,False,TUBB; tubulin beta class
hsa:3032,2.45215185e-06,0.003038160198077347,4.643700167227723e-05,0.00011466494150948807,0.0,0.0012814531,False,HADHB; hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit
hsa:9807,3.5328471e-07,0.0004377116957546075,5.3276161982304465e-05,0.00019621150285905706,0.0,0.0012194308,False,IP6K1; inositol hexakisphosphate kinase
hsa:10062,0.0,0.0,4.6366489620000024e-05,0.00011622862194566875,0.0,0.0007510468,False,NR1H3; nuclear receptor subfamily 1 group H member
hsa:414062,0.0,0.0,0.00010366910017326735,0.0002924154813517011,0.0,0.0017908828,False,CCL3L3; C-C motif chemokine ligand 3 like
hsa:59067,0.0,0.0,3.0680872817079207e-06,1.9422029799994742e-05,0.0,0.00022389599,False,IL21; interleukin
hsa:5289,2.9528183499999998e-05,0.036584745692329064,0.000104586219594901,0.00017364434002363764,0.0,0.0008162244,False,PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type
hsa:9871,1.7413173000000001e-07,0.00021574524078039908,1.2603596468514854e-06,1.8899067230862744e-06,0.0,6.990117e-06,False,SEC24D; SEC24 homolog D
hsa:79071,0.0,0.0,5.76229433750495e-05,0.00016157615915936223,0.0,0.00090987445,False,ELOVL6; ELOVL fatty acid elongase
hsa:5732,0.0,0.0,2.3296250060148513e-05,7.660887578453157e-05,0.0,0.00064185134,False,PTGER2; prostaglandin E receptor
hsa:5885,1.46166405e-08,1.810968411140826e-05,7.75367448069604e-07,1.5035846412443402e-06,0.0,7.641983e-06,False,RAD21; RAD21 cohesin complex
hsa:196385,0.0,0.0,5.99475050960396e-08,1.112168409604617e-07,0.0,7.5999634e-07,False,DNAH10; dynein axonemal heavy chain
hsa:5535,0.0,0.0,9.473617965049506e-06,3.5772030036285934e-05,0.0,0.00027262283,False,PPP3R2; protein phosphatase 3 regulatory subunit B
hsa:1543,3.255052e-06,0.004032935166340561,9.797968978123763e-05,0.0002763188486752893,0.0,0.0031546983,False,CYP1A1; cytochrome P450 family 1 subfamily A member
hsa:10600,0.0,0.0,1.1311949386349513e-05,4.01051489936318e-05,0.0,0.00024602158,False,USP16; ubiquitin specific peptidase
hsa:79154,9.6306865e-07,0.0011932200856346164,8.009807239492085e-05,0.00017571906924866248,0.0,0.00089575164,False,DHRS11; dehydrogenase/reductase
hsa:129685,4.6746896e-08,5.791833764734477e-05,7.854040030831675e-07,1.4804519280262957e-06,0.0,9.507504e-06,False,TAF8; TATA-box binding protein associated factor
hsa:2961,3.18644465e-07,0.0003947932224917679,1.5206059332767324e-06,3.20308282180433e-06,0.0,2.0277594e-05,False,GTF2E2; general transcription factor IIE subunit
hsa:26533,0.0,0.0,1.6690129356435645e-07,2.0348323653441092e-06,0.0,2.8466446e-05,False,OR10G3; olfactory receptor family 10 subfamily G member
hsa:3643,0.0,0.0,0.00019543803268069312,0.0004847969615306083,0.0,0.003504367,False,INSR; insulin
hsa:2235,4.013145e-06,0.004972195097996527,0.0002175374920514555,0.0004348687398225237,0.0,0.0031743755,False,FECH;
hsa:1260,0.0,0.0,8.842407311930692e-07,3.447417627773787e-06,0.0,2.707676e-05,False,CNGA2; cyclic nucleotide gated channel subunit alpha
hsa:100101267,9.081767e-09,1.1252102119047934e-05,3.046023715965348e-07,6.851014379370316e-07,0.0,3.7346329e-06,False,POM121C; POM121 transmembrane nucleoporin
hsa:84952,1.41119005e-08,1.748432276668666e-05,2.693571823132177e-06,1.794197248018344e-05,0.0,0.00015757426,False,CGNL1; cingulin like
hsa:55584,0.0,0.0,4.743299270529703e-07,2.3656486498828163e-06,0.0,1.8701285e-05,False,CHRNA9; cholinergic receptor nicotinic alpha 9
hsa:290,0.0,0.0,0.00010977146026584153,0.0003670171936295397,0.0,0.00201234,False,ANPEP; alanyl aminopeptidase
hsa:11059,7.642369000000001e-08,9.468720835873268e-05,1.2694284307301982e-06,2.896464156490951e-06,0.0,1.6881066e-05,False,WWP1; WW domain containing E3 ubiquitin protein ligase
hsa:392376,0.0,0.0,1.3340057576153461e-05,4.639486623849112e-05,-0.0,0.0004265473,False,OR13C2; olfactory receptor family 13 subfamily C member
hsa:1677,0.0,0.0,1.3214709540333168e-06,2.7140974165923538e-06,0.0,1.7843888e-05,False,DFFB; DNA fragmentation factor subunit
hsa:79541,0.0,0.0,2.0508444386138613e-06,1.2776304533034682e-05,0.0,0.00015851251,False,OR2A4; olfactory receptor family 2 subfamily A member
hsa:58,1.06243585e-08,1.3163337794437462e-05,5.771114263381189e-08,1.3739947857299784e-07,0.0,1.0872053e-06,False,ACTA1; actin alpha 1
hsa:909,1.7230998499999998e-07,0.00021348814028719493,8.05300091245297e-06,1.781881928466775e-05,0.0,0.0001208742,False,CD1A; CD1a
hsa:282616,0.0,0.0,1.7982597795544554e-06,1.830266906054235e-05,0.0,0.0002518349,False,IFNL2; interferon lambda
hsa:93183,1.1370339e-06,0.0014087590614931364,2.3819554534569312e-05,6.238180748509947e-05,0.0,0.00049283763,False,PIGM; phosphatidylinositol glycan anchor biosynthesis class
hsa:2831,0.0,0.0,5.855393659158416e-08,3.507359624623223e-07,0.0,3.752422e-06,False,NPBWR1; neuropeptides B and W receptor
hsa:672,0.0,0.0,4.396187990579209e-05,0.00010652939197156017,0.0,0.00067990815,False,BRCA1; BRCA1 DNA repair
hsa:5213,0.0,0.0,0.00014890902335594066,0.0003974522098348831,0.0,0.002508116,False,PFKM; phosphofructokinase
hsa:8681,0.00024277242500000002,0.3007894958975391,0.0004100688772217821,0.00048608712938102473,0.0,0.0036925483,False,JMJD7-PLA2G4B; JMJD7-PLA2G4B
hsa:693200,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR615; microRNA
hsa:9152,0.0,0.0,2.4934564293405447e-06,1.6668804892641416e-05,0.0,0.00016754834,False,SLC6A5; solute carrier family 6 member
hsa:6778,0.0,0.0,6.318686473985152e-05,0.0002501823025876026,0.0,0.0016625847,False,STAT6; signal transducer and activator of transcription
hsa:6130,0.0,0.0,9.419824099009901e-07,1.8770630597341941e-06,0.0,8.579353e-06,False,RPL7A; ribosomal protein
hsa:27173,0.0,0.0,3.953780152029702e-08,1.9155596561621001e-07,0.0,2.0622704e-06,False,SLC39A1; solute carrier family 39 member
hsa:6843,0.0,0.0,4.172551676361117e-05,0.00010441205473857797,0.0,0.00093510246,False,VAMP1; vesicle associated membrane protein
hsa:4086,1.8943998e-07,0.00023471181328373633,8.634823784284155e-05,0.00022700709482549792,0.0,0.0015030681,False,SMAD1; SMAD family member
hsa:2782,4.3493673e-06,0.005388766857027689,0.0010198388960837622,0.0021865590212431936,0.0,0.010249967,False,GNB1; G protein subunit beta
hsa:8555,0.0,0.0,4.428888937158421e-07,1.2632359617829305e-06,0.0,8.626393e-06,False,CDC14B; cell division cycle
hsa:51109,0.0,0.0,0.00015625046329502084,0.00046634244792544014,0.0,0.0035466508,False,RDH11; retinol dehydrogenase
hsa:6654,0.00022716238,0.2814490062744367,0.0004789545696039605,0.0007745064250228703,0.0,0.005383237,False,SOS1; SOS Ras/Rac guanine nucleotide exchange factor
hsa:404672,0.0,0.0,2.190153028371289e-06,6.659870371417382e-06,0.0,5.630988e-05,False,GTF2H5; general transcription factor IIH subunit
hsa:3693,0.0,0.0,7.538695718039605e-05,0.00024691425150773536,0.0,0.001934876,False,ITGB5; integrin subunit beta
hsa:9958,3.6342508e-07,0.000450275382839393,5.356237780666337e-06,1.0556461741684376e-05,0.0,5.52085e-05,False,USP15; ubiquitin specific peptidase
hsa:8754,0.0,0.0,2.066644171696535e-05,5.975319251441008e-05,0.0,0.00046673426,False,ADAM9; ADAM metallopeptidase domain
hsa:952,0.0,0.0,5.750166378366335e-05,0.00010491873481749666,0.0,0.0007095806,False,CD38; CD38
hsa:1040,4.65222775e-08,5.7640040450353554e-05,1.671809765432277e-05,6.226741016666786e-05,0.0,0.00052246713,False,CDS1; CDP-diacylglycerol synthase
hsa:8288,7.1452976e-06,0.008852860711598097,0.00011452180625711383,0.0002700540121901992,0.0,0.0017742347,False,EPX; eosinophil
hsa:2153,1.3687922499999999e-07,0.00016959023697438384,6.353651157841584e-07,1.643500715473793e-06,0.0,1.513536e-05,False,F5; coagulation factor
hsa:89849,0.0,0.0,1.0727509616881186e-07,2.160833538624274e-07,0.0,1.0032229e-06,False,ATG16L2; autophagy related 16 like
hsa:9488,0.0,0.0,5.071562414336633e-06,1.2682940425982784e-05,0.0,8.27234e-05,False,PIGB; phosphatidylinositol glycan anchor biosynthesis class
hsa:768,0.0,0.0,8.817554120813861e-05,0.0002533058763618303,0.0,0.0018943106,False,CA9; carbonic anhydrase
hsa:4495,3.3992229e-07,0.00042115596222856483,1.8831727894262375e-05,7.733422977188059e-05,0.0,0.0009379416,False,MT1G; metallothionein
hsa:55801,0.0,0.0,1.3416987525391093e-06,4.366403492888678e-06,0.0,2.9138193e-05,False,IL26; interleukin
hsa:55904,0.0,0.0,6.179313004290596e-06,2.4858699553447693e-05,0.0,0.00020276119,False,KMT2E; lysine methyltransferase 2E
hsa:1633,1.0570506000000001e-07,0.0001309661577554334,7.75308801290482e-05,0.00018116987121363488,0.0,0.0008218186,False,DCK; deoxycytidine
hsa:10978,4.8607262000000004e-08,6.022328867843869e-05,4.3559451204702945e-07,8.905809261672018e-07,0.0,4.712321e-06,False,CLP1; cleavage factor polyribonucleotide kinase subunit
hsa:8853,2.0214819e-07,0.00025045699554510754,1.3743177678678223e-05,4.612102522480365e-05,0.0,0.00028681997,False,ASAP2; ArfGAP with SH3 domain
hsa:669,0.0,0.0,2.3578182358069302e-05,6.688444510632108e-05,0.0,0.0006536445,False,BPGM; bisphosphoglycerate
hsa:8930,0.0,0.0,5.410109587564353e-06,4.117028541762103e-05,0.0,0.0004834275,False,MBD4; methyl-CpG binding domain 4
hsa:84667,0.0,0.0,1.3681149190985148e-07,4.5137903313384073e-07,0.0,2.7926908e-06,False,HES7; hes family bHLH transcription factor
hsa:767,0.0,0.0,0.00010713112315801981,0.00032298522781923534,0.0,0.0024624867,False,CA8; carbonic anhydrase
hsa:9456,0.0,0.0,1.4457408196242575e-05,6.25917371814927e-05,0.0,0.00077230507,False,HOMER1; homer scaffold protein
hsa:112483,0.0,0.0,4.710936238668315e-05,0.0001226643020980109,0.0,0.00096900656,False,SAT2; spermidine/spermine N1-acetyltransferase family member
hsa:10026,0.0,0.0,2.7089254865841598e-05,6.104146464794793e-05,0.0,0.00033516623,False,PIGK; phosphatidylinositol glycan anchor biosynthesis class
hsa:5451,2.01972045e-08,2.502387559087284e-05,5.456771426561882e-07,8.773105488598495e-07,0.0,4.2892975e-06,False,POU2F1; POU class 2 homeobox
hsa:51455,0.0,0.0,3.4926114954386136e-05,0.00010921826539562301,0.0,0.0007970094,False,REV1; REV1 DNA directed
hsa:5498,2.1080401e-06,0.002611813590488285,0.0003764629462798513,0.000769563739968098,0.0,0.0038803509,False,PPOX; protoporphyrinogen
hsa:5883,1.06624422e-08,1.3210522629885364e-05,7.020831905913862e-06,2.4978906832713315e-05,0.0,0.00016809451,False,RAD9A; RAD9 checkpoint clamp component
hsa:80168,0.0,0.0,1.620284953574256e-05,0.00011389052939576413,0.0,0.0015848724,False,MOGAT2; monoacylglycerol O-acyltransferase
hsa:8864,0.0,0.0,7.466689639059407e-05,0.00032160007999778337,0.0,0.0025117826,False,PER2; period circadian regulator
hsa:998,0.0,0.0,0.00016984516542722765,0.0003534349024971951,0.0,0.0018275898,False,CDC42; cell division cycle
hsa:388567,0.0,0.0,8.907392947433168e-08,2.3168723157308652e-07,0.0,1.2035838e-06,False,ZNF749; zinc finger protein
hsa:441639,0.0,0.0,2.5548179702970297e-08,3.092863940538414e-07,-0.0,4.3185464e-06,False,OR9K2; olfactory receptor family 9 subfamily K member
hsa:7036,2.94816575e-08,3.652710103978614e-05,0.00013161946280617587,0.00031646253553157324,0.0,0.0030098313,False,TFR2; transferrin receptor
hsa:8818,3.1359723e-06,0.003885398134757875,0.0001586180352648515,0.0003616035478485271,0.0,0.0019682294,False,DPM2; dolichyl-phosphate mannosyltransferase subunit 2
hsa:2744,0.0,0.0,0.0002881221892079208,0.0005322121646913985,0.0,0.0027049466,False,GLS;
hsa:26493,0.0,0.0,1.224411186287129e-06,1.3525426992992127e-05,-0.0,0.00018845988,False,OR8B8; olfactory receptor family 8 subfamily B member
hsa:7082,0.0,0.0,0.00024810582883247524,0.0005579431441275917,0.0,0.0035194864,False,TJP1; tight junction protein
hsa:9113,7.8675023e-05,0.09747655858319697,0.0006350004962574257,0.0012963199067152636,0.0,0.011655173,False,LATS1; large tumor suppressor kinase
hsa:84938,0.0,0.0,1.1545713414846535e-05,6.150253169435205e-05,0.0,0.00065294834,False,ATG4C; autophagy related 4C cysteine
hsa:441670,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR4M1; olfactory receptor family 4 subfamily M member
hsa:64926,0.0,0.0,3.8342096671287117e-07,9.228255885599878e-07,0.0,5.416247e-06,False,RASAL3; RAS protein activator like
hsa:7201,0.0,0.0,7.812086964381187e-07,3.579616242163721e-06,0.0,3.9761147e-05,False,TRHR; thyrotropin releasing hormone
hsa:2335,0.0,0.0,0.00015696480640594066,0.0003572452047908696,0.0,0.0030227308,False,FN1; fibronectin
hsa:79346,0.0,0.0,5.971365183168317e-08,8.291353348489357e-07,0.0,1.1782296e-05,False,OR4C5; olfactory receptor family 4 subfamily C member
hsa:3207,0.0,0.0,2.0446927910034644e-07,1.8523533792342023e-06,0.0,2.2958171e-05,False,HOXA11; homeobox
hsa:57492,0.0,0.0,2.2399807892623755e-06,7.950681585551242e-06,0.0,5.947791e-05,False,ARID1B; AT-rich interaction domain
hsa:414189,0.0,0.0,5.1701227690099e-07,1.0464984948665756e-06,0.0,5.3045546e-06,False,AGAP6; ArfGAP with GTPase domain
hsa:6142,0.0,0.0,1.116045561742079e-06,2.9983859463422687e-06,0.0,1.460788e-05,False,RPL18A; ribosomal protein
hsa:55471,0.0,0.0,3.3654780376237624e-07,1.0056130359411945e-06,0.0,8.874522e-06,False,NDUFAF7; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:10666,9.480687e-08,0.00011746354897976374,5.491920669315593e-07,1.374567189667248e-06,0.0,1.6318016e-05,False,CD226; CD226
hsa:26281,8.60921425e-08,0.00010666620042747481,5.898369133757427e-06,1.3497915314587348e-05,0.0,8.473622e-05,False,FGF20; fibroblast growth factor
hsa:185,0.0,0.0,3.077093034742574e-05,0.00010910699749104837,0.0,0.00081647234,False,AGTR1; angiotensin II receptor type
hsa:3283,0.0,0.0,1.3896771215841583e-06,4.661877394098508e-06,0.0,2.9926005e-05,False,HSD3B1; hydroxy-delta-5-steroid dehydrogenase
hsa:128360,0.0,0.0,1.838285749435644e-05,0.00014159230829836937,0.0,0.0018854383,False,OR10T2; olfactory receptor family 10 subfamily T member
hsa:55850,2.5939436e-07,0.00032138369414510225,4.202322005993567e-05,0.0001193076207273471,0.0,0.0009243467,False,USE1; unconventional SNARE in the ER
hsa:54840,0.0,0.0,1.850558781633316e-05,0.00012785096810939093,0.0,0.001229207,False,APTX;
hsa:8794,4.8130825499999996e-05,0.05963299472449318,0.00011389889230111892,0.00016298577491953144,0.0,0.00093422213,False,TNFRSF10C; TNF receptor superfamily member
hsa:3578,0.0,0.0,0.0,0.0,0.0,0.0,False,IL9; interleukin
hsa:1591,0.0,0.0,2.1378625556584158e-06,1.292262193515271e-05,0.0,0.00015474392,False,CYP24A1; cytochrome P450 family 24 subfamily A member
hsa:81876,8.420507e-07,0.001043281606521704,3.0611537164811894e-05,6.15333161108389e-05,0.0,0.00034014697,False,RAB1B; RAB1B
hsa:401666,0.0,0.0,3.3735960396039606e-09,4.794780858561891e-08,0.0,6.814664e-07,False,OR51A4; olfactory receptor family 51 subfamily A member
hsa:254783,0.0,0.0,0.0,0.0,0.0,0.0,False,OR6C74; olfactory receptor family 6 subfamily C member
hsa:5338,8.4035805e-06,0.010411844517882908,0.00015829516241732677,0.00030641726136192984,0.0,0.0016164598,False,PLD2; phospholipase
hsa:7752,0.0,0.0,8.451947579950496e-08,1.872166153534123e-07,0.0,1.1813785e-06,False,ZNF200; zinc finger protein
hsa:574537,0.0,0.0,1.84013782e-05,0.00010484156758884179,0.0,0.0012333386,False,UGT2A2; UDP glucuronosyltransferase family 2 member
hsa:37,2.4530596000000003e-06,0.003039284879617687,3.424114984526237e-05,7.520817164870797e-05,0.0,0.00055197213,False,ACADVL; acyl-CoA dehydrogenase very long
hsa:7006,0.0,0.0,6.675232795391091e-06,2.5118065953164085e-05,0.0,0.0001704625,False,TEC; tec protein tyrosine
hsa:3562,0.0,0.0,1.0464439554455446e-06,6.232385578223739e-06,0.0,7.279235e-05,False,IL3; interleukin
hsa:5139,2.6277386499999997e-06,0.0032557082373913747,2.3912897170346533e-05,5.6164725571691846e-05,0.0,0.00043344608,False,PDE3A; phosphodiesterase
hsa:84335,0.0,0.0,5.995473858157921e-05,0.00011008978775924608,0.0,0.0005640186,False,AKT1S1; AKT1 substrate
hsa:142,3.6650934e-06,0.004540967106142295,0.00020913415872599004,0.0006704833441848453,0.0,0.0043276222,False,PARP1; poly(ADP-ribose) polymerase
hsa:138474,0.0,0.0,4.946014817797031e-09,2.3212151198265175e-08,-0.0,1.774388e-07,False,TAF1L; TATA-box binding protein associated factor 1
hsa:2587,0.0,0.0,1.0816901582268316e-06,8.823801470636459e-06,0.0,0.00012135733,False,GALR1; galanin receptor
hsa:4199,0.0,0.0,6.358743539596533e-05,0.00025186763238308813,0.0,0.002269563,False,ME1; malic enzyme
hsa:200916,2.29441465e-09,2.8427274059375915e-06,3.101039642391089e-07,7.75185301818747e-07,0.0,4.58551e-06,False,RPL22L1; ribosomal protein L22 like
hsa:112755,6.21580865e-07,0.0007701245108166889,1.760122745359406e-05,7.181935017008234e-05,0.0,0.0008839295,False,STX1B; syntaxin
hsa:2066,0.0,0.0,1.4077608599207918e-06,1.1963801616778831e-05,0.0,0.00016876216,False,ERBB4; erb-b2 receptor tyrosine kinase
hsa:139341,0.0,0.0,2.1508588916480197e-06,6.126796815001079e-06,0.0,3.8770264e-05,False,FUNDC1; FUN14 domain containing
hsa:1200,0.0,0.0,2.150242509970298e-06,5.530042203827557e-06,0.0,2.673636e-05,False,TPP1; tripeptidyl peptidase
hsa:5502,0.0,0.0,9.455213296948515e-05,0.00032369911521885084,0.0,0.002545087,False,PPP1R1A; protein phosphatase 1 regulatory inhibitor subunit
hsa:390648,-0.0,0.0,1.904231788019307e-06,1.5711980091112075e-05,-0.0,0.00016200553,False,OR4F6; olfactory receptor family 4 subfamily F member
hsa:160,9.468447000000001e-06,0.01173118981722313,8.569574296945542e-05,0.00018546679107173656,0.0,0.001334995,False,AP2A1; adaptor related protein complex 2 subunit alpha
hsa:6351,3.34555015e-06,0.004145060309540658,0.0001880986339874753,0.0004133336825454293,0.0,0.0036873687,False,CCL4; C-C motif chemokine ligand
hsa:574493,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR520H; microRNA
hsa:23493,0.0,0.0,3.323298872292079e-05,0.000196617492907294,0.0,0.0017376937,False,HEY2; hes related family bHLH transcription factor with YRPW motif
hsa:5494,0.0,0.0,1.3060604704356434e-07,2.5196654059111893e-07,0.0,1.3276801e-06,False,PPM1A; protein phosphatase
hsa:286204,0.0,0.0,4.241173577504455e-06,1.2864231874672767e-05,0.0,8.2421466e-05,False,CRB2; crumbs cell polarity complex component
hsa:23160,0.0,0.0,3.882202937569853e-07,9.796330520357022e-07,0.0,5.664581e-06,False,WDR43; WD repeat domain
hsa:119774,0.0,0.0,6.786711869801981e-07,4.704670351096162e-06,0.0,4.7733756e-05,False,OR52K2; olfactory receptor family 52 subfamily K member
hsa:911,0.0,0.0,1.1551149383252477e-05,3.4986459449084437e-05,0.0,0.00028160593,False,CD1C; CD1c
hsa:3119,0.0,0.0,0.00016598899681683166,0.000629392056438496,0.0,0.0052530267,False,HLA-DQB1; major histocompatibility complex
hsa:124540,0.0,0.0,1.6749764888475265e-07,7.11293148385467e-07,0.0,5.7750945e-06,False,MSI2; musashi RNA binding protein
hsa:1436,0.0,0.0,0.0001900814511633663,0.0003394818181822359,0.0,0.0016749941,False,CSF1R; colony stimulating factor 1
hsa:10815,0.0,0.0,8.498342667049504e-06,6.747794858438059e-05,0.0,0.00084714964,False,CPLX1; complexin
hsa:53407,2.37246895e-07,0.0002939434902885135,4.2442878979607406e-05,0.00012043035226396268,0.0,0.0008987257,False,STX18; syntaxin
hsa:10133,0.0,0.0,6.65142000749505e-06,1.7367768545542147e-05,0.0,0.00017718214,False,OPTN;
hsa:38,0.0,0.0,6.826736407574256e-05,0.00017308673007210764,0.0,0.0013334221,False,ACAT1; acetyl-CoA acetyltransferase
hsa:90550,0.0,0.0,8.32035156668317e-06,3.307906652781183e-05,0.0,0.0003488598,False,MCU; mitochondrial calcium
hsa:64840,0.0,0.0,1.1193008222450496e-06,7.3276103580033505e-06,0.0,8.59357e-05,False,PORCN; porcupine
hsa:7027,5.2541268e-06,0.006509743236093431,0.00013016362086388117,0.00035365658895323757,0.0,0.003246367,False,TFDP1; transcription factor
hsa:84433,0.0,0.0,1.8528281789950488e-06,4.337035818483244e-06,0.0,4.4742137e-05,False,CARD11; caspase recruitment domain family member
hsa:154796,4.2064676e-07,0.0005211717388881093,1.3916089991435643e-05,4.49719390559005e-05,0.0,0.00044485045,False,AMOT;
hsa:2953,7.406051299999999e-05,0.09175928596990839,0.00023035334237673255,0.0003575876198666322,0.0,0.0021005343,False,GSTT2; glutathione S-transferase theta 2
hsa:23195,8.4113923e-10,1.0421523159862336e-06,3.008740464046979e-06,7.292880693184316e-06,0.0,3.7356378e-05,False,MDN1; midasin AAA ATPase
hsa:144715,0.0,0.0,3.612532703641584e-08,1.3553305512990387e-07,0.0,1.3241187e-06,False,RAD9B; RAD9 checkpoint clamp component
hsa:9550,8.29772025e-05,0.10280686083258023,0.00028907958091089103,0.000486944995121787,0.0,0.0024875633,False,ATP6V1G1; ATPase H+ transporting V1 subunit
hsa:4828,0.0,0.0,3.847055723896042e-06,1.7729194539862395e-05,0.0,0.0001480315,False,NMB; neuromedin
hsa:7184,4.077359e-05,0.05051754779000514,0.0002835742193777227,0.0005559392667122018,0.0,0.0029543478,False,HSP90B1; heat shock protein 90 beta family member
hsa:5424,6.3830675e-07,0.0007908475007427078,0.0003131383304215347,0.0006964413587281168,0.0,0.0032228515,False,POLD1; DNA polymerase delta 1
hsa:23007,9.74224215e-10,1.2070415761634614e-06,3.3070319998880046e-07,1.742336498086643e-06,0.0,2.1174608e-05,False,PLCH1; phospholipase C eta
hsa:54577,0.0,0.0,2.18528091009901e-05,7.889310716480504e-05,0.0,0.0007963661,False,UGT1A7; UDP glucuronosyltransferase family 1 member
hsa:389692,0.0,0.0,1.6785039574702974e-05,5.905296253745645e-05,0.0,0.0006500003,False,MAFA; MAF bZIP transcription factor
hsa:10163,2.6250146e-06,0.003252333201588608,5.6758113651534636e-05,0.00012567321752385069,0.0,0.0007799929,False,WASF2; WASP family member
hsa:1278,0.0,0.0,0.00012173717419455447,0.00031241776171365596,0.0,0.0021506094,False,COL1A2; collagen type I alpha 2
hsa:8703,1.4916922500000001e-05,0.0184817266586914,0.0004986269336930692,0.0009172013719520665,0.0,0.003940264,False,B4GALT3; beta-1
hsa:3626,7.1055755e-07,0.0008803645935929107,1.9753062026962375e-05,0.00010574601119668476,0.0,0.0013976981,False,INHBC; inhibin subunit beta
hsa:23604,0.0,0.0,1.2984276380257427e-05,3.1192972728550386e-05,0.0,0.00022057127,False,DAPK2; death associated protein kinase
hsa:51780,0.0,0.0,6.039206522693069e-07,2.7752662049504126e-06,0.0,2.5320674e-05,False,KDM3B; lysine demethylase
hsa:5367,0.0,0.0,4.789815059064356e-07,1.1717219725308866e-06,0.0,6.829819e-06,False,PMCH; pro-melanin concentrating
hsa:9112,8.16903885e-09,1.0121252764431183e-05,6.698182273805445e-06,2.0846075162042873e-05,0.0,0.0001412927,False,MTA1; metastasis associated
hsa:26301,0.0,0.0,0.00012036633233683164,0.00034229118288618335,0.0,0.0032016698,False,GBGT1; globoside alpha-1
hsa:9462,0.0,0.0,4.864163764455445e-07,1.1363562790826164e-06,0.0,7.1017585e-06,False,RASAL2; RAS protein activator like
hsa:5295,0.0006088700899999999,0.7543761505788362,0.0011481352063049503,0.001444009201831788,0.0,0.0067936853,True,PIK3R1; phosphoinositide-3-kinase regulatory subunit
hsa:406918,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR129-2; microRNA
hsa:26189,0.0,0.0,1.939284554455445e-09,2.2120513127063856e-08,0.0,3.0166018e-07,False,OR1A2; olfactory receptor family 1 subfamily A member
hsa:51144,0.0,0.0,7.528136628396038e-05,0.00018407083035414446,0.0,0.0014305095,False,HSD17B12; hydroxysteroid 17-beta dehydrogenase
hsa:162993,0.0,0.0,6.369131356881188e-08,1.5258056081128956e-07,0.0,8.1038445e-07,False,ZNF846; zinc finger protein
hsa:9744,6.51278985e-09,8.069198039555394e-06,6.290294743490095e-07,2.0683370330764817e-06,0.0,1.6175447e-05,False,ACAP1; ArfGAP with coiled-coil
hsa:23163,8.8495698e-07,0.001096441508565928,3.6034796435805444e-06,7.216079961682778e-06,0.0,4.013656e-05,False,GGA3; golgi associated
hsa:406986,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR203A; microRNA
hsa:4791,0.0,0.0,4.9632823924257436e-05,0.00013824865510440735,0.0,0.0014033534,False,NFKB2; nuclear factor kappa B subunit
hsa:130367,0.0,0.0,1.027361473437624e-05,3.0250700668845453e-05,0.0,0.00018917483,False,SGPP2; sphingosine-1-phosphate phosphatase
hsa:84254,2.7555496249999998e-08,3.4140631195013305e-05,1.7226121870181187e-05,8.833090932407311e-05,0.0,0.0010629944,False,CAMKK1; calcium/calmodulin dependent protein kinase kinase
hsa:4051,3.7844237999999994e-08,4.6888147493054414e-05,1.7884144706831669e-06,1.2571264572150005e-05,-0.0,0.00017199804,False,CYP4F3; cytochrome P450 family 4 subfamily F member
hsa:10308,0.0,0.0,2.5549092076237623e-08,6.034874351719828e-08,0.0,5.4022905e-07,False,ZNF267; zinc finger protein
hsa:55738,0.0,0.0,4.060139678638616e-07,8.121898475346031e-07,0.0,4.7772783e-06,False,ARFGAP1; ADP ribosylation factor GTPase activating protein
hsa:163227,0.0,0.0,4.634476328019804e-08,9.183531561772369e-08,0.0,4.2615923e-07,False,ZNF100; zinc finger protein
hsa:80343,0.0,0.0,1.9032741281069314e-08,7.181815622356846e-08,0.0,7.607101e-07,False,SEL1L2; SEL1L2 adaptor subunit of SYVN1 ubiquitin
hsa:3420,7.3242657e-07,0.000907459810447021,8.692927712891585e-05,0.0003221869805208182,0.0,0.002134048,False,IDH3B; isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit
hsa:4325,8.73446225e-07,0.001082179945730486,1.5404769704131683e-05,4.200688325347618e-05,0.0,0.00032088955,False,MMP16; matrix metallopeptidase
hsa:9341,9.9664905e-08,0.00012348254351220538,3.133494544093417e-05,0.00011151635071257048,0.0,0.0011631859,False,VAMP3; vesicle associated membrane protein
hsa:26,2.2142519499999997e-06,0.0027434076494916703,7.282790739112076e-05,0.00015122702134136981,0.0,0.000777974,False,AOC1; amine oxidase copper containing
hsa:6755,0.0,0.0,4.56136549009901e-08,2.216662807593221e-07,0.0,2.5176616e-06,False,SSTR5; somatostatin receptor
hsa:4886,0.0,0.0,2.0460930576732673e-05,7.982120143808752e-05,0.0,0.00068441767,False,NPY1R; neuropeptide Y receptor
hsa:26872,0.0,0.0,7.154110898569308e-06,2.1066633851533135e-05,0.0,0.00018608016,False,STEAP1; STEAP family member
hsa:9048,0.0,0.0,2.7572333096138615e-07,6.663807616112176e-07,0.0,5.0937706e-06,False,ARTN;
hsa:477,0.0,0.0,0.0005531044056128712,0.0016833674555921604,0.0,0.010366389,False,ATP1A2; ATPase Na+/K+ transporting subunit alpha
hsa:10629,0.0,0.0,5.1619486940099e-07,1.5406168666452323e-06,0.0,1.0344931e-05,False,TAF6L; TATA-box binding protein associated factor 6
hsa:223,0.0,0.0,0.000398584320120297,0.0007588980260484668,0.0,0.005205084,False,ALDH9A1; aldehyde dehydrogenase 9 family member
hsa:83937,0.0,0.0,0.0005593939827618812,0.00111237373178677,0.0,0.0103484085,False,RASSF4; Ras association domain family member
hsa:347168,0.0,0.0,9.6191984869802e-06,4.255583101099706e-05,0.0,0.00044585066,False,OR1J1; olfactory receptor family 1 subfamily J member
hsa:4683,0.0,0.0,1.5440879936894546e-05,3.5732441579321526e-05,0.0,0.0003142154,False,NBN;
hsa:795,0.0,0.0,8.79794108910891e-08,1.2504223692937147e-06,0.0,1.7771841e-05,False,S100G; S100 calcium binding protein
hsa:57016,0.0,0.0,1.881327760762377e-05,6.244729278843848e-05,0.0,0.000468402,False,AKR1B10; aldo-keto reductase family 1 member
hsa:5284,0.0,0.0,9.277693524547526e-06,7.838608630533536e-05,0.0,0.0010910691,False,PIGR; polymeric immunoglobulin
hsa:205,0.0,0.0,1.1860643379292078e-05,3.5977078166380735e-05,0.0,0.00033049914,False,AK4; adenylate kinase
hsa:64106,0.0,0.0,4.875389420406584e-07,1.6136525316213204e-06,0.0,1.189061e-05,False,NPFFR1; neuropeptide FF receptor
hsa:23534,0.0,0.0,5.522380060534804e-05,0.00015867702012428966,0.0,0.0010322798,False,TNPO3; transportin
hsa:9371,0.0,0.0,1.56091322640099e-07,9.156917887042977e-07,0.0,9.086158e-06,False,KIF3B; kinesin family member
hsa:4499,0.0,0.0,3.751836127199256e-05,0.00016903691778606293,0.0,0.0012770122,False,MT1M; metallothionein
hsa:730087,6.92464675e-09,8.57947934243781e-06,1.4663327517796038e-07,3.568227896088249e-07,0.0,2.4565504e-06,False,ZNF726; zinc finger protein
hsa:6363,4.9903633e-06,0.006182946277167102,0.0002159411072847524,0.0005285633205064027,0.0,0.0045624366,False,CCL19; C-C motif chemokine ligand
hsa:5008,0.0,0.0,2.5394919791925738e-05,0.00015922180517278112,0.0,0.0018260271,False,OSM; oncostatin
hsa:4838,8.697473499999999e-07,0.0010775971239926465,7.467515124634405e-06,1.6969864603376517e-05,0.0,0.00014290676,False,NODAL; nodal growth differentiation
hsa:57711,0.0,0.0,6.719561339356437e-08,1.8381040027298196e-07,0.0,1.5658673e-06,False,ZNF529; zinc finger protein
hsa:245972,1.28802455e-07,0.0001595833032100555,2.6817560950125245e-05,7.817210954407357e-05,0.0,0.0007177767,False,ATP6V0D2; ATPase H+ transporting V0 subunit
hsa:55515,4.1342714e-06,0.005122267944185231,0.00011395849821876237,0.00026791955991319814,0.0,0.0019428681,False,ASIC4; acid sensing ion channel subunit family member
hsa:1371,4.159843e-06,0.005153950573187653,0.00010389427602242576,0.00024792909729648725,0.0,0.001669345,False,CPOX; coproporphyrinogen
hsa:83444,0.0,0.0,2.2332411250346535e-06,8.497853265363278e-06,0.0,5.956925e-05,False,INO80B; INO80 complex subunit
hsa:9559,0.0,0.0,1.043846140217821e-06,3.323831784282827e-06,0.0,2.109656e-05,False,VPS26A; VPS26 retromer complex component
hsa:693187,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR602; microRNA
hsa:1469,0.0,0.0,4.1217922848069315e-06,1.3673541021672174e-05,0.0,0.000109461056,False,CST1; cystatin
hsa:136227,6.2715455e-06,0.0077703017937209296,8.718255692321786e-05,0.0001769693072539198,0.0,0.0013680246,False,COL26A1; collagen type XXVI alpha 1
hsa:4773,0.0,0.0,6.997572422772278e-05,0.00024444420603141715,0.0,0.0021689956,False,NFATC2; nuclear factor of activated T cells
hsa:65083,0.0,0.0,3.789511854678219e-07,1.28274277611783e-06,0.0,1.2756543e-05,False,NOL6; nucleolar protein
hsa:10231,0.0,0.0,1.217321611398515e-06,2.974406204592815e-06,0.0,1.8369663e-05,False,RCAN2; regulator of calcineurin
hsa:27068,1.9657846999999999e-07,0.00024355623953424487,1.5506516105356438e-06,3.212332358923605e-06,0.0,1.5829375e-05,False,PPA2; inorganic pyrophosphatase
hsa:51601,4.1376123999999997e-07,0.000512640736696273,9.818612848450491e-06,2.0846461931618346e-05,0.0,0.00014335447,False,LIPT1; lipoyltransferase
hsa:51366,0.0,0.0,8.832958687648515e-07,1.999428436312466e-06,0.0,1.0601203e-05,False,UBR5; ubiquitin protein ligase E3 component n-recognin
hsa:140612,2.0753982e-09,2.5713710210896477e-06,9.917782873202967e-08,2.3230191320555042e-07,0.0,1.1622898e-06,False,ZFP28; ZFP28 zinc finger
hsa:5596,3.2263875e-06,0.003997420504800417,0.00013392997209348017,0.000369102781426748,0.0,0.0026056715,False,MAPK4; mitogen-activated protein kinase
hsa:1132,0.0,0.0,5.719842316831685e-06,4.3197731213513966e-05,0.0,0.00057877874,False,CHRM4; cholinergic receptor muscarinic
hsa:1375,0.000308444925,0.3821562251269033,0.0005052624892775741,0.000811326136560494,0.0,0.008692222,False,CPT1B; carnitine palmitoyltransferase
hsa:79723,0.0,0.0,1.0279811031647527e-05,3.079502315250131e-05,0.0,0.00021456354,False,SUV39H2; SUV39H2 histone lysine
hsa:5609,8.33722475e-05,0.10329631257491398,0.00014806368577079208,0.000203181619796143,0.0,0.001021931,False,MAP2K7; mitogen-activated protein kinase kinase
hsa:4591,0.0,0.0,5.168152808787131e-07,1.3702767715521454e-06,0.0,1.0136615e-05,False,TRIM37; tripartite motif containing
hsa:10479,0.0,0.0,1.8936443229581187e-05,0.00010388903300264446,0.0,0.0008232085,False,SLC9A6; solute carrier family 9 member
hsa:1407,0.0,0.0,0.00031426560637346537,0.0007414442084768929,0.0,0.0038668725,False,CRY1; cryptochrome circadian regulator
hsa:7108,4.0380482e-06,0.005003049594648012,3.551150324024753e-05,7.444662779262199e-05,0.0,0.000598086,False,TM7SF2; transmembrane 7 superfamily member
hsa:5209,9.8276782e-08,0.00012176269078422865,0.00015243818103506928,0.000409305241374294,0.0,0.0023089333,False,PFKFB3; 6-phosphofructo-2-kinase/fructose-2
hsa:83729,1.3697543e-07,0.00016970943277453627,2.413546751911881e-06,9.189501262040659e-06,0.0,0.000103884624,False,INHBE; inhibin subunit beta
hsa:3690,0.0,0.0,0.00018325006956188122,0.0005857890465130155,0.0,0.0034459475,False,ITGB3; integrin subunit beta
hsa:8906,0.0,0.0,2.104432437702969e-06,6.055847184620423e-06,0.0,4.3232896e-05,False,AP1G2; adaptor related protein complex 1 subunit gamma
hsa:9655,0.0,0.0,2.6381584848415852e-05,7.601640620157792e-05,0.0,0.00045206494,False,SOCS5; suppressor of cytokine signaling
hsa:50484,0.0,0.0,8.962353986435643e-05,0.00014071074218360548,0.0,0.00054072053,False,RRM2B; ribonucleotide reductase regulatory TP53 inducible subunit
hsa:378,1.61131685e-09,1.9963848161203257e-06,7.729829635069309e-07,1.993452806553689e-06,0.0,2.1042539e-05,False,ARF4; ADP ribosylation factor
hsa:953,0.0,0.0,2.8029769860648516e-05,0.00010328538082961238,0.0,0.0010189273,False,ENTPD1; ectonucleoside triphosphate diphosphohydrolase
hsa:191,1.19519875e-06,0.0014808239836541107,0.0002640367012007712,0.0007917124147738949,0.0,0.005038835,False,AHCY;
hsa:55168,0.0,0.0,2.2554137362361384e-07,5.738764392048922e-07,0.0,3.1297327e-06,False,MRPS18A; mitochondrial ribosomal protein
hsa:3636,0.0,0.0,2.5378563999108917e-05,5.524636586738421e-05,0.0,0.00039684016,False,INPPL1; inositol polyphosphate phosphatase like
hsa:4216,0.0,0.0,4.262656762995051e-06,1.3848755046487774e-05,0.0,0.00015081899,False,MAP3K4; mitogen-activated protein kinase kinase kinase
hsa:1015,1.5784415999999999e-09,1.9556531313954e-06,3.6722089577529703e-07,1.6470087838447888e-06,0.0,1.5794618e-05,False,CDH17; cadherin
hsa:5315,0.0,0.0,0.00010340689449405941,0.00021248415079292183,0.0,0.0014441705,False,PKM; pyruvate kinase
hsa:4357,0.0,0.0,0.000314659805433698,0.0009247154656254328,0.0,0.0061508873,False,MPST; mercaptopyruvate
hsa:57504,0.0,0.0,3.860137519689605e-06,1.1439362111043128e-05,0.0,8.042426e-05,False,MTA3; metastasis associated 1 family member
hsa:2021,3.37758905e-08,4.184755775696304e-05,3.4711189897574256e-06,7.30412672681146e-06,0.0,3.439593e-05,False,ENDOG; endonuclease
hsa:50940,3.9194379999999997e-07,0.00048560942628540234,1.0764548588138612e-05,2.821680931879748e-05,0.0,0.00025827737,False,PDE11A; phosphodiesterase
hsa:57467,3.1297621000000002e-06,0.0038777038386391014,2.4975114211653468e-05,4.818489646168809e-05,0.0,0.00030516592,False,HHATL; hedgehog acyltransferase
hsa:56904,5.2192446000000005e-09,6.466524986105622e-06,4.385987152202971e-07,9.421402781127782e-07,0.0,6.4480264e-06,False,SH3GLB2; SH3 domain containing GRB2 like
hsa:80896,2.75703105e-07,0.00034158985712786895,3.526097034940595e-05,0.00010165531030602403,0.0,0.00073454296,False,NPL; N-acetylneuraminate pyruvate
hsa:7991,0.0,0.0,0.00016201736019513365,0.0004666886365147024,0.0,0.0026234563,False,TUSC3; tumor suppressor candidate
hsa:406937,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR145; microRNA
hsa:1013,0.0,0.0,1.327254996837e-06,7.633564830775873e-06,0.0,8.663561e-05,False,CDH15; cadherin
hsa:680,0.0,0.0,8.531132949350941e-07,3.2858189012142843e-06,0.0,3.5465306e-05,False,BRS3; bombesin receptor subtype
hsa:84168,0.0,0.0,3.3287905732178217e-07,1.3323252218803587e-06,0.0,1.231856e-05,False,ANTXR1; ANTXR cell adhesion molecule
hsa:761,1.6812172e-06,0.002082989755044347,5.3856811295173255e-05,0.000185967792930213,0.0,0.0013202949,False,CA3; carbonic anhydrase
hsa:8554,2.5549951499999997e-07,0.00031655807004817666,8.068839685806927e-05,0.00025623165326560274,0.0,0.001746523,False,PIAS1; protein inhibitor of activated STAT
hsa:4291,0.0,0.0,1.2001787884127724e-06,6.973387690186073e-06,0.0,8.365373e-05,False,MLF1; myeloid leukemia factor
hsa:10314,0.0,0.0,0.00010057683905809401,0.0003035099232487926,0.0,0.0025267657,False,LANCL1; LanC like glutathione S-transferase
hsa:90990,4.97905315e-08,6.168933259350002e-05,4.1151436114559395e-07,9.91459481025186e-07,0.0,6.0742013e-06,False,KIFC2; kinesin family member
hsa:332,0.00012461129500000002,0.15439055158834258,0.0007619145263073763,0.0015565392062515061,0.0,0.011419313,False,BIRC5; baculoviral IAP repeat containing
hsa:10250,1.097806e-08,1.3601565883493307e-05,7.759866100744553e-07,1.1956271714106698e-06,0.0,5.744184e-06,False,SRRM1; serine and arginine repetitive matrix
hsa:10157,3.4001829e-07,0.0004212749040383942,7.763068592084156e-06,2.5163999786111053e-05,0.0,0.00019350287,False,AASS; aminoadipate-semialdehyde
hsa:90075,1.1413708e-09,1.4141323816498966e-06,2.759054033069307e-08,5.538528533386896e-08,0.0,3.1093808e-07,False,ZNF30; zinc finger protein
hsa:8824,0.0,0.0,2.2395476548195048e-05,6.440446979408753e-05,0.0,0.0004566349,False,CES2; carboxylesterase
hsa:2166,0.0,0.0,1.2454929985002475e-06,2.6970468876657786e-06,0.0,1.299618e-05,False,FAAH; fatty acid amide
hsa:4756,1.5313685999999999e-06,0.0018973307583318828,9.835070486672771e-05,0.00026193701542137247,0.0,0.002489193,False,NEO1; neogenin
hsa:2658,0.0,0.0,6.966850842287129e-07,8.30984637385017e-06,0.0,0.00011770639,False,GDF2; growth differentiation factor
hsa:5566,0.0,0.0,0.0011093345336683166,0.0021134865884996773,0.0,0.011225367,False,PRKACA; protein kinase cAMP-activated catalytic subunit
hsa:150094,0.0,0.0,7.17315113490099e-07,3.5427515145920005e-06,0.0,4.446481e-05,False,SIK1; salt inducible kinase
hsa:7565,1.5262330000000001e-09,1.8909678670968864e-06,1.0407027689272284e-07,2.2542284521070322e-07,0.0,1.1176191e-06,False,ZNF17; zinc finger protein
hsa:7324,9.566916800000001e-08,0.00011853191652905794,1.1497327519282175e-06,2.3569347998576903e-06,0.0,1.5942884e-05,False,UBE2E1; ubiquitin conjugating enzyme E2
hsa:171023,0.0,0.0,1.0989380715227721e-05,6.161283325231503e-05,0.0,0.00061127957,False,ASXL1; ASXL transcriptional regulator
hsa:10055,0.0,0.0,8.349829335504952e-07,2.3819176468220318e-06,0.0,1.4377318e-05,False,SAE1; SUMO1 activating enzyme subunit
hsa:54490,0.0,0.0,2.1594866460396037e-06,1.7152646071036416e-05,0.0,0.00022009999,False,UGT2B28; UDP glucuronosyltransferase family 2 member
hsa:51023,0.0,0.0,9.536670688930699e-08,2.1715074017882345e-07,0.0,1.7394108e-06,False,MRPS18C; mitochondrial ribosomal protein
hsa:84436,0.0,0.0,7.163608705594059e-08,1.8094895635014763e-07,0.0,1.6179467e-06,False,ZNF528; zinc finger protein
hsa:10623,4.87114935e-07,0.0006035242912897233,0.00013868799603163366,0.00043293499622708216,0.0,0.002847829,False,POLR3C; RNA polymerase III subunit
hsa:163,2.4939574999999997e-06,0.0030899564446616483,3.9559976245297043e-05,8.233001259293732e-05,0.0,0.0005691669,False,AP2B1; adaptor related protein complex 2 subunit beta
hsa:140735,2.10212135e-06,0.0026044803942702893,0.00014562408699896046,0.0004758710696352052,0.0,0.0028015366,False,DYNLL2; dynein light chain LC8-type
hsa:339559,0.0,0.0,4.6300252042079186e-08,8.541905065951349e-08,0.0,3.5830735e-07,False,ZFP69; ZFP69 zinc finger
hsa:223117,1.7370419e-08,2.1521552847441528e-05,6.602220484083167e-06,2.9182982534090522e-05,0.0,0.00030511036,False,SEMA3D; semaphorin
hsa:49861,6.8459198e-08,8.481938447486288e-05,4.696263763345544e-06,1.1271195441540331e-05,0.0,6.984035e-05,False,CLDN20; claudin
hsa:4833,0.0,0.0,3.4485371037757436e-05,0.00014552929360750415,0.0,0.0016445381,False,NME4; NME/NM23 nucleoside diphosphate kinase
hsa:6424,0.0,0.0,5.151851508324261e-06,4.407575541402818e-05,0.0,0.0005460836,False,SFRP4; secreted frizzled related protein
hsa:51371,0.0,0.0,3.243503151163366e-06,7.700427380686152e-06,0.0,7.2661074e-05,False,POMP; proteasome maturation
hsa:943,0.0,0.0,1.9027652178861377e-06,1.1534277485515055e-05,0.0,0.000118456766,False,TNFRSF8; TNF receptor superfamily member
hsa:55034,2.0018062e-08,2.4801922120379537e-05,1.2311169163581686e-06,4.858067607478965e-06,0.0,4.3172247e-05,False,MOCOS; molybdenum cofactor
hsa:442361,0.0,0.0,7.960705778514853e-07,4.878271670052215e-06,0.0,3.949096e-05,False,OR2A2; olfactory receptor family 2 subfamily A member
hsa:3696,0.0,0.0,6.99253244262376e-05,0.00030474279911935884,0.0,0.0025881534,False,ITGB8; integrin subunit beta
hsa:23026,2.34542135e-10,2.905923543556586e-07,3.700088034529407e-07,1.5977488052782436e-06,0.0,1.1193576e-05,False,MYO16; myosin
hsa:8632,0.0,0.0,8.158485593079207e-07,2.8522598581648996e-06,0.0,1.636539e-05,False,DNAH17; dynein axonemal heavy chain
hsa:6662,0.0,0.0,3.782403331555446e-05,0.00045398356561388714,0.0,0.006384224,False,SOX9; SRY-box transcription factor
hsa:6358,0.0,0.0,7.119648851089108e-05,0.00023110637088687508,0.0,0.0017261348,False,CCL14; C-C motif chemokine ligand
hsa:7412,0.0,0.0,6.201272350311881e-05,0.0001269563351990736,0.0,0.0009800026,False,VCAM1; vascular cell adhesion molecule
hsa:154,0.0,0.0,6.408421431207922e-05,0.0001451849835585679,0.0,0.0009854385,False,ADRB2; adrenoceptor beta
hsa:1847,0.0,0.0,1.9681739158980195e-05,9.224010909281647e-05,0.0,0.00078743644,False,DUSP5; dual specificity phosphatase
hsa:55613,5.0798885e-08,6.29386595751435e-05,1.1231651365891091e-06,3.546215508847055e-06,0.0,3.056732e-05,False,MTMR8; myotubularin related protein
hsa:3483,0.0,0.0,8.1415056000099e-08,2.3629154985220357e-07,0.0,2.822978e-06,False,IGFALS; insulin like growth factor binding protein acid labile
hsa:51032,0.0,0.0,2.8771194878064352e-05,0.0003069015334524513,0.0,0.0043521086,False,CELA2B; chymotrypsin like elastase
hsa:8878,0.0,0.0,1.6617925933316837e-05,0.00012008492032737714,0.0,0.0015215533,False,SQSTM1; sequestosome
hsa:2176,1.4614867999999999e-06,0.0018107488024346565,9.454903694005944e-05,0.00022658230838295152,0.0,0.001563286,False,FANCC; FA complementation group
hsa:101954267,0.0,0.0,1.9575285789455446e-07,9.09482752984536e-07,0.0,1.04472165e-05,False,RNVU1-15; RNA
hsa:1649,0.0,0.0,5.85533581891089e-06,1.4677323278623784e-05,0.0,0.00012090226,False,DDIT3; DNA damage inducible transcript
hsa:10940,7.275994650000001e-09,9.014791374789337e-06,6.117020674351482e-07,1.5298176259497978e-06,0.0,9.128546e-06,False,POP1; POP1 homolog
hsa:100169768,0.0,0.0,1.1204488540955446e-07,8.015520664108339e-07,0.0,9.695978e-06,False,RNA5S17; RNA
hsa:1632,8.63161365e-07,0.0010694372388321356,1.9284950877366328e-05,9.347464998487446e-05,0.0,0.001169003,False,ECI1; enoyl-CoA delta isomerase
hsa:406984,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR200B; microRNA
hsa:375775,1.3674845e-07,0.00016942820973292095,5.686071602509901e-06,1.341266369285667e-05,0.0,0.000101529055,False,PNPLA7; patatin like phospholipase domain containing
hsa:100131827,0.0,0.0,4.4863035755940566e-08,1.0695465400829966e-07,0.0,7.9306596e-07,False,ZNF717; zinc finger protein
hsa:93343,2.1029419999999997e-08,2.6054971608977523e-05,1.1600852120891094e-06,2.4994913496050376e-06,0.0,1.406436e-05,False,MVB12A; multivesicular body subunit
hsa:3043,4.29033935e-06,0.005315632573657718,0.00013165482690445546,0.00028408749929972313,0.0,0.0020501711,False,HBB; hemoglobin subunit
hsa:81616,9.4135095e-06,0.011663123508082497,4.738402179207426e-05,0.0001110057134294859,0.0,0.0008591891,False,ACSBG2; acyl-CoA synthetase bubblegum family member
hsa:9070,0.0,0.0,3.895095363732673e-06,8.049890978428842e-06,0.0,7.285476e-05,False,ASH2L; ASH2 like
hsa:64324,0.0,0.0,1.601868837277227e-05,4.013335275501805e-05,0.0,0.00026188607,False,NSD1; nuclear receptor binding SET domain protein
hsa:339302,0.0,0.0,3.3138023709862376e-07,1.691072253901227e-06,0.0,1.4412042e-05,False,CPLX4; complexin
hsa:6746,1.1260927e-07,0.0001395203164308709,9.697848243637623e-07,1.808656102441816e-06,0.0,1.2973607e-05,False,SSR2; signal sequence receptor subunit
hsa:2806,0.0,0.0,0.00031390025813217816,0.0007020342971404507,0.0,0.005047352,False,GOT2; glutamic-oxaloacetic transaminase
hsa:2266,0.0,0.0,1.4697738326782178e-06,9.963223532637342e-06,0.0,0.000106082014,False,FGG; fibrinogen gamma
hsa:3662,0.0,0.0,3.2178278938821787e-06,1.5228148273197432e-05,0.0,0.00016710657,False,IRF4; interferon regulatory factor
hsa:343172,0.0,0.0,1.2617370550000002e-06,5.726952754632813e-06,0.0,6.0065897e-05,False,OR2T8; olfactory receptor family 2 subfamily T member
hsa:171546,0.0,0.0,3.5682817798217823e-06,9.317501500659426e-06,0.0,5.9837308e-05,False,SPTSSA; serine palmitoyltransferase small subunit
hsa:406909,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR124-3; microRNA
hsa:3155,0.0,0.0,5.0815729918069306e-05,0.00018180541234088366,0.0,0.0016628491,False,HMGCL; 3-hydroxy-3-methylglutaryl-CoA
hsa:283455,1.0119562e-08,1.2537906447504869e-05,5.062032305208415e-07,1.2515410469911387e-06,0.0,8.537217e-06,False,KSR2; kinase suppressor of ras
hsa:2169,0.0,0.0,6.547129254356438e-07,3.364058879128787e-06,0.0,3.9917417e-05,False,FABP2; fatty acid binding protein
hsa:5770,0.0,0.0,4.222693342115839e-05,0.00011662899522749138,0.0,0.00085855334,False,PTPN1; protein tyrosine phosphatase non-receptor type
hsa:391114,0.0,0.0,1.683084778217822e-06,1.367972976997558e-05,-0.0,0.00015843366,False,OR6K3; olfactory receptor family 6 subfamily K member
hsa:10156,0.0,0.0,2.83272522549505e-07,7.128739054670193e-07,0.0,5.263466e-06,False,RASA4; RAS p21 protein activator
hsa:273,4.61860985e-08,5.722352233903454e-05,3.053731779130694e-06,8.690171227077449e-06,0.0,7.938358e-05,False,AMPH;
hsa:5305,0.0,0.0,8.925637763613862e-06,2.9698900109013392e-05,0.0,0.00019477098,False,PIP4K2A; phosphatidylinositol-5-phosphate 4-kinase type 2
hsa:168374,6.100736350000001e-08,7.558673153758268e-05,1.9973190679356437e-07,2.976814729361931e-07,0.0,1.3867971e-06,False,ZNF92; zinc finger protein
hsa:414328,1.3750881e-06,0.0017037027842585696,5.898584179943465e-05,0.00019107335155491787,0.0,0.0010909361,False,IDNK; IDNK
hsa:83667,0.0,0.0,2.55816961144505e-05,7.291796819248694e-05,0.0,0.00042190938,False,SESN2; sestrin
hsa:9231,0.0,0.0,3.9659477222772285e-06,7.135002019368032e-06,0.0,4.431916e-05,False,DLG5; discs large MAGUK scaffold protein
hsa:6303,0.0,0.0,8.077166227631189e-05,0.0003433962730882467,0.0,0.0027969282,False,SAT1; spermidine/spermine N1-acetyltransferase
hsa:747,0.0,0.0,6.872010776054454e-06,2.1593276643551974e-05,0.0,0.00012322771,False,DAGLA; diacylglycerol lipase
hsa:26873,0.0,0.0,8.87618923377723e-06,6.556103924970695e-05,0.0,0.00090096355,False,OPLAH; 5-oxoprolinase
hsa:7323,1.39736355e-06,0.0017313015586102732,5.960123891585649e-05,0.00019409004675936757,0.0,0.0011037355,False,UBE2D3; ubiquitin conjugating enzyme E2
hsa:1019,0.0002309596,0.2861536752236061,0.0005681943220579206,0.0007702136034429766,0.0,0.0043409634,False,CDK4; cyclin dependent kinase
hsa:51727,0.0,0.0,6.802238679277227e-05,0.0002705429879375786,0.0,0.0023556103,False,CMPK1; cytidine/uridine monophosphate kinase
hsa:81490,0.0,0.0,4.020164492109902e-06,1.0465521650617295e-05,0.0,9.890479e-05,False,PTDSS2; phosphatidylserine synthase
hsa:283617,0.0,0.0,5.287169801980198e-08,7.514480176315738e-07,-0.0,1.0680083e-05,False,OR4K3; olfactory receptor family 4 subfamily K member 3
hsa:100271927,0.0,0.0,2.196435810262376e-06,4.790202047903788e-06,0.0,3.2127027e-05,False,RASA4B; RAS p21 protein activator
hsa:2894,0.0,0.0,1.194996057878564e-05,2.4074741250852745e-05,0.0,0.00017612451,False,GRID1; glutamate ionotropic receptor delta type subunit
hsa:92912,4.1496014e-08,5.141261464442357e-05,4.3081784820099024e-07,7.333438398112974e-07,0.0,4.0065634e-06,False,UBE2Q2; ubiquitin conjugating enzyme E2
hsa:1462,0.0,0.0,5.035812051599011e-06,1.6831412451072948e-05,0.0,0.0001920976,False,VCAN;
hsa:98,0.0,0.0,1.449295949722772e-06,2.7224355216465135e-06,0.0,1.594338e-05,False,ACYP2; acylphosphatase
hsa:3842,2.2960047e-08,2.8446974416117498e-05,1.3054719741499997e-07,2.7353685648652e-07,0.0,1.5118965e-06,False,TNPO1; transportin
hsa:7102,2.9414547500000002e-08,3.64439532808523e-05,1.409215055536377e-05,5.2863058606986416e-05,0.0,0.0004195275,False,TSPAN7; tetraspanin
hsa:8896,7.454448499999999e-09,9.23589162364369e-06,2.0640216445465347e-07,3.7453177776342523e-07,0.0,1.9121544e-06,False,BUD31; BUD31
hsa:3628,0.0,0.0,6.720472082009898e-06,2.0135431674141334e-05,0.0,0.00012921468,False,INPP1; inositol
hsa:10438,0.0,0.0,2.269278043047525e-06,1.0223920799714218e-05,0.0,0.0001178612,False,C1D; C1D nuclear receptor
hsa:7867,0.0,0.0,2.088561399792079e-05,6.984509447951131e-05,0.0,0.00075336226,False,MAPKAPK3; MAPK activated protein kinase
hsa:6342,4.1348011e-05,0.05122924230400508,0.00021831304614435638,0.000299712325010205,0.0,0.0015768355,False,SCP2; sterol carrier protein
hsa:439996,4.8897225e-10,6.058254622014236e-07,5.932805083133665e-09,1.3456955528960134e-08,0.0,1.0713178e-07,False,IFIT1B; interferon induced protein with tetratricopeptide repeats
hsa:10847,0.0,0.0,1.0474071756009898e-06,5.458431889504836e-06,0.0,5.4218435e-05,False,SRCAP; Snf2 related CREBBP activator
hsa:6374,0.0,0.0,1.2206051801039606e-05,3.7903954208415786e-05,0.0,0.00033886312,False,CXCL5; C-X-C motif chemokine ligand
hsa:28234,0.0,0.0,1.0265237872227725e-06,6.195323639493473e-06,0.0,7.681444e-05,False,SLCO1B3; solute carrier organic anion transporter family member
hsa:90381,0.0,0.0,9.597095689736634e-07,3.015254237658087e-06,0.0,1.6474542e-05,False,TICRR; TOPBP1 interacting checkpoint and replication
hsa:23545,1.5406455499999997e-05,0.019088246877349713,9.22557061757426e-05,0.00015771609072451123,0.0,0.0007920034,False,ATP6V0A2; ATPase H+ transporting V0 subunit
hsa:3439,0.0,0.0,3.1582833663366335e-08,3.181450698356223e-07,0.0,3.5024927e-06,False,IFNA1; interferon alpha
hsa:128366,0.0,0.0,2.203208860891089e-06,2.7599136899261354e-05,0.0,0.00038936242,False,OR6P1; olfactory receptor family 6 subfamily P member
hsa:226,0.0,0.0,0.00040628604424207914,0.0009951402809558545,0.0,0.0051750094,False,ALDOA; aldolase
hsa:1584,0.0,0.0,1.036363324289604e-05,5.300138950399293e-05,0.0,0.00040173624,False,CYP11B1; cytochrome P450 family 11 subfamily B member
hsa:9899,2.76048015e-06,0.003420171927489965,2.1029128334138602e-05,5.073813499076666e-05,0.0,0.00029981736,False,SV2B; synaptic vesicle glycoprotein
hsa:8434,0.0,0.0,8.232121870099009e-08,3.1286882788355484e-07,0.0,2.4007322e-06,False,RECK; reversion inducing cysteine rich protein with kazal
hsa:775,0.0,0.0,0.0003089064697772276,0.0006626705198731327,0.0,0.004954167,False,CACNA1C; calcium voltage-gated channel subunit alpha1
hsa:90317,4.518954e-13,5.598880909329665e-10,3.3314382250598005e-08,7.232382977282468e-08,0.0,4.546141e-07,False,ZNF616; zinc finger protein
hsa:80308,5.1277495e-08,6.353164644600218e-05,0.00013508048047198017,0.0002883703741883712,0.0,0.001293936,False,FLAD1; flavin adenine dinucleotide synthetase
hsa:7318,0.0,0.0,3.062088108331683e-07,8.787551710821798e-07,0.0,8.162644e-06,False,UBA7; ubiquitin like modifier activating enzyme
hsa:10452,0.0,0.0,4.6414706707920803e-08,1.288143837779312e-07,0.0,8.383458e-07,False,TOMM40; translocase of outer mitochondrial membrane
hsa:21,8.456591e-05,0.10477523317986652,0.0007433294985396034,0.0015272823442875525,0.0,0.010644812,False,ABCA3; ATP binding cassette subfamily A member
hsa:2869,2.3445675e-06,0.0029048656428865565,8.785704896485147e-06,3.0137301170153862e-05,0.0,0.00036953494,False,GRK5; G protein-coupled receptor kinase
hsa:6391,0.0,0.0,0.00012580914611336636,0.00044494893769889897,0.0,0.0031599489,False,SDHC; succinate dehydrogenase complex subunit
hsa:5288,0.0,0.0,7.667070429790592e-07,5.383345408246856e-06,0.0,5.486746e-05,False,PIK3C2G; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2
hsa:406943,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR152; microRNA
hsa:7295,0.0,0.0,1.1886198524455444e-06,2.3645601395235004e-06,0.0,1.3790774e-05,False,TXN;
hsa:7988,0.0,0.0,3.9717399562376245e-08,8.590112064735858e-08,0.0,4.7414642e-07,False,ZNF212; zinc finger protein
hsa:54575,0.0,0.0,4.7137464469801975e-05,0.00020885138088626995,0.0,0.0018293821,False,UGT1A10; UDP glucuronosyltransferase family 1 member
hsa:91543,0.0,0.0,2.640884381589108e-06,7.083551685663011e-06,0.0,5.190892e-05,False,RSAD2; radical S-adenosyl methionine domain containing
hsa:6569,0.0,0.0,2.6823494956336634e-07,9.028310917535961e-07,0.0,8.492931e-06,False,SLC34A1; solute carrier family 34 member
hsa:129521,0.0,0.0,1.1690569168316832e-08,1.345533627700905e-07,0.0,1.8491094e-06,False,NMS; neuromedin
hsa:84465,7.249464750000001e-08,8.981921433949838e-05,4.682449287163316e-05,0.00012043275177463281,0.0,0.0008451936,False,MEGF11; multiple EGF like domains
hsa:1815,0.0,0.0,3.6242658192326727e-06,9.669545982159669e-06,0.0,9.688124e-05,False,DRD4; dopamine receptor
hsa:56915,7.85679725e-08,9.734392545597678e-05,9.478411018336633e-06,3.752871715947454e-05,0.0,0.0002872923,False,EXOSC5; exosome component
hsa:406971,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR195; microRNA
hsa:9883,0.0,0.0,1.9236647669851493e-07,3.815330253291863e-07,0.0,1.5847553e-06,False,POM121; POM121 transmembrane
hsa:84245,3.468567e-08,4.297475380150111e-05,2.593662536439604e-05,8.831990472572879e-05,0.0,0.0008353677,False,MRI1; methylthioribose-1-phosphate isomerase
hsa:5581,8.022568500000001e-05,0.09939779342396388,0.00029060131586138607,0.0004605778909782683,0.0,0.0027395182,False,PRKCE; protein kinase C
hsa:9175,1.4801793500000001e-08,1.8339084454276348e-05,1.9837021008529692e-07,3.9928327171772216e-07,0.0,2.9909263e-06,False,MAP3K13; mitogen-activated protein kinase kinase kinase
hsa:4853,0.0,0.0,7.041779721584159e-05,0.00022678316553860885,0.0,0.0013340102,False,NOTCH2; notch receptor
hsa:128372,0.0,0.0,8.660623460396039e-07,1.0221866654132054e-05,-0.0,0.00014267075,False,OR6N1; olfactory receptor family 6 subfamily N member
hsa:3443,0.0,0.0,1.671909e-07,1.1730367957809074e-06,0.0,1.2352792e-05,False,IFNA6; interferon alpha
hsa:54600,0.0,0.0,4.638979984059406e-05,0.00020076732101818965,0.0,0.0020001149,False,UGT1A9; UDP glucuronosyltransferase family 1 member
hsa:9107,1.3264918249999999e-07,0.00016434931082224706,3.19311917822594e-05,0.00011573593280181496,0.0,0.0007942123,False,MTMR6; myotubularin related protein
hsa:353091,0.0,0.0,8.841620417081191e-07,5.114998752514916e-06,0.0,4.8355563e-05,False,RAET1G; retinoic acid early transcript
hsa:64600,0.0,0.0,3.0160259623762376e-07,1.5597060881001745e-06,0.0,1.4117727e-05,False,PLA2G2F; phospholipase A2 group
hsa:3992,0.0,0.0,0.00026129110912511186,0.0008533342235350908,0.0,0.004560173,False,FADS1; fatty acid desaturase
hsa:283446,9.995851000000001e-09,1.2384631340881948e-05,1.7362841845168318e-07,6.911896284547886e-07,0.0,8.291068e-06,False,MYO1H; myosin
hsa:3178,1.21459112e-08,1.5048506876612012e-05,5.663505669173268e-07,1.0483142584636144e-06,0.0,5.280109e-06,False,HNRNPA1; heterogeneous nuclear ribonucleoprotein
hsa:8733,2.292366e-06,0.0028401891753260613,3.403868223379456e-05,8.643398998414317e-05,0.0,0.00097070815,False,GPAA1; glycosylphosphatidylinositol anchor attachment
hsa:92283,0.0,0.0,9.689848063861387e-08,2.0120554640508882e-07,0.0,1.004156e-06,False,ZNF461; zinc finger protein
hsa:9274,0.0,0.0,6.966613134761932e-06,1.843286756409334e-05,0.0,0.00011543385,False,BCL7C; BAF chromatin remodeling complex subunit
hsa:23295,1.9364069000000002e-05,0.02399163971375729,0.0001500183307827723,0.00025968473404153723,0.0,0.001499196,False,MGRN1; mahogunin ring finger
hsa:6774,0.0,0.0,0.00019775174789041586,0.0004977205920763862,0.0,0.002986287,False,STAT3; signal transducer and activator of transcription
hsa:10663,0.0,0.0,3.879332809104452e-06,1.79560788021524e-05,0.0,0.00015524523,False,CXCR6; C-X-C motif chemokine receptor
hsa:2064,0.0,0.0,0.00012980827762871285,0.0003305022483366549,0.0,0.0028944528,False,ERBB2; erb-b2 receptor tyrosine kinase
hsa:658,4.2065237e-05,0.052117868955012116,0.0002560318698793563,0.0004755918513444785,0.0,0.0023854852,False,BMPR1B; bone morphogenetic protein receptor type
hsa:6262,0.00019807232499999999,0.24540709179802245,0.0004726025025702971,0.0007677828869618488,0.0,0.00606427,False,RYR2; ryanodine receptor
hsa:406981,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR19B2; microRNA
hsa:10528,1.58090975e-07,0.00019587111129363416,3.626320191767327e-06,7.198959273668889e-06,0.0,3.322409e-05,False,NOP56; NOP56
hsa:9453,0.0,0.0,3.791460318221214e-05,0.00011596417384285846,0.0,0.00073327945,False,GGPS1; geranylgeranyl diphosphate synthase
hsa:653247,3.7910001e-09,4.696962634971909e-06,1.1046741386471287e-05,3.11206952117088e-05,0.0,0.00020354173,False,PRB2; proline rich protein BstNI subfamily
hsa:57455,1.00578155e-07,0.0001246140394270665,8.696388646300003e-07,1.6164352653027605e-06,0.0,1.1183667e-05,False,REXO1; RNA exonuclease 1
hsa:4440,0.0,0.0,3.9274839765079217e-07,8.228439085890799e-07,0.0,4.3129876e-06,False,MSI1; musashi RNA binding protein
hsa:10349,2.1776930499999998e-05,0.02698112006456558,0.00011921839370707924,0.00021760550643414245,0.0,0.0015474674,False,ABCA10; ATP binding cassette subfamily A member
hsa:65008,4.4221311e-09,5.478919545174169e-06,1.565262951992574e-07,3.3464286665843895e-07,0.0,1.520981e-06,False,MRPL1; mitochondrial ribosomal protein
hsa:392133,0.0,0.0,2.6669271802574253e-06,1.914385821374335e-05,0.0,0.0002635062,False,OR10AC1; olfactory receptor family 10 subfamily AC member 1
hsa:5720,3.0813797500000003e-06,0.003817759210797458,1.2396503839193072e-05,2.2288593829381563e-05,0.0,0.0001264195,False,PSME1; proteasome activator subunit
hsa:25906,4.7794553e-07,0.0005921636076880731,5.383625624990098e-06,1.185531913207732e-05,0.0,0.00010949309,False,ANAPC15; anaphase promoting complex subunit
hsa:6572,2.0412368499999997e-06,0.0025290458878061643,3.405375499582176e-05,0.00015264941457945907,0.0,0.001803831,False,SLC18A3; solute carrier family 18 member
hsa:57369,1.357601625e-09,1.682037440674862e-06,6.770065290415769e-05,0.0002262558411063133,0.0,0.0014970411,False,GJD2; gap junction protein delta
hsa:9002,0.0,0.0,1.8535748265346526e-06,5.267225761151296e-06,0.0,4.11945e-05,False,F2RL3; F2R like thrombin or trypsin receptor
hsa:535,5.8743826e-05,0.07278226021605522,0.00016700602874257422,0.00031328852619914854,0.0,0.002125352,False,ATP6V0A1; ATPase H+ transporting V0 subunit
hsa:1896,0.0,0.0,4.127754399619306e-06,3.106272275829611e-05,0.0,0.00042892023,False,EDA; ectodysplasin
hsa:10389,0.0,0.0,0.0001421318555290031,0.0005840868551405122,0.0,0.0037447647,False,SCML2; Scm polycomb group protein like
hsa:55706,0.0,0.0,1.1906548835495057e-07,3.812402463408603e-07,0.0,2.5718628e-06,False,NDC1; NDC1 transmembrane
hsa:3981,3.31773215e-07,0.0004110594442188228,6.434014609722772e-05,0.0001755697577989303,0.0,0.0014244621,False,LIG4; DNA ligase
hsa:6821,0.0,0.0,0.00014437765952074257,0.0004682669292280546,0.0,0.0031561605,False,SUOX; sulfite
hsa:7317,0.0,0.0,4.594511293440594e-07,1.5670190345128903e-06,0.0,1.4568575e-05,False,UBA1; ubiquitin like modifier activating enzyme
hsa:138804,0.0,0.0,4.5610785742574255e-08,3.9286303983282333e-07,0.0,5.1699794e-06,False,OR13C4; olfactory receptor family 13 subfamily C member
hsa:2264,8.6200533e-07,0.0010680049378412387,2.5761571906958917e-05,6.180346762866434e-05,0.0,0.0003592343,False,FGFR4; fibroblast growth factor receptor
hsa:83544,0.0,0.0,7.218043890148514e-08,1.9093682610558204e-07,0.0,1.3443307e-06,False,DNAL1; dynein axonemal light chain
hsa:276,0.0,0.0,6.795196428217822e-07,4.39782610551565e-06,0.0,4.5864137e-05,False,AMY1A; amylase alpha
hsa:65985,6.5744445e-08,8.145586744299103e-05,0.0003102589685421782,0.000996439799194032,0.0,0.0068289316,False,AACS; acetoacetyl-CoA
hsa:79944,3.5459494999999996e-07,0.0004393350532224286,0.0001708695645834901,0.0004972769484933072,0.0,0.0033858195,False,L2HGDH; L-2-hydroxyglutarate
hsa:3248,0.0,0.0,4.96192536180198e-06,3.760933167548392e-05,0.0,0.0005147315,False,HPGD; 15-hydroxyprostaglandin
hsa:57615,0.0,0.0,9.462177332782181e-09,2.1597053662067096e-08,0.0,1.2354975e-07,False,ZNF492; zinc finger protein
hsa:391191,0.0,0.0,1.0221801862846536e-05,4.537401598888496e-05,0.0,0.00046822458,False,OR2AK2; olfactory receptor family 2 subfamily AK member
hsa:11238,6.7711748e-06,0.008389331097739457,0.00016635634161334012,0.0003158881415371681,0.0,0.0019742867,False,CA5B; carbonic anhydrase
hsa:80142,0.0,0.0,2.6976254703613856e-05,5.0199194624179076e-05,0.0,0.00026478572,False,PTGES2; prostaglandin E synthase
hsa:259296,0.0,0.0,1.5334654030099016e-05,4.004315038343153e-05,0.0,0.00036890985,False,TAS2R50; taste 2 receptor member
hsa:8676,0.0,0.0,2.6082061767612877e-05,9.02120344087699e-05,0.0,0.0006622151,False,STX11; syntaxin
hsa:3315,0.0,0.0,4.881337171712871e-05,0.00023720141956494492,0.0,0.003072192,False,HSPB1; heat shock protein family B (small) member
hsa:5207,0.0,0.0,5.220519539316833e-06,1.596440330533226e-05,0.0,0.00012410017,False,PFKFB1; 6-phosphofructo-2-kinase/fructose-2
hsa:1844,3.3787836e-08,4.186235795893509e-05,5.090784930990348e-05,0.00015812842648506292,0.0,0.0009713376,False,DUSP2; dual specificity phosphatase
hsa:101954264,0.0,0.0,2.2184339740940596e-08,1.0865111321785375e-07,0.0,9.776974e-07,False,RNVU1-4; RNA
hsa:4599,0.0,0.0,1.2591828845099007e-05,2.452602552291221e-05,0.0,0.00011561244,False,MX1; MX dynamin like GTPase
hsa:27329,0.0,0.0,4.7488500834356424e-06,1.6910267031655992e-05,0.0,0.00014831094,False,ANGPTL3; angiopoietin like
hsa:8799,2.7142021e-07,0.0003362834479340238,2.209049922942574e-06,7.915113688802968e-06,0.0,6.855476e-05,False,PEX11B; peroxisomal biogenesis factor 11
hsa:59345,0.0,0.0,6.752171474359902e-05,0.00027644416922238045,0.0,0.002035437,False,GNB4; G protein subunit beta
hsa:6741,3.3469142e-08,4.146750336370843e-05,8.732225813306932e-05,0.0003383586732787333,0.0,0.002723124,False,SSB; small RNA binding exonuclease protection factor
hsa:248,0.0,0.0,4.123816333656436e-07,1.8669220130357886e-06,0.0,1.9856287e-05,False,ALPI; alkaline phosphatase
hsa:6120,0.0,0.0,5.90907132918317e-05,0.00013049524796998754,0.0,0.0010232888,False,RPE;
hsa:284486,1.7604841e-09,2.1811996357272977e-06,1.2632912425237622e-06,3.654617920496675e-06,0.0,2.668035e-05,False,THEM5; thioesterase superfamily member
hsa:427,0.0,0.0,1.1176424621534653e-05,3.625789232170565e-05,0.0,0.0003501823,False,ASAH1; N-acylsphingosine amidohydrolase
hsa:27258,0.0,0.0,2.0831179317871294e-06,1.3766701052840345e-05,0.0,0.00015294431,False,LSM3; LSM3 homolog
hsa:84962,0.0,0.0,6.087526743465347e-05,0.00028551878095435545,0.0,0.0027050055,False,AJUBA; ajuba LIM
hsa:353088,0.0,0.0,6.177164389356435e-08,1.5437339145143364e-07,0.0,1.3395313e-06,False,ZNF429; zinc finger protein
hsa:3980,0.0,0.0,1.293101823477227e-05,3.6777406958030775e-05,0.0,0.00027519593,False,LIG3; DNA ligase
hsa:2639,0.0,0.0,4.346511359270048e-05,0.00011547724836177646,0.0,0.00075009733,False,GCDH; glutaryl-CoA
hsa:3589,0.0,0.0,4.7951463336876233e-05,0.00025222139763280023,0.0,0.002237755,False,IL11; interleukin
hsa:2986,0.0,0.0,1.1983661431188118e-07,8.084156997691714e-07,0.0,8.059233e-06,False,GUCY2F; guanylate cyclase 2F
hsa:9282,9.811939e-07,0.001215676856870134,9.723066309044557e-06,2.374908183054013e-05,0.0,0.00017813274,False,MED14; mediator complex subunit
hsa:51135,0.0,0.0,2.6476970681856446e-05,7.575695745799217e-05,0.0,0.00056749734,False,IRAK4; interleukin 1 receptor associated kinase
hsa:57494,0.0,0.0,2.1789137067237627e-05,6.683972457823509e-05,0.0,0.00048517794,False,RIMKLB; ribosomal modification protein rimK like family member
hsa:5686,1.1323673300000001e-07,0.00014029772877275593,3.262869059698021e-06,9.594951448082624e-06,0.0,9.610159e-05,False,PSMA5; proteasome 20S subunit alpha
hsa:7057,0.0,0.0,0.00023486900450495055,0.0007584110769397647,0.0,0.005233048,False,THBS1; thrombospondin
hsa:92359,0.0,0.0,2.355267119607129e-06,1.936454184935375e-05,0.0,0.00026699173,False,CRB3; crumbs cell polarity complex component
hsa:257202,0.0,0.0,1.1461517848019805e-06,8.92537164197079e-06,0.0,0.00010320208,False,GPX6; glutathione peroxidase
hsa:3231,0.0,0.0,1.6512158919374257e-06,9.91491594199606e-06,0.0,9.1674796e-05,False,HOXD1; homeobox
hsa:255631,0.0,0.0,4.861169907118813e-06,2.0659383051613916e-05,0.0,0.00017445211,False,COL24A1; collagen type XXIV alpha 1
hsa:4607,0.0,0.0,3.596042978519802e-06,1.0449938420602608e-05,0.0,7.644273e-05,False,MYBPC3; myosin binding protein
hsa:197342,3.8155995e-06,0.004727440730354373,7.131308986020292e-05,0.00019223853180444704,0.0,0.0013765789,False,EME2; essential meiotic structure-specific endonuclease subunit
hsa:6745,1.2659444e-08,1.5684762299932234e-05,3.471413748156933e-07,9.908444676225497e-07,0.0,1.05002455e-05,False,SSR1; signal sequence receptor subunit
hsa:283297,0.0,0.0,3.3117509158415845e-07,1.5800724117433e-06,0.0,1.1892118e-05,False,OR10A4; olfactory receptor family 10 subfamily A member
hsa:84639,0.0,0.0,9.295537128712872e-09,1.3211440543437546e-07,0.0,1.8776985e-06,False,IL1F10; interleukin 1 family member
hsa:5351,0.0,0.0,4.510133074033365e-05,0.0001317064752191914,0.0,0.0009354568,False,PLOD1; procollagen-lysine
hsa:53632,0.0,0.0,1.589056048679208e-05,9.958948081853006e-05,0.0,0.0010778327,False,PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma
hsa:2962,3.02722905e-08,3.750667728906552e-05,3.658196638357428e-06,1.7766955718896007e-05,0.0,0.00018308232,False,GTF2F1; general transcription factor IIF subunit
hsa:274,0.0,0.0,3.3376707977376226e-06,1.2115174760634588e-05,0.0,0.00011673919,False,BIN1; bridging integrator
hsa:4728,0.0,0.0,3.0711746225643564e-06,1.1549814556887961e-05,0.0,0.00011827864,False,NDUFS8; NADH:ubiquinone oxidoreductase core subunit
hsa:124995,9.92755675e-08,0.00012300016323215913,2.6777561145445546e-07,3.833309490989805e-07,0.0,1.9921483e-06,False,MRPL10; mitochondrial ribosomal protein
hsa:5449,0.0,0.0,4.130639665128713e-08,1.8753568827318988e-07,0.0,2.4852395e-06,False,POU1F1; POU class 1 homeobox
hsa:26595,0.0,0.0,7.70733493910891e-07,5.673478555909597e-06,-0.0,5.4210548e-05,False,OR8B2; olfactory receptor family 8 subfamily B member
hsa:7479,3.0097267e-06,0.00372898271656002,1.0150442259999999e-05,1.8916770362266562e-05,0.0,0.00012471732,False,WNT8B; Wnt family member
hsa:51719,2.3523461499999998e-07,0.0002914503212772277,4.644467162747524e-06,7.458573272786149e-06,0.0,4.3863278e-05,False,CAB39; calcium binding protein
hsa:406989,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR206; microRNA
hsa:5590,1.8183285500000003e-05,0.02252867589597967,8.537642216039604e-05,0.0001784070128296673,0.0,0.0010996368,False,PRKCZ; protein kinase C
hsa:5196,3.97733715e-07,0.0004927829988776751,8.645507645445056e-05,0.0003424104733720437,0.0,0.0029113938,False,PF4; platelet factor
hsa:1191,0.0,0.0,6.333696000905941e-06,2.0687189115029735e-05,0.0,0.00021049034,False,CLU;
hsa:3759,0.0,0.0,1.6215665201732683e-05,6.755506929961977e-05,0.0,0.0007281008,False,KCNJ2; potassium inwardly rectifying channel subfamily J member
hsa:6598,0.0,0.0,1.906659397885495e-05,3.596013322348808e-05,0.0,0.00018743752,False,SMARCB1; SWI/SNF related
hsa:3937,0.0,0.0,2.538294160128714e-05,7.137795050194757e-05,0.0,0.00063997234,False,LCP2; lymphocyte cytosolic protein
hsa:84466,0.0,0.0,1.1518557800337521e-05,4.564000292722024e-05,0.0,0.00036426054,False,MEGF10; multiple EGF like domains
hsa:7156,0.0,0.0,0.0002797445638378219,0.0007617866640485724,0.0,0.0054468336,False,TOP3A; DNA topoisomerase III
hsa:6023,0.0,0.0,1.228965579184703e-06,2.7156571797726256e-06,0.0,1.45647455e-05,False,RMRP; RNA component of mitochondrial RNA processing
hsa:64087,2.3150799e-07,0.00028683311792248445,1.8718124722277224e-06,3.5481708918447004e-06,0.0,2.1377586e-05,False,MCCC2; methylcrotonyl-CoA carboxylase subunit
hsa:111,0.000340212545,0.4215155815516067,0.0006824326186663364,0.0008995906376414242,0.0,0.0052189687,False,ADCY5; adenylate cyclase
hsa:164668,0.0,0.0,1.9316758678896043e-06,1.0170152300629532e-05,0.0,0.00013266619,False,APOBEC3H; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:1347,0.0,0.0,8.179467059782175e-05,0.0003580661280845823,0.0,0.003272853,False,COX7A2; cytochrome c oxidase subunit
hsa:4902,0.0,0.0,2.766980121069307e-08,1.2634961396887627e-07,0.0,1.1533938e-06,False,NRTN;
hsa:56848,0.0,0.0,3.6890528003960386e-05,8.632664609569067e-05,0.0,0.00044401985,False,SPHK2; sphingosine kinase
hsa:9349,5.5405994e-08,6.864676251828054e-05,2.93317072618812e-07,4.739528357810836e-07,0.0,2.5641953e-06,False,RPL23; ribosomal protein
hsa:166336,0.0,0.0,9.80641609126064e-07,7.573641792344303e-06,0.0,0.000100202415,False,PRICKLE2; prickle planar cell polarity protein
hsa:79087,0.0,0.0,1.4665615649735143e-05,6.0492647860478985e-05,0.0,0.00055578595,False,ALG12; ALG12
hsa:6092,0.0,0.0,2.6749284326735646e-05,9.883236471170141e-05,0.0,0.0007124796,False,ROBO2; roundabout guidance receptor
hsa:64170,0.0,0.0,2.5084409281188114e-06,1.1233811489484134e-05,0.0,0.00010482948,False,CARD9; caspase recruitment domain family member
hsa:7125,0.0,0.0,1.2667714536643567e-06,1.2824388499455977e-05,0.0,0.0001801174,False,TNNC2; troponin C2
hsa:127124,0.0,0.0,1.9267540008415843e-06,1.181106588550452e-05,0.0,0.000100183664,False,ATP6V1G3; ATPase H+ transporting V1 subunit
hsa:2633,0.0,0.0,4.3765603945544543e-07,9.681794828652708e-07,0.0,5.6039944e-06,False,GBP1; guanylate binding protein
hsa:1521,3.6612671e-07,0.0004536226407736565,1.3460165512532177e-06,2.153198949683485e-06,0.0,1.1165487e-05,False,CTSW; cathepsin
hsa:51720,1.89532125e-07,0.00023482597883651477,6.731423240899504e-05,0.00017107416489354506,0.0,0.001119726,False,UIMC1; ubiquitin interaction motif containing
hsa:5362,0.0,0.0,6.827941582123761e-06,2.434482549377993e-05,0.0,0.00013488487,False,PLXNA2; plexin
hsa:432,1.108526525e-05,0.013734390742432991,8.525734511893218e-05,0.00017717645526772442,0.0,0.001074675,False,ASGR1; asialoglycoprotein receptor
hsa:83746,3.04034896e-09,3.766922998075285e-06,8.104271924056528e-06,4.3857582731485994e-05,0.0,0.00035540975,False,L3MBTL2; L3MBTL histone methyl-lysine binding protein
hsa:55879,0.0,0.0,5.789149844326732e-05,0.00018023064994309118,0.0,0.0012315618,False,GABRQ; gamma-aminobutyric acid type A receptor subunit
hsa:138805,0.0,0.0,8.683451768316833e-07,9.075401482753525e-06,0.0,0.00012518051,False,OR13F1; olfactory receptor family 13 subfamily F member
hsa:3158,0.0,0.0,2.1795004780693067e-06,1.539098565626105e-05,0.0,0.00015066414,False,HMGCS2; 3-hydroxy-3-methylglutaryl-CoA synthase
hsa:5697,0.0,0.0,2.2337319808811877e-06,9.957183930627876e-06,0.0,9.723791e-05,False,PYY; peptide
hsa:4067,0.0,0.0,2.2845506624108922e-05,8.119346782732535e-05,0.0,0.000525353,False,LYN; LYN proto-oncogene
hsa:229,9.58041385e-07,0.001186991418993035,1.8612707294554455e-05,0.00010764212427819343,0.0,0.0012584277,False,ALDOB; aldolase
hsa:9448,0.0,0.0,2.478338686306931e-07,5.083299516929177e-07,0.0,2.404395e-06,False,MAP4K4; mitogen-activated protein kinase kinase kinase kinase
hsa:84552,0.0,0.0,1.4981436645544553e-05,3.906544359467786e-05,0.0,0.00023326697,False,PARD6G; par-6 family cell polarity regulator
hsa:56246,0.0,0.0,4.563714446787128e-06,2.6973331272220756e-05,0.0,0.00032960475,False,MRAP; melanocortin 2 receptor accessory
hsa:9368,5.7395105e-07,0.0007111122566715031,1.2795017026351488e-05,3.8222630116218346e-05,0.0,0.00046048107,False,NHERF1; NHERF family PDZ scaffold protein
hsa:84516,6.0346912e-06,0.007476844719680644,9.708753463613857e-05,0.0002298283522496715,0.0,0.0014261162,False,DCTN5; dynactin subunit
hsa:5264,7.3338933000000004e-09,9.086526481223473e-06,1.496662599527673e-05,5.034317451922814e-05,0.0,0.00036478954,False,PHYH; phytanoyl-CoA
hsa:5787,1.43546705e-07,0.00017785109258064525,4.370455226955445e-06,1.0714656480227305e-05,0.0,5.0499697e-05,False,PTPRB; protein tyrosine phosphatase receptor type
hsa:2820,0.0,0.0,3.2989439303415815e-06,1.050187879690228e-05,0.0,9.25661e-05,False,GPD2; glycerol-3-phosphate dehydrogenase
hsa:1512,0.0,0.0,2.4548386908514855e-06,4.294441288853142e-06,0.0,2.2564454e-05,False,CTSH; cathepsin
hsa:25939,1.51337785e-06,0.001875040629527845,3.748985769059407e-05,0.00010573046524953362,0.0,0.0006096679,False,SAMHD1; SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase
hsa:10645,1.74279695e-05,0.021592856603968452,5.556350752439108e-05,0.00011195444495995616,0.0,0.0012133967,False,CAMKK2; calcium/calmodulin dependent protein kinase kinase
hsa:917,8.77092635e-07,0.0010866977645302765,2.299112820330842e-05,5.389941841328913e-05,0.0,0.000378184,False,CD3G; CD3 gamma subunit of T-cell receptor
hsa:390168,0.0,0.0,7.76027514851485e-09,8.858618872987235e-08,0.0,1.2085632e-06,False,OR5M1; olfactory receptor family 5 subfamily M member
hsa:9966,0.0,0.0,7.079540991877726e-06,1.978088980180249e-05,0.0,0.000116813026,False,TNFSF15; TNF superfamily member
hsa:768211,0.0,0.0,2.178409372871288e-06,1.0473103062448706e-05,0.0,0.00011411999,False,RELL1; RELT like
hsa:11004,6.60091515e-09,8.17838327574035e-06,7.118750719205446e-07,1.9669281530048426e-06,0.0,1.0740525e-05,False,KIF2C; kinesin family member
hsa:5443,0.0,0.0,2.4809291622425737e-05,7.423842267824047e-05,0.0,0.00053017196,False,POMC;
hsa:10558,0.0,0.0,3.681505335925743e-06,1.1272895332585203e-05,0.0,8.637693e-05,False,SPTLC1; serine palmitoyltransferase long chain base subunit
hsa:10603,0.0,0.0,4.535757849742573e-06,9.328022459183963e-06,0.0,5.250764e-05,False,SH2B2; SH2B adaptor protein
hsa:347169,0.0,0.0,8.89955152539604e-06,3.3599698920832784e-05,-0.0,0.0002242613,False,OR1B1; olfactory receptor family 1 subfamily B member
hsa:781,9.636352700000001e-05,0.11939221148875906,0.00030820507292871275,0.0006776182555244753,0.0,0.0040302007,False,CACNA2D1; calcium voltage-gated channel auxiliary subunit alpha2delta
hsa:150763,0.0,0.0,3.1086885133344556e-05,0.0002227230510232928,0.0,0.0027862333,False,GPAT2; glycerol-3-phosphate acyltransferase 2
hsa:5803,0.0,0.0,1.4547289961927526e-05,0.00012105127383899204,0.0,0.0013131294,False,PTPRZ1; protein tyrosine phosphatase receptor type
hsa:1230,0.0,0.0,6.335736256633666e-05,0.0002348591892107161,0.0,0.0022883138,False,CCR1; C-C motif chemokine receptor
hsa:2590,5.5250933e-06,0.006845464547688522,6.218716606965348e-05,0.00011001917275623288,0.0,0.00056945224,False,GALNT2; polypeptide N-acetylgalactosaminyltransferase
hsa:5260,1.359817e-07,0.0001684782239757682,2.092301712116337e-06,6.328072860696862e-06,0.0,7.235671e-05,False,PHKG1; phosphorylase kinase catalytic subunit gamma
hsa:23165,1.330629175e-08,1.6486191904818196e-05,2.3876022638990105e-07,6.702440712188707e-07,0.0,3.8705807e-06,False,NUP205; nucleoporin
hsa:1558,0.000407983775,0.5054825893699625,0.000682920112489604,0.0008115113740104268,0.0,0.0039597503,False,CYP2C8; cytochrome P450 family 2 subfamily C member
hsa:10110,3.22524815e-07,0.00039960088761438635,7.65596784642574e-06,2.3010711771996646e-05,0.0,0.00023629155,False,SGK2; serum/glucocorticoid regulated kinase
hsa:1777,4.59656725e-07,0.0005695041955389445,1.7912148040653454e-05,7.287720361653176e-05,0.0,0.00050775404,False,DNASE2; deoxyribonuclease 2
hsa:53343,0.0,0.0,1.7977990719306235e-06,7.66084192458921e-06,0.0,8.065731e-05,False,NUDT9; nudix hydrolase
hsa:9926,0.0,0.0,1.4730257531371285e-06,4.656161931472569e-06,0.0,4.5900746e-05,False,LPGAT1; lysophosphatidylglycerol acyltransferase
hsa:103,4.73598075e-06,0.005867772101271177,0.00010796988965499007,0.00020209788222608034,0.0,0.0010077098,False,ADAR; adenosine deaminase RNA
hsa:1237,0.0,0.0,5.988318091542077e-06,2.3342886344655455e-05,0.0,0.00027673037,False,CCR8; C-C motif chemokine receptor
hsa:1783,0.0,0.0,4.5630079044435644e-05,0.00018644463385009035,0.0,0.00120158,False,DYNC1LI2; dynein cytoplasmic 1 light intermediate chain
hsa:122706,0.0,0.0,1.1548789403604946e-08,5.8101288189226324e-08,0.0,5.835235e-07,False,PSMB11; proteasome subunit beta
hsa:5742,0.0,0.0,6.721890048514849e-05,0.00027052592264534264,0.0,0.0024252634,False,PTGS1; prostaglandin-endoperoxide synthase
hsa:947,0.0,0.0,1.4603829610544559e-05,3.180737549445206e-05,0.0,0.00020403154,False,CD34; CD34
hsa:2966,0.0,0.0,1.4639450342777228e-06,3.651824819118493e-06,0.0,2.192507e-05,False,GTF2H2; general transcription factor IIH subunit
hsa:22928,6.50981855e-05,0.08065516666643456,0.00018226696852722776,0.0002907237844029037,0.0,0.0014199975,False,SEPHS2; selenophosphate synthetase
hsa:6319,0.0,0.0,0.00024488517164900997,0.0007756305776926067,0.0,0.0042844345,False,SCD; stearoyl-CoA
hsa:8995,0.0,0.0,2.871670386287128e-06,7.95384392694956e-06,0.0,6.5496046e-05,False,TNFSF18; TNF superfamily member
hsa:100169765,0.0,0.0,4.261503054217822e-07,3.9738512048826894e-06,0.0,5.5286982e-05,False,RNA5S14; RNA
hsa:55754,3.9051654e-08,4.8384108370730795e-05,2.2187510226811864e-05,7.004784093122941e-05,0.0,0.0005137966,False,TMEM30A; transmembrane protein
hsa:55501,4.4397592000000005e-06,0.0055007603589018045,0.0006545342735681042,0.0017415305754286535,0.0,0.012062517,False,CHST12; carbohydrate sulfotransferase
hsa:8074,0.0,0.0,5.246459908133663e-07,4.103489583870942e-06,0.0,4.5620414e-05,False,FGF23; fibroblast growth factor
hsa:10799,0.0,0.0,1.920002592867e-06,4.911934598984676e-06,0.0,3.797564e-05,False,RPP40; ribonuclease P/MRP subunit
hsa:10382,0.0,0.0,1.6734367261712872e-05,0.00010637851117482715,0.0,0.0013310461,False,TUBB4A; tubulin beta 4A class
hsa:1293,0.0,0.0,6.11616444381188e-05,0.000175811188790554,0.0,0.0014671129,False,COL6A3; collagen type VI alpha 3
hsa:3157,7.564307849999999e-06,0.009372004851931999,0.00031170970446589124,0.0009157697229989233,0.0,0.0053721555,False,HMGCS1; 3-hydroxy-3-methylglutaryl-CoA synthase
hsa:3630,0.00151250975,1.8739650734329192,0.002136571790499999,0.0025013308069761456,0.0,0.014028643,True,INS;
hsa:10280,0.0,0.0,3.381633262887624e-08,7.613670464079121e-08,0.0,3.8027878e-07,False,SIGMAR1; sigma non-opioid intracellular receptor
hsa:84441,0.0,0.0,3.507498156965346e-05,0.00013149039134583302,0.0,0.000939533,False,MAML2; mastermind like transcriptional coactivator
hsa:1262,3.397614e-08,4.209566231891539e-05,1.4601703292341585e-05,3.9289386662675046e-05,0.0,0.00038104286,False,CNGA4; cyclic nucleotide gated channel subunit alpha
hsa:373156,1.9870471e-07,0.00024619060238561565,0.00028649004935306935,0.0005176557859124832,0.0,0.0028031797,False,GSTK1; glutathione S-transferase kappa
hsa:2130,0.0,0.0,5.156800821870992e-06,3.181607160842688e-05,0.0,0.00043942576,False,EWSR1; EWS RNA binding protein
hsa:283106,1.0424701e-07,0.00012915966706979063,4.044565578415841e-06,1.1002394941545839e-05,0.0,8.949419e-05,False,CSNK2A3; casein kinase 2 alpha
hsa:6354,0.0,0.0,3.403005532837129e-05,0.00019163525998321617,0.0,0.0019278404,False,CCL7; C-C motif chemokine ligand
hsa:50835,0.0,0.0,2.7540939853465345e-05,7.899988540887829e-05,-0.0,0.0005683626,False,TAS2R9; taste 2 receptor member
hsa:286046,1.0516554000000001e-08,1.3029770478419236e-05,3.093899455789085e-05,8.869199515667197e-05,0.0,0.0005660863,False,XKR6; XK related
hsa:55967,0.0,0.0,3.478531212207921e-06,7.244331161351541e-06,0.0,3.9363716e-05,False,NDUFA12; NADH:ubiquinone oxidoreductase subunit
hsa:148156,5.6292548000000005e-09,6.974518269819162e-06,1.074925027882179e-07,2.368877138292723e-07,0.0,1.2567093e-06,False,ZNF558; zinc finger protein
hsa:6522,0.0,0.0,0.00012543825883861391,0.00030537861933432946,0.0,0.002186017,False,SLC4A2; solute carrier family 4 member
hsa:63916,0.0,0.0,8.318104089011392e-05,0.00029325770775785043,0.0,0.0021073464,False,ELMO2; engulfment and cell motility
hsa:5929,0.0,0.0,6.753860799615149e-06,2.058753231024288e-05,0.0,0.0001273363,False,RBBP5; RB binding protein 5
hsa:805,0.000494618075,0.6128205105710055,0.0013824291565742576,0.0019843925361390756,0.0,0.010784142,False,CALM2; calmodulin
hsa:7942,5.91476115e-07,0.0007328254123848079,2.193010894381189e-06,3.493826487861437e-06,0.0,2.248177e-05,False,TFEB; transcription factor
hsa:5721,0.0,0.0,8.771879009504952e-06,2.325720038794805e-05,0.0,0.0002467261,False,PSME2; proteasome activator subunit
hsa:271,1.95872745e-08,2.4268186235985088e-05,6.963901028071781e-06,2.786329631518415e-05,0.0,0.00029697624,False,AMPD2; adenosine monophosphate deaminase
hsa:8464,0.0,0.0,4.0550046544010755e-06,1.4666443304740796e-05,0.0,0.00013420133,False,SUPT3H; SPT3 homolog
hsa:113146,1.50286105e-08,1.8620105542610375e-05,3.920194671346535e-07,9.387535319666401e-07,0.0,6.058813e-06,False,AHNAK2; AHNAK nucleoprotein
hsa:4121,0.0,0.0,3.306132641885396e-05,0.00012153749084851023,0.0,0.00088772597,False,MAN1A1; mannosidase alpha class 1A member
hsa:4158,0.0,0.0,1.3667463412425742e-06,8.897653931465e-06,0.0,0.000100876416,False,MC2R; melanocortin 2
hsa:1506,6.01111335e-05,0.07447632301442256,0.00014251803563861384,0.00021814608563152448,0.0,0.0015322902,False,CTRL; chymotrypsin
hsa:10552,1.22382785e-07,0.00015162947854018802,6.477019448737625e-05,0.0001780565059775284,0.0,0.0011207269,False,ARPC1A; actin related protein 2/3 complex subunit
hsa:25828,0.0,0.0,1.4689957874009904e-06,2.7512541395367936e-06,0.0,1.3610627e-05,False,TXN2; thioredoxin
hsa:5983,0.0,0.0,3.748220189829208e-05,0.00019689701251470818,0.0,0.0017271349,False,RFC3; replication factor C subunit
hsa:7386,4.4443859499999996e-07,0.0005506492796595846,0.00011706045539623761,0.0002447994630186847,0.0,0.002026052,False,UQCRFS1; ubiquinol-cytochrome c reductase
hsa:5587,0.0,0.0,1.388975761480198e-06,7.68629605781808e-06,0.0,7.867715e-05,False,PRKD1; protein kinase
hsa:285643,0.0,0.0,5.854446500297028e-10,2.1176876893957894e-09,0.0,2.724791e-08,False,KIF4B; kinesin family member
hsa:2731,4.49733975e-08,5.572101346693161e-05,2.2283035631806936e-05,6.282223279808703e-05,0.0,0.00038382894,False,GLDC; glycine
hsa:7993,0.0,0.0,1.9575084188960397e-07,5.778771018749765e-07,0.0,4.8875086e-06,False,UBXN8; UBX domain protein
hsa:26122,0.0,0.0,1.5336293293910895e-06,5.756680829972624e-06,0.0,5.712963e-05,False,EPC2; enhancer of polycomb homolog
hsa:644150,2.183561975e-08,2.7053834706362755e-05,2.3418933283440583e-06,1.1008565404421106e-05,0.0,0.0001358244,False,WIPF3; WAS/WASL interacting protein family member
hsa:1032,1.5538619000000001e-07,0.00019251994438634958,1.6739654543094062e-05,5.541937472864258e-05,0.0,0.00051902834,False,CDKN2D; cyclin dependent kinase inhibitor
hsa:785,6.5669892e-05,0.08136349797686386,0.00016139767135346536,0.0002915166022745736,0.0,0.0016426812,False,CACNB4; calcium voltage-gated channel auxiliary subunit beta
hsa:94235,4.3515054e-05,0.053914159141484834,0.00040128257974341596,0.0007774242423178175,0.0,0.0050957096,False,GNG8; G protein subunit gamma
hsa:10938,0.0,0.0,1.9565753603712876e-07,4.7449772712492416e-07,0.0,3.3024905e-06,False,EHD1; EH domain containing
hsa:26716,0.0,0.0,7.088900490742574e-07,4.471597139854608e-06,-0.0,3.6740403e-05,False,OR2H1; olfactory receptor family 2 subfamily H member
hsa:4952,2.3383203e-07,0.0002897125504611911,0.00010539081256256437,0.0003080218695379925,0.0,0.0020431,False,OCRL; OCRL inositol
hsa:1286,0.0,0.0,9.086858239455448e-06,2.7501553165277757e-05,0.0,0.00028692654,False,COL4A4; collagen type IV alpha 4
hsa:3914,0.0,0.0,1.306579692534653e-05,4.4624734473057574e-05,0.0,0.0003207772,False,LAMB3; laminin subunit beta
hsa:10010,3.93738515e-07,0.00048783303722527637,7.871915721297025e-05,0.00017920585940933625,0.0,0.0012718262,False,TANK; TRAF family member associated NFKB
hsa:1346,3.0146676500000003e-07,0.00037351044408858163,6.662797228886137e-05,0.0003339656355972412,0.0,0.0027547893,False,COX7A1; cytochrome c oxidase subunit
hsa:6348,0.0,0.0,0.00019758367505990092,0.0006117002842200712,0.0,0.0034876743,False,CCL3; C-C motif chemokine ligand
hsa:7248,2.3929493e-06,0.0029648095892907483,2.926682030299999e-05,4.983465699857621e-05,0.0,0.00021821738,False,TSC1; TSC complex subunit
hsa:23370,4.15808525e-08,5.1517727610394504e-05,2.323640527973762e-06,7.821205247347032e-06,0.0,6.3361265e-05,False,ARHGEF18; Rho/Rac guanine nucleotide exchange factor
hsa:2628,0.0,0.0,3.434438375321783e-05,0.00014294787184799762,0.0,0.0014154759,False,GATM; glycine
hsa:84950,5.216772150000001e-09,6.463461676962783e-06,5.658062657300993e-07,1.7236270269290913e-06,0.0,1.1680596e-05,False,PRPF38A; pre-mRNA processing factor
hsa:1609,0.0,0.0,2.948744279039604e-05,5.325298577009414e-05,0.0,0.0002754213,False,DGKQ; diacylglycerol kinase
hsa:131870,1.4488311e-08,1.7950686788653078e-05,5.8550135691683176e-06,2.8959154957800282e-05,0.0,0.00031757445,False,NUDT16; nudix hydrolase
hsa:127062,0.0,0.0,1.3784321316831683e-07,7.473892735487381e-07,0.0,5.920467e-06,False,OR2M3; olfactory receptor family 2 subfamily M member
hsa:11001,7.91400075e-06,0.009805266377041157,8.286309123711393e-05,0.00020617230210718415,0.0,0.0014961321,False,SLC27A2; solute carrier family 27 member
hsa:6396,6.62844185e-08,8.212488229038579e-05,2.4106734437178223e-06,6.43554126597489e-06,0.0,3.954396e-05,False,SEC13; SEC13 homolog
hsa:6528,0.0,0.0,6.505761846418911e-06,2.2119563739885888e-05,0.0,0.000217082,False,SLC5A5; solute carrier family 5 member
hsa:441308,0.0,0.0,1.628393797475247e-05,8.160795721894462e-05,0.0,0.0008734745,False,OR4F21; olfactory receptor family 4 subfamily F member
hsa:3885,0.0,0.0,1.0334520911549506e-06,1.0045609492919774e-05,0.0,0.00013491134,False,KRT34; keratin
hsa:7003,4.7392528999999997e-05,0.05871826220469438,0.0007683415689742575,0.0017326873229272799,0.0,0.010064696,False,TEAD1; TEA domain transcription factor
hsa:54988,0.0,0.0,5.0107085449603996e-05,0.00015655344317094366,0.0,0.0015044359,False,ACSM5; acyl-CoA synthetase medium chain family member
hsa:7490,0.0,0.0,5.014403732263367e-07,2.5745226997098826e-06,0.0,2.2004133e-05,False,WT1; WT1 transcription
hsa:1729,2.383151e-06,0.0029526697191318827,2.5209189841797022e-05,5.699964922378847e-05,0.0,0.00049848517,False,DIAPH1; diaphanous related formin
hsa:896,0.0,0.0,7.487911062524753e-05,0.0002618115283314651,0.0,0.0017179273,False,CCND3; cyclin
hsa:55288,1.296770075e-07,0.00016066685380527213,2.510066704606436e-06,5.2398248883128566e-06,0.0,3.1231433e-05,False,RHOT1; ras homolog family member
hsa:120787,0.0,0.0,8.191855828267328e-06,2.875661609014106e-05,-0.0,0.00026783615,False,OR52W1; olfactory receptor family 52 subfamily W member
hsa:3092,1.4409658e-08,1.785323751606444e-05,5.336175599938121e-08,8.563969404607595e-08,0.0,4.5612467e-07,False,HIP1; huntingtin interacting protein
hsa:5218,0.0,0.0,4.169243914874866e-06,1.801248090542673e-05,0.0,0.0001999884,False,CDK14; cyclin dependent kinase
hsa:7189,0.0,0.0,9.054464471782178e-05,0.00018092589513121556,0.0,0.0008883616,False,TRAF6; TNF receptor associated factor
hsa:8620,0.0,0.0,3.05267213582673e-05,0.00012013373105991425,0.0,0.0013541903,False,NPFF; neuropeptide FF-amide peptide
hsa:100507436,0.0,0.0,4.366706593455445e-06,1.9696991210864942e-05,0.0,0.00017922706,False,MICA; MHC class I polypeptide-related sequence
hsa:55696,1.072582e-08,1.3289046278166652e-05,1.5519502449455447e-07,3.300973332903154e-07,0.0,1.980393e-06,False,RBM22; RNA binding motif protein
hsa:8685,1.9132907e-08,2.3705235269551295e-05,3.392677545469307e-07,1.1801028777470813e-06,0.0,1.0180823e-05,False,MARCO; macrophage receptor with collagenous
hsa:26528,0.0,0.0,9.167554172524759e-08,1.8654996044791923e-07,0.0,1.4621761e-06,False,DAZAP1; DAZ associated protein
hsa:55277,0.0,0.0,2.6952604100593048e-05,9.901341238817264e-05,0.0,0.00075212517,False,FGGY; FGGY carbohydrate kinase domain
hsa:2342,2.2306594e-08,2.7637361057175538e-05,1.3543991298400793e-05,3.154272301950215e-05,0.0,0.00018429721,False,FNTB; farnesyltransferase
hsa:7587,0.0,0.0,4.824657948391089e-08,1.214418548526507e-07,0.0,8.7466526e-07,False,ZNF37A; zinc finger protein
hsa:1911,3.3083785e-08,4.099005483234995e-05,0.00010587732326498497,0.0004119267064485399,0.0,0.002676571,False,PHC1; polyhomeotic homolog
hsa:23114,6.1145215e-08,7.57575264011003e-05,5.650408552361386e-06,1.3450811438586837e-05,0.0,6.0503982e-05,False,NFASC;
hsa:93643,2.6657009e-08,3.302742599060071e-05,1.1652761522052976e-05,3.871639950671799e-05,0.0,0.00026808245,False,TJAP1; tight junction associated protein
hsa:440077,0.0,0.0,9.676823553663363e-10,3.868569636587394e-09,0.0,4.0273385e-08,False,ZNF705A; zinc finger protein
hsa:9447,8.6785278e-08,0.00010752497949858921,9.157139435514852e-06,4.7874341475065885e-05,0.0,0.0005633747,False,AIM2; absent in melanoma
hsa:4487,0.0,0.0,1.7650017123599006e-07,1.1171374608326078e-06,0.0,1.1839596e-05,False,MSX1; msh homeobox
hsa:5526,0.0,0.0,9.7606015519802e-06,2.1031901849626275e-05,0.0,0.00014391,False,PPP2R5B; protein phosphatase 2 regulatory subunit
hsa:1350,0.0,0.0,0.00014821826535529704,0.0005252036507326314,0.0,0.003847401,False,COX7C; cytochrome c oxidase subunit
hsa:406997,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR215; microRNA
hsa:51340,0.0,0.0,1.5066304172536134e-07,3.336047883314818e-07,0.0,1.6727618e-06,False,CRNKL1; crooked neck pre-mRNA splicing factor
hsa:6566,8.00125735e-07,0.0009913375313744877,5.886264291476437e-05,0.00011831933446170614,0.0,0.0006721434,False,SLC16A1; solute carrier family 16 member
hsa:5925,0.0,0.0,0.0001098852362747525,0.0002467678044892677,0.0,0.0022138515,False,RB1; RB transcriptional corepressor
hsa:2657,0.0,0.0,8.846273525443563e-06,2.469869559389201e-05,0.0,0.0002239419,False,GDF1; growth differentiation factor
hsa:339761,0.0,0.0,2.8674169411228705e-05,0.00011202497382347888,0.0,0.0012431619,False,CYP27C1; cytochrome P450 family 27 subfamily C member
hsa:151531,2.61959785e-08,3.2456219719178455e-05,2.0436363009475746e-05,6.158758542590113e-05,0.0,0.0005112693,False,UPP2; uridine phosphorylase
hsa:9651,4.36626325e-08,5.409700553608799e-05,1.1373717618121494e-05,3.943015225686704e-05,0.0,0.00026617944,False,PLCH2; phospholipase C eta
hsa:1440,0.0,0.0,8.940554589306933e-05,0.00048057149901619203,0.0,0.0042221877,False,CSF3; colony stimulating factor
hsa:22938,4.4944957500000005e-05,0.055685776955769664,0.0002736497484333367,0.0005048724177969254,0.0,0.0028519672,False,SNW1; SNW domain containing
hsa:1644,0.00044578698,0.5523198979121551,0.001093102691923762,0.0014133293951606237,0.0,0.0062387153,False,DDC; dopa
hsa:3425,1.7087353499999998e-05,0.02117084115087638,6.735521710618812e-05,0.0001349615659221256,0.0,0.0011781183,False,IDUA;
hsa:2625,0.00017174335,0.21278609244956306,0.0004885823229483662,0.0009374289909258923,0.0,0.006630627,False,GATA3; GATA binding protein
hsa:978,3.6029559e-07,0.0004463980161264461,3.600988340570843e-05,0.0001543991635347993,0.0,0.00171214,False,CDA; cytidine
hsa:5190,2.4543841e-08,3.040925904900176e-05,2.0279010191935942e-05,6.467006929010382e-05,0.0,0.00038901126,False,PEX6; peroxisomal biogenesis factor
hsa:842,0.0,0.0,0.00017897373785297034,0.00037194918025467084,0.0,0.0020547376,False,CASP9; caspase
hsa:26999,1.0694862949999999e-07,0.00013250691199479377,2.1515037221826732e-05,6.672354070878653e-05,0.0,0.0003573847,False,CYFIP2; cytoplasmic FMR1 interacting protein
hsa:4849,3.09073055e-07,0.0003829344638665712,3.3000257101009904e-05,0.00013896502464321868,0.0,0.0012864445,False,CNOT3; CCR4-NOT transcription complex subunit
hsa:2920,0.0,0.0,0.0001363221167367327,0.0004072231185202958,0.0,0.0033939895,False,CXCL2; C-X-C motif chemokine ligand
hsa:374,0.0,0.0,1.636025398965099e-05,0.0001207905448262366,0.0,0.0014742813,False,AREG;
hsa:55558,0.0,0.0,1.4677959530198017e-06,7.032883291420965e-06,0.0,8.5932035e-05,False,PLXNA3; plexin
hsa:10588,1.0720385e-06,0.0013282312437162247,2.3668934077836632e-05,6.953996631080963e-05,0.0,0.0006775359,False,MTHFS; methenyltetrahydrofolate
hsa:112609,0.0,0.0,1.3441519163663365e-06,4.877286389762057e-06,0.0,4.1714346e-05,False,MRAP2; melanocortin 2 receptor accessory protein
hsa:259307,0.0,0.0,4.36067097128713e-05,0.0001540115647492724,0.0,0.0015372123,False,IL4I1; interleukin 4 induced
hsa:10344,0.0,0.0,3.9567259601499994e-05,0.0001531342428754192,0.0,0.0013681585,False,CCL26; C-C motif chemokine ligand
hsa:57216,3.7902532500000003e-08,4.6960373048607526e-05,1.3793710182064352e-05,4.858913573670542e-05,0.0,0.00037504328,False,VANGL2; VANGL planar cell polarity protein
hsa:1646,0.0,0.0,0.00016131236649009897,0.000311692432506026,0.0,0.0014684601,False,AKR1C2; aldo-keto reductase family 1 member
hsa:348158,0.0,0.0,1.323828487189752e-05,9.126707751562823e-05,0.0,0.0012462157,False,ACSM2B; acyl-CoA synthetase medium chain family member
hsa:10084,0.0,0.0,1.3505310787227718e-07,4.1443473554024445e-07,0.0,2.8601694e-06,False,PQBP1; polyglutamine binding protein
hsa:9181,0.0,0.0,2.6066351645891087e-05,9.204490883269442e-05,0.0,0.0006560559,False,ARHGEF2; Rho/Rac guanine nucleotide exchange factor
hsa:1233,6.470327e-07,0.0008016587537164636,1.5713886356721787e-05,4.014055936359073e-05,0.0,0.0002872895,False,CCR4; C-C motif chemokine receptor
hsa:4923,0.0,0.0,7.009560064158417e-07,7.352254056674953e-06,0.0,0.00010232515,False,NTSR1; neurotensin receptor
hsa:55113,0.0,0.0,1.8604916388923264e-05,6.278066802435846e-05,0.0,0.00057614845,False,XKR8; XK related
hsa:10039,1.0533116e-07,0.00013050290418569174,4.775632410123763e-06,1.5947037090303652e-05,0.0,0.00018134229,False,PARP3; poly(ADP-ribose) polymerase family member
hsa:3587,0.0,0.0,0.000132311191329703,0.00044260649556362845,0.0,0.0041516824,False,IL10RA; interleukin 10 receptor subunit
hsa:23383,6.9467989500000005e-09,8.606925412851372e-06,1.2350929846386637e-06,2.100715490558268e-06,0.0,1.001382e-05,False,MAU2; MAU2 sister chromatid cohesion
hsa:51762,0.0,0.0,1.7654595913960395e-06,4.481186735379752e-06,0.0,3.6254987e-05,False,RAB8B; RAB8B
hsa:115209,0.0,0.0,1.0302385292970294e-07,2.725147469808123e-07,0.0,1.6263235e-06,False,OMA1; OMA1 zinc
hsa:10622,0.0,0.0,2.0818611167648516e-05,5.716910631786697e-05,0.0,0.00028311257,False,POLR3G; RNA polymerase III subunit
hsa:2778,0.00181259085,2.2457587101994467,0.004039164138990098,0.004933354083972489,0.0,0.02511599,True,GNAS; GNAS complex
hsa:6601,4.8774347e-08,6.043030318151515e-05,4.057160954014851e-06,7.924628269613335e-06,0.0,3.7215937e-05,False,SMARCC2; SWI/SNF related
hsa:29945,1.31768775e-06,0.0016325850601560802,4.188638661658418e-05,0.00010583338044644814,0.0,0.0006598487,False,ANAPC4; anaphase promoting complex subunit
hsa:27339,1.7500735e-08,2.168301139837615e-05,3.3092054019059417e-07,7.596028377662349e-07,0.0,6.1252667e-06,False,PRPF19; pre-mRNA processing factor
hsa:2047,6.7475335e-08,8.360040066398634e-05,4.5643661203277245e-06,1.6893805598271247e-05,0.0,0.0001322835,False,EPHB1; EPH receptor
hsa:1559,0.0,0.0,2.1318183895891097e-05,9.221619079447028e-05,0.0,0.0010532495,False,CYP2C9; cytochrome P450 family 2 subfamily C member
hsa:406950,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR16-1; microRNA
hsa:5407,0.0,0.0,2.9806548777227713e-06,1.1176645075000065e-05,0.0,8.6836706e-05,False,PNLIPRP1; pancreatic lipase related protein
hsa:134526,0.0,0.0,3.325513044123764e-07,1.908460559069627e-06,0.0,2.0750556e-05,False,ACOT12; acyl-CoA thioesterase
hsa:1030,0.0,0.0,4.7055925600792067e-05,0.00023501972908743587,0.0,0.002794017,False,CDKN2B; cyclin dependent kinase inhibitor
hsa:6643,1.9842818e-08,2.4584798802444777e-05,3.220129051757427e-07,7.542004893641878e-07,0.0,3.6288222e-06,False,SNX2; sorting nexin
hsa:8808,0.0,0.0,6.405329646578713e-07,2.950845488716693e-06,0.0,2.3892015e-05,False,IL1RL2; interleukin 1 receptor like
hsa:2992,0.0,0.0,5.549083315750495e-05,0.0001751016764206335,0.0,0.0013263784,False,GYG1; glycogenin
hsa:23216,0.0,0.0,4.868676764652623e-06,1.0925518552672149e-05,0.0,7.707143e-05,False,TBC1D1; TBC1 domain family member
hsa:54554,0.0,0.0,5.919444295686139e-05,0.00021476935271455257,0.0,0.0014415714,False,WDR5B; WD repeat domain
hsa:23644,3.8551888500000006e-08,4.776491031801958e-05,3.59147672560396e-06,2.4329218981958018e-05,0.0,0.00026846366,False,EDC4; enhancer of mRNA decapping
hsa:9826,2.4691091e-06,0.003059169843959941,9.401035184219803e-05,0.00018478855625045625,0.0,0.0011761433,False,ARHGEF11; Rho guanine nucleotide exchange factor
hsa:3837,5.06236435e-07,0.0006272153935465171,1.0589774422673262e-06,1.2803726974402196e-06,0.0,5.8537603e-06,False,KPNB1; karyopherin subunit beta
hsa:374928,0.0,0.0,3.244746770268812e-08,9.179917278272406e-08,0.0,7.975604e-07,False,ZNF773; zinc finger protein
hsa:40,0.0,0.0,0.0001591603131237623,0.00031831250878429243,0.0,0.0019064567,False,ASIC2; acid sensing ion channel subunit
hsa:119016,0.0,0.0,2.0195293618316822e-07,4.899242868273231e-07,0.0,2.699432e-06,False,AGAP4; ArfGAP with GTPase domain
hsa:64431,0.0,0.0,6.021089589356436e-07,1.3378306298211067e-06,0.0,9.6892345e-06,False,ACTR6; actin related protein
hsa:25937,0.0,0.0,0.0002094261007336634,0.001019209940845404,0.0,0.010141994,False,WWTR1; WW domain containing transcription regulator
hsa:10525,1.0556607e-07,0.00013079395231638981,4.974051483159406e-07,1.0535276090355284e-06,0.0,7.784792e-06,False,HYOU1; hypoxia up-regulated
hsa:11177,0.0,0.0,1.5637042974554462e-07,6.953838198350742e-07,0.0,7.696968e-06,False,BAZ1A; bromodomain adjacent to zinc finger domain
hsa:1269,2.9545134500000004e-10,3.660574759460425e-07,1.946806694089694e-06,6.537328136818844e-06,0.0,5.4163058e-05,False,CNR2; cannabinoid receptor
hsa:1503,0.0,0.0,2.1156867158075034e-05,7.339760569126204e-05,0.0,0.0004492967,False,CTPS1; CTP synthase
hsa:23085,0.0,0.0,3.010473101072774e-06,7.835165668007e-06,0.0,4.565352e-05,False,ERC1; ELKS/RAB6-interacting/CAST family member
hsa:8563,0.0,0.0,4.242238437830914e-07,1.1794316583767636e-06,0.0,7.874143e-06,False,THOC5; THO complex subunit
hsa:79365,0.0,0.0,0.00011647020037135148,0.0006812851611589628,0.0,0.0076344362,False,BHLHE41; basic helix-loop-helix family member
hsa:9553,0.0,0.0,1.4363744928183173e-07,3.3414191871504655e-07,0.0,2.517501e-06,False,MRPL33; mitochondrial ribosomal protein
hsa:9093,0.0,0.0,1.036327161861386e-07,2.2142965864570803e-07,0.0,1.6046477e-06,False,DNAJA3; DnaJ heat shock protein family (Hsp40) member
hsa:140609,0.0,0.0,2.5706330889603956e-07,8.880727038285587e-07,0.0,1.0140985e-05,False,NEK7; NIMA related kinase
hsa:23431,3.23702385e-09,4.010598699789777e-06,1.3340894588584164e-06,2.646793742651283e-06,0.0,1.10752935e-05,False,AP4E1; adaptor related protein complex 4 subunit epsilon
hsa:4986,0.0,0.0,3.703729273910891e-07,3.5603857313316315e-06,0.0,4.20107e-05,False,OPRK1; opioid receptor kappa
hsa:6197,1.054384165e-06,0.001306357925422122,2.8939312509554457e-05,9.044710971344933e-05,0.0,0.00071264105,False,RPS6KA3; ribosomal protein S6 kinase
hsa:147183,0.0,0.0,6.189634048960397e-08,2.556470101092819e-07,0.0,1.7554154e-06,False,KRT25; keratin
hsa:6117,0.0,0.0,0.00013057531061054454,0.00026602821134999243,0.0,0.0016982693,False,RPA1; replication protein
hsa:8893,5.7168213e-09,7.083011165552734e-06,1.5069201881683167e-07,3.611407444772956e-07,0.0,2.575077e-06,False,EIF2B5; eukaryotic translation initiation factor 2B subunit
hsa:310,1.4854633000000002e-09,1.8404551389281335e-06,2.1384255288118813e-08,4.956260864795113e-08,0.0,3.9213245e-07,False,ANXA7; annexin
hsa:7372,2.0897548e-05,0.02589158520954192,9.83430639405337e-05,0.000164015668662596,0.0,0.00090207864,False,UMPS; uridine monophosphate
hsa:1188,0.0,0.0,3.908643763524752e-06,1.8422776648058576e-05,0.0,0.0001631788,False,CLCNKB; chloride voltage-gated channel
hsa:655,4.8112992e-06,0.00596108994248516,6.682282510477224e-05,0.00014707493125839702,0.0,0.00077790796,False,BMP7; bone morphogenetic protein
hsa:5901,1.07152445e-06,0.0013275943474939044,6.437325989396034e-05,0.00016457739650161817,0.0,0.0011542401,False,RAN; RAN
hsa:5408,0.0,0.0,5.126434981356434e-06,2.8982493241048697e-05,0.0,0.00034488825,False,PNLIPRP2; pancreatic lipase related protein 2
hsa:1294,3.12936715e-06,0.0038772145045996,4.984551483331681e-05,0.00011933450759591072,0.0,0.00082280335,False,COL7A1; collagen type VII alpha 1
hsa:346525,0.0,0.0,9.742073767326732e-08,9.362338932776254e-07,0.0,9.905675e-06,False,OR2A12; olfactory receptor family 2 subfamily A member
hsa:554213,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR449A; microRNA
hsa:401152,0.0,0.0,1.634111525564357e-06,7.641705522315225e-06,0.0,7.926529e-05,False,C4orf3; chromosome 4 open reading frame
hsa:4306,0.0,0.0,3.9007088307493074e-05,0.00014542781544300755,0.0,0.0012884219,False,NR3C2; nuclear receptor subfamily 3 group C member
hsa:529,2.715046e-05,0.03363880052187269,0.00010778028860247524,0.0002186027626324509,0.0,0.0011694958,False,ATP6V1E1; ATPase H+ transporting V1 subunit
hsa:407033,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30D; microRNA
hsa:768239,0.0,0.0,4.283482450331683e-08,2.1974535352567637e-07,0.0,1.9935474e-06,False,PSAPL1; prosaposin like
hsa:407009,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR224; microRNA
hsa:58513,0.0,0.0,1.528088816712872e-07,2.9900230753006625e-07,0.0,1.9015414e-06,False,EPS15L1; epidermal growth factor receptor pathway substrate 15 like
hsa:130576,0.0,0.0,5.911204264350493e-06,2.6365029234771626e-05,0.0,0.0002924818,False,LYPD6B; LY6/PLAUR domain containing
hsa:6224,0.0,0.0,6.800844542574256e-07,1.4697121080217844e-06,0.0,6.7104847e-06,False,RPS20; ribosomal protein
hsa:1605,0.0,0.0,0.00024684243367554447,0.0005908095529365897,0.0,0.0037374056,False,DAG1; dystroglycan
hsa:4633,0.0,0.0,1.3707962493316833e-05,0.00010026236974654441,0.0,0.001377047,False,MYL2; myosin light chain
hsa:2736,0.0,0.0,1.538322030823762e-05,6.515062498660483e-05,0.0,0.000480458,False,GLI2; GLI family zinc finger
hsa:1298,9.245584450000001e-05,0.1145506820222118,0.0002565285524406437,0.00038786882150269826,0.0,0.0024990407,False,COL9A2; collagen type IX alpha 2
hsa:84818,0.0,0.0,1.6433361355841585e-05,5.51423802859545e-05,0.0,0.00045623534,False,IL17RC; interleukin 17 receptor
hsa:5719,0.0,0.0,7.051576810742573e-06,1.7281335934208964e-05,0.0,0.00016106412,False,PSMD13; proteasome 26S subunit
hsa:4342,0.0,0.0,2.6027955445544553e-10,3.6992675202586018e-09,0.0,5.257647e-08,False,MOS; MOS proto-oncogene
hsa:246778,0.0,0.0,8.360870622683169e-07,5.545991443588234e-06,0.0,6.831558e-05,False,IL27; interleukin
hsa:10352,0.0,0.0,1.4348214895990093e-06,3.5908109870663122e-06,0.0,1.9750005e-05,False,WARS2; tryptophanyl tRNA synthetase 2
hsa:4283,0.00010182998699999999,0.12616503071542393,0.00023466447978267324,0.0003662792310337181,0.0,0.0027593528,False,CXCL9; C-X-C motif chemokine ligand
hsa:53944,1.18047285e-06,0.0014625789295148789,8.76080200091089e-05,0.00020047861548745096,0.0,0.0010100886,False,CSNK1G1; casein kinase 1 gamma
hsa:9675,0.0,0.0,7.033995070643562e-07,2.447074628291353e-06,0.0,2.1146463e-05,False,TTI1; TELO2 interacting protein
hsa:2957,0.0,0.0,4.265502011569306e-07,1.0921375448844942e-06,0.0,8.182859e-06,False,GTF2A1; general transcription factor IIA subunit
hsa:9075,0.0,0.0,1.1517745900321782e-06,1.2715419841096175e-05,0.0,0.00018017387,False,CLDN2; claudin
hsa:80854,0.0,0.0,1.728431868153466e-05,5.747263766882843e-05,0.0,0.00058346195,False,SETD7; SET domain containing 7
hsa:26153,9.960982e-09,1.2341429445392986e-05,1.209733819851584e-06,3.850204303205504e-06,0.0,2.030675e-05,False,KIF26A; kinesin family member
hsa:57733,0.0,0.0,1.4123498186896042e-05,4.633546234209895e-05,0.0,0.00038350464,False,GBA3; glucosylceramidase beta 3
hsa:330,0.0,0.0,0.00013321129003089104,0.0005483577748782079,0.0,0.004797739,False,BIRC3; baculoviral IAP repeat containing
hsa:2013,1.5734279499999998e-07,0.00019494413334282025,5.077219523871288e-07,8.45044050034777e-07,0.0,5.572172e-06,False,EMP2; epithelial membrane protein
hsa:1488,2.18053845e-06,0.002701637392140813,0.00011798810066326732,0.0003172426235044609,0.0,0.0030415445,False,CTBP2; C-terminal binding protein
hsa:353376,0.0,0.0,1.8408307539108912e-05,4.96285023158919e-05,0.0,0.0004516436,False,TICAM2; TIR domain containing adaptor molecule
hsa:5350,0.0,0.0,1.86052286780099e-05,6.931622607961975e-05,0.0,0.00056985696,False,PLN;
hsa:956,1.07331248e-09,1.3298096758712916e-06,5.273812281366486e-06,2.240468259018395e-05,0.0,0.0002329689,False,ENTPD3; ectonucleoside triphosphate diphosphohydrolase
hsa:54431,1.9750079e-09,2.446989729721805e-06,7.812646569873265e-07,2.5662882193059348e-06,0.0,2.4736988e-05,False,DNAJC10; DnaJ heat shock protein family (Hsp40) member
hsa:80314,2.7264048999999998e-08,3.3779534701421726e-05,1.7800486201500005e-06,6.135854873597002e-06,0.0,5.645988e-05,False,EPC1; enhancer of polycomb homolog
hsa:6773,3.66562925e-05,0.04541631012067265,0.00030584241982722774,0.0005573514827359919,0.0,0.0026520058,False,STAT2; signal transducer and activator of transcription
hsa:132158,2.2941724e-06,0.00284242726371435,0.00010531358715331684,0.00021990976248873565,0.0,0.0014322916,False,GLYCTK; glycerate
hsa:1655,0.0,0.0,7.076746221316833e-06,2.847540324078748e-05,0.0,0.0003207528,False,DDX5; DEAD-box helicase
hsa:1119,1.6816723000000001e-07,0.00020835536135615699,2.7158635294059407e-05,7.617731311843615e-05,0.0,0.00040371346,False,CHKA; choline kinase
hsa:406883,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7A3; microRNA
hsa:6751,0.0,0.0,1.9908376195693068e-06,1.0517886390672793e-05,0.0,0.00012312949,False,SSTR1; somatostatin receptor
hsa:3976,0.0,0.0,6.869830956537126e-05,0.0004210226168938216,0.0,0.0036831982,False,LIF; LIF interleukin 6 family
hsa:351,5.53075045e-07,0.0006852473627474733,9.881728851387624e-05,0.00027305637560676984,0.0,0.0017061753,False,APP; amyloid beta precursor
hsa:222236,1.0730675799999999e-07,0.0001329506250358508,3.839855362362969e-06,9.201825728069583e-06,0.0,4.769377e-05,False,NAPEPLD; N-acyl phosphatidylethanolamine phospholipase
hsa:7059,7.183973349999999e-06,0.008900779083488805,9.660256459059408e-05,0.00016288876045484688,0.0,0.00087802496,False,THBS3; thrombospondin
hsa:124454,1.819642e-06,0.002254494924182554,0.00021310869746019804,0.0004517846491240151,0.0,0.002818824,False,EARS2; glutamyl-tRNA synthetase 2
hsa:196527,5.418883499999999e-07,0.0006713873028588366,0.00016063498200937474,0.00039013683940861523,0.0,0.002370167,False,ANO6; anoctamin
hsa:1062,0.0,0.0,6.885299058009903e-08,3.1804017993083677e-07,0.0,3.7977939e-06,False,CENPE; centromere protein
hsa:1798,3.37788535e-07,0.0004185122884636434,6.095518958429702e-05,0.00016193593707763273,0.0,0.0012523134,False,DPAGT1; dolichyl-phosphate N-acetylglucosaminephosphotransferase
hsa:640,1.32143365e-07,0.00016372261447960784,3.820695743024752e-06,8.728366953220387e-06,0.0,6.4725624e-05,False,BLK; BLK proto-oncogene
hsa:22801,0.0,0.0,7.524743166316832e-05,0.00015807168295993388,0.0,0.001042326,False,ITGA11; integrin subunit alpha
hsa:5420,2.84335665e-08,3.5228540202225e-05,3.9258303601138586e-07,9.713677445932979e-07,0.0,5.945288e-06,False,PODXL; podocalyxin
hsa:1050,0.0,0.0,6.684771507537625e-06,5.991215988739276e-05,0.0,0.00084216485,False,CEBPA; CCAAT enhancer binding protein
hsa:285220,8.20552325e-09,1.016645610366596e-05,4.097325165410197e-06,1.781964647664234e-05,0.0,0.0001328016,False,EPHA6; EPH receptor
hsa:125981,0.0,0.0,1.2631631227425743e-07,7.752989858854655e-07,0.0,1.0514218e-05,False,ACER1; alkaline ceramidase
hsa:4616,0.0,0.0,0.00023938175601980198,0.0007892901779681258,0.0,0.004990072,False,GADD45B; growth arrest and DNA damage inducible
hsa:8844,1.5699195e-06,0.0019450944439209541,1.8351667956e-05,5.015404037332415e-05,0.0,0.00028609938,False,KSR1; kinase suppressor of ras
hsa:152,0.0,0.0,2.8847471040006425e-05,0.00010257311943944139,0.0,0.00064742606,False,ADRA2C; adrenoceptor alpha
hsa:390431,0.0,0.0,6.303881485148515e-09,7.667637217331145e-08,-0.0,1.0720116e-06,False,OR4K2; olfactory receptor family 4 subfamily K member
hsa:5026,1.8096856e-06,0.002242159171730626,2.1625746140967815e-05,4.574651767088296e-05,0.0,0.0003904954,False,P2RX5; purinergic receptor P2X
hsa:23590,2.75524725e-07,0.0003413688483774798,0.00021261974808813432,0.0007828689411451984,0.0,0.0056522326,False,PDSS1; decaprenyl diphosphate synthase subunit
hsa:9927,0.0,0.0,2.52407386470297e-06,7.189140327722602e-06,0.0,5.272841e-05,False,MFN2; mitofusin
hsa:1473,0.0,0.0,1.7766703188613863e-06,1.3089387581190688e-05,0.0,0.00013828183,False,CST5; cystatin
hsa:51360,7.14820135e-09,8.85645839160114e-06,5.964783197872772e-07,1.643622426826578e-06,0.0,1.40323145e-05,False,MBTPS2; membrane bound transcription factor peptidase
hsa:64386,0.0,0.0,2.9457586819762374e-06,1.0237452473626172e-05,0.0,0.000110402514,False,MMP25; matrix metallopeptidase
hsa:57448,6.1708764999999995e-06,0.007645575199411425,0.00031127568055712874,0.0005282199872017102,0.0,0.0029833794,False,BIRC6; baculoviral IAP repeat containing
hsa:10436,6.831232350000001e-10,8.46374103201985e-07,1.7573381326060389e-06,3.89300044051278e-06,0.0,1.843817e-05,False,EMG1; EMG1 N1-specific pseudouridine
hsa:4602,1.7586248e-09,2.178896005445884e-06,1.469923410085644e-07,4.3228683685553194e-07,0.0,3.5641851e-06,False,MYB; MYB proto-oncogene
hsa:95,7.199910000000001e-07,0.0008920524229255652,3.636319204037625e-05,7.159696529028299e-05,0.0,0.00059512147,False,ACY1; aminoacylase
hsa:1287,0.0,0.0,1.588196668574257e-05,5.2319240000719736e-05,0.0,0.00033250597,False,COL4A5; collagen type IV alpha 5
hsa:51287,0.0,0.0,6.44099254371287e-07,2.2434678551403196e-06,0.0,2.1476066e-05,False,COA4; cytochrome c oxidase assembly factor 4
hsa:115361,1.3371443e-09,1.6566912817189501e-06,2.0273525826534652e-07,6.703681332111811e-07,0.0,6.0204447e-06,False,GBP4; guanylate binding protein
hsa:90293,1.3166259e-08,1.6312694522314208e-05,1.785933547054456e-07,4.0369452238896656e-07,0.0,2.4817293e-06,False,KLHL13; kelch like family member
hsa:152404,0.0,0.0,4.072554067830492e-07,1.5371598432977382e-06,0.0,1.3576509e-05,False,IGSF11; immunoglobulin superfamily member
hsa:10114,0.0,0.0,5.835203180623764e-07,1.1301358639850125e-06,0.0,5.3356316e-06,False,HIPK3; homeodomain interacting protein kinase
hsa:7442,2.84864635e-05,0.035294078378418164,9.270985121133667e-05,0.00014374862150656688,0.0,0.00076134474,False,TRPV1; transient receptor potential cation channel subfamily V member
hsa:9261,0.0,0.0,6.220405957227722e-05,0.0002512143521485466,0.0,0.0028312858,False,MAPKAPK2; MAPK activated protein kinase
hsa:7376,0.0,0.0,1.2517029141896037e-05,5.927947404206033e-05,0.0,0.00063864974,False,NR1H2; nuclear receptor subfamily 1 group H member
hsa:2549,4.6440770000000006e-06,0.005753905451738828,2.2409717492178208e-05,9.340854102629978e-05,0.0,0.0009654507,False,GAB1; GRB2 associated binding protein
hsa:7712,0.0,0.0,2.7205657357752484e-08,5.813057534187466e-08,0.0,2.8600218e-07,False,ZNF157; zinc finger protein
hsa:2237,0.0,0.0,0.0001452670313505446,0.0004182228373432219,0.0,0.0026367065,False,FEN1; flap structure-specific endonuclease
hsa:8672,1.05570785e-05,0.013079979409382051,8.952401145722767e-05,0.00026021830184790696,0.0,0.002519257,False,EIF4G3; eukaryotic translation initiation factor 4 gamma
hsa:5093,7.5140975e-08,9.309795373794855e-05,5.3726641128060676e-05,0.00015062076681916474,0.0,0.000980445,False,PCBP1; poly(rC) binding protein
hsa:7450,0.0,0.0,3.3730188911386125e-05,0.00014155671280165045,0.0,0.0014285163,False,VWF; von Willebrand
hsa:6754,0.0,0.0,1.6633376914530193e-07,1.5150847393707916e-06,0.0,2.1092774e-05,False,SSTR4; somatostatin receptor
hsa:6258,0.0,0.0,5.0058376745594026e-05,0.00014743551955988962,0.0,0.0010645755,False,RXRG; retinoid X receptor
hsa:8516,0.0,0.0,7.827185913894556e-05,0.000238408948629133,0.0,0.0019164208,False,ITGA8; integrin subunit alpha
hsa:55070,0.0,0.0,2.0848780888647027e-07,4.4299071046788777e-07,0.0,2.3417688e-06,False,DET1; DET1 partner of COP1 E3 ubiquitin
hsa:2562,0.00012207837,0.15125231530019628,0.000729479174009406,0.0011741942742510955,0.0,0.008387937,False,GABRB3; gamma-aminobutyric acid type A receptor subunit
hsa:7695,2.5574609e-08,3.1686357084774626e-05,8.524722997227724e-08,1.3827266370591634e-07,0.0,6.7132794e-07,False,ZNF136; zinc finger protein
hsa:9110,3.75259765e-06,0.004649382875546058,0.00018577646689958406,0.0005530392081449704,0.0,0.0037003402,False,MTMR4; myotubularin related protein
hsa:65082,1.3713304e-06,0.0016990470796877802,0.0002132645580828796,0.0004774687821886621,0.0,0.0028866725,False,VPS33A; VPS33A core subunit of CORVET and HOPS
hsa:3603,0.0,0.0,2.2449842263019808e-05,7.638522425994668e-05,0.0,0.00052277837,False,IL16; interleukin
hsa:90161,1.7305198e-07,0.00021440745516411515,0.0003726363664776437,0.0011768369600297119,0.0,0.008472559,False,HS6ST2; heparan sulfate 6-O-sulfotransferase
hsa:924,0.0,0.0,1.4113166830321783e-05,6.250441942100865e-05,0.0,0.00072464824,False,CD7; CD7
hsa:170959,0.0,0.0,7.960937072524756e-08,1.8662928211380315e-07,0.0,9.732174e-07,False,ZNF431; zinc finger protein
hsa:119692,0.0,0.0,6.479144554455446e-10,9.208594604944287e-09,0.0,1.3087872e-07,False,OR51S1; olfactory receptor family 51 subfamily S member
hsa:8687,0.0,0.0,1.1181496159306931e-07,8.313350201092945e-07,0.0,9.182591e-06,False,KRT38; keratin
hsa:84618,3.2363934499999995e-05,0.040098176485718964,0.00012375498325403465,0.00021723713064735796,0.0,0.0012651075,False,NT5C1A; 5'-nucleotidase
hsa:27436,0.0,0.0,1.0029010480891091e-05,4.1731028276364795e-05,0.0,0.00051672634,False,EML4; EMAP like
hsa:84700,0.0,0.0,1.744844241252475e-08,7.10220676913529e-08,0.0,7.8280044e-07,False,MYO18B; myosin
hsa:10524,0.0,0.0,3.210328744628712e-06,9.506255929958526e-06,0.0,5.0541334e-05,False,KAT5; lysine acetyltransferase
hsa:2785,0.0,0.0,0.00013870846205311883,0.00041870227764520096,0.0,0.0042861975,False,GNG3; G protein subunit gamma
hsa:5347,2.8814152e-06,0.0035700076953941815,4.468582661089109e-05,0.00011868500389930939,0.0,0.00076343084,False,PLK1; polo like kinase
hsa:51272,0.0,0.0,2.2658463446913362e-05,8.648974417197023e-05,0.0,0.00064608746,False,BET1L; Bet1 golgi vesicular membrane trafficking protein
hsa:9741,3.1257728499999996e-07,0.00038727612489009564,5.29765461982673e-06,9.97048960860286e-06,0.0,6.837819e-05,False,LAPTM4A; lysosomal protein transmembrane 4
hsa:57180,2.1372498500000001e-07,0.00026480038043389444,0.00010509923941244605,0.0002558501905325317,0.0,0.0016550949,False,ACTR3B; actin related protein
hsa:2760,0.0,0.0,8.854029115896038e-06,3.00250237714249e-05,0.0,0.000268367,False,GM2A; ganglioside GM2
hsa:10203,0.0,0.0,6.855528624356435e-06,2.3862251137415052e-05,0.0,0.00022221729,False,CALCRL; calcitonin receptor like
hsa:57332,0.0,0.0,0.00012462882237463573,0.0004515454141390497,0.0,0.0025321846,False,CBX8; chromobox
hsa:2184,3.998113e-07,0.0004953570792940744,5.4699316214901e-05,0.00021371464500624058,0.0,0.0018657546,False,FAH; fumarylacetoacetate
hsa:5422,1.028649925e-08,1.274473789170213e-05,2.595833843825247e-06,1.2016574599971651e-05,0.0,0.00014622307,False,POLA1; DNA polymerase alpha 1
hsa:10211,1.42272945e-07,0.00017627293300055927,1.4563523467128708e-06,3.1908438911394187e-06,0.0,1.858588e-05,False,FLOT1; flotillin
hsa:3861,0.0,0.0,9.678123645e-06,6.514126583281761e-05,0.0,0.00066966115,False,KRT14; keratin
hsa:84444,1.6430429e-06,0.0020356926682634185,4.932233428524753e-05,0.0001918086406072096,0.0,0.0013891914,False,DOT1L; DOT1 like histone lysine
hsa:219431,0.0,0.0,1.532069420792079e-08,1.479099886458793e-07,0.0,1.5823149e-06,False,OR4S2; olfactory receptor family 4 subfamily S member
hsa:1917,0.0,0.0,3.746460848762375e-05,8.234672929899591e-05,0.0,0.000469418,False,EEF1A2; eukaryotic translation elongation factor 1 alpha
hsa:23324,0.0,0.0,7.38397716648515e-05,0.00019367004492898122,0.0,0.001232862,False,MAN2B2; mannosidase alpha class 2B member
hsa:102723849,0.0,0.0,2.68095695049505e-09,1.680050120036788e-08,0.0,1.5893119e-07,False,SPDYE17; speedy/RINGO cell cycle regulator family member
hsa:390054,0.0,0.0,8.61967900990099e-07,1.0263393900493301e-05,0.0,0.0001425764,False,OR52A5; olfactory receptor family 52 subfamily A member
hsa:1081,0.0,0.0,2.4511747878589112e-05,0.00012244904795383904,0.0,0.0010515373,False,CGA; glycoprotein hormones
hsa:11235,0.0,0.0,1.348553652391584e-05,4.448760203746551e-05,0.0,0.00034380055,False,PDCD10; programmed cell death
hsa:26339,0.0,0.0,1.3906846475247526e-06,7.012835885707775e-06,-0.0,6.769219e-05,False,OR5K1; olfactory receptor family 5 subfamily K member
hsa:11128,1.01367915e-06,0.0012559253404926278,0.00019762581215935636,0.0005851921756455238,0.0,0.0036959578,False,POLR3A; RNA polymerase III subunit
hsa:394,0.0,0.0,6.982354295910888e-06,3.149062118416358e-05,0.0,0.0003028097,False,ARHGAP5; Rho GTPase activating protein
hsa:22798,2.2416326000000004e-06,0.002777331650171925,1.0515445720727725e-05,2.010270960235843e-05,0.0,0.00018772703,False,LAMB4; laminin subunit beta
hsa:6581,4.7395615e-09,5.872208568828951e-06,5.8453097433046626e-06,3.132681245949517e-05,0.0,0.00032664536,False,SLC22A3; solute carrier family 22 member
hsa:9942,0.0,0.0,5.783099473614061e-05,0.00010686456001346243,0.0,0.0005898786,False,XYLB;
hsa:22953,1.1907417e-05,0.01475301800388486,9.114377194950492e-05,0.00024099449352003828,0.0,0.0019741796,False,P2RX2; purinergic receptor P2X
hsa:90673,9.032836750000001e-07,0.0011191478655606234,4.149381398871287e-05,9.886966134784406e-05,0.0,0.0006303673,False,PPP1R3E; protein phosphatase 1 regulatory subunit
hsa:55503,2.99998305e-06,0.003716910556504355,3.514807096298515e-05,6.947357637323919e-05,0.0,0.00043732836,False,TRPV6; transient receptor potential cation channel subfamily V member
hsa:9554,4.7103106000000004e-07,0.0005835967371067101,5.513614300942574e-05,0.00011463119014274285,0.0,0.00084991235,False,SEC22B; SEC22 homolog B
hsa:390084,0.0,0.0,1.4248909367673265e-05,6.805835850885241e-05,-0.0,0.0007748274,False,OR56A5; olfactory receptor family 56 subfamily A member
hsa:728927,0.0,0.0,3.804428472064356e-08,1.0050987351223626e-07,0.0,6.1228377e-07,False,ZNF736; zinc finger protein
hsa:89790,0.0,0.0,2.5343782104606926e-05,6.744393009116808e-05,0.0,0.00040765124,False,SIGLEC10; sialic acid binding Ig like lectin
hsa:144983,1.38653385e-09,1.7178838073820535e-06,2.846270846995049e-07,8.924599729750622e-07,0.0,5.9744175e-06,False,HNRNPA1L2; heterogeneous nuclear ribonucleoprotein A1 like
hsa:391189,0.0,0.0,1.311124472772277e-07,9.177243280879787e-07,0.0,8.180139e-06,False,OR11L1; olfactory receptor family 11 subfamily L member
hsa:335,0.0,0.0,6.0977321736633675e-05,0.00019729719905243678,0.0,0.0014344008,False,APOA1; apolipoprotein
hsa:51552,0.0,0.0,8.712487333359404e-05,0.0002569511193778471,0.0,0.0013518715,False,RAB14; RAB14
hsa:53947,0.0,0.0,0.0002289917755937623,0.0011638949078141105,0.0,0.011480345,False,A4GALT; alpha 1
hsa:7249,2.26467465e-05,0.02805880224434203,0.00014897113906202973,0.00032200430335844587,0.0,0.0017858907,False,TSC2; TSC complex subunit
hsa:7733,1.5474093e-08,1.9172048196749023e-05,8.234238082673269e-08,1.392595460376072e-07,0.0,6.765072e-07,False,ZNF180; zinc finger protein
hsa:10670,0.0,0.0,2.499146251133663e-06,1.146751259144699e-05,0.0,0.00012107755,False,RRAGA; Ras related GTP binding
hsa:8905,2.0100175e-10,2.4903658254030776e-07,2.3844660546128704e-06,5.3953808618575565e-06,0.0,2.6894884e-05,False,AP1S2; adaptor related protein complex 1 subunit sigma
hsa:283159,-0.0,0.0,1.2606582424405941e-06,1.2459222032873289e-05,-0.0,0.00017270785,False,OR8D1; olfactory receptor family 8 subfamily D member
hsa:11184,0.0,0.0,3.920492292557118e-07,1.2679627064165346e-06,0.0,9.937042e-06,False,MAP4K1; mitogen-activated protein kinase kinase kinase kinase
hsa:406882,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7A2; microRNA
hsa:1144,0.0,0.0,3.858954566031879e-06,1.6702393811619816e-05,0.0,0.00013549646,False,CHRND; cholinergic receptor nicotinic delta
hsa:602,0.0,0.0,8.775072258861385e-06,3.77772032209705e-05,0.0,0.00031873933,False,BCL3; BCL3 transcription
hsa:1301,6.026145e-07,0.0007466256172856022,2.7558622899504952e-05,6.91959638110744e-05,0.0,0.0004739738,False,COL11A1; collagen type XI alpha 1
hsa:284306,1.071416575e-08,1.3274606928299946e-05,3.7988941141126245e-08,6.138809339102982e-08,0.0,2.759193e-07,False,ZNF547; zinc finger protein
hsa:221178,9.301625500000001e-09,1.1524501784635117e-05,6.354912672241575e-06,2.2095814401914773e-05,0.0,0.00014759458,False,SPATA13; spermatogenesis associated
hsa:79973,1.80578555e-09,2.2373270987574486e-06,1.4293002504702969e-08,2.896106587057362e-08,0.0,1.7587e-07,False,ZNF442; zinc finger protein
hsa:3973,2.7991145e-07,0.0003468039005725185,9.201787099356434e-06,2.9655889966498855e-05,0.0,0.0003425733,False,LHCGR; luteinizing hormone/choriogonadotropin
hsa:219699,6.7292943e-08,8.337442113712802e-05,1.999459535707921e-06,1.897992499131868e-05,0.0,0.00026441953,False,UNC5B; unc-5 netrin receptor
hsa:56052,9.224192e-10,1.142856344472447e-06,3.885331566464555e-05,8.315474675142384e-05,0.0,0.0005298651,False,ALG1; ALG1 chitobiosyldiphosphodolichol
hsa:219428,0.0,0.0,3.908010396039604e-08,5.554326369256497e-07,0.0,7.894181e-06,False,OR4C16; olfactory receptor family 4 subfamily C member
hsa:5336,0.0,0.0,0.0001166516475549505,0.00022767962436358687,0.0,0.0017620154,False,PLCG2; phospholipase C gamma
hsa:51160,1.5101137000000002e-07,0.00018709964221470688,2.8017822070925743e-06,6.2030667729989594e-06,0.0,3.4340108e-05,False,VPS28; VPS28 subunit of
hsa:10018,0.0,0.0,0.00034461315072232667,0.0007570734875981529,0.0,0.0037023532,False,BCL2L11; BCL2 like
hsa:166929,0.0,0.0,7.778762003722778e-06,3.0261050521280014e-05,0.0,0.00026144294,False,SGMS2; sphingomyelin synthase
hsa:1857,8.0708935e-05,0.0999965291489643,0.00045653825655559414,0.0006655881273420069,0.0,0.0032095788,False,DVL3; dishevelled segment polarity protein
hsa:25949,6.9229652e-09,8.577395940351156e-06,5.911818865490099e-07,1.720953236478064e-06,0.0,1.3277395e-05,False,SYF2; SYF2 pre-mRNA splicing
hsa:261729,0.0,0.0,1.0123034031729603e-05,3.1005888421619636e-05,0.0,0.00024006116,False,STEAP2; STEAP2
hsa:150681,0.0,0.0,1.9174400505940592e-06,2.2234037104846797e-05,0.0,0.0003147572,False,OR6B3; olfactory receptor family 6 subfamily B member
hsa:10762,9.012944249999999e-09,1.1166832301939247e-05,2.28554477710891e-07,4.973169763625775e-07,0.0,2.7037754e-06,False,NUP50; nucleoporin
hsa:23350,0.0,0.0,1.69119129779703e-07,3.2027707334435995e-07,0.0,2.202269e-06,False,U2SURP; U2 snRNP associated SURP domain
hsa:10500,2.06420945e-07,0.00025575084151028947,1.3749613901980193e-05,5.451982868106513e-05,0.0,0.00053145515,False,SEMA6C; semaphorin
hsa:3360,3.3402327000000003e-06,0.004138472110304438,3.090715832762376e-05,7.694600709790171e-05,0.0,0.00073499273,False,HTR4; 5-hydroxytryptamine receptor
hsa:216,0.0,0.0,0.00010432058257356437,0.0002525060482856548,0.0,0.0018719647,False,ALDH1A1; aldehyde dehydrogenase 1 family member
hsa:85358,0.0,0.0,9.450266842008412e-05,0.0002877193672328539,0.0,0.0014752813,False,SHANK3; SH3 and multiple ankyrin repeat domains
hsa:140739,0.0,0.0,5.823672605435645e-07,1.4262595405457122e-06,0.0,7.1672284e-06,False,UBE2F; ubiquitin conjugating enzyme E2 F
hsa:9388,0.0,0.0,1.401789625940594e-05,5.328415853208802e-05,0.0,0.00044896567,False,LIPG; lipase G
hsa:150084,1.3183227e-08,1.6333717487201546e-05,7.493046585456931e-06,2.27604111542163e-05,0.0,0.00015136859,False,IGSF5; immunoglobulin superfamily member
hsa:390882,0.0,0.0,3.130460594059406e-08,3.1944692611045954e-07,-0.0,3.7599923e-06,False,OR7G2; olfactory receptor family 7 subfamily G member
hsa:135924,0.0,0.0,1.6888347332178219e-06,1.2185002684815609e-05,0.0,0.00016867119,False,OR9A2; olfactory receptor family 9 subfamily A member
hsa:23710,0.0,0.0,2.8691089193267325e-05,8.078415167090433e-05,0.0,0.0005524431,False,GABARAPL1; GABA type A receptor associated protein like
hsa:338751,0.0,0.0,6.596963822772278e-07,2.579937406632647e-06,0.0,3.0189887e-05,False,OR52L1; olfactory receptor family 52 subfamily L member
hsa:4625,1.3073915e-06,0.0016198282413075844,5.6423743611861396e-05,0.00027881095452669385,0.0,0.0038282122,False,MYH7; myosin heavy chain
hsa:79840,0.0,0.0,9.21545585386634e-05,0.000247767688648758,0.0,0.0015811927,False,NHEJ1; non-homologous end joining factor
hsa:57103,2.8228858999999998e-06,0.00349749122799787,4.968026221029704e-05,0.00018319041847521603,0.0,0.0019374089,False,TIGAR; TP53 induced glycolysis regulatory
hsa:5597,0.0,0.0,7.097610876438616e-05,0.000242469638181297,0.0,0.0014531908,False,MAPK6; mitogen-activated protein kinase
hsa:80235,5.0151232e-06,0.006213623228387874,3.268804093841586e-05,8.529768164401832e-05,0.0,0.0006042442,False,PIGZ; phosphatidylinositol glycan anchor biosynthesis class
hsa:2113,0.0,0.0,5.843387490089108e-06,4.0387283696287e-05,0.0,0.0003828867,False,ETS1; ETS proto-oncogene 1
hsa:9690,2.10016025e-08,2.602050636111369e-05,2.075900147920792e-07,3.725719623521757e-07,0.0,2.7633785e-06,False,UBE3C; ubiquitin protein ligase
hsa:5959,1.1355418e-06,0.0014069103836343198,0.00015419223895569309,0.0003391519352621912,0.0,0.002003671,False,RDH5; retinol dehydrogenase
hsa:8737,0.0,0.0,0.000281140731593713,0.0007292644028737251,0.0,0.004696357,False,RIPK1; receptor interacting serine/threonine kinase
hsa:6605,1.4123426e-07,0.00017498602598240703,4.145644687096535e-06,1.329227221293673e-05,0.0,7.806715e-05,False,SMARCE1; SWI/SNF related
hsa:7410,1.0471142e-05,0.012973506046461204,9.666409332732672e-05,0.00020984853751705308,0.0,0.001408334,False,VAV2; vav guanine nucleotide exchange factor
hsa:407049,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR92A2; microRNA
hsa:84617,0.0,0.0,5.4604211042920784e-05,0.0002188534799850358,0.0,0.0022352547,False,TUBB6; tubulin beta 6 class
hsa:23743,0.0,0.0,1.2344093532476236e-05,5.1125743534624145e-05,0.0,0.0003884643,False,BHMT2; betaine--homocysteine S-methyltransferase
hsa:23500,0.0,0.0,7.998493841623763e-06,7.143859460480584e-05,0.0,0.0009235916,False,DAAM2; dishevelled associated activator of morphogenesis
hsa:9342,2.61517955e-07,0.00032401477990181676,3.369395419381186e-05,9.278561576315093e-05,0.0,0.00068366155,False,SNAP29; synaptosome associated protein
hsa:51585,0.0,0.0,3.4329014143514833e-07,7.692146098952263e-07,0.0,4.4819312e-06,False,PCF11; PCF11 cleavage and polyadenylation factor
hsa:50833,0.0,0.0,4.037508217821782e-10,5.7383773551533304e-09,0.0,8.1557666e-08,False,TAS2R16; taste 2 receptor member
hsa:9771,0.0,0.0,3.590202874787128e-07,8.13903900195347e-07,0.0,4.309998e-06,False,RAPGEF5; Rap guanine nucleotide exchange factor
hsa:1876,0.0,0.0,8.125115639253413e-05,0.000298007437983935,0.0,0.001721375,False,E2F6; E2F transcription factor
hsa:684,0.0,0.0,1.6531422951732676e-05,4.162958055345321e-05,0.0,0.0003742472,False,BST2; bone marrow stromal cell antigen
hsa:3549,2.8165735000000003e-06,0.0034896703084107156,1.2589365389247526e-05,2.3863919971788885e-05,0.0,0.00016178851,False,IHH; Indian hedgehog signaling
hsa:116255,0.0,0.0,1.2281119151782182e-07,6.509008111086442e-07,0.0,7.712487e-06,False,MOGAT1; monoacylglycerol O-acyltransferase
hsa:63035,8.674621e-09,1.074765751378974e-05,4.874860039215541e-05,0.00018553371064710387,0.0,0.0011502358,False,BCORL1; BCL6 corepressor like
hsa:9493,4.37576085e-09,5.421467863327917e-06,2.3253605463440602e-07,6.731765162479732e-07,0.0,6.6389334e-06,False,KIF23; kinesin family member
hsa:137362,0.0,0.0,4.3546227722772275e-08,6.189081819417813e-07,0.0,8.796338e-06,False,GOT1L1; glutamic-oxaloacetic transaminase 1 like
hsa:284307,1.67995465e-09,2.081425484398513e-06,2.3165393074059425e-08,5.1934191805251385e-08,0.0,3.1779464e-07,False,ZIK1; zinc finger protein interacting with K protein
hsa:22916,2.0025395e-07,0.0002481100754008244,6.616744551683165e-07,9.2737926784836e-07,0.0,4.0311015e-06,False,NCBP2; nuclear cap binding protein subunit
hsa:219469,0.0,0.0,4.272465766336633e-07,4.279973766845602e-06,0.0,5.5140765e-05,False,OR8H1; olfactory receptor family 8 subfamily H member
hsa:3791,1.5304142e-06,0.0018961482785058294,1.8512028078569314e-05,8.856357322137663e-05,0.0,0.001113686,False,KDR; kinase insert domain
hsa:342371,0.0,0.0,5.262689688280941e-05,0.00014269989588680342,0.0,0.00083360076,False,ATXN1L; ataxin 1
hsa:84678,0.0,0.0,8.987613870079207e-06,4.990438744954919e-05,0.0,0.00039496366,False,KDM2B; lysine demethylase
hsa:50649,0.0,0.0,8.008768713138613e-07,2.7058628547119358e-06,0.0,1.6683573e-05,False,ARHGEF4; Rho guanine nucleotide exchange factor
hsa:9612,8.0992455e-07,0.0010034780396066035,0.00013195471080391084,0.00034404476820690147,0.0,0.0021163463,False,NCOR2; nuclear receptor corepressor
hsa:7064,0.00029167514,0.36137884410243104,0.0006195699037450494,0.0007341716613511954,0.0,0.002977097,False,THOP1; thimet oligopeptidase
hsa:3685,0.0,0.0,0.00011725306144554456,0.00033105549368897313,0.0,0.0023559274,False,ITGAV; integrin subunit alpha
hsa:6315,0.0,0.0,1.5968407060039603e-08,8.976450155546494e-08,0.0,1.0860596e-06,False,ATXN8OS; ATXN8 opposite strand
hsa:1827,0.0,0.0,4.180110376732674e-06,2.0052495211256025e-05,0.0,0.000204448,False,RCAN1; regulator of calcineurin
hsa:8724,2.20422015e-08,2.730978478159939e-05,1.2499587491633665e-06,3.609076676864318e-06,0.0,2.2366921e-05,False,SNX3; sorting nexin
hsa:10253,1.07846355e-07,0.00013361917340833516,7.327490475905936e-07,1.768216897968758e-06,0.0,1.1268724e-05,False,SPRY2; sprouty RTK signaling antagonist
hsa:6121,0.0,0.0,7.721404060896537e-06,3.517728685287701e-05,0.0,0.00034350695,False,RPE65; retinoid isomerohydrolase
hsa:83660,2.3161235e-08,2.869624175815865e-05,2.7839653510222766e-05,0.00010840888674732446,0.0,0.000807222,False,TLN2; talin
hsa:2583,0.0,0.0,7.886150916151977e-05,0.0002354196264993692,0.0,0.0017162206,False,B4GALNT1; beta-1
hsa:5598,4.77788685e-05,0.05919692803113784,0.00031478601234915843,0.0007695697399429649,0.0,0.0059600333,False,MAPK7; mitogen-activated protein kinase
hsa:81671,0.0,0.0,6.59455562e-08,2.589967842084904e-07,0.0,2.6261043e-06,False,VMP1; vacuole membrane protein
hsa:5745,0.0,0.0,2.2558817735821775e-05,7.465335614946745e-05,0.0,0.00066843396,False,PTH1R; parathyroid hormone 1
hsa:23607,5.38963135e-08,6.677630282105033e-05,2.4574478653871282e-06,7.117638704543446e-06,0.0,5.7171925e-05,False,CD2AP; CD2 associated
hsa:64343,4.2207317e-09,5.229390283355958e-06,2.672068165708248e-05,8.144322830644783e-05,0.0,0.0007683436,False,AZI2; 5-azacytidine induced
hsa:3996,7.169327e-07,0.0008882632589984698,2.325272903765349e-05,6.781258075852358e-05,0.0,0.0004523493,False,LLGL1; LLGL scribble cell polarity complex component
hsa:407043,0.0,0.0,4.4840607425742575e-09,6.37304774037138e-08,0.0,9.0578027e-07,False,MIR7-1; microRNA
hsa:6692,0.0,0.0,6.14495080240594e-06,6.869674280735777e-05,0.0,0.00095219153,False,SPINT1; serine peptidase inhibitor
hsa:3886,0.0,0.0,5.3934471396039605e-08,3.078334137729625e-07,0.0,2.943166e-06,False,KRT35; keratin
hsa:22925,3.59594635e-08,4.4552954887322794e-05,4.951561848841586e-07,1.4554602541227477e-06,0.0,1.0652452e-05,False,PLA2R1; phospholipase A2 receptor
hsa:7532,0.0,0.0,7.881229616138613e-06,1.4702662411698186e-05,0.0,6.196407e-05,False,YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:7738,0.0,0.0,2.3888920905841582e-08,6.680145066913959e-08,0.0,4.9563386e-07,False,ZNF184; zinc finger protein
hsa:27092,0.00056585638,0.7010831452155504,0.0010923200368866339,0.0014033869215699234,0.0,0.008346786,True,CACNG4; calcium voltage-gated channel auxiliary subunit gamma
hsa:162,6.062248749999999e-07,0.0007510987895425051,2.179996454811882e-06,4.209120679773061e-06,0.0,1.9573568e-05,False,AP1B1; adaptor related protein complex 1 subunit beta
hsa:9235,0.0,0.0,3.5838969736831666e-05,0.0001238109505091479,0.0,0.0011736423,False,IL32; interleukin
hsa:79913,0.0,0.0,3.832466675396042e-07,1.1409710031317385e-06,0.0,6.989835e-06,False,ACTR5; actin related protein
hsa:154197,2.7025366499999998e-08,3.3483812529290505e-05,1.5870558137456428e-06,7.048561035057112e-06,0.0,7.521612e-05,False,PNLDC1; PARN like ribonuclease domain containing exonuclease
hsa:29760,0.0,0.0,4.3359393682178216e-05,0.00021315884593459526,0.0,0.002197464,False,BLNK; B cell
hsa:50674,0.0,0.0,4.7844905955297026e-05,0.0004166552602400261,0.0,0.005801951,False,NEUROG3; neurogenin
hsa:63976,0.0,0.0,6.199140213514847e-06,3.3259224296488387e-05,0.0,0.0003405444,False,PRDM16; PR/SET domain
hsa:51056,1.5893687e-07,0.0001969191559001509,9.236084475553963e-05,0.00025352034929719796,0.0,0.0030547779,False,LAP3; leucine aminopeptidase
hsa:5778,0.0,0.0,7.395533750000001e-08,2.652229759979225e-07,0.0,2.4983206e-06,False,PTPN7; protein tyrosine phosphatase non-receptor type
hsa:23678,9.3447945e-08,0.00011577987190765573,9.115516827772277e-07,1.8036383778487412e-06,0.0,1.5143628e-05,False,SGK3; serum/glucocorticoid regulated kinase family member
hsa:80736,0.0,0.0,1.7293084906431187e-06,8.051685514289854e-06,0.0,8.058401e-05,False,SLC44A4; solute carrier family 44 member
hsa:390064,0.0,0.0,3.8380287002475244e-07,3.884805874392533e-06,-0.0,5.080362e-05,False,OR51I2; olfactory receptor family 51 subfamily I member
hsa:2239,0.0,0.0,6.054523584579206e-07,3.2171972113448716e-06,0.0,2.9797195e-05,False,GPC4; glypican
hsa:10229,0.0,0.0,0.00010971439363133663,0.00026189400762891853,0.0,0.0012461671,False,COQ7; coenzyme Q7
hsa:6579,9.707255e-06,0.01202706748099116,0.00021649707135269256,0.0005251127580128721,0.0,0.0045083235,False,SLCO1A2; solute carrier organic anion transporter family member
hsa:1395,3.7085628999999996e-07,0.00045948248249170614,5.487886829407426e-06,1.3918179053848206e-05,0.0,0.00013436389,False,CRHR2; corticotropin releasing hormone receptor
hsa:55670,2.5826448999999997e-07,0.0003199838109922699,8.754307135565348e-05,0.000331979301447744,0.0,0.0020931272,False,PEX26; peroxisomal biogenesis factor
hsa:4909,0.0,0.0,1.3381305668787127e-07,1.1164856762208886e-06,0.0,1.5386982e-05,False,NTF4; neurotrophin
hsa:675,3.0757162e-05,0.03810742201557259,0.00012173373544084159,0.00020801838862446968,0.0,0.0010938419,False,BRCA2; BRCA2 DNA repair
hsa:26851,1.4002781e-10,1.7349126195669208e-07,9.286721537064357e-07,3.5210477154758227e-06,0.0,3.1244475e-05,False,SNORD3B-1; small nucleolar RNA
hsa:51804,0.0,0.0,4.674248446412029e-07,4.143185966556343e-06,0.0,4.85645e-05,False,SIX4; SIX homeobox
hsa:79230,0.0,0.0,7.093402033391088e-08,1.8733240329699792e-07,0.0,1.1197712e-06,False,ZNF557; zinc finger protein
hsa:27183,0.0,0.0,9.342920235344055e-05,0.00029752607498150706,0.0,0.0022587928,False,VPS4A; vacuolar protein sorting 4 homolog
hsa:4734,0.0,0.0,2.1862212497673274e-06,1.2335037978667193e-05,0.0,0.00013479961,False,NEDD4; NEDD4 E3 ubiquitin protein
hsa:55576,0.0,0.0,1.0441910710342458e-05,6.96516060636689e-05,0.0,0.00085909414,False,STAB2; stabilin
hsa:79310,0.0,0.0,2.291106782178218e-09,3.256274555444129e-08,-0.0,4.6280357e-07,False,OR5H2; olfactory receptor family 5 subfamily H member
hsa:92856,1.59494195e-08,1.9760966886018374e-05,1.3267902753665992e-06,2.6911918671818343e-06,0.0,1.3358275e-05,False,IMP4; IMP U3 small nucleolar ribonucleoprotein
hsa:5140,0.000122092732,0.15127010949053762,0.00040285888542128726,0.0006660392997427427,0.0,0.00424216,False,PDE3B; phosphodiesterase
hsa:9583,1.6305998e-06,0.0020202759512437545,0.00023162541171264835,0.0005414250285178431,0.0,0.0032563459,False,ENTPD4; ectonucleoside triphosphate diphosphohydrolase
hsa:406925,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR135A1; microRNA
hsa:9421,1.93734895e-07,0.00024003311498335388,4.307005220624353e-05,0.00011910099588092668,0.0,0.0006353703,False,HAND1; heart and neural crest derivatives expressed
hsa:4055,0.0,0.0,0.0001927852656985149,0.000529649963194167,0.0,0.0034976662,False,LTBR; lymphotoxin beta
hsa:4496,0.0,0.0,1.762724977401946e-05,7.284946513887758e-05,0.0,0.00077022344,False,MT1H; metallothionein
hsa:2165,0.0,0.0,1.3535753933242574e-07,5.242462851906831e-07,0.0,5.1165052e-06,False,F13B; coagulation factor XIII B
hsa:387332,0.0,0.0,8.630334130594053e-08,6.769914403961141e-07,0.0,8.81758e-06,False,TBPL2; TATA-box binding protein like
hsa:92610,0.0,0.0,3.8748004934158413e-07,2.9869018465471908e-06,0.0,3.656016e-05,False,TIFA; TRAF interacting protein with forkhead associated
hsa:3702,1.96205685e-07,0.0002430943674240653,7.935937850787125e-06,2.5782731201245336e-05,0.0,0.0002490566,False,ITK; IL2 inducible T cell
hsa:9900,5.4994115e-06,0.006813645383400232,0.0001564543461999999,0.0003417741601958322,0.0,0.002188309,False,SV2A; synaptic vesicle glycoprotein
hsa:8718,0.0,0.0,4.945210985519801e-05,0.00013312410056653677,0.0,0.0007213953,False,TNFRSF25; TNF receptor superfamily member
hsa:6586,3.1095844e-08,3.852704128678747e-05,5.553319231015346e-06,5.004649968414727e-05,0.0,0.0006818727,False,SLIT3; slit guidance ligand
hsa:219968,0.0,0.0,1.8556107581683172e-06,8.47262644885771e-06,-0.0,7.0823866e-05,False,OR5B21; olfactory receptor family 5 subfamily B member
hsa:9061,1.2282035499999999e-05,0.015217161778734462,0.0008749144022529705,0.0017752254659460765,0.0,0.01255106,False,PAPSS1; 3'-phosphoadenosine 5'-phosphosulfate synthase
hsa:1548,0.0,0.0,7.753592526658416e-05,0.00026485133897098065,0.0,0.002272167,False,CYP2A6; cytochrome P450 family 2 subfamily A member
hsa:255403,0.0,0.0,6.435967694628715e-08,1.839559951054123e-07,0.0,1.0125973e-06,False,ZNF718; zinc finger protein
hsa:7549,0.0,0.0,1.7305698049009898e-08,4.8120104228321394e-08,0.0,4.5079884e-07,False,ZNF2; zinc finger protein
hsa:5283,0.0,0.0,1.4593037286138616e-05,2.9488625188006345e-05,0.0,0.0001580452,False,PIGH; phosphatidylinositol glycan anchor biosynthesis class
hsa:2177,4.93752805e-08,6.117484607815156e-05,3.893279911104454e-05,0.00010235134683340918,0.0,0.0006074258,False,FANCD2; FA complementation group
hsa:6010,9.10397545e-07,0.0011279617881928194,4.1221380144855946e-05,0.00013476421089989615,0.0,0.0011201885,False,RHO;
hsa:79659,0.0,0.0,5.3198133970115866e-05,0.00013794976098364448,0.0,0.0008532424,False,DYNC2H1; dynein cytoplasmic 2 heavy chain
hsa:84376,4.29208165e-08,5.317791243608403e-05,1.945127792841585e-07,6.315831267509561e-07,0.0,5.286611e-06,False,HOOK3; hook microtubule tethering protein
hsa:4129,0.0,0.0,7.784820214504951e-05,0.00021361145774347035,0.0,0.0012624516,False,MAOB; monoamine oxidase
hsa:4296,1.8638423999999998e-07,0.0002309258211382365,1.1483067235896042e-06,2.043275332439467e-06,0.0,1.3011618e-05,False,MAP3K11; mitogen-activated protein kinase kinase kinase
hsa:79695,0.0,0.0,3.430605292657625e-05,0.0001844190269885794,0.0,0.0018913252,False,GALNT12; polypeptide N-acetylgalactosaminyltransferase
hsa:10172,0.0,0.0,6.683131457821782e-08,1.3617549821766287e-07,0.0,5.586434e-07,False,ZNF256; zinc finger protein
hsa:5145,1.9320303499999998e-05,0.023937415257735548,9.293381242948022e-05,0.00016737645055212093,0.0,0.0011663191,False,PDE6A; phosphodiesterase
hsa:89910,3.45883575e-09,4.285418583411549e-06,3.761284981663366e-07,9.83022598350382e-07,0.0,6.351942e-06,False,UBE3B; ubiquitin protein ligase
hsa:3054,1.02459503e-07,0.00012694498667747126,1.5759381475846533e-05,7.637926489708628e-05,0.0,0.0005339504,False,HCFC1; host cell factor
hsa:2817,0.0,0.0,1.2114899463663362e-06,2.0966016875564835e-06,0.0,1.1680127e-05,False,GPC1; glypican
hsa:11025,0.0,0.0,6.788933102950496e-06,1.8627091357817066e-05,0.0,0.00016992136,False,LILRB3; leukocyte immunoglobulin like receptor
hsa:9643,1.9169169e-08,2.3750163060259964e-05,3.4945425102246043e-06,1.795589340727165e-05,0.0,0.0001448764,False,MORF4L2; mortality factor 4 like
hsa:387778,0.0,0.0,8.977785417841092e-08,5.523538498909342e-07,0.0,6.983168e-06,False,SPDYC; speedy/RINGO cell cycle regulator family member
hsa:407048,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR92A1; microRNA
hsa:54675,2.07766275e-07,0.0002574176746875576,7.709792283712876e-06,2.0644818483997382e-05,0.0,0.00013145094,False,CRLS1; cardiolipin synthase
hsa:5189,2.857483e-07,0.0003540356245590032,0.00020707476698366326,0.0008071974673465089,0.0,0.0053311484,False,PEX1; peroxisomal biogenesis factor
hsa:3635,0.0,0.0,1.9161054931633666e-05,4.215480716634579e-05,0.0,0.00024907556,False,INPP5D; inositol polyphosphate-5-phosphatase
hsa:148254,0.0,0.0,5.954259415278466e-08,1.6736370431051738e-07,0.0,8.678584e-07,False,ZNF555; zinc finger protein
hsa:7366,0.0,0.0,3.4840963061881184e-05,0.00023953249290593345,0.0,0.002224197,False,UGT2B15; UDP glucuronosyltransferase family 2 member
hsa:23513,3.7508478e-06,0.004647214851317622,4.537887179223595e-05,0.00012372855599357107,0.0,0.00089280197,False,SCRIB; scribble planar cell polarity
hsa:79901,0.0,0.0,4.1590717071725735e-05,0.0001417372024467598,0.0,0.0009775681,False,CYBRD1; cytochrome b reductase
hsa:6564,0.0,0.0,3.7869760437673267e-06,3.2158034424851824e-05,-0.0,0.0004314717,False,SLC15A1; solute carrier family 15 member
hsa:26658,0.0,0.0,1.441422265841584e-07,1.8721961480161915e-06,-0.0,2.6575759e-05,False,OR7C2; olfactory receptor family 7 subfamily C member
hsa:64077,7.3516265e-08,9.108497511453328e-05,7.932778884782176e-07,1.8021545074789845e-06,0.0,1.32175355e-05,False,LHPP; phospholysine phosphohistidine inorganic pyrophosphate
hsa:5001,1.9943611e-08,2.4709679029925312e-05,7.715379835821782e-07,1.7451597799449713e-06,0.0,9.495929e-06,False,ORC5; origin recognition complex subunit
hsa:55713,3.05759065e-08,3.7882850586285855e-05,1.2887010492475248e-07,1.8981421395863188e-07,0.0,8.9832093e-07,False,ZNF334; zinc finger protein
hsa:10718,1.9411039e-08,2.4049834472170677e-05,3.5890271770064346e-06,9.117770505846749e-06,0.0,8.422502e-05,False,NRG3; neuregulin
hsa:6866,2.67198665e-08,3.310530499905226e-05,2.8438472009013026e-05,8.173268574137687e-05,0.0,0.00060408417,False,TAC3; tachykinin precursor
hsa:5104,5.566984649999999e-07,0.000689736697461764,1.221893447692674e-05,3.728654781694427e-05,0.0,0.0003846729,False,SERPINA5; serpin family A member
hsa:56474,9.3889785e-09,1.1632730158739538e-05,7.881435985428711e-05,0.0001943028103130078,0.0,0.0011903311,False,CTPS2; CTP synthase
hsa:51082,6.296007e-06,0.007800609034149481,0.00014705730411762385,0.00043339087662315885,0.0,0.0030217613,False,POLR1D; RNA polymerase I and III subunit
hsa:100528032,1.2004238499999998e-07,0.00014872977633472294,6.35299401740099e-06,2.5113087933956637e-05,0.0,0.00030123955,False,KLRC4-KLRK1; KLRC4-KLRK1
hsa:5777,0.0,0.0,0.00017457956182099005,0.0003912227541581574,0.0,0.002402472,False,PTPN6; protein tyrosine phosphatase non-receptor type
hsa:9540,6.8329063e-09,8.465815017879889e-06,3.688046690124654e-05,0.00020199918120867867,0.0,0.002040555,False,TP53I3; tumor protein p53 inducible protein
hsa:22920,9.42825275e-09,1.1681390058475903e-05,3.413762543424752e-07,8.728948898677377e-07,0.0,6.668315e-06,False,KIFAP3; kinesin associated protein
hsa:162655,1.47882e-08,1.8322242417902228e-05,7.822781160297027e-08,1.4641804666796236e-07,0.0,7.877205e-07,False,ZNF519; zinc finger protein
hsa:1759,2.7192609e-05,0.03369102217127371,0.0002220110306742575,0.0004500058095477095,0.0,0.0041508125,False,DNM1; dynamin
hsa:10678,1.2498445e-05,0.01548528821200809,0.0001404969935074257,0.00032543790719136964,0.0,0.0024191516,False,B3GNT2; UDP-GlcNAc:betaGal beta-1
hsa:83852,0.0,0.0,2.723689256552474e-05,0.00010442219911131722,0.0,0.0007204574,False,SETDB2; SET domain bifurcated histone lysine methyltransferase
hsa:1912,0.0,0.0,0.00010668123592080895,0.00036658170638293277,0.0,0.0023794696,False,PHC2; polyhomeotic homolog
hsa:23339,8.480123999999999e-08,0.0001050668016809826,4.3535390891455444e-05,0.00018070902233085118,0.0,0.002197616,False,VPS39; VPS39 subunit of HOPS
hsa:9541,4.0615774e-07,0.0005032201736646315,0.0001243525106345049,0.0003288071065984355,0.0,0.0026732844,False,CIR1; corepressor interacting with RBPJ
hsa:60495,0.0,0.0,1.2216375877346534e-06,4.229960611871291e-06,0.0,3.9380255e-05,False,HPSE2; heparanase 2
hsa:6310,6.165144250000001e-07,0.0007638473072438569,0.00015975073579472775,0.00038101969699038925,0.0,0.0023550808,False,ATXN1; ataxin
hsa:147741,2.53958815e-10,3.14649177898134e-07,2.4381304864712883e-08,6.277703734889594e-08,0.0,3.9297348e-07,False,ZNF560; zinc finger protein
hsa:6307,0.0,0.0,2.0884960285742565e-05,5.281406514704897e-05,0.0,0.0003131407,False,MSMO1; methylsterol monooxygenase
hsa:3242,0.0,0.0,2.5622446898118815e-05,0.00010593668156469457,0.0,0.0007992712,False,HPD; 4-hydroxyphenylpyruvate
hsa:1735,0.0,0.0,5.621295602653467e-07,2.377219296653146e-06,0.0,2.7832011e-05,False,DIO3; iodothyronine deiodinase
hsa:55308,0.0,0.0,6.165303038722774e-07,1.0610637644611713e-06,0.0,4.6380674e-06,False,DDX19A; DEAD-box helicase
hsa:27302,0.0,0.0,6.233626998422278e-07,3.4061484739664534e-06,0.0,3.970346e-05,False,BMP10; bone morphogenetic protein
hsa:285704,0.0,0.0,5.684125461284161e-05,0.00025816202048087805,0.0,0.0026698487,False,RGMB; repulsive guidance molecule BMP co-receptor
hsa:643834,2.70709645e-08,3.3540307411005086e-05,1.0117988323282178e-05,3.641623537168009e-05,0.0,0.00041358665,False,PGA3; pepsinogen
hsa:7170,0.0,0.0,0.0004498923083881191,0.0009042152397615394,0.0,0.006516565,False,TPM3; tropomyosin
hsa:26529,0.0,0.0,2.028350139108911e-07,1.4290806395224065e-06,-0.0,1.433466e-05,False,OR12D2; olfactory receptor family 12 subfamily D member
hsa:3607,4.0361987499999995e-08,5.000758168291877e-05,0.00012096853753618284,0.0004742817632274623,0.0,0.0029077136,False,FOXK2; forkhead box
hsa:26060,0.0,0.0,2.001612843316831e-06,4.797461261053189e-06,0.0,3.6443984e-05,False,APPL1; adaptor protein
hsa:10224,4.514972800000001e-09,5.593948293357867e-06,3.924857235881189e-08,7.341344360571103e-08,0.0,4.750114e-07,False,ZNF443; zinc finger protein
hsa:64850,0.0,0.0,7.79744640907426e-08,4.815915990384523e-07,0.0,5.3684457e-06,False,ETNPPL; ethanolamine-phosphate
hsa:26534,0.0,0.0,3.979978124752475e-06,2.0975310272392876e-05,-0.0,0.00024023901,False,OR10G2; olfactory receptor family 10 subfamily G member
hsa:57678,2.03968055e-06,0.002527117667612025,0.00013443493426990106,0.00041832769339129785,0.0,0.003025049,False,GPAM; glycerol-3-phosphate acyltransferase
hsa:85479,0.0,0.0,3.3092178199613856e-08,1.0619100084838035e-07,0.0,9.1199087e-07,False,DNAJC5B; DnaJ heat shock protein family (Hsp40) member C5
hsa:406995,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR181A1; microRNA
hsa:26338,0.0,0.0,2.310315297029703e-09,2.3202483241135288e-08,0.0,2.4731958e-07,False,OR5L2; olfactory receptor family 5 subfamily L member
hsa:7556,1.7573025e-09,2.1772577059132033e-06,1.2551490735297036e-07,2.6657012213678635e-07,0.0,1.479069e-06,False,ZNF10; zinc finger protein
hsa:392309,6.98225525e-07,0.0008650854959641506,6.429523104004802e-05,0.00018529659460277204,0.0,0.0016112197,False,OR13J1; olfactory receptor family 13 subfamily J member
hsa:894,0.0,0.0,0.00011630200132673263,0.00032781516564187415,0.0,0.001791123,False,CCND2; cyclin
hsa:162962,0.0,0.0,3.40158377314208e-08,7.043297143393017e-08,0.0,5.3176643e-07,False,ZNF836; zinc finger protein
hsa:7531,0.0,0.0,2.7082512510098992e-05,4.1612920746103616e-05,0.0,0.00028382108,False,YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:10780,0.0,0.0,7.424627553663368e-08,1.6656843914778543e-07,0.0,1.1196711e-06,False,ZNF234; zinc finger protein
hsa:4850,8.5069715e-08,0.00010539943608091947,2.6649513207435653e-05,0.00011650451827025025,0.0,0.0012126717,False,CNOT4; CCR4-NOT transcription complex subunit
hsa:51028,4.57438395e-09,5.667557352785406e-06,7.627624635792076e-07,1.987448982209384e-06,0.0,1.7929977e-05,False,VPS36; vacuolar protein sorting 36
hsa:10808,3.6264352999999996e-08,4.493070602198914e-05,1.0208170540089106e-06,2.457969823758654e-06,0.0,1.3668255e-05,False,HSPH1; heat shock protein family H (Hsp110) member
hsa:3765,4.995866e-05,0.06189763996926977,0.00017120917559168317,0.00035863382365710245,0.0,0.0022771794,False,KCNJ9; potassium inwardly rectifying channel subfamily J member
hsa:390174,0.0,0.0,2.846379702970297e-09,4.0454656561676676e-08,-0.0,5.749687e-07,False,OR9G1; olfactory receptor family 9 subfamily G member
hsa:9688,3.5432174999999997e-09,4.389965646552893e-06,2.5325359540891075e-07,6.99870853604292e-07,0.0,3.8987073e-06,False,NUP93; nucleoporin
hsa:5985,2.59947175e-06,0.0032206861931802742,0.0001774531757188118,0.0004072584132907618,0.0,0.0021805563,False,RFC5; replication factor C subunit
hsa:339896,0.0,0.0,1.4242603640594055e-06,6.636555020141054e-06,0.0,8.1905455e-05,False,GADL1; glutamate decarboxylase like
hsa:388536,2.3734417e-09,2.940640117942547e-06,6.6992384244802e-08,1.7438440734687408e-07,0.0,1.0031755e-06,False,ZNF790; zinc finger protein
hsa:80222,0.0,0.0,2.3050023429554457e-06,6.782285458950918e-06,0.0,4.118527e-05,False,TARS2; threonyl-tRNA synthetase 2
hsa:9166,3.3713954e-07,0.0004177081984649954,3.5591858830253955e-05,8.885451247779745e-05,0.0,0.00046733816,False,EBAG9; estrogen receptor binding site associated antigen
hsa:5795,2.3408981e-07,0.00029003193400012665,1.5531593002638605e-06,5.333278131991994e-06,0.0,4.309259e-05,False,PTPRJ; protein tyrosine phosphatase receptor type
hsa:4050,2.44601825e-06,0.0030305608076109988,3.0474694914133652e-05,6.505463156537453e-05,0.0,0.0003700035,False,LTB; lymphotoxin
hsa:407029,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30A; microRNA
hsa:10908,5.68294885e-08,7.041043972778207e-05,2.940623725381189e-06,1.141621810334751e-05,0.0,0.00012894598,False,PNPLA6; patatin like phospholipase domain containing
hsa:5150,6.59339275e-07,0.0008169063193758471,8.371423684371287e-06,2.2117648381558132e-05,0.0,0.0001658839,False,PDE7A; phosphodiesterase
hsa:5834,0.0,0.0,0.0001992868424975247,0.0004120975705227837,0.0,0.0016984727,False,PYGB; glycogen phosphorylase
hsa:130574,1.02117997e-08,1.265218685346839e-05,8.430482060835596e-06,2.2640551659565244e-05,0.0,0.00016780318,False,LYPD6; LY6/PLAUR domain containing
hsa:5149,0.0,0.0,5.862083179933662e-09,2.465982750225614e-08,0.0,2.3875788e-07,False,PDE6H; phosphodiesterase
hsa:3632,0.0,0.0,4.801236856678218e-05,0.00016725665370521383,0.0,0.0011687314,False,INPP5A; inositol polyphosphate-5-phosphatase
hsa:165829,0.0,0.0,7.541761149237623e-07,3.5036158180013173e-06,0.0,3.894003e-05,False,GPR156; G protein-coupled receptor
hsa:30833,4.36590155e-06,0.005409252415560723,0.00029214616371386133,0.0005708494927342475,0.0,0.0030784325,False,NT5C; 5'
hsa:406901,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR107; microRNA
hsa:8388,0.0,0.0,7.721650436435644e-07,3.182674938523165e-06,0.0,2.3394758e-05,False,OR1E2; olfactory receptor family 1 subfamily E member
hsa:64283,3.64747245e-09,4.519135151101538e-06,3.871474996770299e-06,1.338072981922042e-05,0.0,0.00014257991,False,ARHGEF28; Rho guanine nucleotide exchange factor
hsa:79816,4.0054853999999996e-06,0.004962705028344765,0.00015345716601334653,0.0003430789761758947,0.0,0.002935136,False,TLE6; TLE family member 6
hsa:79147,1.36489415e-06,0.0016910727127761734,4.1641857763564356e-05,7.485290102836818e-05,0.0,0.0005038324,False,FKRP; fukutin related
hsa:537,0.0,0.0,3.33490636410891e-05,0.0001208414038300047,0.0,0.0010992686,False,ATP6AP1; ATPase H+ transporting accessory protein
hsa:29940,0.0,0.0,9.655080968741584e-05,0.0004232538657033998,0.0,0.0038023146,False,DSE; dermatan sulfate
hsa:9491,0.0,0.0,5.976561738514853e-06,1.868747209422331e-05,0.0,0.00013738479,False,PSMF1; proteasome inhibitor subunit
hsa:5432,0.0,0.0,2.636136702492079e-05,8.783595374005437e-05,0.0,0.00069298455,False,POLR2C; RNA polymerase II subunit
hsa:140032,0.0,0.0,8.001578853960396e-10,5.044956334291725e-09,0.0,5.7237884e-08,False,RPS4Y2; ribosomal protein S4 Y-linked
hsa:3559,1.5857442500000001e-06,0.0019647009481407176,6.547024960445543e-05,0.00013208479643873135,0.0,0.0011138018,False,IL2RA; interleukin 2 receptor subunit
hsa:5827,4.83838705e-07,0.0005994651170645436,0.00018011361056633992,0.0006907909267372778,0.0,0.0045752292,False,PXMP2; peroxisomal membrane protein
hsa:4798,2.3396972e-08,2.8988314522989323e-05,7.108728819806929e-07,3.6199461379269313e-06,0.0,3.0043018e-05,False,NFRKB; nuclear factor related to kappaB binding
hsa:5909,0.0,0.0,9.27646708588614e-07,2.755033766567111e-06,0.0,1.7741822e-05,False,RAP1GAP; RAP1 GTPase activating
hsa:64147,0.0,0.0,1.2085406983945549e-07,5.327734998097243e-07,0.0,5.769614e-06,False,KIF9; kinesin family member
hsa:51382,0.0,0.0,0.00014943772308465342,0.00035794649671344435,0.0,0.0019291741,False,ATP6V1D; ATPase H+ transporting V1 subunit
hsa:27124,1.551724e-07,0.000192255063453814,1.835808294451485e-05,5.984114612784263e-05,0.0,0.000442526,False,INPP5J; inositol polyphosphate-5-phosphatase
hsa:6926,1.3480809999999999e-08,1.670241603506042e-05,8.303942044004949e-06,4.920413734243986e-05,0.0,0.0005956269,False,TBX3; T-box transcription factor
hsa:54884,6.08457795e-06,0.007538653264800488,0.00010047774842722778,0.00023404725639840007,0.0,0.0020353366,False,RETSAT; retinol
hsa:143686,5.36830385e-07,0.0006651205996176535,3.362640924168319e-05,7.325999068891316e-05,0.0,0.0005459662,False,SESN3; sestrin
hsa:5275,0.0,0.0,2.0149039443217818e-08,1.3447547267607571e-07,0.0,1.6073031e-06,False,SERPINB13; serpin family B member
hsa:9253,9.2249752e-07,0.0011429533811656326,0.00016287591373648517,0.0004521635029171171,0.0,0.0027023917,False,NUMBL; NUMB like endocytic adaptor
hsa:28996,0.0,0.0,3.382856303698021e-06,1.296180385224433e-05,0.0,9.5513824e-05,False,HIPK2; homeodomain interacting protein kinase
hsa:399687,0.0,0.0,2.2777514343398028e-06,7.450426563476095e-06,0.0,4.3755037e-05,False,MYO18A; myosin
hsa:9468,2.1896111e-05,0.02712878198504859,0.00031176863123237613,0.000820598475570426,0.0,0.00584058,False,PCYT1B; phosphate cytidylyltransferase 1B
hsa:10803,0.0,0.0,1.6676496645396044e-05,5.3473493714657964e-05,0.0,0.00044277776,False,CCR9; C-C motif chemokine receptor
hsa:225689,0.0,0.0,3.5920686288118794e-06,2.2203583877027382e-05,0.0,0.00022984229,False,MAPK15; mitogen-activated protein kinase
hsa:10768,5.1161675e-06,0.006338814810835179,0.0001546450048012376,0.0004638464074505128,0.0,0.0031421662,False,AHCYL1; adenosylhomocysteinase like
hsa:4878,2.8027794499999998e-05,0.03472579795161999,0.00016782787333217823,0.00041445032109459684,0.0,0.003127969,False,NPPA; natriuretic peptide
hsa:1353,2.6633195e-07,0.00032997920987899916,1.2311993320940593e-06,1.7377471538252307e-06,0.0,1.02282875e-05,False,COX11; cytochrome c oxidase copper chaperone
hsa:131669,0.0,0.0,1.463880358156089e-05,5.054417026705534e-05,-0.0,0.0006215056,False,UROC1; urocanate hydratase
hsa:100533467,0.0,0.0,1.0449352325866335e-06,4.099043623605784e-06,0.0,3.2090622e-05,False,BIVM-ERCC5; BIVM-ERCC5
hsa:6631,0.0,0.0,2.1497192877792073e-07,6.088053132816104e-07,0.0,4.8728198e-06,False,SNRPC; small nuclear ribonucleoprotein polypeptide
hsa:4353,0.0,0.0,5.463399519458414e-06,2.0017294580067745e-05,0.0,0.00018706638,False,MPO;
hsa:5286,6.4428848e-07,0.0007982587277438601,4.750459404600992e-05,0.00012926837168966823,0.0,0.0007783887,False,PIK3C2A; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2
hsa:2868,1.4509391999999998e-06,0.0017976805666705291,4.070280428303961e-05,0.00017665782472610483,0.0,0.0020030073,False,GRK4; G protein-coupled receptor kinase
hsa:22909,8.50678635e-08,0.00010539714211466011,8.741955576711383e-05,0.00029601770924382164,0.0,0.0019366122,False,FAN1; FANCD2 and FANCI associated nuclease
hsa:51806,0.0,0.0,5.378593740099011e-06,4.201161251291474e-05,0.0,0.0005510111,False,CALML5; calmodulin like
hsa:3752,6.2740628e-10,7.773420670990548e-07,1.826482486969307e-08,5.863415883466167e-08,0.0,5.6638754e-07,False,KCND3; potassium voltage-gated channel subfamily D member
hsa:4880,0.0,0.0,4.315357067945544e-06,3.3801271859007904e-05,0.0,0.0004359399,False,NPPC; natriuretic peptide
hsa:22854,0.0,0.0,3.852952489658416e-06,8.359220348902113e-06,0.0,5.8884456e-05,False,NTNG1; netrin
hsa:9963,3.964629049999999e-06,0.00491208494280287,8.708171331337874e-05,0.00019486648616454894,0.0,0.0012734146,False,SLC23A1; solute carrier family 23 member
hsa:81392,0.0,0.0,2.006198490891089e-06,8.867125894604856e-06,0.0,8.7893815e-05,False,OR2AE1; olfactory receptor family 2 subfamily AE member
hsa:132,0.0,0.0,3.685340066638119e-06,1.2301130419092455e-05,0.0,0.00012821051,False,ADK; adenosine
hsa:6499,0.0,0.0,2.41405287649505e-06,1.8046263370746818e-05,0.0,0.00018656008,False,SKIC2; SKI2 subunit of superkiller
hsa:3352,0.0,0.0,2.037718479267326e-05,7.205119685172469e-05,0.0,0.00051292963,False,HTR1D; 5-hydroxytryptamine receptor
hsa:6425,1.2313093500000001e-08,1.5255641932168634e-05,4.168370730833512e-06,5.177684771120533e-05,0.0,0.00073428574,False,SFRP5; secreted frizzled related protein
hsa:2882,6.8131065e-05,0.08441283517398018,0.00016829520281480198,0.0002558169830011441,0.0,0.0014315333,False,GPX7; glutathione peroxidase
hsa:388559,0.0,0.0,2.288507225792079e-09,6.660538392825244e-09,0.0,4.8629914e-08,False,ZNF888; zinc finger protein
hsa:2615,0.0,0.0,2.6742100720849364e-05,0.0001373863856211271,0.0,0.0012302133,False,LRRC32; leucine rich repeat containing
hsa:4659,0.0,0.0,4.58988741580198e-05,0.0001494439376339667,0.0,0.0015741502,False,PPP1R12A; protein phosphatase 1 regulatory subunit
hsa:10268,0.0,0.0,5.349123063128712e-06,3.145353580995998e-05,0.0,0.00043569427,False,RAMP3; receptor activity modifying protein
hsa:9618,1.47559405e-06,0.0018282273633379409,3.6621445303019794e-05,7.593817126240275e-05,0.0,0.0004263715,False,TRAF4; TNF receptor associated factor
hsa:578,0.000137653985,0.17055014693879425,0.0003731582109113863,0.0006723371111186853,0.0,0.003768596,False,BAK1; BCL2 antagonist/killer
hsa:5352,0.0,0.0,1.4113274869702972e-05,5.42356208612156e-05,0.0,0.00053744286,False,PLOD2; procollagen-lysine
hsa:5715,0.0,0.0,2.588734875382673e-06,7.293119113937286e-06,0.0,4.0773844e-05,False,PSMD9; proteasome 26S subunit
hsa:5717,9.450708e-08,0.00011709211600925598,8.208926435564352e-06,1.8796671965389996e-05,0.0,0.00013012052,False,PSMD11; proteasome 26S subunit
hsa:1241,0.0,0.0,2.3887453183683166e-06,6.759285940468073e-06,0.0,5.655837e-05,False,LTB4R; leukotriene B4
hsa:441933,0.0,0.0,1.2271827386138614e-06,4.72063625220401e-06,0.0,3.592954e-05,False,OR13G1; olfactory receptor family 13 subfamily G member
hsa:93,3.47887065e-05,0.04310241367429782,0.00021974010958896036,0.00042843714955633736,0.0,0.0020548678,False,ACVR2B; activin A receptor type
hsa:406895,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR103A1; microRNA
hsa:79139,0.0,0.0,4.0331986823202963e-07,8.519707525379221e-07,0.0,6.312694e-06,False,DERL1; derlin
hsa:5255,6.732942e-07,0.0008341961530793163,1.8350474541737623e-05,6.059560207391993e-05,0.0,0.0005077335,False,PHKA1; phosphorylase kinase regulatory subunit alpha
hsa:3441,0.0,0.0,2.790967994059406e-06,1.2124286811569314e-05,0.0,9.496521e-05,False,IFNA4; interferon alpha
hsa:6360,0.0,0.0,1.8862025408761385e-05,0.00011038248162986646,0.0,0.0014636125,False,CCL16; C-C motif chemokine ligand
hsa:23729,1.3228297e-06,0.0016389558188962064,1.4368166540381184e-05,3.2633018239739435e-05,0.0,0.0002115981,False,SHPK;
hsa:4329,4.1181522999999995e-05,0.05102296747030849,0.0002900342782576238,0.0006455328390615228,0.0,0.0050953603,False,ALDH6A1; aldehyde dehydrogenase 6 family member
hsa:7042,0.0,0.0,5.99274421391089e-05,0.00014441562171233846,0.0,0.0009692162,False,TGFB2; transforming growth factor beta
hsa:407031,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30C1; microRNA
hsa:2915,0.0,0.0,1.191283552613738e-05,5.2891918130279024e-05,0.0,0.00048135497,False,GRM5; glutamate metabotropic receptor
hsa:8590,0.0,0.0,2.0987021016336638e-07,2.438548897107204e-06,0.0,3.4371988e-05,False,OR6A2; olfactory receptor family 6 subfamily A member
hsa:79339,0.0,0.0,1.4714436888925742e-06,6.6370190561851544e-06,0.0,5.7992263e-05,False,OR51B4; olfactory receptor family 51 subfamily B member
hsa:148213,1.7990433999999999e-09,2.2289737287247296e-06,2.9135598580891094e-08,5.194652072980236e-08,0.0,2.218284e-07,False,ZNF681; zinc finger protein
hsa:23409,6.06844515e-07,0.0007518665093658663,0.00010604845199417353,0.0001657158444555954,0.0,0.0009336784,False,SIRT4; sirtuin
hsa:8916,5.537499e-08,6.86083492696144e-05,3.238279833163366e-07,5.257688516534664e-07,0.0,2.2756071e-06,False,HERC3; HECT and RLD domain containing E3 ubiquitin protein ligase
hsa:92745,2.1385741499999998e-06,0.0026496445818259963,4.2509250974459655e-05,0.00016378449643132946,0.0,0.0015335003,False,SLC38A5; solute carrier family 38 member
hsa:54913,0.0,0.0,3.4316171055940594e-07,9.961208305908896e-07,0.0,1.0176579e-05,False,RPP25; ribonuclease P and MRP subunit
hsa:53904,0.0,0.0,2.180908790983168e-08,1.066307710449888e-07,0.0,9.954844e-07,False,MYO3A; myosin
hsa:6119,7.93246775e-06,0.009828146568729896,0.0004136024549928218,0.0007943582006726275,0.0,0.005062053,False,RPA3; replication protein
hsa:219749,0.0,0.0,6.657129113960396e-08,1.7448998713719771e-07,0.0,1.4619553e-06,False,ZNF25; zinc finger protein
hsa:3354,3.5326805e-07,0.0004376910543946934,0.00012051074255032186,0.00033702918687205654,0.0,0.0026261972,False,HTR1E; 5-hydroxytryptamine receptor
hsa:51174,1.8916753e-08,2.3437425394948623e-05,1.2211115365514853e-06,4.0529248789743916e-06,0.0,2.167932e-05,False,TUBD1; tubulin delta
hsa:5465,0.0,0.0,4.687271580356436e-05,0.00026230490418751456,0.0,0.0031335736,False,PPARA; peroxisome proliferator activated receptor
hsa:7766,0.0,0.0,1.0327995348316832e-07,1.9509199412721568e-07,0.0,8.761956e-07,False,ZNF223; zinc finger protein
hsa:5924,2.86140345e-08,3.545213593697798e-05,2.3713943593613857e-07,4.688057455963096e-07,0.0,2.5111392e-06,False,RASGRF2; Ras protein specific guanine nucleotide releasing factor
hsa:10113,1.9724501000000003e-08,2.4438206738761648e-05,6.821970723655448e-07,1.5650071785625214e-06,0.0,8.289861e-06,False,PREB; prolactin regulatory element
hsa:90390,1.5842857e-06,0.0019628938379664816,1.4911469104980941e-05,3.57578134199971e-05,0.0,0.00031997904,False,MED30; mediator complex subunit
hsa:1161,0.0,0.0,5.939987465262373e-06,1.932899435394357e-05,0.0,0.00012910282,False,ERCC8; ERCC excision repair 8
hsa:5879,0.0,0.0,0.00016913106929009907,0.00039617522225329245,0.0,0.0024515681,False,RAC1; Rac family small GTPase
hsa:29979,5.629186e-09,6.974433028188784e-06,1.0411960841034654e-06,2.498632768263731e-06,0.0,2.1706841e-05,False,UBQLN1; ubiquilin
hsa:9063,0.0,0.0,3.106063192076733e-05,9.558908330591549e-05,0.0,0.0005575664,False,PIAS2; protein inhibitor of activated STAT
hsa:64218,0.0,0.0,9.855884096884643e-06,3.5159049040972936e-05,0.0,0.00021234495,False,SEMA4A; semaphorin
hsa:6570,6.6590035e-05,0.08250353416146616,0.0006783130458280691,0.0012714033520471741,0.0,0.0066342074,False,SLC18A1; solute carrier family 18 member
hsa:79902,6.915648999999999e-08,8.568331335464974e-05,3.049400243712872e-07,5.763324593354458e-07,0.0,3.45679e-06,False,NUP85; nucleoporin
hsa:56475,2.78473095e-08,3.4502181154254855e-05,9.999687439870115e-05,0.00021192730698618592,0.0,0.0012889563,False,RPRM; reprimo
hsa:54498,0.0,0.0,0.00012651994958069306,0.0006997678262097898,0.0,0.009437672,False,SMOX; spermine
hsa:91133,2.106352e-09,2.609722073101067e-06,3.266010977576981e-06,1.3061329576528172e-05,0.0,9.760606e-05,False,L3MBTL4; L3MBTL histone methyl-lysine binding protein
hsa:54891,0.0,0.0,6.056685753795885e-07,3.307629671734496e-06,0.0,3.1312153e-05,False,INO80D; INO80 complex subunit
hsa:4149,0.0,0.0,3.0651864445049507e-05,0.0001249692864980415,0.0,0.0009872766,False,MAX; MYC associated factor
hsa:56413,1.85715555e-07,0.00023009733567880164,1.0991979034588614e-05,2.6934664787097038e-05,0.0,0.0001959215,False,LTB4R2; leukotriene B4 receptor
hsa:387082,2.71612285e-09,3.365214244769714e-06,2.3567121534851484e-08,8.663307627679632e-08,0.0,1.0867387e-06,False,SUMO4; small ubiquitin like modifier
hsa:2244,0.0,0.0,1.1620346770470298e-06,7.6089078508627806e-06,0.0,9.3697454e-05,False,FGB; fibrinogen beta
hsa:51513,0.0,0.0,2.684750835129085e-06,3.2644122228820084e-05,0.0,0.00046004867,False,ETV7; ETS variant transcription factor
hsa:2743,0.0,0.0,1.076785896253366e-05,3.6732508222898275e-05,0.0,0.0003660643,False,GLRB; glycine receptor
hsa:683,0.0,0.0,0.0001212362961961881,0.000324275481111817,0.0,0.0017901701,False,BST1; bone marrow stromal cell antigen
hsa:2712,0.0,0.0,1.0406999165346536e-07,7.334777965744287e-07,0.0,7.171285e-06,False,GK2; glycerol kinase
hsa:51588,0.0,0.0,6.322616993900992e-06,3.92140365739383e-05,0.0,0.0003625852,False,PIAS4; protein inhibitor of activated STAT
hsa:81570,0.0,0.0,1.831509451890148e-05,5.168745208859027e-05,0.0,0.00047037384,False,CLPB; ClpB family mitochondrial
hsa:27243,1.20823115e-06,0.0014969708299293215,2.6987411976749008e-05,8.390917873831117e-05,0.0,0.0005450873,False,CHMP2A; charged multivesicular body protein
hsa:1663,6.51879665e-08,8.076640327714592e-05,2.044528867100495e-06,4.37321529962411e-06,0.0,2.101842e-05,False,DDX11; DEAD/H-box helicase
hsa:2635,1.09621553e-07,0.00013581860323047545,4.916386761237624e-07,9.487173064904431e-07,0.0,4.527058e-06,False,GBP3; guanylate binding protein
hsa:824,5.345956449999999e-07,0.0006623518077416318,2.9150705433787113e-05,0.00010247010141777248,0.0,0.0006747746,False,CAPN2; calpain
hsa:9862,5.0548843e-08,6.262886324167107e-05,7.946295255108912e-06,2.3354122353206292e-05,0.0,0.00017827972,False,MED24; mediator complex subunit
hsa:81930,1.90595665e-09,2.3614368063261812e-06,3.0607055468433664e-07,1.0161420494156377e-06,0.0,5.480982e-06,False,KIF18A; kinesin family member
hsa:26827,0.0,0.0,5.892012712871286e-09,3.386468305781485e-08,0.0,2.8294343e-07,False,RNU6-1; RNA
hsa:122011,1.97006115e-06,0.002440860819328332,7.596053968212872e-06,1.6171084756138717e-05,0.0,0.00011381961,False,CSNK1A1L; casein kinase 1 alpha 1
hsa:5798,2.3107487499999998e-05,0.028629649831869018,0.00014230785879851482,0.0002578455429041819,0.0,0.0014009423,False,PTPRN; protein tyrosine phosphatase receptor type
hsa:23521,2.2589453e-08,2.7987816904951834e-05,1.0447673012341585e-06,2.2725485545012694e-06,0.0,1.769491e-05,False,RPL13A; ribosomal protein
hsa:7226,0.0,0.0,6.021755568297025e-07,1.3583442906674737e-06,0.0,8.094545e-06,False,TRPM2; transient receptor potential cation channel subfamily M member
hsa:60682,0.0,0.0,5.645522755198018e-07,1.6332713121386648e-06,0.0,9.187095e-06,False,SMAP1; small ArfGAP
hsa:7529,1.8496544e-06,0.0022916796030713338,1.304935540099009e-05,2.132682292826357e-05,0.0,0.00015076403,False,YWHAB; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:10794,2.6776275e-10,3.31751938436331e-07,1.153307135792079e-08,2.6711552144136034e-08,0.0,2.150121e-07,False,ZNF460; zinc finger protein
hsa:6629,0.0,0.0,1.1299773162326732e-07,3.1595405809499996e-07,0.0,1.6677399e-06,False,SNRPB2; small nuclear ribonucleoprotein polypeptide
hsa:160851,7.35227135e-06,0.009109296465891542,9.43591189666831e-05,0.0002685311286598307,0.0,0.0017030863,False,DGKH; diacylglycerol kinase
hsa:84765,0.0,0.0,1.3209896233960393e-07,3.574113188680753e-07,0.0,2.1845742e-06,False,ZNF577; zinc finger protein
hsa:81309,-0.0,0.0,1.7241602920792082e-08,2.2977868542901806e-07,-0.0,3.2592186e-06,False,OR4C15; olfactory receptor family 4 subfamily C member
hsa:8811,0.0,0.0,4.6257614385544556e-07,2.842696568860646e-06,0.0,3.0968084e-05,False,GALR2; galanin receptor
hsa:1629,7.486952500000001e-07,0.0009276163338088418,3.850756451069306e-05,0.00015235312076132093,0.0,0.0015012369,False,DBT; dihydrolipoamide branched chain transacylase
hsa:130340,0.0,0.0,2.1827448673450491e-07,4.404803008068305e-07,0.0,2.390863e-06,False,AP1S3; adaptor related protein complex 1 subunit sigma
hsa:28,7.744869000000001e-07,0.0009595715997409828,4.649775188366338e-05,0.00020887592437324325,0.0,0.002122099,False,ABO; ABO
hsa:9039,8.378613000000001e-09,1.0380910354998381e-05,6.760547426707748e-07,1.1546164640256813e-06,0.0,6.466656e-06,False,UBA3; ubiquitin like modifier activating enzyme
hsa:10497,0.0,0.0,3.2271954872113857e-05,0.00011548621576694581,0.0,0.00071146653,False,UNC13B; unc-13 homolog
hsa:928,0.0,0.0,3.059387058608912e-05,7.526134479941825e-05,0.0,0.00056809006,False,CD9; CD9
hsa:4193,6.07789645e-05,0.07530375038734083,0.00028954455911386147,0.0005753091942205569,0.0,0.0036020288,False,MDM2; MDM2
hsa:7273,2.4784806e-06,0.0030707809186559395,3.248845598905248e-05,0.00016304398611911,0.0,0.002246445,False,TTN;
hsa:3566,0.0,0.0,7.529979179405938e-05,0.0003393893191692117,0.0,0.0029864481,False,IL4R; interleukin 4
hsa:93010,2.07217745e-07,0.0002567380585318732,1.7201759282321783e-05,5.227634094456561e-05,0.0,0.00034145976,False,B3GNT7; UDP-GlcNAc:betaGal beta-1
hsa:5529,0.0,0.0,7.65552296386139e-06,2.561920947827344e-05,0.0,0.0002975222,False,PPP2R5E; protein phosphatase 2 regulatory subunit
hsa:5130,7.743247e-06,0.009593706376414584,0.00025505401790410886,0.0011139822184339386,0.0,0.013922976,False,PCYT1A; phosphate cytidylyltransferase 1A
hsa:54363,0.0,0.0,1.44097667523198e-07,1.4127438735995816e-06,0.0,1.9356472e-05,False,HAO1; hydroxyacid oxidase
hsa:55315,0.0,0.0,4.8001212334999996e-06,2.909733359997317e-05,0.0,0.0003843679,False,SLC29A3; solute carrier family 29 member
hsa:406912,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR125B2; microRNA
hsa:7409,0.0,0.0,2.0621999946005932e-05,6.527244517051153e-05,0.0,0.00048626706,False,VAV1; vav guanine nucleotide exchange factor
hsa:526,1.23849925e-05,0.0153447231528449,0.00022761130747128708,0.00042460960487290887,0.0,0.0024331275,False,ATP6V1B2; ATPase H+ transporting V1 subunit
hsa:5822,1.44197975e-10,1.7865800125239077e-07,6.476121025938117e-07,2.5820269123937693e-06,0.0,2.889383e-05,False,PWP2; PWP2 small subunit processome
hsa:199692,0.0,0.0,1.0928114862059409e-07,2.8611527479894814e-07,0.0,1.379797e-06,False,ZNF627; zinc finger protein
hsa:83732,8.70931325e-08,0.00010790640420061123,3.0158683324448516e-06,6.254840359461997e-06,0.0,3.7776776e-05,False,RIOK1; RIO kinase
hsa:10200,1.030772e-07,0.00012771029916816052,3.1354710924554463e-06,1.0590362044849973e-05,0.0,7.5310956e-05,False,MPHOSPH6; M-phase phosphoprotein
hsa:10038,0.0,0.0,7.980104538589107e-06,1.758852351076478e-05,0.0,0.0001398184,False,PARP2; poly(ADP-ribose) polymerase
hsa:55762,0.0,0.0,4.056438694275248e-08,9.131667028683203e-08,0.0,4.9893526e-07,False,ZNF701; zinc finger protein
hsa:83443,0.0,0.0,2.4238039246138596e-07,4.174945955806084e-07,0.0,2.770964e-06,False,SF3B5; splicing factor 3b subunit
hsa:26286,1.5184522e-08,1.881327633410216e-05,7.100301063702967e-07,2.0039321902825703e-06,0.0,1.2552317e-05,False,ARFGAP3; ADP ribosylation factor GTPase activating protein
hsa:131405,0.0,0.0,4.3131897020301966e-08,2.876173689614346e-07,0.0,2.9347577e-06,False,TRIM71; tripartite motif containing
hsa:4600,0.0,0.0,9.824631762079204e-06,2.758909936624348e-05,0.0,0.00018421715,False,MX2; MX dynamin like GTPase
hsa:22871,1.5327629500000001e-07,0.00018990583261707954,1.7036590432133656e-06,3.860612211754419e-06,0.0,3.330711e-05,False,NLGN1; neuroligin
hsa:9392,1.4486573000000002e-07,0.00017948533446304293,6.0749929332398e-05,0.00012498970831046445,0.0,0.00089209067,False,TGFBRAP1; transforming growth factor beta receptor associated protein
hsa:5565,0.00016833505499999998,0.2085632927023508,0.0004387937944999999,0.0006787807423910881,0.0,0.0035376952,False,PRKAB2; protein kinase AMP-activated non-catalytic subunit beta
hsa:23235,1.0352386500000001e-07,0.0001282637069128213,1.443098970886138e-06,3.5129400554582406e-06,0.0,2.558304e-05,False,SIK2; salt inducible kinase
hsa:23560,5.1197283e-08,6.3432265607981e-05,2.0418152118767324e-06,4.366549871238907e-06,0.0,2.2142049e-05,False,GTPBP4; GTP binding protein
hsa:9739,0.0,0.0,9.790817440292077e-06,2.8509422096057004e-05,0.0,0.0001736805,False,SETD1A; SET domain containing 1A
hsa:10325,4.98765975e-08,6.179596640396641e-05,2.8550852492653464e-06,5.640953743041311e-06,0.0,3.717881e-05,False,RRAGB; Ras related GTP binding
hsa:8875,2.2370392e-07,0.0002771640532367027,1.3113739583061388e-05,3.6593668699138346e-05,0.0,0.0004179099,False,VNN2; vanin
hsa:402317,0.0,0.0,2.9290195737920783e-06,1.1734855800050903e-05,0.0,0.000111263435,False,OR2A42; olfactory receptor family 2 subfamily A member
hsa:353164,0.0,0.0,1.4349020521287131e-05,5.636088154906283e-05,0.0,0.00070751796,False,TAS2R42; taste 2 receptor member
hsa:9782,0.0,0.0,3.091650346584159e-08,6.343099710578032e-08,0.0,3.3368133e-07,False,MATR3; matrin
hsa:2539,1.6056630499999998e-05,0.019893798869076874,7.105364584801978e-05,0.00013097600192851376,0.0,0.00089373376,False,G6PD; glucose-6-phosphate
hsa:10402,0.0,0.0,4.3375592494059393e-05,0.00016458084462345484,0.0,0.001353333,False,ST3GAL6; ST3 beta-galactoside alpha-2
hsa:4295,0.0,0.0,8.539845861793564e-07,5.075307358359237e-06,0.0,6.3984015e-05,False,MLN;
hsa:6238,0.0,0.0,5.975305948480199e-07,1.5654537167057683e-06,0.0,8.438156e-06,False,RRBP1; ribosome binding protein
hsa:4008,1.4993216499999999e-07,0.00018576253184098912,1.2295066707069307e-05,2.648676314895616e-05,0.0,0.00014380312,False,LMO7; LIM domain
hsa:23464,1.72144935e-06,0.0021328364710269145,1.809475565377228e-05,4.099540109108959e-05,0.0,0.00029976616,False,GCAT; glycine
hsa:7094,0.0,0.0,2.9474528451202966e-06,7.945760940262858e-06,0.0,4.148115e-05,False,TLN1; talin
hsa:5356,2.5088065e-08,3.108354016892443e-05,1.479962365094059e-07,2.459134223030519e-07,0.0,1.7750662e-06,False,PLRG1; pleiotropic regulator
hsa:8667,0.0,0.0,3.819675400983219e-06,1.0656187741799508e-05,0.0,8.891066e-05,False,EIF3H; eukaryotic translation initiation factor 3 subunit
hsa:255043,0.0,0.0,8.962655942722773e-06,1.974301217148232e-05,0.0,0.00017144019,False,TMEM86B; transmembrane protein
hsa:25766,2.64213205e-08,3.273541331616354e-05,1.2343968444009907e-07,2.609430299147803e-07,0.0,1.9675485e-06,False,PRPF40B; pre-mRNA processing factor 40 homolog
hsa:7518,8.1549165e-09,1.0103755494972395e-05,0.00010072025391651482,0.0002935360102080272,0.0,0.0022428187,False,XRCC4; X-ray repair cross complementing
hsa:389090,0.0,0.0,2.4664830482178214e-07,1.1894598341075664e-06,0.0,1.4335937e-05,False,OR6B2; olfactory receptor family 6 subfamily B member
hsa:7035,8.908914e-08,0.00011037941195564234,1.254732880346535e-06,2.176293711632422e-06,0.0,1.47754245e-05,False,TFPI; tissue factor pathway
hsa:3820,0.0,0.0,2.8928560167821786e-06,7.877326142785587e-06,0.0,7.158481e-05,False,KLRB1; killer cell lectin like receptor
hsa:392138,0.0,0.0,2.6146187943564355e-07,1.5025577428306702e-06,-0.0,1.3315026e-05,False,OR2A25; olfactory receptor family 2 subfamily A member
hsa:84701,0.0,0.0,5.778564610100992e-05,0.00017512024479961273,0.0,0.0012973648,False,COX4I2; cytochrome c oxidase subunit
hsa:51652,0.0,0.0,2.4680698260237626e-05,0.00022745554884152078,0.0,0.0030428667,False,CHMP3; charged multivesicular body protein
hsa:26503,8.741254500000001e-08,0.00010830214900094585,6.069026485242079e-07,1.0401371778613237e-06,0.0,6.272419e-06,False,SLC17A5; solute carrier family 17 member
hsa:9156,7.35510235e-06,0.009112804010304322,0.00022706567512427713,0.0005248364751671223,0.0,0.003256351,False,EXO1; exonuclease
hsa:51194,7.383146899999999e-10,9.147550567938174e-07,7.131190189294554e-08,2.7958460933026054e-07,0.0,3.091151e-06,False,IPO11; importin
hsa:23062,2.46367895e-07,0.0003052442011994889,8.764909949574255e-07,1.2986319601424375e-06,0.0,5.0493927e-06,False,GGA2; golgi associated
hsa:109,0.0,0.0,0.0006580121966039605,0.0012684418160699357,0.0,0.0075917575,False,ADCY3; adenylate cyclase
hsa:119687,0.0,0.0,1.1012119801980199e-07,1.2715075894873507e-06,-0.0,1.744696e-05,False,OR51A7; olfactory receptor family 51 subfamily A member
hsa:219954,0.0,0.0,8.027940658415842e-08,9.88186442534326e-07,0.0,1.3918312e-05,False,OR9I1; olfactory receptor family 9 subfamily I member
hsa:55900,0.0,0.0,1.8934570096188125e-07,5.053915611536652e-07,0.0,2.740162e-06,False,ZNF302; zinc finger protein
hsa:10398,0.0,0.0,0.00017772192410460392,0.0011162820391219354,0.0,0.014449082,False,MYL9; myosin light chain
hsa:10728,4.17668225e-06,0.005174814019762332,4.770162800846539e-05,0.0001412839870255279,0.0,0.0015723411,False,PTGES3; prostaglandin E synthase
hsa:80816,1.80847495e-08,2.2406592040007312e-05,9.881779277540591e-06,7.341469118878779e-05,0.0,0.0007769704,False,ASXL3; ASXL transcriptional regulator
hsa:1327,1.29233785e-07,0.00016011771123957322,4.4316612953316806e-05,0.00022863811855237,0.0,0.0026132076,False,COX4I1; cytochrome c oxidase subunit
hsa:2531,0.0,0.0,1.674113236275643e-05,4.4878873180008096e-05,0.0,0.00037316175,False,KDSR; 3-ketodihydrosphingosine
hsa:3162,0.0,0.0,6.265046451980201e-05,0.00022965217457948748,0.0,0.0025930214,False,HMOX1; heme oxygenase
hsa:10838,1.46512345e-08,1.8152545288171145e-05,9.151113302970294e-08,1.7146955668940156e-07,0.0,9.6581e-07,False,ZNF275; zinc finger protein
hsa:256892,0.0,0.0,7.750146633663366e-09,9.064099034522057e-08,0.0,1.250774e-06,False,OR51F1; olfactory receptor family 51 subfamily F member
hsa:1959,0.0,0.0,3.862882376148514e-06,1.8775647125547842e-05,0.0,0.00015500998,False,EGR2; early growth response
hsa:4245,0.0,0.0,3.235701429024752e-05,0.0001262961185298764,0.0,0.0009725542,False,MGAT1; alpha-1
hsa:9626,0.0,0.0,1.1879663313683175e-05,6.465497760599763e-05,0.0,0.000813398,False,GUCA1C; guanylate cyclase activator
hsa:23556,0.0,0.0,9.646213577425741e-06,1.849663023529018e-05,0.0,0.000114921604,False,PIGN; phosphatidylinositol glycan anchor biosynthesis class
hsa:79054,0.0,0.0,6.763570143635151e-06,1.9358760121714893e-05,0.0,0.00019501607,False,TRPM8; transient receptor potential cation channel subfamily M member
hsa:201625,6.4166205e-09,7.950046408939627e-06,3.41715293005e-07,1.4856814634268455e-06,0.0,1.4448397e-05,False,DNAH12; dynein axonemal heavy chain
hsa:3761,0.0,0.0,1.990299379096535e-06,1.0885970523982259e-05,0.0,0.00012989623,False,KCNJ4; potassium inwardly rectifying channel subfamily J member
hsa:1659,2.00287735e-08,2.481519342450441e-05,5.700586473712871e-07,1.5446532853077424e-06,0.0,9.454422e-06,False,DHX8; DEAH-box helicase
hsa:115024,2.1783352e-09,2.69890761565637e-06,0.000363785205268173,0.0009206390443282388,0.0,0.0052632415,False,NT5C3B; 5'-nucleotidase
hsa:10235,1.23803735e-06,0.0015339000317224048,3.8523219659901005e-06,5.440348936697353e-06,0.0,2.4098059e-05,False,RASGRP2; RAS guanyl releasing protein
hsa:64319,8.577607e-08,0.00010627459381094053,1.1510668780365842e-05,4.4863117309431504e-05,0.0,0.00039836744,False,FBRS;
hsa:11019,0.0,0.0,3.1719686213019807e-06,1.0141057546654435e-05,0.0,8.7081666e-05,False,LIAS; lipoic acid
hsa:58478,3.5586221000000002e-06,0.0044090515945080745,0.00014262190800338825,0.0004138367890266856,0.0,0.0028669743,False,ENOPH1; enolase-phosphatase
hsa:29078,0.0,0.0,5.910614925420792e-07,1.7720270921097348e-06,0.0,9.825918e-06,False,NDUFAF4; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:81029,3.0072772e-05,0.03725947841943593,8.282710302178217e-05,0.00019170697789591847,0.0,0.0022406308,False,WNT5B; Wnt family member
hsa:23130,0.0,0.0,3.968841511081681e-05,0.00015209696141084138,0.0,0.0019441183,False,ATG2A; autophagy related
hsa:4069,0.0,0.0,6.648366112004949e-05,0.00023259511831527266,0.0,0.0019815054,False,LYZ;
hsa:3624,0.0,0.0,3.11182100444307e-05,0.00016161496323308715,0.0,0.0014885376,False,INHBA; inhibin subunit beta
hsa:2187,0.0,0.0,2.5335791494554455e-05,7.898514767697941e-05,0.0,0.0004697066,False,FANCB; FA complementation group
hsa:387,0.0,0.0,0.00017191682024801972,0.0003974955033002267,0.0,0.003833102,False,RHOA; ras homolog family member
hsa:5021,0.0,0.0,2.063071625358415e-05,0.00012736310042970838,0.0,0.0017449973,False,OXTR; oxytocin
hsa:57758,2.997989175e-07,0.00037144401908681727,2.9185610385470293e-05,7.333218008143461e-05,0.0,0.0006822142,False,SCUBE2; signal peptide
hsa:8321,0.0,0.0,5.570657204950494e-05,0.00020175033495431344,0.0,0.0016583996,False,FZD1; frizzled class receptor
hsa:6878,2.40084755e-07,0.00029745953408478814,1.1040339278217825e-06,2.257111698310386e-06,0.0,1.7640488e-05,False,TAF6; TATA-box binding protein associated factor
hsa:10266,1.0254225499999999e-07,0.00012704751451754416,5.170680484292082e-06,1.1695253118156945e-05,0.0,0.00011960617,False,RAMP2; receptor activity modifying protein
hsa:784,0.00014503348,0.17969317288594788,0.00031515818143465333,0.0004356862500904106,0.0,0.0025631287,False,CACNB3; calcium voltage-gated channel auxiliary subunit beta
hsa:1195,0.0,0.0,3.0060135505148508e-05,9.549571911582915e-05,0.0,0.00082272704,False,CLK1; CDC like kinase
hsa:3836,4.5340727e-07,0.0005617612633707447,1.2538337631321783e-05,3.038900108903124e-05,0.0,0.00016169078,False,KPNA1; karyopherin subunit alpha
hsa:80328,3.023458e-08,3.745995483990332e-05,3.884796791623761e-06,1.5957221938686674e-05,0.0,0.00013395806,False,ULBP2; UL16 binding protein
hsa:3250,0.0,0.0,2.184068267229455e-05,0.0001149835570597684,0.0,0.0013812198,False,HPR; haptoglobin-related
hsa:3554,0.0,0.0,7.865476703983167e-05,0.00019224933789271668,0.0,0.0017118837,False,IL1R1; interleukin 1 receptor type
hsa:3766,0.0,0.0,4.627417902318812e-06,1.177484241565827e-05,0.0,9.804893e-05,False,KCNJ10; potassium inwardly rectifying channel subfamily J member
hsa:196883,0.0,0.0,0.00037852610593069294,0.0010747223734441091,0.0,0.007837778,False,ADCY4; adenylate cyclase
hsa:6132,8.2887203e-08,0.00010269535350535378,5.013341786633661e-07,1.038177842318839e-06,0.0,5.3100766e-06,False,RPL8; ribosomal protein
hsa:11152,0.0,0.0,1.3791817037408911e-06,4.71465674046786e-06,0.0,3.3178996e-05,False,WDR45; WD repeat domain
hsa:91860,0.00036609210499999995,0.45357976596814453,0.0009147700166806933,0.0011425710720032575,0.0,0.006482732,False,CALML4; calmodulin like
hsa:995,5.7770223e-08,7.157598831110418e-05,2.0352348798311883e-05,6.755121553812625e-05,0.0,0.00050924957,False,CDC25C; cell division cycle
hsa:6990,0.0,0.0,2.649096403450495e-07,5.522463265166425e-07,0.0,3.106348e-06,False,DYNLT3; dynein light chain Tctex-type
hsa:10316,0.0,0.0,6.14153135024653e-07,1.9991023425082933e-06,0.0,1.6247448e-05,False,NMUR1; neuromedin U receptor
hsa:118424,0.0,0.0,1.2660270965965355e-06,3.813935546972512e-06,0.0,3.609701e-05,False,UBE2J2; ubiquitin conjugating enzyme E2
hsa:7205,2.09455685e-07,0.0002595108151348891,4.59164169596703e-07,5.994385258028412e-07,0.0,2.4144388e-06,False,TRIP6; thyroid hormone receptor interactor
hsa:10090,0.0,0.0,3.3114157774504936e-05,0.00016394836688988314,0.0,0.0017444182,False,UST; uronyl
hsa:406917,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR129-1; microRNA
hsa:90427,0.0,0.0,2.1101788815648516e-07,1.6920529220472208e-06,0.0,2.3658416e-05,False,BMF; Bcl2 modifying
hsa:5896,9.054008200000001e-07,0.00112177095991449,3.697114083460396e-05,8.920024634196785e-05,0.0,0.00064848084,False,RAG1; recombination activating
hsa:403253,0.0,0.0,5.66667982970297e-07,4.980185038458688e-06,0.0,5.9578353e-05,False,OR4A47; olfactory receptor family 4 subfamily A member
hsa:26525,0.0,0.0,4.5360745587128716e-08,5.614388612057869e-07,-0.0,7.9721e-06,False,IL36RN; interleukin 36 receptor
hsa:4793,0.0,0.0,3.100580406539604e-05,0.00012011204638097316,0.0,0.0010485423,False,NFKBIB; NFKB inhibitor
hsa:26289,2.8533506e-07,0.0003535236296267752,3.0359015416202964e-05,9.900270313934419e-05,0.0,0.00087554014,False,AK5; adenylate kinase
hsa:729238,0.0,0.0,1.3149375650968814e-06,6.636669803423495e-06,0.0,7.006871e-05,False,SFTPA2; surfactant protein
hsa:2965,0.0,0.0,9.37442081485149e-07,2.1309315537348555e-06,0.0,1.754455e-05,False,GTF2H1; general transcription factor IIH subunit
hsa:55823,0.0,0.0,0.00011270771296096786,0.0002894521417735093,0.0,0.0015275213,False,VPS11; VPS11 core subunit of CORVET and HOPS
hsa:2534,2.77038865e-05,0.034324483329346976,0.00048715080609294575,0.000913878842329633,0.0,0.005576898,False,FYN; FYN proto-oncogene
hsa:2872,1.2352860999999998e-06,0.0015304912957401855,3.195422821975248e-05,8.441344281115209e-05,0.0,0.0005139952,False,MKNK2; MAPK interacting serine/threonine kinase
hsa:87178,0.0,0.0,1.2938418996237632e-06,9.405580006500587e-06,0.0,0.00011328941,False,PNPT1; polyribonucleotide nucleotidyltransferase
hsa:10672,0.0,0.0,0.00018622031206980187,0.0004982694528677808,0.0,0.003202792,False,GNA13; G protein subunit alpha
hsa:645974,0.0,0.0,4.43390509179703e-07,1.5237483945725923e-06,0.0,1.434343e-05,False,PABPC1L2B; poly(A) binding protein cytoplasmic 1 like
hsa:4331,0.0,0.0,2.0009063723836636e-06,9.129538626357709e-06,0.0,0.00010483138,False,MNAT1; MNAT1 component of CDK activating
hsa:6790,2.6649585e-06,0.0033018227823973906,3.689852966470298e-05,0.00011023767264197105,0.0,0.00071373716,False,AURKA; aurora kinase
hsa:338,0.0,0.0,1.6936690987297025e-05,0.00011151688171825256,0.0,0.0013925633,False,APOB; apolipoprotein
hsa:126370,0.0,0.0,4.662365207920792e-08,3.599129302894543e-07,-0.0,3.8168073e-06,False,OR1I1; olfactory receptor family 1 subfamily I member
hsa:2775,1.9026954499999998e-05,0.023573962539281023,0.0002220598678247525,0.0003879967051486565,0.0,0.002156324,False,GNAO1; G protein subunit alpha
hsa:7320,0.0,0.0,8.478804670915841e-07,2.0670661147182524e-06,0.0,1.2298357e-05,False,UBE2B; ubiquitin conjugating enzyme E2
hsa:1630,8.4771468e-08,0.00010502991485220929,1.2896770313909647e-05,4.300228063375622e-05,0.0,0.00030609776,False,DCC; DCC netrin 1
hsa:7832,1.4468712e-07,0.000179264040747901,6.157832906356438e-06,4.7303336737662816e-05,0.0,0.00047609935,False,BTG2; BTG anti-proliferation factor
hsa:6999,3.3121147e-08,4.1036345497962906e-05,7.004673325277227e-06,2.113276434489185e-05,0.0,0.00015182621,False,TDO2; tryptophan
hsa:5473,2.0514625e-07,0.0002541715234865349,8.781484811770543e-05,0.0003866593301712648,0.0,0.0036150864,False,PPBP; pro-platelet basic
hsa:119749,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4C46; olfactory receptor family 4 subfamily C member
hsa:3823,0.0,0.0,7.922412213138617e-07,3.483060239879358e-06,0.0,3.3995046e-05,False,KLRC3; killer cell lectin like receptor
hsa:7874,4.16091465e-07,0.0005155278323088733,3.0143508429653443e-05,9.644723181480943e-05,0.0,0.0007533825,False,USP7; ubiquitin specific peptidase
hsa:64768,0.0,0.0,1.4807087899103966e-05,3.9709352714295144e-05,0.0,0.00028217662,False,IPPK; inositol-pentakisphosphate
hsa:5594,0.0,0.0,0.0007925704774188118,0.001314247204537123,0.0,0.0060856016,False,MAPK1; mitogen-activated protein kinase
hsa:4776,0.0,0.0,0.00016935626553960393,0.00037069682976440183,0.0,0.0021802832,False,NFATC4; nuclear factor of activated T cells
hsa:100169759,0.0,0.0,2.0146155270326737e-07,1.5106287751724132e-06,0.0,1.9434621e-05,False,RNA5S8; RNA
hsa:391,5.2974758999999996e-08,6.563451782015037e-05,9.30324628612376e-06,3.4803702189314383e-05,0.0,0.00029164949,False,RHOG; ras homolog family member
hsa:1021,0.000165885505,0.20552835613706416,0.00039581602789257427,0.00056218156684575,0.0,0.0026489496,False,CDK6; cyclin dependent kinase
hsa:11338,0.0,0.0,2.2989168120891084e-07,5.239307057877536e-07,0.0,2.9923929e-06,False,U2AF2; U2 small nuclear RNA auxiliary factor
hsa:100532726,0.0,0.0,4.0907243590099005e-07,1.2694753194287372e-06,0.0,1.2307787e-05,False,NDUFC2-KCTD14; NDUFC2-KCTD14
hsa:718,0.0,0.0,0.00010516242287920792,0.00020010403237974577,0.0,0.001107224,False,C3; complement
hsa:113235,9.891407e-05,0.12255227607696341,0.0006044163798965347,0.0009977300517137976,0.0,0.0071564694,False,SLC46A1; solute carrier family 46 member
hsa:407036,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR32; microRNA
hsa:50636,2.87021955e-08,3.556136540464847e-05,3.6371857930386147e-06,1.1612341312254484e-05,0.0,8.90066e-05,False,ANO7; anoctamin
hsa:4489,0.0,0.0,4.874189730210396e-06,1.801719890492054e-05,0.0,0.00010704117,False,MT1A; metallothionein
hsa:2245,0.0,0.0,1.35802379079703e-07,8.598235128253301e-07,0.0,9.353721e-06,False,FGD1; FYVE
hsa:390144,0.0,0.0,2.5303110192079205e-07,2.3254025638525114e-06,-0.0,3.056883e-05,False,OR5D16; olfactory receptor family 5 subfamily D member
hsa:79862,0.0,0.0,5.3216800149009886e-08,1.1548285500944012e-07,0.0,5.917999e-07,False,ZNF669; zinc finger protein
hsa:5372,3.00368855e-06,0.0037215015864660497,5.91143580852079e-05,0.000128308088927295,0.0,0.0007406329,False,PMM1; phosphomannomutase
hsa:7200,0.0,0.0,5.53399355327089e-06,1.6941258439223783e-05,0.0,0.00015914673,False,TRH; thyrotropin releasing
hsa:4802,7.5332275e-07,0.0009333497007357728,7.114415671569308e-06,1.6284982440267812e-05,0.0,0.00010989457,False,NFYC; nuclear transcription factor Y subunit
hsa:442194,0.0,0.0,0.0,0.0,0.0,0.0,False,OR10C1; olfactory receptor family 10 subfamily C member
hsa:1300,0.0,0.0,1.334174080125743e-05,0.0001126361112682451,0.0,0.0013607193,False,COL10A1; collagen type X alpha 1
hsa:57571,0.0,0.0,2.694683892720793e-05,6.186687397163911e-05,0.0,0.00048669285,False,CARNS1; carnosine synthase
hsa:51256,2.603154e-07,0.0003225248416922401,2.093814728351485e-06,4.653415702841485e-06,0.0,2.6589636e-05,False,TBC1D7; TBC1 domain family member
hsa:64223,1.7272466e-06,0.0021400191315168447,0.0005925090952160989,0.0019725956304832296,0.0,0.010891147,False,MLST8; MTOR associated protein
hsa:117157,2.9410332e-09,3.6438730372525885e-06,2.275962999873862e-06,8.948148979530965e-06,0.0,7.4653304e-05,False,SH2D1B; SH2 domain containing
hsa:25788,3.800489e-09,4.7087191655895115e-06,8.495049696761884e-06,2.3056925253841166e-05,0.0,0.00013370786,False,RAD54B; RAD54 homolog
hsa:7554,9.75529e-09,1.2086581750107345e-05,8.31128692980198e-08,1.8925644931744717e-07,0.0,9.0187456e-07,False,ZNF8; zinc finger protein
hsa:27034,0.0,0.0,1.2777507580747532e-06,2.2718920504975505e-06,0.0,1.5516493e-05,False,ACAD8; acyl-CoA dehydrogenase family member
hsa:10654,6.269675599999999e-07,0.0007767985030281344,8.419650870883174e-05,0.00028047500617136016,0.0,0.002211218,False,PMVK; phosphomevalonate
hsa:8506,1.1908109e-06,0.001475387537609738,6.301135799222444e-06,9.597219383699905e-06,0.0,4.4692904e-05,False,CNTNAP1; contactin associated protein
hsa:8829,4.9313445e-07,0.000610982333043838,2.0828932443316828e-05,6.042579021842236e-05,0.0,0.0003990647,False,NRP1; neuropilin
hsa:1258,0.0006299014499999999,0.780433525803554,0.0011396396486762377,0.0013295881756098123,0.0,0.006442287,True,CNGB1; cyclic nucleotide gated channel subunit beta
hsa:7802,3.31331655e-08,4.105123614526952e-05,2.7744183883554462e-06,9.372820096342989e-06,0.0,5.4223525e-05,False,DNALI1; dynein axonemal light intermediate chain
hsa:2797,1.09544205e-06,0.0013572277082311418,2.711591606495049e-05,5.237939588502487e-05,0.0,0.0002613636,False,GNRH2; gonadotropin releasing hormone
hsa:6217,0.0,0.0,7.602071973257426e-07,1.5021182063443275e-06,0.0,7.4453733e-06,False,RPS16; ribosomal protein
hsa:9573,0.0,0.0,5.70830626009901e-07,2.550897548557439e-06,0.0,2.493287e-05,False,GDF3; growth differentiation factor
hsa:11340,3.31705595e-08,4.109756645815243e-05,2.826278019114852e-05,0.00011616007455983651,0.0,0.0010107824,False,EXOSC8; exosome component
hsa:6514,0.0,0.0,4.709630092514852e-05,0.00031222000288628967,0.0,0.003108815,False,SLC2A2; solute carrier family 2 member
hsa:90665,0.0,0.0,7.746729927371286e-08,5.385744502310205e-07,0.0,6.2936324e-06,False,TBL1Y; transducin beta like 1
hsa:284716,0.0,0.0,2.3762081556980198e-06,6.606666515958685e-06,0.0,5.252596e-05,False,RIMKLA; ribosomal modification protein rimK like family member
hsa:941,4.1118439e-05,0.05094480783352438,0.00014643599501123754,0.00024486556057354324,0.0,0.0014246755,False,CD80; CD80
hsa:84620,0.0,0.0,2.4994495704138603e-05,0.00010794018878730263,0.0,0.0013010751,False,ST6GAL2; ST6 beta-galactoside alpha-2
hsa:9532,3.1187534999999997e-09,3.864064434392355e-06,1.7777282164504947e-07,4.5189344950131674e-07,0.0,3.4666048e-06,False,BAG2; BAG cochaperone
hsa:4043,0.0,0.0,3.610518740579207e-05,9.583144434354251e-05,0.0,0.00045464057,False,LRPAP1; LDL receptor related protein associated protein
hsa:7625,0.0,0.0,2.144994248272129e-07,5.102435392847367e-07,0.0,2.4742583e-06,False,ZNF74; zinc finger protein
hsa:403282,0.0,0.0,3.0577511386138614e-08,4.3458809109204684e-07,0.0,6.1766573e-06,False,OR6C65; olfactory receptor family 6 subfamily C member
hsa:8772,0.0,0.0,0.00023341545120727724,0.0005231695663060551,0.0,0.0029931446,False,FADD; Fas associated via death
hsa:5031,0.0,0.0,4.939922678564359e-06,1.3415063444286428e-05,0.0,9.062639e-05,False,P2RY6; pyrimidinergic receptor
hsa:6603,0.0,0.0,2.696801090589109e-06,7.841092280416483e-06,0.0,4.370913e-05,False,SMARCD2; SWI/SNF related
hsa:79345,0.0,0.0,6.377933123762377e-08,4.5336676257786043e-07,0.0,4.59494e-06,False,OR51B2; olfactory receptor family 51 subfamily B member
hsa:115,0.0,0.0,0.00016403489005217817,0.0003816560754714017,0.0,0.0019895402,False,ADCY9; adenylate cyclase
hsa:100169762,0.0,0.0,1.2408646446490097e-07,8.953479713025047e-07,0.0,1.0406107e-05,False,RNA5S11; RNA
hsa:7581,1.4264538499999999e-08,1.7673437766360978e-05,5.735978932504949e-08,8.994558502900394e-08,0.0,4.975644e-07,False,ZNF33A; zinc finger protein
hsa:2733,1.3736747999999998e-07,0.00017019517378019877,3.69008133009901e-07,4.881112126338508e-07,0.0,2.070271e-06,False,GLE1; GLE1 RNA export
hsa:5169,0.0,0.0,1.43095336040099e-05,4.012895664110662e-05,0.0,0.00029392348,False,ENPP3; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:4122,0.0,0.0,8.812694183617326e-05,0.0002805141554494288,0.0,0.0018322412,False,MAN2A2; mannosidase alpha class 2A member
hsa:6865,0.0,0.0,9.26511814079208e-07,4.2827403367420105e-06,0.0,3.1141888e-05,False,TACR2; tachykinin receptor
hsa:3059,4.62607815e-07,0.0005731605287219584,1.2621138593702964e-05,5.801093569925948e-05,0.0,0.0005232292,False,HCLS1; hematopoietic cell-specific Lyn substrate
hsa:90952,2.2588809500000002e-06,0.0027987019623132827,3.3890008761831696e-05,7.598902302541219e-05,0.0,0.0004885887,False,ESAM; endothelial cell adhesion
hsa:22908,0.0,0.0,1.3199992644980196e-05,4.11424427787986e-05,0.0,0.00029226753,False,SACM1L; SAC1 like phosphatidylinositide
hsa:22803,0.0,0.0,2.59643105610891e-06,1.11495844613434e-05,0.0,0.00013179767,False,XRN2; 5'-3' exoribonuclease
hsa:25799,6.1264725e-09,7.590559656456601e-06,5.646876350212873e-08,1.0546883127391826e-07,0.0,7.3872087e-07,False,ZNF324; zinc finger protein
hsa:472,0.0,0.0,6.87732671808911e-05,0.0001763398482084355,0.0,0.0009897297,False,ATM; ATM serine/threonine
hsa:4615,0.0,0.0,9.17158550973762e-05,0.00017333074333857534,0.0,0.0010453992,False,MYD88; MYD88 innate immune signal transduction
hsa:3727,1.3371325e-05,0.01656676661788159,4.9126515727227705e-05,0.00011215323983336841,0.0,0.0008143988,False,JUND; JunD proto-oncogene
hsa:147746,0.0,0.0,4.386665831572278e-08,1.230527757505279e-07,0.0,8.842814e-07,False,HIPK4; homeodomain interacting protein kinase
hsa:407040,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR34A; microRNA
hsa:50615,5.453972699999999e-07,0.0006757347746853622,3.174785741427227e-05,6.82935027936636e-05,0.0,0.0005350364,False,IL21R; interleukin 21
hsa:10544,0.0,0.0,1.8368745487876245e-06,6.274963240267788e-06,0.0,7.821115e-05,False,PROCR; protein C
hsa:23657,0.0,0.0,8.405441691250985e-07,2.0474004873179896e-06,0.0,1.4748849e-05,False,SLC7A11; solute carrier family 7 member
hsa:710,2.35419775e-06,0.0029167973029293613,2.6093662154059406e-05,0.00010451842060463717,0.0,0.0011685014,False,SERPING1; serpin family G member
hsa:64241,4.31810675e-05,0.053500357487645506,0.00022960984480950474,0.0004534899639389869,0.0,0.003835646,False,ABCG8; ATP binding cassette subfamily G member
hsa:200931,0.0,0.0,1.8059178775519797e-05,6.428945464538463e-05,0.0,0.0005807442,False,SLC51A; solute carrier family 51 member
hsa:7700,4.4346695e-09,5.4944543367196324e-06,7.659986274554456e-08,1.399367457525237e-07,0.0,7.648381e-07,False,ZNF141; zinc finger protein
hsa:219453,0.0,0.0,4.2855354066188117e-07,5.951629751862017e-06,0.0,8.45751e-05,False,OR8K5; olfactory receptor family 8 subfamily K member
hsa:2661,0.0,0.0,3.870210722579454e-05,8.322188994392105e-05,0.0,0.00044593186,False,GDF9; growth differentiation factor
hsa:10467,3.9065416e-08,4.840115917476071e-05,6.695232719514852e-06,2.0416230391341932e-05,0.0,0.00012169902,False,ZNHIT1; zinc finger HIT-type containing
hsa:9266,3.3499328000000003e-06,0.004150490312903665,7.482358177158419e-06,1.2129762205527823e-05,0.0,8.798719e-05,False,CYTH2; cytohesin
hsa:5646,5.7298059e-05,0.07099098788718468,0.00017685837572277224,0.00027196552528438515,0.0,0.0013183156,False,PRSS3; serine protease
hsa:5555,0.0,0.0,3.579486940018317e-05,9.395176147331491e-05,0.0,0.0009007276,False,PRH2; proline rich protein HaeIII subfamily
hsa:57654,1.1744273499999999e-08,1.4550886929385932e-05,9.59142650993911e-07,1.5825328015761556e-06,0.0,7.8003095e-06,False,UVSSA; UV stimulated scaffold protein
hsa:316,0.0,0.0,8.225840991752475e-05,0.0002789847469575016,0.0,0.0018415077,False,AOX1; aldehyde oxidase
hsa:923,3.0512742e-09,3.780459121183828e-06,3.7790196275391122e-06,1.1287024442182857e-05,0.0,8.650554e-05,False,CD6; CD6
hsa:9953,4.53383485e-08,5.6173179429838235e-05,0.00010967771529439111,0.0004057078954878153,0.0,0.0027345147,False,HS3ST3B1; heparan sulfate-glucosamine 3-sulfotransferase
hsa:2114,0.0,0.0,6.624272196846536e-07,1.4532330428231465e-06,0.0,8.726308e-06,False,ETS2; ETS proto-oncogene 2
hsa:1670,0.0,0.0,9.595363520792079e-06,7.021123276614374e-05,0.0,0.0008178032,False,DEFA5; defensin alpha
hsa:10171,0.0,0.0,1.0587855141341682e-06,3.569233918465409e-06,0.0,3.6170466e-05,False,RCL1; RNA terminal phosphate cyclase like
hsa:340529,0.0,0.0,4.396642771622574e-06,2.6074769478986427e-05,0.0,0.00030696433,False,PABPC1L2A; poly(A) binding protein cytoplasmic 1 like
hsa:9138,1.9678220000000002e-06,0.002438086563562922,8.031026465644057e-05,0.00016284578005771615,0.0,0.0012036025,False,ARHGEF1; Rho guanine nucleotide exchange factor
hsa:25904,2.2511374e-07,0.000278910788052678,3.0624256828396048e-06,2.134108015304185e-05,0.0,0.000231696,False,CNOT10; CCR4-NOT transcription complex subunit
hsa:84186,0.0,0.0,1.2832863283153462e-05,5.2079121003637266e-05,0.0,0.00037901435,False,ZCCHC7; zinc finger CCHC-type containing
hsa:7052,4.4809248e-09,5.551763598138384e-06,4.9539631138247527e-08,9.922589971615014e-08,0.0,5.6646246e-07,False,TGM2; transglutaminase
hsa:56477,1.32957715e-06,0.00164731575550801,6.411901623470297e-05,0.00016605914598415142,0.0,0.0016576009,False,CCL28; C-C motif chemokine ligand
hsa:81466,0.0,0.0,8.716822005693067e-06,3.1601097099380705e-05,-0.0,0.00030206772,False,OR2L5; olfactory receptor family 2 subfamily L member
hsa:6430,2.4802665e-09,3.072993608011921e-06,2.6407484818960395e-07,4.759689057110343e-07,0.0,3.971563e-06,False,SRSF5; serine and arginine rich splicing factor
hsa:6009,6.7690471e-06,0.008386694925981396,3.389265982326733e-05,6.163969302720329e-05,0.0,0.0004153156,False,RHEB; Ras homolog
hsa:944,0.0,0.0,1.7678077333960388e-06,6.275115038463046e-06,0.0,5.8426962e-05,False,TNFSF8; TNF superfamily member
hsa:9074,1.4027157e-07,0.0001737932750354838,5.5044919631336645e-06,1.2318070283267499e-05,0.0,0.0001015212,False,CLDN6; claudin
hsa:7773,0.0,0.0,2.6254094648272284e-08,5.417388600887719e-08,0.0,3.5993364e-07,False,ZNF230; zinc finger protein
hsa:2185,0.0,0.0,1.921020838119802e-05,7.322602865359269e-05,0.0,0.00059933204,False,PTK2B; protein tyrosine kinase 2
hsa:6708,0.0,0.0,6.884529249372772e-08,2.051855420979045e-07,0.0,1.2882789e-06,False,SPTA1; spectrin alpha
hsa:8660,2.56368405e-05,0.031763460493507915,0.00014052243504683172,0.0002432589837381594,0.0,0.0013062863,False,IRS2; insulin receptor substrate
hsa:55577,8.0296759e-08,9.94858524884619e-05,5.0681621586425734e-05,0.00015621534170460867,0.0,0.0010300385,False,NAGK; N-acetylglucosamine
hsa:6772,0.0,0.0,0.0002202598671485148,0.0005098883443401485,0.0,0.0028567866,False,STAT1; signal transducer and activator of transcription
hsa:3800,1.10253905e-06,0.0013660207293182149,3.4360886304851495e-05,9.045921547165371e-05,0.0,0.0006299553,False,KIF5C; kinesin family member
hsa:829,0.0,0.0,8.304521091336632e-07,2.3179420861203484e-06,0.0,1.8196057e-05,False,CAPZA1; capping actin protein of muscle Z-line subunit alpha
hsa:407021,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR29A; microRNA
hsa:10926,0.0,0.0,1.264159617319604e-06,3.2260662882666346e-06,0.0,1.8518405e-05,False,DBF4; DBF4 zinc
hsa:161,2.53416695e-06,0.0031397750358621006,3.379493979113862e-05,0.00011932893943541975,0.0,0.0014135084,False,AP2A2; adaptor related protein complex 2 subunit alpha
hsa:79603,4.7670914999999997e-07,0.0005906317610751893,1.8983414207821777e-05,3.087982926151296e-05,0.0,0.00015651797,False,CERS4; ceramide synthase
hsa:134430,4.2722283e-08,5.2931933958982376e-05,6.258513957310893e-07,1.0908049750148082e-06,0.0,4.9355535e-06,False,WDR36; WD repeat domain
hsa:8417,1.35360465e-09,1.6770852798379583e-06,5.95042646645213e-05,0.00014510303554460992,0.0,0.0009040371,False,STX7; syntaxin
hsa:971,1.2158103e-06,0.0015063612238664903,1.0840875014009898e-05,3.1584269013875e-05,0.0,0.00024715014,False,CD72; CD72
hsa:9785,0.0,0.0,6.999107307069306e-08,2.4279125730645136e-07,0.0,1.9033473e-06,False,DHX38; DEAH-box helicase
hsa:7138,6.903774849999999e-10,8.553619534515124e-07,8.043901651668315e-08,4.562046813141846e-07,0.0,6.1065803e-06,False,TNNT1; troponin T1
hsa:575,0.0,0.0,0.00013344698916223564,0.0002687260386023395,0.0,0.0012350846,False,ADGRB1; adhesion G protein-coupled receptor
hsa:120065,0.0,0.0,3.2401499316831685e-08,4.184196738462365e-07,0.0,5.9373974e-06,False,OR5P2; olfactory receptor family 5 subfamily P member
hsa:144193,2.00866045e-06,0.002488684471413193,2.1063728049415844e-05,4.167001056575904e-05,0.0,0.00028144388,False,AMDHD1; amidohydrolase domain containing
hsa:2870,0.0,0.0,1.939146145266337e-05,9.454689865891932e-05,0.0,0.0011177029,False,GRK6; G protein-coupled receptor kinase
hsa:23035,2.8045772e-08,3.474807166397632e-05,1.0095411615049505e-07,1.74830249826692e-07,0.0,1.1474355e-06,False,PHLPP2; PH domain and leucine rich repeat protein phosphatase
hsa:873,0.0,0.0,0.0002218760640777228,0.0004999098428603602,0.0,0.0033207287,False,CBR1; carbonyl reductase
hsa:7592,9.343312e-09,1.1576150407087739e-05,4.1771624214356435e-08,7.988647826710822e-08,0.0,4.099833e-07,False,ZNF41; zinc finger protein
hsa:2547,1.2662647999999998e-06,0.0015688731982835286,0.00014838105247051985,0.0003123430858291527,0.0,0.0020889472,False,XRCC6; X-ray repair cross complementing
hsa:5013,2.46405355e-11,3.0529061328486614e-08,5.159945355757733e-07,2.182884624543072e-06,0.0,2.1480126e-05,False,OTX1; orthodenticle homeobox
hsa:23498,0.0,0.0,3.57780365740807e-05,0.00016094716749783073,0.0,0.0014645605,False,HAAO; 3-hydroxyanthranilate
hsa:390151,0.0,0.0,4.0943214306930696e-07,5.741114230798159e-06,0.0,8.159453e-05,False,OR8H2; olfactory receptor family 8 subfamily H member
hsa:22992,0.0,0.0,1.540515798187261e-05,4.9914752570829666e-05,0.0,0.00027176292,False,KDM2A; lysine demethylase
hsa:3551,0.0,0.0,0.00017907565824900994,0.0003427031840094368,0.0,0.0016811064,False,IKBKB; inhibitor of nuclear factor kappa B kinase subunit
hsa:5270,0.0,0.0,9.705220355366335e-06,2.5259814942449237e-05,0.0,0.0001743363,False,SERPINE2; serpin family E member
hsa:338674,0.0,0.0,1.0581573762376238e-07,1.5039242023552556e-06,0.0,2.1374779e-05,False,OR5F1; olfactory receptor family 5 subfamily F member
hsa:8520,0.0,0.0,4.262096132252476e-05,0.0001345206838614689,0.0,0.0010116035,False,HAT1; histone acetyltransferase
hsa:9842,9.2710695e-08,0.00011486643597748176,4.84465667090594e-07,1.1936939741012173e-06,0.0,1.2016388e-05,False,PLEKHM1; pleckstrin homology and RUN domain containing
hsa:9104,4.531011399999999e-06,0.0056138197528487945,3.428197370341583e-05,6.460099394998331e-05,0.0,0.0004240325,False,RGN;
hsa:128,0.0,0.0,0.000499104245508911,0.0010707711504301179,0.0,0.007823088,False,ADH5; alcohol dehydrogenase 5 (class III)
hsa:84464,7.256896600000001e-07,0.000899112932654755,3.548626225460397e-05,7.757609178438884e-05,0.0,0.00045799653,False,SLX4; SLX4 structure-specific endonuclease
hsa:4128,0.00086897235,1.0766369166737115,0.0016669252977064355,0.002041710033953418,0.0,0.010294773,True,MAOA; monoamine oxidase
hsa:147929,1.3921304e-09,1.724817805150809e-06,2.5075735466163362e-08,7.588512475694326e-08,0.0,7.1078097e-07,False,ZNF565; zinc finger protein
hsa:1840,1.9039616e-06,0.002358964984891805,0.00039854931278188107,0.0008248466076106731,0.0,0.005683323,False,DTX1; deltex E3 ubiquitin ligase
hsa:7060,8.117743849999999e-07,0.0010057699429689545,1.9994493845396036e-05,9.152182881595725e-05,0.0,0.0011291577,False,THBS4; thrombospondin
hsa:84133,1.144584575e-08,1.418114175554942e-05,1.4540275883826726e-06,1.0039886787581912e-05,0.0,0.00012882674,False,ZNRF3; zinc and ring finger
hsa:7941,0.0,0.0,4.482919546366337e-06,1.2868714759558472e-05,0.0,0.00010579088,False,PLA2G7; phospholipase A2 group
hsa:6138,6.3257635e-08,7.837476658776434e-05,9.495871661732675e-07,2.2026531845381028e-06,0.0,1.4348837e-05,False,RPL15; ribosomal protein
hsa:4712,0.0,0.0,1.6397296132673269e-06,3.0298433008488284e-06,0.0,1.9619267e-05,False,NDUFB6; NADH:ubiquinone oxidoreductase subunit
hsa:9986,4.4778726999999996e-07,0.000554798211586984,0.00024011698824879496,0.0008460265992437187,0.0,0.0051662023,False,RCE1; Ras converting CAAX endopeptidase
hsa:11335,1.080284e-06,0.0013384472301011003,0.00022302771280755445,0.0008808655276932737,0.0,0.00517972,False,CBX3; chromobox
hsa:8698,3.24505685e-07,0.0004020551403522686,8.984243228818318e-06,1.7548814499844315e-05,0.0,9.589486e-05,False,S1PR4; sphingosine-1-phosphate receptor
hsa:4794,8.940309499999999e-06,0.011076839503798584,6.76496557168317e-05,0.0001332105203396086,0.0,0.00073348696,False,NFKBIE; NFKB inhibitor
hsa:116931,4.12676075e-08,5.112962420185284e-05,1.7986342311732676e-06,7.427361853898738e-06,0.0,8.308515e-05,False,MED12L; mediator complex subunit
hsa:64419,0.0,0.0,2.7636794360148515e-05,0.00010063649749070739,0.0,0.00057914713,False,MTMR14; myotubularin related protein
hsa:57644,4.4428386e-09,5.504575665247519e-06,3.6186891297752476e-08,1.706358172049763e-07,0.0,1.8798569e-06,False,MYH7B; myosin heavy chain
hsa:5054,0.0,0.0,0.00010345464323316828,0.0002854358827669578,0.0,0.0022899937,False,SERPINE1; serpin family E member
hsa:9322,0.0,0.0,4.243586971992079e-06,3.4471144332984694e-05,0.0,0.00042785125,False,TRIP10; thyroid hormone receptor interactor
hsa:1979,2.6047519e-07,0.00032272281785674674,1.2771579442787284e-05,6.327612624801836e-05,0.0,0.00057939766,False,EIF4EBP2; eukaryotic translation initiation factor 4E binding protein
hsa:51302,0.0,0.0,1.948994966847525e-05,0.00010323716376233636,0.0,0.0012582939,False,CYP39A1; cytochrome P450 family 39 subfamily A member
hsa:84532,0.0,0.0,7.976793679292081e-05,0.0003933175150079537,0.0,0.0040306924,False,ACSS1; acyl-CoA synthetase short chain family member
hsa:27130,0.0,0.0,6.323105534359904e-06,2.3106478334915912e-05,0.0,0.0001583794,False,INVS;
hsa:101954275,0.0,0.0,1.425028977227723e-08,1.1408918272254005e-07,0.0,1.3340398e-06,False,RNU6-7; RNA
hsa:259289,0.0,0.0,0.00015749553635445546,0.0004044561255108742,0.0,0.003308655,False,TAS2R43; taste 2 receptor member
hsa:9354,0.0,0.0,1.1216401531039606e-07,4.0092130901397626e-07,0.0,3.3876902e-06,False,UBE4A; ubiquitination factor
hsa:5522,5.82595235e-06,0.007218222046756682,2.7355730662871273e-05,4.453284790564357e-05,0.0,0.000235267,False,PPP2R2C; protein phosphatase 2 regulatory subunit
hsa:3398,0.0,0.0,5.327358445851483e-05,0.00017461516217519426,0.0,0.0014562511,False,ID2; inhibitor of DNA binding
hsa:257313,0.0,0.0,3.652222686957922e-07,9.135520371193167e-07,0.0,7.464135e-06,False,UTS2B; urotensin
hsa:10437,5.172971999999999e-07,0.0006409194290381555,1.4202075956069299e-05,4.258658434832922e-05,0.0,0.00033995914,False,IFI30; IFI30 lysosomal thiol
hsa:2984,0.0,0.0,2.9189331162239112e-09,2.0570707315602797e-08,0.0,2.8399143e-07,False,GUCY2C; guanylate cyclase
hsa:54543,0.0,0.0,4.881300371248516e-06,2.0227656709920674e-05,0.0,0.00017870922,False,TOMM7; translocase of outer mitochondrial membrane
hsa:2329,0.0,0.0,5.1254892338118816e-05,0.00014701574834353155,0.0,0.0013865884,False,FMO4; flavin containing dimethylaniline monoxygenase
hsa:1259,0.0,0.0,1.4437108114242574e-05,7.871811669223725e-05,0.0,0.0007862869,False,CNGA1; cyclic nucleotide gated channel subunit alpha
hsa:6401,0.0,0.0,3.376180022871287e-05,0.00010651366119494362,0.0,0.00097525655,False,SELE; selectin
hsa:7155,6.2727727e-07,0.0007771822266523248,1.5875244212752478e-05,4.348135443168182e-05,0.0,0.00035759475,False,TOP2B; DNA topoisomerase II
hsa:81873,0.0,0.0,7.937645183581682e-05,0.00022108723043220757,0.0,0.0013438789,False,ARPC5L; actin related protein 2/3 complex subunit 5
hsa:2103,1.1554302e-09,1.4315516574948441e-06,1.2260900851416833e-06,7.324364663688049e-06,0.0,7.183059e-05,False,ESRRB; estrogen related receptor
hsa:3347,0.0,0.0,1.3458572772252473e-06,6.393972441903404e-06,0.0,5.6871228e-05,False,HTN3; histatin
hsa:2584,4.970090800000001e-06,0.006157829112169542,0.0001563868196324257,0.000360044979144682,0.0,0.0024115306,False,GALK1; galactokinase
hsa:9331,1.23851025e-07,0.0001534485944033533,7.055850585668315e-06,1.8100792782432136e-05,0.0,0.00013748008,False,B4GALT6; beta-1
hsa:9126,0.0,0.0,4.175917400248693e-06,1.02073220942869e-05,0.0,5.2565116e-05,False,SMC3; structural maintenance of chromosomes
hsa:7322,3.83028935e-07,0.00047456411193660594,1.3888433036129202e-05,3.599349404974623e-05,0.0,0.00024061218,False,UBE2D2; ubiquitin conjugating enzyme E2
hsa:1793,0.0,0.0,1.578906560915841e-05,6.795508918246756e-05,0.0,0.00050981244,False,DOCK1; dedicator of cytokinesis
hsa:837,4.440333e-09,5.501471284010972e-06,9.246731764955448e-06,3.5625863507353246e-05,0.0,0.00041631452,False,CASP4; caspase
hsa:11273,1.82658075e-08,2.2630918771299863e-05,1.799239031970297e-07,3.24199238459948e-07,0.0,1.9471177e-06,False,ATXN2L; ataxin 2
hsa:100169761,0.0,0.0,7.306021698623763e-08,5.793855990287701e-07,0.0,7.116647e-06,False,RNA5S10; RNA
hsa:10392,4.80876065e-07,0.0005957944736950346,1.6899505783920797e-05,3.8172763791024114e-05,0.0,0.00022552258,False,NOD1; nucleotide binding oligomerization domain containing
hsa:6696,2.4306026e-06,0.0030114611689579154,8.902989500945544e-05,0.00020021733893187596,0.0,0.0016949082,False,SPP1; secreted phosphoprotein
hsa:10365,0.0,0.0,5.213425325638616e-06,1.3159309890870034e-05,0.0,0.00010091093,False,KLF2; KLF transcription factor
hsa:2919,0.0,0.0,6.893277080148514e-05,0.0002687194350663034,0.0,0.0020679438,False,CXCL1; C-X-C motif chemokine ligand
hsa:29851,2.5767571500000002e-06,0.003192543321997461,9.722876178846537e-05,0.0002885951440664771,0.0,0.0017663027,False,ICOS; inducible T cell
hsa:259294,0.000166826885,0.20669470448015964,0.0003626154884851487,0.0005115303208081925,0.0,0.0037565017,False,TAS2R19; taste 2 receptor member
hsa:3163,0.0,0.0,6.426612341089108e-05,0.0001748348313366817,0.0,0.0015452531,False,HMOX2; heme oxygenase
hsa:89869,0.0,0.0,2.269707217420792e-06,1.0143000499775737e-05,0.0,7.736451e-05,False,PLCZ1; phospholipase C zeta
hsa:598,4.0456913000000004e-05,0.05012519221176209,0.00041210088106435644,0.0007835573138961783,0.0,0.004662362,False,BCL2L1; BCL2 like
hsa:23462,0.0,0.0,6.549496272275249e-05,0.00030154622075898664,0.0,0.002794325,False,HEY1; hes related family bHLH transcription factor with YRPW motif
hsa:933,2.55276e-08,3.162811400625099e-05,6.053947377801979e-06,1.2995139200309955e-05,0.0,0.000107637556,False,CD22; CD22
hsa:10336,2.13549595e-06,0.0026458307622529054,7.70115514962079e-05,0.0001641060514277897,0.0,0.0009117071,False,PCGF3; polycomb group ring finger
hsa:51384,9.9196365e-07,0.0012290203314160697,2.350001248693812e-05,0.00015659747326189887,0.0,0.002180644,False,WNT16; Wnt family member
hsa:1604,0.0,0.0,8.516786604009903e-05,0.00024427589300008476,0.0,0.0017963324,False,CD55; CD55 molecule (Cromer blood
hsa:115752,2.6945298999999996e-07,0.00033384610723472663,1.0588882362970295e-06,2.07887909931227e-06,0.0,1.3249912e-05,False,DIS3L; DIS3 like exosome 3'-5'
hsa:390038,0.0,0.0,1.5272660792079208e-08,1.4626327227637653e-07,-0.0,1.4931425e-06,False,OR51D1; olfactory receptor family 51 subfamily D member
hsa:1848,0.0,0.0,1.0511231241900994e-05,7.12502946547748e-05,0.0,0.00097104855,False,DUSP6; dual specificity phosphatase
hsa:733,9.627516e-07,0.0011928272679178832,3.6212951811762387e-05,0.00011745557659389403,0.0,0.0010954799,False,C8G; complement C8 gamma
hsa:11108,0.0,0.0,2.6500556364742574e-06,5.497564944245444e-06,0.0,2.487769e-05,False,PRDM4; PR/SET domain
hsa:4318,0.0,0.0,0.00011097300146435644,0.0001971225805462604,0.0,0.00078624237,False,MMP9; matrix metallopeptidase
hsa:79092,1.6928496e-08,2.097402033259546e-05,1.1731741908499997e-06,2.141471106242615e-06,0.0,1.0336053e-05,False,CARD14; caspase recruitment domain family member
hsa:1781,0.0,0.0,0.00013345740459683167,0.0003152346501484769,0.0,0.002706396,False,DYNC1I2; dynein cytoplasmic 1 intermediate chain
hsa:6760,0.0,0.0,4.629854974995049e-06,1.8035986918867304e-05,0.0,0.00021485382,False,SS18; SS18 subunit of BAF chromatin remodeling
hsa:91181,0.0,0.0,2.603870733727722e-09,6.4000401077965195e-09,0.0,3.6050253e-08,False,NUP210L; nucleoporin 210
hsa:137682,0.0,0.0,1.2074598598886134e-06,2.901357305537038e-06,0.0,1.725847e-05,False,NDUFAF6; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:7559,0.0,0.0,9.588236970693063e-08,2.3482059640183426e-07,0.0,1.2741914e-06,False,ZNF12; zinc finger protein
hsa:9536,0.0,0.0,2.5578505570420812e-05,0.00011460168315083017,0.0,0.0010126564,False,PTGES; prostaglandin E
hsa:407053,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR96; microRNA
hsa:24137,1.0992425e-08,1.3619363790766213e-05,1.1689070474805446e-06,4.225079931070424e-06,0.0,2.4564606e-05,False,KIF4A; kinesin family member
hsa:6720,0.0,0.0,1.5637204918316832e-05,6.126012224413688e-05,0.0,0.0004891375,False,SREBF1; sterol regulatory element binding transcription factor
hsa:79661,0.0,0.0,4.7011299366881185e-06,1.9334719768192457e-05,0.0,0.00017425173,False,NEIL1; nei like DNA glycosylase
hsa:390148,-0.0,0.0,3.5802453465346533e-07,3.6879244574860487e-06,-0.0,4.782553e-05,False,OR5W2; olfactory receptor family 5 subfamily W member
hsa:501,4.74912575e-05,0.058840584563774986,0.0006189832350816831,0.001247455854645421,0.0,0.007124566,False,ALDH7A1; aldehyde dehydrogenase 7 family member
hsa:6523,1.95076275e-06,0.002416950542007384,1.4503616386826728e-05,4.2295989697296414e-05,0.0,0.00034583863,False,SLC5A1; solute carrier family 5 member
hsa:100500809,0.0,0.0,2.1224e-09,3.016497166449853e-08,0.0,4.287248e-07,False,MIR23C; microRNA
hsa:81839,1.12751955e-08,1.396970998906157e-05,1.2294110542594853e-06,9.84437745655731e-06,0.0,0.00012626627,False,VANGL1; VANGL planar cell polarity protein
hsa:4254,0.0,0.0,2.368118277940595e-05,9.071455390505714e-05,0.0,0.0009918984,False,KITLG; KIT
hsa:27179,0.0,0.0,4.883410410099009e-07,2.179472990819959e-06,0.0,1.9668092e-05,False,IL36A; interleukin 36
hsa:57084,0.0,0.0,0.00011762492123920799,0.000788047141978572,0.0,0.009970534,False,SLC17A6; solute carrier family 17 member
hsa:442117,1.65695115e-06,0.0020529246727067443,0.0001372589005303465,0.0003810651579898537,0.0,0.0029077525,False,GALNTL6; polypeptide N-acetylgalactosaminyltransferase like
hsa:23649,1.72427285e-08,2.136334723110802e-05,8.472853133478218e-06,2.442230622575729e-05,0.0,0.0002010823,False,POLA2; DNA polymerase alpha 2
hsa:197320,0.0,0.0,7.599008094801978e-08,1.588546333539955e-07,0.0,8.9451567e-07,False,ZNF778; zinc finger protein
hsa:6915,0.0,0.0,3.907826232396039e-06,1.581600031913017e-05,0.0,0.00017632273,False,TBXA2R; thromboxane A2
hsa:390441,1.20689e-06,0.0014953091756766896,9.333587299917822e-05,0.00035031287096295847,0.0,0.004036105,False,OR11H7; olfactory receptor family 11 subfamily H member 7
hsa:3161,3.2333578e-06,0.004006056547478059,8.098038490123766e-05,0.0001636648009886431,0.0,0.0009100451,False,HMMR; hyaluronan mediated motility
hsa:54541,0.0,0.0,2.3832345400247523e-06,5.557262338125535e-06,0.0,4.76869e-05,False,DDIT4; DNA damage inducible transcript
hsa:85315,0.0,0.0,2.1754221653465346e-07,4.143635500845179e-07,0.0,2.6759e-06,False,PAQR8; progestin and adipoQ receptor family member
hsa:3447,0.0,0.0,1.4682453168316832e-07,1.5991238590588005e-06,0.0,2.1982467e-05,False,IFNA13; interferon alpha
hsa:9965,1.49079035e-07,0.00018470552323453368,1.351195048723515e-05,3.913707711434942e-05,0.0,0.0002669151,False,FGF19; fibroblast growth factor
hsa:2793,0.0,0.0,4.316983098336631e-05,9.864196072660616e-05,0.0,0.00059025333,False,GNGT2; G protein subunit gamma transducin
hsa:2359,0.0,0.0,4.669681007648514e-05,0.00015644240136399569,0.0,0.0011773482,False,FPR3; formyl peptide receptor
hsa:3304,0.0,0.0,7.487109779455447e-05,0.00012088424151600349,0.0,0.00057836145,False,HSPA1B; heat shock protein family A (Hsp70) member
hsa:84189,0.0,0.0,4.676290203464393e-06,1.3932770222796133e-05,0.0,0.00010311013,False,SLITRK6; SLIT and NTRK like family member
hsa:388112,5.69129545e-09,7.051385219756559e-06,5.259023982485146e-07,1.8182167440131813e-06,0.0,1.4433155e-05,False,NANOGP8; Nanog homeobox retrogene
hsa:63940,0.0,0.0,2.5452394541584156e-07,6.251908914470102e-07,0.0,3.5412195e-06,False,GPSM3; G protein signaling modulator
hsa:135948,0.0,0.0,7.184966134653464e-07,7.885199415172744e-06,-0.0,0.00011023175,False,OR2F2; olfactory receptor family 2 subfamily F member
hsa:1244,1.793932e-05,0.022226408207376272,0.00012830317472821784,0.0003013521834018516,0.0,0.0034577032,False,ABCC2; ATP binding cassette subfamily C member
hsa:8819,0.0,0.0,7.837691715841584e-08,2.2070890797723438e-07,0.0,1.9819292e-06,False,SAP30; Sin3A associated protein
hsa:84440,0.0,0.0,3.2482907792871283e-07,7.059879130011515e-07,0.0,5.7427683e-06,False,RAB11FIP4; RAB11 family interacting protein
hsa:55740,1.8794662500000002e-07,0.00023286158050855166,6.025049208316834e-06,3.360107398236806e-05,0.0,0.00045833807,False,ENAH; ENAH actin
hsa:2779,0.0,0.0,6.450949606663861e-06,4.06372925530892e-05,0.0,0.00053347327,False,GNAT1; G protein subunit alpha transducin
hsa:5228,1.2725724500000001e-06,0.0015766882327290519,1.868712589752476e-06,2.2555588979986988e-06,0.0,9.018535e-06,False,PGF; placental growth
hsa:112,0.0,0.0,0.001010715003138614,0.0018444060757329096,0.0,0.006683472,False,ADCY6; adenylate cyclase
hsa:496,0.0,0.0,6.055555919054454e-07,4.799643968731048e-06,0.0,5.6991987e-05,False,ATP4B; ATPase H+/K+ transporting subunit
hsa:204219,0.0,0.0,6.272162833321783e-07,1.7960057863101539e-06,0.0,1.3201603e-05,False,CERS3; ceramide synthase
hsa:23550,0.0,0.0,1.8101476228506433e-07,3.632638457673603e-07,0.0,2.302694e-06,False,PSD4; pleckstrin and Sec7 domain containing
hsa:11140,4.069144e-07,0.0005041576581419803,1.1492948229709405e-06,1.719186591584643e-06,0.0,1.0433912e-05,False,CDC37; cell division cycle 37
hsa:3351,2.03535055e-05,0.02521752896397846,0.00011457230396633668,0.00020425176863379232,0.0,0.0011951976,False,HTR1B; 5-hydroxytryptamine receptor
hsa:3176,0.0,0.0,0.0001138418145259654,0.00033638538109677125,0.0,0.0034354508,False,HNMT; histamine
hsa:9663,0.0,0.0,5.3385249472772286e-05,0.00011027312047595279,0.0,0.0006068225,False,LPIN2; lipin
hsa:8836,6.97968745e-06,0.008647673514024009,6.656415276881189e-05,0.00013085033486424352,0.0,0.0008380114,False,GGH; gamma-glutamyl
hsa:10905,7.610268649999999e-07,0.0009428949234569557,4.9454574649767324e-05,0.00010577699608821511,0.0,0.00078778336,False,MAN1A2; mannosidase alpha class 1A member
hsa:23305,7.152644000000001e-05,0.0886196273359529,0.0003036139584665842,0.0005431450215718,0.0,0.003467973,False,ACSL6; acyl-CoA synthetase long chain family member
hsa:3074,0.0,0.0,0.0003016518600643565,0.0006072669525489153,0.0,0.0061091427,False,HEXB; hexosaminidase subunit
hsa:8881,0.0,0.0,1.4757513888881184e-05,5.294490237015096e-05,0.0,0.0005266984,False,CDC16; cell division cycle
hsa:6555,0.0,0.0,3.234815292475247e-07,1.7963923860136027e-06,0.0,1.6983671e-05,False,SLC10A2; solute carrier family 10 member
hsa:203,3.0174271999999997e-06,0.0037385234603786763,3.2586881136831674e-05,8.118555289248737e-05,0.0,0.0007679276,False,AK1; adenylate kinase
hsa:23483,0.0,0.0,4.453527908282176e-06,9.087320153399637e-06,0.0,6.3854735e-05,False,TGDS; TDP-glucose
hsa:2588,0.0,0.0,1.8462779944950493e-05,0.00010699584358746426,0.0,0.001376225,False,GALNS; galactosamine
hsa:10294,2.5486814e-10,3.157758108275411e-07,2.9072520922678206e-07,9.183433373476666e-07,0.0,8.64027e-06,False,DNAJA2; DnaJ heat shock protein family (Hsp40) member
hsa:3972,0.0,0.0,1.7546889411881188e-05,0.00010296417388995209,0.0,0.0013243613,False,LHB; luteinizing hormone subunit
hsa:145173,1.1423897699999999e-07,0.0001415394862232832,6.292014710011879e-05,0.00019499655477389944,0.0,0.0013021571,False,B3GLCT; beta
hsa:2214,0.0,0.0,4.8664894818712854e-05,0.00020797742573599898,0.0,0.0019418441,False,FCGR3A; Fc gamma receptor
hsa:8085,5.196237e-06,0.006438019094607391,4.5100539959361374e-05,0.00010103366510258018,0.0,0.00076377264,False,KMT2D; lysine methyltransferase
hsa:58191,0.0,0.0,6.840309581980198e-06,2.7022023239821468e-05,0.0,0.0003260531,False,CXCL16; C-X-C motif chemokine ligand
hsa:7293,3.2260607000000004e-08,3.997015607056123e-05,1.8754773524003463e-05,5.92207485097577e-05,0.0,0.0006504187,False,TNFRSF4; TNF receptor superfamily member
hsa:4705,1.585479e-06,0.0019643723094422043,3.940970273861387e-06,5.673208293533041e-06,0.0,2.6593942e-05,False,NDUFA10; NADH:ubiquinone oxidoreductase subunit
hsa:115196,0.0,0.0,3.3901266097029694e-08,6.877951765338072e-08,0.0,3.755957e-07,False,ZNF554; zinc finger protein
hsa:9470,0.0,0.0,3.284715479522772e-05,6.799364971049135e-05,0.0,0.00045930987,False,EIF4E2; eukaryotic translation initiation factor 4E family member
hsa:80110,0.0,0.0,4.703330457920791e-08,7.440461226668585e-08,0.0,3.0080585e-07,False,ZNF614; zinc finger protein
hsa:6737,0.0,0.0,3.483624408450495e-06,2.057815124232484e-05,0.0,0.00019157193,False,TRIM21; tripartite motif containing
hsa:6500,0.00018298775499999998,0.2267176537115876,0.0017380371280445541,0.004136988079916194,0.0,0.021541005,False,SKP1; S-phase kinase associated protein
hsa:138799,0.0,0.0,9.189061497485149e-06,3.904273900829376e-05,0.0,0.00029126686,False,OR13C5; olfactory receptor family 13 subfamily C member
hsa:222,0.0,0.0,4.720033199816832e-05,0.00030767219794854177,0.0,0.0038968218,False,ALDH3B2; aldehyde dehydrogenase 3 family member
hsa:7272,3.1018328000000003e-09,3.843100073125901e-06,2.222785483511089e-06,5.394962772693079e-06,0.0,3.1727934e-05,False,TTK; TTK protein
hsa:27232,0.0,0.0,3.204783205400989e-05,9.931761827529851e-05,0.0,0.00072932703,False,GNMT; glycine
hsa:552,0.0,0.0,9.389022196034649e-06,4.444831327321332e-05,0.0,0.0005592754,False,AVPR1A; arginine vasopressin receptor
hsa:8760,0.0,0.0,1.0962605523465354e-05,3.365918389625532e-05,0.0,0.000269727,False,CDS2; CDP-diacylglycerol synthase
hsa:55733,0.0,0.0,3.885519607193564e-05,0.0001235483572732706,0.0,0.001010707,False,HHAT; hedgehog
hsa:5296,0.000692675005,0.858208528315254,0.0011234037232772279,0.0014215819287535802,0.0,0.009321619,True,PIK3R2; phosphoinositide-3-kinase regulatory subunit
hsa:5042,0.0,0.0,2.3866872416325245e-06,1.2116681489135974e-05,0.0,0.00013772344,False,PABPC3; poly(A) binding protein cytoplasmic
hsa:4583,0.0,0.0,5.293555608910891e-09,2.7337616310665473e-08,0.0,3.223015e-07,False,MUC2; mucin 2
hsa:293,2.8727202500000002e-05,0.03559234850713183,0.0004108474205691089,0.0009613938347470805,0.0,0.0056130383,False,SLC25A6; solute carrier family 25 member
hsa:5471,1.29732785e-08,1.6073596085524873e-05,8.19386420362525e-05,0.00028535686249113093,0.0,0.0017701592,False,PPAT; phosphoribosyl pyrophosphate
hsa:390066,0.0,0.0,3.08231440049505e-07,1.819241419185054e-06,0.0,1.7600038e-05,False,OR52D1; olfactory receptor family 52 subfamily D member
hsa:338382,0.0,0.0,1.2748065953386143e-05,4.04417757994887e-05,0.0,0.00030421768,False,RAB7B; RAB7B
hsa:253639,1.9556731e-10,2.4230343536312965e-07,2.6377061253514845e-08,4.640792353354226e-08,0.0,2.4144333e-07,False,ZNF620; zinc finger protein
hsa:114799,4.8416643e-08,5.998711608627345e-05,7.58624680879208e-07,1.848883203417829e-06,0.0,9.642737e-06,False,ESCO1; establishment of sister chromatid cohesion N-acetyltransferase
hsa:391192,0.0,0.0,7.661721935252475e-06,2.6674749773683456e-05,0.0,0.00017945941,False,OR2L3; olfactory receptor family 2 subfamily L member
hsa:9344,0.0,0.0,1.7436865826732672e-07,4.487561373428616e-07,0.0,3.7147809e-06,False,TAOK2; TAO kinase
hsa:390077,0.0,0.0,3.169755252049505e-06,2.7000518760370197e-05,0.0,0.00031629257,False,OR52N2; olfactory receptor family 52 subfamily N member
hsa:6476,0.0,0.0,2.3520633866336632e-07,1.1349815258175439e-06,0.0,1.2421762e-05,False,SI;
hsa:3665,0.0,0.0,5.29579873476485e-05,0.0001384746933036665,0.0,0.00093669543,False,IRF7; interferon regulatory factor
hsa:3645,0.0,0.0,0.00010454693121338811,0.0003212481763318035,0.0,0.002803353,False,INSRR; insulin receptor related
hsa:153562,1.10267365e-09,1.3661874956474131e-06,3.199100463739109e-07,1.972274765675699e-06,0.0,2.056589e-05,False,MARVELD2; MARVEL domain containing
hsa:2162,0.0,0.0,8.945206173514852e-07,3.4819187146768356e-06,0.0,3.101332e-05,False,F13A1; coagulation factor XIII A
hsa:23220,0.0,0.0,9.18932506418812e-05,0.00026743701684969566,0.0,0.0017205639,False,DTX4; deltex E3 ubiquitin ligase
hsa:147179,3.1644993e-07,0.0003920742436934983,8.228843379752475e-07,1.3360505426900406e-06,0.0,7.923507e-06,False,WIPF2; WAS/WASL interacting protein family member
hsa:4829,0.0,0.0,1.1848823023114852e-07,4.375967641365757e-07,0.0,3.425321e-06,False,NMBR; neuromedin B
hsa:3988,0.0,0.0,8.783856214623761e-05,0.0002164736907511339,0.0,0.0014450945,False,LIPA; lipase A
hsa:201633,8.851355750000001e-09,1.096662783696412e-05,8.6605629345693e-07,2.048345140844088e-06,0.0,1.7431217e-05,False,TIGIT; T cell immunoreceptor with Ig and ITIM
hsa:81488,6.21567675e-07,0.0007701081687076091,9.942164812722772e-06,2.679908486323566e-05,0.0,0.00016311325,False,POLR2M; RNA polymerase II subunit
hsa:1317,0.0,0.0,6.504154567294555e-05,0.00012167820715994882,0.0,0.00079086813,False,SLC31A1; solute carrier family 31 member
hsa:282775,0.0,0.0,4.795132673267327e-10,6.8151640226451375e-09,-0.0,9.686168e-08,False,OR5J2; olfactory receptor family 5 subfamily J member
hsa:10501,0.0,0.0,8.034275619287128e-07,5.6553160300337845e-06,0.0,7.596865e-05,False,SEMA6B; semaphorin
hsa:56894,0.0,0.0,7.368028957787127e-05,0.0004118363408569418,0.0,0.004873547,False,AGPAT3; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:3600,5.830435999999999e-06,0.007223777186815447,4.829257822623763e-05,9.249169286367033e-05,0.0,0.0005221345,False,IL15; interleukin
hsa:3560,0.0,0.0,0.00010488249047623762,0.0003993508190891171,0.0,0.0030143238,False,IL2RB; interleukin 2 receptor subunit
hsa:5032,0.0,0.0,1.4541029288975256e-05,3.3570591629829477e-05,0.0,0.00019886522,False,P2RY11; purinergic receptor
hsa:123099,0.0,0.0,3.1839035930693063e-06,1.496724172484308e-05,0.0,0.00019637904,False,DEGS2; delta 4-desaturase
hsa:438,0.0,0.0,4.5164848700445546e-07,1.7401469260060195e-06,0.0,1.539625e-05,False,ASMT; acetylserotonin
hsa:8178,2.72295375e-07,0.00033736775740276663,8.681323930752473e-06,2.5666673359409607e-05,0.0,0.00024941962,False,ELL; elongation factor for RNA polymerase
hsa:51208,2.5309157e-09,3.13574681128702e-06,1.3009377321391095e-06,4.567764405459178e-06,0.0,4.129892e-05,False,CLDN18; claudin
hsa:6364,0.0,0.0,2.6629219971618816e-05,0.0001196932450328181,0.0,0.0014114997,False,CCL20; C-C motif chemokine ligand
hsa:81472,0.0,0.0,2.571603211089109e-07,1.2435838543542407e-06,0.0,1.5525748e-05,False,OR2C3; olfactory receptor family 2 subfamily C member
hsa:54108,4.59166905e-09,5.68897319733834e-06,2.1268342694423767e-06,5.481627945083677e-06,0.0,4.065929e-05,False,CHRAC1; chromatin accessibility complex subunit
hsa:54981,0.0,0.0,9.597916891577718e-05,0.00028707044545510336,0.0,0.0026147908,False,NMRK1; nicotinamide riboside kinase
hsa:219,1.66893175e-06,0.002067768362778012,0.00023327621293811867,0.0005724386577592318,0.0,0.0035712132,False,ALDH1B1; aldehyde dehydrogenase 1 family member
hsa:5176,1.01490458e-07,0.00012574436203053276,4.557810680663365e-06,1.4459531312409674e-05,0.0,0.00011367913,False,SERPINF1; serpin family F member
hsa:5718,0.0,0.0,3.4726675513910894e-06,9.157903766640787e-06,0.0,7.924504e-05,False,PSMD12; proteasome 26S subunit
hsa:4258,0.0,0.0,0.00014198845183316836,0.00026845432717751376,0.0,0.0020374605,False,MGST2; microsomal glutathione S-transferase
hsa:4218,0.0,0.0,5.1254419938613845e-05,0.00016394054585955702,0.0,0.0013117602,False,RAB8A; RAB8A
hsa:10138,0.0,0.0,3.288346817990099e-06,8.336134552146485e-06,0.0,5.4459375e-05,False,YAF2; YY1 associated factor
hsa:11014,3.26734665e-07,0.0004048167957197005,3.0449193132701793e-05,7.111592388280145e-05,0.0,0.0004068518,False,KDELR2; KDEL endoplasmic reticulum protein retention receptor
hsa:5563,0.000183450155,0.22729055676226576,0.0008557587109510892,0.0016430378844790746,0.0,0.008608774,False,PRKAA2; protein kinase AMP-activated catalytic subunit alpha
hsa:9019,1.40776625e-06,0.0017441902665801892,1.1428289517594062e-05,2.6909561621283716e-05,0.0,0.00021989841,False,MPZL1; myelin protein zero like
hsa:7767,1.0460932999999999e-08,1.2960857328372158e-05,1.119390538728911e-07,1.9461827277834703e-07,0.0,9.0370685e-07,False,ZNF224; zinc finger protein
hsa:27125,0.0,0.0,6.5178535884306905e-06,1.80917320570669e-05,0.0,0.00012144245,False,AFF4; ALF transcription elongation factor
hsa:55432,0.0,0.0,3.257312337784653e-07,8.020367210208901e-07,0.0,4.873359e-06,False,YOD1; YOD1
hsa:64805,0.0,0.0,9.625145078021782e-06,5.143910494549846e-05,0.0,0.00058438146,False,P2RY12; purinergic receptor
hsa:57468,5.112927199999999e-07,0.0006334800153060281,7.913099369510452e-05,0.000244576550650212,0.0,0.0019140258,False,SLC12A5; solute carrier family 12 member
hsa:100169758,0.0,0.0,5.003781032628713e-07,4.486661144426882e-06,0.0,5.967335e-05,False,RNA5S7; RNA
hsa:2271,0.0,0.0,0.00010846209789702968,0.00036237794370791513,0.0,0.002474554,False,FH; fumarate
hsa:79590,0.0,0.0,1.1914696470396043e-07,4.0933257973742806e-07,0.0,4.2367005e-06,False,MRPL24; mitochondrial ribosomal protein
hsa:10856,3.770349e-10,4.671376393211834e-07,4.554738024602474e-06,1.528324094773287e-05,0.0,9.637008e-05,False,RUVBL2; RuvB like AAA ATPase
hsa:374899,0.0,0.0,6.3977205789108896e-09,2.5511972110634733e-08,0.0,1.70621e-07,False,ZNF829; zinc finger protein
hsa:80380,6.995062799999999e-08,8.666723221896505e-05,1.105515676160396e-06,1.9167161999536598e-06,0.0,1.1748323e-05,False,PDCD1LG2; programmed cell death 1 ligand
hsa:23451,0.0,0.0,1.0502923359532672e-07,3.269274476694277e-07,0.0,2.5996574e-06,False,SF3B1; splicing factor 3b subunit
hsa:174,0.0,0.0,4.1988118240099e-07,4.245837139123001e-06,0.0,5.9838516e-05,False,AFP; alpha
hsa:8383,0.0,0.0,9.786237623762376e-09,1.3908856983737442e-07,-0.0,1.97682e-06,False,OR1A1; olfactory receptor family 1 subfamily A member
hsa:51427,0.0,0.0,4.550772764801979e-08,9.62357263485299e-08,0.0,5.175184e-07,False,ZNF107; zinc finger protein
hsa:54429,5.3256168e-05,0.06598317715100738,0.00032944411039405953,0.000524538739379232,0.0,0.0021201672,False,TAS2R5; taste 2 receptor member
hsa:440073,2.5886627000000002e-08,3.207294026830941e-05,4.669787129574256e-07,1.161061218003022e-06,0.0,8.276169e-06,False,IQSEC3; IQ motif and Sec7 domain ArfGEF
hsa:51077,2.1808956e-07,0.0002702079892842694,1.5879839614113866e-06,4.242709334505741e-06,0.0,3.6356098e-05,False,FCF1; FCF1 rRNA-processing
hsa:3627,0.0,0.0,0.00015399333023599003,0.00032997453175522435,0.0,0.002844329,False,CXCL10; C-X-C motif chemokine ligand
hsa:4493,0.0,0.0,4.454328074907428e-05,0.00019923689838164876,0.0,0.0014478524,False,MT1E; metallothionein
hsa:4240,0.0,0.0,1.2887672921628712e-05,6.445453122154137e-05,0.0,0.0005722657,False,MFGE8; milk fat globule EGF and factor V/VIII domain
hsa:2488,0.0,0.0,3.352873294207921e-07,2.1125245449264416e-06,0.0,1.7822967e-05,False,FSHB; follicle stimulating hormone subunit
hsa:392255,1.4224812e-06,0.001762421753919237,3.4704215018727424e-05,8.593942457899306e-05,0.0,0.00063530105,False,GDF6; growth differentiation factor
hsa:29933,0.0,0.0,3.534542175130989e-06,1.6270046535176505e-05,0.0,0.0001257883,False,GPR132; G protein-coupled receptor
hsa:1667,0.0,0.0,5.811517381742574e-06,2.0938489236754487e-05,0.0,0.00020414733,False,DEFA1; defensin alpha
hsa:285955,8.0312925e-08,9.950588179364631e-05,5.768992257683168e-06,1.8215301578534424e-05,0.0,0.00014525035,False,SPDYE1; speedy/RINGO cell cycle regulator family member
hsa:2979,3.4494051999999998e-06,0.004273734347112733,0.0001447829164234159,0.0003306870420681716,0.0,0.0022460811,False,GUCA1B; guanylate cyclase activator
hsa:56034,0.0,0.0,3.0202012035346542e-05,0.00010890435857419647,0.0,0.0010865688,False,PDGFC; platelet derived growth factor
hsa:91653,0.0,0.0,3.300134606392079e-05,0.00011945222693472464,0.0,0.0009499871,False,BOC; BOC cell adhesion associated
hsa:9267,0.0,0.0,4.156389039752477e-06,1.1162412933669428e-05,0.0,8.765854e-05,False,CYTH1; cytohesin
hsa:2528,0.0,0.0,9.614564546871287e-06,6.664710755339254e-05,0.0,0.00092509517,False,FUT6; fucosyltransferase
hsa:53630,1.4083553000000002e-07,0.0001744920086091439,3.884996005548761e-05,0.00010925892546855619,0.0,0.0011609823,False,BCO1; beta-carotene oxygenase
hsa:125963,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR1M1; olfactory receptor family 1 subfamily M member
hsa:5984,6.74947315e-06,0.008362443248496922,0.0005161198181893071,0.0011611737868766907,0.0,0.0057745846,False,RFC4; replication factor C subunit
hsa:9517,0.0,0.0,1.3375108343267327e-05,3.588099816698424e-05,0.0,0.0002931508,False,SPTLC2; serine palmitoyltransferase long chain base subunit
hsa:5147,4.43568985e-08,5.495718527091084e-05,3.2163309557099006e-06,1.2292861791018429e-05,0.0,0.0001263877,False,PDE6D; phosphodiesterase
hsa:4153,0.0,0.0,3.324928240792078e-07,2.7814786916559557e-06,0.0,3.311009e-05,False,MBL2; mannose binding lectin
hsa:246181,2.7937506499999997e-06,0.003461393317947547,0.00012720551545039602,0.00034638898967615677,0.0,0.0034735363,False,AKR7L; aldo-keto reductase family 7 like
hsa:2673,2.2322270499999997e-05,0.027656783883027516,0.00019695740309702973,0.00037971063130226194,0.0,0.0023431906,False,GFPT1; glutamine--fructose-6-phosphate transaminase
hsa:1594,9.3840558e-07,0.0011626631045747382,8.319882426138614e-06,1.9221212276354807e-05,0.0,0.0001619133,False,CYP27B1; cytochrome P450 family 27 subfamily B member
hsa:390075,0.0,0.0,2.6609688913366336e-07,2.0322219086721834e-06,0.0,2.4807443e-05,False,OR52N5; olfactory receptor family 52 subfamily N member
hsa:5648,2.5485426e-07,0.00031575861382420324,8.975246115224754e-06,2.1322200200607936e-05,0.0,0.00013666124,False,MASP1; MBL associated serine protease
hsa:10345,0.0,0.0,2.4752873931668318e-06,1.2429259443364645e-05,0.0,0.000114859664,False,TRDN;
hsa:84172,5.956234e-07,0.0007379638038824973,1.4683398009381193e-05,5.012158700495167e-05,0.0,0.00039665657,False,POLR1B; RNA polymerase I subunit
hsa:57576,1.0144339e-08,1.2568604585235519e-05,7.378998841237627e-08,3.845922597096393e-07,0.0,4.674457e-06,False,KIF17; kinesin family member
hsa:1944,7.659914500000001e-07,0.0009490459310085361,1.4756610831554461e-05,5.2083754872273206e-05,0.0,0.00049431954,False,EFNA3; ephrin
hsa:5886,3.01823865e-07,0.00037395288284160314,7.21880200498515e-06,1.3383066858520712e-05,0.0,6.759561e-05,False,RAD23A; RAD23 homolog A
hsa:4915,0.0,0.0,2.694899399757425e-06,7.121509658089859e-06,0.0,4.4614648e-05,False,NTRK2; neurotrophic receptor tyrosine kinase
hsa:4799,0.0,0.0,4.858567214408911e-07,1.460988559694909e-06,0.0,7.396309e-06,False,NFX1; nuclear transcription factor
hsa:121275,2.13624695e-06,0.002646761234119383,5.5927948690792084e-05,0.00013256894995644712,0.0,0.0007892582,False,OR10AD1; olfactory receptor family 10 subfamily AD member
hsa:51764,1.0030529000000001e-05,0.012427596591728433,0.00011833278507432676,0.0002748460926785482,0.0,0.0024394796,False,GNG13; G protein subunit gamma
hsa:10096,9.26326675e-08,0.00011476976168512282,1.52651862810198e-05,3.8744971986237035e-05,0.0,0.00022626836,False,ACTR3; actin related protein
hsa:83990,1.12710675e-06,0.0013964595491238907,0.0001443992940199778,0.0003220392595161141,0.0,0.0020809516,False,BRIP1; BRCA1 interacting helicase
hsa:64579,0.0,0.0,6.373542611485147e-06,3.393611229885094e-05,0.0,0.00030405645,False,NDST4; N-deacetylase and N-sulfotransferase
hsa:25780,0.0,0.0,2.567108964356435e-06,5.468039842411477e-06,0.0,5.6561337e-05,False,RASGRP3; RAS guanyl releasing protein
hsa:142680,3.2943394499999997e-07,0.0004081611420575776,5.846026479127719e-06,1.4880055634416343e-05,0.0,0.00015204959,False,SLC34A3; solute carrier family 34 member
hsa:52,0.0,0.0,0.00010143546114356435,0.0002457141692548127,0.0,0.0016951348,False,ACP1; acid phosphatase
hsa:3925,3.3582663e-08,4.160815329280884e-05,2.9710549978712877e-06,7.694843625575765e-06,0.0,4.5886038e-05,False,STMN1; stathmin
hsa:201514,0.0,0.0,7.487581822564357e-08,1.4455954005432127e-07,0.0,7.225667e-07,False,ZNF584; zinc finger protein
hsa:23583,5.207101300000001e-07,0.0006451479714446237,4.9745832322995043e-05,0.00013769723741001094,0.0,0.0010268787,False,SMUG1; single-strand-selective monofunctional uracil-DNA glycosylase
hsa:677,0.0,0.0,7.921501632128711e-07,2.0596000302381175e-06,0.0,1.7172804e-05,False,ZFP36L1; ZFP36 ring finger protein like
hsa:4025,0.0,0.0,6.64301807128713e-06,2.2109761944943264e-05,0.0,0.00021988183,False,LPO;
hsa:259197,1.27617555e-08,1.5811523914269286e-05,5.202006998888115e-06,1.6886186182213527e-05,0.0,0.00013595488,False,NCR3; natural cytotoxicity triggering receptor
hsa:64091,8.23619025e-07,0.0010204451817020512,1.104341823065347e-05,3.715374918915506e-05,0.0,0.0002671511,False,POPDC2; popeye domain containing
hsa:54788,5.71985735e-09,7.086772762237448e-06,2.992311857774257e-07,5.986233753717522e-07,0.0,2.8779632e-06,False,DNAJB12; DnaJ heat shock protein family (Hsp40) member
hsa:479,0.0,0.0,1.0363105415970294e-08,3.924291871061986e-08,0.0,3.5851633e-07,False,ATP12A; ATPase H+/K+ transporting non-gastric alpha2
hsa:10474,0.0,0.0,6.126174340944354e-07,1.8305508748072709e-06,0.0,9.058438e-06,False,TADA3; transcriptional adaptor
hsa:283162,0.0,0.0,2.1026809935643562e-07,2.067471897578752e-06,-0.0,2.5900657e-05,False,OR8B4; olfactory receptor family 8 subfamily B member
hsa:57187,0.0,0.0,4.4408269736371296e-07,9.481003633513382e-07,0.0,5.41081e-06,False,THOC2; THO complex subunit
hsa:2784,0.000183671165,0.22756438311008226,0.001027050735,0.001531926754771524,0.0,0.0070272577,False,GNB3; G protein subunit beta
hsa:6097,1.5811168e-05,0.019589676431626457,0.00034099210906785645,0.0010650156620635762,0.0,0.009184506,False,RORC; RAR related orphan receptor
hsa:64332,0.0,0.0,8.301551052490002e-07,3.091145222573859e-06,0.0,2.8798568e-05,False,NFKBIZ; NFKB inhibitor
hsa:85007,0.0,0.0,1.3354564372452473e-05,3.6664589311543744e-05,0.0,0.00032409237,False,PHYKPL; 5-phosphohydroxy-L-lysine
hsa:145957,8.289976249999999e-08,0.00010271091443931786,2.2487294641524764e-05,4.6963672173676885e-05,0.0,0.00023067661,False,NRG4; neuregulin
hsa:5273,0.0,0.0,2.3637668769009903e-08,1.6919835415052336e-07,0.0,2.1756887e-06,False,SERPINB10; serpin family B member
hsa:5033,0.0,0.0,3.992704093530089e-05,0.00017164921597836888,0.0,0.001212341,False,P4HA1; prolyl 4-hydroxylase subunit alpha
hsa:63826,5.3129049e-05,0.06582567961013551,0.00034580691827574243,0.000812327590457248,0.0,0.0044108615,False,SRR; serine
hsa:57573,1.080188325e-08,1.3383286909588563e-05,7.591028320148515e-08,1.1376373784564438e-07,0.0,4.918537e-07,False,ZNF471; zinc finger protein
hsa:27040,1.6986698e-05,0.021046131282758885,0.00015762552024658412,0.000342252474618049,0.0,0.002015864,False,LAT; linker for activation of T
hsa:4927,0.0,0.0,1.1519345406732677e-07,3.0183042138980603e-07,0.0,2.1934504e-06,False,NUP88; nucleoporin
hsa:116442,1.48743115e-08,1.8428932601830573e-05,2.0447463245524752e-07,3.363580473359969e-07,0.0,1.6997128e-06,False,RAB39B; RAB39B
hsa:2878,0.0,0.0,0.00012738588069752477,0.0003091183969501114,0.0,0.0015955991,False,GPX3; glutathione peroxidase
hsa:84749,0.0,0.0,2.1364644744465353e-06,7.150664125753773e-06,0.0,5.9890855e-05,False,USP30; ubiquitin specific peptidase
hsa:51700,0.0,0.0,3.4030507304287125e-05,0.00011481372791180397,0.0,0.00082433654,False,CYB5R2; cytochrome b5 reductase
hsa:3978,1.74637695e-05,0.02163721198721732,0.00035298369651178224,0.0007311240511957489,0.0,0.0039287824,False,LIG1; DNA ligase
hsa:406979,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR19A; microRNA
hsa:90233,0.0,0.0,2.5971707181435654e-08,6.052726654559481e-08,0.0,4.811733e-07,False,ZNF551; zinc finger protein
hsa:6037,0.0,0.0,7.804792012198022e-06,5.79097951773522e-05,0.0,0.0007434583,False,RNASE3; ribonuclease A family member
hsa:3596,0.0,0.0,7.015246495128715e-06,2.2317164074981994e-05,0.0,0.00016747823,False,IL13; interleukin
hsa:3625,0.0,0.0,4.2395378848876196e-05,0.00019823509832345398,0.0,0.001945778,False,INHBB; inhibin subunit beta
hsa:7596,0.0,0.0,1.2202602246767326e-07,3.051128044777641e-07,0.0,1.3713652e-06,False,ZNF45; zinc finger protein
hsa:390445,0.0,0.0,5.106688463762376e-07,4.588201138502028e-06,0.0,5.7142e-05,False,OR5AU1; olfactory receptor family 5 subfamily AU member
hsa:2331,5.6962073500000006e-08,7.057470951795111e-05,3.4667820483156424e-05,0.00012255048887047557,0.0,0.000955754,False,FMOD;
hsa:4650,2.78167035e-08,3.4464261018508633e-05,2.1348412147049505e-06,7.066740269663649e-06,0.0,3.6274625e-05,False,MYO9B; myosin
hsa:23395,1.07744903e-07,0.00013349347669488923,1.2876406481742576e-06,2.1383936315808135e-06,0.0,1.9845365e-05,False,LARS2; leucyl-tRNA synthetase 2
hsa:9210,0.0,0.0,3.833235255792079e-06,1.304829816411754e-05,0.0,0.00011104446,False,BMP15; bone morphogenetic protein
hsa:2067,0.0,0.0,8.596590781529706e-05,0.0004132846294285962,0.0,0.003511473,False,ERCC1; ERCC excision repair 1
hsa:6150,5.6979050000000006e-08,7.059574301414453e-05,3.532763406707921e-07,6.901547130240993e-07,0.0,4.4888975e-06,False,MRPL23; mitochondrial ribosomal protein
hsa:11015,0.0,0.0,0.00010498067889592128,0.00043586165017026795,0.0,0.0040408433,False,KDELR3; KDEL endoplasmic reticulum protein retention receptor
hsa:4803,0.0,0.0,2.6301377598514845e-05,0.00010916494224508874,0.0,0.0011988004,False,NGF; nerve growth
hsa:3949,0.0,0.0,0.00014257612928118808,0.0005809212980470807,0.0,0.0054001044,False,LDLR; low density lipoprotein
hsa:1002,3.9610383000000003e-07,0.0004907636085473238,1.0500184042282183e-05,2.5463001547998204e-05,0.0,0.000169808,False,CDH4; cadherin
hsa:344,7.409601e-08,9.180326594306999e-05,1.3412473430202974e-05,4.892378666710588e-05,0.0,0.00050478696,False,APOC2; apolipoprotein
hsa:7177,0.0,0.0,7.323201597313882e-06,3.529730341732864e-05,0.0,0.00034631565,False,TPSAB1; tryptase alpha/beta
hsa:1728,0.0,0.0,4.5165351880198e-05,0.0001435536462665417,0.0,0.0011945623,False,NQO1; NAD(P)H quinone dehydrogenase
hsa:610,0.0,0.0,9.854055046019803e-06,2.9470600521002192e-05,0.0,0.00025359023,False,HCN2; hyperpolarization activated cyclic nucleotide gated potassium and sodium channel
hsa:3109,0.0,0.0,0.0004314908130267328,0.0010715382144873837,0.0,0.0063377763,False,HLA-DMB; major histocompatibility complex
hsa:252969,0.0,0.0,2.339498505236831e-05,9.316086193376641e-05,0.0,0.00077986013,False,NEIL2; nei like DNA glycosylase
hsa:6426,2.6826711499999997e-07,0.0003323768351646079,8.778059832026729e-05,0.0002617445935317314,0.0,0.0015656103,False,SRSF1; serine and arginine rich splicing factor
hsa:4000,0.0,0.0,5.5997050350792084e-05,0.0002544691044565836,0.0,0.0019787988,False,LMNA; lamin
hsa:632,4.73540765e-07,0.0005867062043446038,2.3663110908084156e-05,8.005709934141271e-05,0.0,0.00085703254,False,BGLAP; bone gamma-carboxyglutamate
hsa:398,0.0,0.0,4.236691679869308e-05,0.00021055909350632668,0.0,0.002312255,False,ARHGDIG; Rho GDP dissociation inhibitor
hsa:728819,4.05170045e-06,0.005019964420931794,0.00040155855144901004,0.0008242711693098227,0.0,0.0063508535,False,C1GALT1C1L; C1GALT1 specific chaperone 1
hsa:950,6.444584e-07,0.0007984692547472581,3.883027193587128e-06,8.949111842032633e-06,0.0,8.933179e-05,False,SCARB2; scavenger receptor class B member
hsa:57817,0.0,0.0,3.339184283295112e-05,0.0001957286893204369,0.0,0.0015528591,False,HAMP; hepcidin antimicrobial
hsa:54578,0.0,0.0,2.3227136121782184e-05,9.821066360991238e-05,0.0,0.00092393864,False,UGT1A6; UDP glucuronosyltransferase family 1 member
hsa:3452,2.21738705e-06,0.002747291966866629,2.4563892269108912e-05,4.6603650445168186e-05,0.0,0.0002600254,False,IFNA21; interferon alpha
hsa:341208,0.0,0.0,1.8655486313019801e-07,5.98528559070017e-07,0.0,4.833308e-06,False,HEPHL1; hephaestin like
hsa:6839,0.0,0.0,5.0444966730198035e-06,2.0658048349580227e-05,0.0,0.00016253788,False,SUV39H1; SUV39H1 histone lysine
hsa:8200,0.0,0.0,1.2235668458704804e-05,7.19952199978038e-05,0.0,0.0007731338,False,GDF5; growth differentiation factor
hsa:1054,4.18233925e-08,5.181822913701964e-05,1.2228717697227723e-06,3.433852251481075e-06,0.0,2.373276e-05,False,CEBPG; CCAAT enhancer binding protein
hsa:56288,3.11683525e-06,0.0038616877664058437,3.891526071811883e-05,7.754597128820287e-05,0.0,0.00043999517,False,PARD3; par-3 family cell polarity
hsa:256144,0.0,0.0,5.058646534653466e-08,7.189687588509955e-07,0.0,1.0218466e-05,False,OR4C3; olfactory receptor family 4 subfamily C member
hsa:9275,0.0,0.0,6.066829948337128e-06,2.002517895400183e-05,0.0,0.00012158795,False,BCL7B; BAF chromatin remodeling complex subunit
hsa:10482,7.15418325e-08,8.863869829228412e-05,3.944229632177227e-05,0.00011814254416229625,0.0,0.0005822835,False,NXF1; nuclear RNA export factor
hsa:7841,2.1858293e-06,0.0027081926345838936,9.566314233864155e-05,0.00026771025710199377,0.0,0.001545929,False,MOGS; mannosyl-oligosaccharide
hsa:9572,0.0,0.0,0.00017474854925594055,0.0005330173058526598,0.0,0.0034646823,False,NR1D1; nuclear receptor subfamily 1 group D member
hsa:7638,0.0,0.0,1.9566606215643556e-08,3.687842802388813e-08,0.0,1.751465e-07,False,ZNF221; zinc finger protein
hsa:90594,0.0,0.0,7.520420745643565e-08,1.616207712201005e-07,0.0,1.0795594e-06,False,ZNF439; zinc finger protein
hsa:6422,0.0,0.0,2.805707488886139e-06,1.9619851795383783e-05,0.0,0.0002482036,False,SFRP1; secreted frizzled related protein
hsa:10855,1.15462555e-06,0.0014305547145023526,2.12495820179208e-05,4.961566207151836e-05,0.0,0.00026608043,False,HPSE;
hsa:5645,0.0,0.0,2.001991558331682e-06,1.772067043040514e-05,0.0,0.00024964343,False,PRSS2; serine protease
hsa:3605,0.0,0.0,3.432085336633664e-08,2.531786699696897e-07,0.0,3.0089238e-06,False,IL17A; interleukin
hsa:475,4.6083445e-06,0.005709633699449996,0.00017428955091542583,0.0004183125442900972,0.0,0.0026574654,False,ATOX1; antioxidant 1 copper
hsa:780851,4.1993285e-08,5.202872206854501e-05,2.7360244559806943e-06,8.308973183603645e-06,0.0,8.466003e-05,False,SNORD3A; small nucleolar RNA
hsa:4640,1.2624603249999999e-08,1.564159540554877e-05,1.0366975976064354e-07,2.732337539408111e-07,0.0,2.1170222e-06,False,MYO1A; myosin
hsa:1592,1.3091382499999999e-08,1.621992424706745e-05,8.525312398292077e-06,2.1766829963693795e-05,0.0,0.00017019562,False,CYP26A1; cytochrome P450 family 26 subfamily A member
hsa:5591,0.0,0.0,5.419861794549506e-05,0.00017356164464000064,0.0,0.0011013311,False,PRKDC; protein kinase
hsa:10859,0.0,0.0,1.535695889131188e-05,4.500688038864519e-05,0.0,0.00041657343,False,LILRB1; leukocyte immunoglobulin like receptor
hsa:8519,0.0,0.0,5.746140768910889e-06,1.8263007519681798e-05,0.0,0.00012578581,False,IFITM1; interferon induced transmembrane protein
hsa:55586,0.0,0.0,4.894562849114851e-06,1.8026527889169304e-05,0.0,0.00014297698,False,MIOX; myo-inositol
hsa:1514,1.58720625e-07,0.00019665123327862436,1.718956993983168e-05,4.230699503943104e-05,0.0,0.0003848199,False,CTSL; cathepsin
hsa:23595,1.13002348e-09,1.4000733110508034e-06,1.4237334213636637e-06,3.5586824414329707e-06,0.0,1.9150842e-05,False,ORC3; origin recognition complex subunit
hsa:9681,2.0674225e-07,0.00025614893107494803,1.6050793519455436e-06,3.2769017202780447e-06,0.0,1.8168897e-05,False,DEPDC5; DEP domain containing 5
hsa:10797,1.0085906500000001e-06,0.0012496208050830784,3.1726424916831675e-05,7.187194567774156e-05,0.0,0.00059289753,False,MTHFD2; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2
hsa:60482,0.0,0.0,5.65191985116782e-06,2.771825808772015e-05,0.0,0.00023731063,False,SLC5A7; solute carrier family 5 member
hsa:786,3.3503492e-06,0.0041510062230038,0.00010091453523435643,0.000292920091859646,0.0,0.0023775154,False,CACNG1; calcium voltage-gated channel auxiliary subunit gamma
hsa:2899,0.0,0.0,5.909988718648514e-05,0.00020535655143016492,0.0,0.0013842067,False,GRIK3; glutamate ionotropic receptor kainate type subunit
hsa:3615,1.8890464499999998e-06,0.002340485454320175,4.5120484621168324e-05,0.00012372399236291966,0.0,0.00068437133,False,IMPDH2; inosine monophosphate dehydrogenase
hsa:9570,0.0,0.0,3.814624281558416e-05,0.00011559934777644255,0.0,0.0008322954,False,GOSR2; golgi SNAP receptor complex member
hsa:9968,1.7616899e-08,2.182693594417842e-05,4.032124403915841e-06,1.3071471700468591e-05,0.0,0.000101259946,False,MED12; mediator complex subunit
hsa:6536,0.0,0.0,8.17826391653465e-06,5.26099953218434e-05,0.0,0.00062285876,False,SLC6A9; solute carrier family 6 member
hsa:8556,2.9542777999999997e-08,3.660282794486609e-05,2.991430869210891e-07,6.084603408598972e-07,0.0,5.613589e-06,False,CDC14A; cell division cycle
hsa:9915,2.1333208e-06,0.0026431358010273807,1.596126044470297e-05,4.9967433961417275e-05,0.0,0.0004131222,False,ARNT2; aryl hydrocarbon receptor nuclear translocator
hsa:23362,2.06173795e-08,2.554446282988381e-05,4.305488938723763e-07,9.503125702157747e-07,0.0,4.9377436e-06,False,PSD3; pleckstrin and Sec7 domain containing
hsa:8317,0.0,0.0,4.710368664873763e-07,1.115652334810161e-06,0.0,7.4304767e-06,False,CDC7; cell division cycle
hsa:6547,0.00053634883,0.6645239639589828,0.0008640170695391091,0.0010898132104941365,0.0,0.0061255116,True,SLC8A3; solute carrier family 8 member
hsa:219983,0.0,0.0,3.1159442920792077e-08,4.12027985907796e-07,-0.0,5.8406868e-06,False,OR4D6; olfactory receptor family 4 subfamily D member
hsa:8387,0.0,0.0,1.2859427382445545e-05,7.680394708493309e-05,0.0,0.00072323845,False,OR1E1; olfactory receptor family 1 subfamily E member
hsa:163081,1.35235647e-10,1.6755388132942833e-07,4.834244619823763e-08,7.658392467176993e-08,0.0,4.6872034e-07,False,ZNF567; zinc finger protein
hsa:3080,0.0,0.0,4.80218824361386e-08,2.8532693165194274e-07,0.0,3.197184e-06,False,CFHR2; complement factor H related
hsa:8443,1.0802984e-06,0.0013384650713725746,2.750639002100495e-05,8.877283291185796e-05,0.0,0.000594886,False,GNPAT; glyceronephosphate
hsa:84197,0.0,0.0,1.470941206560891e-05,5.145497562652534e-05,0.0,0.00035141062,False,POMK; protein O-mannose
hsa:56479,0.0,0.0,7.632137023930696e-06,1.5210491789300073e-05,0.0,7.754969e-05,False,KCNQ5; potassium voltage-gated channel subfamily Q member
hsa:157506,0.0,0.0,0.00014218742181178212,0.000559225192448604,0.0,0.0055620144,False,RDH10; retinol dehydrogenase
hsa:5330,0.0,0.0,0.00030585052972970295,0.0006142953341242688,0.0,0.0028692372,False,PLCB2; phospholipase C beta
hsa:7582,0.0,0.0,7.81123584138614e-08,1.663330831124466e-07,0.0,8.819737e-07,False,ZNF33B; zinc finger protein
hsa:1365,6.58467215e-07,0.0008158258569312659,2.3672157452282186e-05,7.2896183368883e-05,0.0,0.0007235066,False,CLDN3; claudin
hsa:10164,0.0,0.0,1.418445301119802e-06,1.1372522922440782e-05,0.0,0.00015591804,False,CHST4; carbohydrate sulfotransferase
hsa:6827,0.0,0.0,7.936730269792083e-06,2.1196853388799678e-05,0.0,0.00013679152,False,SUPT4H1; SPT4 homolog
hsa:3782,0.0,0.0,1.1807701175396036e-05,3.7172558506422706e-05,0.0,0.00030321,False,KCNN3; potassium calcium-activated channel subfamily N member
hsa:219487,0.0,0.0,3.15418054009901e-06,2.8190634184341204e-05,-0.0,0.00038613062,False,OR5M11; olfactory receptor family 5 subfamily M member
hsa:8110,6.3827464e-08,7.908077171852743e-05,3.850198405874753e-06,1.0730820198782209e-05,0.0,7.171664e-05,False,DPF3; double PHD fingers
hsa:3295,0.0,0.0,0.00034280693301039575,0.0007860419588650511,0.0,0.0065767705,False,HSD17B4; hydroxysteroid 17-beta dehydrogenase
hsa:3575,5.7982049e-07,0.0007183843589244705,7.922624397727724e-05,0.0001983274982446421,0.0,0.001525081,False,IL7R; interleukin 7
hsa:8310,3.24513265e-05,0.04020645317993364,0.0007076502908774902,0.0014291708464185028,0.0,0.008100144,False,ACOX3; acyl-CoA oxidase 3
hsa:55236,0.0,0.0,2.601586810004951e-07,5.205117631839349e-07,0.0,3.909797e-06,False,UBA6; ubiquitin like modifier activating enzyme
hsa:3623,0.0,0.0,4.76802493634208e-06,2.197019076994267e-05,0.0,0.00018495659,False,INHA; inhibin subunit
hsa:867,1.3005031e-05,0.016112936708614533,4.563790410572276e-05,6.97642186938494e-05,0.0,0.00040979442,False,CBL; Cbl
hsa:11343,0.0,0.0,0.00011357561389257421,0.0004507634724142892,0.0,0.003865276,False,MGLL; monoglyceride
hsa:51068,0.0,0.0,8.496643964143562e-07,2.711913094422892e-06,0.0,2.2831697e-05,False,NMD3; NMD3 ribosome export
hsa:196528,2.6192166e-07,0.0003245149611865788,1.3381565947608908e-06,2.6115850121183487e-06,0.0,1.9436337e-05,False,ARID2; AT-rich interaction domain
hsa:319100,0.0,0.0,2.6525350099009896e-08,3.015802381328262e-07,0.0,4.142229e-06,False,TAAR6; trace amine associated receptor
hsa:4161,0.0,0.0,4.020010880881188e-07,2.477769970800879e-06,0.0,2.5233061e-05,False,MC5R; melanocortin 5
hsa:5025,0.0,0.0,6.769410987425747e-06,1.700601854883007e-05,0.0,0.00013155007,False,P2RX4; purinergic receptor P2X
hsa:51422,0.0,0.0,0.00023999017158118813,0.0005219618947857287,0.0,0.004117995,False,PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma
hsa:10121,1.40234995e-07,0.000173747959444916,5.910893506856436e-07,1.2986835430871636e-06,0.0,1.0320549e-05,False,ACTR1A; actin related protein
hsa:8174,2.4866512e-07,0.0003080904105649604,8.969279606079701e-05,0.0002742579570720535,0.0,0.0018263028,False,MADCAM1; mucosal vascular addressin cell adhesion molecule
hsa:27341,0.0,0.0,1.6928308392480202e-06,3.2387694916805175e-06,0.0,1.5553791e-05,False,RRP7A; ribosomal RNA processing 7 homolog
hsa:5903,1.95457675e-06,0.00242167600099373,7.9935756372143e-05,0.00022901801260038384,0.0,0.0016392694,False,RANBP2; RAN binding protein
hsa:259293,0.0,0.0,1.114661013470297e-05,3.844913380042664e-05,0.0,0.00031256326,False,TAS2R30; taste 2 receptor member
hsa:9955,4.98869485e-07,0.0006180879105681583,4.377018146334652e-05,0.00020022596259595325,0.0,0.0022521724,False,HS3ST3A1; heparan sulfate-glucosamine 3-sulfotransferase
hsa:7157,0.0,0.0,0.00022135055656415833,0.0004360421249978809,0.0,0.0028538462,False,TP53; tumor protein
hsa:3802,0.0,0.0,3.792449361133664e-06,2.0656125141877438e-05,0.0,0.0002593956,False,KIR2DL1; killer cell immunoglobulin like receptor
hsa:5634,4.1129215e-06,0.005095815905167772,1.100086640287129e-05,1.634506145135146e-05,0.0,9.056812e-05,False,PRPS2; phosphoribosyl pyrophosphate synthetase
hsa:84153,3.7559121e-07,0.0004653489403479276,2.808205504201487e-05,6.249927233386733e-05,0.0,0.0004282872,False,RNASEH2C; ribonuclease H2 subunit
hsa:6728,1.76880444e-07,0.00021915083471647526,3.167024328840595e-05,0.0002093313522529682,0.0,0.0023823439,False,SRP19; signal recognition particle
hsa:5621,0.0,0.0,2.196849568624752e-05,0.0001991773774924908,0.0,0.0025693593,False,PRNP; prion
hsa:29082,6.23063055e-06,0.00771960910411595,9.968161463524112e-05,0.0003251625228696497,0.0,0.0023731678,False,CHMP4A; charged multivesicular body protein
hsa:171389,0.0,0.0,9.285234958168316e-09,4.5697964275001884e-08,0.0,6.1789154e-07,False,NLRP6; NLR family pyrin domain containing
hsa:3682,0.0,0.0,2.7061998678465344e-07,1.7812477762041683e-06,0.0,1.541164e-05,False,ITGAE; integrin subunit alpha
hsa:121274,1.2324666e-08,1.5269979995650408e-05,1.0973684138118816e-07,2.2567919723437525e-07,0.0,1.1304772e-06,False,ZNF641; zinc finger protein
hsa:90333,0.0,0.0,4.073146306534654e-08,6.759079920816667e-08,0.0,3.3366413e-07,False,ZNF468; zinc finger protein
hsa:2908,0.0,0.0,5.17032671527723e-06,2.1780562806849046e-05,0.0,0.00016747248,False,NR3C1; nuclear receptor subfamily 3 group C member
hsa:11346,0.0,0.0,8.89487915974406e-06,5.5035434541853825e-05,0.0,0.00052293297,False,SYNPO;
hsa:7137,3.5304731e-05,0.043741756257071704,0.00013811894349653462,0.0002638584257188875,0.0,0.0013974227,False,TNNI3; troponin I3
hsa:5553,0.0,0.0,7.001576874876238e-06,2.9897598682471238e-05,0.0,0.00031452862,False,PRG2; proteoglycan 2
hsa:3763,1.325396e-06,0.001642135406047926,3.679304409501981e-05,0.00016619583192229186,0.0,0.0019191264,False,KCNJ6; potassium inwardly rectifying channel subfamily J member
hsa:57506,0.0,0.0,4.277413619472177e-05,0.0001088697348465085,0.0,0.0005301788,False,MAVS; mitochondrial antiviral signaling
hsa:2081,0.0,0.0,1.5165572430247524e-06,2.785514091557592e-06,0.0,2.3485683e-05,False,ERN1; endoplasmic reticulum to nucleus signaling
hsa:490,0.0,0.0,0.00019323275681089108,0.0003473362116715874,0.0,0.0019154858,False,ATP2B1; ATPase plasma membrane Ca2+ transporting
hsa:8638,0.0,0.0,1.1127919507772273e-07,3.660736784869069e-07,0.0,3.1010063e-06,False,OASL; 2'-5'-oligoadenylate synthetase
hsa:10652,1.6411315e-06,0.0020333244872706288,3.170737139483463e-05,6.8889943015054e-05,0.0,0.0005458911,False,YKT6; YKT6 v-SNARE
hsa:8938,7.8914666e-10,9.777347079291507e-07,1.3270693788302868e-05,4.500246315302283e-05,0.0,0.00031355114,False,BAIAP3; BAI1 associated protein
hsa:9825,2.45122315e-07,0.0003037009559964966,1.2368131103095057e-05,4.419746492071745e-05,0.0,0.00030985803,False,SPATA2; spermatogenesis associated
hsa:5452,0.0,0.0,5.572840214900989e-07,1.1755153281745743e-06,0.0,7.2833504e-06,False,POU2F2; POU class 2 homeobox
hsa:831,0.0,0.0,1.8495551584227724e-06,1.439027979885306e-05,0.0,0.00015348221,False,CAST;
hsa:84572,0.0,0.0,2.2062702063836637e-06,6.157759407809534e-06,0.0,2.833964e-05,False,GNPTG; N-acetylglucosamine-1-phosphate transferase subunit
hsa:3371,1.60577725e-06,0.001989521378102297,3.899362407554457e-05,8.846856236843763e-05,0.0,0.00051917805,False,TNC; tenascin
hsa:60,2.27121175e-05,0.0281397954219499,0.0006530284528217821,0.0010573677032145003,0.0,0.009112671,False,ACTB; actin
hsa:3195,0.0,0.0,5.396108177320544e-07,5.389144231943631e-06,0.0,7.1148446e-05,False,TLX1; T cell leukemia homeobox
hsa:10401,4.1293458e-07,0.0005116165238159236,2.262605729635148e-05,0.00011534748906620288,0.0,0.0011032232,False,PIAS3; protein inhibitor of activated STAT
hsa:6448,4.6053222e-07,0.0005705889138701587,0.00011905103840267324,0.00029385601144171737,0.0,0.0019077194,False,SGSH; N-sulfoglucosamine
hsa:2251,0.0,0.0,1.0656443133663366e-07,6.880558486072201e-07,0.0,8.319812e-06,False,FGF6; fibroblast growth factor
hsa:51512,8.73531215e-07,0.0010822852464015007,0.0001198490397500797,0.0002685561631605495,0.0,0.0015101152,False,GTSE1; G2 and S-phase expressed
hsa:29978,0.0,0.0,3.294051013388911e-07,1.0572075791915932e-06,0.0,5.7870575e-06,False,UBQLN2; ubiquilin
hsa:3422,7.4981672e-08,9.29005809553314e-05,4.803540482429767e-05,0.0002258729255752468,0.0,0.002398345,False,IDI1; isopentenyl-diphosphate delta isomerase
hsa:121601,2.7203242999999997e-09,3.370419745466668e-06,2.5654624193722848e-05,9.829720326207557e-05,0.0,0.0008082142,False,ANO4; anoctamin
hsa:1960,0.0,0.0,7.740434451119803e-06,3.869164169600106e-05,0.0,0.0003436367,False,EGR3; early growth response
hsa:400713,1.04380925e-09,1.2932558469961665e-06,1.651360074509901e-07,4.0662006979600864e-07,0.0,1.9954477e-06,False,ZNF880; zinc finger protein
hsa:390079,0.0,0.0,5.176513056930693e-07,3.4968801695091865e-06,-0.0,3.3518125e-05,False,OR52E8; olfactory receptor family 52 subfamily E member
hsa:245973,2.71130395e-06,0.003359243737609436,0.0001373642744857921,0.00047864532009908974,0.0,0.003838215,False,ATP6V1C2; ATPase H+ transporting V1 subunit
hsa:406969,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR194-1; microRNA
hsa:272,4.2997167999999995e-09,5.327251020267972e-06,4.361352601430497e-07,1.3406785485314573e-06,0.0,8.030198e-06,False,AMPD3; adenosine monophosphate deaminase
hsa:4131,0.0,0.0,9.80898690683416e-06,3.1746595776521024e-05,0.0,0.00026704324,False,MAP1B; microtubule associated protein
hsa:3002,0.0,0.0,2.387191068186635e-05,0.00011054489803184845,0.0,0.0012246139,False,GZMB; granzyme
hsa:148789,0.0,0.0,2.6591411434900974e-05,5.001713586951093e-05,0.0,0.0002786102,False,B3GALNT2; beta-1
hsa:23636,0.0,0.0,1.6869195328451003e-07,4.557981256642887e-07,0.0,2.6005168e-06,False,NUP62; nucleoporin
hsa:8693,0.0,0.0,2.3493233799844058e-05,6.718467243524789e-05,0.0,0.00052285864,False,GALNT4; polypeptide N-acetylgalactosaminyltransferase
hsa:162514,0.0,0.0,1.205898336048515e-05,3.964879213514147e-05,0.0,0.00036325393,False,TRPV3; transient receptor potential cation channel subfamily V member
hsa:22865,0.0,0.0,1.5405565271593564e-06,4.719611453996026e-06,0.0,3.8166996e-05,False,SLITRK3; SLIT and NTRK like family member
hsa:50632,6.12932325e-07,0.00075940916706688,4.948011400953464e-06,9.225285027142138e-06,0.0,6.408314e-05,False,CALY; calcyon neuron specific vesicular
hsa:6949,0.0,0.0,1.1402044598898512e-06,2.469185231930776e-06,0.0,1.1919966e-05,False,TCOF1; treacle ribosome biogenesis factor
hsa:138050,7.2466566000000005e-06,0.00897844220016575,0.00019036890538366323,0.0003835169473653031,0.0,0.0021562227,False,HGSNAT; heparan-alpha-glucosaminide
hsa:6335,0.0,0.0,0.0005951739944949506,0.0010790032287041735,0.0,0.0042596166,False,SCN9A; sodium voltage-gated channel alpha subunit
hsa:2273,1.49940425e-06,0.001857727657925432,7.496238177955447e-05,0.00019096368101153898,0.0,0.0010295527,False,FHL1; four and a half LIM domains
hsa:5683,0.0,0.0,4.026442397638614e-06,1.4988639730433067e-05,0.0,0.00016554694,False,PSMA2; proteasome 20S subunit alpha
hsa:706,0.0,0.0,3.6987688966738115e-05,0.00015980428959479724,0.0,0.0014212173,False,TSPO; translocator
hsa:56624,0.0,0.0,5.315232751575743e-06,1.220809579705102e-05,0.0,7.668789e-05,False,ASAH2; N-acylsphingosine amidohydrolase
hsa:266722,5.947828200000001e-06,0.007369223444397227,0.0001636986051402228,0.0004060058464511844,0.0,0.0031319053,False,HS6ST3; heparan sulfate 6-O-sulfotransferase
hsa:79621,0.0,0.0,1.299736951794356e-05,4.358266426609257e-05,0.0,0.00031073234,False,RNASEH2B; ribonuclease H2 subunit
hsa:390167,0.0,0.0,3.6406852475247524e-08,5.03309563471874e-07,-0.0,7.1515096e-06,False,OR5M10; olfactory receptor family 5 subfamily M member
hsa:9817,0.0,0.0,1.6105519126633665e-06,3.0253823259336438e-06,0.0,2.598123e-05,False,KEAP1; kelch like ECH associated protein
hsa:23456,0.0,0.0,0.0002952672097425742,0.0005482023893179851,0.0,0.0028668002,False,ABCB10; ATP binding cassette subfamily B member
hsa:55240,0.0,0.0,0.00013300253517173024,0.0003118071317580592,0.0,0.0019598866,False,STEAP3; STEAP3
hsa:7525,0.0,0.0,4.888450848061386e-06,2.0629811277332682e-05,0.0,0.00022562235,False,YES1; YES proto-oncogene 1
hsa:8887,3.6557483e-07,0.00045293887404439996,8.211854578971781e-06,1.9796110286380236e-05,0.0,0.00017678765,False,TAX1BP1; Tax1 binding protein
hsa:2181,0.0,0.0,0.0001358718696237624,0.0003461481682679583,0.0,0.0018128091,False,ACSL3; acyl-CoA synthetase long chain family member
hsa:10914,0.0,0.0,3.0803905894851503e-07,9.638629678664453e-07,0.0,6.1885457e-06,False,PAPOLA; poly(A) polymerase
hsa:28972,0.0,0.0,7.361108195468815e-05,0.00028896042859086744,0.0,0.002916702,False,SPCS1; signal peptidase complex subunit
hsa:1716,1.99852025e-08,2.476120994954529e-05,6.578513133036634e-06,2.4867709763661334e-05,0.0,0.0002597087,False,DGUOK; deoxyguanosine
hsa:177,4.76378815e-05,0.05902224835465437,0.00010655925807859899,0.0001595744917420733,0.0,0.0010057691,False,AGER; advanced glycosylation end-product specific
hsa:440567,0.0,0.0,4.132100109978416e-05,9.795654328924391e-05,0.0,0.0004987377,False,UQCRHL; ubiquinol-cytochrome c reductase hinge protein
hsa:127074,0.0,0.0,1.761552636049505e-06,1.4320754163769962e-05,0.0,0.00019115896,False,OR2T4; olfactory receptor family 2 subfamily T member
hsa:642517,2.0144114e-08,2.4958097672594243e-05,6.25798894039604e-07,1.4821738337827281e-06,0.0,7.410684e-06,False,AGAP9; ArfGAP with GTPase domain
hsa:93166,0.0,0.0,1.2098653907287127e-06,4.5900740441582e-06,0.0,3.9001887e-05,False,PRDM6; PR/SET domain
hsa:3945,8.41771775e-05,0.10429360248101764,0.0003506378245983663,0.0005895666738080349,0.0,0.0032566183,False,LDHB; lactate dehydrogenase
hsa:5710,0.0,0.0,1.0354418456534658e-05,3.147450274347423e-05,0.0,0.00022919392,False,PSMD4; proteasome 26S subunit ubiquitin receptor
hsa:2995,0.0,0.0,1.9267106391146043e-05,9.413432401549783e-05,0.0,0.0010153226,False,GYPC; glycophorin C (Gerbich blood
hsa:6872,9.045481e-10,1.1207144592886804e-06,1.320387688377227e-06,5.04102579594655e-06,0.0,5.5498665e-05,False,TAF1; TATA-box binding protein associated factor
hsa:149461,0.0,0.0,1.2669010558049509e-06,7.572779219675723e-06,0.0,8.1754835e-05,False,CLDN19; claudin
hsa:89780,0.0,0.0,4.800541507623764e-07,1.676242909533022e-06,0.0,1.520203e-05,False,WNT3A; Wnt family member
hsa:6483,0.000113148919,0.14018892923016887,0.0007077591894841584,0.0014509249485785587,0.0,0.0075792163,False,ST3GAL2; ST3 beta-galactoside alpha-2
hsa:22876,1.07998125e-06,0.0013380721297581227,4.0419101607108924e-05,8.550368294791003e-05,0.0,0.0006521041,False,INPP5F; inositol polyphosphate-5-phosphatase
hsa:11284,1.36670585e-07,0.00016933173677435468,1.69799063924901e-05,5.663402331825784e-05,0.0,0.00034531002,False,PNKP; polynucleotide kinase
hsa:652,0.0,0.0,6.553198537856437e-05,0.00026581706727642814,0.0,0.0028667662,False,BMP4; bone morphogenetic protein
hsa:29071,0.0,0.0,6.135408526679704e-05,0.00028568955414775177,0.0,0.0034532982,False,C1GALT1C1; C1GALT1 specific chaperone
hsa:64393,0.0,0.0,4.722469573335695e-05,0.0001465795844564898,0.0,0.0009912512,False,ZMAT3; zinc finger matrin-type
hsa:29882,7.1258985e-08,8.828825669274548e-05,1.537168253594059e-05,6.185075790926363e-05,0.0,0.0006419933,False,ANAPC2; anaphase promoting complex subunit
hsa:257364,0.0,0.0,1.812275958311881e-07,3.2632958266241487e-07,0.0,1.7304874e-06,False,SNX33; sorting nexin
hsa:858,6.348619750000001e-07,0.0007865795031077607,1.907912695485396e-05,6.727562391148517e-05,0.0,0.00047009025,False,CAV2; caveolin
hsa:23408,0.0,0.0,4.554704553430694e-05,9.787648897979377e-05,0.0,0.00096568215,False,SIRT5; sirtuin
hsa:388646,0.0,0.0,6.716478331818813e-09,2.859726818815111e-08,0.0,2.996234e-07,False,GBP7; guanylate binding protein
hsa:3340,0.0,0.0,0.00010061299372193067,0.00045648247692411925,0.0,0.0047201337,False,NDST1; N-deacetylase and N-sulfotransferase
hsa:84991,4.2442380000000006e-08,5.258514052776709e-05,6.16928270347525e-07,1.7757820353690639e-06,0.0,1.0757368e-05,False,RBM17; RNA binding motif protein
hsa:4790,0.0,0.0,0.00021235337798663372,0.0004133280984027693,0.0,0.003023923,False,NFKB1; nuclear factor kappa B subunit
hsa:7428,6.81209455e-07,0.0008440029734434928,2.9929706079158423e-05,7.376931777676462e-05,0.0,0.00041007873,False,VHL; von Hippel-Lindau tumor
hsa:10277,0.0,0.0,6.499696694158418e-07,1.3612783710087962e-06,0.0,6.7280453e-06,False,UBE4B; ubiquitination factor
hsa:221264,0.0,0.0,4.0183436404431673e-05,0.00010964891743300545,0.0,0.00072284666,False,AK9; adenylate kinase
hsa:970,0.0,0.0,8.844641506376235e-07,7.1619731919015455e-06,0.0,9.506545e-05,False,CD70; CD70
hsa:997,0.0,0.0,5.855943152970299e-07,1.3520863681369443e-06,0.0,7.3590563e-06,False,CDC34; cell division cycle 34
hsa:10535,0.0,0.0,5.629609905846533e-06,1.94038528745676e-05,0.0,0.00012674788,False,RNASEH2A; ribonuclease H2 subunit
hsa:84868,5.34627235e-09,6.623909470309289e-06,7.326294886199506e-06,2.1964408177689956e-05,0.0,0.00016327704,False,HAVCR2; hepatitis A virus cellular receptor
hsa:1892,0.0,0.0,0.0005138060242574257,0.0012409487514017637,0.0,0.0068207514,False,ECHS1; enoyl-CoA hydratase
hsa:221074,0.0,0.0,2.836145983742574e-10,9.658048860209417e-10,0.0,7.823088e-09,False,SLC39A12; solute carrier family 39 member
hsa:433,0.0,0.0,6.733960431106637e-06,3.0653156978079454e-05,0.0,0.00030177247,False,ASGR2; asialoglycoprotein receptor
hsa:7849,0.0,0.0,2.6174396167475243e-05,9.990200172637602e-05,0.0,0.00068306905,False,PAX8; paired box
hsa:6822,0.0,0.0,7.609799903168315e-06,4.695416329687731e-05,0.0,0.0004783853,False,SULT2A1; sulfotransferase family 2A member
hsa:29117,3.02823815e-07,0.00037519179807846636,4.547033636373762e-06,1.0593211770841125e-05,0.0,5.4865835e-05,False,BRD7; bromodomain containing
hsa:64928,9.2857095e-09,1.1504782223747156e-05,1.818801815217822e-07,5.308034110838223e-07,0.0,3.2763623e-06,False,MRPL14; mitochondrial ribosomal protein
hsa:92595,0.0,0.0,3.211803221881189e-08,1.328128836049128e-07,0.0,1.202265e-06,False,ZNF764; zinc finger protein
hsa:3786,1.0657875e-08,1.3204863973282732e-05,6.853843139440596e-06,3.9020448937383405e-05,0.0,0.00053574453,False,KCNQ3; potassium voltage-gated channel subfamily Q member
hsa:2993,1.5661655250000002e-07,0.00019404433545401817,1.70380796184208e-05,4.998436956481469e-05,0.0,0.00045785768,False,GYPA; glycophorin A (MNS blood
hsa:10628,0.0,0.0,2.3196249099999998e-07,6.578313886034967e-07,0.0,3.9623346e-06,False,TXNIP; thioredoxin interacting
hsa:81849,2.26837685e-06,0.0028104671657711846,2.9407100365554458e-05,5.17322480741628e-05,0.0,0.00029799095,False,ST6GALNAC5; ST6 N-acetylgalactosaminide alpha-2
hsa:54798,2.84338775e-05,0.03522892552412976,0.00019972463393589117,0.0004267747760888927,0.0,0.0032044284,False,DCHS2; dachsous cadherin-related
hsa:1355,9.956858e-07,0.0012336319903479066,0.00020447067056806933,0.000458640582787529,0.0,0.0026645625,False,COX15; cytochrome c oxidase assembly homolog
hsa:5836,0.0,0.0,0.00015130508397396042,0.00043359403435693633,0.0,0.0024643,False,PYGL; glycogen phosphorylase
hsa:23198,1.0406598000000001e-07,0.00012893537502985927,2.4563050026881192e-06,5.772300662289491e-06,0.0,4.254538e-05,False,PSME4; proteasome activator subunit
hsa:4543,0.0,0.0,7.372550940732673e-06,2.8020387661210498e-05,0.0,0.00026063237,False,MTNR1A; melatonin receptor
hsa:23312,0.0,0.0,6.495900847128714e-07,2.303324144534992e-06,0.0,2.2246379e-05,False,DMXL2; Dmx like
hsa:262,7.5905277e-08,9.404490647895067e-05,0.0001917306172721189,0.0004986522919493657,0.0,0.0030910808,False,AMD1; adenosylmethionine decarboxylase
hsa:8986,0.0,0.0,1.389234265199802e-05,5.329077339144611e-05,0.0,0.00042299798,False,RPS6KA4; ribosomal protein S6 kinase
hsa:85569,0.0,0.0,7.50875691579208e-08,6.572090940958651e-07,0.0,8.692789e-06,False,GALP; galanin like
hsa:51263,3.8745503e-08,4.8004794266344654e-05,2.416552482019803e-07,4.905237869365438e-07,0.0,3.2221117e-06,False,MRPL30; mitochondrial ribosomal protein
hsa:345,0.0,0.0,6.816749687762377e-06,7.147368433241123e-05,0.0,0.0010031722,False,APOC3; apolipoprotein
hsa:23308,0.0,0.0,3.9004861613623766e-05,0.0002995489400448639,0.0,0.0029224793,False,ICOSLG; inducible T cell costimulator
hsa:10254,0.0,0.0,4.303233859574262e-05,0.0001508403937823892,0.0,0.000949019,False,STAM2; signal transducing adaptor molecule
hsa:79088,1.42752945e-08,1.7686764204970612e-05,1.3083726214653463e-07,2.4718193248522424e-07,0.0,1.0199296e-06,False,ZNF426; zinc finger protein
hsa:1991,0.0,0.0,1.969917109183168e-06,1.6178898736973765e-05,0.0,0.0002128237,False,ELANE; elastase
hsa:905,6.1821372e-06,0.007659526949806691,7.70227279633663e-05,0.00018946505700107917,0.0,0.0013009419,False,CCNT2; cyclin
hsa:64764,0.0,0.0,0.0003108206013534653,0.0009840587569239848,0.0,0.0074485377,False,CREB3L2; cAMP responsive element binding protein 3 like
hsa:27121,0.0,0.0,4.808621104159406e-07,2.5750473681539086e-06,0.0,2.6861306e-05,False,DKK4; dickkopf WNT signaling pathway inhibitor
hsa:64506,7.5177678e-07,0.0009314342791759614,6.558234025975248e-06,3.350980618024565e-05,0.0,0.00039298402,False,CPEB1; cytoplasmic polyadenylation element binding protein
hsa:126014,3.7431757e-08,4.63770929445104e-05,1.1959789427232673e-05,4.8736319142675546e-05,0.0,0.00040720045,False,OSCAR; osteoclast associated Ig-like
hsa:128869,0.0,0.0,3.342665551465348e-05,7.910185581695047e-05,0.0,0.00046868474,False,PIGU; phosphatidylinositol glycan anchor biosynthesis class
hsa:10560,0.0,0.0,8.81773893608911e-05,0.0002421486007714501,0.0,0.0013035322,False,SLC19A2; solute carrier family 19 member
hsa:29126,9.7357445e-08,0.00012062365321523803,1.4729032288613865e-06,4.478980406054259e-06,0.0,5.3281005e-05,False,CD274; CD274
hsa:144245,3.23463115e-07,0.0004007634199077498,5.2703489664440594e-05,0.00015304437696305893,0.0,0.000923813,False,ALG10B; ALG10 alpha-1
hsa:2324,0.0,0.0,4.099805352691089e-06,1.9644159197458347e-05,0.0,0.00027087255,False,FLT4; fms related receptor tyrosine kinase
hsa:125958,0.0,0.0,2.6343668316831682e-09,3.74413875007623e-08,-0.0,5.321421e-07,False,OR7D4; olfactory receptor family 7 subfamily D member
hsa:64902,0.0,0.0,1.0897157713366338e-06,6.9393763104551394e-06,0.0,6.537797e-05,False,AGXT2; alanine--glyoxylate aminotransferase
hsa:780853,0.0,0.0,4.585454317821781e-08,3.37182743553816e-07,0.0,4.037728e-06,False,SNORD3C; small nucleolar RNA
hsa:7769,2.0606838000000002e-08,2.5531402151880525e-05,5.8900175747524765e-08,9.09724419641495e-08,0.0,5.317745e-07,False,ZNF226; zinc finger protein
hsa:79317,0.0,0.0,1.4251924257425742e-08,1.4297570416786328e-07,0.0,1.4936757e-06,False,OR4K5; olfactory receptor family 4 subfamily K member
hsa:84693,4.3238777e-07,0.0005357185824154496,2.0159950117277238e-05,0.0001392858193964755,0.0,0.001800222,False,MCEE; methylmalonyl-CoA
hsa:4001,0.0,0.0,3.6389146418613864e-06,7.086359272831265e-06,0.0,3.135146e-05,False,LMNB1; lamin
hsa:51529,4.0300828e-06,0.004993180645772858,7.896835013643561e-05,0.00017018211867899212,0.0,0.00091261265,False,ANAPC11; anaphase promoting complex subunit
hsa:399967,5.84167275e-10,7.237699263707115e-07,5.0906676354365835e-06,1.4316436809447806e-05,0.0,9.879186e-05,False,PATE2; prostate and testis expressed
hsa:5898,4.8454569499999995e-06,0.006003410615450774,2.747538572331682e-05,4.940116710924205e-05,0.0,0.00045713983,False,RALA; RAS like proto-oncogene
hsa:7553,0.0,0.0,1.4510296839752475e-07,3.792203016244836e-07,0.0,1.9898687e-06,False,ZNF7; zinc finger protein
hsa:7004,0.0,0.0,0.00016424116213613864,0.0006660698625966132,0.0,0.005695384,False,TEAD4; TEA domain transcription factor
hsa:3294,0.0,0.0,2.4529958169624405e-05,0.00015117426515268034,0.0,0.0020688379,False,HSD17B2; hydroxysteroid 17-beta dehydrogenase
hsa:10285,0.0,0.0,7.979810071287128e-08,1.76886370487295e-07,0.0,1.2786627e-06,False,SMNDC1; survival motor neuron domain containing
hsa:23028,0.0,0.0,3.0245220724623764e-07,1.3721436051053595e-06,0.0,1.0143518e-05,False,KDM1A; lysine demethylase
hsa:9416,7.9591395e-09,9.861192258483191e-06,4.810361609179208e-07,1.5048151048803124e-06,0.0,9.104412e-06,False,DDX23; DEAD-box helicase
hsa:10733,1.7302766e-07,0.00021437732323895838,2.2086576962613856e-05,7.16541826321433e-05,0.0,0.00067032134,False,PLK4; polo like kinase
hsa:346562,0.0,0.0,3.8013420792079205e-06,3.183783174401089e-05,0.0,0.00043631622,False,GNAT3; G protein subunit alpha transducin
hsa:384,2.76939175e-05,0.034312131965782505,0.000131928530930693,0.00033495756416349607,0.0,0.0040051406,False,ARG2; arginase
hsa:51738,1.48392345e-07,0.00018385472999086987,1.3761853059891093e-05,4.781671662805551e-05,0.0,0.00035305158,False,GHRL; ghrelin and obestatin
hsa:283092,0.0,0.0,3.72408304950495e-08,4.898464520821958e-07,0.0,6.940545e-06,False,OR4C13; olfactory receptor family 4 subfamily C member
hsa:6207,0.0,0.0,3.583339820148518e-07,1.1066443943815005e-06,0.0,8.322987e-06,False,RPS13; ribosomal protein
hsa:5423,8.4519185e-08,0.00010471734197086363,5.2106475785698016e-05,0.0001471149341349251,0.0,0.0009860864,False,POLB; DNA polymerase
hsa:2791,0.0,0.0,0.00019065639730450495,0.0005730558885616131,0.0,0.0033495363,False,GNG11; G protein subunit gamma
hsa:390992,0.0,0.0,1.6951004125990095e-08,5.4653841591794716e-08,0.0,4.5840085e-07,False,HES3; hes family bHLH transcription factor
hsa:91862,0.0,0.0,1.7651791026973763e-07,4.684946197128588e-07,0.0,3.620884e-06,False,MARVELD3; MARVEL domain containing
hsa:7533,8.3678555e-06,0.010367582057922969,2.31497211509901e-05,3.588693612847237e-05,0.0,0.00026825618,False,YWHAH; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:4282,2.7738498499999998e-05,0.034367366807699196,0.00029658503876207914,0.0006435406408215544,0.0,0.0041378387,False,MIF; macrophage migration inhibitory
hsa:8437,5.118302e-09,6.341459407638104e-06,8.142621996930694e-08,2.824224115165996e-07,0.0,2.219522e-06,False,RASAL1; RAS protein activator like
hsa:7220,4.6075499e-05,0.05708649208178221,0.00017375798926039612,0.0003094796769001348,0.0,0.0022077041,False,TRPC1; transient receptor potential cation channel subfamily C member
hsa:9372,3.5444629000000004e-07,0.00043915086687399915,6.233600251087869e-05,0.00013749384501678284,0.0,0.0008338437,False,ZFYVE9; zinc finger FYVE-type containing
hsa:728343,0.0,0.0,2.79738962138698e-05,0.0001061582365539195,0.0,0.00062013656,False,NXF2B; nuclear RNA export factor
hsa:1134,0.0,0.0,2.980569341772276e-05,0.00014850406514265257,0.0,0.001682701,False,CHRNA1; cholinergic receptor nicotinic alpha 1
hsa:131873,3.6692779e-07,0.00045461516061759514,2.722165424125248e-05,7.771362251062925e-05,0.0,0.0008830783,False,COL6A6; collagen type VI alpha 6
hsa:5268,0.0,0.0,5.9112781665356436e-06,3.362094662720034e-05,0.0,0.0003852826,False,SERPINB5; serpin family B member
hsa:3845,0.00047730356000000003,0.5913682215041548,0.0005355691983316836,0.000572028299258657,0.0,0.003059757,False,KRAS; KRAS proto-oncogene
hsa:341392,0.0,0.0,7.809887568306933e-06,2.8977089142985332e-05,0.0,0.00024630857,False,ACSM4; acyl-CoA synthetase medium chain family member
hsa:3606,3.7482415e-05,0.046439857050784725,0.0002209920153465347,0.00037782484534019343,0.0,0.0022543212,False,IL18; interleukin
hsa:9648,0.0,0.0,1.970197661806931e-07,8.881365694830785e-07,0.0,9.308795e-06,False,GCC2; GRIP and coiled-coil domain containing
hsa:2887,1.29516615e-07,0.00016046813115701112,1.4081696927425731e-06,2.761610803444583e-06,0.0,1.6898699e-05,False,GRB10; growth factor receptor bound protein
hsa:3052,4.8806599e-07,0.0006047026267370906,5.8862613263613875e-05,0.00015391985650225264,0.0,0.0011191887,False,HCCS; holocytochrome c
hsa:2554,1.37488185e-05,0.017034472452140143,0.0004866437712643565,0.0013059593298576702,0.0,0.009406986,False,GABRA1; gamma-aminobutyric acid type A receptor subunit
hsa:114,2.1150554e-05,0.026205053871392846,0.00027908581575351496,0.0005904060382915404,0.0,0.0042662593,False,ADCY8; adenylate cyclase
hsa:2641,0.0,0.0,7.488065075643564e-07,4.169290618736095e-06,0.0,4.8656508e-05,False,GCG;
hsa:945,2.15030615e-06,0.0026641802621688933,3.594984364480198e-05,6.860183132672866e-05,0.0,0.0004802155,False,CD33; CD33
hsa:3704,0.0,0.0,3.065407518418812e-05,7.449721609064848e-05,0.0,0.00055700564,False,ITPA; inosine
hsa:407016,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR26A2; microRNA
hsa:285,0.0,0.0,4.7590199566336624e-06,1.653684541029155e-05,0.0,0.00014555626,False,ANGPT2; angiopoietin
hsa:5589,7.7334883e-08,9.581615569752275e-05,1.270500419643069e-06,2.966288695877293e-06,0.0,1.5598578e-05,False,PRKCSH; protein kinase C substrate
hsa:6093,0.0,0.0,7.905522670643563e-05,0.00022330457681143064,0.0,0.0013209078,False,ROCK1; Rho associated coiled-coil containing protein kinase
hsa:929,0.0,0.0,0.00012135854132673265,0.00027425098251917645,0.0,0.0017538295,False,CD14; CD14
hsa:392390,0.0,0.0,1.5024399807623764e-06,9.285400924266234e-06,-0.0,8.847862e-05,False,OR1L6; olfactory receptor family 1 subfamily L member
hsa:79295,0.0,0.0,2.9266232693069306e-07,3.5768578507452355e-06,-0.0,5.0399776e-05,False,OR5H6; olfactory receptor family 5 subfamily H member
hsa:861,0.0,0.0,4.9015498996039595e-05,0.00024176769698111195,0.0,0.0027648006,False,RUNX1; RUNX family transcription factor
hsa:8517,7.9385316e-05,0.0983565954053754,0.00041844267149801983,0.0007229963555990137,0.0,0.0037218588,False,IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit
hsa:7084,4.7002307e-07,0.0005823478604932735,3.953829035919356e-05,0.00010901864323325207,0.0,0.00086940185,False,TK2; thymidine kinase
hsa:55862,1.90604315e-06,0.002361543977852746,0.00030394277814225254,0.0010027283938514454,0.0,0.0061068917,False,ECHDC1; ethylmalonyl-CoA decarboxylase
hsa:1723,1.0440074e-08,1.2935013503255176e-05,0.00011722232799120151,0.0003846316375716166,0.0,0.002380136,False,DHODH; dihydroorotate dehydrogenase
hsa:11047,4.12839725e-07,0.0005114990006349718,8.751641401514852e-06,2.1268714766442977e-05,0.0,0.00014192393,False,ADRM1; ADRM1 26S proteasome ubiquitin
hsa:4668,4.26653825e-06,0.0052861435537626175,0.00036909508992088134,0.0009945269709941034,0.0,0.0068879225,False,NAGA;
hsa:57547,0.0,0.0,2.8694587396039605e-08,9.341565704237229e-08,0.0,8.494497e-07,False,ZNF624; zinc finger protein
hsa:1272,4.2787486000000003e-07,0.0005301271898842305,1.232562128100495e-05,2.6845367731198727e-05,0.0,0.00013062119,False,CNTN1; contactin
hsa:84527,0.0,0.0,4.9473214079702966e-08,1.1385557171980238e-07,0.0,7.6345515e-07,False,ZNF559; zinc finger protein
hsa:8803,0.0,0.0,0.000579080188517792,0.0019878885282129345,0.0,0.011511098,False,SUCLA2; succinate-CoA ligase ADP-forming subunit
hsa:27198,1.4570313e-10,1.80522853958367e-07,1.3811384477309895e-06,1.6871635919636958e-05,0.0,0.00023782298,False,HCAR1; hydroxycarboxylic acid receptor
hsa:5173,4.87154425e-08,6.035732184987875e-05,2.7585319037618807e-05,0.0001541933228986858,0.0,0.0020069992,False,PDYN;
hsa:149233,0.0,0.0,9.284005310985146e-07,6.747880555235416e-06,0.0,9.072644e-05,False,IL23R; interleukin 23
hsa:2158,0.0,0.0,1.4289453509900988e-08,1.367378884235099e-07,0.0,1.8493396e-06,False,F9; coagulation factor
hsa:6612,2.91803275e-08,3.615376004441236e-05,7.667284005638614e-07,1.8993766979721758e-06,0.0,1.1240417e-05,False,SUMO3; small ubiquitin like modifier
hsa:3561,0.0002182982,0.2704664894842986,0.0005750182650732674,0.0009011857000903155,0.0,0.0061606113,False,IL2RG; interleukin 2 receptor subunit
hsa:83551,0.0,0.0,2.6266707920792082e-09,3.7332006226458317e-08,0.0,5.305875e-07,False,TAAR8; trace amine associated receptor
hsa:55312,2.60311095e-06,0.0032251950789545557,6.0480226864356406e-05,0.00011953560846622252,0.0,0.0007294312,False,RFK; riboflavin
hsa:7091,5.5420447499999995e-06,0.006866467007503438,0.0003875445817866831,0.0010101389154464722,0.0,0.0071435347,False,TLE4; TLE family member 4
hsa:643847,0.0,0.0,1.003027325991584e-06,3.283698701622094e-06,0.0,1.9485457e-05,False,PGA4; pepsinogen
hsa:25974,2.51018685e-06,0.0031100642390507554,9.730388256670295e-05,0.00017685280992446828,0.0,0.0010192961,False,MMACHC; metabolism of cobalamin associated
hsa:5688,0.0,0.0,2.836234332618812e-06,5.988659135942242e-06,0.0,5.500456e-05,False,PSMA7; proteasome 20S subunit alpha
hsa:54874,0.0,0.0,3.0699004611188117e-07,7.264008356747324e-07,0.0,4.18949e-06,False,FNBP1L; formin binding protein 1
hsa:6194,6.8585142e-07,0.0008497542621754154,3.6628966816039596e-05,8.240279920532907e-05,0.0,0.0005031466,False,RPS6; ribosomal protein
hsa:56903,0.0,0.0,5.480823547643565e-09,1.2784020210723497e-08,0.0,8.0984044e-08,False,PAPOLB; poly(A) polymerase
hsa:8708,0.0,0.0,0.0003858619233128713,0.0007685453919260434,0.0,0.0047066286,False,B3GALT1; beta-1
hsa:2487,0.0,0.0,2.390694848860396e-06,1.8526367730281476e-05,0.0,0.00022620312,False,FRZB; frizzled related
hsa:440387,0.0,0.0,2.8055826655396036e-06,1.1362619470955586e-05,0.0,0.000103462764,False,CTRB2; chymotrypsinogen
hsa:8218,8.5365475e-06,0.010576587597336878,0.00013065774469148508,0.00021276835268836666,0.0,0.0008635227,False,CLTCL1; clathrin heavy chain like
hsa:1152,3.8795118499999994e-06,0.004806626673890287,0.00015468018408316836,0.0002474629368677851,0.0,0.0011676283,False,CKB; creatine kinase
hsa:910,0.0,0.0,1.3332123769403708e-05,3.0302843122732226e-05,0.0,0.0002460871,False,CD1B; CD1b
hsa:8826,5.8705755e-07,0.0007273509111561758,9.160696583148516e-06,3.377560366080338e-05,0.0,0.0004198649,False,IQGAP1; IQ motif containing GTPase activating protein
hsa:283871,8.4164555e-07,0.0010427796349149084,8.523340623465351e-06,1.8003662623595357e-05,0.0,0.00011216463,False,PGP; phosphoglycolate
hsa:4597,0.0,0.0,4.667271575797548e-05,0.0002846917310286835,0.0,0.0029519405,False,MVD; mevalonate diphosphate
hsa:246175,0.0,0.0,7.317619641227724e-07,4.725021344171666e-06,0.0,5.8963185e-05,False,CNOT6L; CCR4-NOT transcription complex subunit 6
hsa:9924,3.07097495e-07,0.0003804867900975452,2.6752149429722777e-05,0.00011525947317081215,0.0,0.001131661,False,PAN2; poly(A) specific ribonuclease subunit
hsa:23225,0.0,0.0,1.4443593655084158e-07,3.723407446103736e-07,0.0,2.3881232e-06,False,NUP210; nucleoporin
hsa:64446,0.0,0.0,9.194961332029707e-09,2.829994934585378e-08,0.0,2.95333e-07,False,DNAI2; dynein axonemal intermediate chain
hsa:6390,0.0,0.0,9.042730408564358e-06,2.305449166603889e-05,0.0,0.0002486011,False,SDHB; succinate dehydrogenase complex iron sulfur subunit
hsa:81127,0.0,0.0,2.7674726237623764e-08,3.9333176252387545e-07,-0.0,5.5902947e-06,False,OR4K15; olfactory receptor family 4 subfamily K member
hsa:1717,0.0,0.0,1.8875881780198017e-05,4.113299975198413e-05,0.0,0.00023936499,False,DHCR7; 7-dehydrocholesterol
hsa:64101,0.0,0.0,6.650732314732674e-06,2.012078183497678e-05,0.0,0.00024755954,False,LRRC4; leucine rich repeat containing
hsa:55257,5.4972827e-08,6.811007848767267e-05,2.582501156236266e-06,7.717682353050645e-06,0.0,4.4359364e-05,False,MRGBP; MRG domain binding
hsa:9670,0.0,0.0,2.653127073021435e-07,5.777441370763135e-07,0.0,3.2410567e-06,False,IPO13; importin
hsa:4907,0.0,0.0,7.098733680267326e-05,0.00024633808741803524,0.0,0.0020793965,False,NT5E; 5'-nucleotidase
hsa:4736,0.0,0.0,3.4840152026930685e-07,9.446435398576818e-07,0.0,6.78376e-06,False,RPL10A; ribosomal protein
hsa:55534,6.401013e-05,0.07930709072513463,0.0004945946854365841,0.0007690910381848318,0.0,0.0039550597,False,MAML3; mastermind like transcriptional coactivator
hsa:10877,-0.0,0.0,5.471586955648515e-07,2.7393926853953166e-06,-0.0,3.0552193e-05,False,CFHR4; complement factor H related
hsa:112849,0.0,0.0,2.6384304141056443e-05,6.77952856994856e-05,0.0,0.0005202209,False,L3HYPDH; trans-L-3-hydroxyproline
hsa:169270,0.0,0.0,1.1393005960346535e-07,3.0511174520450884e-07,0.0,1.8063217e-06,False,ZNF596; zinc finger protein
hsa:3440,0.0,0.0,2.2604042079207922e-10,3.212637998598008e-09,0.0,4.5660165e-08,False,IFNA2; interferon alpha
hsa:1136,1.5202260250000001e-05,0.018835253621166805,3.501550725534656e-05,5.515042372376302e-05,0.0,0.0005777525,False,CHRNA3; cholinergic receptor nicotinic alpha 3
hsa:7932,7.2671415e-07,0.0009003822523917557,4.4741728918143554e-05,0.00016704599775554498,0.0,0.0018936704,False,OR2H2; olfactory receptor family 2 subfamily H member
hsa:5888,9.6974715e-06,0.012014945947694644,7.61720917147475e-05,0.00011557389787188986,0.0,0.0005936825,False,RAD51; RAD51
hsa:8935,4.5855545e-09,5.681397409387379e-06,7.049054962881686e-07,3.402189596506571e-06,0.0,3.1072028e-05,False,SKAP2; src kinase associated phosphoprotein
hsa:2042,0.0,0.0,1.9311919323305247e-06,7.719940811137998e-06,0.0,6.006397e-05,False,EPHA3; EPH receptor
hsa:403284,0.0,0.0,3.216094292079208e-07,4.0608113265418545e-06,-0.0,5.7523102e-05,False,OR6C68; olfactory receptor family 6 subfamily C member
hsa:51421,0.0,0.0,1.046901785517327e-06,4.159055421412932e-06,0.0,4.5116896e-05,False,AMOTL2; angiomotin like
hsa:282618,0.0,0.0,5.406582388366336e-07,3.979782050843449e-06,0.0,5.302156e-05,False,IFNL1; interferon lambda
hsa:25776,1.8960012000000002e-07,0.00023491022309025795,4.729330053316831e-06,1.4364322470863832e-05,0.0,0.000112435446,False,CBY1; chibby 1
hsa:8822,3.2915955499999996e-05,0.04078211791075872,9.37134519191089e-05,0.00014465973629944212,0.0,0.0010049783,False,FGF17; fibroblast growth factor
hsa:5631,1.327661e-06,0.0016449416893735878,6.68723869028515e-05,0.00022782441101576405,0.0,0.0012267916,False,PRPS1; phosphoribosyl pyrophosphate synthetase
hsa:57186,0.0,0.0,8.01170166588119e-07,2.0291116932112595e-06,0.0,1.1525447e-05,False,RALGAPA2; Ral GTPase activating protein catalytic subunit alpha
hsa:7225,0.0,0.0,5.047555396173268e-06,3.2014920508741526e-05,0.0,0.00042759543,False,TRPC6; transient receptor potential cation channel subfamily C member
hsa:1307,0.0,0.0,3.212583112425743e-05,0.00010841728384845464,0.0,0.0012110809,False,COL16A1; collagen type XVI alpha 1
hsa:59343,9.31675725e-07,0.0011543249677665173,7.32820052e-06,2.274801415004897e-05,0.0,0.00013882756,False,SENP2; SUMO specific peptidase
hsa:441478,0.0,0.0,3.9195526785e-05,0.0002085674503176274,0.0,0.0023260035,False,NRARP; NOTCH regulated ankyrin repeat
hsa:51099,0.0,0.0,1.3181163377846536e-05,6.721810871396285e-05,0.0,0.0007649416,False,ABHD5; abhydrolase domain containing 5
hsa:5320,0.0,0.0,4.126835178039604e-05,0.00017236648968108398,0.0,0.0018814002,False,PLA2G2A; phospholipase A2 group
hsa:27071,6.088336600000001e-08,7.543310146399605e-05,1.6363457857851492e-06,2.945931199216495e-06,0.0,1.6328635e-05,False,DAPP1; dual adaptor of phosphotyrosine and 3-phosphoinositides
hsa:651,0.0,0.0,2.1927645073769307e-07,1.168514314642576e-06,0.0,1.2520651e-05,False,BMP3; bone morphogenetic protein
hsa:1975,1.22825985e-06,0.0015217859322890024,3.694186585594058e-06,5.450271159126571e-06,0.0,2.9864917e-05,False,EIF4B; eukaryotic translation initiation factor
hsa:23414,5.49491465e-09,6.808073888842615e-06,4.546297095123266e-07,1.2632968592054984e-06,0.0,8.219919e-06,False,ZFPM2; zinc finger protein
hsa:81285,3.3820996e-07,0.00041903442442413656,8.156438302574258e-06,1.8569261104426605e-05,0.0,0.00011769753,False,OR51E2; olfactory receptor family 51 subfamily E member
hsa:8314,0.0,0.0,1.0094294611773118e-05,5.647260851537302e-05,0.0,0.00053423183,False,BAP1; BRCA1 associated protein
hsa:26152,1.3338687e-08,1.652632888049398e-05,1.798911881133416e-07,4.0902537263273774e-07,0.0,2.1959097e-06,False,ZNF337; zinc finger protein
hsa:155382,2.605372e-09,3.227996468320334e-06,3.4212628549440607e-07,5.76217116493837e-07,0.0,2.8139611e-06,False,VPS37D; VPS37D subunit of
hsa:2571,0.0,0.0,4.9092406469207905e-05,0.0001526168411531346,0.0,0.0013870173,False,GAD1; glutamate decarboxylase
hsa:3875,0.0,0.0,2.1486018789603964e-05,7.920356843934844e-05,0.0,0.0009372649,False,KRT18; keratin
hsa:406954,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR181A2; microRNA
hsa:6346,0.0,0.0,5.569061503480199e-05,0.00040836154382343636,0.0,0.0057048267,False,CCL1; C-C motif chemokine ligand
hsa:955,0.0,0.0,3.077196278983564e-05,7.854900067339231e-05,0.0,0.0005935394,False,ENTPD6; ectonucleoside triphosphate diphosphohydrolase
hsa:2589,0.0,0.0,0.0001881204801623762,0.00040054229276643435,0.0,0.0025689616,False,GALNT1; polypeptide N-acetylgalactosaminyltransferase
hsa:79644,0.0,0.0,8.409217262209412e-05,0.00019967838998334703,0.0,0.0010247672,False,SRD5A3; steroid 5 alpha-reductase
hsa:942,0.0,0.0,0.0002465040028316833,0.0008051238260985682,0.0,0.006152265,False,CD86; CD86
hsa:369,0.0,0.0,0.00025408724839108906,0.00044969386854030546,0.0,0.0022969951,False,ARAF; A-Raf proto-oncogene
hsa:5436,0.0,0.0,0.0002234751288002574,0.0008245281680484288,0.0,0.0058688805,False,POLR2G; RNA polymerase II subunit
hsa:118460,8.9245565e-08,0.000110573218961919,3.0739101962945553e-06,8.130350088658265e-06,0.0,5.6285906e-05,False,EXOSC6; exosome component
hsa:407041,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR34B; microRNA
hsa:961,3.000779e-05,0.037178967203953306,0.00025923177366420796,0.0004232538585904132,0.0,0.0019181286,False,CD47; CD47
hsa:11136,1.431191925e-05,0.017732141434653403,6.440677272413857e-05,0.00010924954043742834,0.0,0.0005229791,False,SLC7A9; solute carrier family 7 member
hsa:20,2.68367695e-05,0.03325014514899479,0.0004015670523353465,0.0007290647950971868,0.0,0.0035932227,False,ABCA2; ATP binding cassette subfamily A member
hsa:1755,0.0,0.0,6.028310111267328e-07,2.490566919790999e-06,0.0,2.5154324e-05,False,DMBT1; deleted in malignant brain tumors
hsa:90249,9.8720155e-08,0.00012231201981599402,2.132592118424651e-05,8.010655653069767e-05,0.0,0.0005838915,False,UNC5A; unc-5 netrin receptor
hsa:4313,0.0,0.0,4.4137749143564356e-05,0.00014826712823814612,0.0,0.000946361,False,MMP2; matrix metallopeptidase
hsa:5997,0.0,0.0,0.00010499441762326734,0.00031218287374057727,0.0,0.00235728,False,RGS2; regulator of G protein signaling
hsa:11317,0.0,0.0,1.254010324579208e-06,1.1911328938199566e-05,0.0,0.00016434646,False,RBPJL; recombination signal binding protein for immunoglobulin kappa J region
hsa:7385,6.1822965e-09,7.659724318872376e-06,1.9908599170772273e-05,5.677963871770639e-05,0.0,0.0004589276,False,UQCRC2; ubiquinol-cytochrome c reductase core protein
hsa:11267,9.051447e-09,1.1214536330776826e-05,9.404201331673265e-07,2.0725839734764006e-06,0.0,1.8769193e-05,False,SNF8; SNF8 subunit of
hsa:79658,1.1594993499999999e-08,1.436593241510127e-05,1.6253173943054453e-06,6.2292400318831475e-06,0.0,4.610012e-05,False,ARHGAP10; Rho GTPase activating protein
hsa:407030,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR30B; microRNA
hsa:113091,0.0,0.0,3.1321302930693066e-07,2.887596380766913e-06,0.0,3.9046477e-05,False,PTH2; parathyroid hormone
hsa:7475,0.0,0.0,2.2660681474064357e-05,8.741365489020826e-05,0.0,0.0009832596,False,WNT6; Wnt family member
hsa:120227,8.937297499999999e-07,0.001107310770451519,4.055535631465346e-05,9.893100942134212e-05,0.0,0.0008543856,False,CYP2R1; cytochrome P450 family 2 subfamily R member
hsa:3316,6.486389799999999e-08,8.036488979903459e-05,3.636224619773267e-07,6.226787792841756e-07,0.0,3.6943798e-06,False,HSPB2; heat shock protein family B (small) member
hsa:25970,1.3983452e-07,0.00017325178005646373,4.500663935049505e-06,1.4764575858735239e-05,0.0,0.00014359811,False,SH2B1; SH2B adaptor protein
hsa:1758,6.723567700000001e-09,8.330346986961047e-06,2.06380420030495e-06,1.4377436986663595e-05,0.0,0.00019783927,False,DMP1; dentin matrix acidic phosphoprotein
hsa:9038,0.0,0.0,0.0,0.0,0.0,0.0,False,TAAR5; trace amine associated receptor
hsa:54407,0.0,0.0,0.00023600689133529697,0.0004883330292212509,0.0,0.003362321,False,SLC38A2; solute carrier family 38 member
hsa:2289,1.6807130999999998e-07,0.0002082365186645024,1.8355954303851483e-05,4.371937270141296e-05,0.0,0.0002557369,False,FKBP5; FKBP prolyl isomerase
hsa:554,0.0,0.0,1.3336981435089108e-05,4.953332718461729e-05,0.0,0.00045925815,False,AVPR2; arginine vasopressin receptor
hsa:407026,0.0,0.0,3.0124354455445545e-08,3.3374932976652494e-07,0.0,4.526354e-06,False,MIR29C; microRNA
hsa:10,0.0,0.0,1.7698492649183162e-05,9.06990752408996e-05,0.0,0.0011170302,False,NAT2; N-acetyltransferase
hsa:64240,6.138677e-05,0.07605680753519752,0.00018044070372509908,0.0002767315039147527,0.0,0.0014540765,False,ABCG5; ATP binding cassette subfamily G member
hsa:573,7.3270637e-08,9.078064762635862e-05,7.28406644393317e-07,1.7930119267834926e-06,0.0,1.7159204e-05,False,BAG1; BAG cochaperone
hsa:23538,0.0,0.0,9.924810891089109e-08,1.019942901199843e-06,-0.0,1.3813374e-05,False,OR52A1; olfactory receptor family 52 subfamily A member
hsa:9563,0.0,0.0,5.608948990746534e-06,1.543173212926926e-05,0.0,0.00012580829,False,H6PD; hexose-6-phosphate dehydrogenase/glucose
hsa:64786,1.4774002e-07,0.00018304651419819338,5.324084553746533e-06,1.1931664923801052e-05,0.0,6.035714e-05,False,TBC1D15; TBC1 domain family member
hsa:1277,0.0,0.0,0.00014761255096980196,0.0003590981806822755,0.0,0.002331389,False,COL1A1; collagen type I alpha 1
hsa:580,1.65339155e-08,2.0485144095164462e-05,6.769640643767332e-06,3.222301139024332e-05,0.0,0.0003891245,False,BARD1; BRCA1 associated RING domain
hsa:682,0.0,0.0,3.298129517901684e-05,9.023467036411397e-05,0.0,0.0006777076,False,BSG; basigin (Ok blood
hsa:84844,0.0,0.0,1.1473824579405938e-07,2.528062013122591e-07,0.0,1.8120882e-06,False,PHF5A; PHD finger protein
hsa:84188,0.0,0.0,0.00012171348117741092,0.0004285059678385841,0.0,0.0026158106,False,FAR1; fatty acyl-CoA reductase
hsa:34,7.312388e-05,0.09059881905151354,0.0002245091289893564,0.0005493910546482256,0.0,0.0053746183,False,ACADM; acyl-CoA dehydrogenase medium
hsa:345630,1.00930875e-08,1.2505105146001457e-05,1.2625421542693063e-06,3.047000148493746e-06,0.0,2.4945439e-05,False,FBLL1; fibrillarin like
hsa:9027,1.04874835e-08,1.2993752792141688e-05,2.244505899904058e-05,9.413494454251896e-05,0.0,0.0008846972,False,NAT8; N-acetyltransferase 8
hsa:7371,2.8736052499999998e-05,0.03560331345522547,0.00022038354807251467,0.00033600428147532324,0.0,0.0014872772,False,UCK2; uridine-cytidine kinase
hsa:10878,0.0,0.0,3.672885699314356e-06,2.1176869655236467e-05,0.0,0.00027730013,False,CFHR3; complement factor H related
hsa:3300,1.2301879000000001e-08,1.524174742251935e-05,6.702789781396041e-07,2.2810573877500686e-06,0.0,2.393354e-05,False,DNAJB2; DnaJ heat shock protein family (Hsp40) member
hsa:57715,2.231272e-08,2.7644951031415276e-05,1.890284031363664e-05,7.287054159123886e-05,0.0,0.00067325024,False,SEMA4G; semaphorin
hsa:80335,0.0,0.0,2.640356470082673e-07,7.678631808342193e-07,0.0,5.6122726e-06,False,WDR82; WD repeat domain
hsa:799,0.0,0.0,2.015041216929208e-06,8.023339964198573e-06,0.0,7.115572e-05,False,CALCR; calcitonin
hsa:27035,0.0,0.0,1.8340559974252477e-06,5.8200387878962536e-06,0.0,3.7186943e-05,False,NOX1; NADPH oxidase
hsa:406903,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR10B; microRNA
hsa:322,0.0,0.0,1.6449580908564356e-08,6.064433554633577e-08,0.0,6.171153e-07,False,APBB1; amyloid beta precursor protein binding family B member
hsa:6818,1.17105225e-05,0.01450907021039061,0.0002215394049321781,0.00034439770203403673,0.0,0.0022186951,False,SULT1A3; sulfotransferase family 1A member
hsa:196743,1.7126156e-07,0.0002121891656312538,2.2907831912623755e-06,9.644257664580765e-06,0.0,0.000100311256,False,PAOX; polyamine
hsa:9724,7.414805e-09,9.1867742315815e-06,9.35046805399307e-07,2.512078336510822e-06,0.0,1.3064777e-05,False,UTP14C; UTP14C small subunit processome
hsa:4645,0.0,0.0,1.1852663952059402e-07,3.130555524071246e-07,0.0,2.5237532e-06,False,MYO5B; myosin
hsa:120586,0.0,0.0,4.6438970297029706e-08,6.6002177871202e-07,-0.0,9.380672e-06,False,OR8I2; olfactory receptor family 8 subfamily I member
hsa:6428,0.0,0.0,2.715321051534654e-07,4.2387604079949586e-07,0.0,2.1015896e-06,False,SRSF3; serine and arginine rich splicing factor
hsa:6521,3.7133017500000003e-07,0.00046006961519536233,4.398785785531188e-05,0.00013631540727910896,0.0,0.00104131,False,SLC4A1; solute carrier family 4 member 1 (Diego blood
hsa:22841,4.0342587000000003e-08,4.998354490602717e-05,8.399792654595053e-07,2.5133839288053607e-06,0.0,1.4940737e-05,False,RAB11FIP2; RAB11 family interacting protein
hsa:341568,0.0,0.0,3.082381617115346e-06,1.9055922505838266e-05,0.0,0.00019495009,False,OR8S1; olfactory receptor family 8 subfamily S member
hsa:114907,3.7157481999999995e-08,4.603727247689634e-05,8.451359411297032e-07,3.165108779920284e-06,0.0,2.9362329e-05,False,FBXO32; F-box protein
hsa:7730,0.0,0.0,4.3683104494178214e-08,8.963950109094461e-08,0.0,5.009569e-07,False,ZNF177; zinc finger protein
hsa:5727,1.9289247499999998e-05,0.02389893758225575,5.600847231856434e-05,0.00011859553519677405,0.0,0.0011301389,False,PTCH1; patched
hsa:9080,7.6955132e-07,0.0009534565287226742,9.65799782349257e-06,2.587372985897071e-05,0.0,0.0002030509,False,CLDN9; claudin
hsa:8471,0.0,0.0,7.273717529356435e-06,2.5255575643229564e-05,0.0,0.00021830421,False,IRS4; insulin receptor substrate
hsa:123264,0.0,0.0,4.591014742361387e-06,2.2450601951171068e-05,0.0,0.00025009093,False,SLC51B; SLC51 subunit
hsa:2783,0.0,0.0,0.00020060002853797032,0.0005277741918104736,0.0,0.0027295947,False,GNB2; G protein subunit beta
hsa:58533,1.7583256299999998e-09,2.178525340641231e-06,2.394005830413861e-07,6.414685586313703e-07,0.0,5.901308e-06,False,SNX6; sorting nexin
hsa:8869,0.0,0.0,8.862538279405936e-05,0.00016297758318754564,0.0,0.0012340839,False,ST3GAL5; ST3 beta-galactoside alpha-2
hsa:2734,0.0,0.0,3.7845404497222777e-06,7.434446870702395e-06,0.0,4.563979e-05,False,GLG1; golgi glycoprotein
hsa:3198,0.0,0.0,1.417639419097179e-06,8.161469720230885e-06,0.0,6.459356e-05,False,HOXA1; homeobox
hsa:7594,3.8280772999999994e-09,4.74290043988238e-06,1.6227577434122772e-07,3.238121543272952e-07,0.0,1.727145e-06,False,ZNF43; zinc finger protein
hsa:3688,0.0,0.0,0.0002950427322336633,0.0004992656063011885,0.0,0.002583049,False,ITGB1; integrin subunit beta
hsa:84108,0.0,0.0,1.23744608114307e-05,3.965892914882916e-05,0.0,0.00023886107,False,PCGF6; polycomb group ring finger
hsa:347468,-0.0,0.0,2.0591634166336636e-06,1.3141964763492714e-05,-0.0,0.00014804957,False,OR13H1; olfactory receptor family 13 subfamily H member
hsa:29119,0.0,0.0,2.8080730177623768e-06,7.826899924254542e-06,0.0,7.302318e-05,False,CTNNA3; catenin alpha
hsa:26869,0.0,0.0,6.928490133546038e-08,1.9203935036130314e-07,0.0,1.7131812e-06,False,RNU1-3; RNA
hsa:4281,2.0278818e-08,2.5124992855419806e-05,1.6044893462851484e-07,3.373844534364582e-07,0.0,2.240657e-06,False,MID1; midline
hsa:9370,0.0,0.0,8.712476314712872e-06,3.72167451317744e-05,0.0,0.0002679385,False,ADIPOQ; adiponectin
hsa:3075,0.0,0.0,6.624389531712871e-05,0.00043760976698583773,0.0,0.0036821025,False,CFH; complement factor
hsa:51692,3.7759229e-09,4.678282328147333e-06,7.716567510844556e-07,1.9074614660780458e-06,0.0,9.134613e-06,False,CPSF3; cleavage and polyadenylation specific factor
hsa:85414,0.0,0.0,5.503056464356436e-06,2.9031992154545644e-05,0.0,0.000365588,False,SLC45A3; solute carrier family 45 member
hsa:1131,0.00018486624,0.22904505377030968,0.0005280452899777227,0.0008273229432000648,0.0,0.0060422425,False,CHRM3; cholinergic receptor muscarinic
hsa:10152,0.0,0.0,2.042438854828861e-05,6.87019944311839e-05,0.0,0.0003617625,False,ABI2; abl interactor
hsa:101954276,0.0,0.0,1.8892360524257428e-08,8.325783692056314e-08,0.0,7.134793e-07,False,RNVU1-6; RNA
hsa:347240,4.8384408e-09,5.994717765669168e-06,3.688837419599009e-07,1.3693113549477937e-06,0.0,8.318082e-06,False,KIF24; kinesin family member
hsa:10015,0.0,0.0,6.336565077128711e-06,1.4239332658292136e-05,0.0,0.00010153931,False,PDCD6IP; programmed cell death 6 interacting
hsa:7923,0.0,0.0,4.255805163544555e-05,0.00012214412666338082,0.0,0.0012527228,False,HSD17B8; hydroxysteroid 17-beta dehydrogenase
hsa:56913,0.0,0.0,0.00014363011363811878,0.0004106751016685472,0.0,0.0024202638,False,C1GALT1; core 1 synthase
hsa:1756,0.0,0.0,5.17741404960396e-05,0.00016208210014465632,0.0,0.0013805206,False,DMD;
hsa:6504,0.0,0.0,7.229411334009903e-08,3.591807795521976e-07,0.0,3.521628e-06,False,SLAMF1; signaling lymphocytic activation molecule family member
hsa:10019,1.17201645e-07,0.0001452101642841535,1.7795833839257414e-06,3.6373660161203825e-06,0.0,3.3564465e-05,False,SH2B3; SH2B adaptor protein
hsa:54811,0.0,0.0,6.959543196188119e-08,1.5863264565858982e-07,0.0,1.0596572e-06,False,ZNF562; zinc finger protein
hsa:64746,0.0,0.0,1.6519233514059403e-07,3.8398849184817884e-07,0.0,3.3220717e-06,False,ACBD3; acyl-CoA binding domain containing
hsa:7037,4.2782416e-05,0.05300643737409144,0.00016065393735742578,0.00025599241368766905,0.0,0.0013413233,False,TFRC; transferrin
hsa:8036,0.0,0.0,5.054156620643564e-07,1.0441536217334874e-06,0.0,4.85502e-06,False,SHOC2; SHOC2 leucine rich repeat scaffold
hsa:1608,1.0907987e-07,0.00013514747035158172,3.219070445621781e-05,7.51341884360106e-05,0.0,0.00046668717,False,DGKG; diacylglycerol kinase
hsa:7378,0.0,0.0,0.00014686321641074252,0.0004108511597405378,0.0,0.0025984484,False,UPP1; uridine phosphorylase
hsa:2517,0.0,0.0,5.203676661831683e-05,0.0001369999723471459,0.0,0.0009642763,False,FUCA1; alpha-L-fucosidase
hsa:6125,0.0,0.0,5.30668731910891e-07,1.1060740064655884e-06,0.0,8.5873935e-06,False,RPL5; ribosomal protein
hsa:285267,0.0,0.0,2.418547961534652e-08,5.610013533309094e-08,0.0,2.9793532e-07,False,ZNF619; zinc finger protein
hsa:345456,0.0,0.0,3.3610354915693065e-07,2.476122101097668e-06,0.0,3.109004e-05,False,PFN3; profilin
hsa:494324,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR375; microRNA
hsa:4723,0.0,0.0,1.0919423203465346e-05,2.806051324976207e-05,0.0,0.0001846046,False,NDUFV1; NADH:ubiquinone oxidoreductase core subunit
hsa:6928,9.871729e-07,0.0012230847014635692,2.4108055546633675e-05,6.253441968128021e-05,-0.0,0.00040727927,False,HNF1B; HNF1 homeobox
hsa:7465,0.0,0.0,6.301452379529703e-07,1.208758296950273e-06,0.0,7.3976307e-06,False,WEE1; WEE1 G2 checkpoint
hsa:9180,0.0,0.0,4.218830145097032e-05,0.0002186965197443794,0.0,0.0017802862,False,OSMR; oncostatin M
hsa:5272,3.3945895e-07,0.00042058189453933215,5.885236914074261e-06,1.9606100048531307e-05,0.0,0.00021156228,False,SERPINB9; serpin family B member
hsa:3482,9.0685295e-05,0.11235701158551932,0.0007385122762500002,0.0013251834837545715,0.0,0.0096810805,False,IGF2R; insulin like growth factor 2
hsa:2132,0.0,0.0,0.00013412391542722772,0.0003280363915696011,0.0,0.001811701,False,EXT2; exostosin glycosyltransferase
hsa:138803,0.0,0.0,1.8777621584158416e-08,1.7127615136368394e-07,0.0,2.3058171e-06,False,OR13C3; olfactory receptor family 13 subfamily C member
hsa:390142,0.0,0.0,6.104044608910891e-08,7.766904246448174e-07,-0.0,1.0983578e-05,False,OR5D13; olfactory receptor family 5 subfamily D member
hsa:23191,1.7291755500000001e-07,0.00021424090565592445,1.7269338163712874e-06,5.771672832503905e-06,0.0,4.4201897e-05,False,CYFIP1; cytoplasmic FMR1 interacting protein
hsa:11127,9.975595999999999e-06,0.012359535857985136,0.00013615902633477226,0.00029096245661976524,0.0,0.0021043445,False,KIF3A; kinesin family member
hsa:221,0.0,0.0,0.0002561370421920791,0.0008526911835354355,0.0,0.009230444,False,ALDH3B1; aldehyde dehydrogenase 3 family member
hsa:9863,1.2214305e-07,0.00015133245234456882,1.5135112260940595e-06,3.9010330760008315e-06,0.0,2.492709e-05,False,MAGI2; membrane associated guanylate kinase
hsa:5175,0.0,0.0,6.093972884887624e-05,0.0001416903339966852,0.0,0.0008678785,False,PECAM1; platelet and endothelial cell adhesion molecule
hsa:10008,4.56155455e-06,0.005651662018878898,4.961575231099011e-05,0.00010763973037195568,0.0,0.000686166,False,KCNE3; potassium voltage-gated channel subfamily E regulatory subunit
hsa:222537,5.3758435e-06,0.006660547450514868,0.00042515176499178224,0.0012194064957944523,0.0,0.007771614,False,HS3ST5; heparan sulfate-glucosamine 3-sulfotransferase
hsa:284521,0.0,0.0,1.9303319289158414e-05,7.29011076420093e-05,0.0,0.0008075533,False,OR2L13; olfactory receptor family 2 subfamily L member
hsa:4905,4.08078415e-06,0.005055998461708192,0.00013854864127039608,0.0003369939570739982,0.0,0.0026974226,False,NSF; N-ethylmaleimide sensitive factor
hsa:3084,1.7403124000000002e-06,0.0021562073596300586,7.367776064564358e-06,1.5707869939507838e-05,0.0,0.00013366767,False,NRG1; neuregulin
hsa:4194,5.5828929999999995e-06,0.006917077057330128,6.300095562519803e-05,0.00014488103830692732,0.0,0.0007612504,False,MDM4; MDM4 regulator of
hsa:64798,0.0,0.0,6.303188541548021e-07,1.6938123478209822e-06,0.0,1.1768692e-05,False,DEPTOR; DEP domain containing MTOR interacting
hsa:55568,0.0,0.0,7.233951931881188e-05,0.00032320860055420984,0.0,0.0031845788,False,GALNT10; polypeptide N-acetylgalactosaminyltransferase
hsa:7711,6.929325350000001e-09,8.585276021098932e-06,7.564952051237625e-08,2.2573809292123647e-07,0.0,1.7694978e-06,False,ZNF155; zinc finger protein
hsa:1577,0.00026089239500000003,0.32323972533351614,0.0008563076451920787,0.0012155247968769582,0.0,0.0056919386,False,CYP3A5; cytochrome P450 family 3 subfamily A member
hsa:9619,1.37836715e-05,0.017077654523994134,0.00020853451502475257,0.0005069658990137176,0.0,0.004419343,False,ABCG1; ATP binding cassette subfamily G member
hsa:1020,4.15251165e-05,0.05144867197797107,0.00020905309080990092,0.0005410092000631831,0.0,0.0037707728,False,CDK5; cyclin dependent kinase
hsa:2068,4.0738812e-07,0.0005047445864144009,3.3310960983554445e-06,5.845418438893523e-06,0.0,3.1303098e-05,False,ERCC2; ERCC excision repair 2
hsa:4848,0.0,0.0,4.36267496120282e-06,3.3924204148282266e-05,0.0,0.00038256703,False,CNOT2; CCR4-NOT transcription complex subunit
hsa:26735,-0.0,0.0,1.872783161940594e-06,8.93986593845425e-06,-0.0,8.537138e-05,False,OR1L3; olfactory receptor family 1 subfamily L member
hsa:54965,4.0649616e-06,0.005036394683238237,4.473442580306931e-05,7.755313867337035e-05,0.0,0.0004640175,False,PIGX; phosphatidylinositol glycan anchor biosynthesis class
hsa:3301,0.0,0.0,1.1552582767839604e-06,3.5187644798967763e-06,0.0,3.270472e-05,False,DNAJA1; DnaJ heat shock protein family (Hsp40) member
hsa:9314,0.0,0.0,1.0863465061792076e-05,5.6876101291666456e-05,0.0,0.0005972046,False,KLF4; KLF transcription factor
hsa:8892,0.0,0.0,5.247559152178215e-08,9.439228195947966e-08,0.0,4.699404e-07,False,EIF2B2; eukaryotic translation initiation factor 2B subunit
hsa:6530,9.334391999999999e-07,0.0011565098730591092,2.5321914861015348e-05,8.408706428144986e-05,0.0,0.0006982564,False,SLC6A2; solute carrier family 6 member
hsa:142827,0.0,0.0,4.320130323242772e-06,1.9349831472531645e-05,0.0,0.0001488351,False,ACSM6; acyl-CoA synthetase medium chain family member
hsa:51083,0.0,0.0,2.5866133583528412e-06,6.98735155793013e-06,0.0,6.779162e-05,False,GAL; galanin and GMAP
hsa:1903,0.0,0.0,1.0783084455297031e-05,4.052894805008637e-05,0.0,0.0003049143,False,S1PR3; sphingosine-1-phosphate receptor
hsa:57101,0.0,0.0,4.494475869462377e-05,0.00018613329129206737,0.0,0.001596505,False,ANO2; anoctamin
hsa:113130,0.0,0.0,1.3764483573910891e-06,3.648539006936092e-06,0.0,2.0106896e-05,False,CDCA5; cell division cycle associated
hsa:4352,0.0,0.0,9.279813686279209e-07,2.909403574152842e-06,0.0,2.0823092e-05,False,MPL; MPL proto-oncogene
hsa:4247,0.0,0.0,3.4511997027193074e-05,0.00011219201997480404,0.0,0.00072875887,False,MGAT2; alpha-1
hsa:23094,1.1888531e-07,0.00014729618680755304,2.4815999037574274e-07,3.5161682832267424e-07,0.0,1.9963645e-06,False,SIPA1L3; signal induced proliferation associated 1 like
hsa:2595,5.40638265e-06,0.0066983847606362276,0.00014430118762326735,0.00038215168283834165,0.0,0.0025478224,False,GANC; glucosidase alpha
hsa:442891,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR135B; microRNA
hsa:8863,0.0,0.0,0.00023090560084383662,0.0005297201912073944,0.0,0.0034064518,False,PER3; period circadian regulator
hsa:9241,6.4420993e-09,7.981614060859216e-06,2.6760122639032682e-05,0.0001309171964387914,0.0,0.0016498639,False,NOG;
hsa:1036,3.9086515999999996e-05,0.048427301593379456,0.00021181603801188117,0.00036621763597172234,0.0,0.0027618394,False,CDO1; cysteine dioxygenase type
hsa:390059,0.0,0.0,4.539245663366336e-09,3.629655736417445e-08,0.0,4.219034e-07,False,OR51M1; olfactory receptor family 51 subfamily M member
hsa:153201,0.0,0.0,1.1747479502376237e-06,1.1167925728791133e-05,0.0,0.00015663561,False,SLC36A2; solute carrier family 36 member
hsa:3065,0.000123187108,0.15262601638713993,0.00032833633951485165,0.0005357337816190758,0.0,0.0032844169,False,HDAC1; histone deacetylase
hsa:3799,2.152473275e-07,0.00026668652806025023,2.0127567245826725e-05,6.106577879274308e-05,0.0,0.00057851063,False,KIF5B; kinesin family member
hsa:55502,1.69691335e-08,2.1024369267980262e-05,6.799138880693068e-08,1.0485646212599461e-07,0.0,7.4375134e-07,False,HES6; hes family bHLH transcription factor
hsa:5293,0.00055875195,0.6922809185279875,0.0009568328278831684,0.0011309271083512372,0.0,0.005600705,True,PIK3CD; phosphatidylinositol-4
hsa:57104,5.06308325e-06,0.006273044636163986,0.00017899917719287124,0.0005025239022613886,0.0,0.0031175858,False,PNPLA2; patatin like phospholipase domain containing
hsa:9821,0.0,0.0,1.6331200038613867e-06,2.8122992215578735e-06,0.0,1.3331264e-05,False,RB1CC1; RB1 inducible coiled-coil
hsa:54807,8.361747e-09,1.0360013765783983e-05,4.213718668648515e-08,8.855191708433054e-08,0.0,6.9188764e-07,False,ZNF586; zinc finger protein
hsa:132789,1.205562625e-07,0.0001493664588334791,1.4792818550209286e-05,3.6358399065500304e-05,0.0,0.00029228037,False,GNPDA2; glucosamine-6-phosphate deaminase
hsa:23385,3.3321656e-07,0.0004128477157449495,0.00010243616021212873,0.0003008433898950789,0.0,0.0017608373,False,NCSTN;
hsa:338755,0.0,0.0,5.852020056326733e-06,4.567617632586836e-05,-0.0,0.00061460305,False,OR2AG2; olfactory receptor family 2 subfamily AG member
hsa:6136,2.3826405999999997e-07,0.00029520373451762897,6.267157581113861e-07,2.046832923159561e-06,0.0,2.1440068e-05,False,RPL12; ribosomal protein
hsa:6096,7.85470275e-07,0.0009731797507882181,0.0002510696018418287,0.000941488422314332,0.0,0.007592862,False,RORB; RAR related orphan receptor
hsa:9087,0.0,0.0,3.1813555153272235e-06,1.8106445810568182e-05,0.0,0.00015417975,False,TMSB4Y; thymosin beta 4
hsa:391194,0.0,0.0,7.599469752475247e-08,4.916501491805293e-07,-0.0,4.7035487e-06,False,OR2M2; olfactory receptor family 2 subfamily M member
hsa:338440,1.6288015e-07,0.00020180478985706697,3.428105992635296e-05,8.475485571047674e-05,0.0,0.0006156105,False,ANO9; anoctamin
hsa:80055,1.4053607e-05,0.01741209845011074,3.97563905300495e-05,6.183554209655773e-05,0.0,0.00042087823,False,PGAP1; post-GPI attachment to proteins inositol deacylase
hsa:2524,2.68008635e-05,0.03320565843416424,0.00032425122216435653,0.000527797051410259,0.0,0.0031397063,False,FUT2; fucosyltransferase
hsa:11040,1.2961779500000001e-08,1.6059349086866256e-05,1.5912479973596044e-05,5.700736621546137e-05,0.0,0.00043809583,False,PIM2; Pim-2 proto-oncogene
hsa:4931,0.0,0.0,2.6333640057570796e-06,8.176476058261243e-06,0.0,4.255604e-05,False,NVL; nuclear VCP
hsa:51251,5.4705722e-08,6.777914148648024e-05,2.1103627232890614e-05,4.373949092352381e-05,0.0,0.00018580667,False,NT5C3A; 5'-nucleotidase
hsa:4724,0.0,0.0,3.2202656910148515e-06,7.638425406959967e-06,0.0,4.1984767e-05,False,NDUFS4; NADH:ubiquinone oxidoreductase subunit
hsa:2792,3.6079680499999996e-05,0.04470190100765879,0.00037422770974539584,0.0007581835517877554,0.0,0.0045994036,False,GNGT1; G protein subunit gamma transducin
hsa:57600,0.0,0.0,1.8740393479851492e-06,4.190323854971333e-06,0.0,2.2323891e-05,False,FNIP2; folliculin interacting protein
hsa:6013,6.364575649999999e-09,7.885564027155274e-06,4.818327351164852e-06,1.3938117206958446e-05,0.0,0.00012694618,False,RLN1; relaxin
hsa:3691,0.0,0.0,0.000132404414679703,0.0005108666702982041,0.0,0.004612729,False,ITGB4; integrin subunit beta
hsa:353288,0.0,0.0,7.021243366336634e-08,6.108603417990125e-07,0.0,8.160979e-06,False,KRT26; keratin
hsa:22800,5.6855805e-07,0.0007044304527089014,3.129293716272279e-05,7.036635838858279e-05,0.0,0.00051900867,False,RRAS2; RAS related
hsa:6222,0.0,0.0,7.451680974633664e-07,1.4883393871891143e-06,0.0,7.3577403e-06,False,RPS18; ribosomal protein
hsa:5828,1.59781485e-07,0.00019796561461587,4.827588969773269e-05,0.0001726918497117384,0.0,0.0011266209,False,PEX2; peroxisomal biogenesis factor
hsa:8639,0.0,0.0,0.0002208679423757425,0.0006819008121656593,0.0,0.0048332615,False,AOC3; amine oxidase copper containing
hsa:7388,0.0,0.0,0.00047163134243672267,0.0015324625038019358,0.0,0.009815977,False,UQCRH; ubiquinol-cytochrome c reductase hinge
hsa:5243,2.08562965e-05,0.025840475542165092,0.00022277018305346535,0.0004155455998024489,0.0,0.0023641568,False,ABCB1; ATP binding cassette subfamily B member
hsa:1628,1.79290825e-05,0.02221372417843744,0.0009174305270615347,0.002003877249722747,0.0,0.011381367,False,DBP; D-box binding PAR bZIP transcription
hsa:53905,2.21212315e-06,0.002740770114858704,4.5184848732227646e-05,7.864264505873124e-05,0.0,0.0003901734,False,DUOX1; dual oxidase
hsa:64321,0.0,0.0,4.76060976219406e-06,3.809412640920391e-05,0.0,0.0004175519,False,SOX17; SRY-box transcription factor
hsa:151636,0.0,0.0,5.430316164722773e-05,0.00029380933783524987,0.0,0.002937869,False,DTX3L; deltex E3 ubiquitin ligase
hsa:868,1.55302165e-06,0.0019241583932831925,3.200775190196534e-05,6.200287865013343e-05,0.0,0.0003615122,False,CBLB; Cbl proto-oncogene
hsa:100134444,0.0,0.0,5.000600318128712e-08,3.1927865491357535e-07,0.0,3.5067649e-06,False,KCNJ18; potassium inwardly rectifying channel subfamily J member
hsa:406977,0.0,0.0,1.4994154455445544e-09,2.1310697525519623e-08,-0.0,3.0288192e-07,False,MIR199A2; microRNA
hsa:5143,0.0,0.0,1.3394589197881185e-05,3.958781745928406e-05,0.0,0.00024525248,False,PDE4C; phosphodiesterase
hsa:9294,0.0,0.0,4.4878417014356435e-06,1.3160580837991488e-05,0.0,0.00010199378,False,S1PR2; sphingosine-1-phosphate receptor
hsa:3476,1.9924734999999998e-05,0.02468629209656761,0.0005222735626852257,0.0011957958009127315,0.0,0.0060865297,False,IGBP1; immunoglobulin binding protein
hsa:83549,0.0,0.0,4.092922694715346e-05,0.0001394819144252807,0.0,0.0011666989,False,UCK1; uridine-cytidine kinase
hsa:29934,3.9764648e-09,4.9267491670287855e-06,4.866251960639111e-07,1.166200378198669e-06,0.0,1.0234047e-05,False,SNX12; sorting nexin
hsa:56171,7.009453999999999e-09,8.684553590371676e-06,2.8479301415099e-08,1.0478167455936093e-07,0.0,1.2216287e-06,False,DNAH7; dynein axonemal heavy chain
hsa:6635,0.0,0.0,1.615776339693069e-07,4.738671772690139e-07,0.0,3.3181816e-06,False,SNRPE; small nuclear ribonucleoprotein polypeptide
hsa:2811,1.65963675e-05,0.02056252069836721,5.8587789794999996e-05,0.00012837957643418638,0.0,0.0012467917,False,GP1BA; glycoprotein Ib platelet subunit
hsa:55301,0.0,0.0,2.709763064950495e-06,1.4989894200791985e-05,0.0,0.00019827497,False,OLAH; oleoyl-ACP
hsa:23527,6.37524285e-08,7.898780444590816e-05,1.1643390755842081e-06,3.2101820720993684e-06,0.0,2.1610844e-05,False,ACAP2; ArfGAP with coiled-coil
hsa:835,2.50536345e-07,0.00031040881564931407,1.2975174566943073e-06,2.7321877902855257e-06,0.0,1.3881459e-05,False,CASP2; caspase
hsa:7448,4.02673745e-06,0.004989035833444601,6.320282294133661e-05,0.00011900914345845193,0.0,0.00091528904,False,VTN;
hsa:3308,0.0,0.0,1.3987966931564356e-05,2.822495824653357e-05,0.0,0.00017834204,False,HSPA4; heat shock protein family A (Hsp70) member
hsa:10864,1.7641815499999997e-05,0.021857806919226473,0.00012419628128969312,0.0002689116442773897,0.0,0.0018230282,False,SLC22A7; solute carrier family 22 member
hsa:2017,0.0,0.0,8.589949992544556e-06,4.54180758591553e-05,0.0,0.00043368211,False,CTTN;
hsa:112714,0.0,0.0,5.270368377481385e-06,3.22180472754256e-05,0.0,0.0004505981,False,TUBA3E; tubulin alpha
hsa:2592,0.000106950368,0.13250906595663117,0.00033659591827673273,0.0005283253138976932,0.0,0.002911217,False,GALT; galactose-1-phosphate
hsa:2050,1.290708025e-08,1.599157796404012e-05,1.1376104651391094e-06,7.968918141348938e-06,0.0,0.00010865886,False,EPHB4; EPH receptor
hsa:7029,6.0448025e-08,7.48937238969864e-05,1.5272993886291925e-06,3.4785418767535706e-06,0.0,1.8791028e-05,False,TFDP2; transcription factor
hsa:29072,0.0,0.0,5.870803578272277e-06,2.1031522719126348e-05,0.0,0.00015772347,False,SETD2; SET domain containing 2
hsa:100506742,0.0,0.0,1.3701163092311886e-07,4.496791857870325e-07,0.0,4.8894735e-06,False,CASP12; caspase 12
hsa:9131,2.4228308499999998e-08,3.0018321480147756e-05,8.399164858489106e-06,6.224495021635109e-05,0.0,0.0008620031,False,AIFM1; apoptosis inducing factor mitochondria associated
hsa:25833,0.0,0.0,1.6423956894306933e-08,8.311980203916031e-08,0.0,1.0567472e-06,False,POU2F3; POU class 2 homeobox
hsa:55556,0.0,0.0,8.225950991178225e-05,0.00025692752964534755,0.0,0.0013213516,False,ENOSF1; enolase superfamily member
hsa:4048,2.14974625e-05,0.026634865588426072,0.0001415895178969307,0.00033214986261457104,0.0,0.0021268076,False,LTA4H; leukotriene A4
hsa:55970,0.0,0.0,0.0002108586258466832,0.000620364024599817,0.0,0.004231091,False,GNG12; G protein subunit gamma
hsa:1555,0.0,0.0,4.5246062217821785e-06,2.617566555788951e-05,0.0,0.00025245946,False,CYP2B6; cytochrome P450 family 2 subfamily B member
hsa:257397,5.28503815e-06,0.006548041693523317,4.128224096663369e-05,8.710725395701729e-05,0.0,0.00047006228,False,TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein
hsa:6048,0.0,0.0,2.6069964148514846e-07,9.904276428093876e-07,0.0,8.545385e-06,False,RNF5; ring finger protein
hsa:8790,0.0,0.0,3.814518557395991e-05,0.0001079741735731655,0.0,0.0005162815,False,FPGT; fucose-1-phosphate
hsa:126328,0.0,0.0,4.1274041055792075e-06,9.04014626239492e-06,0.0,8.722757e-05,False,NDUFA11; NADH:ubiquinone oxidoreductase subunit
hsa:8326,0.0,0.0,2.2137355734950495e-06,5.812450441051379e-06,0.0,4.755979e-05,False,FZD9; frizzled class receptor
hsa:5592,0.0,0.0,0.00013258414645544555,0.0004356329180794727,0.0,0.0029845138,False,PRKG1; protein kinase cGMP-dependent
hsa:80146,0.0,0.0,6.6863466566831665e-06,2.7226911003000304e-05,0.0,0.00029164858,False,UXS1; UDP-glucuronate decarboxylase
hsa:8115,8.2497275e-09,1.0221224160927937e-05,1.0497070769178217e-07,3.144885876332071e-07,0.0,2.6638504e-06,False,TCL1A; TCL1 family AKT coactivator
hsa:6507,0.0,0.0,3.828911962435298e-05,0.0001772208597124084,0.0,0.0018116618,False,SLC1A3; solute carrier family 1 member
hsa:5079,2.12486195e-09,2.6326554788599314e-06,2.927943179332184e-06,1.1941205564639815e-05,0.0,9.1580434e-05,False,PAX5; paired box
hsa:80228,6.139913900000001e-08,7.607213244400773e-05,1.389332645930693e-06,4.457676404726254e-06,0.0,4.837396e-05,False,ORAI2; ORAI calcium release-activated calcium modulator
hsa:26683,0.0,0.0,2.0513584396039604e-06,7.420409690962885e-06,-0.0,6.590236e-05,False,OR4F3; olfactory receptor family 4 subfamily F member
hsa:6614,1.6180664e-07,0.00020047473545842194,1.811266047891089e-06,5.848420737314084e-06,0.0,7.026701e-05,False,SIGLEC1; sialic acid binding Ig like lectin
hsa:56998,0.0,0.0,4.0599945145643555e-06,2.914929268166024e-05,0.0,0.00035776972,False,CTNNBIP1; catenin beta interacting protein
hsa:4688,0.0,0.0,1.8030948705247525e-05,4.3949960760708826e-05,0.0,0.000306501,False,NCF2; neutrophil cytosolic factor
hsa:5226,0.0,0.0,3.576874103133663e-05,0.00014515096922103406,0.0,0.0019151852,False,PGD; phosphogluconate
hsa:3948,3.4812104e-08,4.313140264300076e-05,1.2651163543301978e-05,3.779467630493201e-05,0.0,0.0003676868,False,LDHC; lactate dehydrogenase
hsa:442898,0.0,0.0,1.4632268241930693e-08,1.3826750803401435e-07,-0.0,1.5130674e-06,False,MIR324; microRNA
hsa:2771,0.0,0.0,0.0004336607598762376,0.0014442255764754676,0.0,0.00957625,False,GNAI2; G protein subunit alpha
hsa:51085,0.0,0.0,2.7555855695346527e-06,1.4873709961705824e-05,0.0,0.00012420904,False,MLXIPL; MLX interacting protein
hsa:406951,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR16-2; microRNA
hsa:79646,1.3845720499999999e-06,0.0017154531819391027,5.164981612702968e-05,0.0001304806053974667,0.0,0.00062485394,False,PANK3; pantothenate kinase
hsa:7799,0.0,0.0,2.3587386054417827e-05,5.7892384790052964e-05,0.0,0.00030855782,False,PRDM2; PR/SET domain
hsa:5899,0.0,0.0,5.388536825678217e-05,0.00011790363838197247,0.0,0.000638125,False,RALB; RAS like proto-oncogene
hsa:79611,0.0,0.0,6.800058874052476e-05,0.00031809043249148315,0.0,0.0034782097,False,ACSS3; acyl-CoA synthetase short chain family member
hsa:7341,0.0,0.0,7.875991727475246e-07,1.2177042429667328e-06,0.0,5.6871236e-06,False,SUMO1; small ubiquitin like modifier
hsa:898,2.2887203e-05,0.028356722362000725,9.831915927346535e-05,0.00020999976640296704,0.0,0.0012492987,False,CCNE1; cyclin
hsa:64399,3.5668121999999997e-06,0.00441919894155686,2.542890145056437e-05,5.2013782803272946e-05,0.0,0.00039164905,False,HHIP; hedgehog interacting
hsa:594855,0.0,0.0,6.06744996859604e-06,2.180330974718952e-05,0.0,0.00018652684,False,CPLX3; complexin
hsa:653361,0.0,0.0,6.3428995245049505e-06,1.61137189503393e-05,0.0,0.00011795266,False,NCF1; neutrophil cytosolic factor
hsa:80022,0.0,0.0,9.780079929123764e-07,3.1889968892316406e-06,0.0,1.844535e-05,False,MYO15B; myosin
hsa:55423,7.4009554e-07,0.0009169614893150117,4.749604824283168e-05,0.00012926045895057464,0.0,0.0008313966,False,SIRPG; signal regulatory protein
hsa:64581,3.86801505e-07,0.0004792382400981472,6.654714193138618e-06,1.9462103411862143e-05,0.0,0.00016071474,False,CLEC7A; C-type lectin domain containing
hsa:6616,2.5950116500000003e-05,0.032151602310342337,0.00010505047002327241,0.00017984907150812507,0.0,0.0012227434,False,SNAP25; synaptosome associated protein
hsa:56655,0.0,0.0,2.5507356479554444e-05,7.185331833600841e-05,0.0,0.00057923043,False,POLE4; DNA polymerase epsilon 4
hsa:1982,1.5525287e-05,0.019235476394794906,0.00015056244113331694,0.0003328699856886567,0.0,0.0021210846,False,EIF4G2; eukaryotic translation initiation factor 4 gamma
hsa:85417,2.9484417e-09,3.6530519997330137e-06,1.4729210776709899e-05,5.4741080017537975e-05,0.0,0.00069096667,False,CCNB3; cyclin
hsa:22808,0.0,0.0,2.2031808873222776e-05,5.7780885156779564e-05,0.0,0.000357854,False,MRAS; muscle RAS oncogene
hsa:6799,0.0,0.0,1.4947632046336632e-05,6.582024503133705e-05,0.0,0.00063467363,False,SULT1A2; sulfotransferase family 1A member
hsa:64374,1.0338505e-09,1.2809171829478523e-06,1.4574571720103955e-06,6.279377228595162e-06,0.0,6.0756935e-05,False,SIL1; SIL1 nucleotide exchange
hsa:5906,0.0,0.0,9.962174892841585e-05,0.0005117935883591536,0.0,0.0060121524,False,RAP1A; RAP1A
hsa:101954278,0.0,0.0,3.6946682044554453e-09,2.973482745091907e-08,0.0,3.335706e-07,False,RNU6-8; RNA
hsa:25973,3.6856173e-08,4.5663957500043465e-05,4.085110716680198e-06,1.3108815936872553e-05,0.0,7.585736e-05,False,PARS2; prolyl-tRNA synthetase 2
hsa:2395,0.0,0.0,9.80926598746039e-05,0.00025873890283893366,0.0,0.0016993992,False,FXN;
hsa:2852,0.0,0.0,2.200830729211881e-05,5.7738160317389554e-05,0.0,0.00040792226,False,GPER1; G protein-coupled estrogen receptor
hsa:7480,4.6171009999999996e-07,0.0005720482803176775,1.8298506773168314e-05,3.9774341420124115e-05,0.0,0.00037139398,False,WNT10B; Wnt family member
hsa:10400,0.0,0.0,9.183353204589112e-06,2.4271194948903214e-05,0.0,0.0002275179,False,PEMT; phosphatidylethanolamine
hsa:5536,0.0,0.0,1.324478375742574e-07,6.455584933358362e-07,0.0,7.333278e-06,False,PPP5C; protein phosphatase 5 catalytic
hsa:9060,0.0,0.0,0.0003513736970445545,0.0008377725400449491,0.0,0.005793664,False,PAPSS2; 3'-phosphoadenosine 5'-phosphosulfate synthase
hsa:4322,0.0,0.0,2.74248643008599e-06,3.157533754613897e-05,0.0,0.0004479659,False,MMP13; matrix metallopeptidase
hsa:54948,1.8026486e-10,2.233440489274696e-07,1.2345908573277232e-07,2.083933476672117e-07,0.0,1.2448992e-06,False,MRPL16; mitochondrial ribosomal protein
hsa:3770,0.0,0.0,2.2895477726442583e-06,8.702477648172058e-06,0.0,9.874949e-05,False,KCNJ14; potassium inwardly rectifying channel subfamily J member
hsa:116983,0.0,0.0,1.1944217861584158e-07,2.884452569700733e-07,0.0,2.0151838e-06,False,ACAP3; ArfGAP with coiled-coil
hsa:4722,0.0,0.0,4.496976399257426e-06,8.077202618455308e-06,0.0,5.8999005e-05,False,NDUFS3; NADH:ubiquinone oxidoreductase core subunit
hsa:23221,5.1805824999999995e-09,6.418623526253497e-06,5.040118441893564e-07,1.1898246819308283e-06,0.0,7.521402e-06,False,RHOBTB2; Rho related BTB domain containing
hsa:54880,1.1755803500000001e-08,1.4565172336337316e-05,0.0001594346929383701,0.0006385901559729018,0.0,0.0040857196,False,BCOR; BCL6
hsa:8622,0.0,0.0,4.3996645331450485e-05,0.00012252229718349067,0.0,0.0010839333,False,PDE8B; phosphodiesterase
hsa:3421,0.0,0.0,9.769825518990598e-06,4.064737328313779e-05,0.0,0.00046470235,False,IDH3G; isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit
hsa:51187,3.5485106999999994e-08,4.396523800592359e-05,5.123214536178218e-07,1.208170835308306e-06,0.0,6.2842237e-06,False,RSL24D1; ribosomal L24 domain containing
hsa:55585,0.0,0.0,2.899469755757426e-07,6.311114465924918e-07,0.0,2.9026107e-06,False,UBE2Q1; ubiquitin conjugating enzyme E2
hsa:1757,0.0,0.0,3.5937039419654456e-05,9.132981862178794e-05,0.0,0.00067542284,False,SARDH; sarcosine
hsa:10509,4.39471405e-07,0.0005444950445724354,1.0849969969835636e-05,4.015042248862812e-05,0.0,0.00036310815,False,SEMA4B; semaphorin
hsa:390261,0.0,0.0,4.326530851980198e-07,3.274121255917832e-06,0.0,3.8784518e-05,False,OR6M1; olfactory receptor family 6 subfamily M member
hsa:920,0.0,0.0,0.0005038794058886138,0.0013112299192354277,0.0,0.009304682,False,CD4; CD4
hsa:839,0.0,0.0,4.944217354851488e-07,1.483423485081153e-06,0.0,1.5566968e-05,False,CASP6; caspase
hsa:10788,0.0,0.0,4.428927319107425e-07,3.3892799685161176e-06,0.0,3.2619322e-05,False,IQGAP2; IQ motif containing GTPase activating protein
hsa:57693,0.0,0.0,6.284425244554455e-08,1.1639255874912237e-07,0.0,7.6745084e-07,False,ZNF317; zinc finger protein
hsa:1969,6.14423765e-08,7.61257027200754e-05,1.2847466601881186e-06,4.504703523702937e-06,0.0,5.8484748e-05,False,EPHA2; EPH receptor
hsa:91584,1.92559425e-07,0.00023857673447085263,1.5887389215315653e-05,6.329960592322985e-05,0.0,0.00046218614,False,PLXNA4; plexin
hsa:8802,1.8103822e-07,0.00022430222432382003,0.00010835735427554452,0.0003700760085603617,0.0,0.0040722704,False,SUCLG1; succinate-CoA ligase GDP/ADP-forming subunit
hsa:55274,8.1812307e-08,0.00010136358188432936,2.6906988715990075e-06,1.0217705744143073e-05,0.0,9.261656e-05,False,PHF10; PHD finger protein
hsa:5152,0.0,0.0,5.060674261235773e-06,2.3157413625926176e-05,0.0,0.00026081502,False,PDE9A; phosphodiesterase
hsa:7364,0.0,0.0,3.754621943069307e-06,2.6341748195521666e-05,0.0,0.00028788106,False,UGT2B7; UDP glucuronosyltransferase family 2 member
hsa:50855,1.52415315e-06,0.001888390980397161,1.258755913742574e-05,2.3374286837610555e-05,0.0,0.00015464806,False,PARD6A; par-6 family cell polarity regulator
hsa:64802,6.0359134e-08,7.478358997597033e-05,1.5235201569653468e-05,3.760781786856317e-05,0.0,0.00027344783,False,NMNAT1; nicotinamide nucleotide adenylyltransferase
hsa:51071,0.0,0.0,4.046864136089108e-06,9.21745240725166e-06,0.0,5.5196146e-05,False,DERA; deoxyribose-phosphate
hsa:7050,0.0,0.0,6.275998220029703e-05,0.000356507775337793,0.0,0.0034169946,False,TGIF1; TGFB induced factor homeobox
hsa:818,0.0009162696700000001,1.1352372170995306,0.0014143128025247524,0.0016986594379750724,0.0,0.00787205,True,CAMK2G; calcium/calmodulin dependent protein kinase II
hsa:4056,0.0,0.0,1.914641783549505e-05,4.344052176081275e-05,0.0,0.00023422106,False,LTC4S; leukotriene C4
hsa:8193,0.0,0.0,2.5829457528089108e-06,8.11455629850186e-06,0.0,7.6683806e-05,False,DPF1; double PHD fingers
hsa:163223,0.0,0.0,1.0033423624178217e-08,4.155921023620416e-08,0.0,3.2149e-07,False,ZNF676; zinc finger protein
hsa:391107,0.0,0.0,1.9507685544554454e-07,1.8007546750871597e-06,0.0,2.3867859e-05,False,OR10K2; olfactory receptor family 10 subfamily K member
hsa:9575,1.0347783500000001e-05,0.01282066767929625,0.00028975485565396037,0.0007387381185097189,0.0,0.0040376824,False,CLOCK; clock circadian
hsa:9476,5.48401685e-10,6.79457176326805e-07,4.420676706801882e-07,1.2244922596295291e-06,0.0,6.5550666e-06,False,NAPSA; napsin A aspartic
hsa:4300,7.71299115e-07,0.0009556220068529942,2.431510329253961e-05,5.754424359690256e-05,0.0,0.00030402667,False,MLLT3; MLLT3 super elongation complex
hsa:55578,0.0,0.0,2.103552893861881e-07,4.464654737006274e-07,0.0,3.7494613e-06,False,SUPT20H; SPT20 homolog
hsa:6183,7.468192e-10,9.252919506595667e-07,1.0092716346980195e-07,2.8854952507292223e-07,0.0,2.872937e-06,False,MRPS12; mitochondrial ribosomal protein
hsa:3417,4.8213512e-06,0.005973544141156043,7.852148794331686e-05,0.00022697180807071447,0.0,0.0016463982,False,IDH1; isocitrate dehydrogenase (NADP(+))
hsa:10376,0.0,0.0,3.484216077772279e-05,0.00021823417033453962,0.0,0.0024545852,False,TUBA1B; tubulin alpha
hsa:5411,4.3136851e-08,5.3445574252913004e-05,7.33943339249505e-07,1.1999316855384074e-06,0.0,5.2305927e-06,False,PNN; pinin
hsa:10120,6.1520851e-08,7.622293083523638e-05,4.505147794212871e-07,9.160651493154662e-07,0.0,6.81614e-06,False,ACTR1B; actin related protein
hsa:3270,0.0,0.0,1.054218329918812e-05,4.757928104114769e-05,0.0,0.00034016898,False,HRC; histidine rich calcium binding
hsa:134,0.0,0.0,1.6120853164108908e-05,7.362820977598415e-05,0.0,0.0009293779,False,ADORA1; adenosine A1
hsa:51084,0.0,0.0,6.948214519341409e-05,0.00022356032169114498,0.0,0.001861565,False,CRYL1; crystallin lambda
hsa:57406,7.734744500000001e-08,9.58317197289298e-05,5.732894628128708e-07,9.939622600920875e-07,0.0,5.721999e-06,False,ABHD6; abhydrolase domain containing 6
hsa:25956,0.0,0.0,2.0890147845064354e-07,5.443802681701165e-07,0.0,3.7744924e-06,False,SEC31B; SEC31 homolog B
hsa:5932,0.0,0.0,8.559873189999999e-06,3.955314356404174e-05,0.0,0.0004046849,False,RBBP8; RB binding protein 8
hsa:1441,0.0,0.0,4.514723410252971e-05,0.00017457533244468406,0.0,0.0016295923,False,CSF3R; colony stimulating factor 3
hsa:4771,6.8470193e-05,0.08483300702901991,0.0004431333765717822,0.0008038629191203375,0.0,0.004240041,False,NF2; NF2
hsa:8797,0.0,0.0,4.1485269363217813e-05,0.0001714058999962392,0.0,0.0013043528,False,TNFRSF10A; TNF receptor superfamily member
hsa:64221,2.71849475e-07,0.00033681529747565296,1.9825944386257422e-05,7.698459632800379e-05,0.0,0.0007352447,False,ROBO3; roundabout guidance receptor
hsa:6846,1.55263785e-07,0.0001923682873839312,9.468289791606931e-05,0.00023431408892555573,0.0,0.0014769873,False,XCL2; X-C motif chemokine ligand
hsa:100289635,0.0,0.0,8.504289377821782e-08,1.6342362923444998e-07,0.0,7.9705114e-07,False,ZNF605; zinc finger protein
hsa:5050,4.737509e-07,0.0005869665568155256,2.7207608044935656e-05,6.272423226488176e-05,0.0,0.00035571927,False,PAFAH1B3; platelet activating factor acetylhydrolase 1b catalytic subunit
hsa:4208,0.0,0.0,3.4634792438019806e-05,0.00018050330659717545,0.0,0.0018354274,False,MEF2C; myocyte enhancer factor
hsa:57053,2.1363676999999998e-08,2.646910840614559e-05,8.664987697709852e-06,1.6619661612588887e-05,0.0,8.370681e-05,False,CHRNA10; cholinergic receptor nicotinic alpha 10
hsa:1535,0.0,0.0,6.419160429252476e-05,0.00020914675085636036,0.0,0.0019214294,False,CYBA; cytochrome b-245 alpha
hsa:1491,0.0,0.0,4.84086591019802e-05,0.0001188885541261722,0.0,0.0009782283,False,CTH; cystathionine
hsa:84890,1.9700821e-05,0.024408867759003732,0.0005703777380649504,0.001091389546793559,0.0,0.006516472,False,ADO; 2-aminoethanethiol
hsa:4825,1.21722235e-05,0.015081107216015896,0.00039423728789227716,0.0010608297129694189,0.0,0.008773443,False,NKX6-1; NK6 homeobox
hsa:3676,0.0,0.0,7.11289752259406e-05,0.00014896583325834157,0.0,0.0007167293,False,ITGA4; integrin subunit alpha
hsa:26047,2.9481505e-07,0.0003652691209576531,5.7405893603663385e-06,8.804346879002202e-06,0.0,3.6915844e-05,False,CNTNAP2; contactin associated protein
hsa:7567,0.0,0.0,5.0626533202970304e-08,8.265290772677493e-08,0.0,5.015067e-07,False,ZNF19; zinc finger protein
hsa:4994,0.0,0.0,2.9138066970297033e-06,1.3282995801702528e-05,0.0,0.00010178226,False,OR3A1; olfactory receptor family 3 subfamily A member
hsa:4717,1.9934256e-06,0.0024698088398352872,5.713562786917821e-06,8.032410801262592e-06,0.0,3.743738e-05,False,NDUFC1; NADH:ubiquinone oxidoreductase subunit
hsa:199777,0.0,0.0,2.804522920940593e-08,6.001857308890952e-08,0.0,4.162142e-07,False,ZNF626; zinc finger protein
hsa:63982,1.08403075e-10,1.3430893678717064e-07,5.761648980149755e-06,1.745710195117702e-05,0.0,0.00012969182,False,ANO3; anoctamin
hsa:406996,0.0,0.0,1.844306871287129e-09,1.8973287986538816e-08,0.0,2.539535e-07,False,MIR214; microRNA
hsa:721,0.0,0.0,5.6069688272029696e-05,0.00014395740018703076,0.0,0.0009001251,False,C4B; complement C4B (Chido blood
hsa:267,7.09186095e-08,8.786653921366657e-05,7.27060874642277e-07,1.7273539736940865e-06,0.0,1.6955944e-05,False,AMFR; autocrine motility factor
hsa:406881,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7A1; microRNA
hsa:57551,0.0,0.0,1.510214738663367e-07,4.325281436875112e-07,0.0,4.8835127e-06,False,TAOK1; TAO kinase
hsa:958,0.0,0.0,0.00017925910887623761,0.0006896469085394803,0.0,0.0061642863,False,CD40; CD40
hsa:925,8.77498075e-05,0.10872000954404559,0.0003078401848777228,0.0005064233701976713,0.0,0.0026243892,False,CD8A; CD8 subunit
hsa:57396,8.7748497e-07,0.001087183858644437,4.064522898959901e-05,7.391373097516837e-05,0.0,0.00033202834,False,CLK4; CDC like kinase
hsa:624,0.0,0.0,7.477910815544553e-05,0.0002248831253946912,0.0,0.0018636183,False,BDKRB2; bradykinin receptor
hsa:7514,3.3762854499999995e-07,0.00041831406450369956,0.00012227296512747524,0.0002835452978297512,0.0,0.0020784605,False,XPO1; exportin
hsa:2014,0.0,0.0,7.770948589393069e-05,0.0005008566933811837,0.0,0.0047254963,False,EMP3; epithelial membrane protein
hsa:4685,1.37134765e-06,0.0016990684520442338,0.00034676128018118816,0.0012636880613314787,0.0,0.011761711,False,NCAM2; neural cell adhesion molecule
hsa:8021,5.5904339e-08,6.926420060389945e-05,4.3895417557425785e-07,9.038973767070575e-07,0.0,4.757595e-06,False,NUP214; nucleoporin
hsa:5630,0.0,0.0,4.3476054485698025e-08,8.59932059452695e-08,0.0,4.9317896e-07,False,PRPH;
hsa:213,2.1943424e-07,0.0002718740171263668,2.646144549319306e-05,6.675036411865193e-05,0.0,0.00045762493,False,ALB;
hsa:94,0.0,0.0,2.8085463671584153e-05,7.293091084143203e-05,0.0,0.0005460275,False,ACVRL1; activin A receptor like type
hsa:862,9.08987475e-07,0.0011262147436325476,3.1073726225925234e-05,7.094450718219161e-05,0.0,0.000402263,False,RUNX1T1; RUNX1 partner transcriptional co-repressor
hsa:59348,0.0,0.0,2.506527476460396e-08,5.183028547073959e-08,0.0,3.0310332e-07,False,ZNF350; zinc finger protein
hsa:4696,1.6219434e-07,0.00020095508691332656,6.578105960034656e-06,1.0589767120805848e-05,0.0,5.7249144e-05,False,NDUFA3; NADH:ubiquinone oxidoreductase subunit
hsa:2054,0.0,0.0,4.0139932888415825e-05,0.00011271129532895205,0.0,0.0010163354,False,STX2; syntaxin
hsa:9500,2.518585e-09,3.120469355303031e-06,4.623154545346535e-06,1.1903752052930213e-05,0.0,0.000110761044,False,MAGED1; MAGE family member
hsa:7187,0.0,0.0,9.285356193267324e-05,0.00020259019601201732,0.0,0.0010254815,False,TRAF3; TNF receptor associated factor
hsa:1656,1.83681135e-07,0.00022757673571262397,1.6675845614081199e-06,1.0378095516294577e-05,0.0,0.00011771445,False,DDX6; DEAD-box helicase
hsa:375189,7.08873825e-08,8.782784967308802e-05,4.392883192861387e-06,1.32315671699895e-05,0.0,8.087017e-05,False,PFN4; profilin family member
hsa:2052,0.0,0.0,0.00023623696589108908,0.0005748313216399014,0.0,0.0044932915,False,EPHX1; epoxide hydrolase
hsa:55845,1.3436483e-07,0.00016647495893348896,1.2284070059356437e-06,2.8580409398120475e-06,0.0,1.5500482e-05,False,BRK1; BRICK1 subunit of SCAR/WAVE actin nucleating
hsa:7761,0.0,0.0,1.402441183252475e-08,3.683459766758393e-08,0.0,2.8519378e-07,False,ZNF214; zinc finger protein
hsa:123688,0.0,0.0,7.48764430813663e-06,2.3289054748260762e-05,0.0,0.0002012929,False,HYKK; hydroxylysine
hsa:55183,2.9616815e-07,0.0003669455809876543,5.359459826839602e-06,1.5346865085502187e-05,0.0,9.693577e-05,False,RIF1; replication timing regulatory factor
hsa:29982,0.0,0.0,1.7461583804603966e-07,4.6185469973688655e-07,0.0,4.349891e-06,False,NRBF2; nuclear receptor binding factor
hsa:23471,0.0,0.0,2.0145314639554456e-07,7.485719192391153e-07,0.0,6.404524e-06,False,TRAM1; translocation associated membrane protein
hsa:328,0.0,0.0,1.3337378616980192e-05,8.781014733940995e-05,0.0,0.0008794018,False,APEX1; apurinic/apyrimidinic endodeoxyribonuclease
hsa:8992,0.0,0.0,5.794201972277228e-05,0.0001664413579008689,0.0,0.001071287,False,ATP6V0E1; ATPase H+ transporting V0 subunit
hsa:8645,0.0,0.0,0.00010885270130965345,0.0004900826726402509,0.0,0.0052700466,False,KCNK5; potassium two pore domain channel subfamily K member
hsa:55624,1.2335399499999999e-05,0.015283278557273362,0.00010715026675544558,0.00024262512351816534,0.0,0.0014107304,False,POMGNT1; protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta
hsa:5197,0.0,0.0,1.7044250603099007e-05,0.00010871301493564217,0.0,0.0011962446,False,PF4V1; platelet factor 4 variant
hsa:949,0.000222488435,0.27565809505211475,0.0007692035461881186,0.0011242103424782108,0.0,0.0074388254,False,SCARB1; scavenger receptor class B member
hsa:162605,0.0,0.0,2.509992056717822e-07,8.919709130501355e-07,0.0,7.963907e-06,False,KRT28; keratin
hsa:56603,0.0,0.0,4.2234225181301986e-05,0.00016280062662337613,0.0,0.0017407199,False,CYP26B1; cytochrome P450 family 26 subfamily B member
hsa:3055,0.0,0.0,2.244178252183168e-06,8.038943972928641e-06,0.0,7.202899e-05,False,HCK; HCK proto-oncogene
hsa:63923,0.0,0.0,2.012869508905941e-06,7.874911480755792e-06,0.0,6.041183e-05,False,TNN; tenascin
hsa:4277,0.0,0.0,3.1654049756381188e-06,1.6495203060732837e-05,0.0,0.00017126216,False,MICB; MHC class I polypeptide-related sequence
hsa:9722,2.0616473e-07,0.00025543339697064955,2.0338645472920777e-05,6.312489817580825e-05,0.0,0.00043431035,False,NOS1AP; nitric oxide synthase 1 adaptor
hsa:51555,1.6116305500000001e-09,1.996773483263487e-06,1.6740996059376247e-06,7.752989918413562e-06,0.0,8.853068e-05,False,PEX5L; peroxisomal biogenesis factor 5
hsa:26229,0.0,0.0,0.00038929377381138604,0.0010639903031109373,0.0,0.005796388,False,B3GAT3; beta-1
hsa:3834,1.69167525e-08,2.095947040401493e-05,8.159196804168316e-08,1.6474511897228976e-07,0.0,1.2511196e-06,False,KIF25; kinesin family member
hsa:1585,0.0,0.0,4.810603331831684e-07,4.156483200022025e-06,0.0,5.372099e-05,False,CYP11B2; cytochrome P450 family 11 subfamily B member
hsa:390201,0.0,0.0,6.05773369059406e-07,5.4144550317468286e-06,-0.0,6.753277e-05,False,OR10V1; olfactory receptor family 10 subfamily V member
hsa:7415,1.27229275e-07,0.0001576341690810205,3.203474407302326e-05,6.939908456668898e-05,0.0,0.00036226248,False,VCP; valosin containing
hsa:148198,1.06803095e-09,1.3232659806955825e-06,2.927785328909407e-08,9.531557876610122e-08,0.0,6.07639e-07,False,ZNF98; zinc finger protein
hsa:241,1.77004615e-07,0.0002193046797526036,1.7738029593267327e-06,4.268691213786614e-06,0.0,3.837382e-05,False,ALOX5AP; arachidonate 5-lipoxygenase activating
hsa:22914,8.34548225e-07,0.0010339862111602503,2.964705619158417e-05,7.013991257547199e-05,0.0,0.00036600386,False,KLRK1; killer cell lectin like receptor
hsa:1643,8.32130725e-05,0.1030990983813766,0.00018282068662871297,0.00028153628137910804,0.0,0.0026535331,False,DDB2; damage specific DNA binding protein
hsa:406980,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR19B1; microRNA
hsa:100169756,0.0,0.0,4.4557194072643566e-07,3.940764749608774e-06,0.0,5.3228963e-05,False,RNA5S5; RNA
hsa:84987,0.0,0.0,4.5052246779207913e-07,1.0632124879939226e-06,0.0,6.8566965e-06,False,COX14; cytochrome c oxidase assembly factor
hsa:83737,0.0,0.0,3.429922654072276e-05,8.008438620550895e-05,0.0,0.00048041463,False,ITCH; itchy E3 ubiquitin protein
hsa:7852,0.00030273105999999996,0.37507687674960466,0.0008063560330693065,0.0014197537776018795,0.0,0.009328618,False,CXCR4; C-X-C motif chemokine receptor
hsa:1455,7.0075417e-08,8.68218429429942e-05,0.00010811375020210397,0.0002705403647707597,0.0,0.0018794049,False,CSNK1G2; casein kinase 1 gamma
hsa:3093,2.12662475e-07,0.00026348395478429233,8.71771563038614e-07,1.3449739553089069e-06,0.0,5.2469386e-06,False,UBE2K; ubiquitin conjugating enzyme E2
hsa:6355,0.0,0.0,2.358401254900991e-05,8.841140394153863e-05,0.0,0.0006818932,False,CCL8; C-C motif chemokine ligand
hsa:8862,0.0,0.0,1.931024595e-06,9.87396197642406e-06,0.0,0.00010629643,False,APLN;
hsa:7023,2.8479770500000002e-08,3.528578590411413e-05,4.292497310525739e-07,1.059915125311399e-06,0.0,7.8107105e-06,False,TFAP4; transcription factor
hsa:471,3.68077905e-06,0.004560401268635525,9.751809594851484e-05,0.0001578064511234447,0.0,0.0009667802,False,ATIC; 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP
hsa:3687,0.0,0.0,2.167977124128713e-06,8.48416313340931e-06,0.0,8.611851e-05,False,ITGAX; integrin subunit alpha
hsa:1519,5.4375371999999995e-08,6.736984537317679e-05,2.551137661306931e-06,4.369984705221246e-06,0.0,2.0669659e-05,False,CTSO; cathepsin
hsa:51706,0.0,0.0,5.926745813939602e-05,0.00012998574104094144,0.0,0.00078351714,False,CYB5R1; cytochrome b5 reductase
hsa:64754,0.0,0.0,9.341297340673756e-06,3.582141636251991e-05,0.0,0.00045290365,False,SMYD3; SET and MYND domain containing
hsa:100529063,0.0,0.0,2.2929823362896536e-05,8.572805306115739e-05,0.0,0.0004742149,False,BCL2L2-PABPN1; BCL2L2-PABPN1
hsa:6011,4.2429005e-05,0.052568569207908034,0.0002546876783597524,0.0005563207145242551,0.0,0.003948976,False,GRK1; G protein-coupled receptor kinase
hsa:171568,3.5627827000000004e-06,0.004414206482986992,8.419488716168313e-05,0.00020913599565508664,0.0,0.0011138553,False,POLR3H; RNA polymerase III subunit
hsa:2934,0.0,0.0,6.068144605081188e-06,3.939498687502995e-05,0.0,0.00040037232,False,GSN;
hsa:340252,1.213591375e-08,1.503612026414661e-05,1.0970627069059404e-07,1.8330832407927776e-07,0.0,9.592487e-07,False,ZNF680; zinc finger protein
hsa:5922,1.2720021e-07,0.00015759815820911747,5.438214384504949e-07,8.252201570268359e-07,0.0,4.6217147e-06,False,RASA2; RAS p21 protein activator
hsa:406991,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR21; microRNA
hsa:5585,0.0,0.0,2.170783279554455e-06,4.9698832151236425e-06,0.0,2.17945e-05,False,PKN1; protein kinase
hsa:390323,0.0,0.0,8.692462128712873e-09,7.207005645644507e-08,0.0,7.3037165e-07,False,OR6C75; olfactory receptor family 6 subfamily C member
hsa:4316,0.0,0.0,1.0800087095288613e-06,5.814123718924288e-06,0.0,6.7895235e-05,False,MMP7; matrix metallopeptidase
hsa:25961,7.947989700000001e-07,0.0009847377910657822,9.276450185698022e-05,0.00020342642492463366,0.0,0.0012038966,False,NUDT13; nudix hydrolase
hsa:4036,0.0,0.0,1.5077516053247525e-05,6.168772823729349e-05,0.0,0.00073268835,False,LRP2; LDL receptor related protein
hsa:1767,0.0,0.0,6.80574637653465e-09,2.0000601567562854e-08,0.0,1.5659079e-07,False,DNAH5; dynein axonemal heavy chain
hsa:6311,0.0,0.0,2.126684820822772e-07,3.7868611575007086e-07,0.0,1.7291212e-06,False,ATXN2; ataxin
hsa:23237,0.0,0.0,1.6603991325007427e-05,4.696771507404763e-05,0.0,0.00027708372,False,ARC; activity regulated cytoskeleton associated
hsa:3356,0.0,0.0,1.3967359999504947e-05,5.052467975491139e-05,0.0,0.00042174556,False,HTR2A; 5-hydroxytryptamine receptor
hsa:7143,4.40643475e-06,0.005459472125625053,7.118573713282677e-05,0.00014456572127961745,0.0,0.0008882022,False,TNR; tenascin
hsa:23214,2.87394675e-08,3.5607544562314716e-05,2.757215056321782e-07,3.831644362820379e-07,0.0,1.6705753e-06,False,XPO6; exportin
hsa:85363,1.2495776999999999e-07,0.0001548198262087658,1.1667003420584158e-05,3.270515653150451e-05,0.0,0.0003000152,False,TRIM5; tripartite motif containing
hsa:8706,0.00011203423000000001,0.13880785498999298,0.0006318842088039603,0.000945810134053548,0.0,0.0043804646,False,B3GALNT1; beta-1
hsa:6697,0.0,0.0,4.254726311272278e-06,1.9787469502255408e-05,0.0,0.00019253691,False,SPR; sepiapterin
hsa:91373,1.11166675e-08,1.3773297413763344e-05,1.0874846001202972e-05,2.9857065824499286e-05,0.0,0.00028741694,False,UAP1L1; UDP-N-acetylglucosamine pyrophosphorylase 1 like
hsa:7569,0.0,0.0,6.063839123114491e-08,1.6556010152499616e-07,0.0,9.552286e-07,False,ZNF182; zinc finger protein
hsa:54107,9.316995e-07,0.0011543544244491078,2.7877543949554447e-05,6.49102056439369e-05,0.0,0.00044439032,False,POLE3; DNA polymerase epsilon 3
hsa:26508,0.0,0.0,3.8001689845504956e-05,0.00014093253968044508,0.0,0.00092354446,False,HEYL; hes related family bHLH transcription factor with YRPW motif
hsa:7879,0.0,0.0,0.00010980906368584157,0.00040087547137181314,0.0,0.0053365687,False,RAB7A; RAB7A
hsa:10105,0.0,0.0,4.5031461791336625e-05,0.00011343454021590199,0.0,0.00061779557,False,PPIF; peptidylprolyl isomerase
hsa:100528030,1.39283535e-08,1.7256912221178843e-05,1.439771410403466e-05,3.5864337752307724e-05,0.0,0.00021616204,False,POC1B-GALNT4; POC1B-GALNT4
hsa:2867,2.73034735e-10,3.3828380757480246e-07,5.1442581035364855e-06,4.492039098033879e-05,0.0,0.0006265931,False,FFAR2; free fatty acid receptor
hsa:122970,0.0,0.0,3.210298521414851e-05,0.000146918206797747,0.0,0.0015971084,False,ACOT4; acyl-CoA thioesterase
hsa:4257,0.0,0.0,0.00022247381322178225,0.0006687659582449459,0.0,0.004621798,False,MGST1; microsomal glutathione S-transferase
hsa:8605,0.0,0.0,0.00022232463111386137,0.0005798557325213,0.0,0.0062920507,False,PLA2G4C; phospholipase A2 group
hsa:10941,0.0,0.0,7.797594890841583e-05,0.00042297065691872227,0.0,0.005470849,False,UGT2A1; UDP glucuronosyltransferase family 2 member A1 complex
hsa:5030,0.0,0.0,9.121293559900992e-06,2.2340120254970495e-05,0.0,0.00018726023,False,P2RY4; pyrimidinergic receptor
hsa:8029,0.0,0.0,2.9119119136559386e-05,8.085234858413815e-05,0.0,0.0005848244,False,CUBN;
hsa:4170,3.28235825e-06,0.004066766987118197,7.407772979452969e-05,0.00020184009778071658,0.0,0.0014764885,False,MCL1; MCL1 apoptosis regulator
hsa:5595,0.0,0.0,0.0008702198595544555,0.0015313157745489626,0.0,0.006618802,False,MAPK3; mitogen-activated protein kinase
hsa:5158,3.9444125e-05,0.04887037098578851,0.0002154671626664357,0.0005112122242494452,0.0,0.003377294,False,PDE6B; phosphodiesterase
hsa:3798,0.0,0.0,4.976109178683167e-05,0.00017036289225248253,0.0,0.0012798934,False,KIF5A; kinesin family member
hsa:51691,2.2575989e-07,0.00027971135316123266,3.7346268955316797e-05,0.0001595862246868147,0.0,0.00163102,False,LSM8; LSM8 homolog
hsa:54881,0.0,0.0,0.00010279024476868366,0.00039480424875504836,0.0,0.0023910028,False,TEX10; testis expressed
hsa:60559,0.0,0.0,1.8838350834430695e-05,9.756291585368674e-05,0.0,0.00091481186,False,SPCS3; signal peptidase complex subunit
hsa:163702,1.7678272e-07,0.0002190297569099777,1.690958263018218e-05,5.517681960486354e-05,0.0,0.00051985146,False,IFNLR1; interferon lambda receptor
hsa:57804,0.0,0.0,0.0002590735153676831,0.000774890908805501,0.0,0.0065975375,False,POLD4; DNA polymerase delta 4
hsa:388333,0.0,0.0,5.2484494851485125e-08,3.568341703135091e-07,0.0,4.7177364e-06,False,SPDYE4; speedy/RINGO cell cycle regulator family member
hsa:91750,1.3251193e-09,1.6417925810606365e-06,9.928176749470296e-07,1.7898973738942393e-06,0.0,9.394756e-06,False,LIN52; lin-52 DREAM MuvB core complex
hsa:6241,4.50627315e-06,0.005583169625484094,0.00026580313517178224,0.0006116152314313453,0.0,0.0035143355,False,RRM2; ribonucleotide reductase regulatory subunit
hsa:3030,0.0,0.0,0.0005377325022871288,0.001353243898877349,0.0,0.007414072,False,HADHA; hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit
hsa:54460,2.94274115e-08,3.645989148336943e-05,4.1178123519455413e-07,7.835766127199627e-07,0.0,3.6875495e-06,False,MRPS21; mitochondrial ribosomal protein
hsa:7335,2.98870085e-08,3.7029321680995955e-05,2.8547185270717826e-06,9.961415249454308e-06,0.0,8.568282e-05,False,UBE2V1; ubiquitin conjugating enzyme E2
hsa:4882,0.0,0.0,9.31418186470297e-06,6.423050189844076e-05,0.0,0.00088137377,False,NPR2; natriuretic peptide receptor
hsa:7473,3.32908975e-06,0.0041246662494727904,4.040179949059409e-05,6.56299385338344e-05,0.0,0.0004394293,False,WNT3; Wnt family member
hsa:55616,1.73544935e-08,2.1501821516270304e-05,3.6921447314138628e-06,1.0525563073643882e-05,0.0,9.603247e-05,False,ASAP3; ArfGAP with SH3 domain
hsa:79490,0.0,0.0,4.940169801980198e-07,7.021300513312474e-06,-0.0,9.979143e-05,False,OR10G6; olfactory receptor family 10 subfamily G member
hsa:6171,9.978468e-09,1.2363094200462531e-05,1.0674182263564353e-06,1.985936658563616e-06,0.0,1.1745754e-05,False,RPL41; ribosomal protein
hsa:154807,4.8883803e-05,0.0605659166683556,0.00044732488479398024,0.0009333692532007744,0.0,0.004733017,False,VKORC1L1; vitamin K epoxide reductase complex subunit 1 like
hsa:6427,2.2939568500000002e-08,2.8421602021819682e-05,3.2396333107574254e-07,5.236038705460087e-07,0.0,2.3847329e-06,False,SRSF2; serine and arginine rich splicing factor
hsa:81797,0.0,0.0,1.7731935643564357e-10,2.520181569189743e-09,-0.0,3.581851e-08,False,OR12D3; olfactory receptor family 12 subfamily D member
hsa:1978,5.1907107e-05,0.06431172134985932,0.00014108699988712873,0.00018058948966461914,0.0,0.00063531287,False,EIF4EBP1; eukaryotic translation initiation factor 4E binding protein
hsa:284390,0.0,0.0,3.161855512673267e-08,6.542594448150844e-08,0.0,4.1762837e-07,False,ZNF763; zinc finger protein
hsa:55349,0.0,0.0,3.3246300087403723e-06,1.234775259490459e-05,0.0,0.000112206915,False,CHDH; choline
hsa:5210,0.0,0.0,0.00010093835427628714,0.0002395512566232042,0.0,0.0011905786,False,PFKFB4; 6-phosphofructo-2-kinase/fructose-2
hsa:6594,0.0,0.0,2.127143133423266e-06,1.0685728846411975e-05,0.0,8.458025e-05,False,SMARCA1; SWI/SNF related
hsa:2944,5.46806855e-07,0.000677481218341699,0.00021694860031787127,0.0004192512195443204,0.0,0.0024171977,False,GSTM1; glutathione S-transferase mu
hsa:22901,1.8469709e-08,2.2883548077934468e-05,4.443884080951979e-07,1.0033364466483305e-06,0.0,5.9986696e-06,False,ARSG; arylsulfatase
hsa:7048,0.0,0.0,0.0001621268355509901,0.00046183121573895264,0.0,0.0028743646,False,TGFBR2; transforming growth factor beta receptor
hsa:6223,0.0,0.0,5.626351269851485e-07,2.504711050865333e-06,0.0,2.640859e-05,False,RPS19; ribosomal protein
hsa:10484,0.0,0.0,1.9091825778331698e-07,4.96633864566118e-07,0.0,4.2764555e-06,False,SEC23A; SEC23 homolog A
hsa:81567,1.6481148999999998e-08,2.0419767605494032e-05,8.24794171297921e-07,2.0909743467397197e-06,0.0,1.337366e-05,False,TXNDC5; thioredoxin domain containing
hsa:1736,9.428185749999999e-09,1.1681307047004457e-05,1.599415320472277e-06,3.7228237765235346e-06,0.0,1.9442185e-05,False,DKC1; dyskerin pseudouridine synthase
hsa:6794,0.0,0.0,3.055333123539604e-05,7.849602354986779e-05,0.0,0.00048346265,False,STK11; serine/threonine kinase
hsa:2916,3.72394675e-06,0.00461388506409564,2.0957836614752477e-05,4.9532325757457975e-05,0.0,0.0004299039,False,GRM6; glutamate metabotropic receptor
hsa:10767,0.0,0.0,1.964290093402475e-05,6.789431630123076e-05,0.0,0.0006685144,False,HBS1L; HBS1 like translational
hsa:2155,0.0,0.0,9.23948080573515e-07,3.3003689544581652e-06,0.0,3.07589e-05,False,F7; coagulation factor
hsa:8688,0.0,0.0,8.55944741470792e-07,5.817388155387151e-06,0.0,7.5954595e-05,False,KRT37; keratin
hsa:637,0.0,0.0,0.0001481566929009901,0.0003621115397254636,0.0,0.0031808289,False,BID; BH3 interacting domain death
hsa:6996,1.4876508e-07,0.00018431654015219014,2.2548248587713963e-05,9.133697191523747e-05,0.0,0.00082706625,False,TDG; thymine DNA
hsa:153090,5.989246e-07,0.0007420539153680045,4.26533863959406e-06,1.4582511635305292e-05,0.0,0.0001447538,False,DAB2IP; DAB2 interacting
hsa:8607,0.0,0.0,5.867074669301979e-06,2.1142446756681395e-05,0.0,0.00020650281,False,RUVBL1; RuvB like AAA ATPase
hsa:116228,0.0,0.0,7.029674721386135e-07,1.1702559086963475e-06,0.0,5.1268885e-06,False,COX20; cytochrome c oxidase assembly factor
hsa:7066,0.0,0.0,7.79898718319307e-06,4.039942751548627e-05,0.0,0.00039603404,False,THPO;
hsa:57786,0.0,0.0,1.200711621292079e-07,3.116211011953057e-07,0.0,1.7076237e-06,False,RBAK; RB associated KRAB zinc
hsa:7381,0.0,0.0,0.00025672196465391085,0.0005545612486475819,0.0,0.0030624464,False,UQCRB; ubiquinol-cytochrome c reductase binding
hsa:10775,1.5176024999999998e-07,0.00018802748744955076,2.1897985779246534e-06,6.404255434443206e-06,0.0,5.7098132e-05,False,POP4; POP4 homolog
hsa:1645,2.77304385e-05,0.03435738065158228,0.00020318390228589109,0.0005657023634422973,0.0,0.0052223187,False,AKR1C1; aldo-keto reductase family 1 member
hsa:51128,0.0,0.0,7.532264809978217e-06,3.2424506866795016e-05,0.0,0.00027697164,False,SAR1B; secretion associated Ras related GTPase
hsa:125,0.0,0.0,0.0001318476206734158,0.00043352689575356545,0.0,0.0036779435,False,ADH1B; alcohol dehydrogenase 1B (class I)
hsa:101954273,0.0,0.0,3.458969733663366e-09,1.9736315782091477e-08,0.0,2.1720136e-07,False,RNVU1-1; RNA
hsa:4090,4.40022785e-07,0.0005451781918130992,4.590119249345546e-05,0.0001821936644905921,0.0,0.0012719211,False,SMAD5; SMAD family member
hsa:3815,7.421916e-05,0.09195584598349173,0.00019675876207079208,0.00030782435886098146,0.0,0.0023995647,False,KIT; KIT proto-oncogene
hsa:6646,0.0,0.0,2.771020389737623e-05,0.00010337633735201214,0.0,0.0005980802,False,SOAT1; sterol O-acyltransferase
hsa:7779,3.7974199e-07,0.0004704916620708811,1.5097569460693064e-05,4.682644117310764e-05,0.0,0.00035971418,False,SLC30A1; solute carrier family 30 member
hsa:2316,3.8057952e-07,0.00047152934263323926,2.062049844475247e-06,3.4574836545640694e-06,0.0,1.984487e-05,False,FLNA; filamin
hsa:1263,0.0,0.0,6.147457979004949e-06,2.175416051873153e-05,0.0,0.00015914754,False,PLK3; polo like kinase
hsa:3428,0.0,0.0,2.1370224228415845e-07,6.727902728461525e-07,0.0,6.1136916e-06,False,IFI16; interferon gamma inducible protein
hsa:81168,0.0,0.0,3.468362920792079e-08,3.53015602234744e-07,0.0,4.11499e-06,False,OR8J3; olfactory receptor family 8 subfamily J member
hsa:91012,0.0,0.0,6.67291802936139e-06,2.0304559701145945e-05,0.0,0.00012853715,False,CERS5; ceramide synthase
hsa:4620,0.0,0.0,1.3678807681237624e-09,1.7994254657245253e-08,0.0,2.5565967e-07,False,MYH2; myosin heavy chain
hsa:11226,9.3332125e-06,0.011563637357000533,0.00028665518662982685,0.00058342610789314,0.0,0.003273861,False,GALNT6; polypeptide N-acetylgalactosaminyltransferase
hsa:340665,8.09424715e-09,1.0028587554449778e-05,1.4116071020212873e-06,4.128219937187323e-06,0.0,3.625389e-05,False,CYP26C1; cytochrome P450 family 26 subfamily C member
hsa:3455,0.0,0.0,5.826381273054456e-05,0.00013653344284470873,0.0,0.00080155546,False,IFNAR2; interferon alpha and beta receptor subunit
hsa:2634,0.0,0.0,4.338922462945545e-07,9.373175249645201e-07,0.0,8.069738e-06,False,GBP2; guanylate binding protein
hsa:3809,0.0,0.0,3.5271538176282185e-06,2.8521383403827577e-05,0.0,0.0003884683,False,KIR2DS4; killer cell immunoglobulin like receptor
hsa:9436,0.0,0.0,1.2394227979094054e-06,5.82223217258444e-06,0.0,4.310583e-05,False,NCR2; natural cytotoxicity triggering receptor
hsa:6636,1.2302766000000002e-09,1.5242846395283089e-06,5.30720594733663e-07,1.3593518565209379e-06,0.0,8.55394e-06,False,SNRPF; small nuclear ribonucleoprotein polypeptide
hsa:7770,0.0,0.0,6.070481117970298e-08,1.0381635325083867e-07,0.0,4.8168823e-07,False,ZNF227; zinc finger protein
hsa:23547,0.0,0.0,6.12372846493317e-06,1.4950889763434813e-05,0.0,9.864262e-05,False,LILRA4; leukocyte immunoglobulin like receptor
hsa:7414,0.0,0.0,2.1286497792574257e-05,8.564635070250146e-05,0.0,0.0006988179,False,VCL;
hsa:5540,0.0,0.0,2.624160196774752e-07,1.280303765410112e-06,0.0,1.1873385e-05,False,NPY4R; neuropeptide Y receptor
hsa:55341,1.2867143e-07,0.0001594209662242962,1.881288805071782e-06,3.9291104170867745e-06,0.0,2.9045386e-05,False,LSG1; large 60S subunit nuclear export GTPase
hsa:4547,8.195104999999999e-07,0.0010153548129600805,9.55182059837624e-06,2.8456774994061618e-05,0.0,0.00029513796,False,MTTP; microsomal triglyceride transfer
hsa:84647,0.0,0.0,7.920103843910893e-06,5.19850116776685e-05,0.0,0.00068178505,False,PLA2G12B; phospholipase A2 group
hsa:2173,0.0,0.0,1.777933693961436e-05,0.00017104324161457295,0.0,0.0022142446,False,FABP7; fatty acid binding protein
hsa:96459,2.0976735e-07,0.0002598969609594774,9.852216654455444e-07,2.498280129703367e-06,0.0,2.4588946e-05,False,FNIP1; folliculin interacting protein
hsa:5144,0.0,0.0,2.2189064341336635e-05,0.0001267630227235594,0.0,0.0013696811,False,PDE4D; phosphodiesterase
hsa:11264,3.8844035e-07,0.0004812687316640827,3.4070702649658405e-05,0.0001335880459191525,0.0,0.00092965184,False,PXMP4; peroxisomal membrane protein
hsa:840,0.0,0.0,0.0003723501496846536,0.0009302800268044745,0.0,0.0046009454,False,CASP7; caspase
hsa:6185,0.0,0.0,0.00012516161707481184,0.0003518848806428692,0.0,0.0018248878,False,RPN2; ribophorin
hsa:9442,5.5219065000000004e-08,6.841516175193062e-05,1.5452849701544545e-06,4.207042035101038e-06,0.0,4.7646576e-05,False,MED27; mediator complex subunit
hsa:23382,0.0,0.0,0.0001159650841536634,0.00037735883829787464,0.0,0.002581509,False,AHCYL2; adenosylhomocysteinase like
hsa:8642,0.00045133945,0.559199281566564,0.0010506021295891086,0.0016009535251765665,0.0,0.010636107,False,DCHS1; dachsous cadherin-related
hsa:94033,0.0,0.0,2.7169661801980197e-08,1.846246451237953e-07,0.0,1.5177598e-06,False,FTMT; ferritin
hsa:8399,1.9074283999999998e-05,0.02363260270999268,7.888777669173265e-05,0.00012065618284341275,0.0,0.00073874055,False,PLA2G10; phospholipase A2 group
hsa:406884,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7B; microRNA
hsa:56953,4.5480065e-05,0.05634876294017869,0.00035108816852871285,0.000765105959533187,0.0,0.0040129772,False,NT5M; 5'
hsa:3670,3.19981265e-09,3.964494871936417e-06,8.78743962326549e-05,0.00021584234864167868,0.0,0.0011354142,False,ISL1; ISL LIM homeobox
hsa:11091,1.5306607500000001e-06,0.0018964537483309694,8.45835246760247e-05,0.0002558364510867336,0.0,0.0014915481,False,WDR5; WD repeat domain
hsa:7185,0.0,0.0,1.5228900433069305e-05,5.153605612062375e-05,0.0,0.0005369886,False,TRAF1; TNF receptor associated factor
hsa:5252,0.0,0.0,3.464602463583046e-05,0.00016677264834485812,0.0,0.001395863,False,PHF1; PHD finger protein
hsa:56670,1.274209e-09,1.578715880842346e-06,2.39894147682205e-06,2.475631393342709e-05,0.0,0.00033399148,False,SUCNR1; succinate receptor
hsa:10911,0.0,0.0,6.3167993781811874e-06,5.3760756088947345e-05,0.0,0.0007444398,False,UTS2; urotensin
hsa:390321,0.0,0.0,6.961822678217822e-07,6.152122743264015e-06,-0.0,7.2478346e-05,False,OR6C1; olfactory receptor family 6 subfamily C member
hsa:2049,7.60280195e-08,9.419698163616923e-05,1.3816541666707917e-06,5.667384477324571e-06,0.0,7.3182804e-05,False,EPHB3; EPH receptor
hsa:1296,0.0,0.0,9.155211505861386e-06,6.743032272158461e-05,0.0,0.00084836397,False,COL8A2; collagen type VIII alpha 2
hsa:23025,0.0,0.0,3.483807075188118e-06,1.004889247958242e-05,0.0,6.892923e-05,False,UNC13A; unc-13 homolog
hsa:1852,6.0855485e-09,7.5398557541080905e-06,1.1625499756312872e-05,4.51230935579132e-05,0.0,0.0003853446,False,DUSP9; dual specificity phosphatase
hsa:4337,0.0,0.0,5.785193747020296e-06,2.198093319626148e-05,0.0,0.0002490729,False,MOCS1; molybdenum cofactor synthesis
hsa:7476,0.0,0.0,2.864309323324257e-06,1.227830448618911e-05,0.0,0.000143039,False,WNT7A; Wnt family member
hsa:10427,1.1299198500000001e-07,0.0001399944915845047,1.0893111832029702e-06,2.2114413166029986e-06,0.0,1.1894049e-05,False,SEC24B; SEC24 homolog B
hsa:219473,0.0,0.0,4.306159303960396e-06,2.9967508894577295e-05,0.0,0.00038615748,False,OR8K3; olfactory receptor family 8 subfamily K member 3
hsa:60412,1.34432665e-08,1.6655900495088248e-05,2.687740913490099e-07,6.792631097048853e-07,0.0,6.477635e-06,False,EXOC4; exocyst complex component
hsa:25,5.0214033000000004e-06,0.006221404129011931,0.0001229679917938614,0.0003067159996894771,0.0,0.0019699847,False,ABL1; ABL proto-oncogene 1
hsa:4860,0.0,0.0,3.612394438247525e-05,0.00018126831889496057,0.0,0.0023575043,False,PNP; purine nucleoside
hsa:292,0.0,0.0,0.00026786306898277237,0.0009132158796273693,0.0,0.0063536703,False,SLC25A5; solute carrier family 25 member
hsa:1356,0.0,0.0,1.791328345396039e-05,7.12381575805804e-05,0.0,0.0007825657,False,CP;
hsa:3680,0.0,0.0,5.940583539809901e-05,0.00016539152613920683,0.0,0.0010727196,False,ITGA9; integrin subunit alpha
hsa:81,1.29390065e-05,0.016031133859415795,9.54286534480842e-05,0.00021821261000478441,0.0,0.0012733256,False,ACTN4; actinin alpha
hsa:9489,4.5252705000000004e-08,5.606706908723282e-05,5.471314369517329e-06,1.6367437037754213e-05,0.0,0.0001795601,False,PGS1; phosphatidylglycerophosphate synthase
hsa:406894,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR101-2; microRNA
hsa:219986,0.0,0.0,5.80395100990099e-08,6.172468329646617e-07,-0.0,8.024856e-06,False,OR4D11; olfactory receptor family 4 subfamily D member
hsa:1135,0.0,0.0,7.722584036888018e-07,5.019896574069973e-06,0.0,6.411146e-05,False,CHRNA2; cholinergic receptor nicotinic alpha 2
hsa:220441,2.3779041499999998e-07,0.00029461689916849746,1.1601679581317822e-06,2.2411799843028783e-06,0.0,1.324996e-05,False,RNF152; ring finger protein
hsa:1654,0.0,0.0,1.0266342411485148e-05,6.231003891048275e-05,0.0,0.00065895286,False,DDX3X; DEAD-box helicase 3
hsa:7456,0.0,0.0,5.296148747289604e-06,1.1989230425405915e-05,0.0,0.00011708753,False,WIPF1; WAS/WASL interacting protein family member
hsa:8801,0.0,0.0,0.0001671674159409901,0.0007419903137365555,0.0,0.008921726,False,SUCLG2; succinate-CoA ligase GDP-forming subunit
hsa:5373,0.0,0.0,1.86362678350495e-05,3.937745017345835e-05,0.0,0.0003178148,False,PMM2; phosphomannomutase
hsa:6344,5.688322199999999e-07,0.0007047701430839109,1.772931349871287e-05,6.016837076754726e-05,0.0,0.00051950896,False,SCTR; secretin
hsa:219429,0.0,0.0,8.132950495049506e-08,1.155909447945433e-06,0.0,1.642856e-05,False,OR4C11; olfactory receptor family 4 subfamily C member
hsa:390916,0.0,0.0,2.0000575201881186e-06,7.379289158020925e-06,0.0,6.7249886e-05,False,NUDT19; nudix hydrolase
hsa:3880,1.26026825e-05,0.015614436096404841,0.00025148339348263866,0.0006481923386982204,0.0,0.0047051883,False,KRT19; keratin
hsa:3667,0.0,0.0,8.862924801831683e-05,0.0002796765492112188,0.0,0.0029332587,False,IRS1; insulin receptor substrate
hsa:1742,3.8722839e-05,0.047976714087407446,0.00019983498934656937,0.00033109563899163445,0.0,0.0016251369,False,DLG4; discs large MAGUK scaffold protein
hsa:487,0.00010819767,0.13405444467833727,0.000256766270940099,0.00035987645234890467,0.0,0.002567682,False,ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting
hsa:84671,0.0,0.0,8.962571978554456e-08,2.4739003646641834e-07,0.0,1.2812466e-06,False,ZNF347; zinc finger protein
hsa:100169763,0.0,0.0,3.254731945485149e-07,3.5885139341571792e-06,0.0,5.0410825e-05,False,RNA5S12; RNA
hsa:7374,9.490412300000001e-05,0.11758404322800683,0.0004555471503004952,0.0007828816314592075,0.0,0.0033740061,False,UNG; uracil DNA
hsa:10573,4.2886568e-08,5.313547932593881e-05,2.1296992451188114e-07,4.6133745624218113e-07,0.0,3.0042982e-06,False,MRPL28; mitochondrial ribosomal protein
hsa:137970,3.23797085e-08,4.011772011184656e-05,6.165122921308808e-06,2.51398585542701e-05,0.0,0.00023185254,False,UNC5D; unc-5 netrin receptor
hsa:3772,0.0,0.0,5.4985218625158455e-06,3.247607265967532e-05,0.0,0.00041880825,False,KCNJ15; potassium inwardly rectifying channel subfamily J member
hsa:10841,5.8429865e-05,0.07239326969984858,0.00018706410773583956,0.0004399559453843319,0.0,0.004781974,False,FTCD; formimidoyltransferase
hsa:6456,1.49415335e-08,1.8512219126209218e-05,3.128886688228066e-07,6.991422673169831e-07,0.0,5.3145263e-06,False,SH3GL2; SH3 domain containing GRB2 like 2
hsa:1589,0.0,0.0,3.8726704515742574e-05,0.0001399107599546625,0.0,0.0011858527,False,CYP21A2; cytochrome P450 family 21 subfamily A member
hsa:765,0.0,0.0,3.833358766732673e-06,2.3811715939377657e-05,0.0,0.00029336012,False,CA6; carbonic anhydrase
hsa:97,0.0,0.0,1.8262065577878715e-06,6.141569637660154e-06,0.0,4.0991406e-05,False,ACYP1; acylphosphatase
hsa:5705,0.0,0.0,2.615834006688118e-06,6.261702783149379e-06,0.0,4.8857062e-05,False,PSMC5; proteasome 26S subunit
hsa:4889,0.0,0.0,1.6070103602251485e-06,7.441455012295163e-06,0.0,8.745329e-05,False,NPY5R; neuropeptide Y receptor
hsa:57452,6.28337915e-06,0.007784963416094754,0.00011996813023811879,0.0002514489872089912,0.0,0.0018577304,False,GALNT16; polypeptide N-acetylgalactosaminyltransferase
hsa:1807,6.8473078e-06,0.008483658147820072,8.040363095400991e-05,0.00021960421400458834,0.0,0.001424132,False,DPYS;
hsa:138716,0.0,0.0,8.987613355336141e-07,2.656791094361341e-06,0.0,3.24483e-05,False,RPP25L; ribonuclease P/MRP subunit p25
hsa:6875,0.0,0.0,3.075976696445543e-07,1.1637509036901606e-06,0.0,8.815598e-06,False,TAF4B; TATA-box binding protein associated factor
hsa:390883,0.0,0.0,6.936014767326734e-07,6.427097881511956e-06,0.0,8.22076e-05,False,OR7G3; olfactory receptor family 7 subfamily G member
hsa:204851,3.6536787e-09,4.526824553260429e-06,9.238607023348515e-07,2.0201691421569554e-06,0.0,1.2542903e-05,False,HIPK1; homeodomain interacting protein kinase
hsa:28227,1.0118686e-05,0.012536821103490177,2.668139737611881e-05,4.4390950535994276e-05,0.0,0.00024704385,False,PPP2R3B; protein phosphatase 2 regulatory subunit
hsa:4635,0.0,0.0,2.2838205384118808e-05,0.00013124981289063258,0.0,0.0017604016,False,MYL4; myosin light chain
hsa:9020,1.8027253e-05,0.022335355188248415,0.0001724757310277228,0.00033802316262504474,0.0,0.0021684836,False,MAP3K14; mitogen-activated protein kinase kinase kinase
hsa:341276,0.0,0.0,2.8310539445544555e-08,2.57632671746035e-07,0.0,3.5309008e-06,False,OR10A2; olfactory receptor family 10 subfamily A member
hsa:3817,5.9349467e-06,0.007353263559779341,4.516101243712872e-05,0.00010492267418128523,0.0,0.00069106155,False,KLK2; kallikrein related peptidase
hsa:2149,0.0,0.0,5.422160037326734e-05,0.00047207644904945646,0.0,0.0062985155,False,F2R; coagulation factor II thrombin
hsa:51143,9.403553750000001e-06,0.011650788560965741,0.0001282878287839208,0.000278706460297591,0.0,0.0016516409,False,DYNC1LI1; dynein cytoplasmic 1 light intermediate chain
hsa:8717,0.0,0.0,3.55382347970297e-05,9.534475836494015e-05,0.0,0.00066603784,False,TRADD; TNFRSF1A associated via death
hsa:63934,0.0,0.0,9.534029011782178e-08,1.9805885236083938e-07,0.0,1.0188882e-06,False,ZNF667; zinc finger protein
hsa:285203,0.0,0.0,6.441612012509901e-05,0.00016830778283658698,0.0,0.0016567565,False,EOGT; EGF domain specific O-linked N-acetylglucosamine
hsa:5980,0.0,0.0,7.551237663630841e-05,0.00021643824808646555,0.0,0.0013038374,False,REV3L; REV3 like
hsa:55788,6.3870385e-05,0.07913394985831583,0.0004346561866550496,0.0008426600804885743,0.0,0.004707961,False,LMBRD1; LMBR1 domain containing
hsa:1357,2.6530968000000003e-06,0.0032871264067135058,1.8563477475202973e-05,4.745649900881952e-05,0.0,0.0005286525,False,CPA1; carboxypeptidase
hsa:3674,0.00030037548,0.3721583668704604,0.000656580303136634,0.000890492982783153,0.0,0.0052048624,False,ITGA2B; integrin subunit alpha
hsa:23533,0.0,0.0,1.848642476638614e-05,7.772448268368574e-05,0.0,0.0005575096,False,PIK3R5; phosphoinositide-3-kinase regulatory subunit
hsa:951,0.0,0.0,3.873596850450494e-05,0.00012435168315645217,0.0,0.0012298055,False,CD37; CD37
hsa:26831,0.0,0.0,1.1967527383613862e-07,8.571093492809878e-07,0.0,8.4587155e-06,False,RNU5A-1; RNA
hsa:403273,0.0,0.0,3.691491584158416e-09,5.246595318312928e-08,-0.0,7.456813e-07,False,OR5H14; olfactory receptor family 5 subfamily H member
hsa:5644,0.0,0.0,5.483580814099009e-06,3.033110300147492e-05,0.0,0.00038032685,False,PRSS1; serine protease
hsa:8315,1.8728462e-07,0.00023204137141671737,6.55618079378218e-07,1.024018525335315e-06,0.0,4.923585e-06,False,BRAP; BRCA1 associated
hsa:2259,0.0,0.0,4.6448152786138606e-08,1.467865043382408e-07,0.0,1.5316227e-06,False,FGF14; fibroblast growth factor
hsa:84823,0.0,0.0,1.9384728966708913e-06,3.610835605776089e-06,0.0,1.6833483e-05,False,LMNB2; lamin
hsa:58538,1.6326543e-09,2.0228214298718214e-06,1.5104321055791605e-06,6.0792000506360855e-06,0.0,4.5540368e-05,False,MPP4; MAGUK p55 scaffold protein
hsa:3460,0.0,0.0,0.00018401689276980197,0.0003812900355912993,0.0,0.0023461806,False,IFNGR2; interferon gamma receptor
hsa:9037,1.5617579e-07,0.00019349824077219608,3.847168019399155e-06,1.345204890901591e-05,0.0,0.00010215747,False,SEMA5A; semaphorin
hsa:1610,3.09893655e-06,0.0038395116854517512,9.823462134861383e-05,0.00022947800819480722,0.0,0.001443921,False,DAO; D-amino acid
hsa:5208,6.95104035e-08,8.612180410686895e-05,6.0953926845049505e-05,0.00016514790917606463,0.0,0.0010208308,False,PFKFB2; 6-phosphofructo-2-kinase/fructose-2
hsa:122481,3.5926344999999997e-07,0.0004451192182139743,1.7664306164554455e-05,3.7748495898628596e-05,0.0,0.000241012,False,AK7; adenylate kinase
hsa:5551,1.898942e-06,0.0023527458150103524,9.435166943331684e-05,0.00028040820132422157,0.0,0.0027307663,False,PRF1; perforin
hsa:6403,0.0,0.0,3.237089381542079e-05,0.00012689678155736192,0.0,0.0010623963,False,SELP; selectin
hsa:4142,0.0,0.0,4.1615757497524756e-07,1.7784036405776928e-06,0.0,1.340825e-05,False,MAS1; MAS1 proto-oncogene
hsa:54995,0.000183712715,0.22761586261214908,0.0007054543924891087,0.0010798413904114332,0.0,0.004303315,False,OXSM; 3-oxoacyl-ACP synthase
hsa:253314,3.2530976e-08,4.030513709328785e-05,9.632944111517824e-06,3.919008331673131e-05,0.0,0.0003078171,False,EIF4E1B; eukaryotic translation initiation factor 4E family member
hsa:284406,5.1548274e-10,6.386713544937495e-07,2.4041258747079214e-08,5.139429339908798e-08,0.0,4.4056296e-07,False,ZFP82; ZFP82 zinc finger
hsa:8807,0.0,0.0,2.0094816894623768e-05,4.928171585859417e-05,0.0,0.00036695556,False,IL18RAP; interleukin 18 receptor accessory
hsa:7425,0.0,0.0,2.655330876093069e-06,9.955454376387038e-06,0.0,8.5816406e-05,False,VGF; VGF nerve growth factor
hsa:79290,1.9741617e-06,0.002445941307227247,9.28665446268317e-05,0.0002883937098895968,0.0,0.0021814723,False,OR13A1; olfactory receptor family 13 subfamily A member
hsa:139735,3.46731605e-10,4.2959254816396324e-07,1.6664933744767327e-08,3.970525811771371e-08,0.0,3.165229e-07,False,ZFP92; ZFP92 zinc finger
hsa:728358,0.0,0.0,1.2286573567168316e-05,7.466613584893465e-05,0.0,0.0007320998,False,DEFA1B; defensin alpha
hsa:2290,0.0,0.0,1.161744378821782e-08,7.272872627191407e-08,0.0,7.118342e-07,False,FOXG1; forkhead box
hsa:4710,6.430904650000001e-07,0.0007967744144907066,1.1601341732821782e-05,2.7726406471660135e-05,0.0,0.0001886125,False,NDUFB4; NADH:ubiquinone oxidoreductase subunit
hsa:390649,0.0,0.0,1.6216992930198023e-07,2.1488990751153185e-06,0.0,3.0482775e-05,False,OR4F15; olfactory receptor family 4 subfamily F member
hsa:57704,0.0,0.0,0.00016232779438118814,0.0002817433483719027,0.0,0.0013907651,False,GBA2; glucosylceramidase beta
hsa:5696,0.0,0.0,6.331346914770794e-06,1.8018171101457437e-05,0.0,0.00012298384,False,PSMB8; proteasome 20S subunit beta
hsa:440153,0.0,0.0,2.07451394029703e-06,9.827450315748843e-06,-0.0,0.000113306836,False,OR11H12; olfactory receptor family 11 subfamily H member
hsa:8646,2.1319552e-08,2.6414438537825585e-05,2.8405594875395037e-05,0.00013869327331994237,0.0,0.001197415,False,CHRD;
hsa:4490,0.0,0.0,7.102308514851484e-08,8.355811890002801e-07,-0.0,1.1557562e-05,False,MT1B; metallothionein
hsa:8654,0.0,0.0,2.4886605106722777e-05,8.686361158473808e-05,0.0,0.00064008415,False,PDE5A; phosphodiesterase
hsa:547,0.0,0.0,2.812327444072525e-06,9.265113027933362e-06,0.0,4.8888858e-05,False,KIF1A; kinesin family member
hsa:144811,8.429772e-07,0.001044429518884276,3.2104118611470305e-05,0.00010307336785015388,0.0,0.0007135052,False,LACC1; laccase domain containing
hsa:2717,7.535112750000001e-05,0.09335832789097112,0.0003825793447346533,0.0006288666698833952,0.0,0.00327067,False,GLA; galactosidase
hsa:59344,0.0,0.0,4.286633170263367e-06,2.5783836616783087e-05,-0.0,0.00025968108,False,ALOXE3; arachidonate lipoxygenase
hsa:1544,0.0,0.0,1.2647177918316835e-05,7.076213089070455e-05,0.0,0.000814347,False,CYP1A2; cytochrome P450 family 1 subfamily A member
hsa:2766,2.2348289e-09,2.768902021093424e-06,2.8317237216191585e-06,1.1147417393789538e-05,0.0,0.00012506916,False,GMPR; guanosine monophosphate
hsa:9212,0.0,0.0,7.404195850176737e-06,3.19005910486775e-05,0.0,0.00039585918,False,AURKB; aurora kinase
hsa:282770,0.0,0.0,9.828779207920792e-11,1.3969319935146187e-09,0.0,1.9854134e-08,False,OR10AG1; olfactory receptor family 10 subfamily AG member
hsa:5133,0.0,0.0,2.695404933873761e-06,8.198351852231289e-06,0.0,6.1130944e-05,False,PDCD1; programmed cell death
hsa:119678,0.0,0.0,3.541495287128713e-08,3.49954824182639e-07,0.0,4.000239e-06,False,OR52E2; olfactory receptor family 52 subfamily E member
hsa:79744,7.917442749999999e-09,9.809530936514413e-06,5.959660521173266e-08,1.0461598611055071e-07,0.0,5.550229e-07,False,ZNF419; zinc finger protein
hsa:3598,9.955061000000001e-07,0.0012334093461476325,3.503864367178711e-05,0.00010910092136866028,0.0,0.00087569014,False,IL13RA2; interleukin 13 receptor subunit alpha
hsa:1073,1.9173868e-06,0.0023755985014055677,4.551669167424258e-05,0.00014460986028446375,0.0,0.0009873315,False,CFL2; cofilin
hsa:29956,0.0,0.0,4.207109754311881e-05,0.00010801964528523579,0.0,0.00069101114,False,CERS2; ceramide synthase
hsa:54766,0.0,0.0,7.21936389283515e-08,8.200321123311526e-07,0.0,1.1492782e-05,False,BTG4; BTG anti-proliferation factor
hsa:50838,9.55631275e-06,0.011840053476879532,4.322189701856436e-05,9.492049416070489e-05,0.0,0.0007833063,False,TAS2R13; taste 2 receptor member
hsa:10220,2.1607209e-07,0.00026770838998138976,1.3375931346138613e-05,2.519615321757779e-05,0.0,0.00014236818,False,GDF11; growth differentiation factor
hsa:55705,0.0,0.0,3.654551571547525e-07,1.1214431674605945e-06,0.0,6.081466e-06,False,IPO9; importin
hsa:219493,0.0,0.0,1.8514082524752474e-07,2.267412040549846e-06,-0.0,3.201272e-05,False,OR5AR1; olfactory receptor family 5 subfamily AR member
hsa:23262,0.0,0.0,3.262754756116831e-06,1.0709752061703068e-05,0.0,0.0001146347,False,PPIP5K2; diphosphoinositol pentakisphosphate kinase
hsa:11277,1.9911185e-06,0.002466950395570107,0.00012093407294798417,0.0003105001814061982,0.0,0.0016665609,False,TREX1; three prime repair exonuclease
hsa:9759,0.0,0.0,3.3183830764158425e-05,0.00010068220659071469,0.0,0.00077519356,False,HDAC4; histone deacetylase
hsa:27345,0.0,0.0,1.818949300940595e-05,8.738981308955986e-05,0.0,0.0010936691,False,KCNMB4; potassium calcium-activated channel subfamily M regulatory beta subunit
hsa:51393,1.8057053e-06,0.0022372276708382947,0.00013737104467927228,0.0003875344532364114,0.0,0.0032992733,False,TRPV2; transient receptor potential cation channel subfamily V member
hsa:30844,7.601760499999999e-09,9.41840783082685e-06,5.329673801168315e-07,1.0638319160731828e-06,0.0,7.182178e-06,False,EHD4; EH domain containing
hsa:8932,0.0,0.0,2.3243846888019806e-06,1.2212306955597961e-05,0.0,0.00010469361,False,MBD2; methyl-CpG binding domain protein
hsa:5223,0.0,0.0,9.195627892673267e-05,0.00047023564399776885,0.0,0.005319656,False,PGAM1; phosphoglycerate mutase
hsa:1843,0.0,0.0,0.0001105723618158119,0.0003210480647089215,0.0,0.0020695182,False,DUSP1; dual specificity phosphatase
hsa:27248,1.5849395499999999e-07,0.0001963703943199366,1.339888661295812e-06,3.889121411973734e-06,0.0,3.838143e-05,False,ERLEC1; endoplasmic reticulum lectin
hsa:27094,7.3002201e-07,0.00090448061546532,6.443380143227724e-05,0.00012350909803592172,0.0,0.00075487624,False,KCNMB3; potassium calcium-activated channel subfamily M regulatory beta subunit
hsa:29088,0.0,0.0,8.290683442821785e-08,1.6853098328481322e-07,0.0,9.892362e-07,False,MRPL15; mitochondrial ribosomal protein
hsa:163255,2.4576965e-09,3.045029892930163e-06,5.0027778589693054e-08,9.570210768953126e-08,0.0,5.578737e-07,False,ZNF540; zinc finger protein
hsa:85407,3.13621915e-08,3.8857039762761705e-05,2.937109213797031e-06,6.403387229703372e-06,0.0,3.1600266e-05,False,NKD1; NKD inhibitor of WNT signaling pathway
hsa:6165,0.0,0.0,1.1934488565643565e-06,3.1040570166742145e-06,0.0,1.4769199e-05,False,RPL35A; ribosomal protein
hsa:26147,2.6796444e-07,0.00033200182774491933,2.1878242244599007e-05,6.718929832337822e-05,0.0,0.0004251954,False,PHF19; PHD finger protein
hsa:219482,0.0,0.0,1.821629405940594e-08,2.58902183440517e-07,0.0,3.6796914e-06,False,OR5M3; olfactory receptor family 5 subfamily M member
hsa:8809,0.0,0.0,1.081170161862871e-05,3.714984854792435e-05,0.0,0.00037803393,False,IL18R1; interleukin 18 receptor
hsa:147923,5.31906165e-09,6.590196033801748e-06,9.151239789930694e-08,2.108631873505973e-07,0.0,1.084027e-06,False,ZNF420; zinc finger protein
hsa:79334,0.0,0.0,4.683343678217822e-08,5.008992435553559e-07,0.0,6.770886e-06,False,OR11H2; olfactory receptor family 11 subfamily H member
hsa:79623,2.7542764999999997e-07,0.0003412485746671757,5.1752163355594055e-05,0.0001131999960090889,0.0,0.00075549405,False,GALNT14; polypeptide N-acetylgalactosaminyltransferase
hsa:2189,0.0,0.0,0.00014467359381244553,0.0004168619216288675,0.0,0.0028565775,False,FANCG; FA complementation group
hsa:1595,3.15448485e-06,0.003908334761857423,3.533685448906435e-05,0.00010420004524134436,0.0,0.0010020271,False,CYP51A1; cytochrome P450 family 51 subfamily A member
hsa:23039,2.3256066e-08,2.8813735203657902e-05,3.3522536050445536e-07,6.282197372484469e-07,0.0,2.736025e-06,False,XPO7; exportin
hsa:124583,2.3578932e-07,0.00029213758811703395,9.570361021733658e-05,0.0002660520607831545,0.0,0.001586682,False,CANT1; calcium activated nucleotidase
hsa:6541,0.0,0.0,3.1384981049801987e-07,6.210538756362535e-07,0.0,4.0852747e-06,False,SLC7A1; solute carrier family 7 member
hsa:401993,0.0,0.0,2.3102655495049505e-07,1.2176133500103843e-06,-0.0,1.118192e-05,False,OR2T5; olfactory receptor family 2 subfamily T member
hsa:4049,0.00010037633499999999,0.12436398905144397,0.0002448805261366335,0.00043035144386697593,0.0,0.0032386659,False,LTA; lymphotoxin
hsa:79748,0.0,0.0,1.0134848611282177e-08,2.51592758872756e-08,0.0,2.0113717e-07,False,LMAN1L; lectin
hsa:9831,0.0,0.0,2.7305047283168313e-08,6.211156065972338e-08,0.0,4.9618467e-07,False,ZNF623; zinc finger protein
hsa:4632,0.0,0.0,1.4220428519292077e-08,1.0148836709314383e-07,-0.0,9.712203e-07,False,MYL1; myosin light chain
hsa:54468,1.62311265e-09,2.0109995432076718e-06,1.4270573256475247e-06,3.887560623277804e-06,0.0,2.0805746e-05,False,MIOS; meiosis regulator for oocyte
hsa:6095,1.7693695499999998e-06,0.002192208505562176,0.0004573510438851485,0.0013993532490818468,0.0,0.010240337,False,RORA; RAR related orphan receptor
hsa:10772,0.0,0.0,5.081599542326729e-07,1.311327055904253e-06,0.0,7.199248e-06,False,SRSF10; serine and arginine rich splicing factor
hsa:54457,0.0,0.0,3.817052176925743e-08,1.2820325335001973e-07,0.0,1.3104208e-06,False,TAF7L; TATA-box binding protein associated factor 7
hsa:1176,1.48438895e-06,0.0018391240437886523,3.847106399566336e-06,8.93628866702315e-06,0.0,0.000103437,False,AP3S1; adaptor related protein complex 3 subunit sigma
hsa:525,3.536935e-08,4.382181772383591e-05,2.3313887006485154e-05,9.834316878942446e-05,0.0,0.0009907663,False,ATP6V1B1; ATPase H+ transporting V1 subunit
hsa:51729,4.33914985e-08,5.3761076695814293e-05,2.6364908617376243e-07,5.736065522314618e-07,0.0,3.7989266e-06,False,WBP11; WW domain binding protein
hsa:9248,0.0,0.0,1.7278374644970297e-07,1.0659259813250787e-06,0.0,1.3068529e-05,False,GPR50; G protein-coupled receptor
hsa:169200,1.51136e-07,0.00018725405594136347,2.3335971973871285e-05,5.999561500735753e-05,0.0,0.0003816539,False,TMEM64; transmembrane protein
hsa:1828,0.0,0.0,1.9905565497920793e-07,1.0802432285720799e-06,0.0,1.314822e-05,False,DSG1; desmoglein
hsa:59272,1.76012395e-06,0.00218075341809386,1.8317519599455446e-05,4.9154418329902136e-05,0.0,0.00042566634,False,ACE2; angiotensin converting enzyme
hsa:26539,0.0,0.0,2.9669222871287127e-07,3.965705430495964e-06,0.0,5.63163e-05,False,OR10H1; olfactory receptor family 10 subfamily H member
hsa:23049,1.072107e-08,1.3283161136534469e-05,5.023348109727719e-07,1.1976625470987013e-06,0.0,6.920306e-06,False,SMG1; SMG1 nonsense mediated mRNA decay associated PI3K related
hsa:1901,0.0,0.0,1.609070578504951e-05,6.129806371180926e-05,0.0,0.00040072537,False,S1PR1; sphingosine-1-phosphate receptor
hsa:29904,5.38919095e-07,0.000667708463655244,1.379203783628713e-06,1.821053752147917e-06,0.0,1.1509439e-05,False,EEF2K; eukaryotic elongation factor 2
hsa:4609,0.0,0.0,0.00023541364138613858,0.0008801179750643895,0.0,0.007575838,False,MYC; MYC proto-oncogene
hsa:9133,9.7096237e-07,0.0012030002246250983,7.369078594239108e-05,0.000158321510070966,0.0,0.0011667267,False,CCNB2; cyclin
hsa:6788,0.0,0.0,6.553762013663365e-05,0.0003021384674885975,0.0,0.003042993,False,STK3; serine/threonine kinase
hsa:24,0.0,0.0,5.3832304729703e-05,0.00019037133734936675,0.0,0.001770243,False,ABCA4; ATP binding cassette subfamily A member
hsa:2959,0.0,0.0,9.973166970247525e-07,4.226013177907604e-06,0.0,3.6398596e-05,False,GTF2B; general transcription factor
hsa:3107,0.0,0.0,0.0001841278297237624,0.0004403378552789317,0.0,0.0033773521,False,HLA-C; major histocompatibility complex
hsa:100529097,0.0,0.0,4.479940224131682e-08,9.227819614456827e-08,0.0,5.669973e-07,False,RPL36A-HNRNPH2; RPL36A-HNRNPH2
hsa:6041,6.7555133e-07,0.0008369926856545264,1.1630654323613858e-05,2.9885467866662753e-05,0.0,0.00019036145,False,RNASEL; ribonuclease
hsa:4891,4.5709204000000004e-05,0.05663266093353797,0.00017911429959900993,0.0002536059941104792,0.0,0.001111569,False,SLC11A2; solute carrier family 11 member
hsa:9351,1.8164102e-06,0.0022504907977137357,0.0003831549533385643,0.0010980918533632594,0.0,0.0093034245,False,NHERF2; NHERF family PDZ scaffold protein
hsa:10885,0.0,0.0,2.5707992043712877e-07,7.326628674455162e-07,0.0,4.9188748e-06,False,WDR3; WD repeat domain
hsa:5281,0.0,0.0,2.3804409369792074e-05,6.838806804583899e-05,0.0,0.00054524123,False,PIGF; phosphatidylinositol glycan anchor biosynthesis class
hsa:50613,0.0,0.0,4.2218730826732677e-10,3.2564140090524247e-09,0.0,3.9737447e-08,False,UBQLN3; ubiquilin
hsa:342892,1.19142782e-08,1.4761518874151539e-05,5.270681035599011e-08,8.484088045578585e-08,0.0,4.1445378e-07,False,ZNF850; zinc finger protein
hsa:54464,0.0,0.0,3.4493994216237647e-06,1.4401029722262013e-05,0.0,0.00014632016,False,XRN1; 5'-3' exoribonuclease
hsa:135,0.0,0.0,0.00011746933722341587,0.0002910968663066565,0.0,0.0019277893,False,ADORA2A; adenosine A2a
hsa:10671,7.21911865e-07,0.000894432330837418,0.0001039908540333169,0.0002630551257618914,0.0,0.0015830522,False,DCTN6; dynactin subunit
hsa:50,1.46361605e-06,0.0018133868946073565,2.020305285188119e-05,4.5170408850801186e-05,0.0,0.00045026685,False,ACO2; aconitase
hsa:1749,0.0,0.0,2.6925699107262378e-06,1.1107126182314445e-05,0.0,9.163103e-05,False,DLX5; distal-less homeobox
hsa:5880,0.0,0.0,0.00016334837546732673,0.0003910924283418395,0.0,0.0036051976,False,RAC2; Rac family small GTPase
hsa:84274,2.0806815500000001e-07,0.0002577916971203835,0.00033528218693470313,0.0006184483613929743,0.0,0.004362137,False,COQ5; coenzyme Q5
hsa:3777,2.0983949499999998e-06,0.0025998634696854125,6.93067594638317e-05,0.00014158991006114785,0.0,0.0008658628,False,KCNK3; potassium two pore domain channel subfamily K member
hsa:463,4.800712e-08,5.947972643224479e-05,3.27266685660693e-05,8.051389006959437e-05,0.0,0.0004213422,False,ZFHX3; zinc finger homeobox
hsa:5569,0.0,0.0,4.7172081528366355e-05,0.0001602417326164527,0.0,0.0011307476,False,PKIA; cAMP-dependent protein kinase inhibitor
hsa:713,1.5633823999999998e-05,0.01936995126160167,0.00040400666234653466,0.0009688051399039648,0.0,0.0066822576,False,C1QB; complement C1q B
hsa:2046,3.3916042000000004e-08,4.202120226800784e-05,4.987229160860389e-06,2.4144582877737627e-05,0.0,0.00023638914,False,EPHA8; EPH receptor
hsa:79153,0.0,0.0,1.1899293027722774e-05,3.3487562786728176e-05,0.0,0.00024791114,False,GDPD3; glycerophosphodiester phosphodiesterase domain containing
hsa:23236,0.0,0.0,0.00015796289425742575,0.0004337713442664776,0.0,0.003626975,False,PLCB1; phospholipase C beta
hsa:1946,7.435633649999999e-07,0.0009212580453740899,4.036290579776238e-06,9.534213891932905e-06,0.0,8.465559e-05,False,EFNA5; ephrin
hsa:5890,0.0,0.0,6.038265551436633e-06,2.6724772768027306e-05,0.0,0.00024989035,False,RAD51B; RAD51 paralog
hsa:93589,0.0,0.0,0.00014825500809405946,0.0004902919908341185,0.0,0.003708483,False,CACNA2D4; calcium voltage-gated channel auxiliary subunit alpha2delta
hsa:189,6.0010105e-08,7.43511510078148e-05,3.305126070123762e-05,9.506900809842873e-05,0.0,0.00069746916,False,AGXT; alanine--glyoxylate
hsa:129607,0.0,0.0,1.5489819162979213e-05,6.508212834982435e-05,0.0,0.00072461896,False,CMPK2; cytidine/uridine monophosphate kinase
hsa:1295,0.0,0.0,3.175984600180989e-05,0.00014202418202153026,0.0,0.001583122,False,COL8A1; collagen type VIII alpha 1
hsa:2925,0.0,0.0,2.2455675446138618e-07,9.892054022165115e-07,0.0,1.0003899e-05,False,GRPR; gastrin releasing peptide
hsa:153,0.0,0.0,7.057864281732674e-06,2.391904463388121e-05,0.0,0.0002016366,False,ADRB1; adrenoceptor beta
hsa:5976,0.0,0.0,1.320023022460396e-07,4.370955296515589e-07,0.0,3.5727815e-06,False,UPF1; UPF1 RNA helicase and
hsa:55512,7.755586499999999e-09,9.608994735397807e-06,4.297268611111389e-05,0.00012174066820693195,0.0,0.00077315024,False,SMPD3; sphingomyelin phosphodiesterase
hsa:285268,0.0,0.0,4.01210206381188e-08,7.135313512195699e-08,0.0,3.751281e-07,False,ZNF621; zinc finger protein
hsa:121364,0.0,0.0,3.100155227722772e-08,4.3052499336578543e-07,-0.0,6.1179244e-06,False,OR10A7; olfactory receptor family 10 subfamily A member
hsa:441272,5.935168000000001e-07,0.0007353537745430542,1.0185011789356436e-05,2.8251111264826167e-05,0.0,0.00033706424,False,SPDYE3; speedy/RINGO cell cycle regulator family member
hsa:4209,3.08126505e-06,0.0038176171001142556,2.6835132333514843e-05,0.00013718236507576263,0.0,0.001716215,False,MEF2D; myocyte enhancer factor
hsa:284383,0.0,0.0,8.229216930693068e-08,9.972900949284299e-07,0.0,1.4105432e-05,False,OR2Z1; olfactory receptor family 2 subfamily Z member
hsa:133686,2.53230885e-05,0.031374728923533095,0.00012900363314202967,0.0002461218914055762,0.0,0.0019243044,False,NADK2; NAD kinase 2
hsa:3064,1.5060489e-08,1.8659602276825436e-05,4.3573151367326744e-08,6.789861620864803e-08,0.0,4.2313332e-07,False,HTT;
hsa:3081,0.0,0.0,1.2271298960556433e-05,3.344037180834713e-05,0.0,0.00018175167,False,HGD; homogentisate
hsa:2028,0.0,0.0,6.2272406409901e-05,0.00021895997146037814,0.0,0.0014898197,False,ENPEP; glutamyl
hsa:587,9.356586e-05,0.1159259659025102,0.00017668740255295066,0.00020468248925237017,0.0,0.00096273125,False,BCAT2; branched chain amino acid transaminase
hsa:255743,0.0,0.0,1.2684301635163369e-05,6.236639686990603e-05,0.0,0.00053116767,False,NPNT;
hsa:11149,0.0,0.0,3.151424847274752e-05,0.00012590945208466672,0.0,0.0009893889,False,BVES; blood vessel epicardial
hsa:1118,0.0,0.0,3.9801299687514863e-07,1.0837620583812748e-06,0.0,6.9643615e-06,False,CHIT1; chitinase
hsa:2695,0.0,0.0,4.813894159237623e-06,4.11801446951153e-05,0.0,0.00056921557,False,GIP; gastric inhibitory
hsa:5153,0.0,0.0,0.0004778465954257426,0.0022372662527894087,0.0,0.01998825,False,PDE1B; phosphodiesterase
hsa:54556,4.8320553000000006e-08,5.9868062768497373e-05,2.430299732208615e-06,7.86887350498934e-06,0.0,4.682196e-05,False,ING3; inhibitor of growth family member
hsa:23439,0.0,0.0,4.0537762600346513e-05,0.0003610053429952596,0.0,0.0043518753,False,ATP1B4; ATPase Na+/K+ transporting family member beta
hsa:2530,3.8072611500000003e-06,0.004717109704937803,5.207085095049503e-05,0.00014467619749914296,0.0,0.0010880555,False,FUT8; fucosyltransferase
hsa:10455,2.8582855e-06,0.003541350524781575,9.633918381438612e-05,0.00030972100900424207,0.0,0.0019401902,False,ECI2; enoyl-CoA delta isomerase
hsa:51330,0.0,0.0,1.8109953785533167e-05,0.00010263376111133839,0.0,0.001202919,False,TNFRSF12A; TNF receptor superfamily member
hsa:150,0.0,0.0,1.620039040483663e-05,0.00014406758568201786,0.0,0.0019968834,False,ADRA2A; adrenoceptor alpha
hsa:57634,0.0,0.0,7.3907954849084155e-06,2.340767000670424e-05,0.0,0.0001296207,False,EP400; E1A binding protein
hsa:255738,0.0,0.0,7.031152310378713e-07,3.3515576227547593e-06,0.0,3.9678445e-05,False,PCSK9; proprotein convertase subtilisin/kexin type
hsa:7786,0.0,0.0,1.4907716625084163e-07,3.28384978048459e-07,0.0,1.7602773e-06,False,MAP3K12; mitogen-activated protein kinase kinase kinase
hsa:771,3.86731925e-06,0.0047915203206556475,5.530502114923266e-05,0.00012573759567891397,0.0,0.0011046989,False,CA12; carbonic anhydrase
hsa:26037,3.43477595e-07,0.0004255609040118502,9.04095770747525e-07,1.1757124165668012e-06,0.0,5.783362e-06,False,SIPA1L1; signal induced proliferation associated 1 like
hsa:117283,5.63922e-09,6.986864925270324e-06,6.183088557341585e-07,2.5253325025722243e-06,0.0,2.092339e-05,False,IP6K3; inositol hexakisphosphate kinase
hsa:1487,0.0,0.0,5.196216149599011e-05,0.0001854731825289015,0.0,0.0014780747,False,CTBP1; C-terminal binding protein
hsa:735,0.0,0.0,5.616098092425741e-07,2.72625162313754e-06,0.0,2.308131e-05,False,C9; complement
hsa:10577,0.0,0.0,4.730939505621781e-05,0.0001256743909050252,0.0,0.0008552753,False,NPC2; NPC intracellular cholesterol transporter
hsa:23542,0.0,0.0,2.249096760495049e-07,4.991459852370446e-07,0.0,3.910001e-06,False,MAPK8IP2; mitogen-activated protein kinase 8 interacting protein
hsa:200315,2.4810169e-07,0.00030739233364920877,1.575142931116832e-06,3.841357916642021e-06,0.0,2.798796e-05,False,APOBEC3A; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:4654,0.0,0.0,7.139465665000001e-10,3.911506371917786e-09,0.0,4.862994e-08,False,MYOD1; myogenic differentiation
hsa:27091,9.473365499999999e-06,0.011737283726511106,5.1994272917920804e-05,0.00011814174805717394,0.0,0.0008322665,False,CACNG5; calcium voltage-gated channel auxiliary subunit gamma
hsa:152138,0.0,0.0,2.4670978415841584e-10,1.6486021589855498e-09,0.0,1.8702902e-08,False,PYDC2; pyrin domain containing
hsa:391190,0.0,0.0,2.106764413049505e-06,9.955421142050465e-06,0.0,8.401948e-05,False,OR2L8; olfactory receptor family 2 subfamily L member
hsa:5649,1.8085623e-06,0.0022407674286579037,3.9458870072767334e-05,9.005893793138196e-05,0.0,0.0005447615,False,RELN;
hsa:25836,6.23217025e-08,7.721516757288807e-05,8.401299702275245e-07,1.2932494681041307e-06,0.0,5.565604e-06,False,NIPBL; NIPBL cohesin loading
hsa:254786,0.0,0.0,1.8964288777227725e-07,2.3476046938415465e-06,-0.0,3.2994794e-05,False,OR6C3; olfactory receptor family 6 subfamily C member
hsa:931,1.52549525e-07,0.00018900538116781192,2.8991034569172283e-05,0.00011588582973993067,0.0,0.0013471076,False,MS4A1; membrane spanning 4-domains
hsa:5887,2.7888872000000005e-07,0.00034553676143536454,3.5508683509653473e-06,6.388659022591681e-06,0.0,3.280243e-05,False,RAD23B; RAD23 homolog B
hsa:6529,0.0,0.0,7.833654032351487e-06,3.4319424855133714e-05,0.0,0.0002763956,False,SLC6A1; solute carrier family 6 member
hsa:7568,4.531167e-09,5.614012537698894e-06,3.306879871841584e-08,6.41818810901611e-08,0.0,6.2872726e-07,False,ZNF20; zinc finger protein
hsa:729020,0.0,0.0,7.054818244560397e-06,2.2367425637606078e-05,0.0,0.0002524452,False,RPEL1; ribulose-5-phosphate-3-epimerase like
hsa:4159,0.0,0.0,1.8409381249752474e-08,1.7458860370851716e-07,0.0,2.392902e-06,False,MC3R; melanocortin 3
hsa:113189,0.0,0.0,0.0003983842182820297,0.001048271339904434,0.0,0.0056398157,False,CHST14; carbohydrate sulfotransferase
hsa:7040,0.0,0.0,0.00021380026085643557,0.0006500250237107876,0.0,0.004526003,False,TGFB1; transforming growth factor beta
hsa:6129,3.8342895000000004e-08,4.750597213955528e-05,3.1923987358910883e-07,5.737978998711479e-07,0.0,4.130195e-06,False,RPL7; ribosomal protein
hsa:407011,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR23B; microRNA
hsa:4174,1.9862474e-07,0.0002460915213800734,1.6815121313772275e-05,4.022453525007141e-05,0.0,0.00024996907,False,MCM5; minichromosome maintenance complex component
hsa:5571,0.0,0.0,0.0005440278008430694,0.0015166349905271406,0.0,0.008598241,False,PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma
hsa:25996,2.5018805e-09,3.0997728609041282e-06,2.3265903416314354e-06,9.74731329450697e-06,0.0,0.00010833095,False,REXO2; RNA exonuclease
hsa:28958,2.15260565e-07,0.00026670292902074625,1.5143155562836643e-06,3.0802553274001475e-06,0.0,1.760706e-05,False,COA3; cytochrome c oxidase assembly factor
hsa:2677,5.6603823e-06,0.00701308453216774,8.626524964084162e-05,0.0002539398932287399,0.0,0.0025494078,False,GGCX; gamma-glutamyl
hsa:440738,0.0,0.0,1.2582978453628712e-06,9.40061882848663e-06,0.0,0.00013065692,False,MAP1LC3C; microtubule associated protein 1 light chain 3
hsa:7096,0.0,0.0,3.1741702023608934e-06,2.3712339500970383e-05,0.0,0.00023877977,False,TLR1; toll like receptor
hsa:2057,0.0,0.0,7.936881034391093e-05,0.00012221338557838934,0.0,0.0006755693,False,EPOR; erythropoietin
hsa:6015,0.0,0.0,5.610439302777626e-05,0.00017659336817592677,0.0,0.0011151378,False,RING1; ring finger protein
hsa:8945,5.6833836499999994e-05,0.07041582680058558,0.00026393039501242577,0.00046087021861087544,0.0,0.0030959921,False,BTRC; beta-transducin repeat containing E3 ubiquitin protein
hsa:1949,1.8102592e-07,0.00022428698490443565,1.262269759961386e-05,4.6789209800622806e-05,0.0,0.00041865802,False,EFNB3; ephrin
hsa:341152,0.0,0.0,1.243719046039604e-07,1.1761437926394708e-06,0.0,1.5759395e-05,False,OR2AT4; olfactory receptor family 2 subfamily AT member
hsa:84458,1.1393198e-08,1.4115912394419797e-05,6.652992276612129e-05,0.0002487674897910269,0.0,0.0017253571,False,LCOR; ligand dependent nuclear receptor
hsa:9568,1.3334218000000001e-05,0.016520791891450982,0.00016109894761499007,0.0003589459664744535,0.0,0.0022622906,False,GABBR2; gamma-aminobutyric acid type B receptor subunit
hsa:10333,0.0,0.0,6.162568372272278e-06,2.6055109454867313e-05,0.0,0.0002467203,False,TLR6; toll like receptor
hsa:2326,0.0,0.0,0.0001428169173009901,0.0004994831173632099,0.0,0.0040041385,False,FMO1; flavin containing dimethylaniline monoxygenase
hsa:627,0.0,0.0,1.735418642082178e-05,5.641614935563852e-05,0.0,0.00045777473,False,BDNF; brain derived neurotrophic
hsa:122740,0.0,0.0,4.2060794059405936e-07,4.804324984978301e-06,-0.0,6.556588e-05,False,OR4K14; olfactory receptor family 4 subfamily K member
hsa:2570,0.0,0.0,4.8205121735470313e-05,0.00011673394507937524,0.0,0.0007465224,False,GABRR2; gamma-aminobutyric acid type A receptor subunit
hsa:113675,0.0,0.0,5.079832331702968e-05,0.00018053053666209617,0.0,0.0021824557,False,SDSL; serine dehydratase
hsa:51604,0.0,0.0,3.3320951848019816e-05,6.508165547457643e-05,0.0,0.0005515589,False,PIGT; phosphatidylinositol glycan anchor biosynthesis class
hsa:22955,0.0,0.0,7.596533784038861e-05,0.0002914670790227228,0.0,0.0019623332,False,SCMH1; Scm polycomb group protein homolog
hsa:2152,0.0,0.0,2.3905452606287128e-05,0.00014183049201067357,0.0,0.0017106069,False,F3; coagulation factor III
hsa:11021,9.9533605e-09,1.2331986580772004e-05,5.068669781717821e-07,8.448013156717233e-07,0.0,3.6223216e-06,False,RAB35; RAB35
hsa:3993,0.0,0.0,2.996711403734654e-06,1.4406282811832735e-05,0.0,0.00013837537,False,LLGL2; LLGL scribble cell polarity complex component
hsa:406970,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR194-2; microRNA
hsa:186,0.0,0.0,6.57720586620297e-07,4.371528985948838e-06,0.0,5.1104296e-05,False,AGTR2; angiotensin II receptor type
hsa:6387,4.423395e-07,0.0005480485488439204,0.00020782088873366335,0.00045210305287279076,0.0,0.0031883128,False,CXCL12; C-X-C motif chemokine ligand
hsa:10312,0.0,0.0,0.00013181739583267328,0.0007457443150739625,0.0,0.006658678,False,TCIRG1; T cell immune regulator 1
hsa:54539,0.0,0.0,5.130775298415844e-06,1.082221388739551e-05,0.0,6.01437e-05,False,NDUFB11; NADH:ubiquinone oxidoreductase subunit
hsa:5593,0.000238869865,0.2959543130916256,0.0004979066233608912,0.0006409231279245989,0.0,0.0030385156,False,PRKG2; protein kinase cGMP-dependent
hsa:7571,0.0,0.0,8.179244993168317e-08,1.5241865866386825e-07,0.0,8.183919e-07,False,ZNF23; zinc finger protein
hsa:2582,0.0,0.0,0.00015188006601277233,0.000404188336633202,0.0,0.0026943851,False,GALE;
hsa:2914,0.00035081802500000004,0.4346555293152436,0.0008117465555321779,0.001243701435747307,0.0,0.007667205,False,GRM4; glutamate metabotropic receptor
hsa:56924,8.8076747e-07,0.0010912508012565713,1.4278044379610892e-05,2.652060000571699e-05,0.0,0.00013819068,False,PAK6; p21 (RAC1) activated kinase
hsa:6729,0.0,0.0,2.1976603997693065e-05,7.277792768346572e-05,0.0,0.00044610188,False,SRP54; signal recognition particle
hsa:8723,1.9365910999999998e-08,2.3993921909733387e-05,3.3653045100435656e-07,6.403943830508796e-07,0.0,3.6127255e-06,False,SNX4; sorting nexin
hsa:84674,7.89414175e-09,9.780661529109894e-06,1.3167646560346538e-07,3.457273243664397e-07,0.0,3.0965887e-06,False,CARD6; caspase recruitment domain family member
hsa:10747,0.0,0.0,1.5956116854559403e-05,3.400597696807386e-05,0.0,0.00017573236,False,MASP2; MBL associated serine protease
hsa:25814,0.0,0.0,2.3110499350198024e-07,5.662279497563717e-07,0.0,2.6896043e-06,False,ATXN10; ataxin
hsa:286410,0.0,0.0,0.00012967589611246038,0.0003547915871523481,0.0,0.0025254535,False,ATP11C; ATPase phospholipid transporting
hsa:406953,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR18A; microRNA
hsa:6196,0.0,0.0,2.78494253650495e-05,7.928142797519425e-05,0.0,0.0006534416,False,RPS6KA2; ribosomal protein S6 kinase
hsa:138881,0.0,0.0,4.150552631881189e-06,2.3091165044308403e-05,0.0,0.00030213795,False,OR1L8; olfactory receptor family 1 subfamily L member
hsa:4619,0.0,0.0,3.8621086510495044e-09,2.3530285400715867e-08,0.0,2.5114105e-07,False,MYH1; myosin heavy chain
hsa:55615,0.0,0.0,1.0110959237955446e-06,2.081901865980925e-06,0.0,1.0643207e-05,False,PRR5; proline rich
hsa:3753,0.0,0.0,1.376959668922871e-07,5.802017253328143e-07,0.0,5.037425e-06,False,KCNE1; potassium voltage-gated channel subfamily E regulatory subunit
hsa:4627,2.16482205e-06,0.0026821651310991236,3.330945941544555e-05,7.414566168608485e-05,0.0,0.00048413564,False,MYH9; myosin heavy chain
hsa:1950,0.0,0.0,6.23243265579208e-06,3.012114222513863e-05,0.0,0.00026480772,False,EGF; epidermal growth
hsa:22888,2.3018646000000002e-08,2.8519577240223657e-05,4.246327803795545e-07,8.497162948175801e-07,0.0,4.165464e-06,False,UBOX5; U-box domain containing
hsa:27101,0.0,0.0,3.38319459762376e-06,1.1833480033212533e-05,0.0,0.00012743531,False,CACYBP; calcyclin binding
hsa:114769,0.0,0.0,5.586496330594059e-07,1.2150112100761548e-06,0.0,5.113843e-06,False,CARD16; caspase recruitment domain family member
hsa:10468,0.0,0.0,4.8683237997077024e-05,0.0002754700692443338,0.0,0.0025224024,False,FST;
hsa:57697,9.4622705e-07,0.0011723537274635515,4.52643779465396e-05,0.00013075745856008667,0.0,0.0009911251,False,FANCM; FA complementation group
hsa:695,0.0,0.0,5.889617334752477e-05,0.00011820566245268888,0.0,0.0006081301,False,BTK; Bruton tyrosine
hsa:128866,4.8343105e-07,0.0005989600418198977,0.00020983717473866342,0.0005107442856764473,0.0,0.0033105144,False,CHMP4B; charged multivesicular body protein
hsa:965,0.0,0.0,2.0377934907118813e-06,8.266204126518221e-06,0.0,7.738738e-05,False,CD58; CD58
hsa:26253,0.0,0.0,2.228819817442079e-06,7.260384818366994e-06,0.0,4.8838516e-05,False,CLEC4E; C-type lectin domain family 4 member
hsa:4060,1.4347475e-07,0.00017776194197724655,1.2423088647784162e-06,4.934922886959858e-06,0.0,4.9817503e-05,False,LUM;
hsa:56000,0.0,0.0,2.455823648940594e-07,1.0677226287740584e-06,0.0,1.2030146e-05,False,NXF3; nuclear RNA export factor
hsa:8574,6.509178550000001e-06,0.008064723721244595,0.0002131800112125248,0.00044866232220576083,0.0,0.0021201489,False,AKR7A2; aldo-keto reductase family 7 member
hsa:8503,0.00045362018,0.562025054003357,0.0009992186690148518,0.001229645149613346,0.0,0.0059583536,False,PIK3R3; phosphoinositide-3-kinase regulatory subunit
hsa:23279,1.1444820900000001e-07,0.00014179871989780635,2.398276525534653e-07,3.009256347677671e-07,0.0,1.3688427e-06,False,NUP160; nucleoporin
hsa:2932,0.00019309577999999998,0.2392412660793008,0.0004234334322638614,0.000581343434388393,0.0,0.003925075,False,GSK3B; glycogen synthase kinase 3
hsa:83988,7.2799095000000005e-06,0.009019641784624863,4.931647729900989e-05,0.00019513721698055514,0.0,0.0016199894,False,NCALD; neurocalcin
hsa:239,0.0,0.0,6.63286632129703e-05,0.00022170347622023457,0.0,0.0024126202,False,ALOX12; arachidonate 12-lipoxygenase
hsa:7321,0.0,0.0,1.0755266413415837e-05,4.1263472865780747e-05,0.0,0.0003290066,False,UBE2D1; ubiquitin conjugating enzyme E2
hsa:219960,0.0,0.0,2.2685818981683173e-06,1.451733123489655e-05,0.0,0.00013221403,False,OR10Q1; olfactory receptor family 10 subfamily Q member
hsa:8795,0.0,0.0,0.0001165400044043812,0.0002176015865383393,0.0,0.0012468847,False,TNFRSF10B; TNF receptor superfamily member
hsa:5141,0.0,0.0,5.5433176450099014e-05,0.00045306225370750857,0.0,0.0061642607,False,PDE4A; phosphodiesterase
hsa:9466,3.38034825e-07,0.000418817436154715,3.6156119594326735e-05,0.00013708639740438029,0.0,0.0012464329,False,IL27RA; interleukin 27 receptor subunit
hsa:29954,0.0,0.0,0.00024233842934975248,0.0005281709105944213,0.0,0.00318724,False,POMT2; protein O-mannosyltransferase
hsa:2898,6.54263685e-07,0.0008106177791617655,6.000238588425743e-05,0.0001830971323270238,0.0,0.002134761,False,GRIK2; glutamate ionotropic receptor kainate type subunit
hsa:25902,9.218422999999999e-07,0.0011421415785340034,2.060063993153465e-05,6.405671887766485e-05,0.0,0.00055309467,False,MTHFD1L; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1
hsa:9410,0.0,0.0,1.8836817608168313e-07,3.805305137637178e-07,0.0,2.1584121e-06,False,SNRNP40; small nuclear ribonucleoprotein U5 subunit
hsa:22894,0.0,0.0,6.176773209009901e-07,2.487523161042852e-06,0.0,3.2269756e-05,False,DIS3; DIS3 homolog
hsa:143,0.0,0.0,1.6773034245379702e-05,5.7015271274888846e-05,0.0,0.00044145115,False,PARP4; poly(ADP-ribose) polymerase family member
hsa:4172,0.0,0.0,2.1418734146683174e-05,6.562012562878472e-05,0.0,0.0004367486,False,MCM3; minichromosome maintenance complex component
hsa:55818,0.0,0.0,6.345698474356435e-07,1.5263807067682214e-06,0.0,1.1346733e-05,False,KDM3A; lysine demethylase
hsa:9547,0.0,0.0,5.7784210895811896e-05,0.0002183908075400884,0.0,0.0014170344,False,CXCL14; C-X-C motif chemokine ligand
hsa:7922,0.0,0.0,8.813253035445543e-08,5.65734354396715e-07,0.0,6.48361e-06,False,SLC39A7; solute carrier family 39 member
hsa:8689,3.1273346e-07,0.00038746962215207605,6.083973579451484e-06,1.5411626411541533e-05,0.0,0.00013168681,False,KRT36; keratin
hsa:83440,4.1407995e-07,0.0005130356111151346,2.714876408032377e-05,8.38926686242307e-05,0.0,0.00045593185,False,ADPGK; ADP dependent
hsa:442590,0.0,0.0,7.937388863099013e-06,2.5541236282382916e-05,0.0,0.00015019262,False,SPDYE5; speedy/RINGO cell cycle regulator family member
hsa:219870,0.0,0.0,3.429266691089109e-08,4.498295663550954e-07,0.0,6.3742636e-06,False,OR10G9; olfactory receptor family 10 subfamily G member
hsa:23048,0.0,0.0,3.1571555270990103e-06,1.1126434317293233e-05,0.0,7.055905e-05,False,FNBP1; formin binding protein
hsa:5232,0.0,0.0,2.786566351485149e-09,2.914022040861964e-08,0.0,3.8056797e-07,False,PGK2; phosphoglycerate kinase
hsa:3985,0.0,0.0,1.4123373695544554e-05,4.0240494910076396e-05,0.0,0.00027025992,False,LIMK2; LIM domain kinase
hsa:1994,1.3266776e-06,0.001643723279209148,1.0914980465049508e-05,3.038126530547862e-05,0.0,0.0003268246,False,ELAVL1; ELAV like RNA binding protein
hsa:2247,0.0,0.0,1.1684923322722767e-05,4.814846067452373e-05,0.0,0.00045263304,False,FGF2; fibroblast growth factor
hsa:823,0.0,0.0,3.992283704341585e-06,1.577663973759683e-05,0.0,0.00020793981,False,CAPN1; calpain
hsa:1525,0.000211557235,0.26211458763954437,0.0009227823618034647,0.0014728777311405537,0.0,0.009965941,False,CXADR; CXADR Ig-like cell adhesion
hsa:5142,0.0,0.0,1.7714161845099006e-05,6.601387554605235e-05,0.0,0.0006883227,False,PDE4B; phosphodiesterase
hsa:10061,3.6437362e-07,0.0004514506022591382,8.479122141336634e-07,1.3680743274472518e-06,0.0,8.593406e-06,False,ABCF2; ATP binding cassette subfamily F member
hsa:114798,1.4602106000000001e-07,0.00018091676197502378,4.547457172594455e-06,1.059457036606058e-05,0.0,7.5264674e-05,False,SLITRK1; SLIT and NTRK like family member
hsa:574457,0.0,0.0,8.719945346534654e-10,7.37045925366086e-09,0.0,7.751372e-08,False,MIR181D; microRNA
hsa:54617,0.0,0.0,6.958170652869307e-07,3.8293631929187085e-06,0.0,3.4639386e-05,False,INO80; INO80 complex ATPase
hsa:142678,9.4326242e-08,0.00011686806185294427,7.106452947574259e-07,1.2086712276326778e-06,0.0,5.8362657e-06,False,MIB2; MIB E3 ubiquitin protein ligase
hsa:10606,1.05433005e-09,1.3062908781717165e-06,1.4905702079976742e-06,3.9735605057641285e-06,0.0,2.2058708e-05,False,PAICS; phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide
hsa:6634,7.5623675e-08,9.369600802549683e-05,5.261387148213369e-05,0.00020696130129819283,0.0,0.0017720073,False,SNRPD3; small nuclear ribonucleoprotein D3
hsa:26664,0.0,0.0,3.1126083903465354e-06,1.0038640535739058e-05,-0.0,0.00010224671,False,OR7C1; olfactory receptor family 7 subfamily C member
hsa:10136,0.0,0.0,1.345454315594059e-07,1.3890263180287692e-06,0.0,1.86877e-05,False,CELA3A; chymotrypsin like elastase
hsa:9437,0.0,0.0,1.9833381477309404e-06,1.1666398889731584e-05,0.0,0.00010809044,False,NCR1; natural cytotoxicity triggering receptor
hsa:120776,0.0,0.0,2.902996437376238e-07,1.5425001847038942e-06,0.0,1.7872346e-05,False,OR2D2; olfactory receptor family 2 subfamily D member
hsa:23659,4.05580055e-07,0.0005025044351290974,4.787107647717821e-05,0.00014442955554280103,0.0,0.00080138486,False,PLA2G15; phospholipase A2 group
hsa:494335,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR423; microRNA
hsa:3177,1.31333815e-07,0.00016271960049890613,3.524346317317031e-05,0.0001326938432023907,0.0,0.0014551963,False,SLC29A2; solute carrier family 29 member
hsa:5582,1.2317652000000001e-05,0.01526128980966975,0.00011715137516689111,0.0003155169620554126,0.0,0.002022812,False,PRKCG; protein kinase C
hsa:127066,0.0,0.0,3.418985832524753e-07,2.8659205520369725e-06,0.0,3.165384e-05,False,OR14C36; olfactory receptor family 14 subfamily C member
hsa:5161,0.0,0.0,4.6148169534653466e-07,2.200358748613065e-06,0.0,1.720019e-05,False,PDHA2; pyruvate dehydrogenase E1 subunit alpha
hsa:10451,1.6916775e-06,0.0020959498281001607,5.520325774605941e-05,0.00013400389001941,0.0,0.0014326108,False,VAV3; vav guanine nucleotide exchange factor
hsa:54187,0.0,0.0,3.96270609514505e-06,1.4411934779975519e-05,0.0,0.00010942919,False,NANS; N-acetylneuraminate
hsa:9287,0.0,0.0,5.285621782178218e-10,7.512280026793352e-09,-0.0,1.0676956e-07,False,TAAR2; trace amine associated receptor
hsa:51477,2.8032532000000004e-07,0.00034731667606037356,2.1927003351079205e-05,6.589664028281497e-05,0.0,0.00036650535,False,ISYNA1; inositol-3-phosphate synthase
hsa:483,0.0,0.0,0.0006170093715841586,0.0011478793820861363,0.0,0.007284937,False,ATP1B3; ATPase Na+/K+ transporting subunit beta
hsa:406933,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR141; microRNA
hsa:7678,8.46154575e-09,1.048366214019761e-05,1.0963778503415842e-07,2.3597544443402478e-07,0.0,1.5227332e-06,False,ZNF124; zinc finger protein
hsa:1479,0.0,0.0,5.18396744170792e-07,1.555564622285444e-06,0.0,8.305277e-06,False,CSTF3; cleavage stimulation factor subunit
hsa:26974,1.051228e-08,1.3024475089927459e-05,6.430360847266833e-08,1.194053291213467e-07,0.0,6.3827906e-07,False,ZNF285; zinc finger protein
hsa:9320,0.0,0.0,1.1655006699752477e-07,4.5654348896811825e-07,0.0,4.1734907e-06,False,TRIP12; thyroid hormone receptor interactor
hsa:31,2.5383093e-05,0.03144907313007378,0.000554276552980495,0.000978766477806304,0.0,0.005301116,False,ACACA; acetyl-CoA carboxylase
hsa:7012,0.0,0.0,5.792363256707921e-08,3.646122290153777e-07,0.0,3.6583644e-06,False,TERC; telomerase RNA
hsa:5981,0.0,0.0,9.046627391172276e-05,0.000219345281875062,0.0,0.0015874264,False,RFC1; replication factor C subunit
hsa:101060200,2.0849869e-08,2.583251201630386e-05,3.922424305715842e-08,5.2023436032663346e-08,0.0,2.7689586e-07,False,ZNF891; zinc finger protein
hsa:51318,7.7737145e-08,9.631454913820588e-05,2.504017695774257e-07,4.7643150562423114e-07,0.0,2.755815e-06,False,MRPL35; mitochondrial ribosomal protein
hsa:51660,0.0,0.0,1.204592694985149e-06,3.288043884968516e-06,0.0,1.823525e-05,False,MPC1; mitochondrial pyruvate carrier
hsa:23265,0.0,0.0,1.4978336471611879e-06,8.02828635468483e-06,0.0,0.00010226373,False,EXOC7; exocyst complex component
hsa:1306,0.0,0.0,5.5627785135099006e-05,0.00019443787301830288,0.0,0.0015066899,False,COL15A1; collagen type XV alpha 1
hsa:1511,0.0,0.0,4.7319420057920785e-05,0.00017530962976658855,0.0,0.0013671779,False,CTSG; cathepsin
hsa:1470,0.0,0.0,3.545301451424752e-05,0.0001837242572644397,0.0,0.0018203367,False,CST2; cystatin
hsa:27159,0.0,0.0,2.514934250425743e-07,1.5777374646372452e-06,0.0,1.6583006e-05,False,CHIA; chitinase
hsa:6235,3.8024961000000005e-07,0.00047112059166989765,1.1237594670806928e-06,1.7054673337402166e-06,0.0,7.2145967e-06,False,RPS29; ribosomal protein
hsa:1409,0.0,0.0,1.007529599178218e-08,4.888534562580896e-08,0.0,6.2090766e-07,False,CRYAA; crystallin alpha
hsa:200576,0.0,0.0,6.3295822460371285e-06,1.8126340189250327e-05,0.0,0.00010518363,False,PIKFYVE; phosphoinositide kinase
hsa:26052,1.1574754e-06,0.001434085613635084,3.765181003120298e-05,0.00010586583826026069,0.0,0.00092703255,False,DNM3; dynamin
hsa:25874,0.0,0.0,3.2189709190099003e-07,7.127376174391162e-07,0.0,5.829993e-06,False,MPC2; mitochondrial pyruvate carrier
hsa:79899,1.1144201750000001e-07,0.00013807411721339328,4.5626799215841614e-07,1.9199643993001025e-06,0.0,1.9619194e-05,False,PRR5L; proline rich 5
hsa:53615,0.0,0.0,1.5599235583712865e-06,4.940225160867398e-06,0.0,2.759113e-05,False,MBD3; methyl-CpG binding domain protein
hsa:5119,0.0,0.0,1.3589532605443564e-05,0.00010399093462107698,0.0,0.0013716125,False,CHMP1A; charged multivesicular body protein
hsa:7539,0.0,0.0,5.347377132678219e-08,1.2769823022933782e-07,0.0,6.822384e-07,False,ZFP37; ZFP37 zinc finger
hsa:3206,0.0,0.0,3.046766410157357e-06,3.052869824945083e-05,0.0,0.00039669272,False,HOXA10; homeobox
hsa:87,2.6929349e-05,0.03336484903736039,0.00013639961143811882,0.0002850058753580246,0.0,0.002257931,False,ACTN1; actinin alpha
hsa:340385,5.3941927e-09,6.683281690691129e-06,1.1856754585479702e-07,2.2046402967130398e-07,0.0,1.0114725e-06,False,ZNF517; zinc finger protein
hsa:2161,1.99761695e-07,0.00024750018268626656,1.0485984042965349e-05,3.207339503006174e-05,0.0,0.00031628914,False,F12; coagulation factor
hsa:375,0.0,0.0,2.8997030706188108e-05,6.442315130997119e-05,0.0,0.00037879954,False,ARF1; ADP ribosylation factor
hsa:9765,0.0,0.0,0.00012071060885064361,0.00026833420277006995,0.0,0.001812251,False,ZFYVE16; zinc finger FYVE-type containing
hsa:9820,1.10665e-09,1.3711141025798612e-06,3.743567771841585e-07,7.999807556980826e-07,0.0,3.5272662e-06,False,CUL7; cullin
hsa:4846,0.0,0.0,9.222610393167325e-05,0.00036122931026698004,0.0,0.004109495,False,NOS3; nitric oxide synthase
hsa:5156,0.0,0.0,0.00011644100548118809,0.0004699055127897832,0.0,0.0044851415,False,PDGFRA; platelet derived growth factor receptor
hsa:4544,0.0,0.0,3.4190776568316824e-07,1.9869837560966623e-06,0.0,1.869222e-05,False,MTNR1B; melatonin receptor
hsa:60481,1.1398351e-06,0.0014122296843857823,8.985351762935642e-05,0.00040244449031596276,0.0,0.0033450287,False,ELOVL5; ELOVL fatty acid elongase
hsa:64064,0.0,0.0,2.4831974398178212e-05,9.21274442575104e-05,0.0,0.0009386049,False,OXCT2; 3-oxoacid CoA-transferase
hsa:55697,0.0,0.0,3.0237581342202977e-06,1.26050323943148e-05,0.0,8.997864e-05,False,VAC14; VAC14 component of PIKFYVE
hsa:4660,1.4460225e-06,0.0017915888875414876,1.3273331595965352e-05,5.5852442402180157e-05,0.0,0.0007436395,False,PPP1R12B; protein phosphatase 1 regulatory subunit
hsa:8566,1.09691135e-05,0.013590481374101241,0.0002139306305867822,0.00037266402818188004,0.0,0.0018859124,False,PDXK; pyridoxal
hsa:55004,0.0,0.0,1.320705505970297e-06,6.635058755266443e-06,0.0,8.1084836e-05,False,LAMTOR1; late endosomal/lysosomal adaptor
hsa:64137,0.0001473333,0.18254259739721632,0.0007851345658529701,0.0018654275562827482,0.0,0.013370776,False,ABCG4; ATP binding cassette subfamily G member
hsa:9218,4.5862135000000005e-06,0.005682213895352771,0.00019418049187341587,0.0003781860087440091,0.0,0.0017330657,False,VAPA; VAMP associated protein
hsa:9265,0.0,0.0,4.807485589064355e-06,1.5323284060268555e-05,0.0,0.00011931216,False,CYTH3; cytohesin
hsa:7134,0.0,0.0,7.970387733118812e-05,0.0003004946155707918,0.0,0.0025655488,False,TNNC1; troponin C1
hsa:3113,0.0,0.0,0.0003621704034430694,0.0007182368095841466,0.0,0.0055113873,False,HLA-DPA1; major histocompatibility complex
hsa:55799,0.0005919964750000001,0.7334701265531706,0.0011621474213168322,0.0016177078499990674,0.0,0.009431303,True,CACNA2D3; calcium voltage-gated channel auxiliary subunit alpha2delta
hsa:491,0.000289691495,0.3589211532028584,0.00042002870399405925,0.0005251376982862051,0.0,0.0029312065,False,ATP2B2; ATPase plasma membrane Ca2+ transporting
hsa:283,0.0,0.0,4.904633336356436e-09,1.5003888682816083e-08,0.0,1.13690994e-07,False,ANG;
hsa:1340,0.0,0.0,0.00016362037036633673,0.00032131263352160554,0.0,0.0017663495,False,COX6B1; cytochrome c oxidase subunit
hsa:2319,7.11606675e-08,8.816644355328818e-05,4.2256318981608915e-06,1.260772431547305e-05,0.0,9.668464e-05,False,FLOT2; flotillin
hsa:6742,4.0360087000000005e-05,0.05000522700677732,0.00017810276001757418,0.0004344146055533525,0.0,0.0038034732,False,SSBP1; single stranded DNA binding protein
hsa:1524,0.0,0.0,4.183174825429208e-05,0.00016459102276985245,0.0,0.0011951042,False,CX3CR1; C-X3-C motif chemokine receptor
hsa:3646,2.4274785500000003e-07,0.00030075905422808594,1.1143112917990098e-06,1.7753251101221644e-06,0.0,1.069829e-05,False,EIF3E; eukaryotic translation initiation factor 3 subunit
hsa:10201,7.448932249999999e-07,0.0009229057115742947,4.161346542425743e-05,9.463710688813308e-05,0.0,0.00062941987,False,NME6; NME/NM23 nucleoside diphosphate kinase
hsa:7791,4.2792495e-07,0.0005301892502514632,1.1993674596094056e-06,1.8358135828286735e-06,0.0,1.1331154e-05,False,ZYX;
hsa:406916,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR128-2; microRNA
hsa:6367,0.0,0.0,1.963933984499011e-05,7.322208143627436e-05,0.0,0.0006896521,False,CCL22; C-C motif chemokine ligand
hsa:92126,1.2711733e-06,0.001574954717799648,0.00031534608060563375,0.0007904735315295817,0.0,0.0043621194,False,DSEL; dermatan sulfate epimerase
hsa:7128,0.0,0.0,1.5623017972772274e-05,7.232416923849485e-05,0.0,0.000954119,False,TNFAIP3; TNF alpha induced protein
hsa:3939,0.0,0.0,0.0003691219273693068,0.0008552830900150861,0.0,0.00802277,False,LDHA; lactate dehydrogenase
hsa:26530,0.0,0.0,1.614569743069307e-07,1.5811527386334636e-06,-0.0,1.850631e-05,False,OR12D1; olfactory receptor family 12 subfamily D member 1
hsa:57335,3.10923595e-09,3.852272407078382e-06,1.028030528733168e-07,2.1342075695683013e-07,0.0,1.1155804e-06,False,ZNF286A; zinc finger protein
hsa:3838,7.984498000000001e-07,0.0009892610861447337,1.3962711952448513e-05,2.8284647394027823e-05,0.0,0.00016750213,False,KPNA2; karyopherin subunit alpha
hsa:130013,4.4611528e-09,5.5272665412222785e-06,1.2406627887405207e-05,2.90050091882757e-05,0.0,0.00021316015,False,ACMSD; aminocarboxymuconate semialdehyde
hsa:51301,3.6417674e-08,4.512066724308131e-05,6.8375717095297015e-06,2.7775638153482393e-05,0.0,0.0002552085,False,GCNT4; glucosaminyl (N-acetyl) transferase
hsa:84126,0.0,0.0,1.4037248444555442e-05,8.907454869234214e-05,0.0,0.00086648035,False,ATRIP; ATR interacting
hsa:8891,2.65749025e-09,3.2925697910301186e-06,5.924471388366336e-08,1.341692346371826e-07,0.0,1.0881396e-06,False,EIF2B3; eukaryotic translation initiation factor 2B subunit
hsa:7471,0.0,0.0,9.703302541732673e-07,3.7458314300302853e-06,0.0,3.4532462e-05,False,WNT1; Wnt family member
hsa:23190,2.5590739e-08,3.1706341786780326e-05,3.126710790653465e-07,6.88001410252491e-07,0.0,4.6076934e-06,False,UBXN4; UBX domain protein
hsa:147694,0.0,0.0,3.365229804702971e-08,7.325242181713311e-08,0.0,4.1762436e-07,False,ZNF548; zinc finger protein
hsa:23746,0.0,0.0,5.979790677964852e-08,3.8959797664441484e-07,0.0,5.227896e-06,False,AIPL1; aryl hydrocarbon receptor interacting protein like
hsa:81494,0.0,0.0,4.4159630172029706e-08,1.8809954476564469e-07,-0.0,1.8988222e-06,False,CFHR5; complement factor H related
hsa:2355,1.3099004999999999e-08,1.6229368350665623e-05,4.526699966697031e-06,1.1420792127313625e-05,0.0,7.151036e-05,False,FOSL2; FOS like 2
hsa:57818,0.0,0.0,2.490607906851485e-06,9.322928066041772e-06,0.0,7.701238e-05,False,G6PC2; glucose-6-phosphatase catalytic subunit
hsa:5921,0.0,0.0,1.959585633252475e-06,1.5810825437171003e-05,0.0,0.00021583035,False,RASA1; RAS p21 protein activator
hsa:11185,0.0,0.0,7.58709217206931e-05,0.00020963643075966827,0.0,0.0012833865,False,INMT; indolethylamine
hsa:26019,0.0,0.0,6.427832675508412e-07,1.4924995466827602e-06,0.0,1.023516e-05,False,UPF2; UPF2 regulator of nonsense mediated mRNA
hsa:90993,0.0,0.0,0.00028401228176732685,0.0008188242812901134,0.0,0.0054961005,False,CREB3L1; cAMP responsive element binding protein 3 like
hsa:91252,0.0,0.0,1.1627274023737624e-07,3.689219684159437e-07,0.0,3.8454627e-06,False,SLC39A13; solute carrier family 39 member
hsa:1312,2.9599082e-06,0.003667258731633102,0.00020227965263960396,0.0004533442991794312,0.0,0.0029128722,False,COMT;
hsa:164284,0.0,0.0,2.3598574120183167e-07,1.4850556758368313e-06,0.0,1.2742135e-05,False,APCDD1L; APC down-regulated 1
hsa:1174,0.0,0.0,8.408767081881181e-07,2.1442897301089265e-06,0.0,1.1061648e-05,False,AP1S1; adaptor related protein complex 1 subunit sigma
hsa:148,0.0,0.0,1.151429525827822e-05,6.20005394390105e-05,0.0,0.0008088322,False,ADRA1A; adrenoceptor alpha
hsa:699,5.0134781000000005e-08,6.211584987019642e-05,2.4148569891683166e-06,9.793796860335058e-06,0.0,9.110871e-05,False,BUB1; BUB1 mitotic checkpoint serine/threonine
hsa:2519,5.6920667e-06,0.0070523407809110475,5.463896571534654e-05,0.00010784909832663046,0.0,0.0006291213,False,FUCA2; alpha-L-fucosidase
hsa:54815,0.0,0.0,7.736383050351487e-07,3.4135164385667317e-06,0.0,2.6478681e-05,False,GATAD2A; GATA zinc finger domain containing
hsa:342372,0.0,0.0,2.883474871359901e-06,1.63886228047529e-05,0.0,0.00019517903,False,PKD1L3; polycystin 1 like 3
hsa:51616,1.10673222e-07,0.0001371215971284071,2.4787669490668315e-06,8.842426269120565e-06,0.0,9.3887174e-05,False,TAF9B; TATA-box binding protein associated factor
hsa:390327,0.0,0.0,3.417094603960396e-08,3.4325070345023265e-07,-0.0,3.6697013e-06,False,OR6C70; olfactory receptor family 6 subfamily C member
hsa:56920,0.0,0.0,2.909334209189109e-06,2.886661482746169e-05,0.0,0.00039357858,False,SEMA3G; semaphorin
hsa:23404,2.40828835e-07,0.0002983814322291405,1.681512393381435e-05,6.553001758455898e-05,0.0,0.0005649649,False,EXOSC2; exosome component
hsa:9249,0.0,0.0,6.02190691640099e-05,0.00020674520982806726,0.0,0.0018162162,False,DHRS3; dehydrogenase/reductase
hsa:5618,0.0,0.0,1.0585325225658414e-05,6.710876074064475e-05,0.0,0.00064551516,False,PRLR; prolactin
hsa:146433,0.0,0.0,0.00010853548233594061,0.0003801460396386178,0.0,0.0023003872,False,IL34; interleukin
hsa:6900,2.10983365e-07,0.00026140357580197376,4.176369026635644e-06,1.1307025899063e-05,0.0,5.3755506e-05,False,CNTN2; contactin
hsa:7481,0.0,0.0,2.592557188267327e-05,0.00010144477627509871,0.0,0.001128421,False,WNT11; Wnt family member
hsa:26333,0.0,0.0,5.269028712871287e-09,7.488696844289086e-08,-0.0,1.0643438e-06,False,OR7A17; olfactory receptor family 7 subfamily A member
hsa:199704,1.377545e-08,1.7067468273061716e-05,1.4193568303910896e-07,3.4597526596981245e-07,0.0,1.9120841e-06,False,ZNF585A; zinc finger protein
hsa:2357,0.0,0.0,4.1848877827079205e-05,0.000196590791758331,0.0,0.0018202156,False,FPR1; formyl peptide receptor
hsa:51081,1.74958195e-07,0.00021676921206019727,4.951477878886139e-07,8.816353502781069e-07,0.0,4.6917735e-06,False,MRPS7; mitochondrial ribosomal protein
hsa:5530,4.8785179000000004e-05,0.0604437237823909,0.0005158906912742572,0.000897800228090832,0.0,0.0043879445,False,PPP3CA; protein phosphatase 3 catalytic subunit
hsa:55968,1.82161975e-08,2.2569453113116167e-05,5.656628891747031e-07,1.2602934960253694e-06,0.0,9.198944e-06,False,NSFL1C; NSFL1
hsa:5894,0.000281787855,0.34912872355869423,0.0007808192424603962,0.0011896073412548801,0.0,0.0070056585,False,RAF1; Raf-1 proto-oncogene
hsa:2810,1.14149885e-07,0.00014142910326785284,4.195385497414701e-05,0.00015048717602629292,0.0,0.0010911053,False,SFN;
hsa:56901,0.0,0.0,2.021483308712872e-06,3.2531203410613267e-06,0.0,1.954684e-05,False,NDUFA4L2; NDUFA4 mitochondrial complex associated like
hsa:10527,0.0,0.0,2.201409153974751e-07,4.338161236270815e-07,0.0,1.9700844e-06,False,IPO7; importin
hsa:406942,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR150; microRNA
hsa:116379,0.0,0.0,2.6423600659599015e-06,1.1008597632367438e-05,0.0,0.00010135941,False,IL22RA2; interleukin 22 receptor subunit alpha
hsa:63917,0.0,0.0,0.0003707540411317822,0.0010278418637652146,0.0,0.009562158,False,GALNT11; polypeptide N-acetylgalactosaminyltransferase
hsa:2770,0.00017490931,0.21670864466047324,0.0007443166404158416,0.0011341214152711663,0.0,0.006028649,False,GNAI1; G protein subunit alpha
hsa:2317,0.0,0.0,1.6750651381603959e-06,5.393679786741464e-06,0.0,4.930205e-05,False,FLNB; filamin
hsa:5269,4.41042745e-07,0.0005464418989834486,1.2003764175480204e-05,3.4130215517629717e-05,0.0,0.00018081318,False,SERPINB6; serpin family B member
hsa:5972,0.0,0.0,5.8285014504391105e-06,2.1213979608002347e-05,0.0,0.00022479203,False,REN;
hsa:6167,1.4760274499999998e-07,0.0001828764336050233,8.409726808752477e-07,1.6565968190924004e-06,0.0,9.708376e-06,False,RPL37; ribosomal protein
hsa:1184,0.0,0.0,3.661301497396038e-06,9.769216797595561e-06,0.0,5.666375e-05,False,CLCN5; chloride voltage-gated channel
hsa:55768,9.924996000000001e-10,1.2296843612387576e-06,2.7641606819329706e-07,5.630075491000472e-07,0.0,3.0718231e-06,False,NGLY1; N-glycanase
hsa:2268,4.0925318e-08,5.070553532044045e-05,4.4118515102524755e-07,1.0173726968246946e-06,0.0,6.5195673e-06,False,FGR; FGR proto-oncogene
hsa:1647,0.0,0.0,9.243759067014852e-05,0.0002570075240983501,0.0,0.0022003686,False,GADD45A; growth arrest and DNA damage inducible
hsa:9033,2.24796825e-05,0.02785181375978648,0.0002735612304470743,0.0006023705333087387,0.0,0.0037108434,False,PKD2L1; polycystin 2 like 1
hsa:6128,1.23526995e-07,0.00015304712862586364,9.216610928118812e-07,2.4030651780362407e-06,0.0,2.1894888e-05,False,RPL6; ribosomal protein
hsa:10059,2.951194e-06,0.0036564620366412778,0.00017032322328653466,0.000611055778148133,0.0,0.0038732972,False,DNM1L; dynamin 1
hsa:2805,1.4512585500000001e-05,0.017980762340347903,0.00044133537784603967,0.0008184979904808289,0.0,0.004909079,False,GOT1; glutamic-oxaloacetic transaminase
hsa:72,1.002553975e-07,0.00012421415024804568,2.0766935178896535e-05,6.820018233030449e-05,0.0,0.00062669103,False,ACTG2; actin gamma 2
hsa:641371,0.0,0.0,0.00011084278480019803,0.00026756145801238635,0.0,0.0018396522,False,ACOT1; acyl-CoA thioesterase
hsa:10319,0.0,0.0,1.835295868255446e-05,5.902529463111854e-05,0.0,0.00048522063,False,LAMC3; laminin subunit gamma
hsa:10006,2.6924988500000003e-08,3.3359446477342047e-05,1.4150009703465349e-06,4.2975818017216734e-06,0.0,2.9150428e-05,False,ABI1; abl interactor
hsa:441282,0.0,0.0,4.717555040915842e-06,1.682555617949717e-05,0.0,0.00012556021,False,AKR1B15; aldo-keto reductase family 1 member
hsa:126295,1.1664968e-08,1.4452629224183614e-05,6.884040070851485e-08,1.575423804868194e-07,0.0,9.4873036e-07,False,ZNF57; zinc finger protein
hsa:7846,0.0,0.0,0.0001473437240128713,0.0004232633804653928,0.0,0.003653417,False,TUBA1A; tubulin alpha
hsa:553,0.0,0.0,2.284253922970297e-08,9.739902821769793e-08,0.0,9.690584e-07,False,AVPR1B; arginine vasopressin receptor
hsa:64682,4.44160725e-08,5.5030500506898784e-05,2.100197899289604e-05,5.702690579551902e-05,0.0,0.00042227955,False,ANAPC1; anaphase promoting complex subunit
hsa:9775,2.1959019e-08,2.7206723561848028e-05,2.16187071639604e-06,3.808050046896274e-06,0.0,2.0497018e-05,False,EIF4A3; eukaryotic translation initiation factor
hsa:56259,0.0,0.0,8.484925038836632e-07,2.796955472674287e-06,0.0,2.1779855e-05,False,CTNNBL1; catenin beta like
hsa:6272,2.6240518e-06,0.003251140314354194,5.533103674451979e-05,0.00011430746593884064,0.0,0.0008382858,False,SORT1; sortilin
hsa:2242,0.0,0.0,4.657307196509901e-06,4.266583432787603e-05,0.0,0.00056013465,False,FES; FES proto-oncogene
hsa:5516,0.0,0.0,0.0002228576400108912,0.0007395670781024397,0.0,0.0061468696,False,PPP2CB; protein phosphatase 2 catalytic subunit
hsa:18,0.000181183495,0.22448221673447588,0.0014787839571480193,0.0022302988088178217,0.0,0.008439699,False,ABAT; 4-aminobutyrate
hsa:1325,2.98702675e-08,3.7008579963929775e-05,1.3173350349633664e-05,3.6834917984607796e-05,0.0,0.00029426764,False,CORT;
hsa:199713,0.0,0.0,1.1803351442574258e-09,5.405464382745724e-09,0.0,6.26589e-08,False,NLRP7; NLR family pyrin domain containing
hsa:30012,2.36755955e-09,2.933352268289549e-06,6.403972364656512e-06,2.104321721822218e-05,0.0,0.00015184146,False,TLX3; T cell leukemia homeobox
hsa:124602,0.0,0.0,7.981238429693562e-08,7.691714508199769e-07,0.0,1.044915e-05,False,KIF19; kinesin family member
hsa:4772,0.0,0.0,9.509439972574256e-05,0.0004084276748224863,0.0,0.004319898,False,NFATC1; nuclear factor of activated T cells
hsa:390157,0.0,0.0,5.364385643564357e-08,7.624224506952599e-07,0.0,1.0836059e-05,False,OR8K1; olfactory receptor family 8 subfamily K member
hsa:55081,0.0,0.0,2.8827978843960393e-08,9.99634848132644e-08,0.0,1.0178115e-06,False,IFT57; intraflagellar transport
hsa:81608,0.0,0.0,5.574776451087129e-07,1.1240512608564166e-06,0.0,9.0297235e-06,False,FIP1L1; factor interacting with PAPOLA and
hsa:255967,0.0,0.0,1.7374614273891095e-05,7.393742667853564e-05,0.0,0.0006768488,False,PAN3; poly(A) specific ribonuclease subunit
hsa:84333,0.0,0.0,1.854834908615693e-05,9.880222239845551e-05,0.0,0.00080413034,False,PCGF5; polycomb group ring finger
hsa:2212,0.0,0.0,6.280488236757426e-05,0.0003613317188523538,0.0,0.003120038,False,FCGR2A; Fc gamma receptor
hsa:23646,0.0,0.0,7.243906018099012e-05,0.0001889811718442912,0.0,0.0011612767,False,PLD3; phospholipase D family member
hsa:3577,0.0,0.0,8.057637621587278e-06,2.9615006229659163e-05,0.0,0.0003260125,False,CXCR1; C-X-C motif chemokine receptor
hsa:25805,0.0,0.0,2.4999324097524746e-05,0.0001474469716220539,0.0,0.0018376114,False,BAMBI; BMP and activin membrane bound
hsa:79823,7.8714365e-08,9.752530242363767e-05,1.4178127380967826e-05,3.659151387109822e-05,0.0,0.00020845255,False,CAMKMT; calmodulin-lysine
hsa:389668,2.0553074499999998e-08,2.5464790401955924e-05,1.5841649809213118e-05,5.158265278666895e-05,0.0,0.0005181656,False,XKR9; XK related
hsa:3312,0.0,0.0,0.00012054510370435643,0.00040330370816953585,0.0,0.0045267837,False,HSPA8; heat shock protein family A (Hsp70) member
hsa:10542,7.0285395e-08,8.708200089449786e-05,4.314133843757426e-06,9.298499609565663e-06,0.0,4.6912683e-05,False,LAMTOR5; late endosomal/lysosomal adaptor
hsa:10286,1.78063735e-08,2.2061690526954608e-05,4.7584773972831717e-07,1.3375295111072876e-06,0.0,1.1398175e-05,False,BCAS2; BCAS2 pre-mRNA processing
hsa:256987,5.3378478000000003e-08,6.61347164505931e-05,1.316769418835792e-05,3.754357062185751e-05,0.0,0.000289293,False,SERINC5; serine incorporator
hsa:2822,2.1592532000000003e-06,0.0026752654529984127,2.1264896330742567e-05,4.2250386724002014e-05,0.0,0.0004099559,False,GPLD1; glycosylphosphatidylinositol specific phospholipase
hsa:100507027,0.0,0.0,2.604413115648515e-06,2.0370154592601083e-05,0.0,0.00022609033,False,MRLN;
hsa:8031,7.543243e-06,0.009345905983361333,4.2011928723316846e-05,9.847366399234478e-05,0.0,0.00061890396,False,NCOA4; nuclear receptor coactivator
hsa:816,0.0012177302,1.5087399361653593,0.0017687035221366336,0.0017565689910053345,0.0,0.008620598,True,CAMK2B; calcium/calmodulin dependent protein kinase II
hsa:23654,0.0,0.0,8.101955444554458e-07,4.731204339030456e-06,0.0,6.438675e-05,False,PLXNB2; plexin
hsa:91,1.63458515e-05,0.020252137089708737,0.00032367494958613854,0.0005866700543022888,0.0,0.0031279726,False,ACVR1B; activin A receptor type
hsa:6331,3.9335916e-08,4.873630250349867e-05,5.133909191102973e-07,9.562913463836077e-07,0.0,4.583338e-06,False,SCN5A; sodium voltage-gated channel alpha subunit
hsa:5523,2.43698015e-06,0.0030193628079087202,6.243109389801981e-06,1.2327500380977041e-05,0.0,8.945053e-05,False,PPP2R3A; protein phosphatase 2 regulatory subunit
hsa:7368,0.0,0.0,2.4141853449354453e-06,9.902794527347912e-06,0.0,0.00011990619,False,UGT8; UDP glycosyltransferase
hsa:140564,0.0,0.0,6.047658324504949e-06,1.8811509055142843e-05,0.0,0.00015072891,False,APOBEC3D; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:140679,4.58260975e-06,0.0056777489313197226,0.00018634191439608917,0.0011951803207444628,0.0,0.016513668,False,SLC32A1; solute carrier family 32 member
hsa:5625,0.0,0.0,1.5191108004702967e-05,4.4255667067270984e-05,0.0,0.00029201998,False,PRODH; proline dehydrogenase
hsa:55699,1.5386010499999999e-07,0.00019062915988787615,5.973060787026733e-06,1.362189492200248e-05,0.0,7.826436e-05,False,IARS2; isoleucyl-tRNA synthetase 2
hsa:5957,0.0,0.0,5.041025112231683e-05,0.00025680645554941877,0.0,0.0024333154,False,RCVRN;
hsa:7099,0.0,0.0,5.1212675518811865e-05,0.00019262677341753991,0.0,0.0018240563,False,TLR4; toll like receptor
hsa:51377,4.2484282e-08,5.263705614980323e-05,6.336352432350991e-07,2.5163613176708877e-06,0.0,1.9012887e-05,False,UCHL5; ubiquitin C-terminal hydrolase
hsa:3265,0.00031287791,0.3876485924065535,0.0010119934511584165,0.0014600295147793889,0.0,0.01053887,False,HRAS; HRas proto-oncogene
hsa:2569,0.0,0.0,2.079082573350593e-05,0.00016846281589441835,0.0,0.001743996,False,GABRR1; gamma-aminobutyric acid type A receptor subunit
hsa:55191,0.0,0.0,5.372579969093565e-05,0.00011179728469554376,0.0,0.00047852195,False,NADSYN1; NAD synthetase
hsa:3364,0.0,0.0,3.157981735039603e-07,6.961083814125201e-07,0.0,4.025e-06,False,HUS1; HUS1 checkpoint clamp
hsa:26035,0.0,0.0,3.1031762607772275e-05,0.00011025856353830134,0.0,0.0007428336,False,GLCE; glucuronic acid
hsa:407020,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR28; microRNA
hsa:55930,4.42267215e-09,5.479589893780503e-06,1.2677638591311882e-07,2.933928592839425e-07,0.0,2.4099998e-06,False,MYO5C; myosin
hsa:353514,0.0,0.0,7.216888108089108e-06,2.585912472419185e-05,0.0,0.00024444592,False,LILRA5; leukocyte immunoglobulin like receptor
hsa:6610,0.0,0.0,1.0287297157425741e-05,2.358241997690466e-05,0.0,0.00016236314,False,SMPD2; sphingomyelin phosphodiesterase
hsa:91120,0.0,0.0,4.402456609797028e-08,7.450725095087498e-08,0.0,3.3994735e-07,False,ZNF682; zinc finger protein
hsa:9296,0.0,0.0,0.00016780596862178219,0.000416864782703546,0.0,0.0025054112,False,ATP6V1F; ATPase H+ transporting V1 subunit
hsa:1366,0.0,0.0,2.443028641079208e-06,1.0454438223199819e-05,0.0,0.00010904131,False,CLDN7; claudin
hsa:116988,3.1060171000000003e-09,3.848284325364119e-06,2.278695371337623e-06,6.203350801086133e-06,0.0,3.835982e-05,False,AGAP3; ArfGAP with GTPase domain
hsa:81617,8.679062300000001e-08,0.00010753160183164691,1.445319513643069e-06,4.328018382220895e-06,0.0,3.706464e-05,False,CAB39L; calcium binding protein 39
hsa:8911,1.04889325e-05,0.0129955480700838,7.035184341975245e-05,0.00013456889256855203,0.0,0.00077763305,False,CACNA1I; calcium voltage-gated channel subunit alpha1
hsa:80032,0.0,0.0,3.668231176188119e-09,9.286114386724191e-09,0.0,7.6395644e-08,False,ZNF556; zinc finger protein
hsa:55753,0.0,0.0,7.629087466039599e-06,1.76170902112662e-05,0.0,0.00012517162,False,OGDHL; oxoglutarate dehydrogenase
hsa:4488,0.0,0.0,4.985988148554455e-08,2.936099608637143e-07,0.0,2.6640307e-06,False,MSX2; msh homeobox
hsa:1737,0.0,0.0,3.5129580107277226e-05,7.778682815748579e-05,0.0,0.0005395422,False,DLAT; dihydrolipoamide
hsa:196294,1.0328673499999998e-06,0.0012796990825277089,0.0001805333045140941,0.0005865806170902708,0.0,0.004358327,False,IMMP1L; inner mitochondrial membrane peptidase subunit
hsa:7466,0.0,0.0,1.0087269212201988e-06,3.765018046540224e-06,0.0,3.8330763e-05,False,WFS1; wolframin ER transmembrane
hsa:56994,0.0,0.0,0.00025800998591920794,0.0005836130825453434,0.0,0.0029739605,False,CHPT1; choline phosphotransferase
hsa:10054,4.7108875e-08,5.8366821370055436e-05,4.887036319059404e-07,8.572577453368921e-07,0.0,5.6940275e-06,False,UBA2; ubiquitin like modifier activating enzyme
hsa:10396,9.03654925e-07,0.0011196078358408229,0.00013854847697708115,0.00034342907503607335,0.0,0.0039733164,False,ATP8A1; ATPase phospholipid transporting
hsa:53919,0.0,0.0,6.85837004739604e-07,2.880689817815069e-06,0.0,3.090524e-05,False,SLCO1C1; solute carrier organic anion transporter family member
hsa:10331,0.0,0.0,5.359426426287129e-06,5.0407027312566285e-05,0.0,0.0007028186,False,B3GNT3; UDP-GlcNAc:betaGal beta-1
hsa:56979,0.0,0.0,3.54632314559406e-07,1.818650644259172e-06,0.0,1.6785903e-05,False,PRDM9; PR/SET domain
hsa:353500,3.4773389e-07,0.00043083435641255507,2.0574255086831683e-05,9.27431122106331e-05,0.0,0.001166034,False,BMP8A; bone morphogenetic protein
hsa:27235,1.7173005e-08,2.1276961405299295e-05,0.0001232359965924752,0.00032493054360922526,0.0,0.0021477682,False,COQ2; coenzyme Q2
hsa:100528021,0.0,0.0,6.940699381190596e-06,1.9990149752923403e-05,0.0,0.00017955578,False,ST20-MTHFS; ST20-MTHFS
hsa:8001,0.0,0.0,1.1189446307497525e-07,8.476974003128567e-07,0.0,1.1702006e-05,False,GLRA3; glycine receptor alpha
hsa:402569,0.0,0.0,6.213465416762377e-08,4.4266920485286266e-07,0.0,4.958978e-06,False,KPNA7; karyopherin subunit alpha
hsa:3953,0.0,0.0,4.8017913017326725e-05,0.0002670400588246171,0.0,0.0024813893,False,LEPR; leptin
hsa:3728,3.61445255e-06,0.004478224248326698,3.2662722500712876e-05,7.340199464091691e-05,0.0,0.0006763641,False,JUP; junction
hsa:64284,2.9889182e-09,3.7032014597909122e-06,7.41618168641505e-06,1.7578987576437583e-05,0.0,0.00012216401,False,RAB17; RAB17
hsa:1445,1.854897e-07,0.00022981750648652026,6.048524978960395e-06,3.8408082633077026e-05,0.0,0.00035687452,False,CSK; C-terminal Src
hsa:3930,0.0,0.0,3.711310125126731e-05,9.932955553636466e-05,0.0,0.0010508605,False,LBR; lamin B
hsa:79792,3.49917315e-06,0.004335395701742914,1.6669601037123767e-05,3.923433604246786e-05,0.0,0.00028623006,False,GSDMD; gasdermin
hsa:5230,0.0,0.0,3.288059606277229e-05,9.050742405426804e-05,0.0,0.00066557695,False,PGK1; phosphoglycerate kinase
hsa:3568,0.0,0.0,3.612567305618019e-06,8.633037352767677e-06,0.0,5.0774215e-05,False,IL5RA; interleukin 5 receptor subunit
hsa:4775,0.0,0.0,0.0001099869684549505,0.0002589803886428299,0.0,0.0013302214,False,NFATC3; nuclear factor of activated T cells
hsa:407044,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR7-2; microRNA
hsa:1739,1.5902823e-06,0.0019703234885583855,4.0747713487277236e-05,0.00014233566956404998,0.0,0.0009967966,False,DLG1; discs large MAGUK scaffold protein
hsa:23046,0.0,0.0,9.765324081988117e-07,3.867468325201498e-06,0.0,3.1901134e-05,False,KIF21B; kinesin family member
hsa:27244,1.7818464500000002e-06,0.0022076671000107184,0.0001839487611451138,0.0005210397025022737,0.0,0.0027873416,False,SESN1; sestrin
hsa:622,1.01403755e-05,0.012563693899159907,0.00023771164287207926,0.0005624614963184935,0.0,0.0034455184,False,BDH1; 3-hydroxybutyrate dehydrogenase
hsa:406999,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR217; microRNA
hsa:132014,0.0,0.0,1.1339684811719805e-05,5.1195235450355204e-05,0.0,0.00045766946,False,IL17RE; interleukin 17 receptor
hsa:8513,4.9619295e-07,0.0006147717447663704,1.0632819764108913e-05,2.275824064262316e-05,0.0,0.00020954134,False,LIPF; lipase F
hsa:390265,0.0,0.0,1.3044985283316832e-06,1.4907801575852651e-05,-0.0,0.00020860913,False,OR10G7; olfactory receptor family 10 subfamily G member
hsa:2686,0.00014120945,0.17495528695842924,0.0008263042625103962,0.0012716314690385787,0.0,0.0061475346,False,GGT7; gamma-glutamyltransferase
hsa:5055,0.0,0.0,1.4590754207915842e-07,7.151168696892429e-07,0.0,7.649019e-06,False,SERPINB2; serpin family B member
hsa:26496,0.0,0.0,8.963345346534653e-09,8.405612216450408e-08,0.0,1.0816068e-06,False,OR10A3; olfactory receptor family 10 subfamily A member
hsa:9411,0.0,0.0,1.1663551143014853e-05,2.542868500086681e-05,0.0,0.00015301615,False,ARHGAP29; Rho GTPase activating protein
hsa:1522,1.9525615000000003e-06,0.002419179152220203,5.796225773043567e-06,1.0568817610660275e-05,0.0,9.993164e-05,False,CTSZ; cathepsin
hsa:5256,0.0,0.0,2.3599668336861384e-05,7.648229994425341e-05,0.0,0.00038829836,False,PHKA2; phosphorylase kinase regulatory subunit alpha
hsa:1551,2.9524774000000003e-06,0.0036580521399614345,2.943021262188119e-05,8.341421026383964e-05,0.0,0.0006443566,False,CYP3A7; cytochrome P450 family 3 subfamily A member
hsa:643,8.8131075e-06,0.010919239127820305,0.0002538030811690892,0.0005939130367038263,0.0,0.0038249397,False,CXCR5; C-X-C motif chemokine receptor
hsa:4166,1.1237175e-08,1.3922603456971806e-05,5.01370863699723e-06,1.8249150231191193e-05,0.0,0.00013853816,False,CHST6; carbohydrate sulfotransferase
hsa:124044,0.0,0.0,6.213484695002526e-05,0.00024628464894875984,0.0,0.0018090684,False,SPATA2L; spermatogenesis associated 2
hsa:56242,1.8536595e-08,2.2966418305978706e-05,1.4998634869514847e-07,2.5369686552850055e-07,0.0,1.2381915e-06,False,ZNF253; zinc finger protein
hsa:10056,1.4324158000000002e-07,0.00017747304966685165,9.046480934987128e-06,2.631159468456956e-05,0.0,0.0001779155,False,FARSB; phenylalanyl-tRNA synthetase subunit
hsa:112817,1.2751435000000001e-06,0.0015798737050224038,2.2713846508900998e-05,5.822269453919169e-05,0.0,0.0003670594,False,HOGA1; 4-hydroxy-2-oxoglutarate aldolase
hsa:51107,2.99621275e-06,0.003712239240821025,0.00029797932499381195,0.0005731908788164919,0.0,0.0037319767,False,APH1A; aph-1 homolog A
hsa:1811,1.233720665e-08,1.528551757489454e-05,5.562487222872773e-06,1.2462084549256204e-05,0.0,9.8679004e-05,False,SLC26A3; solute carrier family 26 member
hsa:63924,0.0,0.0,1.355379773939109e-05,7.793453957063222e-05,0.0,0.0008281652,False,CIDEC; cell death inducing DFFA like effector
hsa:1363,1.7792034e-07,0.0002204392421359994,0.00011889082470386138,0.0002698234786986511,0.0,0.002419371,False,CPE; carboxypeptidase
hsa:51497,5.8900835e-07,0.0007297679078500833,8.727045150669059e-05,0.0002764201639649314,0.0,0.0020129057,False,NELFCD; negative elongation factor complex member
hsa:653689,0.00041470012999999997,0.513803999986176,0.000789918022661881,0.0011585558370554212,0.0,0.0066470993,False,GSTT2B; glutathione S-transferase theta
hsa:2348,0.0,0.0,3.2349728490783164e-05,0.0002252695057398143,0.0,0.0030887716,False,FOLR1; folate receptor
hsa:7222,0.0,0.0,1.0737771480702966e-06,5.559146422980546e-06,0.0,3.748994e-05,False,TRPC3; transient receptor potential cation channel subfamily C member
hsa:56985,0.0,0.0,1.5862895297772273e-06,1.1932602075097694e-05,0.0,0.00016574204,False,ADPRM; ADP-ribose/CDP-alcohol diphosphatase
hsa:55770,0.0,0.0,1.7115221593861387e-06,3.1336831194736287e-06,0.0,1.3028186e-05,False,EXOC2; exocyst complex component
hsa:116285,0.0,0.0,7.315079700854949e-06,2.2836665323596685e-05,0.0,0.00021579076,False,ACSM1; acyl-CoA synthetase medium chain family member
hsa:285362,2.1797557e-07,0.0002700667582748689,1.17409001469901e-06,2.5393525069011356e-06,0.0,1.8310018e-05,False,SUMF1; sulfatase modifying factor
hsa:51495,5.367858e-06,0.006650653598198281,0.00047460757396188116,0.0013795132520995942,0.0,0.0073393523,False,HACD3; 3-hydroxyacyl-CoA dehydratase
hsa:7328,9.2798305e-09,1.1497498276872293e-05,1.4579202569470295e-06,2.675579053973663e-06,0.0,1.582434e-05,False,UBE2H; ubiquitin conjugating enzyme E2
hsa:4023,0.0,0.0,5.678881078316832e-05,0.00021367721114010237,0.0,0.001813257,False,LPL; lipoprotein
hsa:5105,0.0,0.0,2.049465465284654e-05,9.53746397208467e-05,0.0,0.0010176648,False,PCK1; phosphoenolpyruvate carboxykinase
hsa:9534,3.3665493e-09,4.171077777310224e-06,4.33323683211386e-08,8.064373162070018e-08,0.0,4.774556e-07,False,ZNF254; zinc finger protein
hsa:7512,0.0,0.0,8.58818111570297e-06,5.688540498111756e-05,0.0,0.0006987484,False,XPNPEP2; X-prolyl aminopeptidase
hsa:79993,3.5773405999999997e-07,0.00044322433889590216,4.129178344994804e-05,0.00026834113124132115,0.0,0.0026193918,False,ELOVL7; ELOVL fatty acid elongase
hsa:63931,0.0,0.0,6.677090184460396e-08,2.2763599348131288e-07,0.0,1.9577412e-06,False,MRPS14; mitochondrial ribosomal protein
hsa:9167,3.1709725e-07,0.0003928762584053601,0.00014209011663094057,0.00040713850933106905,0.0,0.0032803018,False,COX7A2L; cytochrome c oxidase subunit 7A2
hsa:7297,0.0,0.0,0.0001722019291836634,0.00043299264363806504,0.0,0.0031108088,False,TYK2; tyrosine kinase
hsa:11006,0.0,0.0,3.803779216920792e-06,1.0789116482201727e-05,0.0,8.097261e-05,False,LILRB4; leukocyte immunoglobulin like receptor
hsa:10109,7.1152787e-07,0.000881566797935761,0.0001453641791696213,0.00030947193897857325,0.0,0.0016733763,False,ARPC2; actin related protein 2/3 complex subunit
hsa:442909,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR342; microRNA
hsa:5337,0.0,0.0,9.03234794701485e-05,0.0002908000740608618,0.0,0.00287627,False,PLD1; phospholipase
hsa:2033,9.013380900000001e-07,0.0011167373301327393,0.00027581316448067325,0.00048823376766103785,0.0,0.003905187,False,EP300; E1A binding protein
hsa:730291,0.0,0.0,2.6817005118811878e-11,1.7487796882054888e-10,0.0,2.0305007e-09,False,ZNF735; zinc finger protein
hsa:9088,0.0,0.0,4.5879557217886265e-05,0.00015158823129562496,0.0,0.00087311136,False,PKMYT1; protein kinase
hsa:23269,0.0,0.0,7.929747133738982e-05,0.00030148439771127545,0.0,0.0019133982,False,MGA; MAX dimerization protein
hsa:5701,0.0,0.0,6.184697603757425e-06,1.5799135781776264e-05,0.0,0.00010992662,False,PSMC2; proteasome 26S subunit
hsa:4999,0.0,0.0,1.2507323084219804e-06,3.5156367043761123e-06,0.0,1.9598981e-05,False,ORC2; origin recognition complex subunit
hsa:375387,2.9801651000000002e-08,3.692356568586565e-05,2.5218925930500003e-05,9.411153818041068e-05,0.0,0.00075252965,False,NRROS; negative regulator of reactive oxygen
hsa:51733,1.079068875e-05,0.013369417179482992,0.0001902353767441583,0.0004408397988876755,0.0,0.0030318254,False,UPB1; beta-ureidopropionase
hsa:10886,0.0,0.0,1.3079978223006636e-06,7.887511199359487e-06,0.0,8.815948e-05,False,NPFFR2; neuropeptide FF receptor
hsa:127550,0.0,0.0,4.236140929554456e-06,1.2079019094221723e-05,0.0,7.4202195e-05,False,A3GALT2; alpha 1
hsa:8771,7.242373e-08,8.97313491749299e-05,1.6442375362589104e-05,4.664318038801939e-05,0.0,0.00037936823,False,TNFRSF6B; TNF receptor superfamily member
hsa:94005,0.0,0.0,7.034640966237624e-05,0.00017266247007259697,0.0,0.0012684641,False,PIGS; phosphatidylinositol glycan anchor biosynthesis class
hsa:50848,1.2230354e-06,0.0015153129579310544,3.118952334894901e-05,7.43667203829766e-05,0.0,0.00041520823,False,F11R; F11
hsa:5714,0.0,0.0,7.679622786103962e-06,1.6337855485382935e-05,0.0,0.00010167782,False,PSMD8; proteasome 26S subunit
hsa:8841,6.47687325e-06,0.00802469819156667,7.400531253599011e-05,0.00018536124513865006,0.0,0.0014133838,False,HDAC3; histone deacetylase
hsa:100169760,0.0,0.0,1.6362517600801978e-07,1.1003378176224196e-06,0.0,1.3870191e-05,False,RNA5S9; RNA
hsa:389114,0.0,0.0,6.185340093861384e-08,1.360707351522985e-07,0.0,7.1458044e-07,False,ZNF662; zinc finger protein
hsa:79717,9.8930945e-06,0.012257318381697248,2.9789735100396026e-05,4.1543729591835865e-05,0.0,0.00016696681,False,PPCS; phosphopantothenoylcysteine
hsa:23244,0.0,0.0,8.55833193840792e-07,2.3177268673232265e-06,0.0,1.1747979e-05,False,PDS5A; PDS5 cohesin associated factor
hsa:103910,0.0,0.0,0.00013888230527326733,0.00037380582479223164,0.0,0.0020720183,False,MYL12B; myosin light chain
hsa:4864,0.0,0.0,5.119817108748514e-05,0.0001362919056694107,0.0,0.0006781846,False,NPC1; NPC intracellular cholesterol transporter
hsa:84876,0.0,0.0,0.0001310853595019802,0.0004189171160332613,0.0,0.0029143414,False,ORAI1; ORAI calcium release-activated calcium modulator
hsa:10892,2.2530312e-06,0.0027914542555211017,4.4945827303861394e-05,0.00010569025543087598,0.0,0.00072316476,False,MALT1; MALT1
hsa:2897,4.1101781000000006e-08,5.092416895156462e-05,5.2696649133168325e-06,1.7730576264218467e-05,0.0,0.00014087012,False,GRIK1; glutamate ionotropic receptor kainate type subunit
hsa:7704,0.0,0.0,3.7250857752143594e-06,1.4791754623635348e-05,0.0,0.00014305976,False,ZBTB16; zinc finger and BTB domain containing
hsa:7398,1.6239042999999999e-07,0.00020119803794967488,0.00012440581820772275,0.0004097256950579627,0.0,0.002677946,False,USP1; ubiquitin specific peptidase
hsa:100287226,0.0,0.0,2.236099064064357e-09,1.0160587518957034e-08,0.0,1.2397572e-07,False,ZNF729; zinc finger protein
hsa:353497,0.0,0.0,1.3355808995702978e-05,4.2994123679163904e-05,0.0,0.0003777556,False,POLN; DNA polymerase
hsa:64816,0.0,0.0,4.007742082321782e-06,1.8191956698240156e-05,0.0,0.0001984973,False,CYP3A43; cytochrome P450 family 3 subfamily A member
hsa:51227,0.0,0.0,4.0062127811287125e-05,0.00011104898882991679,0.0,0.00077476195,False,PIGP; phosphatidylinositol glycan anchor biosynthesis class
hsa:3673,0.0,0.0,7.57998102668317e-05,0.00024173425259804942,0.0,0.001623331,False,ITGA2; integrin subunit alpha
hsa:80778,1.8494375e-08,2.2914108689197502e-05,1.5739326748019804e-07,2.643268883558221e-07,0.0,1.1123053e-06,False,ZNF34; zinc finger protein
hsa:6347,0.0,0.0,0.00031815465407326724,0.0007323354059261068,0.0,0.0058158175,False,CCL2; C-C motif chemokine ligand
hsa:93474,8.74051275e-09,1.0829295888767073e-05,6.536192408465348e-08,1.177031027664534e-07,0.0,6.601587e-07,False,ZNF670; zinc finger protein
hsa:6770,0.0,0.0,6.434956263118812e-05,0.00018493068114774135,0.0,0.001731926,False,STAR; steroidogenic acute regulatory
hsa:7070,1.9064328e-06,0.002362026745313163,1.7067412960908905e-05,3.819965951016121e-05,0.0,0.0002610733,False,THY1; Thy-1 cell surface
hsa:685,0.0,0.0,8.175693306805594e-06,5.372128220085171e-05,0.0,0.00052674196,False,BTC;
hsa:56548,0.0,0.0,0.00010848177487990588,0.000532259608896282,0.0,0.0037047383,False,CHST7; carbohydrate sulfotransferase
hsa:2752,0.0,0.0,0.0005059491317757427,0.001123136730131988,0.0,0.009421927,False,GLUL; glutamate-ammonia
hsa:9435,0.0,0.0,1.7974322291816835e-05,0.00012019002306285653,0.0,0.0013285277,False,CHST2; carbohydrate sulfotransferase
hsa:219869,0.0,0.0,1.575336881188119e-08,2.2389743866886064e-07,0.0,3.1821805e-06,False,OR10G8; olfactory receptor family 10 subfamily G member
hsa:6558,5.195586e-09,6.437212520459486e-06,3.831541184273266e-05,9.793373904080662e-05,0.0,0.0008469034,False,SLC12A2; solute carrier family 12 member
hsa:126068,0.0,0.0,7.395355059198021e-08,2.2566488574927935e-07,0.0,1.4640997e-06,False,ZNF441; zinc finger protein
hsa:58517,4.0120615e-09,4.970852666215797e-06,1.719772647648515e-07,5.576472470381652e-07,0.0,4.7431813e-06,False,RBM25; RNA binding motif protein
hsa:7298,6.266988000000001e-05,0.07764655155197,0.0006520815604677968,0.0012313953378106889,0.0,0.006151683,False,TYMS; thymidylate
hsa:9601,0.0,0.0,0.00017542519473648515,0.000543254093657853,0.0,0.00539191,False,PDIA4; protein disulfide isomerase family A member
hsa:59341,0.0,0.0,1.681864237821288e-05,4.997147536455855e-05,0.0,0.00035965806,False,TRPV4; transient receptor potential cation channel subfamily V member
hsa:493753,1.8784190200000002e-08,2.3273183110073124e-05,8.40972579432673e-07,1.709091511815384e-06,0.0,8.099521e-06,False,COA5; cytochrome c oxidase assembly factor
hsa:79728,9.983811e-09,1.2369714055565845e-05,8.54286919920495e-05,0.00021499493853721995,0.0,0.0014924348,False,PALB2; partner and localizer of
hsa:2206,0.0,0.0,5.445832935057425e-06,3.075226532788509e-05,0.0,0.00031558127,False,MS4A2; membrane spanning 4-domains
hsa:347148,0.0,0.0,1.525030311782945e-06,7.371779702152432e-06,0.0,8.587932e-05,False,QRFP; pyroglutamylated RFamide
hsa:6369,1.5759893e-05,0.019526147876428528,0.00019306338148910896,0.00046699844492777663,0.0,0.003019005,False,CCL24; C-C motif chemokine ligand
hsa:80326,3.12536955e-06,0.003872261569401956,3.31739937258911e-05,0.0001115513518903171,0.0,0.00088879187,False,WNT10A; Wnt family member
hsa:6295,0.0,0.0,2.477115035707921e-05,9.801622670787539e-05,0.0,0.00086086383,False,SAG; S-antigen visual
hsa:3557,0.0,0.0,3.1505001611584166e-06,1.6595961038529596e-05,0.0,0.0001453434,False,IL1RN; interleukin 1 receptor
hsa:79799,0.0,0.0,1.0019331575742574e-05,6.758611481781879e-05,0.0,0.00074916123,False,UGT2A3; UDP glucuronosyltransferase family 2 member
hsa:23162,8.6176483e-08,0.00010677069638280725,3.228420253188118e-07,5.605006233038854e-07,0.0,4.4055314e-06,False,MAPK8IP3; mitogen-activated protein kinase 8 interacting protein
hsa:4715,0.0,0.0,7.007871329257428e-06,1.7181112033633554e-05,0.0,0.00011435562,False,NDUFB9; NADH:ubiquinone oxidoreductase subunit
hsa:5300,3.228523e-07,0.0004000066340580527,0.0001782951893481684,0.0004154266235491778,0.0,0.0029770217,False,PIN1; peptidylprolyl cis/trans isomerase
hsa:3062,0.0,0.0,4.788697279172426e-07,2.768405771443889e-06,0.0,2.9390618e-05,False,HCRTR2; hypocretin receptor
hsa:113220,0.0,0.0,1.3850933380496535e-07,9.30315694310259e-07,0.0,1.1761367e-05,False,KIF12; kinesin family member
hsa:10565,2.6450909999999997e-10,3.2772074031600476e-07,1.3531272695926238e-06,4.038889687603942e-06,0.0,2.4262668e-05,False,ARFGEF1; ADP ribosylation factor guanine nucleotide exchange factor
hsa:4130,8.1538591e-08,0.00010102445400496211,6.077685511715344e-06,1.3132749180968643e-05,0.0,7.89896e-05,False,MAP1A; microtubule associated protein
hsa:9049,6.01465075e-07,0.0007452015059339031,1.319275885686634e-05,3.4279552797143755e-05,0.0,0.00023629302,False,AIP; aryl hydrocarbon receptor interacting
hsa:288,5.7531605e-09,7.128034605300145e-06,6.609480816589406e-07,1.185204769648447e-06,0.0,5.9533386e-06,False,ANK3; ankyrin
hsa:23460,0.0,0.0,0.00017354147621881187,0.0005841137114035966,0.0,0.0040424736,False,ABCA6; ATP binding cassette subfamily A member
hsa:57107,0.0,0.0,1.822800456316593e-05,9.212799030823798e-05,0.0,0.0009850193,False,PDSS2; decaprenyl diphosphate synthase subunit
hsa:391109,0.0,0.0,2.7000291787128716e-07,2.4047662496711573e-06,-0.0,2.9345252e-05,False,OR10K1; olfactory receptor family 10 subfamily K member
hsa:55224,0.0,0.0,1.593396819341584e-06,7.870667946624583e-06,0.0,9.485916e-05,False,ETNK2; ethanolamine kinase
hsa:1270,0.0,0.0,3.4112666044292075e-06,1.3193193741735703e-05,0.0,0.00014138327,False,CNTF; ciliary neurotrophic
hsa:54922,1.9491933000000002e-08,2.4150060292632524e-05,4.005961026418812e-06,2.4856652114848622e-05,0.0,0.00033286362,False,RASIP1; Ras interacting protein
hsa:5365,0.0,0.0,2.455956498554455e-06,1.6830645549086192e-05,0.0,0.00018325917,False,PLXNB3; plexin
hsa:197322,0.0,0.0,2.2723661773613857e-05,4.6186337379458045e-05,0.0,0.0003835287,False,ACSF3; acyl-CoA synthetase family member
hsa:586,0.0,0.0,7.725553453841585e-05,0.00013383382429937036,0.0,0.0006953411,False,BCAT1; branched chain amino acid transaminase
hsa:23020,2.7788621500000002e-08,3.4429468061179176e-05,1.0073366284143562e-06,3.015845703752588e-06,0.0,1.8644152e-05,False,SNRNP200; small nuclear ribonucleoprotein U5 subunit
hsa:10717,1.1953988e-07,0.00014810718410401147,3.415005636646189e-06,7.49476607810208e-06,0.0,3.676821e-05,False,AP4B1; adaptor related protein complex 4 subunit beta
hsa:7018,7.756572e-07,0.0009610215747414339,4.460259653529702e-05,9.408534173528312e-05,0.0,0.00056398293,False,TF;
hsa:5431,9.8914505e-08,0.0001225528150320392,3.410364050584654e-05,0.00010678774927010635,0.0,0.0008953048,False,POLR2B; RNA polymerase II subunit
hsa:2354,0.0,0.0,0.00011695256066138613,0.0003274843175725707,0.0,0.0023856414,False,FOSB; FosB proto-oncogene
hsa:7136,1.7232138000000003e-08,2.135022584322263e-05,1.482471709032178e-07,4.518449471847246e-07,0.0,3.1934712e-06,False,TNNI2; troponin I2
hsa:84128,0.0,0.0,2.1330124963981933e-06,4.3871076653986e-06,0.0,1.9652945e-05,False,WDR75; WD repeat domain
hsa:8027,4.4521106e-07,0.0005516063461713537,6.598167508074261e-05,0.00020292116071640186,0.0,0.0015089737,False,STAM; signal transducing adaptor
hsa:10791,0.0,0.0,0.00010989015456770295,0.00030157546638992673,0.0,0.0016318365,False,VAMP5; vesicle associated membrane protein
hsa:3725,0.0,0.0,0.00030070179749554444,0.0007684721038786593,0.0,0.0077016084,False,JUN; Jun proto-oncogene
hsa:8890,0.0,0.0,2.477439617534653e-07,6.353195515798647e-07,0.0,3.5652356e-06,False,EIF2B4; eukaryotic translation initiation factor 2B subunit
hsa:51380,0.0,0.0,0.0002026113300148514,0.0003740042192839989,0.0,0.002099684,False,CSAD; cysteine sulfinic acid
hsa:57555,1.65602295e-06,0.0020517746540829563,1.1542383176014849e-05,1.939414536973703e-05,0.0,0.00014620912,False,NLGN2; neuroligin
hsa:902,0.0,0.0,9.445198738688121e-06,2.6126003432891494e-05,0.0,0.00017446929,False,CCNH; cyclin
hsa:777,2.53170965e-05,0.03136730497223624,0.00022381014904727722,0.0004906397578276194,0.0,0.0042776554,False,CACNA1E; calcium voltage-gated channel subunit alpha1
hsa:2776,0.0008163301499999999,1.0114144318674678,0.0013100072429544551,0.0014774828593026347,0.0,0.007002788,True,GNAQ; G protein subunit alpha
hsa:121278,0.0,0.0,4.427710721321783e-06,1.8495171505147186e-05,0.0,0.0001678231,False,TPH2; tryptophan hydroxylase
hsa:3748,0.0,0.0,5.1079975246534644e-08,1.1064130802841413e-07,0.0,5.6790907e-07,False,KCNC3; potassium voltage-gated channel subfamily C member
hsa:2159,3.44800595e-08,4.272000708285611e-05,4.5837604584356435e-07,1.2560869989125272e-06,0.0,8.85899e-06,False,F10; coagulation factor
hsa:51773,5.4769245e-08,6.78578450342489e-05,4.973922376133169e-06,1.746979144355617e-05,0.0,0.00014355266,False,RSF1; remodeling and spacing factor
hsa:2963,4.2307758e-08,5.241834694107074e-05,1.4449029772326738e-06,3.0913521278957393e-06,0.0,2.5522431e-05,False,GTF2F2; general transcription factor IIF subunit
hsa:54714,0.0,0.0,3.9177524898138596e-08,2.9980398699528603e-07,0.0,3.875948e-06,False,CNGB3; cyclic nucleotide gated channel subunit beta
hsa:25888,2.5682425e-08,3.181993864903049e-05,6.017641236633661e-08,8.120691160232927e-08,0.0,4.370753e-07,False,ZNF473; zinc finger protein
hsa:51503,6.9762043e-08,8.643357970639559e-05,2.0655970975792081e-07,2.863664574836522e-07,0.0,1.7106114e-06,False,CWC15; CWC15 spliceosome associated protein
hsa:81328,0.0,0.0,0.0,0.0,0.0,0.0,False,OR4A15; olfactory receptor family 4 subfamily A member
hsa:9641,0.0,0.0,2.7452223311831674e-05,9.219339728081732e-05,0.0,0.0006735568,False,IKBKE; inhibitor of nuclear factor kappa B kinase subunit
hsa:50616,0.0,0.0,2.8443284591485154e-06,1.6156279825055826e-05,0.0,0.0001889674,False,IL22; interleukin
hsa:192134,0.0,0.0,4.439019305542079e-06,1.7565900520117885e-05,0.0,0.00014419752,False,B3GNT6; UDP-GlcNAc:betaGal beta-1
hsa:3082,0.0,0.0,3.432170636915842e-05,8.692968893750635e-05,0.0,0.000733799,False,HGF; hepatocyte growth
hsa:84265,4.63697235e-07,0.0005745102952476283,0.0001419725510458911,0.0004199445009646228,0.0,0.0024408342,False,POLR3GL; RNA polymerase III subunit
hsa:27074,0.0,0.0,1.9024935175451495e-07,5.040035875214053e-07,0.0,3.680226e-06,False,LAMP3; lysosomal associated membrane protein
hsa:9969,1.497579e-07,0.0001855466214817192,9.495492084362871e-06,2.5815570608073716e-05,0.0,0.0002084927,False,MED13; mediator complex subunit
hsa:2044,0.0,0.0,3.745972973477229e-07,2.8144327148538486e-06,0.0,3.0871113e-05,False,EPHA5; EPH receptor
hsa:2135,1.4000468749999999e-05,0.01734626137067152,0.00011275841042935644,0.00026163502374141657,0.0,0.0024126114,False,EXTL2; exostosin like glycosyltransferase
hsa:5788,1.6599668999999998e-05,0.020566611181545867,0.00015279342941158422,0.0003467742941186257,0.0,0.0029430722,False,PTPRC; protein tyrosine phosphatase receptor type
hsa:8527,0.0,0.0,5.4235670244207924e-05,0.0001011300469815233,0.0,0.0005348315,False,DGKD; diacylglycerol kinase
hsa:122618,1.6954943000000002e-06,0.002100678756222627,1.6949046922009897e-05,3.41293451982302e-05,0.0,0.0001758539,False,PLD4; phospholipase D family member
hsa:9021,0.0,0.0,0.00025171872733811883,0.0009217496626351852,0.0,0.0073312647,False,SOCS3; suppressor of cytokine signaling
hsa:23450,0.0,0.0,5.851382952673267e-07,1.5832160538143636e-06,0.0,1.010009e-05,False,SF3B3; splicing factor 3b subunit
hsa:51264,0.0,0.0,2.3060923010183166e-07,6.490651321347279e-07,0.0,3.9490446e-06,False,MRPL27; mitochondrial ribosomal protein
hsa:9337,0.0,0.0,2.0017590433019798e-06,1.2563613581021478e-05,0.0,0.00013721065,False,CNOT8; CCR4-NOT transcription complex subunit
hsa:2877,8.663588e-06,0.010733987878499664,2.95274820668812e-05,7.742783701108628e-05,0.0,0.000937523,False,GPX2; glutathione peroxidase
hsa:27334,0.0,0.0,1.1349329766516831e-06,5.199867130140913e-06,0.0,5.0004448e-05,False,P2RY10; P2Y receptor family member
hsa:1832,7.5839e-08,9.396279078801254e-05,3.768321922504456e-06,1.1271456797869524e-05,0.0,0.000105259605,False,DSP;
hsa:6748,2.7969603e-08,3.465370001071702e-05,1.3697056489811891e-06,4.179593104128728e-06,0.0,3.6882924e-05,False,SSR4; signal sequence receptor subunit
hsa:70,0.0,0.0,2.0100056524653472e-05,6.11078252569636e-05,0.0,0.0006272204,False,ACTC1; actin alpha cardiac muscle
hsa:23166,0.0,0.0,8.423627905274007e-05,0.0002109979487849478,0.0,0.00110039,False,STAB1; stabilin
hsa:5564,6.4847645e-05,0.08034475270283505,0.0009797814410372277,0.0024743334316100663,0.0,0.014807677,False,PRKAB1; protein kinase AMP-activated non-catalytic subunit beta
hsa:7332,1.0114812000000001e-07,0.00012532021305872688,9.450104163381185e-07,1.9056012115134354e-06,0.0,1.0885015e-05,False,UBE2L3; ubiquitin conjugating enzyme E2
hsa:51735,0.0,0.0,2.9089845282679208e-05,0.00010587724268172482,0.0,0.0006670249,False,RAPGEF6; Rap guanine nucleotide exchange factor
hsa:6469,0.0,0.0,2.048815613207921e-05,9.346676449514867e-05,0.0,0.0008969101,False,SHH; sonic hedgehog signaling
hsa:5699,0.0,0.0,3.7624716890297043e-06,9.130380689653067e-06,0.0,7.076816e-05,False,PSMB10; proteasome 20S subunit beta
hsa:389015,0.0,0.0,6.400019728814357e-07,4.061363538175757e-06,0.0,4.5394452e-05,False,SLC9A4; solute carrier family 9 member
hsa:7067,2.32852125e-06,0.0028849847052201563,4.6121708298514825e-05,9.249083585235637e-05,0.0,0.000670907,False,THRA; thyroid hormone receptor
hsa:2012,0.0,0.0,5.773002726980198e-07,1.4302715470840872e-06,0.0,9.938814e-06,False,EMP1; epithelial membrane protein
hsa:3381,0.0,0.0,8.963674406954454e-06,3.8183235404090776e-05,0.0,0.0002895205,False,IBSP; integrin binding
hsa:100271849,1.26847075e-07,0.00015716063200063734,6.562804835679207e-06,2.620324592825169e-05,0.0,0.00024385583,False,MEF2B; myocyte enhancer factor
hsa:22827,0.0,0.0,1.5995007724311877e-07,3.987832268074756e-07,0.0,2.196143e-06,False,PUF60; poly(U) binding splicing factor
hsa:8908,1.81688775e-05,0.022510824712687776,0.00015866192440902466,0.00023663844045520782,0.0,0.0012250734,False,GYG2; glycogenin
hsa:27131,1.6190215e-08,2.005930701694303e-05,5.152792146384157e-07,1.1363545450068445e-06,0.0,9.970983e-06,False,SNX5; sorting nexin
hsa:5706,0.0,0.0,4.478741188861387e-06,1.158532464774781e-05,0.0,0.00011453633,False,PSMC6; proteasome 26S subunit
hsa:56649,0.0,0.0,9.956292423450743e-08,1.2471982425863703e-06,0.0,1.771441e-05,False,TMPRSS4; transmembrane serine protease
hsa:256076,0.0,0.0,3.3645638453836635e-06,1.1486249556769778e-05,0.0,0.0001320087,False,COL6A5; collagen type VI alpha 5
hsa:23118,0.0,0.0,3.2548559637623766e-05,8.175770156714692e-05,0.0,0.00073959096,False,TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein
hsa:10369,0.000135513995,0.16789874815111985,0.0002822714702202969,0.0005451547062006878,0.0,0.0039810166,False,CACNG2; calcium voltage-gated channel auxiliary subunit gamma
hsa:5792,1.3031063500000001e-05,0.016145190382201857,7.03720788430693e-05,0.00010549132618847477,0.0,0.0004449432,False,PTPRF; protein tyrosine phosphatase receptor type
hsa:84570,0.0,0.0,7.237092304193067e-06,2.1699227611848484e-05,0.0,0.00015098663,False,COL25A1; collagen type XXV alpha 1
hsa:231,5.5879485499999996e-05,0.06923340768441408,0.0007040249162252475,0.0015062367907146825,0.0,0.01131575,False,AKR1B1; aldo-keto reductase family 1 member
hsa:29074,2.1928896e-08,2.7169401852082504e-05,1.4063202427509898e-07,2.5119561869411085e-07,0.0,1.943731e-06,False,MRPL18; mitochondrial ribosomal protein
hsa:390264,0.0,0.0,1.9540821950495048e-07,2.102559154797409e-06,0.0,2.8701996e-05,False,OR10G4; olfactory receptor family 10 subfamily G member
hsa:91522,1.2323609e-07,0.00015268670396765099,1.137899049420792e-05,3.1118290322187375e-05,0.0,0.00022513627,False,COL23A1; collagen type XXIII alpha 1
hsa:51365,4.7891831e-08,5.933688599148003e-05,5.181354411734654e-06,2.2133263377822047e-05,0.0,0.00019690063,False,PLA1A; phospholipase A1 member
hsa:10350,0.0,0.0,0.00016633202508970296,0.0007438699333257273,0.0,0.006268,False,ABCA9; ATP binding cassette subfamily A member
hsa:5091,0.0,0.0,3.712274704760965e-05,0.00014244172067507475,0.0,0.0009412204,False,PC; pyruvate
hsa:5604,0.0,0.0,0.0002500376759158415,0.0005968358495818905,0.0,0.0058517815,False,MAP2K1; mitogen-activated protein kinase kinase
hsa:64772,0.0,0.0,4.443463330173268e-05,0.00010733201222249582,0.0,0.0005618748,False,ENGASE;
hsa:389541,0.0,0.0,1.720581336336634e-06,6.588374906405234e-06,0.0,7.658984e-05,False,LAMTOR4; late endosomal/lysosomal adaptor
hsa:1303,0.0,0.0,4.076374775990099e-05,0.00017819893592387236,0.0,0.0012878164,False,COL12A1; collagen type XII alpha 1
hsa:162239,9.715849499999999e-09,1.2037715870413853e-05,7.559245356198024e-08,1.2898854052372615e-07,0.0,8.199847e-07,False,ZFP1; ZFP1 zinc finger
hsa:9972,8.935495749999999e-07,0.0011070875377370815,2.016346734336634e-05,4.007365646207095e-05,0.0,0.00021973021,False,NUP153; nucleoporin
hsa:11325,0.0,0.0,1.342067150626237e-07,2.6362867761895244e-07,0.0,1.4350369e-06,False,DDX42; DEAD-box helicase
hsa:2353,0.0,0.0,0.00020003601759900985,0.0005977610626092769,0.0,0.0049749566,False,FOS; Fos proto-oncogene
hsa:55698,1.8946009499999998e-08,2.3473673530982713e-05,4.0774839185080664e-05,7.884384431932756e-05,0.0,0.00034814535,False,RADIL; Rap associating with DIL
hsa:55742,1.05239345e-08,1.3038914749538459e-05,6.03168654359901e-07,1.1952462136935769e-06,0.0,9.484417e-06,False,PARVA; parvin
hsa:4922,0.0,0.0,2.079824304936189e-05,4.983564028059229e-05,0.0,0.00032971616,False,NTS;
hsa:120793,0.0,0.0,5.081222481287129e-07,4.02382432826504e-06,0.0,4.690985e-05,False,OR56A4; olfactory receptor family 56 subfamily A member
hsa:124872,0.0,0.0,6.6042312280983155e-06,4.604695026754211e-05,0.0,0.0005056079,False,B4GALNT2; beta-1
hsa:7389,0.0,0.0,0.00012277693642970294,0.00032582627392533644,0.0,0.0020022914,False,UROD; uroporphyrinogen
hsa:55540,8.0895445e-06,0.01002276107838734,5.924203738599012e-05,0.0001327827612552464,0.0,0.0009520573,False,IL17RB; interleukin 17 receptor
hsa:57007,0.0,0.0,8.420888399702972e-05,0.00030954853967794197,0.0,0.0027222403,False,ACKR3; atypical chemokine receptor
hsa:5611,0.0,0.0,4.842804476910892e-06,1.7774432136836327e-05,0.0,0.00016464583,False,DNAJC3; DnaJ heat shock protein family (Hsp40) member
hsa:3732,0.0,0.0,4.514405589555446e-05,0.00024431596919788416,0.0,0.0024078141,False,CD82; CD82
hsa:5607,0.0,0.0,0.0002471259963285347,0.0008936025089797902,0.0,0.0069677564,False,MAP2K5; mitogen-activated protein kinase kinase
hsa:7408,0.0,0.0,6.563337945453962e-05,0.00014396036224831424,0.0,0.0007554132,False,VASP; vasodilator stimulated
hsa:220992,0.0,0.0,2.68156640239604e-08,6.45863997612658e-08,0.0,4.3863614e-07,False,ZNF485; zinc finger protein
hsa:9934,0.0,0.0,8.5340941090099e-07,5.281805010255043e-06,0.0,5.5870863e-05,False,P2RY14; purinergic receptor
hsa:7757,0.0,0.0,9.021577683577232e-08,2.9210466101515315e-07,0.0,2.4346268e-06,False,ZNF208; zinc finger protein
hsa:1281,0.0,0.0,0.0001018239517462871,0.00022278035801625098,0.0,0.0016136813,False,COL3A1; collagen type III alpha 1
hsa:168391,0.0,0.0,2.467586559220792e-05,0.00017391502108193022,-0.0,0.002333735,False,GALNTL5; polypeptide N-acetylgalactosaminyltransferase like
hsa:166824,6.826001e-07,0.0008457259508719318,2.372613622683169e-05,6.663545857975341e-05,0.0,0.0004694503,False,RASSF6; Ras association domain family member
hsa:406976,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR199A1; microRNA
hsa:9894,0.0,0.0,5.245103564873267e-05,0.00019787901580341447,0.0,0.0016553176,False,TELO2; telomere maintenance
hsa:19,0.0,0.0,0.00029908483060514843,0.0010655480889130383,0.0,0.008646533,False,ABCA1; ATP binding cassette subfamily A member
hsa:54518,1.6711802e-07,0.00020705541410312496,8.003298614455446e-07,1.4037787802773704e-06,0.0,1.2667272e-05,False,APBB1IP; amyloid beta precursor protein binding family B member 1 interacting
hsa:55422,2.03152725e-08,2.517015914923673e-05,1.483056971089109e-07,3.372386606831046e-07,0.0,3.037556e-06,False,ZNF331; zinc finger protein
hsa:10092,0.0,0.0,7.750508927361386e-05,0.00026051303129970114,0.0,0.0015381284,False,ARPC5; actin related protein 2/3 complex subunit
hsa:23457,0.0,0.0,0.00029401516036534655,0.0010024390717971981,0.0,0.0069378195,False,ABCB9; ATP binding cassette subfamily B member
hsa:7432,0.0,0.0,2.0732087161702973e-05,0.00014490748205392496,0.0,0.0017754337,False,VIP; vasoactive intestinal
hsa:51426,0.0,0.0,8.99129899381188e-05,0.00018465799158300317,0.0,0.0013597298,False,POLK; DNA polymerase
hsa:11157,4.3566842999999995e-08,5.3978324530956217e-05,4.658061884965345e-06,1.7081952279953864e-05,0.0,0.00014737119,False,LSM6; LSM6 homolog
hsa:219931,4.4606154e-06,0.005526600714882671,4.805176924990097e-05,9.114165773550636e-05,0.0,0.0005765198,False,TPCN2; two pore segment channel
hsa:494143,1.1299118250000001e-07,0.00013999349730531318,5.512630459903711e-05,0.00018786912810345597,0.0,0.0015325294,False,CHAC2; ChaC glutathione specific gamma-glutamylcyclotransferase
hsa:959,3.3776674999999996e-05,0.04184852973456524,0.00016379112771930694,0.0002753534841436654,0.0,0.0015408476,False,CD40LG; CD40
hsa:10242,0.0,0.0,2.174764473095693e-05,7.58279739753651e-05,0.0,0.0006049117,False,KCNMB2; potassium calcium-activated channel subfamily M regulatory beta subunit
hsa:7561,0.0,0.0,4.28844861169802e-08,8.723567190382782e-08,0.0,3.8788917e-07,False,ZNF14; zinc finger protein
hsa:3306,5.0378335e-07,0.0006241760771968789,3.373023255772278e-06,8.169259446797235e-06,0.0,7.469993e-05,False,HSPA2; heat shock protein family A (Hsp70) member
hsa:27316,0.0,0.0,9.469208387476729e-07,2.692631750689479e-06,0.0,1.7182743e-05,False,RBMX; RNA binding motif protein
hsa:112724,0.0,0.0,6.333026281828218e-05,0.00026546421237941064,0.0,0.0033345905,False,RDH13; retinol dehydrogenase
hsa:4899,9.459876e-10,1.1720570543764304e-06,2.6142899227534665e-06,4.7596710793936045e-06,0.0,3.8770027e-05,False,NRF1; nuclear respiratory factor
hsa:1437,0.0,0.0,7.116229395148513e-06,3.696905513663916e-05,0.0,0.0004908594,False,CSF2; colony stimulating factor
hsa:388753,3.2532928e-07,0.0004030755557675438,9.836800164374257e-07,2.276328191767888e-06,0.0,2.0379191e-05,False,COA6; cytochrome c oxidase assembly factor
hsa:117,7.104205e-05,0.08801947917696076,0.00034281458778910893,0.0006729329410909136,0.0,0.0034353076,False,ADCYAP1R1; ADCYAP receptor type
hsa:55102,3.8071137999999996e-06,0.004716927141649486,0.0004223800952659901,0.001304183350727878,0.0,0.007335441,False,ATG2B; autophagy related
hsa:138429,2.6473673e-07,0.0003280027686927909,1.4708538800487767e-05,5.460029834324722e-05,0.0,0.00040929334,False,PIP5KL1; phosphatidylinositol-4-phosphate 5-kinase like
hsa:6556,0.0,0.0,4.007109955288613e-07,1.5903406236038554e-06,0.0,1.4450179e-05,False,SLC11A1; solute carrier family 11 member
hsa:2687,0.0,0.0,0.00020226547226584153,0.0008241710967739712,0.0,0.005974463,False,GGT5; gamma-glutamyltransferase
hsa:3479,0.0,0.0,0.00019047011665346535,0.0006025689164653122,0.0,0.0038836808,False,IGF1; insulin like growth factor
hsa:5662,0.0,0.0,4.16465116829208e-07,1.0577890554609884e-06,0.0,6.0791244e-06,False,PSD; pleckstrin and Sec7 domain
hsa:124975,0.0,0.0,2.663129176089109e-06,9.539328675835705e-06,0.0,8.733321e-05,False,GGT6; gamma-glutamyltransferase
hsa:8463,0.0,0.0,0.00011680486732178217,0.00034696234612678574,0.0,0.0025069632,False,TEAD2; TEA domain transcription factor
hsa:81888,2.31547413e-07,0.0002868819621200772,1.480494253626733e-05,2.5081208974908026e-05,0.0,0.00012493235,False,HYI; hydroxypyruvate isomerase
hsa:93432,2.885657e-06,0.0035752631888205794,2.369354857470297e-05,5.740401991722278e-05,0.0,0.00048689562,False,MGAM2; maltase-glucoamylase 2
hsa:2821,9.6035825e-05,0.1189861961870434,0.0005022275318977228,0.0007996549811765694,0.0,0.0036576407,False,GPI; glucose-6-phosphate
hsa:27178,0.0,0.0,2.070712444280693e-05,7.621711086314724e-05,0.0,0.0006610477,False,IL37; interleukin
hsa:6352,9.4913955e-06,0.011759622485169683,9.405800301881187e-05,0.00017603504664782775,0.0,0.0011471926,False,CCL5; C-C motif chemokine ligand
hsa:1910,0.0,0.0,4.3998513290099004e-05,0.00025076749694376624,0.0,0.0028188971,False,EDNRB; endothelin receptor type
hsa:55454,1.2744597500000001e-06,0.001579026554371666,0.0004647453130887131,0.0011577601622898754,0.0,0.006118282,False,CSGALNACT2; chondroitin sulfate N-acetylgalactosaminyltransferase
hsa:2241,7.1240305e-08,8.826511259891618e-05,3.964948623742575e-06,1.1792129509265914e-05,0.0,7.829743e-05,False,FER; FER tyrosine
hsa:55746,0.0,0.0,1.8802299834930703e-07,4.260411055591352e-07,0.0,2.2153702e-06,False,NUP133; nucleoporin
hsa:4698,1.3840702499999999e-06,0.0017148314631873075,5.180826109950494e-06,6.911216345688532e-06,0.0,4.134626e-05,False,NDUFA5; NADH:ubiquinone oxidoreductase subunit
hsa:219438,0.0,0.0,6.318017326732673e-08,7.367949229444862e-07,-0.0,1.0155001e-05,False,OR5D18; olfactory receptor family 5 subfamily D member
hsa:148327,0.0010044290999999999,1.2444647395758346,0.001461765710475248,0.0013851265281721093,0.0,0.0071232594,True,CREB3L4; cAMP responsive element binding protein 3 like
hsa:23480,6.02984185e-06,0.007470836485665061,0.00015136087373336643,0.00039058830396286945,0.0,0.0028226967,False,SEC61G; SEC61 translocon subunit
hsa:493,0.0,0.0,0.00022913475410148517,0.00043257732550756856,0.0,0.002765591,False,ATP2B4; ATPase plasma membrane Ca2+ transporting
hsa:9071,1.8025475e-06,0.00223331522868122,1.5833810596148515e-05,3.953543666354532e-05,0.0,0.00034013015,False,CLDN10; claudin
hsa:1183,0.0,0.0,3.2591408847277228e-06,1.6262935201342824e-05,0.0,0.00018612768,False,CLCN4; chloride voltage-gated channel
hsa:7056,0.0,0.0,2.7161063462871283e-05,0.00016408072710356455,0.0,0.0020729806,False,THBD;
hsa:81578,0.0,0.0,7.409777776148516e-06,2.9957627901252637e-05,0.0,0.00022764801,False,COL21A1; collagen type XXI alpha 1
hsa:554235,0.0,0.0,7.703083676582674e-05,0.00019634290570835192,0.0,0.001309196,False,ASPDH; aspartate dehydrogenase domain
hsa:54480,4.4374863e-06,0.0054979442876563756,0.0008769168842523767,0.0018748074805729595,0.0,0.009014397,False,CHPF2; chondroitin polymerizing factor
hsa:115019,0.0,0.0,1.555938926153317e-06,4.844040569005136e-06,0.0,3.851254e-05,False,SLC26A9; solute carrier family 26 member
hsa:406957,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR181C; microRNA
hsa:64841,4.994495700000001e-07,0.0006188066226489382,1.7289522346287135e-05,4.764814346929439e-05,0.0,0.00028187523,False,GNPNAT1; glucosamine-phosphate N-acetyltransferase
hsa:29949,0.0,0.0,2.1569720973465353e-06,1.106337156767175e-05,0.0,0.00011510662,False,IL19; interleukin
hsa:10368,0.0,0.0,9.836393799087127e-05,0.0002421182002228628,0.0,0.0013925638,False,CACNG3; calcium voltage-gated channel auxiliary subunit gamma
hsa:84892,7.138014e-07,0.0008843836497368168,5.8176316895049494e-05,0.00011480359182959274,0.0,0.00063026085,False,POMGNT2; protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta
hsa:7508,0.0,0.0,1.441108656377029e-06,3.4284237631542968e-06,0.0,1.9151299e-05,False,XPC; XPC complex subunit
hsa:64132,0.0,0.0,0.00019594212107574264,0.0006253786906261242,0.0,0.0060839127,False,XYLT2; xylosyltransferase
hsa:94274,4.8759935e-07,0.0006041244704231451,3.347724266621782e-05,0.00011273631549883062,0.0,0.00077335484,False,PPP1R14A; protein phosphatase 1 regulatory inhibitor subunit
hsa:1948,0.0,0.0,2.3790167942579204e-06,2.1545046816216398e-05,0.0,0.000299876,False,EFNB2; ephrin
hsa:10950,1.229323325e-07,0.00015231035535515888,2.422950999262377e-06,5.688235976334633e-06,0.0,3.7401198e-05,False,BTG3; BTG anti-proliferation factor
hsa:4294,6.566815699999999e-08,8.136134835144663e-05,2.3193942716336651e-07,7.328991917298627e-07,0.0,9.373434e-06,False,MAP3K10; mitogen-activated protein kinase kinase kinase
hsa:10248,1.17333337e-07,0.00014537332766769565,3.643790461539602e-07,7.36212964480683e-07,0.0,6.5078107e-06,False,POP7; POP7 homolog
hsa:1387,9.811935e-05,0.12156763612792597,0.00034327821321287116,0.0005525173970288711,0.0,0.002996986,False,CREBBP; CREB binding
hsa:220988,0.0,0.0,1.6790686145049497e-07,3.073549330226306e-07,0.0,1.9857878e-06,False,HNRNPA3; heterogeneous nuclear ribonucleoprotein
hsa:258010,1.5379e-08,1.905423013922711e-05,9.369753161790096e-07,2.3993145469639664e-06,0.0,2.3260021e-05,False,SVIP; small VCP interacting
hsa:10291,0.0,0.0,3.928684273970296e-07,9.901747571173305e-07,0.0,5.0460085e-06,False,SF3A1; splicing factor 3a subunit
hsa:167227,2.1537062499999998e-08,2.6683929084980688e-05,1.8813709290347519e-06,7.356487115105622e-06,0.0,7.6094904e-05,False,DCP2; decapping mRNA
hsa:259295,0.000135892135,0.16836725498412897,0.0004699245937029699,0.0007242990640635739,0.0,0.0043316092,False,TAS2R20; taste 2 receptor member
hsa:137075,0.0,0.0,3.6632568130767332e-06,1.3416193482989645e-05,0.0,0.00011195996,False,CLDN23; claudin
hsa:5704,0.0,0.0,6.567368639435643e-06,1.6042017034068675e-05,0.0,8.990983e-05,False,PSMC4; proteasome 26S subunit
hsa:9127,0.0,0.0,9.594286944801982e-06,2.5096473021792435e-05,0.0,0.00015466163,False,P2RX6; purinergic receptor P2X
hsa:65110,1.9243142999999998e-07,0.00023841815158596604,1.2294258420480202e-06,2.0648674207519187e-06,0.0,1.0289809e-05,False,UPF3A; UPF3A regulator of nonsense mediated mRNA
hsa:3572,0.0,0.0,0.00019135800552838117,0.0004861501332603487,0.0,0.0036398056,False,IL6ST; interleukin 6 cytokine family signal
hsa:4837,0.0,0.0,8.50541994890099e-05,0.0004482238838592402,0.0,0.005822614,False,NNMT; nicotinamide
hsa:51434,0.0,0.0,1.8160207926356433e-05,5.191001509627744e-05,0.0,0.0004186989,False,ANAPC7; anaphase promoting complex subunit
hsa:5576,1.1647248999999999e-07,0.00014430675787429796,1.0760627609497522e-06,2.546695511964203e-06,0.0,1.5457323e-05,False,PRKAR2A; protein kinase cAMP-dependent type II regulatory subunit
hsa:406890,0.0,0.0,0.0,0.0,0.0,0.0,False,MIRLET7G; microRNA
hsa:657,2.27496115e-06,0.0028186249632551385,5.345579653980197e-05,0.00013620413671855253,0.0,0.0010503434,False,BMPR1A; bone morphogenetic protein receptor type
hsa:5287,3.1657950000000003e-07,0.0003922347779674523,1.0157669186727722e-05,2.087573769540338e-05,0.0,0.00013178978,False,PIK3C2B; phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2
hsa:3822,0.0,0.0,3.0482806460188115e-07,1.336403262857616e-06,0.0,1.2045609e-05,False,KLRC2; killer cell lectin like receptor
hsa:27250,2.0797372e-10,2.576746943098498e-07,1.1546656223893073e-06,3.458255745193306e-06,0.0,3.27646e-05,False,PDCD4; programmed cell death
hsa:92960,0.0,0.0,1.406648219837822e-05,5.603375443585884e-05,0.0,0.00037741096,False,PEX11G; peroxisomal biogenesis factor 11
hsa:783,5.25576905e-05,0.06511777946376685,0.00015876109353712872,0.00031981958433104817,0.0,0.0021473174,False,CACNB2; calcium voltage-gated channel auxiliary subunit beta
hsa:64109,0.0,0.0,1.214009665497822e-06,7.4076303818273725e-06,0.0,8.353955e-05,False,CRLF2; cytokine receptor like factor
hsa:3292,0.0,0.0,9.875207483212871e-05,0.0002162506188517361,0.0,0.0013819677,False,HSD17B1; hydroxysteroid 17-beta dehydrogenase
hsa:376497,0.0,0.0,7.848741387574255e-05,0.00030674890531731214,0.0,0.0026634533,False,SLC27A1; solute carrier family 27 member
hsa:4638,0.0,0.0,4.0331005627435635e-05,0.00020762503655585523,0.0,0.0026395102,False,MYLK; myosin light chain
hsa:29926,0.0,0.0,0.0001141804689700495,0.0003069754189791597,0.0,0.002206051,False,GMPPA; GDP-mannose pyrophosphorylase
hsa:5878,2.33901075e-06,0.0028979809564097935,0.00016329958311188131,0.0005253160752957316,0.0,0.005237029,False,RAB5C; RAB5C
hsa:5982,8.649358e-06,0.010716357233146833,0.00023936404599806923,0.000487739343808548,0.0,0.002615678,False,RFC2; replication factor C subunit
hsa:10298,1.1482914999999999e-05,0.014227069710591267,4.61026159912871e-05,7.445798674226566e-05,0.0,0.00049495755,False,PAK4; p21 (RAC1) activated kinase
hsa:23461,0.0,0.0,0.00016867159349678217,0.00046358892672833705,0.0,0.004384401,False,ABCA5; ATP binding cassette subfamily A member
hsa:9801,3.56855245e-09,4.421355071604315e-06,1.7891760531999993e-07,4.261720694059511e-07,0.0,2.6772475e-06,False,MRPL19; mitochondrial ribosomal protein
hsa:406913,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR126; microRNA
hsa:2862,0.0,0.0,9.590866800371287e-08,4.92150925111679e-07,0.0,5.40203e-06,False,MLNR; motilin
hsa:57498,1.1369891500000001e-06,0.0014087036172640754,5.947942964861387e-06,1.3387159678182966e-05,0.0,8.3195875e-05,False,KIDINS220; kinase D interacting substrate
hsa:22929,0.0,0.0,0.00021460178120000006,0.0004549418399605757,0.0,0.00205465,False,SEPHS1; selenophosphate synthetase
hsa:364,0.0,0.0,1.4532035783841587e-05,8.571793921920757e-05,0.0,0.00084432634,False,AQP7; aquaporin
hsa:6647,4.5087249e-06,0.00558620728779919,0.0001330979142768317,0.0003053015113704408,0.0,0.0032220942,False,SOD1; superoxide dismutase
hsa:8625,0.0,0.0,0.0003484405130155942,0.0009291387887508344,0.0,0.004888604,False,RFXANK; regulatory factor X associated ankyrin containing
hsa:23705,8.229211000000001e-08,0.0001019580468549706,8.596387255851486e-06,2.256259280876855e-05,0.0,0.0001618799,False,CADM1; cell adhesion molecule
hsa:284532,0.0,0.0,6.126434965346535e-08,6.321106790748667e-07,0.0,8.658702e-06,False,OR14A16; olfactory receptor family 14 subfamily A member
hsa:11227,0.0,0.0,1.2625275173633662e-05,6.082141598556673e-05,0.0,0.0007216279,False,GALNT5; polypeptide N-acetylgalactosaminyltransferase
hsa:6198,0.000169548545,0.21006677912745325,0.00025943594115742573,0.00032489520143924225,0.0,0.0017281747,False,RPS6KB1; ribosomal protein S6 kinase
hsa:64601,2.33689445e-07,0.0002895358908991648,0.00018860188021699992,0.0004316731982091105,0.0,0.0022036445,False,VPS16; VPS16 core subunit of CORVET and HOPS
hsa:1869,0.0001929961,0.23911776483342803,0.00047435419073267327,0.0007303040005024876,0.0,0.00459319,False,E2F1; E2F transcription factor
hsa:1392,0.0,0.0,2.499563756678217e-05,9.718273147423347e-05,0.0,0.00072235096,False,CRH; corticotropin releasing
hsa:715,0.0,0.0,6.531569675668317e-05,0.00014520148241260744,0.0,0.0008642591,False,C1R; complement
hsa:548644,4.8835185e-07,0.0006050568007554013,7.010315198772278e-05,0.00019819176588304943,0.0,0.0012551111,False,POLR2J3; RNA polymerase II subunit
hsa:8312,0.0,0.0,4.295719986307923e-05,9.700422444363201e-05,0.0,0.0007096995,False,AXIN1; axin
hsa:84733,8.8080895e-08,0.00010913021940302351,0.00011198846907385446,0.00041306404037896177,0.0,0.0025542085,False,CBX2; chromobox
hsa:793,5.346397249999999e-07,0.0006624064218559785,6.927238618589457e-05,0.0002525974555471364,0.0,0.002221966,False,CALB1; calbindin
hsa:2253,1.67827815e-06,0.002079348339146649,1.0824901479504951e-05,4.2166037252460844e-05,0.0,0.00053218834,False,FGF8; fibroblast growth factor
hsa:286,5.0500395e-09,6.2568837274977175e-06,4.4722181196316837e-07,8.165032198348258e-07,0.0,4.602023e-06,False,ANK1; ankyrin
hsa:407017,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR26B; microRNA
hsa:81458,0.0,0.0,7.104906980198019e-08,6.770193716098717e-07,-0.0,8.323523e-06,False,OR2T7; olfactory receptor family 2 subfamily T member
hsa:8549,1.4161461e-09,1.7545727095499663e-06,1.549647471975247e-07,4.7681474116204856e-07,0.0,3.552195e-06,False,LGR5; leucine rich repeat containing G protein-coupled receptor
hsa:6712,3.4910843e-08,4.325373801134182e-05,1.8777217131603967e-07,2.7966617263793847e-07,0.0,1.2525562e-06,False,SPTBN2; spectrin beta
hsa:4897,7.05301535e-07,0.0008738525109200952,1.4663145255544558e-05,2.5840294703138012e-05,0.0,0.00013484759,False,NRCAM; neuronal cell adhesion
hsa:10381,0.0,0.0,0.0004323678899408912,0.0014447379482192615,0.0,0.010812598,False,TUBB3; tubulin beta 3 class
hsa:101954269,0.0,0.0,0.0,0.0,0.0,0.0,False,RNVU1-17; RNA
hsa:8559,1.199481445e-08,1.4861301450525187e-05,1.6968903003534656e-07,3.294211315822481e-07,0.0,1.400842e-06,False,PRPF18; pre-mRNA processing factor
hsa:8411,0.0,0.0,4.7593367295792087e-07,8.297478468153339e-07,0.0,4.828791e-06,False,EEA1; early endosome antigen
hsa:122748,-0.0,0.0,2.916095915940594e-06,1.630408884727803e-05,-0.0,0.00016563677,False,OR11H6; olfactory receptor family 11 subfamily H member
hsa:5172,0.0,0.0,3.5538212467670302e-06,1.4530868917371758e-05,0.0,0.00011850868,False,SLC26A4; solute carrier family 26 member
hsa:2071,2.7198080999999995e-07,0.0003369780185443398,3.8105367557970294e-06,8.201104600993249e-06,0.0,4.272652e-05,False,ERCC3; ERCC excision repair 3
hsa:4047,0.0,0.0,1.8310224566039605e-05,7.318721254978175e-05,0.0,0.00070073875,False,LSS; lanosterol
hsa:116443,1.03890875e-06,0.0012871842392975332,8.799459372272277e-05,0.00022961161378949122,0.0,0.002012957,False,GRIN3A; glutamate ionotropic receptor NMDA type subunit
hsa:11214,1.0237648000000001e-07,0.00012684212307458102,8.695238748668319e-06,4.614316403822375e-05,0.0,0.00056433346,False,AKAP13; A-kinase anchoring protein
hsa:23624,0.0,0.0,2.482927461782178e-09,2.7258001967751827e-08,0.0,3.8429397e-07,False,CBLC; Cbl proto-oncogene
hsa:23303,1.41401435e-08,1.7519315199343022e-05,1.5040994863960395e-07,7.973527378071511e-07,0.0,8.527278e-06,False,KIF13B; kinesin family member
hsa:900,2.9457036499999997e-07,0.0003649659618249646,0.00016328209490262376,0.0004932077823648715,0.0,0.0031338676,False,CCNG1; cyclin
hsa:5789,1.95152335e-08,2.4178929080548445e-05,4.325957387696187e-06,9.528512903714642e-06,0.0,7.9979414e-05,False,PTPRD; protein tyrosine phosphatase receptor type
hsa:10195,2.9217068e-07,0.00036199280685704396,7.785867873304455e-05,0.00019479540428993242,0.0,0.001647535,False,ALG3; ALG3 alpha-1
hsa:55176,1.66883075e-07,0.00020676432260822539,0.0001031359339439282,0.00021745468965899458,0.0,0.001092526,False,SEC61A2; SEC61 translocon subunit alpha
hsa:100132463,0.0,0.0,8.378244278643562e-07,3.525191938724416e-06,0.0,3.236209e-05,False,CLDN24; claudin
hsa:6567,0.0,0.0,1.9979208664539606e-06,6.537876682911438e-06,0.0,5.699593e-05,False,SLC16A2; solute carrier family 16 member
hsa:51024,0.0,0.0,1.2152109149183165e-06,5.367019619882603e-06,0.0,4.2854375e-05,False,FIS1; fission
hsa:406915,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR128-1; microRNA
hsa:7755,0.0,0.0,4.2698670195544555e-08,1.2977365901422548e-07,0.0,8.7127296e-07,False,ZNF205; zinc finger protein
hsa:4832,0.0,0.0,4.943964412155445e-05,0.0001545546521081284,0.0,0.0015068342,False,NME3; NME/NM23 nucleoside diphosphate kinase
hsa:9056,0.0,0.0,2.1250639036316825e-05,5.811903707374452e-05,0.0,0.0004178605,False,SLC7A7; solute carrier family 7 member
hsa:445329,1.4944527500000001e-05,0.01851592862390327,0.00010607311401831681,0.00021363683235299885,0.0,0.0012052176,False,SULT1A4; sulfotransferase family 1A member
hsa:10929,5.56578435e-09,6.895879830301618e-06,1.884676130252475e-07,4.914155925521741e-07,0.0,3.6716121e-06,False,SRSF8; serine and arginine rich splicing factor
hsa:27304,2.3440579e-06,0.0029042342601127125,7.201845664866336e-05,0.0001914998916120031,0.0,0.0012925413,False,MOCS3; molybdenum cofactor synthesis
hsa:4701,0.0,0.0,1.4243029537722773e-06,2.894212188936179e-06,0.0,1.7629702e-05,False,NDUFA7; NADH:ubiquinone oxidoreductase subunit
hsa:1380,1.52148275e-06,0.0018850824157204075,2.4924888202400982e-05,7.175516429333235e-05,0.0,0.000618859,False,CR2; complement C3d receptor
hsa:349075,0.0,0.0,4.9948032171386154e-08,1.0406834736923687e-07,0.0,5.8587216e-07,False,ZNF713; zinc finger protein
hsa:55283,5.94867e-09,7.370266415392167e-06,1.4623775373168312e-07,7.856566827553987e-07,0.0,7.983629e-06,False,MCOLN3; mucolipin TRP cation channel
hsa:3516,5.30451045e-07,0.0006572167428976863,7.717731414108909e-05,0.00015242719605307485,0.0,0.0007710837,False,RBPJ; recombination signal binding protein for immunoglobulin kappa J
hsa:23405,0.0,0.0,4.084600782920792e-07,1.0176586423834672e-06,0.0,8.092866e-06,False,DICER1; dicer 1
hsa:6779,0.0,0.0,1.6378079680267326e-05,0.00022255567037851175,0.0,0.0031628546,False,STATH;
hsa:146850,0.0,0.0,8.217970876504948e-06,3.324361689224894e-05,0.0,0.00036819195,False,PIK3R6; phosphoinositide-3-kinase regulatory subunit
hsa:23207,1.041673125e-08,1.290609236855315e-05,2.727477331651981e-07,6.153920000534451e-07,0.0,4.801829e-06,False,PLEKHM2; pleckstrin homology and RUN domain containing
hsa:4351,0.0,0.0,2.8521205104623762e-05,7.750572286011612e-05,0.0,0.0005550651,False,MPI; mannose phosphate
hsa:30000,0.0,0.0,3.540339879027722e-07,7.834419858566697e-07,0.0,4.3021996e-06,False,TNPO2; transportin
hsa:2006,3.8316272e-06,0.004747298684993978,3.6250111607574264e-05,7.371565672690137e-05,0.0,0.0004054212,False,ELN;
hsa:90,0.0,0.0,6.964822709921782e-05,0.000348243519715518,0.0,0.003708594,False,ACVR1; activin A receptor type
hsa:79818,0.0,0.0,2.787737606173267e-08,7.163725931761768e-08,0.0,6.101415e-07,False,ZNF552; zinc finger protein
hsa:169044,2.82736675e-05,0.03503042898920515,0.00013617669743262376,0.0003060630914522336,0.0,0.0021628318,False,COL22A1; collagen type XXII alpha 1
hsa:2591,1.0620979e-07,0.00013159150671038312,8.492585716797026e-05,0.00021437067573072506,0.0,0.0020810536,False,GALNT3; polypeptide N-acetylgalactosaminyltransferase
hsa:3105,1.9907877e-05,0.024665405419170703,0.0002229868963485149,0.00042832094873440754,0.0,0.0027788118,False,HLA-A; major histocompatibility complex
hsa:147660,0.0,0.0,2.1380717146529696e-08,4.777616201044366e-08,0.0,2.7403152e-07,False,ZNF578; zinc finger protein
hsa:91664,0.0,0.0,2.2137267847673265e-08,4.259440947197767e-08,0.0,2.4951112e-07,False,ZNF845; zinc finger protein
hsa:10403,8.072112499999999e-09,1.0001163228085822e-05,1.9846496354906987e-06,5.808035900078415e-06,0.0,3.303095e-05,False,NDC80; NDC80 kinetochore complex
hsa:54822,1.0887174749999999e-05,0.013488961132224616,8.602827092727725e-05,0.00017143048051900138,0.0,0.0009067856,False,TRPM7; transient receptor potential cation channel subfamily M member
hsa:53842,0.0,0.0,2.8054693128653455e-06,1.2899745048204053e-05,0.0,0.00013064666,False,CLDN22; claudin
hsa:5164,0.0,0.0,8.298786118237623e-07,1.4483809016551296e-06,0.0,9.764352e-06,False,PDK2; pyruvate dehydrogenase kinase
hsa:5192,0.0,0.0,2.1615341282871286e-06,1.3413932446907197e-05,0.0,0.00013550297,False,PEX10; peroxisomal biogenesis factor
hsa:32,0.0,0.0,0.00012984373886831683,0.000450285209166573,0.0,0.003735842,False,ACACB; acetyl-CoA carboxylase
hsa:374291,0.0,0.0,4.475822954173267e-06,1.0616509819044294e-05,0.0,6.983676e-05,False,NDUFS7; NADH:ubiquinone oxidoreductase core subunit
hsa:160428,4.3169795e-08,5.3486391117319456e-05,5.9476900949455426e-06,1.693070918490573e-05,0.0,0.00017557101,False,ALDH1L2; aldehyde dehydrogenase 1 family member
hsa:4534,0.0,0.0,2.6027015936391103e-06,1.5204734836502244e-05,0.0,0.00017473903,False,MTM1; myotubularin
hsa:4719,1.902889e-07,0.0002357636057962399,2.8038175549207927e-06,5.852193388349706e-06,0.0,4.8228285e-05,False,NDUFS1; NADH:ubiquinone oxidoreductase core subunit
hsa:4641,0.0,0.0,1.238890625e-06,3.3041262977522426e-06,0.0,1.8314824e-05,False,MYO1C; myosin
hsa:10540,1.58154705e-06,0.0019595007130968024,0.00015436991429079201,0.00053681098867922,0.0,0.0041241474,False,DCTN2; dynactin subunit
hsa:2874,1.7547182e-10,2.1740558171721403e-07,3.339515393076238e-07,9.665966743168854e-07,0.0,8.314178e-06,False,GPS2; G protein pathway suppressor
hsa:1557,0.0,0.0,1.2492106547821779e-05,4.554128649567391e-05,0.0,0.0005630005,False,CYP2C19; cytochrome P450 family 2 subfamily C member
hsa:4919,0.0,0.0,2.1335737007376243e-06,1.9917846712686346e-05,0.0,0.00026983526,False,ROR1; receptor tyrosine kinase like orphan receptor
hsa:51241,2.19924265e-08,2.7248114692180053e-05,9.162055022574256e-07,2.772637519900342e-06,0.0,2.5886713e-05,False,COX16; cytochrome c oxidase assembly factor
hsa:5684,2.6697860500000002e-08,3.307804006710326e-05,8.793769163386137e-06,2.8959664852428406e-05,0.0,0.00022626785,False,PSMA3; proteasome 20S subunit alpha
hsa:10991,0.0,0.0,7.890181840742571e-05,0.00017827337655729116,0.0,0.0012857732,False,SLC38A3; solute carrier family 38 member
hsa:147687,1.3107200499999999e-08,1.623952238819121e-05,4.76544359519802e-08,7.867141927836862e-08,0.0,3.9609282e-07,False,ZNF417; zinc finger protein
hsa:4666,4.82372465e-07,0.0005976484791557497,6.668448046963366e-06,1.5637020049490886e-05,0.0,0.00012523966,False,NACA; nascent polypeptide associated complex subunit
hsa:6376,0.0,0.0,4.19442615278218e-05,0.00010705688338008193,0.0,0.0006540865,False,CX3CL1; C-X3-C motif chemokine ligand
hsa:84924,0.0,0.0,4.027828155678219e-08,8.641424924532487e-08,0.0,5.043511e-07,False,ZNF566; zinc finger protein
hsa:57530,4.19041635e-08,5.191830256328764e-05,1.6564102428903168e-05,6.566228307013397e-05,0.0,0.0004869266,False,CGN;
hsa:538,1.1850149999999999e-06,0.0014682065497390086,6.218281873594058e-05,0.00010553190665552845,0.0,0.0007312031,False,ATP7A; ATPase copper transporting
hsa:3459,1.98837705e-05,0.024635538015643076,0.00012846010546782187,0.00023786670704457782,0.0,0.0016916572,False,IFNGR1; interferon gamma receptor
hsa:9414,0.0,0.0,3.821388269858911e-05,0.00014777891023894378,0.0,0.0013366032,False,TJP2; tight junction protein
hsa:1958,0.0,0.0,5.255815611801979e-05,0.00018796073433353477,0.0,0.001429404,False,EGR1; early growth response
hsa:27330,2.5410991e-05,0.03148363811560107,0.000254304793383218,0.0005151447651151166,0.0,0.0028709648,False,RPS6KA6; ribosomal protein S6 kinase
hsa:10477,9.640478699999999e-08,0.00011944333168744196,4.461768168595051e-07,7.538732429381296e-07,0.0,4.9388395e-06,False,UBE2E3; ubiquitin conjugating enzyme E2
hsa:207,0.000130110525,0.16120397209738363,0.0005971274370306931,0.0008665758129346425,0.0,0.00378162,False,AKT1; AKT serine/threonine kinase
hsa:8789,0.0,0.0,2.1460878169306934e-05,6.345151782602682e-05,0.0,0.00042727002,False,FBP2; fructose-bisphosphatase
hsa:345462,0.0,0.0,9.420481149455444e-08,2.589462388096807e-07,0.0,1.9160025e-06,False,ZNF879; zinc finger protein
hsa:8318,5.30571865e-09,6.573664361212652e-06,8.799487276790299e-07,2.0341932647687693e-06,0.0,1.3942915e-05,False,CDC45; cell division cycle
hsa:390792,0.0,0.0,3.333960398613861e-07,2.160525367185898e-06,0.0,2.473552e-05,False,KRT39; keratin
hsa:9402,6.30116575e-09,7.807000607706327e-06,8.438382864237624e-08,1.970637574358501e-07,0.0,1.6290792e-06,False,GRAP2; GRB2 related adaptor protein
hsa:441925,0.0,0.0,2.3920369167649014e-05,0.00010787353676247605,0.0,0.0012586879,False,BECN2; beclin
hsa:7078,8.012997550000001e-08,9.927921153700697e-05,1.0310645796113864e-06,2.307563838234097e-06,0.0,1.1468631e-05,False,TIMP3; TIMP metallopeptidase inhibitor
hsa:8761,0.0,0.0,1.5020572982277221e-06,9.151566143499009e-06,0.0,9.651327e-05,False,PABPC4; poly(A) binding protein cytoplasmic
hsa:117247,2.47248165e-07,0.00030633483564676496,2.4189432750371285e-05,5.799613174379114e-05,0.0,0.00044584743,False,SLC16A10; solute carrier family 16 member
hsa:10135,0.0,0.0,3.770197394074259e-05,0.00010709806518928825,0.0,0.0008951662,False,NAMPT; nicotinamide
hsa:80319,0.0,0.0,1.2375368285869306e-05,4.343239333337049e-05,0.0,0.00030560282,False,CXXC4; CXXC finger protein
hsa:162417,0.0,0.0,1.723916450065099e-05,4.455796709541397e-05,0.0,0.000410448,False,NAGS; N-acetylglutamate
hsa:219957,0.0,0.0,2.3482682871287127e-07,3.2424968221043185e-06,0.0,4.6071138e-05,False,OR9Q2; olfactory receptor family 9 subfamily Q member
hsa:9839,1.4308962000000001e-09,1.7728477469370924e-06,2.4399032033168317e-07,5.9547849832163e-07,0.0,4.573433e-06,False,ZEB2; zinc finger E-box binding homeobox
hsa:1103,0.0,0.0,3.813838333495049e-06,1.1356025084198622e-05,0.0,6.251947e-05,False,CHAT; choline
hsa:119765,0.0,0.0,9.333077722772277e-08,8.494871629102046e-07,-0.0,9.747e-06,False,OR4B1; olfactory receptor family 4 subfamily B member
hsa:4077,0.0,0.0,2.5939854858727724e-06,6.118985063897118e-06,0.0,2.9530516e-05,False,NBR1; NBR1 autophagy cargo
hsa:7357,9.2660518e-07,0.0011480426781923377,8.23557484940594e-06,1.7496072525713486e-05,0.0,0.00011219544,False,UGCG; UDP-glucose ceramide
hsa:147948,1.9827326500000003e-09,2.4565605187372156e-06,1.0097421854554459e-07,2.1990777970374245e-07,0.0,1.1464078e-06,False,ZNF582; zinc finger protein
hsa:3767,1.8126937e-05,0.022458861390029977,0.00010187218047272277,0.00030445905249759154,0.0,0.0029199827,False,KCNJ11; potassium inwardly rectifying channel subfamily J member
hsa:246721,7.6236027e-08,9.44546981831284e-05,6.158704562519802e-06,2.838331008271808e-05,0.0,0.00028641577,False,POLR2J2; RNA polymerase II subunit
hsa:3679,1.5169254999999999e-05,0.018794360869407733,0.00014548052138415842,0.0003148026308678602,0.0,0.0022323418,False,ITGA7; integrin subunit alpha
hsa:26211,0.0,0.0,1.6005162415841583e-07,1.6954856870508817e-06,0.0,2.3751632e-05,False,OR2F1; olfactory receptor family 2 subfamily F member
hsa:54331,0.0,0.0,0.0001377844051229208,0.000281928292252046,0.0,0.0017962795,False,GNG2; G protein subunit gamma
hsa:6945,4.2700557999999996e-07,0.0005290501717962256,1.959579050030692e-05,5.4257551481399e-05,0.0,0.00046151693,False,MLX; MAX dimerization protein
hsa:4292,0.0,0.0,0.0001019489587787624,0.0002181863749626354,0.0,0.0015097237,False,MLH1; mutL homolog
hsa:22875,3.3404306e-09,4.138717303889493e-06,2.876061392724258e-07,9.398919626388823e-07,0.0,6.641659e-06,False,ENPP4; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:51129,0.0,0.0,0.00011029675454613863,0.0005102305594861114,0.0,0.0039738365,False,ANGPTL4; angiopoietin like
hsa:5464,2.78363005e-07,0.0003448854125441724,1.7430378682475253e-06,3.0367534761346644e-06,0.0,1.6725173e-05,False,PPA1; inorganic pyrophosphatase
hsa:9045,2.63059105e-07,0.00032592422959159303,1.1642799119405935e-06,1.799579335498395e-06,0.0,8.284241e-06,False,RPL14; ribosomal protein
hsa:2475,0.00019129744000000003,0.23701316384712856,0.0005816027598608912,0.00112786277383499,0.0,0.005938857,False,MTOR; mechanistic target of rapamycin
hsa:1937,0.0,0.0,8.912685326183165e-05,0.00024526544647779684,0.0,0.002185341,False,EEF1G; eukaryotic translation elongation factor 1
hsa:8976,3.7160531e-07,0.0004604105011833561,2.4435000158398525e-05,3.576802108392552e-05,0.0,0.00019594871,False,WASL; WASP like actin nucleation promoting
hsa:406935,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR143; microRNA
hsa:54472,0.0,0.0,5.3848469119470295e-06,1.6486243092204292e-05,0.0,0.00013342685,False,TOLLIP; toll interacting
hsa:8655,0.0,0.0,0.00017819324002648504,0.000628987699722192,0.0,0.005482402,False,DYNLL1; dynein light chain LC8-type
hsa:283375,0.0,0.0,4.558032861049504e-09,2.1365184622621026e-08,0.0,2.421699e-07,False,SLC39A5; solute carrier family 39 member
hsa:341418,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR6C4; olfactory receptor family 6 subfamily C member
hsa:397,0.0,0.0,8.540311309158415e-05,0.00023739580943403914,0.0,0.0017619216,False,ARHGDIB; Rho GDP dissociation inhibitor
hsa:79175,0.0,0.0,5.352110825049506e-08,1.1400681165375856e-07,0.0,5.9828085e-07,False,ZNF343; zinc finger protein
hsa:5364,1.0509105e-07,0.00013020541337362788,2.8645365438673274e-06,2.379638738538331e-05,0.0,0.0003319922,False,PLXNB1; plexin
hsa:57026,0.0,0.0,0.0002188189763826237,0.000638185778110486,0.0,0.003995004,False,PDXP; pyridoxal
hsa:89846,0.0,0.0,1.164264104226552e-05,4.2578742407020156e-05,0.0,0.00028848447,False,FGD3; FYVE
hsa:2525,0.0,0.0,1.1287567725544556e-05,4.3000502134457015e-05,0.0,0.0004012066,False,FUT3; fucosyltransferase 3 (Lewis blood
hsa:4248,6.8104763e-08,8.438024759604131e-05,0.00012347774574598264,0.0003391469970383168,0.0,0.0017729764,False,MGAT3; beta-1
hsa:10720,0.0,0.0,3.6345575475247523e-06,1.6715549955772527e-05,0.0,0.00013702783,False,UGT2B11; UDP glucuronosyltransferase family 2 member
hsa:2252,0.0,0.0,3.574185993297029e-05,0.00023838595018965523,0.0,0.0030095815,False,FGF7; fibroblast growth factor
hsa:1841,2.55346615e-08,3.163686304364797e-05,9.735974633849703e-05,0.0002749151155677508,0.0,0.0016730028,False,DTYMK; deoxythymidylate
hsa:3656,2.4435841499999997e-07,0.0003027545013243231,1.3695740593811881e-06,2.5697203018520508e-06,0.0,1.6661937e-05,False,IRAK2; interleukin 1 receptor associated kinase
hsa:91942,1.0950946500000001e-08,1.356797287556822e-05,6.654802250212873e-07,2.1139476356450498e-06,0.0,1.9228437e-05,False,NDUFAF2; NADH:ubiquinone oxidoreductase complex assembly factor
hsa:339327,1.2263044e-09,1.5193631743511814e-06,3.7627565504059395e-08,7.829632082430564e-08,0.0,3.8427908e-07,False,ZNF546; zinc finger protein
hsa:1385,0.00032718145999999996,0.4053703645313953,0.001331758945752475,0.003345177036102344,0.0,0.01812792,False,CREB1; cAMP responsive element binding protein
hsa:10563,0.0,0.0,1.7808884148316825e-05,6.566386220440096e-05,0.0,0.00067284796,False,CXCL13; C-X-C motif chemokine ligand
hsa:22900,0.0,0.0,2.5009293918316834e-07,8.399684069924868e-07,0.0,7.6037477e-06,False,CARD8; caspase recruitment domain family member
hsa:1452,9.660659e-06,0.011969336100045233,0.000202878801344406,0.0004547119694620454,0.0,0.0024735327,False,CSNK1A1; casein kinase 1 alpha
hsa:494551,0.0,0.0,5.18177113155e-08,1.7411218591104328e-07,0.0,1.2960207e-06,False,WEE2; WEE2 oocyte meiosis inhibiting
hsa:1337,0.0,0.0,0.00025413165093495047,0.0006219525468839705,0.0,0.0033904596,False,COX6A1; cytochrome c oxidase subunit
hsa:10488,0.0,0.0,0.00028230564588069295,0.0006074642511902906,0.0,0.0036217133,False,CREB3; cAMP responsive element binding protein
hsa:3115,0.0,0.0,0.0005936801283405942,0.0011920722797509964,0.0,0.006423019,False,HLA-DPB1; major histocompatibility complex
hsa:7046,7.387879e-05,0.09153413531878735,0.0002627820506237623,0.0003745447046397257,0.0,0.0019057051,False,TGFBR1; transforming growth factor beta receptor
hsa:5602,0.000767369845,0.9507537309664502,0.0011374013400693073,0.001498848167052627,0.0,0.008817523,True,MAPK10; mitogen-activated protein kinase
hsa:2967,0.0,0.0,5.200975023871286e-06,1.286820548771713e-05,0.0,0.00012972826,False,GTF2H3; general transcription factor IIH subunit
hsa:36,0.0,0.0,4.610407016628713e-06,2.0981361775246856e-05,0.0,0.00022513699,False,ACADSB; acyl-CoA dehydrogenase short/branched
hsa:5049,0.0,0.0,1.4196780436584152e-05,4.318056469286379e-05,0.0,0.0003419145,False,PAFAH1B2; platelet activating factor acetylhydrolase 1b catalytic subunit
hsa:4171,0.0,0.0,6.146329352688121e-06,3.0622903446754385e-05,0.0,0.00028621298,False,MCM2; minichromosome maintenance complex component
hsa:6123,2.0555876e-10,2.5468261396541724e-07,2.6867481348074266e-08,2.2756295212132497e-07,0.0,3.2064088e-06,False,RPL3L; ribosomal protein L3
hsa:65251,1.797259e-08,2.226762897834526e-05,7.89719527019802e-08,1.6056355108110853e-07,0.0,1.3128862e-06,False,ZNF649; zinc finger protein
hsa:390061,0.0,0.0,1.149764159009901e-07,1.071662926059877e-06,0.0,1.336822e-05,False,OR51Q1; olfactory receptor family 51 subfamily Q member
hsa:9700,0.0,0.0,1.2699617859923414e-05,4.956183684004862e-05,0.0,0.00052123057,False,ESPL1; extra spindle pole bodies like 1
hsa:7434,1.21314265e-08,1.5030560663769977e-05,1.592620590088415e-05,4.4395725510810796e-05,0.0,0.0002534955,False,VIPR2; vasoactive intestinal peptide receptor
hsa:6916,0.0,0.0,1.9899555604920792e-05,8.985768132347529e-05,0.0,0.0008639887,False,TBXAS1; thromboxane A synthase
hsa:2969,7.253950650000001e-07,0.0008987479361707271,9.958143178544549e-05,0.0002910957223062232,0.0,0.001873594,False,GTF2I; general transcription factor
hsa:5998,0.0,0.0,3.7990472565990127e-06,3.610621726386492e-05,0.0,0.0004922326,False,RGS3; regulator of G protein signaling
hsa:406904,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR1-1; microRNA
hsa:26084,0.0,0.0,2.973119172820842e-06,1.581094901725903e-05,0.0,0.0001594997,False,ARHGEF26; Rho guanine nucleotide exchange factor
hsa:51809,9.7935175e-06,0.012133944750474553,0.00016710753172975246,0.000374191063780834,0.0,0.0019782607,False,GALNT7; polypeptide N-acetylgalactosaminyltransferase
hsa:132864,0.0,0.0,7.178737685841587e-06,4.205660889835921e-05,0.0,0.00047043353,False,CPEB2; cytoplasmic polyadenylation element binding protein
hsa:3028,8.0395195e-07,0.000996078124467157,6.685464796811877e-06,1.1666511381202246e-05,0.0,6.905958e-05,False,HSD17B10; hydroxysteroid 17-beta dehydrogenase
hsa:7159,0.0,0.0,2.875244493953465e-06,5.48115099784382e-06,0.0,3.0930983e-05,False,TP53BP2; tumor protein p53 binding protein
hsa:9732,0.0,0.0,1.0162428012965346e-06,2.488418469040781e-06,0.0,1.5890986e-05,False,DOCK4; dedicator of cytokinesis
hsa:857,0.0,0.0,3.2428043141089105e-05,0.00010880213583328251,0.0,0.0008987214,False,CAV1; caveolin
hsa:5090,1.1389761e-08,1.4111654029832466e-05,9.190753391458687e-06,2.993246041782294e-05,0.0,0.00028962802,False,PBX3; PBX homeobox
hsa:1133,8.9656762e-08,0.00011108268266375654,4.620884050808416e-06,1.2317799167739657e-05,0.0,0.000109821885,False,CHRM5; cholinergic receptor muscarinic
hsa:27242,0.0,0.0,1.8996032794524745e-05,6.95416515499104e-05,0.0,0.00065322197,False,TNFRSF21; TNF receptor superfamily member
hsa:836,0.00026202275000000003,0.3246402093902836,0.001126348665732674,0.0017975308968828298,0.0,0.010434427,False,CASP3; caspase
hsa:51726,4.3705896e-08,5.41506080255625e-05,5.188027391099013e-07,1.0031854681080914e-06,0.0,5.5898754e-06,False,DNAJB11; DnaJ heat shock protein family (Hsp40) member
hsa:39,8.3550263e-05,0.10351686971811899,0.0003579474567345396,0.0005426605699297446,0.0,0.0030498237,False,ACAT2; acetyl-CoA acetyltransferase
hsa:9530,1.21641105e-06,0.001507105539410813,7.280473101534653e-06,2.015528298773153e-05,0.0,0.00014268838,False,BAG4; BAG cochaperone
hsa:401994,-0.0,0.0,2.2201358164207924e-05,0.00017275648239283833,-0.0,0.0023956522,False,OR14I1; olfactory receptor family 14 subfamily I member
hsa:3087,0.0,0.0,0.00020792273114247526,0.0009066353935801906,0.0,0.008307779,False,HHEX; hematopoietically expressed
hsa:8913,4.7597698e-05,0.05897246191491189,0.00021283805221547012,0.00037847434928189346,0.0,0.0030197953,False,CACNA1G; calcium voltage-gated channel subunit alpha1
hsa:8743,0.0,0.0,5.364024973841583e-05,0.00016113205817566657,0.0,0.0013685599,False,TNFSF10; TNF superfamily member
hsa:10557,1.4277026e-10,1.768890949396769e-07,1.364821647703148e-06,2.7383449236785794e-06,0.0,1.561544e-05,False,RPP38; ribonuclease P/MRP subunit
hsa:6929,2.60962585e-07,0.000323326689142182,1.5729512174009013e-05,4.811400740891492e-05,0.0,0.0004325888,False,TCF3; transcription factor
hsa:112936,0.0,0.0,2.687556873584158e-07,5.519213823306737e-07,0.0,3.4087823e-06,False,VPS26B; VPS26 retromer complex component
hsa:23759,0.0,0.0,2.865475966910149e-07,1.0652225309274335e-06,0.0,8.240954e-06,False,PPIL2; peptidylprolyl isomerase like
hsa:22926,2.8339793500000004e-07,0.00035112357594588246,1.1726763100643566e-06,2.5710009786862297e-06,0.0,1.9259754e-05,False,ATF6; activating transcription factor
hsa:3108,0.00012957867,0.16054501588627113,0.00029042758636089094,0.00038663751935199186,0.0,0.0015355337,False,HLA-DMA; major histocompatibility complex
hsa:30846,1.0070961e-07,0.00012477690917301568,7.364886495911882e-07,1.4329183243097962e-06,0.0,6.8419995e-06,False,EHD2; EH domain containing
hsa:26270,2.8328299e-08,3.5098116171326954e-05,3.555922043317823e-07,9.458205176607754e-07,0.0,9.254582e-06,False,FBXO6; F-box protein
hsa:83439,0.0,0.0,6.406248283168316e-05,0.0002548835060234748,0.0,0.0023473813,False,TCF7L1; transcription factor 7 like
hsa:10919,0.0,0.0,2.4358830385742592e-05,6.588103005027203e-05,0.0,0.00039498444,False,EHMT2; euchromatic histone lysine methyltransferase
hsa:55958,1.3761221500000001e-08,1.7049839486174663e-05,1.4939850779504954e-07,3.0497615118311675e-07,0.0,1.7355869e-06,False,KLHL9; kelch like family member
hsa:147,0.0,0.0,4.51028778441089e-05,0.0003124996560098153,0.0,0.0041356613,False,ADRA1B; adrenoceptor alpha
hsa:5893,5.401653e-08,6.692524832189775e-05,2.4014318005267323e-05,7.606080077769567e-05,0.0,0.0007781808,False,RAD52; RAD52 homolog
hsa:55504,0.0,0.0,7.63213386661881e-06,2.365105115153605e-05,0.0,0.00015671461,False,TNFRSF19; TNF receptor superfamily member
hsa:48,0.0,0.0,5.80653856658911e-06,1.934050268167896e-05,0.0,0.00017147795,False,ACO1; aconitase
hsa:283209,0.0,0.0,7.93999552509901e-05,0.00016721341788757715,0.0,0.0009406891,False,PGM2L1; phosphoglucomutase 2 like
hsa:8631,2.5074325000000003e-09,3.1066516622392606e-06,4.334165701266335e-07,1.3662229642286e-06,0.0,1.3950327e-05,False,SKAP1; src kinase associated phosphoprotein
hsa:3397,0.0,0.0,7.577625575499997e-05,0.0004205985776883927,0.0,0.0043283897,False,ID1; inhibitor of DNA binding
hsa:57510,2.6195275499999997e-08,3.245534871821689e-05,2.8267320989534646e-07,5.764659881135373e-07,0.0,3.0154715e-06,False,XPO5; exportin
hsa:51067,2.53272895e-07,0.0003137993386669032,2.429228348247524e-06,5.109657439961597e-06,0.0,3.287415e-05,False,YARS2; tyrosyl-tRNA synthetase
hsa:57617,8.5291915e-09,1.0567473681158702e-05,3.3868435955346525e-05,0.00011465600532557213,0.0,0.0010378986,False,VPS18; VPS18 core subunit of CORVET and HOPS
hsa:830,0.0,0.0,5.936371082178218e-07,1.206167014118994e-06,0.0,8.167792e-06,False,CAPZA2; capping actin protein of muscle Z-line subunit alpha
hsa:7691,0.0,0.0,2.62818337075495e-08,5.812140970182749e-08,0.0,3.7345413e-07,False,ZNF132; zinc finger protein
hsa:181,0.0,0.0,1.0615854509161386e-06,3.7918133167063622e-06,0.0,3.24154e-05,False,AGRP; agouti related
hsa:8493,7.2609008500000006e-06,0.008996090500943478,0.00015105244763993818,0.00039358415145421906,0.0,0.0023518747,False,PPM1D; protein phosphatase
hsa:5695,0.0,0.0,6.410150481361389e-06,1.4716106663997436e-05,0.0,7.958087e-05,False,PSMB7; proteasome 20S subunit beta
hsa:57122,7.91932625e-09,9.811864550043723e-06,1.602976670579208e-07,3.38585612459041e-07,0.0,1.6280061e-06,False,NUP107; nucleoporin
hsa:27445,5.3921441e-06,0.006680743522028457,7.301407288517823e-05,0.0001841144333062594,0.0,0.0016269959,False,PCLO; piccolo presynaptic cytomatrix
hsa:84769,4.71763055e-07,0.000584503662211773,4.118330609697106e-05,0.00015501091321740786,0.0,0.0012266751,False,MPV17L2; MPV17 mitochondrial inner membrane protein like
hsa:81470,0.0,0.0,2.4850644257425745e-08,3.407825574558306e-07,-0.0,4.841018e-06,False,OR2G2; olfactory receptor family 2 subfamily G member
hsa:29844,0.0,0.0,5.274190949325247e-06,1.7513802023956206e-05,0.0,0.000100078,False,TFPT; TCF3 fusion
hsa:23658,0.0,0.0,5.027969280069303e-06,1.985762454543753e-05,0.0,0.00017203485,False,LSM5; LSM5 homolog
hsa:1954,1.1065207999999999e-05,0.013709540267274655,5.925216211092822e-05,0.0001220662490883374,0.0,0.00082253275,False,MEGF8; multiple EGF like domains
hsa:1786,1.46922835e-06,0.001820340406266787,6.541936063911383e-05,0.0001726050799384604,0.0,0.0011987846,False,DNMT1; DNA methyltransferase
hsa:2350,1.267298225e-05,0.015701535882816843,0.00016966656409363607,0.00030001617609147485,0.0,0.0016543325,False,FOLR2; folate receptor
hsa:4035,0.0,0.0,9.355121156782177e-05,0.0002899919369835231,0.0,0.0026315986,False,LRP1; LDL receptor related protein
hsa:6573,0.00047096075,0.5835096246207818,0.0006604273542722768,0.0008832790878919036,0.0,0.0071440744,False,SLC19A1; solute carrier family 19 member
hsa:5900,4.5211218e-06,0.005601566764072874,0.00010656491351534653,0.00019813565379079985,0.0,0.0012993156,False,RALGDS; ral guanine nucleotide dissociation
hsa:342574,0.0,0.0,3.502154790764356e-06,1.288497329369155e-05,0.0,0.000100374054,False,KRT27; keratin
hsa:128239,0.0,0.0,5.150925198060394e-08,2.307681547920626e-07,0.0,2.708699e-06,False,IQGAP3; IQ motif containing GTPase activating protein
hsa:5724,0.0,0.0,7.217778943366338e-06,3.066263514905446e-05,0.0,0.0003312944,False,PTAFR; platelet activating factor
hsa:1160,0.0,0.0,9.76080316955495e-06,4.55471307116382e-05,0.0,0.00035184046,False,CKMT2; creatine kinase
hsa:766,0.0,0.0,1.5389700674049507e-06,8.994328192048798e-06,0.0,9.4830684e-05,False,CA7; carbonic anhydrase
hsa:338324,0.0,0.0,1.2462639891089109e-08,1.2839346008570574e-07,0.0,1.7840979e-06,False,S100A7A; S100 calcium binding protein
hsa:160287,2.3781412000000002e-05,0.029464626912268504,0.0003376273661934161,0.0007318793727356996,0.0,0.004738019,False,LDHAL6A; lactate dehydrogenase A like
hsa:57680,8.568933499999999e-08,0.00010616713112473687,5.90026848842228e-06,1.9390189746924074e-05,0.0,0.00014151876,False,CHD8; chromodomain helicase DNA binding protein
hsa:57381,1.14920475e-08,1.4238384669739877e-05,2.7275273707576734e-07,4.547744408201758e-07,0.0,2.556245e-06,False,RHOJ; ras homolog family member
hsa:125061,2.8910515e-06,0.0035819468512489593,0.00012139248832227718,0.0002879001536028953,0.0,0.0026318228,False,AFMID;
hsa:79444,0.0,0.0,6.028375163925743e-05,0.0001416137610129168,0.0,0.0009890227,False,BIRC7; baculoviral IAP repeat containing
hsa:2645,6.3628518e-05,0.07883428216333667,0.000275104521330198,0.0004733723124761287,0.0,0.002369415,False,GCK;
hsa:3843,0.0,0.0,2.519179293663366e-07,5.492352635382401e-07,0.0,2.641468e-06,False,IPO5; importin
hsa:7124,0.00012910942,0.15996362584187082,0.00048461488750504956,0.0007711915761457323,0.0,0.0035661927,False,TNF; tumor necrosis
hsa:9374,0.0,0.0,5.499007603168316e-06,1.7794249019393674e-05,0.0,0.000120609824,False,PPT2; palmitoyl-protein thioesterase
hsa:10413,0.0,0.0,0.0002044016403399505,0.0010660675527840529,0.0,0.011023348,False,YAP1; Yes1 associated transcriptional
hsa:5191,4.66630895e-08,5.7814503305829514e-05,2.3400950418316834e-06,9.613757772375741e-06,0.0,9.386432e-05,False,PEX7; peroxisomal biogenesis factor
hsa:126375,0.0,0.0,8.197692729207919e-09,2.5274734385624598e-08,0.0,2.956032e-07,False,ZNF792; zinc finger protein
hsa:10921,2.2674371e-08,2.8093028369609024e-05,1.311713196448316e-06,2.53385853137468e-06,0.0,1.3892183e-05,False,RNPS1; RNA binding protein with serine rich domain
hsa:65980,9.7867318e-08,0.00012125537422985395,6.763519825492575e-06,2.0592422116059966e-05,0.0,0.00012812279,False,BRD9; bromodomain containing
hsa:1268,1.1097545e-06,0.0013749605072529369,1.5397760571633663e-05,4.587642318947694e-05,0.0,0.0004978566,False,CNR1; cannabinoid receptor
hsa:390190,0.0,0.0,3.8099369143325252e-06,2.063058681311907e-05,0.0,0.0002357133,False,OR5B2; olfactory receptor family 5 subfamily B member
hsa:10490,1.4566566e-06,0.0018047642948321797,7.967338510773267e-05,0.00017332199038702168,0.0,0.00091527903,False,VTI1B; vesicle transport through interaction with t-SNAREs
hsa:367,0.0,0.0,9.757019975000497e-07,7.806670093609654e-06,0.0,9.5769065e-05,False,AR; androgen
hsa:163688,1.6054506e-05,0.01989116666204581,9.903609877960395e-05,0.00017128048616251148,0.0,0.0009913995,False,CALML6; calmodulin like
hsa:4074,4.421548e-07,0.0005478197097577174,5.138399059549505e-06,9.451927188391843e-06,0.0,7.415478e-05,False,M6PR; mannose-6-phosphate receptor
hsa:3384,1.1740556999999999e-07,0.00014546282270675194,1.520156196525545e-05,3.0236977151181716e-05,0.0,0.00027595973,False,ICAM2; intercellular adhesion molecule
hsa:3451,0.0,0.0,4.016025747524753e-07,2.211269668399367e-06,0.0,1.93756e-05,False,IFNA17; interferon alpha
hsa:182,0.0,0.0,0.00010672633706831687,0.00047245639902860893,0.0,0.0043014064,False,JAG1; jagged canonical Notch ligand
hsa:390082,0.0,0.0,6.087627485163367e-06,3.1650532062402705e-05,-0.0,0.0003089256,False,OR52E5; olfactory receptor family 52 subfamily E member
hsa:56916,1.8769676000000002e-07,0.00023255200347404112,1.4162119742818621e-05,4.488461253815316e-05,0.0,0.00023430602,False,SMARCAD1; SWI/SNF-related
hsa:23478,0.0,0.0,3.8532744646881174e-05,0.00024296057633534223,0.0,0.0026353628,False,SEC11A; SEC11 homolog A
hsa:10351,0.0,0.0,0.00036551042925420796,0.0017205321534858487,0.0,0.0143918,False,ABCA8; ATP binding cassette subfamily A member
hsa:80143,0.0,0.0,1.2731553460267329e-05,4.986482018943613e-05,0.0,0.00047516372,False,SIKE1; suppressor of IKBKE
hsa:4852,8.9717595e-05,0.11115805336289561,0.00027440927842079215,0.0004137085661488992,0.0,0.0028428943,False,NPY; neuropeptide
hsa:1496,6.879038e-05,0.08522971141718486,0.00021072362724628706,0.00038200977922601774,0.0,0.0020808468,False,CTNNA2; catenin alpha
hsa:7305,0.0,0.0,2.7768550602970304e-05,8.78012729865001e-05,0.0,0.0007255191,False,TYROBP; transmembrane immune signaling adaptor
hsa:10014,7.60531825e-07,0.0009422815801909356,3.9346354671188095e-05,0.0001717854117425762,0.0,0.0021053215,False,HDAC5; histone deacetylase
hsa:414325,0.0,0.0,4.103945234158416e-07,3.810520616477097e-06,0.0,4.043877e-05,False,DEFB103A; defensin beta
hsa:864,0.0,0.0,3.2089180518202958e-06,1.1589958938348972e-05,0.0,0.00012429882,False,RUNX3; RUNX family transcription factor
hsa:4094,0.0,0.0,1.8596458980866337e-05,0.0001102124480944223,0.0,0.0013447916,False,MAF; MAF bZIP transcription
hsa:406886,0.0,0.0,2.0996047029702967e-09,2.984098962106439e-08,0.0,4.2412015e-07,False,MIRLET7D; microRNA
hsa:5216,1.0627385e-06,0.001316708755889005,1.4174213826777226e-05,3.258644531984673e-05,0.0,0.00017230185,False,PFN1; profilin
hsa:64111,0.0,0.0,3.162711823316832e-08,2.2876567611741487e-07,0.0,2.6210496e-06,False,NPVF; neuropeptide VF
hsa:406926,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR135A2; microRNA
hsa:6613,0.0,0.0,1.902920692792079e-06,3.678773794487907e-06,0.0,2.4194156e-05,False,SUMO2; small ubiquitin like modifier
hsa:4973,0.0,0.0,2.0137198399055943e-05,0.00016392614791644773,0.0,0.0019631032,False,OLR1; oxidized low density lipoprotein receptor
hsa:2041,0.0,0.0,4.000737758521783e-06,1.616593691839525e-05,0.0,0.00012371487,False,EPHA1; EPH receptor
hsa:4643,1.55395545e-08,1.9253153501792203e-05,3.632532644752475e-07,7.387251380462519e-07,0.0,6.2216977e-06,False,MYO1E; myosin
hsa:6338,0.0,0.0,3.59467830999703e-05,0.0001591956490248598,0.0,0.0018782285,False,SCNN1B; sodium channel epithelial 1 subunit
hsa:3709,0.0,0.0,0.00014255063410396042,0.0003640230522275386,0.0,0.002142349,False,ITPR2; inositol 1
hsa:127059,0.0,0.0,1.7711048019801978e-07,1.5856431072743168e-06,-0.0,2.0351628e-05,False,OR2M5; olfactory receptor family 2 subfamily M member
hsa:55567,0.0,0.0,6.346555788009902e-08,2.9736125822293634e-07,0.0,3.6668903e-06,False,DNAH3; dynein axonemal heavy chain
hsa:57232,1.43028415e-09,1.772089430950571e-06,5.031957762475247e-08,8.940381930422288e-08,0.0,4.324987e-07,False,ZNF630; zinc finger protein
hsa:4681,0.0,0.0,3.982427630537623e-05,0.00022248972047189374,0.0,0.0019600657,False,NBL1; NBL1
hsa:10637,6.46092105e-07,0.000800493377970459,6.670778184976482e-05,0.00016973759795021695,0.0,0.0017309012,False,LEFTY1; left-right determination factor
hsa:51433,1.3850668250000001e-05,0.01716066196876169,9.988263993326726e-05,0.000228588774531397,0.0,0.001333571,False,ANAPC5; anaphase promoting complex subunit
hsa:10318,7.5783325e-08,9.389381073319743e-05,9.611589766247523e-07,6.436130430940281e-06,0.0,6.960504e-05,False,TNIP1; TNFAIP3 interacting protein
hsa:143496,0.0,0.0,9.549185148514853e-10,1.3571942113833392e-08,0.0,1.9289354e-07,False,OR52B4; olfactory receptor family 52 subfamily B member
hsa:51454,0.0,0.0,1.732410206880594e-05,8.412589529074479e-05,0.0,0.0008481947,False,GULP1; GULP PTB domain containing engulfment adaptor
hsa:641339,0.0,0.0,6.133003360445544e-08,1.3899003678913748e-07,0.0,7.147369e-07,False,ZNF674; zinc finger protein
hsa:9698,4.2254253e-08,5.235205546674866e-05,2.30206435509901e-07,4.1222356882249953e-07,0.0,2.3680045e-06,False,PUM1; pumilio RNA binding family member
hsa:132430,0.0,0.0,7.817896008727722e-07,7.111526991277144e-06,0.0,7.710453e-05,False,PABPC4L; poly(A) binding protein cytoplasmic 4
hsa:3236,0.0,0.0,3.3898289060247525e-07,1.2494934663711672e-06,0.0,1.1440865e-05,False,HOXD10; homeobox
hsa:4993,1.6067417e-07,0.00019907163096490675,1.1446330916717824e-05,4.135776413467218e-05,0.0,0.00030623848,False,OR2C1; olfactory receptor family 2 subfamily C member
hsa:10961,0.0,0.0,2.668612620637624e-07,6.688386718189426e-07,0.0,5.632082e-06,False,ERP29; endoplasmic reticulum protein
hsa:6714,0.000123375315,0.1528592005663332,0.00027916983898663365,0.00037736416440614087,0.0,0.0020553493,False,SRC; SRC proto-oncogene
hsa:131,0.0,0.0,1.8436550841584158e-06,1.8909439867425745e-05,0.0,0.0002640053,False,ADH7; alcohol dehydrogenase 7 (class IV)
hsa:59340,0.0,0.0,3.1793442076940585e-07,1.0855024084218693e-06,0.0,8.7520675e-06,False,HRH4; histamine receptor
hsa:6518,0.0,0.0,7.254959471529703e-05,0.00030734136562085964,0.0,0.0030494898,False,SLC2A5; solute carrier family 2 member
hsa:593,7.19857975e-07,0.0008918876079854344,0.00011653205623227722,0.0003305515614571974,0.0,0.0019635553,False,BCKDHA; branched chain keto acid dehydrogenase E1 subunit
hsa:374879,7.242744e-09,8.973594578028892e-06,4.1605569618663356e-08,7.513039459606864e-08,0.0,4.3662885e-07,False,ZNF699; zinc finger protein
hsa:119391,5.1625706e-05,0.06396307193081982,0.0001386515539704456,0.0001969434049632841,0.0,0.001065697,False,GSTO2; glutathione S-transferase omega
hsa:59352,5.90811025e-10,7.320013810483556e-07,1.819068100862376e-07,1.2208229115038578e-06,0.0,1.4194704e-05,False,LGR6; leucine rich repeat containing G protein-coupled receptor
hsa:284217,2.46862235e-05,0.0305856677181479,0.00011646860113910888,0.00026452973166693695,0.0,0.0020596518,False,LAMA1; laminin subunit alpha
hsa:528,1.20017455e-05,0.014869888863348292,0.00030168507293811865,0.0006557646184210414,0.0,0.0038729482,False,ATP6V1C1; ATPase H+ transporting V1 subunit
hsa:6366,9.9298475e-08,0.00012302854510204108,0.00019421253951393554,0.0004828229207728039,0.0,0.0038789946,False,CCL21; C-C motif chemokine ligand
hsa:5028,0.0,0.0,0.00018872978374950494,0.001015061974073347,0.0,0.010231108,False,P2RY1; purinergic receptor
hsa:355,0.0,0.0,0.00015725648643878716,0.00042598396341313985,0.0,0.0030122513,False,FAS; Fas cell surface death
hsa:7316,1.3173871500000001e-05,0.01632212623614052,0.00019867886671386136,0.0004879534404361614,0.0,0.004118619,False,UBC; ubiquitin
hsa:5534,0.0,0.0,0.0001743458951287129,0.00034070542180542746,0.0,0.0020702933,False,PPP3R1; protein phosphatase 3 regulatory subunit B
hsa:208,0.0,0.0,0.0005322916343628711,0.0009418208128564358,0.0,0.0062527163,False,AKT2; AKT serine/threonine kinase
hsa:406923,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR133A2; microRNA
hsa:2846,0.0,0.0,1.6658751944242579e-06,5.8320921349821526e-06,0.0,4.404015e-05,False,LPAR4; lysophosphatidic acid receptor
hsa:1734,1.3697644e-09,1.6971068414149387e-06,1.254149489872772e-06,7.155998732465825e-06,0.0,6.332694e-05,False,DIO2; iodothyronine deiodinase
hsa:114131,0.0,0.0,1.2007077415691579e-06,3.7693835720808717e-06,0.0,3.129482e-05,False,UCN3; urocortin
hsa:84249,0.0,0.0,1.3249376001327232e-07,2.2817109952364892e-07,0.0,1.1819476e-06,False,PSD2; pleckstrin and Sec7 domain containing
hsa:6777,9.4153625e-05,0.11665419332807642,0.00033913805535940603,0.0005569407207636251,0.0,0.0028944216,False,STAT5B; signal transducer and activator of transcription
hsa:9762,0.0,0.0,3.9681640506470306e-05,0.00015700568997607483,0.0,0.0018253268,False,LZTS3; leucine zipper tumor suppressor family member
hsa:2168,0.0,0.0,9.37085884846535e-06,4.783127138580083e-05,0.0,0.00059797766,False,FABP1; fatty acid binding protein
hsa:23283,7.0560695e-08,8.742309131372727e-05,5.142288874762377e-07,9.819277765758005e-07,0.0,5.536796e-06,False,CSTF2T; cleavage stimulation factor subunit 2 tau
hsa:5605,0.00018403561,0.22801592215053296,0.000696519553250297,0.0013240124018786845,0.0,0.010548759,False,MAP2K2; mitogen-activated protein kinase kinase
hsa:11213,0.0,0.0,7.403269161336635e-07,3.74509923511796e-06,0.0,4.4010703e-05,False,IRAK3; interleukin 1 receptor associated kinase
hsa:81327,0.0,0.0,1.4640949752475247e-08,1.945292676101156e-07,-0.0,2.7586088e-06,False,OR4A16; olfactory receptor family 4 subfamily A member
hsa:79875,0.0,0.0,1.605796253663663e-05,6.436918220434407e-05,0.0,0.0005563153,False,THSD4; thrombospondin type 1 domain containing
hsa:79053,3.3022965e-07,0.000409147002399143,3.2909856134272274e-05,0.00010697237259707587,0.0,0.0011250692,False,ALG8; ALG8
hsa:5931,0.0,0.0,2.081638199619307e-05,0.00011451781405235107,0.0,0.0009422277,False,RBBP7; RB binding protein 7
hsa:2826,4.2263457e-05,0.05236345901276604,0.0002810556069663367,0.0004039050012743374,0.0,0.0019039116,False,CCR10; C-C motif chemokine receptor
hsa:90592,6.2817571e-09,7.782953733150653e-06,9.841305326435647e-08,2.1888405012947345e-07,0.0,1.7208591e-06,False,ZNF700; zinc finger protein
hsa:8722,0.0,0.0,2.2861628333826717e-06,4.554074851689332e-06,0.0,2.9069464e-05,False,CTSF; cathepsin
hsa:51246,1.38392253e-08,1.7146484414774323e-05,0.00018542749236095642,0.0005437268617599599,0.0,0.0029703858,False,SHISA5; shisa family member
hsa:347344,0.0,0.0,2.7834037849801985e-08,5.841804860039699e-08,0.0,3.8075305e-07,False,ZNF81; zinc finger protein
hsa:22849,6.5741315e-07,0.0008145198944439972,1.3982644656336624e-05,4.4087137909946314e-05,0.0,0.00043881993,False,CPEB3; cytoplasmic polyadenylation element binding protein
hsa:23495,0.0,0.0,2.004404869138119e-05,5.8855698908419784e-05,0.0,0.00050531834,False,TNFRSF13B; TNF receptor superfamily member
hsa:10094,0.0,0.0,9.061261493343565e-05,0.00022700673339784666,0.0,0.0014569026,False,ARPC3; actin related protein 2/3 complex subunit
hsa:5429,0.0,0.0,2.9703620232673262e-05,6.241526719252153e-05,0.0,0.0005057916,False,POLH; DNA polymerase
hsa:10111,3.60203845e-06,0.004462843461645419,7.955027825033659e-05,0.00019423152732337117,0.0,0.0013199538,False,RAD50; RAD50 double strand break repair
hsa:278,0.0,0.0,4.426358997029704e-06,6.173450508358606e-05,0.0,0.0008774377,False,AMY1C; amylase alpha
hsa:6323,0.0,0.0,1.2295169628714012e-06,5.5342036811879325e-06,0.0,6.633512e-05,False,SCN1A; sodium voltage-gated channel alpha subunit
hsa:8467,4.037998e-09,5.0029873979932886e-06,4.715213146148516e-06,1.5308047846586105e-05,0.0,0.00011397288,False,SMARCA5; SWI/SNF related
hsa:57209,1.3266692250000001e-08,1.643712902775218e-05,1.567756043757426e-07,3.932262639768951e-07,0.0,2.3489033e-06,False,ZNF248; zinc finger protein
hsa:57835,4.11164525e-05,0.05094234660534493,0.00011961046671712875,0.0001761200969479434,0.0,0.0010819605,False,SLC4A5; solute carrier family 4 member
hsa:197259,0.0,0.0,2.7665059894108912e-05,0.0001040260867049686,0.0,0.0009214375,False,MLKL; mixed lineage kinase domain like
hsa:8985,0.0,0.0,4.590213391049504e-05,0.00016384888124263317,0.0,0.0012748761,False,PLOD3; procollagen-lysine
hsa:7038,8.791773e-05,0.10892806169051508,0.0002979655045346535,0.0005206377422961216,0.0,0.0038934238,False,TG;
hsa:9108,0.0,0.0,0.00012542955805573664,0.0003511256131174435,0.0,0.0022167796,False,MTMR7; myotubularin related protein
hsa:9446,0.0,0.0,0.00038424814455445566,0.0007591465221886101,0.0,0.0038647032,False,GSTO1; glutathione S-transferase omega
hsa:79465,0.0,0.0,3.0752274880940106e-05,0.00011546478889668914,0.0,0.0010893092,False,ULBP3; UL16 binding protein
hsa:5238,2.34634565e-06,0.0029070687301693495,0.00010915034120306084,0.0003314230679972497,0.0,0.002318855,False,PGM3; phosphoglucomutase
hsa:6709,1.55013215e-09,1.920578368705047e-06,3.017007065179702e-06,6.3120204712268965e-06,0.0,5.147027e-05,False,SPTAN1; spectrin alpha
hsa:10053,0.0,0.0,8.665115695376236e-08,2.5487385641961543e-07,0.0,2.004453e-06,False,AP1M2; adaptor related protein complex 1 subunit mu
hsa:6543,0.00013873650500000002,0.17189136452188264,0.0004090294037311882,0.0006507185212156852,0.0,0.0034849537,False,SLC8A2; solute carrier family 8 member
hsa:8989,9.3845962e-08,0.00011627300589018545,3.23995874668911e-05,0.00010171520820367266,0.0,0.0010812583,False,TRPA1; transient receptor potential cation channel subfamily A member
hsa:57552,0.0,0.0,5.308092143564356e-05,0.0002019311113316464,0.0,0.0014679293,False,NCEH1; neutral cholesterol ester hydrolase
hsa:196,0.0,0.0,1.3736034661633666e-05,4.32136593290743e-05,0.0,0.0002624667,False,AHR; aryl hydrocarbon
hsa:1129,3.6846429e-07,0.0004565188490634579,3.737125909903466e-05,0.00010283471729038074,0.0,0.0010123432,False,CHRM2; cholinergic receptor muscarinic
hsa:130075,0.0,0.0,7.317954999915842e-07,4.378329598602545e-06,0.0,4.8043064e-05,False,OR9A4; olfactory receptor family 9 subfamily A member
hsa:442904,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR335; microRNA
hsa:84135,0.0,0.0,4.091534721854853e-07,2.6401889832501425e-06,0.0,3.133918e-05,False,UTP15; UTP15 small subunit processome
hsa:388585,1.9111773e-06,0.002367905072570823,2.2046693940613846e-05,5.489893791519134e-05,0.0,0.00050083286,False,HES5; hes family bHLH transcription factor
hsa:5159,1.47742005e-05,0.018304897356790705,0.00016420325677079202,0.0006738247930410108,0.0,0.008004753,False,PDGFRB; platelet derived growth factor receptor
hsa:133522,0.0,0.0,1.024173330431411e-06,3.3776863356403636e-06,0.0,2.7289345e-05,False,PPARGC1B; PPARG coactivator 1
hsa:9945,0.0,0.0,2.8769449933316826e-05,7.637457391999791e-05,0.0,0.0007972157,False,GFPT2; glutamine-fructose-6-phosphate transaminase
hsa:2922,0.0,0.0,8.790767875006436e-07,5.077030638971067e-06,0.0,4.954694e-05,False,GRP; gastrin releasing
hsa:4684,3.5595889e-05,0.044102494376512306,0.0010951743639613862,0.0018887082031996108,0.0,0.009127565,False,NCAM1; neural cell adhesion molecule
hsa:55929,5.0338718499999996e-08,6.23685237800097e-05,8.585358233915839e-06,2.8070269149197078e-05,0.0,0.00015956347,False,DMAP1; DNA methyltransferase 1 associated protein
hsa:57642,2.3376318e-06,0.002896272468819541,2.8797560213546524e-05,7.678240375685403e-05,0.0,0.00060188316,False,COL20A1; collagen type XX alpha 1
hsa:3117,0.0,0.0,0.0002277540171816832,0.0004349514567019634,0.0,0.0029727018,False,HLA-DQA1; major histocompatibility complex
hsa:1173,7.18667675e-06,0.008904128534412688,5.677834421346533e-05,0.00018785647097154778,0.0,0.0023322345,False,AP2M1; adaptor related protein complex 2 subunit mu
hsa:10199,1.346272e-10,1.6680002937770698e-07,1.5447698251950487e-06,2.7535056345687173e-06,0.0,1.3610402e-05,False,MPHOSPH10; M-phase phosphoprotein
hsa:9232,9.180315199999999e-07,0.0011374201090541957,6.800951675017823e-06,1.4210616671236258e-05,0.0,0.00010261917,False,PTTG1; PTTG1 regulator of sister chromatid separation
hsa:6874,1.82152925e-09,2.256833183876309e-06,1.366133365774753e-06,4.168751962189175e-06,0.0,2.7353777e-05,False,TAF4; TATA-box binding protein associated factor
hsa:100169757,0.0,0.0,1.9139606537059404e-07,1.3469195281584353e-06,0.0,1.7333668e-05,False,RNA5S6; RNA
hsa:1349,0.0,0.0,0.00026700844515381203,0.0008587245609462986,0.0,0.0051570507,False,COX7B; cytochrome c oxidase subunit
hsa:146227,1.2650062e-09,1.5673138215975784e-06,9.363333744702972e-08,2.2489050506032648e-07,0.0,1.6602071e-06,False,BEAN1; brain expressed associated with NEDD4
hsa:5781,0.00018131411000000001,0.22464404573958904,0.00030578980238613854,0.0003498171533677704,0.0,0.0018243497,False,PTPN11; protein tyrosine phosphatase non-receptor type
hsa:356,4.16037185e-06,0.005154605806272324,2.126571605899008e-05,4.271456539768423e-05,0.0,0.0002902238,False,FASLG; Fas
hsa:3309,0.0,0.0,0.00021322415284752487,0.0004638315413854167,0.0,0.00287407,False,HSPA5; heat shock protein family A (Hsp70) member
hsa:9560,9.6734635e-06,0.011985200583419817,0.0001576444779227723,0.0002670181473215423,0.0,0.002228867,False,CCL4L2; C-C motif chemokine ligand 4 like
hsa:558,0.0,0.0,2.3264854179851484e-05,9.724900445953797e-05,0.0,0.0005707624,False,AXL; AXL receptor tyrosine
hsa:222545,0.0,0.0,5.530125677425742e-10,2.967098591459717e-09,0.0,2.8646161e-08,False,GPRC6A; G protein-coupled receptor class C group 6 member
hsa:5610,0.0,0.0,7.610787883331685e-05,0.0002343152287665701,0.0,0.0017535542,False,EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase
hsa:6747,2.5063706e-08,3.1053359923657416e-05,5.647798222244059e-07,1.2308113305989302e-06,0.0,9.523059e-06,False,SSR3; signal sequence receptor subunit
hsa:5868,4.3927155e-07,0.0005442474287869828,0.00016279739298938128,0.0002956837330882291,0.0,0.001455019,False,RAB5A; RAB5A
hsa:6948,0.0,0.0,0.0001739518862094059,0.0005167604395496536,0.0,0.0043115416,False,TCN2; transcobalamin
hsa:170589,0.0,0.0,2.4223990382138614e-06,1.3220953576357225e-05,0.0,0.00017171988,False,GPHA2; glycoprotein hormone subunit alpha
hsa:6715,2.1597594500000001e-07,0.0002675892685198685,7.432285585602026e-05,0.00016809511116916436,0.0,0.0010207677,False,SRD5A1; steroid 5 alpha-reductase
hsa:57505,0.0,0.0,1.3621599711415838e-05,4.923812015779577e-05,0.0,0.0002819056,False,AARS2; alanyl-tRNA synthetase 2
hsa:1565,6.61179455e-07,0.00081918626041347,0.0002077891413077722,0.0003906840702923784,0.0,0.0018563116,False,CYP2D6; cytochrome P450 family 2 subfamily D member
hsa:25898,0.0,0.0,2.3729562812772274e-05,8.715135265151829e-05,0.0,0.0006271093,False,RCHY1; ring finger and CHY zinc finger domain containing
hsa:5332,0.00133231,1.650701694310012,0.0020630546623267325,0.002049511918658795,0.0,0.00942773,True,PLCB4; phospholipase C beta
hsa:84309,3.48426815e-07,0.00043169287467897184,7.511244138183168e-07,9.487893311976237e-07,0.0,4.891061e-06,False,NUDT16L1; nudix hydrolase 16 like
hsa:5327,0.0,0.0,1.9441139619603973e-05,0.00016627449054417052,0.0,0.0022107556,False,PLAT; plasminogen activator
hsa:407046,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR9-1; microRNA
hsa:112399,4.1088535e-06,0.0050907757459762535,1.4230172066965345e-05,2.744376422244839e-05,0.0,0.00014091872,False,EGLN3; egl-9 family hypoxia inducible factor
hsa:10975,2.47325545e-07,0.00030643070770139613,3.923757158680199e-05,0.00012560882342483958,0.0,0.001338123,False,UQCR11; ubiquinol-cytochrome c reductase
hsa:9254,0.00023575848,0.2920993780606263,0.0008063502665772275,0.0015522431433796274,0.0,0.010083226,False,CACNA2D2; calcium voltage-gated channel auxiliary subunit alpha2delta
hsa:3816,8.96919375e-06,0.011112626430575293,5.982895357845048e-05,0.00013180944822804833,0.0,0.0013460387,False,KLK1; kallikrein
hsa:56949,3.46413415e-09,4.291983180132381e-06,2.099980498564355e-07,4.2136385054409664e-07,0.0,2.3145449e-06,False,XAB2; XPA binding protein
hsa:51065,0.0,0.0,3.032862905678217e-07,6.24750149227e-07,0.0,4.191253e-06,False,RPS27L; ribosomal protein S27
hsa:219927,0.0,0.0,1.2260302767955446e-07,2.363223986689429e-07,0.0,1.4542537e-06,False,MRPL21; mitochondrial ribosomal protein
hsa:57580,3.32439375e-07,0.00041188480126086376,6.62134065821782e-07,8.77075082674046e-07,0.0,4.650777e-06,False,PREX1; phosphatidylinositol-3
hsa:50807,6.378884e-07,0.000790329174637061,6.877998119950494e-06,1.782338025816034e-05,0.0,0.00011457529,False,ASAP1; ArfGAP with SH3 domain
hsa:1501,0.0,0.0,1.2888303394618803e-05,4.717574975513042e-05,0.0,0.00032372057,False,CTNND2; catenin delta
hsa:154810,0.0,0.0,1.2432959700772776e-06,4.5213297748325496e-06,0.0,4.2034448e-05,False,AMOTL1; angiomotin like
hsa:4670,0.0,0.0,7.722564173019799e-08,2.2945549887353967e-07,0.0,2.086154e-06,False,HNRNPM; heterogeneous nuclear ribonucleoprotein
hsa:28998,1.3379701999999999e-08,1.6577145529766386e-05,1.1426667366244299e-07,2.6555640700496567e-07,0.0,1.6251655e-06,False,MRPL13; mitochondrial ribosomal protein
hsa:4507,0.0,0.0,4.510526182950494e-06,3.4167029087172314e-05,0.0,0.00047367226,False,MTAP; methylthioadenosine
hsa:3916,1.329767e-07,0.00016475509753267195,2.5362496144306927e-06,4.799956460737035e-06,0.0,2.5422629e-05,False,LAMP1; lysosomal associated membrane protein
hsa:8431,2.8317701999999996e-07,0.00035084986730089845,1.3949899264232674e-05,4.4064361825852595e-05,-0.0,0.00038789547,False,NR0B2; nuclear receptor subfamily 0 group B member
hsa:54207,1.4614171499999998e-07,0.0001810662507673671,6.439139610538265e-05,0.00017826804884754155,0.0,0.0012652365,False,KCNK10; potassium two pore domain channel subfamily K member
hsa:2880,0.0,0.0,1.444704181485148e-06,8.314387318560276e-06,0.0,9.606663e-05,False,GPX5; glutathione peroxidase
hsa:9217,1.14450375e-06,0.001418014035223906,0.0001450141609592425,0.00031564831078090185,0.0,0.001711394,False,VAPB; VAMP associated protein B and
hsa:406947,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR155; microRNA
hsa:730,2.45508625e-08,3.0417958527311313e-05,2.6030429229955445e-05,8.564141252586414e-05,0.0,0.0005859635,False,C7; complement
hsa:2182,0.0,0.0,9.296356462524753e-05,0.0002490922785849447,0.0,0.0020302213,False,ACSL4; acyl-CoA synthetase long chain family member
hsa:725,0.0,0.0,5.50029553620792e-07,2.1958823914892015e-06,0.0,1.843843e-05,False,C4BPB; complement component 4 binding protein
hsa:7507,4.542307e-08,5.627814743547842e-05,4.46477512610396e-06,9.911960536646458e-06,0.0,7.39017e-05,False,XPA; XPA
hsa:79228,1.7226558499999998e-09,2.1343312970014886e-06,2.5485837070792077e-07,5.481092426417428e-07,0.0,2.8091024e-06,False,THOC6; THO complex subunit
hsa:3355,0.0,0.0,1.401854563970792e-05,5.0068898473911375e-05,0.0,0.00050578173,False,HTR1F; 5-hydroxytryptamine receptor
hsa:3073,0.0,0.0,0.0003627872744381188,0.0009450697723540161,0.0,0.0052490137,False,HEXA; hexosaminidase subunit
hsa:4145,0.0,0.0,2.0771430330304954e-06,1.0831483083269835e-05,0.0,0.00014400354,False,MATK; megakaryocyte-associated tyrosine
hsa:1621,0.0,0.0,0.00013441305039519803,0.00035665239078796536,0.0,0.0021136862,False,DBH; dopamine
hsa:60489,1.2752869500000002e-06,0.0015800514362996957,2.348107074970298e-05,6.668908351884018e-05,0.0,0.0004969289,False,APOBEC3G; apolipoprotein B mRNA editing enzyme catalytic subunit
hsa:5663,0.0,0.0,0.00019376566568264856,0.0005693299828591135,0.0,0.0037119598,False,PSEN1; presenilin
hsa:7976,2.7600071e-05,0.0341958582933226,0.00010829791025940592,0.0002121829894518519,0.0,0.0022341756,False,FZD3; frizzled class receptor
hsa:23786,0.0,0.0,1.9063354610311886e-05,5.019577424633937e-05,0.0,0.00036621522,False,BCL2L13; BCL2 like
hsa:219958,0.0,0.0,3.524335227722772e-08,4.15327224468568e-07,-0.0,5.8395467e-06,False,OR1S2; olfactory receptor family 1 subfamily S member
hsa:10990,0.0,0.0,4.187675941133662e-06,1.135387790458582e-05,0.0,6.577e-05,False,LILRB5; leukocyte immunoglobulin like receptor
hsa:58476,6.821746000000001e-08,8.45198766079407e-05,5.18087277603911e-07,1.4377616957356268e-06,0.0,1.5455345e-05,False,TP53INP2; tumor protein p53 inducible nuclear protein
hsa:126070,2.42666545e-08,3.0065831299311476e-05,7.142175925584162e-08,1.1720712180566434e-07,0.0,7.2645247e-07,False,ZNF440; zinc finger protein
hsa:11168,0.0,0.0,1.2345268691550993e-05,3.2622462728422935e-05,0.0,0.00025730848,False,PSIP1; PC4 and SRSF1 interacting protein
hsa:8148,0.0,0.0,7.53565306826733e-06,6.448733713935121e-05,0.0,0.00088495505,False,TAF15; TATA-box binding protein associated factor
hsa:8323,0.0,0.0,3.0173381736824748e-05,0.00013631630370760853,0.0,0.0011293752,False,FZD6; frizzled class receptor
hsa:51466,1.4180117499999999e-07,0.00017568842073365092,1.034005403069307e-06,1.4732966550865735e-06,0.0,6.9836137e-06,False,EVL;
hsa:400916,0.0,0.0,3.609009288638614e-08,7.414602389907671e-08,0.0,6.5650175e-07,False,CHCHD10; coiled-coil-helix-coiled-coil-helix domain containing
hsa:55741,2.7536067e-08,3.411655879752761e-05,2.017835143024752e-07,4.070667420640209e-07,0.0,3.218397e-06,False,EDEM2; ER degradation enhancing alpha-mannosidase like protein
hsa:23765,0.0,0.0,1.62432079959901e-05,5.2638159502165795e-05,0.0,0.00045788466,False,IL17RA; interleukin 17 receptor
hsa:9377,4.0750228000000005e-06,0.00504886028049923,0.00048392404524542096,0.0014362398743043442,0.0,0.0089722,False,COX5A; cytochrome c oxidase subunit
hsa:10636,1.9609863e-07,0.00024296172872144778,7.403483843559407e-07,1.007273977971835e-06,0.0,4.706985e-06,False,RGS14; regulator of G protein signaling
hsa:80781,0.0,0.0,3.434658736836633e-05,0.00012736160398949542,0.0,0.0011946358,False,COL18A1; collagen type XVIII alpha 1
hsa:7478,4.6777640000000004e-07,0.0005795642876194263,3.259740236123762e-06,7.043218779358274e-06,0.0,6.0801696e-05,False,WNT8A; Wnt family member
hsa:5052,0.0,0.0,2.4540541061782182e-05,6.596341412878399e-05,0.0,0.00057170633,False,PRDX1; peroxiredoxin
hsa:51021,1.052280675e-08,1.3037517493017262e-05,1.5895898648747537e-07,3.980083227826608e-07,0.0,3.3910135e-06,False,MRPS16; mitochondrial ribosomal protein
hsa:5864,1.9774109999999998e-05,0.02449967115796815,9.53511407866337e-05,0.00023278154612411944,0.0,0.0023439664,False,RAB3A; RAB3A
hsa:10713,1.167769e-10,1.4468391491940377e-07,1.8869199766980197e-07,3.8140613575578964e-07,0.0,2.0737623e-06,False,USP39; ubiquitin specific peptidase
hsa:54344,0.0,0.0,3.766950491430693e-05,0.00011325522960994718,0.0,0.0007935557,False,DPM3; dolichyl-phosphate mannosyltransferase subunit 3
hsa:3175,0.0,0.0,1.2404667308039601e-05,4.482356980225224e-05,0.0,0.0005184397,False,ONECUT1; one cut homeobox
hsa:2861,2.3240885000000002e-10,2.879492629100145e-07,6.130098835277229e-09,3.0501975495190495e-08,0.0,3.353187e-07,False,GPR37; G protein-coupled receptor
hsa:5729,0.0,0.0,5.299068295188122e-07,1.955912241058547e-06,0.0,1.9434234e-05,False,PTGDR; prostaglandin D2
hsa:2948,0.0,0.0,0.00018405501421782172,0.0003465248669216729,0.0,0.0022316794,False,GSTM4; glutathione S-transferase mu
hsa:64421,5.318190149999999e-06,0.006589116265184391,8.089635512015349e-05,0.0001313337143658993,0.0,0.0005817125,False,DCLRE1C; DNA cross-link repair
hsa:10162,2.5673758e-06,0.0031809200433761827,4.517540915084156e-05,0.0001001536113496197,0.0,0.00055347395,False,LPCAT3; lysophosphatidylcholine acyltransferase
hsa:407015,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR26A1; microRNA
hsa:5460,3.2438047499999998e-09,4.019000080188443e-06,1.0759779115990797e-06,7.56882499033713e-06,0.0,8.9946836e-05,False,POU5F1; POU class 5 homeobox
hsa:255061,0.0,0.0,7.132573041800993e-07,3.160679402075114e-06,0.0,2.9917239e-05,False,TAC4; tachykinin precursor
hsa:22802,0.0,0.0,1.322210812261386e-06,5.224790970295687e-06,0.0,5.039714e-05,False,CLCA4; chloride channel accessory
hsa:26686,0.0,0.0,5.234633331683169e-07,3.7871789586797495e-06,-0.0,3.548591e-05,False,OR4E2; olfactory receptor family 4 subfamily E member
hsa:6205,0.0,0.0,2.622682304455446e-07,8.091756070268084e-07,0.0,7.650907e-06,False,RPS11; ribosomal protein
hsa:51606,0.0,0.0,0.00012854790126866334,0.0002714745754475146,0.0,0.0018262822,False,ATP6V1H; ATPase H+ transporting V1 subunit
hsa:1788,6.408172000000001e-05,0.07939578910186051,0.00036648949769340115,0.0007316584338466716,0.0,0.0053568445,False,DNMT3A; DNA methyltransferase 3
hsa:10874,0.0,0.0,1.2159757695975025e-05,3.0405348549234743e-05,0.0,0.00016367952,False,NMU; neuromedin
hsa:27294,1.1915535e-06,0.0014763076020678557,4.4150488761806915e-05,9.692498556998268e-05,0.0,0.00070714497,False,DHDH; dihydrodiol
hsa:51324,9.4534957e-10,1.1712665497626236e-06,7.136443843468812e-07,1.587176759319306e-06,0.0,1.3441781e-05,False,SPG21; SPG21 abhydrolase domain containing
hsa:399,0.0,0.0,4.08761758294802e-06,1.7123317933662407e-05,0.0,0.0002023276,False,RHOH; ras homolog family member
hsa:54511,9.402476e-07,0.0011649453253303828,0.00013240437743910894,0.0003671929946787382,0.0,0.0021404135,False,HMGCLL1; 3-hydroxy-3-methylglutaryl-CoA lyase like
hsa:80271,1.24202255e-07,0.00015388376036029461,6.743125573524753e-06,3.514191511831546e-05,0.0,0.00033599083,False,ITPKC; inositol-trisphosphate 3-kinase
hsa:3543,0.0,0.0,0.00012181508645859359,0.000331846936332483,0.0,0.0021122016,False,IGLL1; immunoglobulin lambda like polypeptide
hsa:27189,1.45084865e-07,0.00017975683772863623,6.448857484618813e-06,1.6334450348247792e-05,0.0,0.00016330779,False,IL17C; interleukin
hsa:53833,4.4797874e-05,0.05550354385487344,0.00017469616352891083,0.0003312491121658032,0.0,0.001713764,False,IL20RB; interleukin 20 receptor subunit
hsa:8974,0.0,0.0,2.77956272383782e-05,0.00012198600902355291,0.0,0.0011426018,False,P4HA2; prolyl 4-hydroxylase subunit alpha
hsa:51164,3.75613485e-07,0.0004653765385647396,0.0001920535596551832,0.00047010778907534667,0.0,0.0026984273,False,DCTN4; dynactin subunit
hsa:80153,0.0,0.0,1.688714977183169e-06,1.2384306200283457e-05,0.0,0.0001451259,False,EDC3; enhancer of mRNA decapping
hsa:144124,0.0,0.0,1.051975235148515e-07,1.2807305590757617e-06,0.0,1.8089371e-05,False,OR10A5; olfactory receptor family 10 subfamily A member
hsa:282617,0.0,0.0,1.1147763072574256e-06,4.48467846292139e-06,0.0,3.595569e-05,False,IFNL3; interferon lambda
hsa:5603,0.0,0.0,0.00010122022176584162,0.00022743058776062712,0.0,0.0014171508,False,MAPK13; mitogen-activated protein kinase
hsa:253152,0.0,0.0,1.0913943321831678e-07,2.7207549525523655e-07,0.0,2.2847348e-06,False,EPHX4; epoxide hydrolase
hsa:51,1.66379815e-05,0.020614079494973864,0.00021636476713702974,0.0006148034907070567,0.0,0.0047966526,False,ACOX1; acyl-CoA oxidase
hsa:8704,0.0,0.0,0.0005714250466737623,0.0012851560821943223,0.0,0.0059758113,False,B4GALT2; beta-1
hsa:55750,6.18512285e-06,0.007663226102041243,7.718866077386133e-05,0.0001691989843306194,0.0,0.0009168983,False,AGK; acylglycerol
hsa:84612,3.57593295e-08,4.430499342723539e-05,1.7128543805247516e-06,3.2935599005358304e-06,0.0,2.0072508e-05,False,PARD6B; par-6 family cell polarity regulator
hsa:22885,6.018211e-08,7.4564261278645e-05,4.0230030267544565e-06,1.3392701419386183e-05,0.0,0.00010232926,False,ABLIM3; actin binding LIM protein family member
hsa:51548,6.18763605e-06,0.007666339899504402,0.00015728574326089113,0.00042575481010271676,0.0,0.0029933057,False,SIRT6; sirtuin
hsa:10269,0.0,0.0,4.746605809233337e-05,0.00021739070294289834,0.0,0.0025194192,False,ZMPSTE24; zinc metallopeptidase
hsa:55014,0.0,0.0,1.9056820876876237e-05,5.390201398755145e-05,0.0,0.00040937585,False,STX17; syntaxin
hsa:29102,1.3131526e-06,0.0016269661127722506,6.084381498316834e-06,1.0851709477614274e-05,0.0,5.279777e-05,False,DROSHA; drosha ribonuclease
hsa:406948,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR15A; microRNA
hsa:2521,3.43542925e-07,0.0004256418463913934,4.573990952851483e-06,1.2407573949583798e-05,0.0,0.00011527429,False,FUS; FUS RNA binding
hsa:57689,7.0869129e-07,0.0008780523400302842,3.915330040542201e-06,6.513986089226322e-06,0.0,3.0514728e-05,False,LRRC4C; leucine rich repeat containing
hsa:6624,0.0,0.0,2.22764067980198e-07,7.02576939563516e-07,0.0,6.801225e-06,False,FSCN1; fascin actin-bundling protein
hsa:6890,0.0,0.0,0.00028655480705396045,0.0009007712684171537,0.0,0.007708139,False,TAP1; transporter 1
hsa:30849,1.5477607500000002e-07,0.00019176402582068248,4.001410045392575e-05,9.970389179884998e-05,0.0,0.00049433287,False,PIK3R4; phosphoinositide-3-kinase regulatory subunit
hsa:1311,0.0,0.0,1.01301844600198e-05,5.0825415508088055e-05,0.0,0.0004820144,False,COMP; cartilage oligomeric matrix
hsa:55718,2.6014645e-06,0.0032231551649671234,0.00026791032076351487,0.0005864517371447489,0.0,0.0030648818,False,POLR3E; RNA polymerase III subunit
hsa:3778,0.000113496905,0.14062007594511972,0.0003061283436560889,0.0004877043298904882,0.0,0.0029450015,False,KCNMA1; potassium calcium-activated channel subfamily M alpha
hsa:6100,6.4928003e-09,8.044431443152534e-06,3.9293066043663376e-07,9.621042570671692e-07,0.0,6.0471084e-06,False,RP9; RP9 pre-mRNA splicing
hsa:51547,1.9413955500000002e-05,0.02405344794913284,0.0001762861192238613,0.00043892145602081507,0.0,0.0030966555,False,SIRT7; sirtuin
hsa:10274,4.2412667e-09,5.254832679864771e-06,8.312646602223762e-07,2.3127001297768366e-06,0.0,2.1166652e-05,False,STAG1; STAG1 cohesin complex
hsa:53373,0.0,0.0,1.2002016236138611e-06,2.7337120006653928e-06,0.0,1.8159348e-05,False,TPCN1; two pore segment channel
hsa:55054,0.0,0.0,0.0005169553963630197,0.0013333278117495832,0.0,0.006039393,False,ATG16L1; autophagy related 16 like
hsa:5265,0.0,0.0,1.7740098378465341e-06,7.055553962269237e-06,0.0,7.1985945e-05,False,SERPINA1; serpin family A member
hsa:9170,8.431699e-06,0.010446682697879647,8.914605207490094e-05,0.0001898011737079697,0.0,0.0011670026,False,LPAR2; lysophosphatidic acid receptor
hsa:55120,4.172826299999999e-06,0.005170036585683044,9.974602272250492e-05,0.0001620118639747194,0.0,0.0007755546,False,FANCL; FA complementation group
hsa:2837,0.0,0.0,3.2012020853907426e-07,1.3857398545219854e-06,0.0,1.7371847e-05,False,UTS2R; urotensin 2
hsa:128368,0.0,0.0,2.2722708032673272e-07,2.251513355324956e-06,-0.0,3.098349e-05,False,OR10Z1; olfactory receptor family 10 subfamily Z member
hsa:219952,0.0,0.0,7.12787255940594e-08,9.554191287374416e-07,0.0,1.3557166e-05,False,OR6Q1; olfactory receptor family 6 subfamily Q member
hsa:8648,4.19749915e-06,0.005200605683939799,2.6761316094306942e-05,5.532425309367506e-05,0.0,0.00032210271,False,NCOA1; nuclear receptor coactivator
hsa:2250,0.0,0.0,1.425457076551485e-06,8.05086745155924e-06,0.0,8.9107794e-05,False,FGF5; fibroblast growth factor
hsa:79966,2.83563965e-05,0.03513292833280279,0.0004482032550166337,0.001329339039194132,0.0,0.009419735,False,SCD5; stearoyl-CoA desaturase
hsa:406893,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR101-1; microRNA
hsa:4628,7.1818623e-06,0.008898163540700886,0.00017398019372718166,0.0003762323938626304,0.0,0.002968352,False,MYH10; myosin heavy chain
hsa:366,0.0,0.0,1.8305415291386138e-05,0.00011098915166600134,0.0,0.0013524495,False,AQP9; aquaporin
hsa:1234,0.0,0.0,8.353743402811881e-05,0.0003304006874227309,0.0,0.0037601604,False,CCR5; C-C motif chemokine receptor
hsa:3350,0.0,0.0,5.1477138e-06,2.3269798812926918e-05,0.0,0.0002603862,False,HTR1A; 5-hydroxytryptamine receptor
hsa:6362,6.602860249999999e-05,0.08180793210264298,0.0004842940718609898,0.0009634586118061685,0.0,0.0058442554,False,CCL18; C-C motif chemokine ligand
hsa:50846,0.0,0.0,2.5789151434554454e-05,0.0001153166826917917,0.0,0.0009937505,False,DHH; desert hedgehog signaling
hsa:10159,8.493479e-06,0.010523226708413587,0.0003243136886962376,0.0005800816820862824,0.0,0.0027344108,False,ATP6AP2; ATPase H+ transporting accessory protein
hsa:85464,1.3861845500000001e-07,0.00017174510326510808,1.9358872556995055e-05,6.094292272593548e-05,0.0,0.000381627,False,SSH2; slingshot protein phosphatase
hsa:1586,0.0,0.0,1.623921564732179e-05,7.746311415168713e-05,0.0,0.00068244553,False,CYP17A1; cytochrome P450 family 17 subfamily A member
hsa:64131,1.98466365e-06,0.002458952983682846,0.0002528935261609704,0.0005657598317566967,0.0,0.003344984,False,XYLT1; xylosyltransferase
hsa:84735,7.603688e-06,0.009420795959352333,9.443855627396036e-05,0.00019394545111921943,0.0,0.0015247602,False,CNDP1; carnosine dipeptidase
hsa:127068,0.0,0.0,3.6303623415841586e-07,3.5117960832733323e-06,-0.0,4.7453075e-05,False,OR2T34; olfactory receptor family 2 subfamily T member
hsa:6431,0.0,0.0,2.9953247140099027e-07,4.804942240408867e-07,0.0,2.3819005e-06,False,SRSF6; serine and arginine rich splicing factor
hsa:23095,4.2384542e-08,5.251348056529926e-05,1.2062153981272279e-06,3.727432667088628e-06,0.0,1.7777567e-05,False,KIF1B; kinesin family member
hsa:5478,3.7879706e-06,0.004693209153587763,0.00035993516505940617,0.0010377097845277812,0.0,0.00732027,False,PPIA; peptidylprolyl isomerase
hsa:23673,1.5737943e-08,1.949895232720192e-05,1.3508126915232676e-06,3.891377450061122e-06,0.0,2.8367982e-05,False,STX12; syntaxin
hsa:54552,2.6177101e-08,3.243283092735497e-05,4.858398864084159e-07,1.1920744278695709e-06,0.0,8.349492e-06,False,GNL3L; G protein nucleolar 3
hsa:214,3.55832425e-06,0.004408682565153307,1.7716509232821775e-05,3.7584744993142776e-05,0.0,0.0003525914,False,ALCAM; activated leukocyte cell adhesion
hsa:1549,0.0,0.0,2.045098118267327e-05,6.270312852785535e-05,0.0,0.00048292862,False,CYP2A7; cytochrome P450 family 2 subfamily A member
hsa:4211,1.47385105e-06,0.0018260678261032266,4.59393298652228e-05,8.56135330532839e-05,0.0,0.00054904475,False,MEIS1; Meis homeobox
hsa:10642,0.0,0.0,3.2299683124257423e-08,9.990708457816853e-08,0.0,1.2109961e-06,False,IGF2BP1; insulin like growth factor 2 mRNA binding protein
hsa:51094,3.6260177e-06,0.004492553205326157,4.3620885087722784e-05,7.94579152643694e-05,0.0,0.00047626658,False,ADIPOR1; adiponectin receptor
hsa:3293,4.12258315e-07,0.0005107786469094209,2.2533116926938122e-05,7.135758380936782e-05,0.0,0.0004946498,False,HSD17B3; hydroxysteroid 17-beta dehydrogenase
hsa:84105,1.89291255e-07,0.00023452754640178975,2.7112522156930696e-06,7.741323745040874e-06,0.0,8.371774e-05,False,PCBD2; pterin-4 alpha-carbinolamine dehydratase
hsa:3034,3.53026455e-07,0.00043739172370150874,3.656114046385149e-06,8.024137262561328e-06,0.0,7.018859e-05,False,HAL; histidine
hsa:5933,3.4990721e-07,0.00043352705030982956,4.3829158722168306e-05,9.543297768580905e-05,0.0,0.00057142624,False,RBL1; RB transcriptional corepressor like
hsa:54925,0.0,0.0,6.418007797772276e-08,1.6137572411464417e-07,0.0,1.4253678e-06,False,ZSCAN32; zinc finger and SCAN domain containing
hsa:2261,0.0,0.0,1.0442517716831681e-05,6.996450295482504e-05,0.0,0.0008921085,False,FGFR3; fibroblast growth factor receptor
hsa:23019,8.4568433e-08,0.0001047783591193061,1.9486416262866332e-05,8.075902427250298e-05,0.0,0.0007342473,False,CNOT1; CCR4-NOT transcription complex subunit
hsa:1613,0.0,0.0,6.728607861044555e-05,0.00018826709602260335,0.0,0.0012404729,False,DAPK3; death associated protein kinase
hsa:8091,0.0,0.0,1.9667251672544306e-06,1.918355431951083e-05,0.0,0.00023933317,False,HMGA2; high mobility group AT-hook
hsa:6181,0.0,0.0,6.986093544336635e-07,1.3731933051874598e-06,0.0,6.431017e-06,False,RPLP2; ribosomal protein lateral stalk subunit
hsa:3651,0.0,0.0,1.0744186622772277e-05,0.00011819698756077558,0.0,0.0016588435,False,PDX1; pancreatic and duodenal homeobox
hsa:6192,3.6494645e-09,4.521603255604357e-06,3.403361347922773e-07,6.419675003831844e-07,0.0,2.9910125e-06,False,RPS4Y1; ribosomal protein S4 Y-linked
hsa:9311,2.2183492e-05,0.027484840487658722,0.00011599489709227719,0.00018517651082784872,0.0,0.0009109685,False,ASIC3; acid sensing ion channel subunit
hsa:83447,4.4798541999999996e-08,5.550437149163349e-05,4.566805165829207e-06,1.4071805332512961e-05,0.0,0.00012014119,False,SLC25A31; solute carrier family 25 member
hsa:144125,0.0,0.0,5.66788867029703e-07,3.5286016688147674e-06,-0.0,3.6340767e-05,False,OR2AG1; olfactory receptor family 2 subfamily AG member
hsa:51311,0.0,0.0,1.4982711062561884e-06,4.649099421230297e-06,0.0,3.8391325e-05,False,TLR8; toll like receptor
hsa:65109,0.0,0.0,3.1313588962653473e-07,7.174656345632642e-07,0.0,5.423174e-06,False,UPF3B; UPF3B regulator of nonsense mediated mRNA
hsa:570,0.00012340787699999998,0.1528995441414547,0.00033815131772277243,0.00089072542443919,0.0,0.01023588,False,BAAT; bile acid-CoA:amino acid
hsa:29915,1.8773962e-08,2.3260510603622115e-05,1.0454168481656923e-05,5.51118166729561e-05,0.0,0.0005318301,False,HCFC2; host cell factor
hsa:4622,0.0,0.0,1.0553154621831684e-09,8.68397079227536e-09,0.0,9.640209e-08,False,MYH4; myosin heavy chain
hsa:2796,1.0838065e-05,0.01342811527237808,4.558334495537128e-05,7.731948483724095e-05,0.0,0.00061197317,False,GNRH1; gonadotropin releasing hormone
hsa:4190,4.3349369499999995e-05,0.05370887982595698,0.0005283874384455444,0.0009935946973098741,0.0,0.0069792527,False,MDH1; malate dehydrogenase
hsa:26088,1.9334843e-07,0.00023955429366527363,2.3594665631569306e-06,5.013386250704247e-06,0.0,3.9978633e-05,False,GGA1; golgi associated
hsa:2950,0.0,0.0,0.0003369613140792081,0.0009375854853096226,0.0,0.0063108723,False,GSTP1; glutathione S-transferase pi
hsa:10555,0.0,0.0,7.357586438465348e-05,0.0002319368000254573,0.0,0.0014187566,False,AGPAT2; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:58498,1.1070335000000001e-07,0.00013715892503305855,2.268853008627524e-05,5.6755649862040856e-05,0.0,0.0004232511,False,MYL7; myosin light chain
hsa:729092,1.7647988e-08,2.186545450590535e-05,3.107473623156435e-07,6.758726596320335e-07,0.0,3.966743e-06,False,AGAP5; ArfGAP with GTPase domain
hsa:126,0.0,0.0,7.210451789237327e-05,0.0003166320721102093,0.0,0.00349309,False,ADH1C; alcohol dehydrogenase 1C (class I)
hsa:27306,0.0,0.0,6.545867742287127e-05,0.00022812298511965082,0.0,0.0016315193,False,HPGDS; hematopoietic prostaglandin D
hsa:401667,0.0,0.0,4.55919603960396e-09,6.47983506160704e-08,-0.0,9.209576e-07,False,OR51A2; olfactory receptor family 51 subfamily A member
hsa:57863,4.09560485e-06,0.0050743609708846305,2.463905065479224e-05,4.018006620512651e-05,0.0,0.00017469627,False,CADM3; cell adhesion molecule
hsa:80835,0.0,0.0,2.255520846074257e-05,0.00017794979255916985,0.0,0.0024154624,False,TAS1R1; taste 1 receptor member
hsa:3881,0.0,0.0,2.920259049782178e-07,1.7649278206881003e-06,0.0,2.0543874e-05,False,KRT31; keratin
hsa:3077,0.0,0.0,1.7784355867195695e-05,0.00010936183023976974,0.0,0.0012010083,False,HFE; homeostatic iron
hsa:162998,0.0,0.0,2.7173888808891085e-05,0.0001329153887329064,0.0,0.0012185225,False,OR7D2; olfactory receptor family 7 subfamily D member
hsa:7472,0.0,0.0,9.644914979207917e-06,4.318472650579063e-05,0.0,0.00047750215,False,WNT2; Wnt family member
hsa:7015,0.0,0.0,1.7659865735577226e-05,0.00011344885079940338,0.0,0.0014658826,False,TERT; telomerase reverse
hsa:5539,0.0,0.0,2.6364822179447537e-06,1.7694406686418517e-05,0.0,0.00023298961,False,PPY; pancreatic
hsa:4792,0.0,0.0,0.00020551568440227726,0.0008438049166736387,0.0,0.009790538,False,NFKBIA; NFKB inhibitor
hsa:5291,0.0,0.0,0.00020030231827574264,0.00044365326177792374,0.0,0.0029320023,False,PIK3CB; phosphatidylinositol-4
hsa:5318,3.4726649e-07,0.0004302552584759484,1.2900375318198021e-05,4.711164684512551e-05,0.0,0.00051901065,False,PKP2; plakophilin
hsa:9855,7.8706245e-08,9.751524192888959e-05,2.4336264246074256e-05,6.602336180701382e-05,0.0,0.00038175474,False,FARP2; FERM
hsa:283111,0.0,0.0,2.0155135831683167e-07,2.8398799315293175e-06,-0.0,4.0362498e-05,False,OR51V1; olfactory receptor family 51 subfamily V member
hsa:3362,2.0045877e-06,0.0024836384270800413,2.517216207791583e-05,5.0275469326160484e-05,0.0,0.00036166684,False,HTR6; 5-hydroxytryptamine receptor
hsa:4760,0.0,0.0,5.133272012332178e-05,0.0001991829205024036,0.0,0.0019318806,False,NEUROD1; neuronal differentiation
hsa:29906,0.0,0.0,1.1779887896732678e-05,5.2461659336348415e-05,0.0,0.000685575,False,ST8SIA5; ST8 alpha-N-acetyl-neuraminide alpha-2
hsa:5434,0.0,0.0,0.00010610394152851487,0.0003207992626585406,0.0,0.001781759,False,POLR2E; RNA polymerase II
hsa:407055,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR99A; microRNA
hsa:64900,1.2064052e-06,0.0014947085195370514,5.168862091742573e-05,0.00021239992409579492,0.0,0.0022942084,False,LPIN3; lipin
hsa:4286,0.0,0.0,2.5437603674628722e-05,9.546095275587885e-05,0.0,0.000833928,False,MITF; melanocyte inducing transcription
hsa:406905,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR1-2; microRNA
hsa:6730,0.0,0.0,8.758907093485144e-05,0.0002362885076578014,0.0,0.0014986184,False,SRP68; signal recognition particle
hsa:55339,5.8116688e-08,7.200525054175554e-05,4.6325634093712903e-07,1.1248492785318986e-06,0.0,5.5377077e-06,False,WDR33; WD repeat domain
hsa:915,8.2289695e-05,0.10195505472506707,0.00035792038280346527,0.0006200062032056243,0.0,0.004117684,False,CD3D; CD3 delta subunit of T-cell receptor
hsa:5441,0.0,0.0,2.5095261642326738e-05,9.547068443912902e-05,0.0,0.000799149,False,POLR2L; RNA polymerase II
hsa:1302,5.9171847e-05,0.07331256847006537,0.000142053566559703,0.00022136481775812447,0.0,0.0013165553,False,COL11A2; collagen type XI alpha 2
hsa:57153,3.0608239e-08,3.792290981614323e-05,9.568739293871292e-06,2.6887167154339176e-05,0.0,0.00017294241,False,SLC44A2; solute carrier family 44 member
hsa:2632,2.10343185e-06,0.002606104073872179,5.70103563420792e-05,0.0001248797871154419,0.0,0.0006901301,False,GBE1; 1
hsa:123,0.0,0.0,8.87986423981188e-06,4.403428415944633e-05,0.0,0.00045510067,False,PLIN2; perilipin
hsa:406955,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR181B1; microRNA
hsa:1056,0.00022513446499999997,0.2789364658548521,0.0005272698958702968,0.0006763569302385609,0.0,0.0034302047,False,CEL; carboxyl ester
hsa:2026,5.7272798499999996e-08,7.095969070398474e-05,0.00019311897901669295,0.0004016388500978469,0.0,0.0019969945,False,ENO2; enolase
hsa:8386,0.0,0.0,7.193435326237625e-07,6.626917425670089e-06,0.0,9.279543e-05,False,OR1D5; olfactory receptor family 1 subfamily D member
hsa:4982,0.0,0.0,1.7061997106064356e-05,6.785872244868743e-05,0.0,0.0006815397,False,TNFRSF11B; TNF receptor superfamily member
hsa:206358,3.3933535e-08,4.2042875695917684e-05,2.8000533026089117e-05,6.0719061375090224e-05,0.0,0.00060469226,False,SLC36A1; solute carrier family 36 member
hsa:5600,0.000584927155,0.7247114003545982,0.0006893736811400987,0.0006327363213991498,0.0,0.0028173586,True,MAPK11; mitogen-activated protein kinase
hsa:55957,0.0,0.0,3.958421598183169e-06,1.3187393296446862e-05,0.0,9.238992e-05,False,LIN37; lin-37 DREAM MuvB core complex
hsa:5361,1.0319734000000001e-07,0.00012785914988725324,1.4408182003861387e-05,5.506317083919262e-05,0.0,0.0004911211,False,PLXNA1; plexin
hsa:4005,0.0,0.0,2.727413963074259e-06,1.7638174685795806e-05,0.0,0.00024276722,False,LMO2; LIM domain only
hsa:2120,0.0,0.0,4.628987218405643e-06,5.053950844211867e-05,0.0,0.0007088094,False,ETV6; ETS variant transcription factor
hsa:85320,1.2367540500000001e-06,0.0015323100522999671,4.21795949779703e-05,8.506334071653074e-05,0.0,0.00047980552,False,ABCC11; ATP binding cassette subfamily C member
hsa:3552,0.0,0.0,9.559131962277229e-06,3.8320742470284316e-05,0.0,0.00033260375,False,IL1A; interleukin 1
hsa:388523,6.6835712e-11,8.280792235952293e-08,7.239057837252477e-09,2.5436284546857863e-08,0.0,2.414191e-07,False,ZNF728; zinc finger protein
hsa:246,4.7376017e-06,0.005869780421340373,5.172058006283215e-05,0.00018009451919910778,0.0,0.0017727041,False,ALOX15; arachidonate
hsa:79711,0.0,0.0,1.0442751689975248e-07,2.068168806590418e-07,0.0,1.1670586e-06,False,IPO4; importin
hsa:2815,0.0,0.0,1.384837918292079e-06,9.004944540181814e-06,0.0,0.00011770396,False,GP9; glycoprotein IX
hsa:7482,7.58913685e-06,0.009402767416476304,4.020965304257424e-05,8.493742293559525e-05,0.0,0.0009017873,False,WNT2B; Wnt family member
hsa:6202,1.027059135e-08,1.2725028366529373e-05,7.799135994440593e-07,1.8905580580385098e-06,0.0,1.0928715e-05,False,RPS8; ribosomal protein
hsa:51035,0.0,0.0,6.834757308806932e-07,1.608058264246622e-06,0.0,8.868544e-06,False,UBXN1; UBX domain protein
hsa:5168,0.0,0.0,2.955335467663367e-05,7.845547849789144e-05,0.0,0.00048456102,False,ENPP2; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:9776,3.52674385e-06,0.004369555170037315,0.00013614353892707923,0.0003157784745948099,0.0,0.0020656758,False,ATG13; autophagy related
hsa:9533,2.94510025e-06,0.0036489120194157813,0.0003407528471817825,0.0008311045083219563,0.0,0.0051629813,False,POLR1C; RNA polymerase I and III subunit
hsa:7454,0.0,0.0,2.2902125196198022e-05,6.974897275814678e-05,0.0,0.0004185612,False,WAS; WASP actin nucleation promoting
hsa:3812,0.0,0.0,1.1246415412138614e-06,6.693962704375768e-06,0.0,8.796197e-05,False,KIR3DL2; killer cell immunoglobulin like receptor
hsa:22989,0.0,0.0,3.0120536677188123e-07,1.1472474009103412e-06,0.0,8.853677e-06,False,MYH15; myosin heavy chain
hsa:23430,0.0,0.0,8.714989317138614e-07,4.165012201729146e-06,0.0,4.3255648e-05,False,TPSD1; tryptase delta
hsa:4704,1.0113450000000001e-06,0.0012530333818945734,9.088082186683162e-06,2.3506844274172355e-05,0.0,0.00015773217,False,NDUFA9; NADH:ubiquinone oxidoreductase subunit
hsa:64411,9.0679859e-07,0.0011235027650553773,2.928128115431683e-05,0.00010631298515641376,0.0,0.0007632983,False,ARAP3; ArfGAP with RhoGAP domain
hsa:381,7.4905729e-09,9.280648931091608e-06,1.2035008866693073e-06,3.6405695946123307e-06,0.0,2.285536e-05,False,ARF5; ADP ribosylation factor
hsa:9177,2.21799575e-06,0.0027480461322795784,4.315960546201484e-05,0.00011155075458431439,0.0,0.00088136445,False,HTR3B; 5-hydroxytryptamine receptor
hsa:5468,0.0,0.0,4.556537079915843e-05,0.00015356013657873943,0.0,0.0014791571,False,PPARG; peroxisome proliferator activated receptor
hsa:3112,6.228789999999999e-05,0.07717328704656766,0.00014076996248212875,0.00019692375574602652,0.0,0.00091434375,False,HLA-DOB; major histocompatibility complex
hsa:112398,5.39587625e-07,0.0006685367570732152,5.2832835491831655e-05,0.0001596516013350197,0.0,0.0008636358,False,EGLN2; egl-9 family hypoxia inducible factor
hsa:57474,0.0,0.0,1.0761116804455445e-08,2.2648299007291327e-08,0.0,1.3210925e-07,False,ZNF490; zinc finger protein
hsa:4720,0.0,0.0,4.286539740574256e-06,6.8819142579212555e-06,0.0,3.0663716e-05,False,NDUFS2; NADH:ubiquinone oxidoreductase core subunit
hsa:51305,0.0,0.0,1.374471267440594e-06,4.290076373093649e-06,0.0,3.776429e-05,False,KCNK9; potassium two pore domain channel subfamily K member
hsa:1676,0.0,0.0,1.5102207264908412e-06,3.242632466803334e-06,0.0,1.7373834e-05,False,DFFA; DNA fragmentation factor subunit
hsa:8540,1.3547748e-06,0.0016785350689918317,2.122219375460397e-05,4.519427822610127e-05,0.0,0.00023860174,False,AGPS; alkylglycerone phosphate
hsa:999,0.0,0.0,2.6132312658168324e-05,0.00012295012126163537,0.0,0.0010386986,False,CDH1; cadherin
hsa:2526,0.0,0.0,4.4051952390594065e-05,7.047780663466757e-05,0.0,0.0004141216,False,FUT4; fucosyltransferase
hsa:55669,0.0,0.0,2.609477512960792e-06,7.470541193789135e-06,0.0,6.692656e-05,False,MFN1; mitofusin
hsa:2812,5.58352075e-05,0.06917854825258467,0.0002427922830192575,0.00036172052484838524,0.0,0.0021579608,False,GP1BB; glycoprotein Ib platelet subunit
hsa:79869,1.9096425e-08,2.3660034903861763e-05,9.330080892917377e-05,0.0002878626850524761,0.0,0.002148358,False,CPSF7; cleavage and polyadenylation specific factor
hsa:2890,0.00027525421499999996,0.3410336926589699,0.0009670891415405943,0.001771144337471783,0.0,0.010353352,False,GRIA1; glutamate ionotropic receptor AMPA type subunit
hsa:7139,0.0,0.0,0.0001025055767868812,0.0003635917019195296,0.0,0.0030059123,False,TNNT2; troponin T2
hsa:2100,0.0,0.0,4.565339858217822e-06,1.4156487071426841e-05,0.0,0.000120554476,False,ESR2; estrogen receptor
hsa:64135,0.0,0.0,8.15747323370792e-06,5.279095341365997e-05,0.0,0.00057501957,False,IFIH1; interferon induced with helicase C domain
hsa:79602,0.0,0.0,1.9503624416732668e-05,4.016082157125462e-05,0.0,0.00022253652,False,ADIPOR2; adiponectin receptor
hsa:2909,3.76450705e-06,0.0046641383504417025,3.797337047178218e-05,7.178532531089292e-05,0.0,0.00034135385,False,ARHGAP35; Rho GTPase activating protein
hsa:1634,0.0,0.0,7.62541497676733e-05,0.0004678162957758777,0.0,0.0040828087,False,DCN;
hsa:3558,0.0,0.0,1.4495841059999999e-05,3.8989776861741944e-05,0.0,0.00038751587,False,IL2; interleukin
hsa:29935,0.0,0.0,4.547039183281188e-06,1.565048129092741e-05,0.0,0.00012906194,False,RPA4; replication protein
hsa:3726,0.0,0.0,4.492674786864357e-05,0.00014702867421218898,0.0,0.0010828152,False,JUNB; JunB proto-oncogene
hsa:9380,0.0,0.0,6.078510026237622e-05,0.0001515357441018705,0.0,0.0012722049,False,GRHPR; glyoxylate and hydroxypyruvate
hsa:9525,3.7106042500000005e-07,0.00045973540109951375,0.00013730747099176242,0.00033660641420502286,0.0,0.002208447,False,VPS4B; vacuolar protein sorting 4 homolog
hsa:343637,0.0,0.0,1.47526980812203e-06,5.346532491616898e-06,0.0,3.946307e-05,False,RSPO4; R-spondin
hsa:138882,0.0,0.0,2.023448639826733e-07,1.8821821378859478e-06,0.0,2.4024546e-05,False,OR1N2; olfactory receptor family 1 subfamily N member
hsa:3911,0.0,0.0,9.99257894890446e-05,0.00020132623126030343,0.0,0.00107004,False,LAMA5; laminin subunit alpha
hsa:3938,1.2201236e-06,0.0015117053041616675,8.146390351851486e-06,3.36840144218676e-05,-0.0,0.0004513738,False,LCT;
hsa:26330,0.0,0.0,8.797596270185642e-08,5.344365593764879e-07,0.0,5.3324848e-06,False,GAPDHS; glyceraldehyde-3-phosphate dehydrogenase
hsa:55582,0.0,0.0,7.02135842017772e-08,1.3994693678375406e-07,0.0,6.864445e-07,False,KIF27; kinesin family member
hsa:80150,4.2731998e-06,0.005294397062234168,3.2436273473960395e-05,6.385443154772308e-05,0.0,0.00042415387,False,ASRGL1; asparaginase and isoaspartyl peptidase
hsa:9939,8.8229365e-08,0.00010931417034578773,5.93253512569307e-07,1.0122764665191154e-06,0.0,5.268934e-06,False,RBM8A; RNA binding motif protein
hsa:2864,0.0,0.0,1.3436672533085645e-07,7.894183621389627e-07,0.0,9.817108e-06,False,FFAR1; free fatty acid receptor
hsa:3614,0.0,0.0,4.8964774384980206e-05,0.00014137842916097287,0.0,0.00096090726,False,IMPDH1; inosine monophosphate dehydrogenase
hsa:9984,0.0,0.0,2.782910037976733e-07,5.367049206121922e-07,0.0,2.712443e-06,False,THOC1; THO complex subunit
hsa:10640,0.0,0.0,1.735600348391089e-07,3.0117023567405394e-07,0.0,1.3158335e-06,False,EXOC5; exocyst complex component
hsa:1733,1.17694455e-08,1.4582074463104943e-05,6.58484128619802e-07,1.8710096534727496e-06,0.0,1.633355e-05,False,DIO1; iodothyronine deiodinase
hsa:5406,0.0,0.0,5.604008773118815e-06,5.674403944092729e-05,0.0,0.0007983355,False,PNLIP; pancreatic
hsa:80208,3.3186449e-09,4.111725318614496e-06,6.516099940047275e-08,1.2376246066249533e-07,0.0,6.8515266e-07,False,SPG11; SPG11 vesicle trafficking associated
hsa:344787,0.0,0.0,4.6118734714455445e-09,1.266164273920442e-08,0.0,1.1613222e-07,False,ZNF860; zinc finger protein
hsa:7709,2.31597075e-06,0.0028694349220507454,1.2636265717158414e-05,3.1114769147139344e-05,0.0,0.0002555892,False,ZBTB17; zinc finger and BTB domain containing
hsa:51465,0.0,0.0,6.944084550742573e-07,1.7037349403205882e-06,0.0,8.630278e-06,False,UBE2J1; ubiquitin conjugating enzyme E2
hsa:22941,3.0087243e-08,3.7277407658290516e-05,7.118689019930694e-06,1.617021654495936e-05,0.0,0.00014365434,False,SHANK2; SH3 and multiple ankyrin repeat domains
hsa:83860,2.31024475e-08,2.8623405386852983e-05,4.0063843790594056e-07,8.739524600639054e-07,0.0,7.1957793e-06,False,TAF3; TATA-box binding protein associated factor
hsa:22933,9.001359e-08,0.00011152478441498355,6.417842994408913e-05,0.0001292062376256482,0.0,0.0011059565,False,SIRT2; sirtuin
hsa:7528,7.077053050000001e-08,8.768307271098198e-05,9.387101085670579e-05,0.0003239640243678883,0.0,0.0018507213,False,YY1; YY1 transcription
hsa:3358,0.0,0.0,8.201658346336636e-06,2.1036716215673425e-05,0.0,0.00014967495,False,HTR2C; 5-hydroxytryptamine receptor
hsa:9886,1.1910775999999999e-07,0.000147571797282517,3.029084648805444e-07,4.506338292932506e-07,0.0,2.7645299e-06,False,RHOBTB1; Rho related BTB domain containing
hsa:6604,0.0,0.0,6.908185141623761e-06,1.9953532033937282e-05,0.0,0.00010758623,False,SMARCD3; SWI/SNF related
hsa:10021,6.171978e-05,0.07646939932781498,0.0002702348048212872,0.00046827040099311297,0.0,0.003710178,False,HCN4; hyperpolarization activated cyclic nucleotide gated potassium channel
hsa:81341,0.0,0.0,2.399212871287129e-10,3.409922176756357e-09,0.0,4.84641e-08,False,OR10W1; olfactory receptor family 10 subfamily W member
hsa:6296,0.0,0.0,9.897603447945546e-06,2.2550480854576798e-05,0.0,0.0002030809,False,ACSM3; acyl-CoA synthetase medium chain family member
hsa:79685,6.4027565e-09,7.932869229236769e-06,2.912695544207426e-07,5.492853949224525e-07,0.0,2.5902598e-06,False,SAP30L; SAP30
hsa:2529,1.8650583e-06,0.0023107646837424852,0.0001879372004565842,0.00045312986952841426,0.0,0.0035276904,False,FUT7; fucosyltransferase
hsa:55012,1.08849715e-05,0.013486231355740175,1.5048526415099012e-05,2.1191605458993394e-05,0.0,0.0001842501,False,PPP2R3C; protein phosphatase 2 regulatory subunit
hsa:220,0.0,0.0,5.11848026381683e-05,0.00019818354990473847,0.0,0.0020228762,False,ALDH1A3; aldehyde dehydrogenase 1 family member
hsa:442918,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR373; microRNA
hsa:722,0.0,0.0,1.3640742223910894e-07,6.090260365131744e-07,0.0,4.1108224e-06,False,C4BPA; complement component 4 binding protein
hsa:6812,0.0,0.0,1.1819347480435645e-05,6.373451950145781e-05,0.0,0.0007912973,False,STXBP1; syntaxin binding protein
hsa:219965,0.0,0.0,3.809453168316832e-09,5.414250229905338e-08,-0.0,7.6950954e-07,False,OR5B17; olfactory receptor family 5 subfamily B member
hsa:1489,0.0,0.0,4.6817795699480225e-05,0.00030411703604490145,0.0,0.0024937,False,CTF1; cardiotrophin
hsa:4144,0.0,0.0,2.8905001228118798e-05,8.096275795014856e-05,0.0,0.0008025008,False,MAT2A; methionine adenosyltransferase
hsa:10585,0.0,0.0,0.00018770076190297033,0.000452826214637698,0.0,0.0026019905,False,POMT1; protein O-mannosyltransferase
hsa:5872,0.0,0.0,4.584993953382425e-06,3.07231646371333e-05,0.0,0.00028200992,False,RAB13; RAB13
hsa:3181,0.0,0.0,4.241540298128713e-08,9.006802818462758e-08,0.0,5.3375567e-07,False,HNRNPA2B1; heterogeneous nuclear ribonucleoprotein
hsa:2209,0.0,0.0,7.705442332376238e-05,0.0002444744351236426,0.0,0.0014907444,False,FCGR1A; Fc gamma receptor
hsa:4116,0.0,0.0,9.973733981386142e-07,1.8894537898996793e-06,0.0,9.0909225e-06,False,MAGOH; mago homolog
hsa:5051,0.0,0.0,3.2904106323267344e-06,1.4541940972815802e-05,0.0,0.00015405728,False,PAFAH2; platelet activating factor acetylhydrolase
hsa:1942,0.0,0.0,3.527603230099011e-06,1.6721972297726443e-05,0.0,0.00021632807,False,EFNA1; ephrin
hsa:11017,0.0,0.0,1.563307387821782e-07,3.2596618291529334e-07,0.0,2.3082343e-06,False,SNRNP27; small nuclear ribonucleoprotein U4/U6.U5 subunit
hsa:246243,3.5842351e-08,4.4407855171659855e-05,1.5820183472700985e-05,3.7643446492580184e-05,0.0,0.00026632095,False,RNASEH1; ribonuclease
hsa:407018,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR27A; microRNA
hsa:1639,0.0,0.0,0.0001441706963913193,0.00042257012406377796,0.0,0.0027273363,False,DCTN1; dynactin subunit
hsa:1163,2.0708262e-06,0.0025657064173965245,2.2701265198034656e-05,6.487224108234033e-05,0.0,0.00055537146,False,CKS1B; CDC28 protein kinase regulatory subunit
hsa:5439,0.0,0.0,0.00019889431873980188,0.000751958929020815,0.0,0.004822568,False,POLR2J; RNA polymerase II subunit
hsa:3659,0.0,0.0,3.156470111965346e-05,7.561490751876089e-05,0.0,0.0004562346,False,IRF1; interferon regulatory factor
hsa:27443,3.71611615e-11,4.604183129345121e-08,2.1021552929015846e-07,1.237137991280221e-06,0.0,1.4137535e-05,False,CECR2; CECR2 histone acetyl-lysine
hsa:407008,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR223; microRNA
hsa:5542,0.0,0.0,7.960037996955446e-07,8.14483150451731e-06,0.0,0.000112000766,False,PRB1; proline rich protein BstNI subfamily
hsa:2799,0.0,0.0,6.68700761020792e-05,0.00017850372920112675,0.0,0.0012435224,False,GNS; glucosamine
hsa:51100,0.0,0.0,3.37872631671287e-07,1.1242746180748413e-06,0.0,9.838109e-06,False,SH3GLB1; SH3 domain containing GRB2 like
hsa:9247,0.0,0.0,8.087142954445545e-08,3.5200139462662e-07,0.0,2.4001563e-06,False,GCM2; glial cells missing transcription factor
hsa:4694,0.0,0.0,4.230899417623763e-06,6.088020688941468e-06,0.0,2.9862258e-05,False,NDUFA1; NADH:ubiquinone oxidoreductase subunit
hsa:3762,0.0,0.0,4.991889545027228e-05,0.00019347968324097439,0.0,0.0018903952,False,KCNJ5; potassium inwardly rectifying channel subfamily J member
hsa:93129,2.2015802e-07,0.0002727707640338491,3.06972985744213e-06,1.002132832251987e-05,0.0,9.665574e-05,False,ORAI3; ORAI calcium release-activated calcium modulator
hsa:6554,6.975789800000001e-07,0.0008642844414596078,1.0835705531354553e-05,3.70427712413936e-05,0.0,0.00041822784,False,SLC10A1; solute carrier family 10 member
hsa:10945,0.0,0.0,3.8049381070861384e-05,0.0001376601539778257,0.0,0.0011857974,False,KDELR1; KDEL endoplasmic reticulum protein retention receptor
hsa:6432,1.3912653499999998e-07,0.00017237460279362994,3.158828834925743e-07,4.4881341472496724e-07,0.0,2.2639483e-06,False,SRSF7; serine and arginine rich splicing factor
hsa:10170,0.0,0.0,1.7171566066272282e-05,6.544973259467687e-05,0.0,0.0005618954,False,DHRS9; dehydrogenase/reductase
hsa:5368,0.0,0.0,4.719723295156486e-06,1.467499771368484e-05,0.0,0.000109252804,False,PNOC;
hsa:55786,0.0,0.0,3.547584458539605e-08,9.890056679271118e-08,0.0,8.764837e-07,False,ZNF415; zinc finger protein
hsa:29110,4.10847865e-06,0.0050903113153781855,0.0001130718548169802,0.00030318649894004433,0.0,0.001462504,False,TBK1; TANK binding kinase
hsa:6844,3.3197519e-05,0.041130968663590915,0.00022437041242737615,0.000393464832400376,0.0,0.0020661773,False,VAMP2; vesicle associated membrane protein
hsa:6159,1.4541112000000002e-07,0.00018016106023036415,1.6946839558118813e-06,3.2537470893003917e-06,0.0,1.3266517e-05,False,RPL29; ribosomal protein
hsa:9420,0.0,0.0,7.590937302198019e-05,0.000292086408899068,0.0,0.002698963,False,CYP7B1; cytochrome P450 family 7 subfamily B member
hsa:338442,6.344774e-11,7.861030234565613e-08,1.3604620963429703e-06,1.558823966993384e-05,0.0,0.00021791115,False,HCAR2; hydroxycarboxylic acid receptor
hsa:83539,7.7384338e-10,9.587742931424265e-07,3.33239689301297e-06,1.5858430686175745e-05,0.0,0.00014256831,False,CHST9; carbohydrate sulfotransferase
hsa:80347,7.985754749999999e-06,0.009894167946025491,5.495039091282178e-05,0.00010102465060542986,0.0,0.0005056992,False,COASY; Coenzyme A
hsa:26737,0.0,0.0,4.749869152643564e-06,2.8068220716364788e-05,0.0,0.0003109995,False,OR1L1; olfactory receptor family 1 subfamily L member
hsa:8439,0.0,0.0,2.4123852810346532e-06,1.009250897368155e-05,0.0,7.9624275e-05,False,NSMAF; neutral sphingomyelinase activation associated
hsa:91442,0.0,0.0,9.469891659173267e-06,4.193445489339262e-05,0.0,0.00054283,False,FAAP24; FA core complex associated protein
hsa:80144,4.0093524e-08,4.967496153121955e-05,1.1230375870960398e-05,3.961157395821146e-05,0.0,0.00027227472,False,FRAS1; Fraser extracellular matrix complex subunit
hsa:26835,0.0,0.0,1.281260913012129e-07,4.3683210858645814e-07,0.0,3.1920192e-06,False,RNU4-1; RNA
hsa:89853,4.27410795e-09,5.295522239365381e-06,2.857899567351485e-07,6.520200134215736e-07,0.0,3.7657896e-06,False,MVB12B; multivesicular body subunit
hsa:919,6.3957384e-06,0.007924173963449651,3.409017505377722e-05,5.8572825501685815e-05,0.0,0.00033629584,False,CD247; CD247
hsa:8289,0.0,0.0,1.1549901834158415e-06,2.59627946829052e-06,0.0,1.6264205e-05,False,ARID1A; AT-rich interaction domain
hsa:656,0.0,0.0,7.180660736872774e-05,0.0003699295900323928,0.0,0.0032990212,False,BMP8B; bone morphogenetic protein
hsa:3170,0.0,0.0,4.253553202673267e-05,0.00026064262194153376,0.0,0.0029825107,False,FOXA2; forkhead box
hsa:57666,7.6227402e-09,9.444401200490156e-06,1.2416233571568317e-05,6.618891727103826e-05,0.0,0.000551585,False,FBRSL1; fibrosin like
hsa:127069,0.0,0.0,3.4500265772277224e-07,2.797380498246747e-06,-0.0,3.5080677e-05,False,OR2T10; olfactory receptor family 2 subfamily T member
hsa:50839,4.9764179999999996e-06,0.006165668368619044,0.00013478244571465346,0.00028511863323249574,0.0,0.0019171597,False,TAS2R10; taste 2 receptor member
hsa:2581,2.1569489e-08,2.672410477869352e-05,4.06909204036881e-06,1.3469631937365656e-05,0.0,0.00015175017,False,GALC;
hsa:218,0.0,0.0,2.2255521275891094e-05,7.522220687131018e-05,0.0,0.0008806697,False,ALDH3A1; aldehyde dehydrogenase 3 family member
hsa:29109,9.46273425e-08,0.00011724111850305394,5.007407145959404e-07,1.18989507207989e-06,0.0,6.758634e-06,False,FHOD1; formin homology 2 domain containing
hsa:2954,0.0,0.0,9.41254967960396e-05,0.00028396716333394325,0.0,0.0023876242,False,GSTZ1; glutathione S-transferase zeta
hsa:1361,1.3104858500000001e-06,0.001623662070362225,1.5257852156465344e-05,8.44800399575654e-05,0.0,0.0010538963,False,CPB2; carboxypeptidase
hsa:10023,4.1930939999999995e-07,0.0005195147803590114,9.041627840029703e-06,2.8381428801616175e-05,0.0,0.00023755233,False,FRAT1; FRAT regulator of WNT signaling pathway
hsa:440503,3.6559804e-08,4.5296763070488064e-05,9.224922285475395e-06,3.192751047421683e-05,0.0,0.0002642444,False,PLIN5; perilipin
hsa:4953,0.000117556425,0.14564972861010414,0.0003663816907714849,0.0005385844087666726,0.0,0.0029646582,False,ODC1; ornithine decarboxylase
hsa:8651,0.0,0.0,5.222211739554455e-05,0.0002197655570326664,0.0,0.0017886164,False,SOCS1; suppressor of cytokine signaling
hsa:84790,0.0,0.0,9.00294452433168e-05,0.000440118589311839,0.0,0.0048860125,False,TUBA1C; tubulin alpha
hsa:56270,0.0,0.0,2.447067439811881e-07,6.607438506533011e-07,0.0,3.4592963e-06,False,WDR45B; WD repeat domain
hsa:8061,0.0,0.0,2.5613024165073514e-05,0.00010063831291536412,0.0,0.0009461493,False,FOSL1; FOS like 1
hsa:361,1.9128897500000002e-06,0.0023700267590525143,4.8258559944619796e-05,0.0001920217225786101,0.0,0.002361359,False,AQP4; aquaporin
hsa:716,0.0,0.0,5.5388836065742577e-05,0.00019529496946313378,0.0,0.0015598272,False,C1S; complement
hsa:6152,4.7227295999999997e-07,0.0005851354228736588,9.431353992277232e-07,1.1842911373160796e-06,0.0,5.411028e-06,False,RPL24; ribosomal protein
hsa:26707,0.0,0.0,2.476576907920792e-07,2.325535711668475e-06,-0.0,2.4232831e-05,False,OR2J2; olfactory receptor family 2 subfamily J member
hsa:6633,1.298961e-08,1.6093830441433504e-05,4.1772297000772297e-07,1.2301795316785236e-06,0.0,7.1279783e-06,False,SNRPD2; small nuclear ribonucleoprotein D2
hsa:126374,0.0,0.0,0.00019372601593564356,0.0006999661908062296,0.0,0.006332427,False,WTIP; WT1 interacting
hsa:9627,2.35800935e-09,2.921519788370462e-06,3.023292346165842e-08,6.116531321101693e-08,0.0,3.6118206e-07,False,SNCAIP; synuclein alpha interacting
hsa:158131,0.0,0.0,9.581999587679058e-06,3.066782721434902e-05,0.0,0.00024445914,False,OR1Q1; olfactory receptor family 1 subfamily Q member
hsa:1856,7.5241905e-05,0.09322300370530352,0.0003523796247898021,0.0007296910312722399,0.0,0.0047120606,False,DVL2; dishevelled segment polarity protein
hsa:5562,0.0,0.0,0.000217129576250495,0.000582273173937284,0.0,0.004257279,False,PRKAA1; protein kinase AMP-activated catalytic subunit alpha
hsa:282763,0.0,0.0,1.0155058121188118e-06,5.103787931419467e-06,0.0,5.6611843e-05,False,OR51B5; olfactory receptor family 51 subfamily B member
hsa:1457,7.216073e-06,0.008940549817508485,9.479342410628714e-05,0.0002426767883704757,0.0,0.0015466472,False,CSNK2A1; casein kinase 2 alpha
hsa:2328,0.0,0.0,0.00010703957970039605,0.0002785343203750552,0.0,0.0016782318,False,FMO3; flavin containing dimethylaniline monoxygenase
hsa:7319,6.5586258e-09,8.125987735891314e-06,7.216974986227721e-07,1.6909767278293509e-06,0.0,1.0336171e-05,False,UBE2A; ubiquitin conjugating enzyme E2
hsa:7158,0.0,0.0,1.7296227886138617e-07,5.316857051886818e-07,0.0,3.9587853e-06,False,TP53BP1; tumor protein p53 binding protein
hsa:127064,0.0,0.0,2.8722630955445544e-08,2.3625839456521757e-07,0.0,2.9891394e-06,False,OR2T12; olfactory receptor family 2 subfamily T member
hsa:3661,0.0,0.0,0.00019036353545000002,0.0004336355658965763,0.0,0.0021743118,False,IRF3; interferon regulatory factor
hsa:57620,7.541950749999999e-07,0.0009344304915093082,1.720913883981436e-05,7.045900136279577e-05,0.0,0.00070177455,False,STIM2; stromal interaction molecule
hsa:11255,2.57380985e-08,3.1888916845379806e-05,1.9738524030397522e-05,4.960563255235451e-05,0.0,0.000380981,False,HRH3; histamine receptor
hsa:100534599,0.0,0.0,3.9401800288118826e-08,9.780943462419431e-08,0.0,5.8780296e-07,False,ISY1-RAB43; ISY1-RAB43
hsa:22949,0.0,0.0,2.052374566698019e-05,0.00010496825754815087,0.0,0.0011638587,False,PTGR1; prostaglandin reductase
hsa:9882,0.0,0.0,1.1636884287079205e-05,3.8581629724068194e-05,0.0,0.00025672687,False,TBC1D4; TBC1 domain family member
hsa:3955,0.0,0.0,6.683070946861386e-05,0.00015127014250281695,0.0,0.00079976727,False,LFNG; LFNG O-fucosylpeptide
hsa:140775,0.0,0.0,7.83244551298515e-07,2.422307918557333e-06,0.0,1.7241087e-05,False,SMCR8; SMCR8-C9orf72 complex
hsa:10238,2.60307435e-08,3.2251497323895587e-05,4.137206684777921e-05,0.0001260909290298736,0.0,0.0007758198,False,DCAF7; DDB1 and CUL4 associated factor
hsa:2690,0.0,0.0,8.935269113378217e-06,2.8709215385603374e-05,0.0,0.00020575785,False,GHR; growth hormone
hsa:219982,0.0,0.0,2.512414603960396e-08,2.554207797915201e-07,-0.0,2.963271e-06,False,OR5A1; olfactory receptor family 5 subfamily A member
hsa:5137,0.0,0.0,9.091850608069306e-05,0.0003814498067259113,0.0,0.0028254834,False,PDE1C; phosphodiesterase
hsa:727897,0.0,0.0,4.975426871059406e-06,2.45015517957534e-05,0.0,0.00029929023,False,MUC5B; mucin 5B
hsa:1111,4.3251148e-06,0.005358718562830954,0.0001045000315143416,0.0002171526609308374,0.0,0.0011420463,False,CHEK1; checkpoint kinase
hsa:2323,7.90094075e-08,9.789085334995621e-05,1.963958524833663e-05,9.798203261605421e-05,0.0,0.0011080869,False,FLT3LG; fms related receptor tyrosine kinase 3
hsa:2151,0.0,0.0,3.3211765973655597e-06,1.797204120620615e-05,0.0,0.00017319329,False,F2RL2; coagulation factor II thrombin receptor like
hsa:10723,1.1647992499999999e-06,0.001443159696696738,3.867022449626238e-05,0.00018882004379695095,0.0,0.0018105948,False,SLC12A7; solute carrier family 12 member
hsa:23355,0.0,0.0,5.337032171364257e-05,0.0001509635017736967,0.0,0.0010805357,False,VPS8; VPS8 subunit of CORVET
hsa:26232,9.053950200000001e-08,0.00011217637738468129,6.550672006509901e-07,1.3290652205709459e-06,0.0,8.115175e-06,False,FBXO2; F-box protein
hsa:3310,0.0,0.0,5.8143106947673254e-05,0.00018255409616991985,0.0,0.0016376748,False,HSPA6; heat shock protein family A (Hsp70) member
hsa:7403,0.0,0.0,7.812337802942078e-06,2.858755611452899e-05,0.0,0.00027499077,False,KDM6A; lysine demethylase
hsa:8726,0.0,0.0,4.509610370483169e-06,2.5024611581145867e-05,0.0,0.00020724176,False,EED; embryonic ectoderm
hsa:26532,0.0,0.0,8.351447475247525e-08,1.0405403290631945e-06,-0.0,1.4629285e-05,False,OR10H3; olfactory receptor family 10 subfamily H member
hsa:1028,1.7404149e-10,2.156334354791595e-07,8.625879749229703e-07,1.6264144258192097e-06,0.0,7.2173675e-06,False,CDKN1C; cyclin dependent kinase inhibitor
hsa:7484,0.0,0.0,7.300766992252968e-06,4.9414339343829266e-05,0.0,0.0005296048,False,WNT9B; Wnt family member
hsa:6429,0.0,0.0,2.9728443368564354e-07,5.681463861032782e-07,0.0,2.8990082e-06,False,SRSF4; serine and arginine rich splicing factor
hsa:196335,-0.0,0.0,1.30914461230198e-05,6.0766641974068476e-05,-0.0,0.00057168584,False,OR56B4; olfactory receptor family 56 subfamily B member
hsa:26863,0.0,0.0,5.444285292070297e-08,2.664151773459437e-07,0.0,3.0491103e-06,False,RNVU1-18; RNA
hsa:9755,3.6404775e-07,0.00045104685676362687,0.00018023798479472767,0.0004487940336384197,0.0,0.0034086336,False,TBKBP1; TBK1 binding protein
hsa:1780,6.40366e-07,0.000793398864512407,6.343981595378216e-05,0.0002932517087382587,0.0,0.0030530442,False,DYNC1I1; dynein cytoplasmic 1 intermediate chain
hsa:163049,9.061109e-09,1.1226507328345277e-05,7.776745942079204e-08,1.4282404288212552e-07,0.0,9.712148e-07,False,ZNF791; zinc finger protein
hsa:4763,3.30760755e-07,0.00040980502937736616,1.9012065790445551e-06,4.998685638596759e-06,0.0,5.5766308e-05,False,NF1; neurofibromin
hsa:5394,0.0,0.0,6.092906705643563e-07,1.934948298762808e-06,0.0,2.1520087e-05,False,EXOSC10; exosome component
hsa:1289,0.0,0.0,6.452385074049505e-05,0.00020493490727637823,0.0,0.0017432617,False,COL5A1; collagen type V alpha 1
hsa:15,0.0,0.0,6.556686795531141e-06,1.5774936428312712e-05,0.0,8.757718e-05,False,AANAT; aralkylamine
hsa:79957,0.0,0.0,8.634507341603466e-06,1.8098853652453357e-05,0.0,0.00010301271,False,PAQR6; progestin and adipoQ receptor family member
hsa:217,0.0,0.0,0.0003261745760955445,0.0008311720958465792,0.0,0.0045619356,False,ALDH2; aldehyde dehydrogenase 2 family
hsa:1351,1.4836821e-06,0.0018382482727649244,0.0002492081456882327,0.0007163526202800445,0.0,0.004107384,False,COX8A; cytochrome c oxidase subunit
hsa:130,1.8502462500000002e-05,0.022924128917187037,9.666447676980199e-05,0.00013958661216942572,0.0,0.00064223364,False,ADH6; alcohol dehydrogenase 6 (class
hsa:916,3.35056705e-05,0.0415127613418371,0.00015430818943341584,0.00037483840309867977,0.0,0.003439565,False,CD3E; CD3 epsilon subunit of T-cell receptor
hsa:6146,1.21204435e-07,0.00015016952977339184,1.3948628188282176e-06,2.708296143289582e-06,0.0,1.225709e-05,False,RPL22; ribosomal protein
hsa:27072,1.08776055e-06,0.0013477105049790141,0.00020708427416481684,0.000504784994510843,0.0,0.004032505,False,VPS41; VPS41 subunit of HOPS
hsa:7252,2.7701245e-07,0.00034321210571110883,3.970953892856437e-05,8.444553091658189e-05,0.0,0.00048375074,False,TSHB; thyroid stimulating hormone subunit
hsa:10971,2.8782747e-08,3.5661166875424194e-05,1.7705142457148516e-05,2.725273507001086e-05,0.0,0.00013648612,False,YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
hsa:284,1.9203123750000002e-08,2.379223222085688e-05,4.693513989720297e-06,1.618788179383504e-05,0.0,0.00013567955,False,ANGPT1; angiopoietin
hsa:6891,0.0,0.0,0.00029747097134207934,0.0012092308967406643,0.0,0.010095178,False,TAP2; transporter 2
hsa:5440,9.1024955e-06,0.011277784257642184,0.00014851443045495053,0.00034874132618122,0.0,0.0015611104,False,POLR2K; RNA polymerase II
hsa:123263,3.35595145e-08,4.1579472829425146e-05,1.6695175787670792e-05,4.706234263675333e-05,0.0,0.0003305902,False,MTFMT; mitochondrial methionyl-tRNA
hsa:80315,0.0,0.0,6.375147654009903e-06,3.0312849849310886e-05,0.0,0.00033037516,False,CPEB4; cytoplasmic polyadenylation element binding protein
hsa:407025,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR29B2; microRNA
hsa:5702,0.0,0.0,4.309606110594059e-06,1.1992596678742442e-05,0.0,8.041337e-05,False,PSMC3; proteasome 26S subunit
hsa:1778,0.0,0.0,0.0003372837410742079,0.0009117074054351927,0.0,0.0067908033,False,DYNC1H1; dynein cytoplasmic 1 heavy chain
hsa:54677,0.0,0.0,6.473927415923665e-05,0.0002496917508358132,0.0,0.0017402157,False,CROT; carnitine
hsa:124944,0.0,0.0,2.2403233384405945e-06,1.1596671237369594e-05,0.0,0.00012857479,False,C17orf49; chromosome 17 open reading frame
hsa:190,0.0,0.0,8.10525924850396e-06,3.455204127722567e-05,0.0,0.00040819944,False,NR0B1; nuclear receptor subfamily 0 group B member
hsa:55552,0.0,0.0,5.3994456452970264e-08,1.223664857988449e-07,0.0,6.6605406e-07,False,ZNF823; zinc finger protein
hsa:283899,0.0,0.0,7.321569026273765e-06,2.500252532513291e-05,0.0,0.00016367718,False,INO80E; INO80 complex subunit
hsa:9635,0.0,0.0,2.955337634821781e-07,1.1170971115579606e-06,0.0,1.1536914e-05,False,CLCA2; chloride channel accessory
hsa:10273,1.3777994500000002e-07,0.0001707062085051079,6.749812736039603e-07,1.3672763957233293e-06,0.0,1.0700966e-05,False,STUB1; STIP1 homology and U-box containing protein
hsa:27165,4.9932881999999995e-05,0.06186570161537621,0.00024193735960925742,0.00042782499064409225,0.0,0.0030184921,False,GLS2; glutaminase
hsa:30832,2.21525095e-09,2.7446453877002074e-06,3.137079942113862e-08,6.28337522174037e-08,0.0,4.1095944e-07,False,ZNF354C; zinc finger protein
hsa:51701,3.841988e-07,0.0004760135479819812,3.6658647977282176e-05,7.395987110410523e-05,0.0,0.0003812456,False,NLK; nemo like
hsa:3801,1.7013837500000002e-08,2.1079756504090805e-05,3.7100652631485134e-07,2.1046264564107275e-06,0.0,2.3535125e-05,False,KIFC3; kinesin family member
hsa:6597,1.05640785e-07,0.00013088652249682107,3.9270242847029715e-06,1.1579202562395335e-05,0.0,8.39726e-05,False,SMARCA4; SWI/SNF related
hsa:125115,0.0,0.0,1.4450910368316825e-07,6.269775991955882e-07,0.0,6.4482956e-06,False,KRT40; keratin
hsa:9631,9.0441435e-09,1.12054874609009e-05,8.808268636782179e-08,1.5465985774561954e-07,0.0,7.798867e-07,False,NUP155; nucleoporin
hsa:2875,0.0,0.0,4.7913173020539594e-05,0.0001262887700363184,0.0,0.0008145007,False,GPT; glutamic--pyruvic
hsa:133022,0.0,0.0,2.1058371472613858e-07,6.165520549367633e-07,0.0,5.527729e-06,False,TRAM1L1; translocation associated membrane protein 1 like
hsa:5546,4.4514183e-06,0.005515205717807862,4.176936567638612e-05,8.904295962937324e-05,0.0,0.00055288384,False,PRCC; proline rich mitotic checkpoint control
hsa:284098,3.0356053500000002e-05,0.0376104577350732,6.759773638663369e-05,0.00011335607701597727,0.0,0.00080955797,False,PIGW; phosphatidylinositol glycan anchor biosynthesis class
hsa:5294,0.0,0.0,1.161188584091089e-05,4.461525124417525e-05,0.0,0.00043085494,False,PIK3CG; phosphatidylinositol-4
hsa:3446,0.0,0.0,5.0909042e-07,3.470971723786023e-06,0.0,3.5409834e-05,False,IFNA10; interferon alpha
hsa:26263,4.9095682499999995e-09,6.082843053497789e-06,1.6025243875099016e-07,3.336679091519891e-07,0.0,2.2932122e-06,False,FBXO22; F-box protein
hsa:8842,0.0,0.0,2.5750081690785617e-06,8.714424899485828e-06,0.0,6.974741e-05,False,PROM1; prominin
hsa:338707,0.0,0.0,4.029155695151783e-05,0.00012123534976192395,0.0,0.0010218964,False,B4GALNT4; beta-1
hsa:641,1.3700157e-07,0.00016974181963817108,0.00019925708043497868,0.0005748480789610034,0.0,0.0039464375,False,BLM; BLM RecQ like
hsa:6434,0.0,0.0,4.9502412458202e-06,1.1893428447291169e-05,0.0,9.55924e-05,False,TRA2B; transformer 2 beta
hsa:90987,3.2468106e-09,4.022724259762147e-06,1.3723959576732671e-07,3.712254579856625e-07,0.0,2.2833199e-06,False,ZNF251; zinc finger protein
hsa:79094,9.043641999999999e-07,0.001120486611384226,4.2419444696035145e-05,0.00012935589257610837,0.0,0.0009994173,False,CHAC1; ChaC glutathione specific gamma-glutamylcyclotransferase
hsa:27128,0.0,0.0,4.241150589504949e-06,1.2374914793325069e-05,0.0,0.000119064316,False,CYTH4; cytohesin
hsa:7311,1.2415411499999999e-06,0.0015382411599857394,7.0825484475742625e-06,1.4801237544615828e-05,0.0,0.00010123845,False,UBA52; ubiquitin A-52 residue ribosomal protein fusion product
hsa:100526842,2.03135075e-08,2.5167972354503933e-05,2.503794774485148e-07,4.1421020486028356e-07,0.0,3.1016655e-06,False,RPL17-C18orf32; RPL17-C18orf32
hsa:826,1.82908935e-07,0.000226619997529809,4.214324861034653e-06,1.5334855120726035e-05,0.0,0.00013684202,False,CAPNS1; calpain small subunit
hsa:6227,0.0,0.0,7.97569059979703e-07,1.7883277168946435e-06,0.0,8.697683e-06,False,RPS21; ribosomal protein
hsa:51367,0.0,0.0,7.518892234768464e-07,3.0929878736738865e-06,0.0,2.8798557e-05,False,POP5; POP5 homolog
hsa:4913,0.0,0.0,7.735399182155944e-06,5.0829536968383146e-05,0.0,0.00046101608,False,NTHL1; nth like DNA glycosylase
hsa:7617,0.0,0.0,5.051722856239607e-08,1.1027213212181318e-07,0.0,7.251771e-07,False,ZNF66; zinc finger protein
hsa:160065,0.0,0.0,3.796868448232624e-07,1.5216702236399589e-06,0.0,1.2334688e-05,False,PATE1; prostate and testis expressed
hsa:10818,0.0,0.0,3.33114171500495e-06,8.171224992447033e-06,0.0,3.943085e-05,False,FRS2; fibroblast growth factor receptor substrate
hsa:51690,0.0,0.0,2.0434905547376232e-06,9.14317744512377e-06,0.0,9.5886004e-05,False,LSM7; LSM7 homolog
hsa:1282,0.0,0.0,0.0001725074274222772,0.0003925147554379639,0.0,0.0025576397,False,COL4A1; collagen type IV alpha 1
hsa:29994,2.7586522999999998e-08,3.417907263041042e-05,1.7250146537524762e-06,5.334072489324843e-06,0.0,2.8377059e-05,False,BAZ2B; bromodomain adjacent to zinc finger domain
hsa:119694,0.0,0.0,3.337925643564357e-08,3.4355071404383986e-07,0.0,4.568835e-06,False,OR51F2; olfactory receptor family 51 subfamily F member
hsa:1673,0.0,0.0,0.0,0.0,0.0,0.0,False,DEFB4A; defensin beta
hsa:6726,1.16969305e-06,0.0014492230032482271,0.0002935196134121733,0.0008669193150719953,0.0,0.006310611,False,SRP9; signal recognition particle
hsa:646625,0.0,0.0,1.876123407792079e-09,2.272897867242794e-08,0.0,3.2235513e-07,False,URAD; ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-)
hsa:406892,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR100; microRNA
hsa:64098,2.6339275e-08,3.2633760813472346e-05,4.192372581346533e-07,7.350762551619512e-07,0.0,3.6245315e-06,False,PARVG; parvin
hsa:1981,1.5152177500000001e-06,0.001877320223651856,7.509592893128713e-05,0.00023381241054477202,0.0,0.0022090948,False,EIF4G1; eukaryotic translation initiation factor 4 gamma
hsa:54579,0.0,0.0,2.54949098019802e-06,2.199818001989507e-05,0.0,0.0002716087,False,UGT1A5; UDP glucuronosyltransferase family 1 member
hsa:6234,1.0126050000000001e-07,0.00012545944931485837,8.688788848168316e-07,1.8678150169020782e-06,0.0,9.594003e-06,False,RPS28; ribosomal protein
hsa:10888,1.3633555e-09,1.6891663605293613e-06,2.0417141672226237e-06,1.3905876228148348e-05,0.0,0.00019131646,False,GPR83; G protein-coupled receptor
hsa:2798,0.0,0.0,2.327732521717327e-06,8.056975674126308e-06,0.0,6.7833666e-05,False,GNRHR; gonadotropin releasing hormone
hsa:3781,1.1242633e-05,0.013929365794451481,6.201879566602973e-05,0.00011644823945816973,0.0,0.0006066431,False,KCNN2; potassium calcium-activated channel subfamily N member
hsa:6357,0.0,0.0,2.1592676396673266e-05,9.620975931027079e-05,0.0,0.0008514056,False,CCL13; C-C motif chemokine ligand
hsa:7172,0.0,0.0,1.6774186652792078e-05,6.0914598240516505e-05,0.0,0.0005539029,False,TPMT; thiopurine
hsa:8776,7.093717999999999e-07,0.0008788954763949402,5.367984315944062e-05,0.00018314584058491595,0.0,0.0011957637,False,MTMR1; myotubularin related protein
hsa:5682,0.0,0.0,2.896017140198021e-06,1.1008649581547679e-05,0.0,0.0001218522,False,PSMA1; proteasome 20S subunit alpha
hsa:50832,3.02519595e-05,0.03748148764390259,0.00019676576841772274,0.0004262048440150081,0.0,0.0025360566,False,TAS2R4; taste 2 receptor member
hsa:83452,0.0,0.0,5.8009958763910905e-08,1.4633798663933626e-07,0.0,8.03302e-07,False,RAB33B; RAB33B
hsa:8943,0.0,0.0,2.1240161089628705e-06,8.17541715857274e-06,0.0,9.485456e-05,False,AP3D1; adaptor related protein complex 3 subunit delta
hsa:8874,0.0,0.0,2.9908968457917318e-05,7.977842590100379e-05,0.0,0.0004177559,False,ARHGEF7; Rho guanine nucleotide exchange factor
hsa:8451,7.45530325e-07,0.0009236950639393188,6.162726089405942e-06,1.2196602673986035e-05,0.0,6.611852e-05,False,CUL4A; cullin
hsa:6534,2.8682874e-08,3.5537426506954526e-05,1.8879067116814844e-06,1.0522299475679405e-05,0.0,0.00013348079,False,SLC6A7; solute carrier family 6 member
hsa:65018,0.0,0.0,6.466406764747527e-06,1.9609469188393247e-05,0.0,0.00010676769,False,PINK1; PTEN induced kinase
hsa:3920,2.77968035e-07,0.00034439605372512755,2.3838294084455447e-06,4.720780397559736e-06,0.0,4.0802475e-05,False,LAMP2; lysosomal associated membrane protein
hsa:3779,0.0,0.0,2.05693418259901e-05,0.00010205736753736331,0.0,0.0008903937,False,KCNMB1; potassium calcium-activated channel subfamily M regulatory beta subunit
hsa:23286,9.185587e-06,0.01138073273046965,0.00011912548753188115,0.00020059796543738531,0.0,0.0013510777,False,WWC1; WW and C2 domain containing
hsa:8608,1.44248505e-05,0.01787206067695853,8.610801099613862e-05,0.00018907915238411814,0.0,0.0012270351,False,RDH16; retinol dehydrogenase
hsa:27434,1.8160017999999998e-06,0.0022499847994310864,6.460668554698764e-05,0.00011808014182453196,0.0,0.00076908275,False,POLM; DNA polymerase
hsa:1408,0.0,0.0,0.0002118201069482674,0.000676508610963087,0.0,0.006063734,False,CRY2; cryptochrome circadian regulator
hsa:5993,6.3232245e-05,0.07834330895701884,0.0006285816632267331,0.0011488282588209885,0.0,0.005862539,False,RFX5; regulatory factor
hsa:100529239,0.0,0.0,2.272496937566337e-07,5.095242044012806e-07,0.0,2.8102816e-06,False,RPS10-NUDT3; RPS10-NUDT3
hsa:1374,0.0,0.0,0.00010784161707722771,0.00040506757047553286,0.0,0.0045278086,False,CPT1A; carnitine palmitoyltransferase
hsa:51268,0.0,0.0,9.952184392638614e-05,0.00025011783641922425,0.0,0.0016065175,False,PIPOX; pipecolic acid and sarcosine
hsa:406938,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR146A; microRNA
hsa:9901,3.588125e-08,4.4456050145207284e-05,2.2624250414912367e-05,8.332328537920512e-05,0.0,0.00065677264,False,SRGAP3; SLIT-ROBO Rho GTPase activating protein
hsa:2997,0.0,0.0,7.167398833361386e-05,0.00015687880464852896,0.0,0.0009507284,False,GYS1; glycogen synthase
hsa:57522,0.0,0.0,2.989534491589109e-07,1.3438119274802523e-06,0.0,1.7707784e-05,False,SRGAP1; SLIT-ROBO Rho GTPase activating protein
hsa:2272,7.502379449999999e-07,0.0009295276977183698,2.8561947147722767e-05,8.623240675053008e-05,0.0,0.0008670124,False,FHIT; fragile histidine triad diadenosine
hsa:79898,2.9841265000000002e-09,3.6972646528100865e-06,4.76012786571287e-08,1.1277460012311185e-07,0.0,6.643344e-07,False,ZNF613; zinc finger protein
hsa:6231,2.9298305e-07,0.00036299931475340945,1.5618989295910885e-06,3.2628590253363797e-06,0.0,1.8895551e-05,False,RPS26; ribosomal protein
hsa:219956,0.0,0.0,6.821370252475247e-08,8.491518737338959e-07,0.0,1.19852875e-05,False,OR9Q1; olfactory receptor family 9 subfamily Q member
hsa:6652,7.0748555e-05,0.0876558455678371,0.0002793814560371288,0.0005516526682282847,0.0,0.004777481,False,SORD; sorbitol
hsa:64080,7.558684200000001e-08,9.365037277881513e-05,6.476756768569307e-06,1.610908932789525e-05,0.0,9.3911076e-05,False,RBKS;
hsa:51373,2.3484711e-08,2.9097021142287437e-05,1.7974322467386134e-07,3.286389759540228e-07,0.0,1.7895236e-06,False,MRPS17; mitochondrial ribosomal protein
hsa:66008,0.0,0.0,0.00013230011700234655,0.0004432305206296781,0.0,0.0029121663,False,TRAK2; trafficking kinesin protein
hsa:3486,0.0,0.0,6.619938661049505e-05,0.0002981928207082329,0.0,0.0031782938,False,IGFBP3; insulin like growth factor binding protein
hsa:120103,1.1593598000000001e-05,0.014364203422438597,0.00011373366780371284,0.00026722231078337366,0.0,0.0023966855,False,SLC36A4; solute carrier family 36 member
hsa:55808,0.0,0.0,1.118580175440495e-05,6.92939522857649e-05,0.0,0.00082696084,False,ST6GALNAC1; ST6 N-acetylgalactosaminide alpha-2
hsa:686,0.0,0.0,0.0002219535407158416,0.000648620507215832,0.0,0.0038996493,False,BTD;
hsa:10734,4.53202665e-08,5.6150776244366e-05,6.151410514048019e-06,1.3519322157883441e-05,0.0,5.523936e-05,False,STAG3; STAG3 cohesin complex
hsa:7365,0.0,0.0,9.137513203316831e-06,9.147086150969234e-05,0.0,0.0012743351,False,UGT2B10; UDP glucuronosyltransferase family 2 member
hsa:5623,1.08393015e-08,1.3429647267668225e-05,1.790350434992573e-07,4.020282627051549e-07,0.0,2.8967418e-06,False,PSPN;
hsa:6419,0.0,0.0,1.3306563314232677e-05,3.807624279514456e-05,0.0,0.00024784522,False,SETMAR; SET domain and mariner transposase fusion
hsa:4879,0.0,0.0,3.2548134013564344e-06,1.3440485475092432e-05,0.0,0.00012225,False,NPPB; natriuretic peptide
hsa:1669,0.0,0.0,5.231373755693067e-06,1.9316163163151744e-05,0.0,0.00017630056,False,DEFA4; defensin alpha
hsa:64121,5.080448e-09,6.294559165249763e-06,2.086511712772277e-06,5.2964079875086146e-06,0.0,3.2949818e-05,False,RRAGC; Ras related GTP binding
hsa:443,0.0,0.0,0.00011738244774239116,0.0005169810702943626,0.0,0.005087214,False,ASPA;
hsa:3363,0.0,0.0,4.690706921980199e-06,2.1670327969733434e-05,0.0,0.00019216302,False,HTR7; 5-hydroxytryptamine receptor
hsa:5261,0.0,0.0,7.045137193440595e-06,1.846573432846676e-05,0.0,0.00018079669,False,PHKG2; phosphorylase kinase catalytic subunit gamma
hsa:9623,0.0,0.0,8.952592383069305e-09,2.8504451188933342e-08,0.0,1.7912743e-07,False,TCL1B; TCL1 family AKT coactivator
hsa:1208,0.0,0.0,8.090683361881187e-06,2.6579690871008992e-05,0.0,0.00022019589,False,CLPS;
hsa:59283,1.41077215e-06,0.0017479145081027527,1.4396796925297025e-05,3.388342632522959e-05,0.0,0.00019707288,False,CACNG8; calcium voltage-gated channel auxiliary subunit gamma
hsa:55201,0.0,0.0,0.00011243176708735645,0.0003591760335428678,0.0,0.0026373523,False,MAP1S; microtubule associated protein
hsa:1493,0.0,0.0,5.9020427953861385e-06,3.251056610740912e-05,0.0,0.00030605297,False,CTLA4; cytotoxic T-lymphocyte associated protein
hsa:5020,0.0,0.0,1.584742578564886e-06,7.782221082306385e-06,0.0,0.000100514706,False,OXT; oxytocin/neurophysin I
hsa:26341,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR5H1; olfactory receptor family 5 subfamily H member
hsa:353355,0.0,0.0,1.817348903960396e-08,3.3026467229452637e-08,0.0,1.5536405e-07,False,ZNF233; zinc finger protein
hsa:406907,0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR124-1; microRNA
hsa:3710,0.0,0.0,0.0006253518841089109,0.001916352856173476,0.0,0.010697976,False,ITPR3; inositol 1
hsa:23632,0.0,0.0,6.185542738418812e-05,0.00017356564233617167,0.0,0.0013404284,False,CA14; carbonic anhydrase
hsa:6199,9.710261e-05,0.12030791846411443,0.000256787953470297,0.0003949085907791141,0.0,0.002311423,False,RPS6KB2; ribosomal protein S6 kinase
hsa:7430,4.339971799999999e-06,0.0053771260468792334,6.340446562673268e-05,0.00011639622130673039,0.0,0.00074745936,False,EZR;
hsa:6608,0.0,0.0,4.541916058247525e-05,0.00011369705479011622,0.0,0.0006908609,False,SMO; smoothened
hsa:5179,0.0,0.0,2.8582610933845047e-06,1.578223051835272e-05,0.0,0.00017755078,False,PENK;
hsa:57826,0.0,0.0,1.2975672984222777e-06,4.955809367512641e-06,0.0,4.715275e-05,False,RAP2C; RAP2C
hsa:51295,0.0,0.0,1.722357390960397e-07,4.994137232881202e-07,0.0,4.9296254e-06,False,ECSIT; ECSIT signaling
hsa:3654,0.0,0.0,4.09729181129208e-05,0.00010275789181595413,0.0,0.00072630984,False,IRAK1; interleukin 1 receptor associated kinase
hsa:81061,0.0,0.0,3.245188295435644e-06,1.9628127162459567e-05,0.0,0.00018453787,False,OR11H1; olfactory receptor family 11 subfamily H member
hsa:1612,6.89055075e-06,0.008537235176313412,9.434537167200493e-05,0.0002400467138283195,0.0,0.0023186079,False,DAPK1; death associated protein kinase
hsa:22845,4.9124590499999995e-08,6.0864246887462756e-05,2.1883403320762378e-05,6.906446993804067e-05,0.0,0.00046234392,False,DOLK; dolichol
hsa:343173,0.0,0.0,4.3675177227722775e-08,3.950300784326832e-07,0.0,4.1535986e-06,False,OR2T3; olfactory receptor family 2 subfamily T member
hsa:3797,2.5996001500000002e-08,3.220845277850922e-05,1.7517019618316825e-07,3.828037628875003e-07,0.0,2.2789566e-06,False,KIF3C; kinesin family member
hsa:3663,0.0,0.0,3.2966844071485154e-06,7.552801017030692e-06,0.0,5.4189317e-05,False,IRF5; interferon regulatory factor
hsa:80310,0.0,0.0,1.2540535202673267e-05,7.648075792634052e-05,0.0,0.0009054029,False,PDGFD; platelet derived growth factor
hsa:4176,0.0,0.0,4.70508728559406e-06,2.27587140260486e-05,0.0,0.00025169653,False,MCM7; minichromosome maintenance complex component
hsa:54583,0.0,0.0,3.7935855518168318e-06,1.232218128322136e-05,0.0,0.00010301907,False,EGLN1; egl-9 family hypoxia inducible factor
hsa:55193,2.1009073500000002e-07,0.00026029762759668224,3.742683072631189e-06,1.2252138475895119e-05,0.0,8.415399e-05,False,PBRM1; polybromo
hsa:165679,9.160302e-08,0.00011349405192328655,4.356223799732673e-06,1.3075572382530122e-05,0.0,0.000104272185,False,SPTSSB; serine palmitoyltransferase small subunit
hsa:4542,1.003898425e-08,1.2438072453578014e-05,6.61279478340099e-07,1.7067990031700868e-06,0.0,1.4155616e-05,False,MYO1F; myosin
hsa:155066,4.2124207e-06,0.005219093143965418,0.0004113159216548019,0.0013421483536447528,0.0,0.008671661,False,ATP6V0E2; ATPase H+ transporting V0 subunit
hsa:54852,2.78404135e-10,3.4493637167582115e-07,1.7882463277292074e-08,5.46439202260973e-08,0.0,5.820302e-07,False,PAQR5; progestin and adipoQ receptor family member
hsa:1572,0.0,0.0,1.0331597510918812e-06,6.090511330666271e-06,0.0,6.0034654e-05,False,CYP2F1; cytochrome P450 family 2 subfamily F member
hsa:27297,7.850165e-08,9.72617533915767e-05,0.00015525798845537127,0.0006134784662756235,0.0,0.0045136716,False,CRCP; CGRP receptor
hsa:390152,0.0,0.0,0.0,0.0,-0.0,-0.0,False,OR8H3; olfactory receptor family 8 subfamily H member
hsa:33,2.9409395000000004e-07,0.0003643756945090287,5.140138510105448e-06,2.800810412936555e-05,0.0,0.00038549802,False,ACADL; acyl-CoA dehydrogenase long
hsa:8491,0.0,0.0,1.516948308874257e-07,4.424965895565788e-07,0.0,3.318009e-06,False,MAP4K3; mitogen-activated protein kinase kinase kinase kinase
hsa:25851,0.0,0.0,9.528753918366337e-07,7.02989631183933e-06,0.0,7.6512995e-05,False,TECPR1; tectonin beta-propeller repeat containing
hsa:391195,0.0,0.0,3.107030638168317e-06,2.4583765094499388e-05,0.0,0.00033118573,False,OR2T33; olfactory receptor family 2 subfamily T member
hsa:26224,0.0,0.0,0.0002974740678066337,0.0008739771005648348,0.0,0.0045107696,False,FBXL3; F-box and leucine rich repeat protein
hsa:1460,0.0,0.0,8.380330493945542e-05,0.0001726627041872519,0.0,0.0010852247,False,CSNK2B; casein kinase 2
hsa:4671,1.2215823e-06,0.001513512600182481,3.4622865178485144e-05,6.832419333259689e-05,0.0,0.00047264853,False,NAIP; NLR family apoptosis inhibitory
hsa:10097,1.15112635e-06,0.0014262192855340721,5.824517510465342e-05,0.00012523717986739636,0.0,0.00064139324,False,ACTR2; actin related protein
hsa:1182,0.0,0.0,6.695879306064355e-06,2.2118761535506836e-05,0.0,0.00018934018,False,CLCN3; chloride voltage-gated channel
hsa:406985,-0.0,0.0,0.0,0.0,-0.0,-0.0,False,MIR200C; microRNA
hsa:9538,0.0,0.0,7.619840585913714e-05,0.00019325775404874853,0.0,0.0015881234,False,EI24; EI24 autophagy associated transmembrane
hsa:5986,6.962478449999999e-05,0.08626351955634907,0.0007277688310736143,0.0009775243195801566,0.0,0.004707115,False,RFNG; RFNG O-fucosylpeptide
hsa:84914,0.0,0.0,1.0646448173069307e-07,2.0032347167118777e-07,0.0,9.923889e-07,False,ZNF587; zinc finger protein
hsa:79731,0.0,0.0,9.654369240117822e-06,3.245452036527518e-05,0.0,0.00023182215,False,NARS2; asparaginyl-tRNA synthetase 2
hsa:63036,0.0,0.0,5.363450547920791e-06,1.726802495514316e-05,0.0,0.00016802925,False,CELA2A; chymotrypsin like elastase
hsa:55680,0.0,0.0,1.7472394522549506e-07,3.768220394385177e-07,0.0,1.8868034e-06,False,RUFY2; RUN and FYVE domain containing
hsa:3313,0.0,0.0,2.685646141178218e-06,1.5657154113351657e-05,0.0,0.00018044033,False,HSPA9; heat shock protein family A (Hsp70) member
hsa:23389,4.0350038000000004e-07,0.0004999277652503799,3.834948193791586e-06,1.3060675924763975e-05,0.0,0.00015055868,False,MED13L; mediator complex subunit
hsa:147837,0.0,0.0,7.831958857673268e-09,2.6721724751799647e-08,0.0,2.0522116e-07,False,ZNF563; zinc finger protein
hsa:150572,0.0,0.0,4.058461528729209e-07,2.3690490364961103e-06,0.0,2.194491e-05,False,SMYD1; SET and MYND domain containing
hsa:1606,0.0,0.0,0.00012579883410811883,0.0003179954299932427,0.0,0.0020905696,False,DGKA; diacylglycerol kinase
hsa:55769,1.9204618000000003e-08,2.379408356251665e-05,8.38747306272277e-08,1.4952640215951718e-07,0.0,1.2176913e-06,False,ZNF83; zinc finger protein
hsa:23438,9.6203738e-07,0.0011919423656322962,2.0608621535054455e-05,7.007985444017481e-05,0.0,0.00039543913,False,HARS2; histidyl-tRNA synthetase 2
hsa:55114,0.0,0.0,3.219212225049505e-06,1.7077457582009517e-05,0.0,0.0001640679,False,ARHGAP17; Rho GTPase activating protein
hsa:10599,0.0,0.0,7.959677647668317e-06,3.7655439144067936e-05,-0.0,0.000402777,False,SLCO1B1; solute carrier organic anion transporter family member
hsa:9184,9.3717967e-08,0.0001161144230052989,1.783403057259853e-05,6.669487274170232e-05,0.0,0.00048172227,False,BUB3; BUB3 mitotic checkpoint
hsa:9896,0.0,0.0,2.169424091509406e-05,8.236223747757383e-05,0.0,0.0006280845,False,FIG4; FIG4 phosphoinositide
hsa:2626,4.01401275e-09,4.973270220449438e-06,5.80698902642822e-06,3.703044811714644e-05,0.0,0.00048997375,False,GATA4; GATA binding protein
hsa:6627,0.0,0.0,4.278199837762377e-07,1.0956680398878199e-06,0.0,6.5998993e-06,False,SNRPA1; small nuclear ribonucleoprotein polypeptide
hsa:27087,0.0,0.0,0.00013837698757673266,0.00030739279765803974,0.0,0.001470844,False,B3GAT1; beta-1
hsa:56955,0.0,0.0,1.4539585678331682e-06,1.622902987635449e-05,0.0,0.00022988152,False,MEPE; matrix extracellular
hsa:2947,0.000102755085,0.1273112060319815,0.00027891133926237624,0.00040330515899276553,0.0,0.00286161,False,GSTM3; glutathione S-transferase mu
hsa:22977,6.457937350000001e-07,0.0008001237043475548,3.1612258410767334e-05,0.00010132564448541645,0.0,0.0008820333,False,AKR7A3; aldo-keto reductase family 7 member
hsa:29093,0.0,0.0,2.259428389010545e-07,5.325647456030778e-07,0.0,4.192075e-06,False,MRPL22; mitochondrial ribosomal protein
hsa:3118,0.0,0.0,0.0001276151551857921,0.0002699061281488354,0.0,0.0016603118,False,HLA-DQA2; major histocompatibility complex
hsa:6472,2.24723485e-05,0.02784272710110639,0.00025657334977742573,0.0006156265471917208,0.0,0.005175607,False,SHMT2; serine hydroxymethyltransferase
hsa:5726,0.0,0.0,7.868883371881189e-05,0.0002791413689943797,0.0,0.0028371844,False,TAS2R38; taste 2 receptor member
hsa:26271,0.0,0.0,8.406076092376235e-07,2.0552378930868035e-06,0.0,1.8947816e-05,False,FBXO5; F-box protein
hsa:7122,1.71647555e-06,0.002126674046300568,1.784231410111386e-05,5.34351634195823e-05,0.0,0.00043217494,False,CLDN5; claudin
hsa:6359,0.0,0.0,3.918217033946784e-05,0.00032223668648199,0.0,0.0038347912,False,CCL15; C-C motif chemokine ligand
hsa:5567,0.0039081358,4.842091094905551,0.004597186136613861,0.0039520197462483,0.0,0.014597563,True,PRKACB; protein kinase cAMP-activated catalytic subunit
hsa:2693,0.0,0.0,9.726122517821782e-08,9.810455584321641e-07,0.0,1.3331215e-05,False,GHSR; growth hormone secretagogue
hsa:145482,7.813561e-06,0.009680823818251479,4.4320579585544545e-05,0.00012409877458495944,0.0,0.0009438015,False,PTGR2; prostaglandin reductase
hsa:480,2.9278537000000002e-05,0.03627543937433358,0.0001861222793077228,0.0003575046994626831,0.0,0.0021762683,False,ATP1A4; ATPase Na+/K+ transporting subunit alpha
hsa:891,1.1630498e-05,0.014409921680591756,0.00013493816569980197,0.00024632132137845556,0.0,0.0009439431,False,CCNB1; cyclin
hsa:26659,0.0,0.0,1.4658717985148512e-06,9.64443683145335e-06,0.0,0.00011684279,False,OR7A5; olfactory receptor family 7 subfamily A member
hsa:79852,2.08209235e-08,2.5796649202174524e-05,1.1513833976089115e-07,2.508215101047754e-07,0.0,1.9391848e-06,False,EPHX3; epoxide hydrolase
hsa:9076,0.0,0.0,9.693420100253467e-06,4.72423187379201e-05,0.0,0.00034322718,False,CLDN1; claudin
hsa:55589,0.0,0.0,4.089529342987625e-06,4.139460337562382e-05,0.0,0.00057760713,False,BMP2K; BMP2 inducible
hsa:27349,1.08450845e-06,0.0013436812272733256,6.0626165947698046e-05,0.00016764705521475095,0.0,0.0014033838,False,MCAT; malonyl-CoA-acyl carrier protein
hsa:122809,7.4257528e-06,0.009200338306015353,0.00016545464169257426,0.00032842025747619965,0.0,0.0016427704,False,SOCS4; suppressor of cytokine signaling
hsa:64806,0.0,0.0,1.0447375920396042e-06,4.0211135173649765e-06,0.0,4.1191095e-05,False,IL25; interleukin
hsa:8867,4.07120935e-07,0.0005044135502950336,6.271760570884307e-05,0.00023508088065891713,0.0,0.0016085574,False,SYNJ1; synaptojanin
hsa:8744,0.0,0.0,3.4757732437400987e-06,1.623751055524945e-05,0.0,0.00013709332,False,TNFSF9; TNF superfamily member
hsa:940,3.6238598e-06,0.004489879616457086,5.016983706661386e-05,0.00011921475570323339,0.0,0.0007998422,False,CD28; CD28
hsa:993,1.6265232999999998e-06,0.0020152252607461563,1.2393699747707923e-05,3.760026491128752e-05,0.0,0.00028564443,False,CDC25A; cell division cycle
hsa:93134,9.874183e-10,1.2233887464649455e-06,8.302860877499998e-08,1.4658216002414045e-07,0.0,6.279303e-07,False,ZNF561; zinc finger protein
hsa:2005,3.13841715e-08,3.888427248130389e-05,6.611461402673266e-06,2.0376227050013247e-05,0.0,0.0001367511,False,ELK4; ETS transcription factor
hsa:8877,0.0,0.0,4.2607466987128716e-05,0.00014435275430945674,0.0,0.001067229,False,SPHK1; sphingosine kinase
hsa:6318,0.0,0.0,1.8697776195544554e-07,1.5232754530360697e-06,0.0,1.772966e-05,False,SERPINB4; serpin family B member
hsa:10317,3.6763308499999997e-06,0.004554890050317993,0.00017641141602084157,0.0003938807702664768,0.0,0.0033916156,False,B3GALT5; beta-1
hsa:80270,0.0,0.0,4.8957785927722776e-05,0.00017601986054853445,0.0,0.0015009589,False,HSD3B7; hydroxy-delta-5-steroid dehydrogenase
hsa:440193,2.4377144e-07,0.0003020272526907337,4.009992053551978e-06,1.2880024690256016e-05,0.0,8.499174e-05,False,CCDC88C; coiled-coil domain containing
hsa:6372,0.0,0.0,2.8617974029009894e-05,0.000106073751251318,0.0,0.0008721534,False,CXCL6; C-X-C motif chemokine ligand
hsa:10161,4.3654463e-07,0.0005408688371196923,1.307064504856436e-05,3.7825062110876824e-05,0.0,0.00023981431,False,LPAR6; lysophosphatidic acid receptor
hsa:6147,1.01923425e-07,0.0001262807982657035,8.254858196386141e-07,1.6211448558705296e-06,0.0,7.700527e-06,False,RPL23A; ribosomal protein
hsa:440138,0.0,0.0,1.2792838260507424e-05,3.890955193913821e-05,0.0,0.00029365093,False,ALG11; ALG11
hsa:26693,0.0,0.0,5.470495430693069e-08,6.095521196555632e-07,0.0,8.5375605e-06,False,OR2V1; olfactory receptor family 2 subfamily V member
hsa:478,0.0016134256000000001,1.9989975092607182,0.0018187488055643568,0.001973658968021611,0.0,0.013740299,True,ATP1A3; ATPase Na+/K+ transporting subunit alpha
hsa:138802,0.0,0.0,1.2546681451980198e-06,1.0913992717736818e-05,-0.0,0.00011325852,False,OR13C8; olfactory receptor family 13 subfamily C member
hsa:5154,0.0,0.0,5.582124106237624e-05,0.00012082692496617211,0.0,0.000636979,False,PDGFA; platelet derived growth factor subunit
hsa:8898,0.0,0.0,5.1662478343465375e-06,1.635631443956157e-05,0.0,0.00015866868,False,MTMR2; myotubularin related protein
hsa:1671,0.0,0.0,1.068217356948317e-05,7.239925264493459e-05,0.0,0.0009798724,False,DEFA6; defensin alpha
hsa:406900,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR106B; microRNA
hsa:55255,0.0,0.0,1.3439409808440596e-06,3.6825238053589524e-06,0.0,3.1269075e-05,False,WDR41; WD repeat domain
hsa:9227,0.0,0.0,4.7752611076584156e-05,0.00021800843982103783,0.0,0.0022783312,False,LRAT; lecithin retinol
hsa:4338,9.658259500000001e-06,0.011966363174288093,8.161718306237624e-05,0.00019077972655425393,0.0,0.0012847196,False,MOCS2; molybdenum cofactor synthesis
hsa:3783,0.0,0.0,3.43829080450495e-05,0.00014358147038113275,0.0,0.0011082749,False,KCNN4; potassium calcium-activated channel subfamily N member
hsa:5167,0.0,0.0,6.821524047173269e-05,0.0002652584892888911,0.0,0.0033809897,False,ENPP1; ectonucleotide pyrophosphatase/phosphodiesterase
hsa:196513,0.0,0.0,2.410493653638862e-05,0.00010089969384865603,0.0,0.00094367564,False,DCP1B; decapping mRNA
hsa:4783,0.0,0.0,0.00025814182124405945,0.001055114670056847,0.0,0.0100041265,False,NFIL3; nuclear factor
hsa:29927,1.2993392999999998e-06,0.0016098517492127093,0.00012499143967945547,0.0002281173168351982,0.0,0.0016484549,False,SEC61A1; SEC61 translocon subunit alpha
hsa:81448,0.0,0.0,1.2608588267326732e-07,1.6858320407988198e-06,-0.0,2.3917595e-05,False,OR6K2; olfactory receptor family 6 subfamily K member
hsa:6279,1.045318625e-07,0.00012951259281858668,5.230356662605938e-06,1.3220844261434855e-05,0.0,9.131941e-05,False,S100A8; S100 calcium binding protein
hsa:9794,1.69422295e-05,0.020991035825775578,0.0002129754840759901,0.00041418012240197245,0.0,0.0028979746,False,MAML1; mastermind like transcriptional coactivator
hsa:9114,0.0,0.0,5.261059990579206e-05,0.00016008861674617297,0.0,0.0014736578,False,ATP6V0D1; ATPase H+ transporting V0 subunit
hsa:55757,6.564671799999999e-08,8.133478591956191e-05,4.433072192594057e-07,1.2485061867268955e-06,0.0,1.2490002e-05,False,UGGT2; UDP-glucose glycoprotein glucosyltransferase
hsa:22821,2.0949939499999998e-08,2.5956497082767702e-05,8.058166457772276e-07,1.5474415403696955e-06,0.0,9.2608625e-06,False,RASA3; RAS p21 protein activator
hsa:63875,7.70055e-09,9.540805767515788e-06,1.0043627524806729e-07,2.1571690985263447e-07,0.0,1.3672864e-06,False,MRPL17; mitochondrial ribosomal protein
hsa:10766,5.7464012499999997e-08,7.119660048757548e-05,2.563132159638614e-06,1.8549638524808587e-05,0.0,0.00019249336,False,TOB2; transducer of ERBB2
hsa:93034,6.24977585e-09,7.743329694029764e-06,1.5281739698877225e-05,9.28523828496717e-05,0.0,0.0011908051,False,NT5C1B; 5'-nucleotidase
hsa:3039,2.2675433e-06,0.0028094344163380257,0.00011788256428492079,0.00038871435778184025,0.0,0.004980088,False,HBA1; hemoglobin subunit alpha
hsa:3190,0.0,0.0,1.3617220476039614e-06,3.7030195283222377e-06,0.0,3.786981e-05,False,HNRNPK; heterogeneous nuclear ribonucleoprotein
hsa:5586,1.97700505e-07,0.0002449464153008271,8.064725543514847e-07,1.7879215985287549e-06,0.0,1.34565935e-05,False,PKN2; protein kinase
hsa:3172,0.0,0.0,4.676651339921782e-05,0.00021080908773396905,0.0,0.002457126,False,HNF4A; hepatocyte nuclear factor 4
hsa:6204,1.2194633e-08,1.5108872075259349e-05,1.126955179449802e-06,2.0129593548652312e-06,0.0,1.0376134e-05,False,RPS10; ribosomal protein
hsa:55869,1.13522015e-06,0.001406511866622532,5.067477795841586e-05,0.00012363677173874547,0.0,0.0008017491,False,HDAC8; histone deacetylase
hsa:442185,0.0,0.0,6.735453465346534e-08,9.096330023423073e-07,-0.0,1.2913204e-05,False,OR2J1; olfactory receptor family 2 subfamily J member
hsa:91782,0.0,0.0,0.00015198221047528862,0.0005640901624285992,0.0,0.0037376063,False,CHMP7; charged multivesicular body protein
hsa:4831,0.0,0.0,4.606561886074255e-05,0.00015870228674746118,0.0,0.0014651429,False,NME2; NME/NM23 nucleoside diphosphate kinase
hsa:5978,3.5235061e-08,4.3655436716542406e-05,2.577393651762376e-06,1.3652336762614364e-05,0.0,0.000116810355,False,REST; RE1 silencing transcription
hsa:152687,4.1911953e-09,5.192795357607583e-06,5.9016717961435656e-08,1.0005842414226453e-07,0.0,4.7736137e-07,False,ZNF595; zinc finger protein
hsa:53,1.9748719999999997e-05,0.024468213527222657,9.867240090608915e-05,0.00016233771754967674,0.0,0.0009790371,False,ACP2; acid phosphatase 2
hsa:406928,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR137; microRNA
hsa:23511,2.5897483000000002e-08,3.208639060463761e-05,2.2580526072574264e-07,5.548777014062068e-07,0.0,3.2355504e-06,False,NUP188; nucleoporin
hsa:4729,0.0,0.0,5.660684499207921e-06,8.371548452972972e-06,0.0,3.832869e-05,False,NDUFV2; NADH:ubiquinone oxidoreductase core subunit
hsa:1509,0.0,0.0,1.634909086555445e-05,6.662476073246542e-05,0.0,0.00079208886,False,CTSD; cathepsin
hsa:10140,1.42643265e-07,0.00017673175103197604,2.9223702504366337e-06,2.2499672101201034e-05,0.0,0.0002425566,False,TOB1; transducer of ERBB2
hsa:4689,1.27681145e-06,0.0015819402570193294,2.8071312373861403e-05,7.437150609016944e-05,0.0,0.0005729148,False,NCF4; neutrophil cytosolic factor
hsa:55272,0.0,0.0,4.316144296356435e-07,2.0209305258632643e-06,0.0,1.7856255e-05,False,IMP3; IMP U3 small nucleolar ribonucleoprotein
hsa:3040,2.64900595e-06,0.003282057936893293,0.0004062224357011387,0.0008503009030541011,0.0,0.005438997,False,HBA2; hemoglobin subunit alpha
hsa:3764,8.772216400000001e-08,0.00010868575987821208,4.690003334604508e-05,0.00017568128693080847,0.0,0.001426675,False,KCNJ8; potassium inwardly rectifying channel subfamily J member
hsa:5744,0.0,0.0,8.50544806764406e-06,5.248054093960551e-05,0.0,0.0005128738,False,PTHLH; parathyroid hormone like
hsa:662,2.29786265e-07,0.0002846999399273963,2.733337850820397e-05,5.7548721893799484e-05,0.0,0.00037794796,False,BNIP1; BCL2 interacting protein
hsa:23288,2.3823753e-07,0.0002951708644528918,9.339589576205447e-05,0.00023216626718577715,0.0,0.0013632543,False,IQCE; IQ motif containing
hsa:8449,7.9246425e-09,9.818451262507322e-06,7.260567209559403e-07,2.355105735219194e-06,0.0,1.41983055e-05,False,DHX16; DEAH-box helicase
hsa:26219,0.0,0.0,3.1417874804950493e-07,1.7754450504763528e-06,0.0,1.644491e-05,False,OR1J4; olfactory receptor family 1 subfamily J member
hsa:3795,0.0,0.0,0.000133519876651901,0.00045256396885506715,0.0,0.0027942737,False,KHK;
hsa:23594,1.8356895e-07,0.00022743774105704368,9.746536201084152e-07,1.6905182603624493e-06,0.0,1.0560615e-05,False,ORC6; origin recognition complex subunit
hsa:8851,2.8103449e-05,0.03481953215111724,0.0003411002350243832,0.0007506565182527489,0.0,0.0057559717,False,CDK5R1; cyclin dependent kinase 5 regulatory subunit
hsa:5096,7.4965335e-07,0.0009288033978504824,0.0004339953137315843,0.0014152044861824975,0.0,0.0088620605,False,PCCB; propionyl-CoA carboxylase subunit
hsa:259292,0.0,0.0,2.0179776907673277e-05,5.245800413174176e-05,0.0,0.0003615971,False,TAS2R46; taste 2 receptor member
hsa:9587,0.0,0.0,1.0071326172836638e-06,2.360321840624765e-06,0.0,1.8985518e-05,False,MAD2L1BP; MAD2L1 binding
hsa:415117,0.0,0.0,9.339901009438911e-07,3.276453979356287e-06,0.0,2.6273814e-05,False,STX19; syntaxin
hsa:2260,0.0,0.0,1.4889499957425744e-05,4.613738542849364e-05,0.0,0.00027671186,False,FGFR1; fibroblast growth factor receptor
hsa:3426,0.0,0.0,5.7145519967574256e-05,0.00038250693640471377,0.0,0.00331599,False,CFI; complement factor
hsa:2030,0.0,0.0,4.952694454616336e-06,2.7861653723890114e-05,0.0,0.00037861406,False,SLC29A1; solute carrier family 29 member 1 (Augustine blood
hsa:2819,0.0,0.0,8.306048582866334e-07,3.342236001425207e-06,0.0,3.3705855e-05,False,GPD1; glycerol-3-phosphate dehydrogenase
hsa:10380,0.0,0.0,9.694130481170792e-05,0.00027256818317338965,0.0,0.0017660088,False,BPNT1; 3'(2')
hsa:285521,8.622926e-09,1.0683608588173813e-05,2.527499537615348e-07,5.00795122569507e-07,0.0,2.882013e-06,False,COX18; cytochrome c oxidase assembly factor
hsa:4714,0.0,0.0,6.586268575594061e-06,1.5443760362192393e-05,0.0,0.00010294359,False,NDUFB8; NADH:ubiquinone oxidoreductase subunit
hsa:3913,0.0,0.0,0.00010550606382178217,0.00021750505367727153,0.0,0.0012109202,False,LAMB2; laminin subunit beta
hsa:2670,0.0,0.0,2.3550251620081185e-05,0.00016341192896871532,0.0,0.001526295,False,GFAP; glial fibrillary acidic
hsa:2978,1.232862275e-05,0.015274882318630015,0.00010015116336386143,0.00023736011882763652,0.0,0.001929793,False,GUCA1A; guanylate cyclase activator
hsa:2720,0.0,0.0,0.0001616199685589109,0.00035435712420326293,0.0,0.0028729923,False,GLB1; galactosidase beta
hsa:4052,1.124456125e-07,0.0001393175485220985,3.13665514060792e-05,0.0001727910296794801,0.0,0.0014478472,False,LTBP1; latent transforming growth factor beta binding protein
hsa:6632,0.0,0.0,4.321878881173268e-06,1.6201364790591973e-05,0.0,0.00016185566,False,SNRPD1; small nuclear ribonucleoprotein D1
hsa:2557,0.0,0.0,8.129718151900986e-05,0.0002906589634241266,0.0,0.0028619806,False,GABRA4; gamma-aminobutyric acid type A receptor subunit
hsa:10912,0.0,0.0,7.485711034470298e-05,0.00019232744913637417,0.0,0.0013582105,False,GADD45G; growth arrest and DNA damage inducible
hsa:2254,2.59042595e-07,0.0003209478653353666,2.2645979810341593e-05,6.002233328573614e-05,0.0,0.00036164714,False,FGF9; fibroblast growth factor
hsa:5515,4.1877091e-05,0.05188476035342717,0.0005110360489653465,0.0009512609794208573,0.0,0.0077030784,False,PPP2CA; protein phosphatase 2 catalytic subunit
hsa:2892,0.0,0.0,8.279236573787127e-05,0.0002980674184515372,0.0,0.0024443155,False,GRIA3; glutamate ionotropic receptor AMPA type subunit
hsa:957,0.0,0.0,4.040429147542346e-05,0.00013476741902171096,0.0,0.0008371548,False,ENTPD5; ectonucleoside triphosphate diphosphohydrolase 5
hsa:57152,0.0,0.0,2.402627150792079e-07,1.6212673982631034e-06,0.0,2.0575148e-05,False,SLURP1; secreted LY6/PLAUR domain containing
hsa:58500,1.1879239250000001e-08,1.4718106414489869e-05,9.275352087475249e-08,1.647879698263439e-07,0.0,1.2808091e-06,False,ZNF250; zinc finger protein
hsa:1149,0.0,0.0,9.527953692742575e-08,5.318896396516223e-07,0.0,5.7037378e-06,False,CIDEA; cell death inducing DFFA like effector
hsa:5308,0.0,0.0,6.002306285354952e-07,4.076323054467279e-06,0.0,5.0760445e-05,False,PITX2; paired like homeodomain
hsa:810,0.0,0.0,6.444709282178218e-07,2.8372770879522945e-06,0.0,3.132219e-05,False,CALML3; calmodulin like
hsa:760,1.0367038e-05,0.012844523565518743,0.0002292565483091089,0.00036159255363643915,0.0,0.0020092214,False,CA2; carbonic anhydrase
hsa:113451,0.0,0.0,1.418258528252228e-05,6.780364521249724e-05,0.0,0.00059850834,False,AZIN2; antizyme inhibitor
hsa:3280,0.0,0.0,0.0003824250985990099,0.0011527682277859641,0.0,0.006258311,False,HES1; hes family bHLH transcription factor
hsa:240,0.0,0.0,7.276776973585642e-05,0.00018424558711868815,0.0,0.0010129191,False,ALOX5; arachidonate
hsa:7363,0.0,0.0,2.813932763975248e-05,0.00013796637064064713,0.0,0.0011819198,False,UGT2B4; UDP glucuronosyltransferase family 2 member
hsa:441024,5.2214534e-07,0.0006469261638913444,9.357141348547032e-06,3.420765129906416e-05,0.0,0.00038178355,False,MTHFD2L; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2
hsa:1593,0.0,0.0,0.00017207144819702971,0.00047673320747216485,0.0,0.0025740364,False,CYP27A1; cytochrome P450 family 27 subfamily A member
hsa:128178,3.149019e-08,3.9015626984068415e-05,3.1775988624059396e-07,1.0044980797124553e-06,0.0,9.128009e-06,False,EDARADD; EDAR associated via death
hsa:6667,0.0,0.0,6.167178155247524e-05,0.0001365178070485218,0.0,0.0010830483,False,SP1; Sp1 transcription
hsa:6206,1.20507485e-07,0.00014930602462380252,1.4679900005386142e-06,2.821336957721095e-06,0.0,1.26523655e-05,False,RPS12; ribosomal protein
hsa:2137,0.0,0.0,0.00012182301351489107,0.000505032869067449,0.0,0.0050184326,False,EXTL3; exostosin like glycosyltransferase
hsa:2895,6.93257385e-07,0.000858930083848675,9.407569177017328e-06,2.1864535213453136e-05,0.0,0.00017196176,False,GRID2; glutamate ionotropic receptor delta type subunit
hsa:11009,0.0,0.0,1.4152864658287128e-05,5.510398497946249e-05,0.0,0.00047018926,False,IL24; interleukin
hsa:1636,7.615007199999999e-05,0.09434820189912961,0.00043570347470643574,0.0007269542898619119,0.0,0.0038647675,False,ACE; angiotensin I converting
hsa:50837,0.0,0.0,2.786858572178218e-05,7.37094562754308e-05,-0.0,0.00058130326,False,TAS2R7; taste 2 receptor member
hsa:90338,0.0,0.0,3.88993437299505e-08,8.758705896054802e-08,0.0,4.6817794e-07,False,ZNF160; zinc finger protein
hsa:147111,1.7472043e-07,0.00021647462664963393,9.215711748021286e-06,3.4449107005472945e-05,0.0,0.0002749936,False,NOTUM; notum
hsa:84706,0.0,0.0,4.160992987930694e-05,8.095207636999872e-05,0.0,0.00042075926,False,GPT2; glutamic--pyruvic transaminase
hsa:3840,0.0,0.0,5.233970186039603e-07,1.1050903712594141e-06,0.0,8.496766e-06,False,KPNA4; karyopherin subunit alpha
hsa:2516,0.0,0.0,4.642684960098021e-06,2.1037467738714746e-05,0.0,0.00022857146,False,NR5A1; nuclear receptor subfamily 5 group A member
hsa:28984,9.25232e-09,1.1463413395004472e-05,4.107537182359405e-06,1.4209231546615007e-05,0.0,9.144699e-05,False,RGCC; regulator of cell
hsa:1203,1.99751075e-07,0.00024748702474855424,2.128019876266337e-06,4.544958047572432e-06,0.0,2.216802e-05,False,CLN5; CLN5 intracellular trafficking
hsa:974,2.4407397999999997e-07,0.00030240209284850217,7.149194249772284e-06,1.9581153473468486e-05,0.0,0.00015942626,False,CD79B; CD79b
hsa:51166,4.0581209e-05,0.05027919212003865,0.0001358493624077227,0.00018568288987906557,0.0,0.00091427815,False,AADAT; aminoadipate
hsa:3174,0.0,0.0,1.654696675495049e-05,5.567068007175878e-05,0.0,0.00050405046,False,HNF4G; hepatocyte nuclear factor 4
hsa:84076,0.0,0.0,1.809401498795297e-05,8.373687962499959e-05,0.0,0.0008329321,False,TKTL2; transketolase like
hsa:405753,0.0,0.0,1.5796388432645545e-06,6.7448028340802175e-06,0.0,6.920736e-05,False,DUOXA2; dual oxidase maturation factor
hsa:338675,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5AP2; olfactory receptor family 5 subfamily AP member
hsa:6280,1.3485348e-07,0.0001670803851352923,3.20730008060693e-05,0.00010689798225950182,0.0,0.00063633424,False,S100A9; S100 calcium binding protein
hsa:1965,0.0,0.0,5.205872090841584e-06,1.622765913646751e-05,0.0,0.00013335531,False,EIF2S1; eukaryotic translation initiation factor 2 subunit
hsa:29116,5.21351285e-07,0.0006459423478621355,2.7070679394108907e-05,7.897488293666467e-05,0.0,0.00066285644,False,MYLIP; myosin regulatory light chain interacting
hsa:27127,0.0,0.0,3.6376782172940595e-08,9.171417275576762e-08,0.0,5.4326085e-07,False,SMC1B; structural maintenance of chromosomes
hsa:201163,3.6387043000000003e-06,0.004508271613290545,4.672129661683168e-06,5.4431396982055514e-06,0.0,2.7771326e-05,False,FLCN;
hsa:23645,2.18716095e-07,0.0002709842518553261,1.6172145003712874e-06,5.391054768338059e-06,0.0,6.058606e-05,False,PPP1R15A; protein phosphatase 1 regulatory subunit
hsa:1352,0.0,0.0,2.3396031856549504e-05,6.595025014866692e-05,0.0,0.00048226435,False,COX10; cytochrome c oxidase assembly factor heme A:farnesyltransferase
hsa:27102,9.0341835e-08,0.00011193147248131106,1.4663388851336632e-06,3.529594023450275e-06,0.0,2.8108678e-05,False,EIF2AK1; eukaryotic translation initiation factor 2 alpha kinase
hsa:1031,0.0,0.0,1.3267137758792082e-05,2.853597239261786e-05,0.0,0.00024112758,False,CDKN2C; cyclin dependent kinase inhibitor
hsa:57192,1.13021135e-07,0.00014003060776946851,3.315436173910891e-06,6.6636607620588264e-06,0.0,5.0721763e-05,False,MCOLN1; mucolipin TRP cation channel
hsa:51347,0.0,0.0,5.13183594260396e-07,1.0980490997182888e-06,0.0,6.2574522e-06,False,TAOK3; TAO kinase
hsa:9040,0.0,0.0,3.7893112143564356e-07,9.907595877397543e-07,0.0,5.2333885e-06,False,UBE2M; ubiquitin conjugating enzyme E2
hsa:6505,0.0,0.0,6.296907509029704e-05,0.0001419935510787983,0.0,0.0009934021,False,SLC1A1; solute carrier family 1 member
hsa:3303,0.0,0.0,8.645695710217826e-05,0.00019353768661178967,0.0,0.0012129729,False,HSPA1A; heat shock protein family A (Hsp70) member
hsa:8535,0.0,0.0,4.233828464623606e-05,0.00015272532356262535,0.0,0.00090708444,False,CBX4; chromobox
hsa:1515,4.69592025e-07,0.0005818138055722538,1.4915161754121285e-06,2.5995609668822176e-06,0.0,2.0486736e-05,False,CTSV; cathepsin
hsa:2171,2.3853205e-06,0.002955357680136308,0.00019630041160969818,0.000671283874007069,0.0,0.00694508,False,FABP5; fatty acid binding protein
hsa:1290,0.0,0.0,4.9152758320891086e-05,0.00022884239400463557,0.0,0.002013504,False,COL5A2; collagen type V alpha 2
hsa:200186,1.47338425e-05,0.018254894715529314,4.304777658178219e-05,7.183763384270308e-05,0.0,0.0004433391,False,CRTC2; CREB regulated transcription coactivator
hsa:81889,3.5463549e-07,0.0004393852813575379,7.602035184197478e-05,0.0002091396561817036,0.0,0.0013205723,False,FAHD1; fumarylacetoacetate hydrolase domain containing
hsa:79369,4.0596467e-05,0.050298096433938407,0.00040088197161475226,0.0007789240582301898,0.0,0.0049999407,False,B3GNT4; UDP-GlcNAc:betaGal beta-1
hsa:2559,0.0,0.0,4.483981102475247e-06,2.6985814736536825e-05,0.0,0.00034001342,False,GABRA6; gamma-aminobutyric acid type A receptor subunit
hsa:6324,2.45349665e-08,3.0398263745967062e-05,3.2785794055891095e-07,1.1048479951473214e-06,0.0,9.986297e-06,False,SCN1B; sodium voltage-gated channel beta subunit
hsa:286365,0.0,0.0,5.3185691603960406e-06,2.133703145223835e-05,-0.0,0.00020921623,False,OR13D1; olfactory receptor family 13 subfamily D member
hsa:1588,0.0,0.0,4.0844278676331195e-05,0.0001431913328598533,0.0,0.00093004847,False,CYP19A1; cytochrome P450 family 19 subfamily A member
hsa:92,3.20442675e-05,0.039702116365690605,0.00019171314887400987,0.00034544944321466116,0.0,0.001734957,False,ACVR2A; activin A receptor type
hsa:6883,4.816544e-07,0.0005967588130028837,3.0848249516066828e-06,1.467628454223978e-05,0.0,0.00016653757,False,TAF12; TATA-box binding protein associated factor
hsa:26864,0.0,0.0,1.70593054009901e-07,1.1116506019612271e-06,0.0,1.3054118e-05,False,RNVU1-7; RNA
hsa:253260,1.36885325e-08,1.6959779473521673e-05,5.978214859024754e-07,1.808554836020604e-06,0.0,1.3277741e-05,False,RICTOR; RPTOR independent companion of MTOR complex
hsa:58985,0.0,0.0,1.1738447895645298e-05,4.2142650945786434e-05,0.0,0.00032836723,False,IL22RA1; interleukin 22 receptor subunit alpha
hsa:22856,0.0,0.0,5.3626912795133645e-05,0.00019837067335571958,0.0,0.0017833622,False,CHSY1; chondroitin sulfate synthase
hsa:3445,0.0,0.0,3.5556311881188116e-08,5.053501415332233e-07,0.0,7.182375e-06,False,IFNA8; interferon alpha
hsa:5737,2.06407185e-06,0.0025573379318421393,1.4494592605297035e-05,3.65168417369912e-05,0.0,0.00032232367,False,PTGFR; prostaglandin F
hsa:9699,2.9337058500000002e-06,0.003634794617770784,4.849726395048661e-05,0.00012573698883969263,0.0,0.0011270846,False,RIMS2; regulating synaptic membrane exocytosis
hsa:1137,5.7738449e-06,0.007153662105000505,0.0001967458954795049,0.0006336767962046521,0.0,0.0054427637,False,CHRNA4; cholinergic receptor nicotinic alpha 4
hsa:6531,3.9817702e-07,0.0004933322436589919,2.000330381285446e-05,8.133253833045522e-05,0.0,0.0008056947,False,SLC6A3; solute carrier family 6 member
hsa:9586,0.0,0.0,0.0002932626518861387,0.0006740240585732607,0.0,0.0038198996,False,CREB5; cAMP responsive element binding protein
hsa:10379,0.0,0.0,9.069530996237623e-05,0.00043214659291524794,0.0,0.0038369508,False,IRF9; interferon regulatory factor
hsa:146540,8.7638747e-10,1.0858240811831066e-06,9.472178029573265e-08,1.773763917180244e-07,0.0,9.324882e-07,False,ZNF785; zinc finger protein
hsa:114609,0.0,0.0,1.7480218032821783e-05,3.931256634333907e-05,0.0,0.0001926751,False,TIRAP; TIR domain containing adaptor
hsa:7516,1.54124365e-07,0.00019095657199897522,3.0990467309460394e-05,8.010826231767778e-05,0.0,0.0006398518,False,XRCC2; X-ray repair cross complementing
hsa:26985,2.850218e-07,0.00035313550763357577,1.9305377875821775e-06,3.890306807286314e-06,0.0,3.4579178e-05,False,AP3M1; adaptor related protein complex 3 subunit mu
hsa:4624,0.0,0.0,5.505155482706185e-05,0.00015001210453780968,0.0,0.0009012469,False,MYH6; myosin heavy chain
hsa:29889,0.0,0.0,8.687712355487131e-07,2.879211516267906e-06,0.0,3.3095625e-05,False,GNL2; G protein nucleolar
hsa:353,0.0,0.0,1.4023421612549504e-06,4.612974846346273e-06,0.0,4.8430058e-05,False,APRT; adenine
hsa:904,1.33667675e-06,0.001656111997935766,3.0446914514985156e-05,7.349534432979474e-05,0.0,0.0005453565,False,CCNT1; cyclin
hsa:163071,3.4436555e-12,4.266610599987984e-09,8.671454550346536e-09,2.3808722682315634e-08,0.0,1.8122223e-07,False,ZNF114; zinc finger protein
hsa:5908,0.0,0.0,7.367187086089108e-05,0.00022830104399968357,0.0,0.0016437165,False,RAP1B; RAP1B
hsa:54894,1.5726562999999999e-09,1.9484852766828394e-06,7.022322434745044e-07,3.770853045621008e-06,0.0,4.452515e-05,False,RNF43; ring finger protein
hsa:10262,1.4650091499999998e-09,1.8151129137247861e-06,1.4123030828861386e-07,2.5752610374751674e-07,0.0,1.4241085e-06,False,SF3B4; splicing factor 3b subunit
hsa:56919,8.5470045e-08,0.0001058954358176798,3.389553623722772e-07,5.608786787754587e-07,0.0,3.2031141e-06,False,DHX33; DEAH-box helicase
hsa:2204,0.0,0.0,9.562493829834653e-06,7.973727880601518e-05,0.0,0.00097049616,False,FCAR; Fc alpha
hsa:2356,9.5025735e-07,0.0011773471772151692,0.00014931508690232671,0.00026180878445456927,0.0,0.001264597,False,FPGS; folylpolyglutamate
hsa:2308,0.0,0.0,6.494774382673267e-05,0.00021737815636942615,0.0,0.002353744,False,FOXO1; forkhead box
hsa:4830,0.0,0.0,0.0005085065932696536,0.0010832362738243822,0.0,0.005418006,False,NME1; NME/NM23 nucleoside diphosphate kinase
hsa:7005,0.0,0.0,0.00010647645730693069,0.00025730030048650777,0.0,0.0014100434,False,TEAD3; TEA domain transcription factor
hsa:8392,0.0,0.0,1.6275960851846532e-05,7.013949453478223e-05,0.0,0.0006686591,False,OR3A3; olfactory receptor family 3 subfamily A member
hsa:6906,0.0,0.0,9.214942416972278e-07,8.216573344744566e-06,0.0,0.00010442191,False,SERPINA7; serpin family A member
hsa:23562,0.0,0.0,2.011777516898515e-06,9.655768239720005e-06,0.0,9.2718874e-05,False,CLDN14; claudin
hsa:80198,6.5595285e-07,0.0008127106160596866,0.00010843136842943562,0.0003409674815522399,0.0,0.003009086,False,MUS81; MUS81 structure-specific endonuclease
hsa:120892,5.8455535e-10,7.242507424420607e-07,2.7752426103737637e-08,5.62173588243964e-08,0.0,3.0732085e-07,False,LRRK2; leucine rich repeat kinase
hsa:84447,0.0,0.0,1.3875172395594064e-06,4.628071710327241e-06,0.0,4.5780165e-05,False,SYVN1; synoviolin
hsa:285641,0.0,0.0,1.2945525788960395e-07,6.298488363079452e-07,0.0,4.940871e-06,False,SLC36A3; solute carrier family 36 member
hsa:51802,0.0,0.0,4.882581945544555e-08,6.605324269215885e-07,-0.0,9.382884e-06,False,ASIC5; acid sensing ion channel subunit family member
hsa:8536,1.2484062e-05,0.015467468003145841,4.778782147891088e-05,8.693378837464985e-05,0.0,0.0005618812,False,CAMK1; calcium/calmodulin dependent protein kinase
hsa:10956,0.0,0.0,4.235950608133664e-07,1.1220618473054157e-06,0.0,6.1292994e-06,False,OS9; OS9 endoplasmic reticulum
hsa:23096,2.977279e-09,3.6887807565308506e-06,2.569695216747525e-07,5.41442716666257e-07,0.0,3.0997205e-06,False,IQSEC2; IQ motif and Sec7 domain ArfGEF
hsa:30845,0.0,0.0,7.154394277325247e-07,1.672754581725354e-06,0.0,1.1477674e-05,False,EHD3; EH domain containing
hsa:51289,0.0,0.0,1.1642002707326732e-07,4.84122316246837e-07,0.0,4.3977657e-06,False,RXFP3; relaxin family peptide receptor
hsa:340273,0.0,0.0,5.0211678886584174e-05,0.0002782301689261305,0.0,0.0029256714,False,ABCB5; ATP binding cassette subfamily B member
hsa:2213,0.0,0.0,5.1304864912450486e-05,0.00020591671929680137,0.0,0.0017401339,False,FCGR2B; Fc gamma receptor
hsa:115650,0.00016473835,0.20410705726357659,0.0004306498833683171,0.0007215561926690768,0.0,0.0039779753,False,TNFRSF13C; TNF receptor superfamily member
hsa:1459,0.0,0.0,2.1510943650871286e-05,5.676346927605711e-05,0.0,0.0005077585,False,CSNK2A2; casein kinase 2 alpha
hsa:26687,0.0,0.0,1.8702117976732675e-06,1.9065410765136106e-05,-0.0,0.0002566882,False,OR4E1; olfactory receptor family 4 subfamily E member
hsa:51449,5.7185878e-10,7.085199818751314e-07,2.9003736849334156e-05,7.98785103129597e-05,0.0,0.000501401,False,PCYOX1; prenylcysteine oxidase
hsa:63893,5.1106608500000005e-08,6.33199219711542e-05,4.92519410871287e-07,8.970581040622886e-07,0.0,4.27335e-06,False,UBE2O; ubiquitin conjugating enzyme E2
hsa:65260,0.0,0.0,3.7904970704950494e-07,6.410655081097915e-07,0.0,3.3318668e-06,False,COA7; cytochrome c oxidase assembly factor
hsa:3416,6.215975e-05,0.07701451212021734,0.00047384680815628716,0.0008719966211212308,0.0,0.0046205716,False,IDE; insulin degrading
hsa:6487,5.4684146e-05,0.06775240931472108,0.00040479335266797016,0.0009160408233023826,0.0,0.006379498,False,ST3GAL3; ST3 beta-galactoside alpha-2
hsa:22835,0.0,0.0,6.668422046237626e-08,1.08886866955056e-07,0.0,4.620873e-07,False,ZFP30; ZFP30 zinc finger
hsa:6882,0.0,0.0,9.215801529950499e-07,2.5525022027064224e-06,0.0,2.15739e-05,False,TAF11; TATA-box binding protein associated factor
hsa:5532,0.00013365988,0.16560154196641388,0.0005559644842178219,0.0009662900941514605,0.0,0.0049582166,False,PPP3CB; protein phosphatase 3 catalytic subunit
hsa:7296,0.0,0.0,7.672859913861389e-05,0.00018063548680360313,0.0,0.00096921355,False,TXNRD1; thioredoxin reductase
hsa:359,0.0,0.0,4.125420338859406e-06,1.5518633340484542e-05,0.0,0.00013190258,False,AQP2; aquaporin
hsa:9367,0.0,0.0,8.797993803775253e-07,4.982396756723717e-06,0.0,6.0951676e-05,False,RAB9A; RAB9A
hsa:55894,0.0,0.0,9.123042081188118e-08,1.0240016210004054e-06,0.0,1.4416375e-05,False,DEFB103B; defensin beta
hsa:10963,5.166141e-09,6.4007308372258846e-06,4.0107234995396034e-08,7.698206324629527e-08,0.0,4.0207001e-07,False,STIP1; stress induced phosphoprotein
hsa:1280,9.1137705e-06,0.011291753725411207,3.930147001569307e-05,7.274073948654905e-05,0.0,0.00051898987,False,COL2A1; collagen type II alpha 1
hsa:10075,9.563991699999999e-08,0.00011849567520739833,4.1936533252574264e-07,6.510256644675488e-07,0.0,3.57292e-06,False,HUWE1; HECT
hsa:2648,7.5052662e-06,0.009298853594574585,0.0002049398714346535,0.0004920257543507596,0.0,0.0034455245,False,KAT2A; lysine acetyltransferase
hsa:9487,9.2963065e-06,0.011517911664984257,5.53174414807921e-05,0.0001181953826193541,0.0,0.0008540732,False,PIGL; phosphatidylinositol glycan anchor biosynthesis class
hsa:8940,0.0,0.0,6.981451685537078e-05,0.00018806311540220055,0.0,0.0014642355,False,TOP3B; DNA topoisomerase III
hsa:2072,1.56272e-08,1.9361744276723446e-05,2.154825664485643e-05,5.6180906225340735e-05,0.0,0.00035365624,False,ERCC4; ERCC excision repair 4
hsa:6879,1.2863854000000002e-07,0.00015938021626465783,2.1810914941386127e-06,4.86484335792371e-06,0.0,2.9212442e-05,False,TAF7; TATA-box binding protein associated factor
hsa:10933,8.180081e-08,0.00010134933736362511,8.132339539647823e-06,2.49686495886874e-05,0.0,0.00016479516,False,MORF4L1; mortality factor 4 like
hsa:90353,0.0,0.0,2.750999912687623e-05,8.439846558007223e-05,0.0,0.0006170664,False,CTU1; cytosolic thiouridylase subunit
hsa:51478,3.04403305e-05,0.03771487501535434,0.00032820905865796996,0.0005641688592574273,0.0,0.0034451722,False,HSD17B7; hydroxysteroid 17-beta dehydrogenase
hsa:28965,0.0,0.0,2.205520006683168e-06,1.9956856973923167e-05,0.0,0.00028005292,False,SLC27A6; solute carrier family 27 member
hsa:5195,5.96368835e-08,7.388873808409362e-05,0.00011223503114059997,0.00042866367968325155,0.0,0.0026170898,False,PEX14; peroxisomal biogenesis factor
hsa:1650,8.456630699999999e-08,0.00010477572505380925,4.298643814294059e-05,0.00012106870661544683,0.0,0.0012382896,False,DDOST; dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic
hsa:2330,1.2651631499999999e-05,0.015675082790668773,0.0001132346841090347,0.0001923887588481628,0.0,0.0010895574,False,FMO5; flavin containing dimethylaniline monoxygenase
hsa:406952,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR17; microRNA
hsa:8525,1.183204585e-06,0.0014659634868573188,0.00012087532515183163,0.00031408556083670295,0.0,0.0022880812,False,DGKZ; diacylglycerol kinase
hsa:3910,0.0,0.0,0.0001233963194059406,0.000328929997317953,0.0,0.0023745275,False,LAMA4; laminin subunit alpha
hsa:85015,2.4300870999999997e-09,3.010822476218675e-06,6.595653982717721e-05,0.00026066728113437036,0.0,0.002038029,False,USP45; ubiquitin specific peptidase
hsa:1845,0.0,0.0,1.673328918094059e-07,4.381282210099364e-07,0.0,4.113223e-06,False,DUSP3; dual specificity phosphatase
hsa:5889,0.0,0.0,0.0001325367914819266,0.0003292993533326269,0.0,0.0018467506,False,RAD51C; RAD51 paralog
hsa:3773,0.0,0.0,1.408824169975248e-06,5.269197504556088e-06,0.0,6.183736e-05,False,KCNJ16; potassium inwardly rectifying channel subfamily J member
hsa:22863,1.4060088e-08,1.7420128261251408e-05,9.253917374242574e-07,4.862420828953913e-06,0.0,5.2786374e-05,False,ATG14; autophagy related
hsa:29920,2.8808421000000003e-06,0.003569297637569044,0.00014606401826014852,0.00022246618342938536,0.0,0.0012797046,False,PYCR2; pyrroline-5-carboxylate reductase
hsa:7188,4.3329140000000004e-06,0.005368381593697842,7.185176896430697e-05,0.0001613402076529549,0.0,0.0009518753,False,TRAF5; TNF receptor associated factor
hsa:10512,1.5107401e-08,1.8717725174562053e-05,3.206704573655594e-06,2.487858569716462e-05,0.0,0.00024754356,False,SEMA3C; semaphorin
hsa:101447996,0.0,0.0,0.0,0.0,0.0,0.0,False,RNVU1-8; RNA
hsa:2833,0.0,0.0,2.798061645521288e-05,8.604004310178597e-05,0.0,0.0007575851,False,CXCR3; C-X-C motif chemokine receptor
hsa:57403,5.0648026e-09,6.275174871588259e-06,3.709500372598514e-07,9.10655934483852e-07,0.0,9.041647e-06,False,RAB22A; RAB22A
hsa:50511,0.0,0.0,1.2282731850900149e-05,3.640315865089576e-05,0.0,0.00033742635,False,SYCP3; synaptonemal complex protein
hsa:128371,0.0,0.0,3.853973267326733e-09,5.4775251792614697e-08,0.0,7.785026e-07,False,OR6K6; olfactory receptor family 6 subfamily K member
hsa:347733,2.1786035499999998e-05,0.026992400951841584,0.0005916403896820099,0.0019279201003870516,0.0,0.014762564,False,TUBB2B; tubulin beta 2B class
hsa:838,0.0,0.0,2.0167323640099e-08,5.025649726014696e-08,0.0,4.3901227e-07,False,CASP5; caspase
hsa:10326,0.0,0.0,7.900804773562128e-06,2.881469858684743e-05,0.0,0.00023753969,False,SIRPB1; signal regulatory protein beta
hsa:441608,0.0,0.0,9.216896153465346e-08,1.1752698618436408e-06,-0.0,1.6643535e-05,False,OR5B3; olfactory receptor family 5 subfamily B member
hsa:4586,0.0,0.0,7.341446046039604e-08,4.1125058619575634e-07,0.0,3.9199927e-06,False,MUC5AC; mucin 5AC
hsa:8564,1.31457965e-08,1.628734195165136e-05,2.8353778842297026e-05,0.00010526262426813803,0.0,0.0009931886,False,KMO; kynurenine
hsa:7140,0.0,0.0,5.395118878827625e-08,3.4453153394801106e-07,0.0,3.9906295e-06,False,TNNT3; troponin T3
hsa:29941,1.21344785e-08,1.50343420221408e-05,1.4223643938316833e-07,2.7433051226213e-07,0.0,1.7231085e-06,False,PKN3; protein kinase
hsa:1576,0.0,0.0,2.1507307526831683e-05,6.746013660539111e-05,0.0,0.0005909761,False,CYP3A4; cytochrome P450 family 3 subfamily A member
hsa:4589,0.0,0.0,4.947224374579208e-07,2.8386854014970062e-06,0.0,2.5247162e-05,False,MUC7; mucin 7
hsa:27231,0.0,0.0,8.003332585915347e-06,4.7332955668228655e-05,0.0,0.000606722,False,NMRK2; nicotinamide riboside kinase
hsa:728957,0.0,0.0,1.128792377970297e-10,6.920373838727127e-10,0.0,7.3482673e-09,False,ZNF705D; zinc finger protein
hsa:10526,0.0,0.0,8.218543966470299e-08,3.051039303241927e-07,0.0,2.8544518e-06,False,IPO8; importin
hsa:8175,0.0,0.0,2.473768033648515e-07,4.3971704761439456e-07,0.0,1.8008177e-06,False,SF3A2; splicing factor 3a subunit
hsa:10130,2.62039545e-08,3.246610180121177e-05,1.6168877272143563e-06,4.914281395093623e-06,0.0,4.7296748e-05,False,PDIA6; protein disulfide isomerase family A member
hsa:2730,0.0,0.0,2.6507307633801973e-05,0.00019781416153465925,0.0,0.0024492873,False,GCLM; glutamate-cysteine ligase modifier
hsa:2653,2.72121685e-05,0.03371525594553785,9.812786343678219e-05,0.00018938794105678638,0.0,0.0009996253,False,GCSH; glycine cleavage system protein
hsa:80381,2.10442415e-07,0.0002607333510933571,1.0568169569193071e-05,2.2932596659954547e-05,0.0,0.0001477889,False,CD276; CD276
hsa:8837,0.0,0.0,3.237906869687129e-05,0.00011323889683963656,0.0,0.0010535805,False,CFLAR; CASP8 and FADD like apoptosis
hsa:4436,0.0,0.0,3.6163224881386136e-05,0.00010844682140863296,0.0,0.0010720856,False,MSH2; mutS homolog
hsa:85365,1.9138721e-08,2.3712438682909086e-05,1.3730796232529702e-05,6.76147639258536e-05,0.0,0.00060197734,False,ALG2; ALG2
hsa:1545,0.0,0.0,0.0004057051675128714,0.001196709407307624,0.0,0.0061970116,False,CYP1B1; cytochrome P450 family 1 subfamily B member
hsa:10554,4.56847445e-05,0.05660235617106379,0.00035659245738316826,0.0006540483568356438,0.0,0.003553826,False,AGPAT1; 1-acylglycerol-3-phosphate O-acyltransferase
hsa:51808,0.0,0.0,2.059977270087624e-07,3.08374250416552e-07,0.0,1.1324278e-06,False,PHAX; phosphorylated adaptor for RNA
hsa:23064,0.0,0.0,1.2614283108732672e-08,2.1188704098472153e-08,0.0,1.2161146e-07,False,SETX;
hsa:9887,0.0,0.0,1.8309166309603962e-07,4.909353435415618e-07,0.0,2.838206e-06,False,SMG7; SMG7 nonsense mediated mRNA decay
hsa:546,0.0,0.0,1.1895834497356439e-06,2.385181526881147e-06,0.0,1.1774501e-05,False,ATRX; ATRX chromatin
hsa:3858,6.00794965e-06,0.007443712549319784,0.00010116541213292078,0.00028256294230504967,0.0,0.0015860813,False,KRT10; keratin
hsa:219874,0.0,0.0,3.2700905336633667e-06,2.8389156705932927e-05,0.0,0.00028644287,False,OR6T1; olfactory receptor family 6 subfamily T member
hsa:629,0.0,0.0,8.767774088118813e-06,4.468288845158379e-05,0.0,0.00033351296,False,CFB; complement factor
hsa:406978,0.0,0.0,9.290522277227722e-10,1.3204313100309434e-08,0.0,1.8766855e-07,False,MIR199B; microRNA
hsa:101954266,0.0,0.0,4.020761345853465e-08,2.120093632833863e-07,0.0,2.2901465e-06,False,RNVU1-14; RNA
hsa:9128,3.3262845e-09,4.121190608722542e-06,1.3236883580346535e-07,3.869483940104718e-07,0.0,3.3333897e-06,False,PRPF4; pre-mRNA processing factor
hsa:7360,2.52471735e-05,0.031280671970478964,0.00022673885939108906,0.00036577663156186097,0.0,0.0019300656,False,UGP2; UDP-glucose pyrophosphorylase
hsa:118672,6.39954e-05,0.07928884059118893,0.00026062827768118805,0.0005759846700399474,0.0,0.0035033221,False,PSTK; phosphoseryl-tRNA
hsa:7562,0.0,0.0,6.568976884475248e-08,1.3575302234114137e-07,0.0,7.6123143e-07,False,ZNF708; zinc finger protein
hsa:23186,0.0,0.0,3.811486702871287e-08,8.209872845495059e-08,0.0,4.1967755e-07,False,RCOR1; REST corepressor
hsa:331,9.278956000000001e-05,0.11496414791323378,0.0005810528196108912,0.0011207998242009681,0.0,0.006033924,False,XIAP; X-linked inhibitor of
hsa:1143,1.0172115e-05,0.012603018415546145,4.135398828059405e-05,7.723147949196895e-05,0.0,0.0005712169,False,CHRNB4; cholinergic receptor nicotinic beta 4
hsa:5583,0.0,0.0,8.238369493158422e-05,0.00019345787765736723,0.0,0.0009780806,False,PRKCH; protein kinase C
hsa:343702,2.49923835e-07,0.00030964992973328716,0.00020147964091668348,0.0005003206058015194,0.0,0.002844902,False,XKR7; XK related
hsa:7743,6.06533865e-09,7.514816211031216e-06,6.974195900297025e-08,1.565319571427731e-07,0.0,1.3507092e-06,False,ZNF189; zinc finger protein
hsa:6066,0.0,0.0,9.88962958069307e-10,1.2274881621944876e-08,0.0,1.7427132e-07,False,RNU2-1; RNA
hsa:7019,4.7591785e-08,5.8965135842812715e-05,2.477353060362377e-06,4.750611838702202e-06,0.0,3.0156876e-05,False,TFAM; transcription factor A
hsa:846,0.0,0.0,8.669847212666337e-07,4.091608656259199e-06,0.0,4.8753456e-05,False,CASR; calcium sensing
hsa:81282,0.0,0.0,7.068758910891089e-10,1.0046594056266561e-08,-0.0,1.4278893e-07,False,OR51G2; olfactory receptor family 51 subfamily G member
hsa:27300,1.6695477e-08,2.068531510775558e-05,7.617766701831685e-08,1.4139013588306794e-07,0.0,1.3089884e-06,False,ZNF544; zinc finger protein
hsa:55660,1.67793105e-08,2.0789182901654848e-05,6.469751096435644e-07,1.7295138669317422e-06,0.0,1.0141793e-05,False,PRPF40A; pre-mRNA processing factor 40 homolog
hsa:6118,0.0,0.0,0.0001514979229502673,0.00037571521888466017,0.0,0.002677365,False,RPA2; replication protein
hsa:407042,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR34C; microRNA
hsa:2274,0.0,0.0,6.33401868551683e-05,0.00026676157472642364,0.0,0.0026162863,False,FHL2; four and a half LIM domains
hsa:55630,0.0,0.0,2.9694566505940608e-05,7.678391301988981e-05,0.0,0.00044507967,False,SLC39A4; solute carrier family 39 member
hsa:113835,0.0,0.0,1.5771154862529712e-08,3.467095568230717e-08,0.0,1.699763e-07,False,ZNF257; zinc finger protein
hsa:5608,1.75445e-05,0.021737235234909294,0.00014724348855445544,0.0003159959526535217,0.0,0.0020650441,False,MAP2K6; mitogen-activated protein kinase kinase
hsa:4125,0.0,0.0,3.106869842920791e-05,8.173942894345549e-05,0.0,0.00066387997,False,MAN2B1; mannosidase alpha class 2B member
hsa:64969,4.8083083999999995e-08,5.9573844095181013e-05,2.452870436392079e-07,4.6362560895600546e-07,0.0,3.7134348e-06,False,MRPS5; mitochondrial ribosomal protein
hsa:7337,0.0,0.0,1.1589952917737625e-06,2.3777578633603393e-06,0.0,1.0926673e-05,False,UBE3A; ubiquitin protein ligase
hsa:5506,0.0,0.0,2.165050010495049e-08,1.1597015510372586e-07,0.0,1.1723486e-06,False,PPP1R3A; protein phosphatase 1 regulatory subunit
hsa:51429,0.0,0.0,2.743531752790099e-07,9.76568930153132e-07,0.0,9.335622e-06,False,SNX9; sorting nexin
hsa:26762,0.0,0.0,5.2747781482277255e-06,1.5848308628304914e-05,0.0,0.00011231031,False,HAVCR1; hepatitis A virus cellular receptor
hsa:6628,0.0,0.0,0.00018069920677327478,0.0006574392731089385,0.0,0.0057269856,False,SNRPB; small nuclear ribonucleoprotein polypeptides B and
hsa:348,0.0,0.0,4.519298716420793e-05,0.00012957292396512503,0.0,0.00086677156,False,APOE; apolipoprotein
hsa:10627,0.0,0.0,2.9648745402574264e-05,9.168124134785189e-05,0.0,0.0005968415,False,MYL12A; myosin light chain
hsa:195814,0.0,0.0,5.5066310554361386e-06,2.8083847963280375e-05,0.0,0.00029952094,False,SDR16C5; short chain dehydrogenase/reductase family 16C member
hsa:219873,0.0,0.0,8.340153064356437e-08,8.750265470255568e-07,0.0,1.1350557e-05,False,OR10S1; olfactory receptor family 10 subfamily S member
hsa:51684,1.39490235e-05,0.017282521879607726,0.00010112848433465348,0.00016441497365367438,0.0,0.0010322104,False,SUFU; SUFU negative regulator of hedgehog
hsa:11051,0.0,0.0,2.2624225217574256e-07,6.08658996395602e-07,0.0,3.402848e-06,False,NUDT21; nudix hydrolase
hsa:2027,2.68902115e-06,0.0033316358567754174,8.172879009674747e-05,0.00017063000482992212,0.0,0.00095562317,False,ENO3; enolase
hsa:8529,-0.0,0.0,5.155487332620594e-06,4.1228058588213564e-05,-0.0,0.00052825996,False,CYP4F2; cytochrome P450 family 4 subfamily F member
hsa:1373,0.0,0.0,3.3270617675742576e-05,8.194679436506586e-05,0.0,0.0007824062,False,CPS1; carbamoyl-phosphate synthase
hsa:83943,6.02985865e-08,7.470857300481779e-05,4.174404197216584e-05,0.00015130668804651557,0.0,0.0013444285,False,IMMP2L; inner mitochondrial membrane peptidase subunit
hsa:5689,1.64859865e-06,0.0020425761157629964,5.032018019237624e-06,7.699193335333508e-06,0.0,3.8311016e-05,False,PSMB1; proteasome 20S subunit beta
hsa:4762,0.0,0.0,4.3506756863366333e-10,4.2162023507778495e-09,0.0,4.8033776e-08,False,NEUROG1; neurogenin
hsa:1672,7.68077525e-06,0.009516305303412423,0.0002018551048311882,0.0006028147194635223,0.0,0.006110297,False,DEFB1; defensin beta
hsa:10383,4.12102965e-06,0.005105861718036189,4.2703970610495034e-05,9.482143602666576e-05,0.0,0.000797762,False,TUBB4B; tubulin beta 4B class
hsa:5971,0.0,0.0,3.5583210839683164e-05,9.289616941495326e-05,0.0,0.00071492116,False,RELB; RELB proto-oncogene
hsa:22934,1.3109542500000001e-08,1.6242424072760175e-05,3.7177355119747024e-05,0.00010811002786701544,0.0,0.0006673321,False,RPIA; ribose 5-phosphate isomerase
hsa:3906,0.0,0.0,1.1970505542574257e-07,7.878758668060763e-07,-0.0,9.200937e-06,False,LALBA; lactalbumin
hsa:688,9.080986e-09,1.1251134477865885e-05,1.7818865484579215e-07,4.4886570163176825e-07,0.0,3.3036504e-06,False,KLF5; KLF transcription factor
hsa:727936,1.92514525e-07,0.00023852110439521367,3.0802320412466844e-05,0.00016750152954314904,0.0,0.001611364,False,GXYLT2; glucoside xylosyltransferase
hsa:64834,0.0,0.0,7.717295713108913e-05,0.0004024936785870786,0.0,0.004332439,False,ELOVL1; ELOVL fatty acid elongase
hsa:345611,0.0,0.0,1.6576883710123765e-06,7.589618875272967e-06,0.0,5.859575e-05,False,IRGM; immunity related GTPase
hsa:113612,2.1843482e-06,0.00270635758547412,4.0552601481534624e-05,0.00011584586795079904,0.0,0.0008166831,False,CYP2U1; cytochrome P450 family 2 subfamily U member
hsa:7380,0.0,0.0,6.700922766696041e-06,2.3036939312381377e-05,0.0,0.00018834854,False,UPK3A; uroplakin
hsa:762,0.0,0.0,6.302711215772278e-05,0.00014598401189956406,0.0,0.0009305319,False,CA4; carbonic anhydrase
hsa:53981,0.0,0.0,1.3319341053745543e-07,3.3189560404802453e-07,0.0,1.7759787e-06,False,CPSF2; cleavage and polyadenylation specific factor
hsa:9415,5.0074307000000005e-06,0.006204092396386704,0.00011470930530876239,0.0005243614964775634,0.0,0.0055145454,False,FADS2; fatty acid desaturase
hsa:10288,0.0,0.0,5.56557496128713e-06,1.3328308141934574e-05,0.0,9.148787e-05,False,LILRB2; leukocyte immunoglobulin like receptor
hsa:2788,0.0,0.0,0.00013354339762376236,0.0003739522786044229,0.0,0.001963459,False,GNG7; G protein subunit gamma
hsa:406922,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR133A1; microRNA
hsa:23200,9.8372535e-09,1.2188132656669315e-05,8.343260743485705e-05,0.0001960608551470027,0.0,0.0009724291,False,ATP11B; ATPase phospholipid transporting 11B
hsa:2065,0.0,0.0,9.802820411871285e-06,4.011317347372056e-05,0.0,0.00031868825,False,ERBB3; erb-b2 receptor tyrosine kinase
hsa:83706,0.0,0.0,4.4548418378465344e-07,1.003561288424705e-06,0.0,6.298946e-06,False,FERMT3; FERM domain containing kindlin
hsa:25796,0.0,0.0,4.8534112566069306e-05,0.0001661959756554919,0.0,0.0010450884,False,PGLS;
hsa:90827,0.0,0.0,4.824588869158416e-10,2.873831449777719e-09,0.0,2.9366955e-08,False,ZNF479; zinc finger protein
hsa:5831,2.2628031e-08,2.803561416682264e-05,0.0001477118058581391,0.00032842902938916806,0.0,0.0024931422,False,PYCR1; pyrroline-5-carboxylate reductase
hsa:10093,1.41045885e-07,0.0001747526336550466,1.992181296830694e-05,5.745253790541571e-05,0.0,0.0004681725,False,ARPC4; actin related protein 2/3 complex subunit
hsa:6513,0.0,0.0,0.00010925797792574258,0.000295044418938377,0.0,0.002616272,False,SLC2A1; solute carrier family 2 member
hsa:143471,0.0,0.0,4.880720348282178e-08,1.9254249595607777e-07,0.0,1.8171875e-06,False,PSMA8; proteasome 20S subunit alpha
hsa:2532,0.0,0.0,1.7646128281831684e-05,4.77496947245242e-05,0.0,0.00035669268,False,ACKR1; atypical chemokine receptor 1 (Duffy blood
hsa:5861,0.0,0.0,3.07576004655792e-05,6.804917472310729e-05,0.0,0.00038000144,False,RAB1A; RAB1A
hsa:284309,1.2142959e-10,1.504484916816432e-07,7.47569516711881e-08,1.440677390561671e-07,0.0,9.607387e-07,False,ZNF776; zinc finger protein
hsa:3061,0.0,0.0,4.548871640698269e-06,1.715523312832067e-05,0.0,0.00018105003,False,HCRTR1; hypocretin receptor
hsa:814,7.80357975e-06,0.00966845727721649,0.00040249471599158415,0.0008062871799086681,0.0,0.0050067306,False,CAMK4; calcium/calmodulin dependent protein kinase
hsa:79837,0.0,0.0,6.548315834324754e-05,0.0002015792411365137,0.0,0.0013866089,False,PIP4K2C; phosphatidylinositol-5-phosphate 4-kinase type 2
hsa:27090,0.0,0.0,0.00013626778138514854,0.00048359378063247467,0.0,0.00494344,False,ST6GALNAC4; ST6 N-acetylgalactosaminide alpha-2
hsa:28973,4.58799165e-08,5.684416982635563e-05,2.001862324257426e-07,2.997249037395876e-07,0.0,1.7144184e-06,False,MRPS18B; mitochondrial ribosomal protein
hsa:79784,0.0,0.0,5.473638119809407e-06,2.8777742681865174e-05,0.0,0.0002690475,False,MYH14; myosin heavy chain
hsa:26692,0.0,0.0,7.685623762376236e-08,8.636829351114487e-07,-0.0,1.2079864e-05,False,OR2W1; olfactory receptor family 2 subfamily W member
hsa:390155,0.0,0.0,0.0,0.0,0.0,0.0,False,OR5T1; olfactory receptor family 5 subfamily T member
hsa:11197,0.0,0.0,2.974485237653466e-07,2.816588414326312e-06,0.0,3.959029e-05,False,WIF1; WNT inhibitory factor
hsa:4731,0.0,0.0,1.2813703222475249e-06,2.882588537841367e-06,0.0,1.8315954e-05,False,NDUFV3; NADH:ubiquinone oxidoreductase subunit
hsa:10686,0.0,0.0,3.195858705232674e-07,2.2792367303239005e-06,0.0,2.6620115e-05,False,CLDN16; claudin
hsa:468,0.0,0.0,0.0004040826294356436,0.0006280356636418819,0.0,0.0036111106,False,ATF4; activating transcription factor
hsa:123041,0.0,0.0,2.487040226049505e-05,0.00015725005924059052,0.0,0.0020103368,False,SLC24A4; solute carrier family 24 member
hsa:55334,0.0,0.0,7.525022154988117e-08,2.130178912599598e-07,0.0,1.7948832e-06,False,SLC39A9; solute carrier family 39 member
hsa:644672,0.0,0.0,9.547879905940593e-08,7.106016381454807e-07,0.0,7.069582e-06,False,CLDN25; claudin
hsa:406983,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR200A; microRNA
hsa:7915,2.1857547e-05,0.02708100206885839,0.00021641914105321783,0.00047933760417673645,0.0,0.0029692396,False,ALDH5A1; aldehyde dehydrogenase 5 family member
hsa:9668,0.0,0.0,5.6008091080990114e-08,9.48873403993884e-08,0.0,4.4273818e-07,False,ZNF432; zinc finger protein
hsa:4485,0.0,0.0,1.5086918717067331e-05,6.134205048239911e-05,0.0,0.0005265333,False,MST1; macrophage stimulating
hsa:3448,0.0,0.0,2.5609574014851488e-06,1.0285457229566631e-05,0.0,8.4369516e-05,False,IFNA14; interferon alpha
hsa:5826,0.0,0.0,0.00029492581694554444,0.0008726447410992787,0.0,0.008697783,False,ABCD4; ATP binding cassette subfamily D member
hsa:1438,0.0,0.0,5.3805645638321774e-05,0.0002180208147518053,0.0,0.0021079343,False,CSF2RA; colony stimulating factor 2 receptor subunit
hsa:3714,3.9582353e-05,0.04904163232421657,0.0002069732209398019,0.00034443601455434703,0.0,0.0019617728,False,JAG2; jagged canonical Notch ligand
hsa:1947,0.0,0.0,1.0996770155297028e-06,8.876371791628416e-06,0.0,0.00011794205,False,EFNB1; ephrin
hsa:7652,0.0,0.0,4.405704776727723e-09,1.7858173764619307e-08,0.0,1.9544152e-07,False,ZNF99; zinc finger protein
hsa:442902,0.0,0.0,0.0,0.0,0.0,0.0,False,MIR330; microRNA
hsa:55278,0.0,0.0,1.229982181765347e-06,4.824506206446227e-06,0.0,5.4227097e-05,False,QRSL1; glutaminyl-tRNA amidotransferase subunit
hsa:23152,0.0,0.0,1.7132158103069318e-07,4.2639163034700185e-07,0.0,2.0918922e-06,False,CIC; capicua transcriptional
hsa:346171,0.0,0.0,7.074172146079203e-09,2.391558198078865e-08,0.0,1.6801262e-07,False,ZFP57; ZFP57 zinc finger
hsa:100289462,0.0,0.0,1.0576380198019801e-09,1.503186058171086e-08,0.0,2.1364288e-07,False,DEFB4B; defensin beta
hsa:9734,3.8530012499999997e-07,0.00047737806453104705,2.8195975752415844e-05,9.954969485901071e-05,0.0,0.0008408999,False,HDAC9; histone deacetylase
hsa:7307,0.0,0.0,1.981962618856436e-06,6.969393500541681e-06,0.0,4.0828225e-05,False,U2AF1; U2 small nuclear RNA auxiliary factor
